activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	129351	CHEMBL704118	Inhibition of Janus kinase 3	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	129351	CHEMBL704118	Inhibition of Janus kinase 3	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	506157	CHEMBL872505	Inhibition of protein kinase Jak 3	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	uM	0.005
	512200	CHEMBL704115	Inhibition of Jak3 kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	=	IC50	nM	44.0	CHEMBL2148	Homo sapiens	IC50	uM	0.044
	592735	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(NC(=O)c3ccccc3)cc2/C1=C/c1ccc[nH]1		CHEMBL104409	=	IC50	nM	870.0	CHEMBL2148	Homo sapiens	IC50	uM	0.87
	596590	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1ccc[nH]1		CHEMBL107225	=	IC50	nM	213.0	CHEMBL2148	Homo sapiens	IC50	uM	0.213
	597821	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	IC50	nM	900.0	CHEMBL2148	Homo sapiens	IC50	uM	0.9
	600307	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	CN(C)C(=O)c1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL421213	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	uM	0.21
	601569	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)c3cccs3)cc2/C1=C/C(=O)c1ccc[nH]1		CHEMBL106961	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	uM	0.26
	602753	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)c3cccs3)cc2/C1=C/c1ccc(F)cc1		CHEMBL107273	=	IC50	nM	4900.0	CHEMBL2148	Homo sapiens	IC50	uM	4.9
	602754	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ncc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL320646	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	uM	0.35
	609005	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C/c1ccc[nH]1		CHEMBL87325	=	IC50	nM	710.0	CHEMBL2148	Homo sapiens	IC50	uM	0.71
	611293	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	CC(=O)Nc1ccc(/C=C2\C(=O)Nc3ccc(C(=O)c4cccs4)cc32)cc1		CHEMBL104062	=	IC50	nM	700.0	CHEMBL2148	Homo sapiens	IC50	uM	0.7
	612549	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL106944	=	IC50	nM	168.0	CHEMBL2148	Homo sapiens	IC50	uM	0.168
	617952	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)c3cccs3)cc2/C1=C/c1ccccc1		CHEMBL321855	=	IC50	nM	2300.0	CHEMBL2148	Homo sapiens	IC50	uM	2.3
	619248	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	CS(=O)(=O)c1ccc(/C=C2\C(=O)Nc3ccc(C(=O)c4cccs4)cc32)cc1		CHEMBL104640	=	IC50	nM	7100.0	CHEMBL2148	Homo sapiens	IC50	uM	7.1
	621513	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(O)c3cccs3)cc2/C1=C/c1ccc[nH]1		CHEMBL107166	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	uM	0.19
	624103	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(C(=O)c3cccs3)cc2/C1=C/c1ccc[nH]1		CHEMBL104963	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	uM	0.026
	624104	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(-c3cccnc3)nc2/C1=C/c1ccc[nH]1		CHEMBL318390	=	IC50	nM	235.0	CHEMBL2148	Homo sapiens	IC50	uM	0.235
Active	624106	CHEMBL704114	Inhibition of Janus kinase 3 phosphorylation at 3 uM	F	O=C1Nc2ccc(-c3cccnc3)nc2/C1=C/c1ccc[nH]1		CHEMBL318390		Inhibition	%		CHEMBL2148	Homo sapiens	Inhibition	%	
	626621	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL323994	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	uM	0.027
Active	626623	CHEMBL704114	Inhibition of Janus kinase 3 phosphorylation at 3 uM	F	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL323994		Inhibition	%		CHEMBL2148	Homo sapiens	Inhibition	%	
	626630	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	O=C1Nc2cnc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL106571	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	uM	0.03
Active	626632	CHEMBL704114	Inhibition of Janus kinase 3 phosphorylation at 3 uM	F	O=C1Nc2cnc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL106571		Inhibition	%		CHEMBL2148	Homo sapiens	Inhibition	%	
	631785	CHEMBL704113	Inhibitory activity against Janus Kinase 3 protein tyrosine kinase.	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccc(C(=O)c4cccs4)cc32)cc1		CHEMBL105255	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	uM	0.2
	946873	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O/N=C(/CCN1CCOCC1)c1ccc2ccccc2c1	Outside typical range	CHEMBL544174	<	IC50	nM	1000000000000.0	CHEMBL2148	Homo sapiens	Log IC50		3.0
	949419	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(CCN1CCOCC1)c1ccc2ccc3ccccc3c2c1	Outside typical range	CHEMBL543228	=	IC50	nM	1995262314968882.8	CHEMBL2148	Homo sapiens	Log IC50		6.3
	952146	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	COc1cc2ccc(C(=O)CCN3CCOCC3)cc2cc1OC.Cl	Outside typical range	CHEMBL542762	=	IC50	nM	5011872336272.71	CHEMBL2148	Homo sapiens	Log IC50		3.7
	953462	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(CCN1CCOCC1)c1ccc2ccccc2c1	Outside typical range	CHEMBL543939	=	IC50	nM	501187233627271.44	CHEMBL2148	Homo sapiens	Log IC50		5.7
	953463	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(CCN1CCCCCC1)c1ccc2ccccc2c1	Outside typical range	CHEMBL544872	=	IC50	nM	1258925411794166.2	CHEMBL2148	Homo sapiens	Log IC50		6.1
	958772	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1	Outside typical range	CHEMBL56543	=	IC50	nM	79432823472428.22	CHEMBL2148	Homo sapiens	Log IC50		4.9
	958773	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=c1c(CN2CCOCC2)coc2cc3ccccc3cc12	Outside typical range	CHEMBL542023	<	IC50	nM	1000000000000.0	CHEMBL2148	Homo sapiens	Log IC50		3.0
	961095	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(CCNCc1ccccc1)c1ccc2ccccc2c1	Outside typical range	CHEMBL540593	<	IC50	nM	1000000000000.0	CHEMBL2148	Homo sapiens	Log IC50		3.0
	963608	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	CN(C)CCC(=O)c1ccc2ccccc2c1.Cl	Outside typical range	CHEMBL541346	=	IC50	nM	1584893192461111.0	CHEMBL2148	Homo sapiens	Log IC50		6.2
	965077	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	C=CC(O)c1ccc2ccccc2c1	Outside typical range	CHEMBL154693	=	IC50	nM	1995262314968.88	CHEMBL2148	Homo sapiens	Log IC50		3.3
	967650	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	C/C(=C\c1ccccc1)C(=O)CCN1CCOCC1.Cl	Outside typical range	CHEMBL543226	=	IC50	nM	79432823472428.22	CHEMBL2148	Homo sapiens	Log IC50		4.9
	972647	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1.Cl	Outside typical range	CHEMBL538798	=	IC50	nM	12589254117941714	CHEMBL2148	Homo sapiens	Log IC50		7.1
	972652	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(/C=C/c1ccccc1Cl)CCN1CCOCC1	Outside typical range	CHEMBL225385	=	IC50	nM	79432823472428.22	CHEMBL2148	Homo sapiens	Log IC50		4.9
	972653	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	CC(C)(CN1CCOCC1)C(=O)c1ccc2ccccc2c1.Cl	Outside typical range	CHEMBL541100	<	IC50	nM	1000000000000.0	CHEMBL2148	Homo sapiens	Log IC50		3.0
	978693	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	C=CC(=O)c1ccc2ccccc2c1	Outside typical range	CHEMBL154580	=	IC50	nM	12589254117941714	CHEMBL2148	Homo sapiens	Log IC50		7.1
	980128	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	COc1ccc2cc(C(=O)CCN3CCOCC3)ccc2c1.Cl	Outside typical range	CHEMBL542522	=	IC50	nM	63095734448019.43	CHEMBL2148	Homo sapiens	Log IC50		4.8
	981267	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	Cl.O=C(CCN1CCOCC1)c1cccc2ccccc12	Outside typical range	CHEMBL552585	=	IC50	nM	316227766016837.94	CHEMBL2148	Homo sapiens	Log IC50		5.5
	984992	CHEMBL704117	In vitro inhibition of Janus kinase 3.	B	O=C(CCCN1CCOCC1)c1ccc2ccccc2c1	Outside typical range	CHEMBL154877	<	IC50	nM	1000000000000.0	CHEMBL2148	Homo sapiens	Log IC50		3.0
	1257905	CHEMBL704116	Inhibition of Janus kinase 3	B	COc1cc2ncc(N[C@H]3CC[C@H](O)CC3)nc2cc1OC		CHEMBL104466	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	uM	50.0
	1460072	CHEMBL827042	inhibitory activity against Janus kinase 3	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	uM	0.006
	1606833	CHEMBL882901	Inhibitory concentration against JAK3	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	uM	50.0
	1663209	CHEMBL863890	Inhibitory activity against JAK3	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	1678208	CHEMBL862106	Inhibitory activity against JAK3	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	1699827	CHEMBL860745	Inhibitory activity against JAK3	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
	1723352	CHEMBL861309	Inhibition of JAK3	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1723619	CHEMBL861309	Inhibition of JAK3	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1723620	CHEMBL861309	Inhibition of JAK3	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1723621	CHEMBL861309	Inhibition of JAK3	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1723622	CHEMBL861309	Inhibition of JAK3	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1723623	CHEMBL861309	Inhibition of JAK3	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	1744438	CHEMBL866118	Inhibition of JAK3	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	uM	1.7
	1744564	CHEMBL866182	Inhibition of JAK3	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
	1748675	CHEMBL870361	Inhibition of JAK3	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	uM	1.2
	1765221	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212964	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	1765222	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NC3CC3)ncc2c1		CHEMBL212181	=	IC50	nM	331.0	CHEMBL2148	Homo sapiens	IC50	nM	331.0
	1765223	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(Nc3ccccc3)ncc2c1		CHEMBL215863	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	1765224	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NC3CCN(C)CC3)ncc2c1		CHEMBL215691	>	IC50	nM	8333.0	CHEMBL2148	Homo sapiens	IC50	nM	8333.0
	1765225	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCCC3)ncc2c1		CHEMBL214556	>	IC50	nM	8333.0	CHEMBL2148	Homo sapiens	IC50	nM	8333.0
	1765226	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCCCC3)ncc2c1		CHEMBL384942	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	1765227	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(N(C)CCCN3CCOCC3)ncc2c1		CHEMBL212195	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	1765228	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCCN3CCOCC3)ncc2c1		CHEMBL214530	=	IC50	nM	2189.0	CHEMBL2148	Homo sapiens	IC50	nM	2189.0
	1765229	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL213290	=	IC50	nM	626.0	CHEMBL2148	Homo sapiens	IC50	nM	626.0
	1765230	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	=	IC50	nM	72.0	CHEMBL2148	Homo sapiens	IC50	nM	72.0
	1765231	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(N)ncc2c1		CHEMBL215813	=	IC50	nM	557.0	CHEMBL2148	Homo sapiens	IC50	nM	557.0
	1765232	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	1765233	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	Cc1ccccc1-c1ccc2nc(N)ncc2c1		CHEMBL215952	=	IC50	nM	9819.0	CHEMBL2148	Homo sapiens	IC50	nM	9819.0
	1765234	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(Nc4nc5cc(C(F)(F)F)ccc5[nH]4)ccc3C)ccc2n1		CHEMBL213478	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	1765235	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(NC(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL424719	=	IC50	nM	1141.0	CHEMBL2148	Homo sapiens	IC50	nM	1141.0
	1765236	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212128	=	IC50	nM	154.0	CHEMBL2148	Homo sapiens	IC50	nM	154.0
	1765237	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CC(C)(C)C4=O)ccc3C)ccc2n1		CHEMBL385055	=	IC50	nM	193.0	CHEMBL2148	Homo sapiens	IC50	nM	193.0
	1765238	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CCN(CC)CC(=O)Nc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(-c2ccc3nc(NC)ncc3c2)c1		CHEMBL212953	>	IC50	nM	8333.0	CHEMBL2148	Homo sapiens	IC50	nM	8333.0
	1765239	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4NC(=O)NCCN4CCOCC4)ccc3C)ccc2n1		CHEMBL213831	=	IC50	nM	722.0	CHEMBL2148	Homo sapiens	IC50	nM	722.0
	1765240	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CCN(C)C4=O)ccc3C)ccc2n1		CHEMBL385598	=	IC50	nM	987.0	CHEMBL2148	Homo sapiens	IC50	nM	987.0
	1765241	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CCCCC4)ccc3C)ccc2n1		CHEMBL214495	=	IC50	nM	253.0	CHEMBL2148	Homo sapiens	IC50	nM	253.0
	1765242	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	=	IC50	nM	868.0	CHEMBL2148	Homo sapiens	IC50	nM	868.0
	1765243	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4C)ccc3C)ccc2n1		CHEMBL212183	=	IC50	nM	106.0	CHEMBL2148	Homo sapiens	IC50	nM	106.0
	1765244	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL215019	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	1765245	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(OC5CCN(C)CC5)cc4)ccc3C)ccc2n1		CHEMBL427226	>	IC50	nM	8333.0	CHEMBL2148	Homo sapiens	IC50	nM	8333.0
	1765246	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc5c4CCC5)ccc3C)ccc2n1		CHEMBL427233	=	IC50	nM	1339.0	CHEMBL2148	Homo sapiens	IC50	nM	1339.0
	1765247	CHEMBL853499	Inhibition of Jak3 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4C)ccc3C)ccc2n1		CHEMBL215969	=	IC50	nM	133.0	CHEMBL2148	Homo sapiens	IC50	nM	133.0
	1790561	CHEMBL856418	Inhibition of human recombinant JAK3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	Ki	uM	10.0
	1807584	CHEMBL908417	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	1807586	CHEMBL908417	Inhibition of JAK3	B	COC[C@H](C)Nc1cc(-c2ccoc2)nc(-n2cnc3ccncc32)n1.Cl		CHEMBL557844	=	IC50	nM	51.0	CHEMBL2148	Homo sapiens	IC50	nM	51.0
	1807587	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2ccoc2)nc(-n2cnc3ccncc32)n1)c1ccc(F)cc1		CHEMBL221378	=	IC50	nM	83.0	CHEMBL2148	Homo sapiens	IC50	nM	83.0
	1807588	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2ccoc2)nc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1		CHEMBL375205	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	1807589	CHEMBL908417	Inhibition of JAK3	B	COC[C@H](C)Nc1cc(-c2ccoc2)nc(-n2cnc3ccncc32)n1		CHEMBL220484	=	IC50	nM	165.0	CHEMBL2148	Homo sapiens	IC50	nM	165.0
	1807590	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2cccc(C#N)c2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL220969	=	IC50	nM	167.0	CHEMBL2148	Homo sapiens	IC50	nM	167.0
	1807591	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2ccc(C#N)cc2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL374321	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
	1807592	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2cnn(C)c2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL221376	=	IC50	nM	245.0	CHEMBL2148	Homo sapiens	IC50	nM	245.0
	1807593	CHEMBL908417	Inhibition of JAK3	B	COc1ccc(-c2cc(N[C@@H](C)c3ccccc3)nc(-n3cnc4ccncc43)n2)cc1OC		CHEMBL220483	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	1807594	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2cccc(N(C)C)c2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL373523	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	nM	470.0
	1807595	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2ccc(N(C)C)cc2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL384820	=	IC50	nM	62.0	CHEMBL2148	Homo sapiens	IC50	nM	62.0
	1807596	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(-c2ccoc2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL222027	=	IC50	nM	60.0	CHEMBL2148	Homo sapiens	IC50	nM	60.0
	1807597	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(N2CC[C@@H](O)C2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL221037	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
	1807598	CHEMBL908417	Inhibition of JAK3	B	CN1CCN(c2cc(Nc3ccccc3Cl)nc(-n3cnc4ccncc43)n2)CC1		CHEMBL376885	=	IC50	nM	131.0	CHEMBL2148	Homo sapiens	IC50	nM	131.0
	1807599	CHEMBL908417	Inhibition of JAK3	B	CN1CCN(c2cc(Oc3c(F)cccc3F)nc(-n3cnc4ccncc43)n2)CC1		CHEMBL385114	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
	1807600	CHEMBL908417	Inhibition of JAK3	B	CN1CCN(c2cc(Oc3ccccc3Cl)nc(-n3cnc4ccncc43)n2)CC1		CHEMBL218439	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	1807601	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(N2CCN(C)CC2)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL375296	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	nM	61.0
	1807602	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1cc(N(C)C)nc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL218579	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	1807603	CHEMBL908417	Inhibition of JAK3	B	COC[C@H](C)Nc1ccnc(-n2cnc3ccc(C#N)cc32)n1		CHEMBL221912	=	IC50	nM	45.0	CHEMBL2148	Homo sapiens	IC50	nM	45.0
	1807604	CHEMBL908417	Inhibition of JAK3	B	Cc1nc2ccncc2n1-c1nccc(N[C@@H](C)c2ccccc2)n1		CHEMBL217937	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	1807605	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1ccnc(-n2ccc3ccncc32)n1)c1ccccc1		CHEMBL222028	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	1807606	CHEMBL908417	Inhibition of JAK3	B	C[C@@H](Nc1nccc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL375076	=	IC50	nM	145.0	CHEMBL2148	Homo sapiens	IC50	nM	145.0
	1807607	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1ccnc(-n2cnc3cnccc32)n1)c1ccccc1		CHEMBL220585	=	IC50	nM	700.0	CHEMBL2148	Homo sapiens	IC50	nM	700.0
	1807608	CHEMBL908417	Inhibition of JAK3	B	c1ccc2c(c1)CCC[C@@H]2Nc1ccnc(-n2cnc3ccncc32)n1		CHEMBL221038	=	IC50	nM	9097.0	CHEMBL2148	Homo sapiens	IC50	nM	9097.0
	1807609	CHEMBL908417	Inhibition of JAK3	B	C[C@@H](c1ccccc1)N(C)c1ccnc(-n2cnc3ccncc32)n1		CHEMBL218602	=	IC50	nM	860.0	CHEMBL2148	Homo sapiens	IC50	nM	860.0
	1807610	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1ccnc(-n2cnc3ccncc32)n1)c1ccc(Cl)cc1		CHEMBL218746	=	IC50	nM	1928.0	CHEMBL2148	Homo sapiens	IC50	nM	1928.0
	1807611	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1ccnc(-n2cnc3ccncc32)n1)c1ccc(F)cc1		CHEMBL221976	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
	1807612	CHEMBL908417	Inhibition of JAK3	B	C[C@H](Nc1ccnc(-n2cnc3ccncc32)n1)c1ccccc1		CHEMBL221029	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	1807613	CHEMBL908417	Inhibition of JAK3	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C/c1ccc[nH]1		CHEMBL323994	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	1807643	CHEMBL908417	Inhibition of JAK3	B	c1ccc(CNc2ccnc(-n3cnc4ccncc43)n2)cc1		CHEMBL374854	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	1815209	CHEMBL908518	Inhibition of Jak3	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	1815350	CHEMBL910183	Inhibition of Jak3	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	1700.0	CHEMBL2148	Homo sapiens	IC50	nM	1700.0
	1824607	CHEMBL914326	Inhibition of JAK3	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	Ki	uM	10.0
	1824733	CHEMBL914326	Inhibition of JAK3	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	Ki	uM	10.0
	1824804	CHEMBL914326	Inhibition of JAK3	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	Ki	uM	10.0
	1838312	CHEMBL904281	Inhibition of JAK3	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCN(C)CC3)n2)c1		CHEMBL225088	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	1898418	CHEMBL887691	Inhibition of JAK3	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL2148	Homo sapiens	Activity	uM	10.0
	1956274	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(O)C3		CHEMBL234086	=	IC50	nM	142.0	CHEMBL2148	Homo sapiens	IC50	nM	142.0
	1956275	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(/C=C/Cn4ccnc4)ccc3n3c1c1c2c2cc(CO)ccc2n1CC(CO)C3		CHEMBL234066	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	1956276	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CN(C)CCCNC(=O)/C=C/c1ccc2c(c1)c1c3c(c4c5ccccc5n5c4c1n2CC(CO)C5)CNC3=O		CHEMBL233856	=	IC50	nM	237.0	CHEMBL2148	Homo sapiens	IC50	nM	237.0
	1956277	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C(O)/C=C/c1ccc2c(c1)c1c3c(c4c5ccccc5n5c4c1n2CC(CO)C5)CNC3=O		CHEMBL233854	=	IC50	nM	686.0	CHEMBL2148	Homo sapiens	IC50	nM	686.0
	1956278	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(/C=C/CNC4=NCCN4)ccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL388221	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	1956279	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(/C=C/Cn4ccnc4)ccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL243018	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	1956280	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(/C=C/n4ccnc4)ccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL388220	=	IC50	nM	109.0	CHEMBL2148	Homo sapiens	IC50	nM	109.0
	1956281	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	Cc1ncsc1/C=C/c1ccc2c(c1)c1c3c(c4c5ccccc5n5c4c1n2CC(CO)C5)CNC3=O		CHEMBL245172	=	IC50	nM	592.0	CHEMBL2148	Homo sapiens	IC50	nM	592.0
	1956282	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(/C=C/c4ccccn4)ccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL243016	=	IC50	nM	354.0	CHEMBL2148	Homo sapiens	IC50	nM	354.0
	1956283	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(CN4CCOCC4)ccc3n3c1c1c2c2cc(CN4CCOCC4)ccc2n1CC(CO)C3		CHEMBL389797	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	uM	5.0
	1956284	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c5cc(COC(C)C)ccc5n5c4c1n2CC(CO)C5)C(=O)NC3		CHEMBL243015	=	IC50	nM	1050.0	CHEMBL2148	Homo sapiens	IC50	uM	1.05
	1956285	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(CO)ccc3n3c1c1c2c2cc(CO)ccc2n1CC(CO)C3		CHEMBL232033	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	1956286	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(Br)ccc3n3c1c1c2c2cc(CN4CCOCC4)ccc2n1CC(CO)C3		CHEMBL396213	=	IC50	nM	3130.0	CHEMBL2148	Homo sapiens	IC50	uM	3.13
	1956287	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c5cc(Br)ccc5n5c4c1n2CC(CO)C5)C(=O)NC3		CHEMBL231822	=	IC50	nM	70.0	CHEMBL2148	Homo sapiens	IC50	nM	70.0
	1956288	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=Cc1ccc2c(c1)c1c3c(c4c5cc(Br)ccc5n5c4c1n2CC(CO)C5)C(=O)NC3		CHEMBL231821	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	1956289	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3cc(Br)ccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL397664	=	IC50	nM	23.5	CHEMBL2148	Homo sapiens	IC50	nM	23.5
	1956290	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CN(C)Cc1ccc2c(c1)c1c3c(c4c5ccccc5n5c4c1n2CC(CO)C5)C(=O)NC3		CHEMBL234937	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	nM	250.0
	1956291	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c5ccccc5n5c4c1n2CC(CO)C5)C(=O)NC3		CHEMBL397663	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
	1956292	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2cc(CO)ccc2n1CC(CO)C3		CHEMBL234936	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	1956293	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(CO)C3		CHEMBL396449	=	IC50	nM	17.5	CHEMBL2148	Homo sapiens	IC50	nM	17.5
	1956294	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(O)(CO)C3		CHEMBL234718	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	1956295	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	C=C1Cn2c3ccccc3c3c4c(c5c6ccccc6n(c5c32)C1)C(=O)NC4		CHEMBL396194	=	IC50	nM	72.0	CHEMBL2148	Homo sapiens	IC50	nM	72.0
	1956296	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(=C(CO)CO)C3		CHEMBL234293	=	IC50	nM	36.0	CHEMBL2148	Homo sapiens	IC50	nM	36.0
	1956297	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(CO)(CO)C3		CHEMBL234292	=	IC50	nM	13.5	CHEMBL2148	Homo sapiens	IC50	nM	13.5
	1956298	CHEMBL889938	Inhibition of JAK3 expressed in Sf21 cells	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	1964021	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	1964022	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	CN1CCN(C(=O)c2cc3c(NCc4ccccc4F)nc(-n4cnc5ccncc54)nc3n2C)CC1		CHEMBL231925	=	IC50	nM	3050.0	CHEMBL2148	Homo sapiens	IC50	nM	3050.0
	1964023	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)N1CCN(C)CC1)n2C)c1ccccc1		CHEMBL392371	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
	1964024	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	CN1CCN(C(=O)c2cc3c(NC(C)(C)C)nc(-n4cnc5ccncc54)nc3n2C)CC1		CHEMBL232149	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
	1964025	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)NS(=O)(=O)c1ccccc1)n2C)c1ccccc1		CHEMBL392998	=	IC50	nM	143.0	CHEMBL2148	Homo sapiens	IC50	nM	143.0
	1964026	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)N1CCN(C)CC1)n2C)C(C)(C)O		CHEMBL232147	=	IC50	nM	142.0	CHEMBL2148	Homo sapiens	IC50	nM	142.0
	1964027	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	COc1ccc(Cl)c(Nc2nc(-n3cnc4ccncc43)nc3c2cc(C(=O)N2CCN(C)CC2)n3C)c1		CHEMBL393375	=	IC50	nM	142.0	CHEMBL2148	Homo sapiens	IC50	nM	142.0
	1964028	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	COC[C@H](C)Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)N1CCN(C)CC1)n2C		CHEMBL231949	=	IC50	nM	126.0	CHEMBL2148	Homo sapiens	IC50	nM	126.0
	1964029	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	COCCNC(=O)c1cc2c(N[C@@H](C)c3ccccc3)nc(-n3cnc4ccncc43)nc2n1C		CHEMBL231948	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	nM	77.0
	1964030	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)NCCCn1ccnc1)n2C)c1ccccc1		CHEMBL231733	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
	1964031	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)N1CCOCC1)n2C)c1ccccc1		CHEMBL391096	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	1964032	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)NCCCN1CCOCC1)n2C)c1ccccc1		CHEMBL233969	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	1964033	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)NS(C)(=O)=O)n2C)c1ccccc1		CHEMBL394174	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
	1964034	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)NCCN(C)C)n2C)c1ccccc1		CHEMBL233555	=	IC50	nM	34.0	CHEMBL2148	Homo sapiens	IC50	nM	34.0
	1964035	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	CONC(=O)c1cc2c(N[C@@H](C)c3ccccc3)nc(-n3cnc4ccncc43)nc2n1C		CHEMBL391492	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	1964036	CHEMBL897051	Inhibition of JAK3 by kinase-Glo luminescent assay	B	C[C@H](Nc1nc(-n2cnc3ccncc32)nc2c1cc(C(=O)N1CCN(C)CC1)n2C)c1ccccc1		CHEMBL233151	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	1968068	CHEMBL895288	Inhibition of JAK3 at 10 uM	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	=	Inhibition	%	-7.0	CHEMBL2148	Homo sapiens	Inhibition	%	-7.0
	2000776	CHEMBL901551	Inhibition of JAK3 at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	16.0	CHEMBL2148	Homo sapiens	Inhibition	%	16.0
	2000797	CHEMBL901551	Inhibition of JAK3 at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	95.3	CHEMBL2148	Homo sapiens	Inhibition	%	95.3
	2021945	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2oc3nccc(NC[C@@H]4CCCO4)c3c2-c2ccccc2)cc1		CHEMBL240429	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	uM	0.026
	2021975	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCCC4)cc3)oc3nccc(NCCCn4ccnc4)c23)cc1		CHEMBL239591	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	uM	1.4
	2021976	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCCC4)cc3)oc3nccc(NCCc4cccnc4)c23)cc1		CHEMBL437754	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	uM	0.037
	2021977	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCCC4)cc3)oc3nccc(NCCc4ccncc4)c23)cc1		CHEMBL427687	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	uM	0.08
	2021978	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCCC4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1		CHEMBL393596	=	IC50	nM	71.0	CHEMBL2148	Homo sapiens	IC50	uM	0.071
	2021979	CHEMBL903617	Inhibition of JAK3	B	CC(C)N(CCOc1ccc(-c2oc3nccc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1)C(C)C		CHEMBL239590	=	IC50	nM	44.0	CHEMBL2148	Homo sapiens	IC50	uM	0.044
	2021980	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCn4ccnc4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1		CHEMBL240432	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	uM	0.025
	2021981	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1		CHEMBL240431	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	uM	0.11
	2021982	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCOCC4)cc3)oc3nccc(NCCN4CCNCC4)c23)cc1		CHEMBL240430	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	uM	0.032
	2021983	CHEMBL903617	Inhibition of JAK3	B	c1ccc(-c2oc3nccc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1		CHEMBL392990	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	uM	0.14
	2022205	CHEMBL902559	Inhibition of Jak3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1		CHEMBL247468	=	IC50	nM	960.0	CHEMBL2148	Homo sapiens	IC50	uM	0.96
	2022213	CHEMBL902559	Inhibition of Jak3	B	CC(C)Nc1ncnc2oc(-c3ccc(OCCN4CCCC4)cc3)c(-c3ccccc3)c12		CHEMBL247866	=	IC50	nM	1426.0	CHEMBL2148	Homo sapiens	IC50	uM	1.426
	2051635	CHEMBL941772	Inhibition of JAK3	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1722.0	CHEMBL2148	Homo sapiens	Ki	uM	1.722
	2089232	CHEMBL945938	Inhibition of human JAK3	B	N#Cc1cccc(C#N)c1-c1nc2c3ccc(Cl)cc3c3ccccc3c2[nH]1		CHEMBL412099	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	2089236	CHEMBL945938	Inhibition of human JAK3	B	O=c1[nH]ccc2c3[nH]c(-c4c(F)cccc4Cl)nc3c3ccc(F)cc3c12		CHEMBL272424	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	2089238	CHEMBL945938	Inhibition of human JAK3	B	Fc1cccc(Cl)c1-c1nc2c3ccccc3c3ccccc3c2[nH]1		CHEMBL270347	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	2096360	CHEMBL948991	Inhibition of Jak3	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	2096382	CHEMBL948991	Inhibition of Jak3	B	COc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2F)ccc1C		CHEMBL257858	=	IC50	nM	334.0	CHEMBL2148	Homo sapiens	IC50	nM	334.0
	2096384	CHEMBL948991	Inhibition of Jak3	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(OC)n1		CHEMBL271018	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096393	CHEMBL948991	Inhibition of Jak3	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(NC)n1		CHEMBL269936	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096394	CHEMBL948991	Inhibition of Jak3	B	COc1nc(NCCCCN(C)C)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255132	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096395	CHEMBL948991	Inhibition of Jak3	B	COc1nc(NCCCN2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255989	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096396	CHEMBL948991	Inhibition of Jak3	B	COc1nc(NCCN2CCOCC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL270793	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096397	CHEMBL948991	Inhibition of Jak3	B	COc1nc(NC2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL271650	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096398	CHEMBL948991	Inhibition of Jak3	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(NCCN2CCOCC2)nc1Oc1ccccc1		CHEMBL408292	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096399	CHEMBL948991	Inhibition of Jak3	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(Oc2ccccc2)n1		CHEMBL271099	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096400	CHEMBL948991	Inhibition of Jak3	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3C)ccc2C)c(OC)n1		CHEMBL271101	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2096401	CHEMBL948991	Inhibition of Jak3	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(OC)n1		CHEMBL255533	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2112049	CHEMBL934200	Inhibition of JAK3 by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL410295	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	uM	0.15
	2120250	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	2120327	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4c(Cl)cccc4Cl)cn3)cc2)CC1		CHEMBL541726	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120328	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)c(C)c1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL438016	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120329	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	CCc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL270765	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120330	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4cc(NC(=O)c5ccc6c(c5)OC(F)(F)O6)ccc4Cl)cn3)cc2)CC1		CHEMBL271154	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	2120331	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	COc1cc(OC)cc(C(=O)Nc2ccc(C)c(C(=O)Nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3)c2)c1		CHEMBL272850	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120332	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405401	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120333	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271141	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120334	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271140	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120335	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cc(F)cc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL407063	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120336	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	COc1ccccc1C(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL409734	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120337	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2ccccc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271760	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120338	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cnoc2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL411050	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120339	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	CC(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL271201	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120340	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NC2CCN(C)CC2)nc1		CHEMBL271372	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120341	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCN2CCOCC2)nc1		CHEMBL272673	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120342	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCCN2CCOCC2)nc1		CHEMBL259465	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120343	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL259247	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120344	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405666	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120345	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL271375	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120346	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120347	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL411632	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120348	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL272902	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	2120393	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL409914	=	IC50	nM	3040.0	CHEMBL2148	Homo sapiens	IC50	nM	3040.0
	2120394	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL429582	=	IC50	nM	156.0	CHEMBL2148	Homo sapiens	IC50	nM	156.0
	2120395	CHEMBL951935	Inhibition of Jak3 by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL408070	=	IC50	nM	438.0	CHEMBL2148	Homo sapiens	IC50	nM	438.0
	2137277	CHEMBL937066	Inhibition of JAK3	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	2147289	CHEMBL921879	Activity of human JAK3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	2158771	CHEMBL922534	Inhibition of Jak3	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	uM	50.0
	2164866	CHEMBL929430	Inhibition of JAK3	B	Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1		CHEMBL258694	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
	2164875	CHEMBL929430	Inhibition of JAK3	B	Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1		CHEMBL261592	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
	2167622	CHEMBL932342	Inhibition of JAK3	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	20500.0	CHEMBL2148	Homo sapiens	IC50	uM	20.5
Not Active	2170361	CHEMBL930316	Activity at JAK3 at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL2148	Homo sapiens	Activity		
	2182428	CHEMBL941327	Inhibition of JAK3 at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	27.0	CHEMBL2148	Homo sapiens	INH	%	27.0
	2182815	CHEMBL941441	Inhibition of JAK3 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	2232199	CHEMBL973642	Inhibition of JAK3	B	COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C(F)(F)F)c5)nn(C)c4c3)c2cc1OC	Outside typical range	CHEMBL462168	=	IC50	nM	25000000.0	CHEMBL2148	Homo sapiens	IC50	uM	25000.0
	2251199	CHEMBL1009896	Inhibition of JAK3	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	2264658	CHEMBL1011747	Inhibition of JAK3	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL480411	=	IC50	nM	2930.0	CHEMBL2148	Homo sapiens	IC50	uM	2.93
	2341438	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2341479	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	91.0	CHEMBL2148	Homo sapiens	INH	%	91.0
	2341520	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2341561	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	11.0	CHEMBL2148	Homo sapiens	INH	%	11.0
	2341602	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2341643	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	2341684	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	16.0	CHEMBL2148	Homo sapiens	INH	%	16.0
	2341725	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2341766	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	11.0	CHEMBL2148	Homo sapiens	INH	%	11.0
	2341807	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	12.0	CHEMBL2148	Homo sapiens	INH	%	12.0
	2341848	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	4.0	CHEMBL2148	Homo sapiens	INH	%	4.0
	2341889	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	2341930	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	41.0	CHEMBL2148	Homo sapiens	INH	%	41.0
	2341971	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342012	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	18.0	CHEMBL2148	Homo sapiens	INH	%	18.0
	2342053	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	2342094	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	2342135	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342176	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	2342224	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	3.0	CHEMBL2148	Homo sapiens	INH	%	3.0
	2342262	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	2342299	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	15.0	CHEMBL2148	Homo sapiens	INH	%	15.0
	2342340	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342381	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	28.0	CHEMBL2148	Homo sapiens	INH	%	28.0
	2342422	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	11.0	CHEMBL2148	Homo sapiens	INH	%	11.0
	2342463	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342504	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342545	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	2342666	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342667	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342668	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342669	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342670	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342671	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342672	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342673	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342674	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342675	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342676	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342677	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342678	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342679	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342680	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342681	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342682	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342683	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342684	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342685	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	2342686	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	9.0	CHEMBL2148	Homo sapiens	INH	%	9.0
	2342687	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	2342688	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	2342689	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	3.0	CHEMBL2148	Homo sapiens	INH	%	3.0
	2342690	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	8.0	CHEMBL2148	Homo sapiens	INH	%	8.0
	2342691	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	2342692	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	2342693	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	84.0	CHEMBL2148	Homo sapiens	INH	%	84.0
	2342694	CHEMBL953399	Inhibition of JAK3 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	2361177	CHEMBL979863	Inhibition of JAK3	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	>	IC50	nM	8300.0	CHEMBL2148	Homo sapiens	IC50	nM	8300.0
	2361199	CHEMBL979863	Inhibition of JAK3	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	2361222	CHEMBL979863	Inhibition of JAK3	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
Not Active	2458080	CHEMBL1020096	Inhibition of JAK3 at 1 uM	B	CCOC(=O)c1cn(-c2c(F)c(F)c(C#N)c(F)c2F)c2c(F)c(F)c(F)cc2c1=O		CHEMBL524195		Activity			CHEMBL2148	Homo sapiens	Activity		
Not Active	2458083	CHEMBL1020099	Inhibition of JAK3 at 10 uM	B	CCOC(=O)c1cn(-c2c(F)c(F)c(C#N)c(F)c2F)c2c(F)c(F)c(F)cc2c1=O		CHEMBL524195		Activity			CHEMBL2148	Homo sapiens	Activity		
	2476199	CHEMBL987114	Inhibition of JAK3	B	Cc1cc(C(=O)Nc2ccc3[nH]ncc3c2)nn1-c1cccc(C(F)(F)F)c1		CHEMBL485370	=	IC50	nM	2640.0	CHEMBL2148	Homo sapiens	IC50	nM	2640.0
	2476200	CHEMBL987114	Inhibition of JAK3	B	CN1CCN(c2ccc(Nc3ncc4[nH]nc(-c5ccccc5)c4n3)cc2)CC1		CHEMBL449888	=	IC50	nM	98.0	CHEMBL2148	Homo sapiens	IC50	nM	98.0
	2476201	CHEMBL987114	Inhibition of JAK3	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	IC50	nM	957.0	CHEMBL2148	Homo sapiens	IC50	nM	957.0
	2476202	CHEMBL987114	Inhibition of JAK3	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	2511591	CHEMBL973445	Inhibition of JAK3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.15	CHEMBL2148	Homo sapiens	IC50	uM	0.00015
	2526445	CHEMBL981441	Binding affinity to Jak3	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
Not Active	2527104	CHEMBL984152	Inhibition of JAK3 at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL2148	Homo sapiens	Activity		
	2584881	CHEMBL955791	Inhibition of JAK3	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	uM	0.31
	2584910	CHEMBL955791	Inhibition of JAK3	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	2585363	CHEMBL1018105	Inhibition of Jak3	B	CCOc1ccccc1Oc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1C(=O)Nc1c(C)cccc1C		CHEMBL459044	=	Ki	nM	74.0	CHEMBL2148	Homo sapiens	Ki	uM	0.074
	2585364	CHEMBL1018105	Inhibition of Jak3	B	COC(C)(C)CCn1nc(Nc2c(C)cccc2C)c2cnc(Nc3ccc(OCCN4CCCC4)cc3)nc21		CHEMBL458333	=	Ki	nM	170.0	CHEMBL2148	Homo sapiens	Ki	uM	0.17
	2585365	CHEMBL1018105	Inhibition of Jak3	B	COC(C)(C)CCn1nc(Nc2c(C)cccc2C)c2cnc(Nc3ccc(OCCN4CCCC4)c(F)c3)nc21		CHEMBL502156	>	Ki	nM	12500.0	CHEMBL2148	Homo sapiens	Ki	uM	12.5
	2595776	CHEMBL1019774	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	2595780	CHEMBL1019774	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	0.7	CHEMBL2148	Homo sapiens	Kd	nM	0.7
	2595794	CHEMBL1019774	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459977	=	Kd	nM	150.0	CHEMBL2148	Homo sapiens	Kd	nM	150.0
	2595795	CHEMBL1019774	Inhibition of JAK3	B	C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459769	=	Kd	nM	180.0	CHEMBL2148	Homo sapiens	Kd	nM	180.0
	2595796	CHEMBL1019774	Inhibition of JAK3	B	C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL457871	=	Kd	nM	190.0	CHEMBL2148	Homo sapiens	Kd	nM	190.0
	2603072	CHEMBL1023867	Inhibition of JAK3	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
Active	2613244	CHEMBL1013506	Inhibition of IL2-induced JAK3 phosphorylation in human YT cells at 30 ng/ml by immunoblotting analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Activity			CHEMBL2148	Homo sapiens	Activity		
	2613260	CHEMBL1016957	Inhibition of JAK3 in human DND/L12 cells after 30 mins by luciferase assay in presence of human serum albumin	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC90	nM	160.0	CHEMBL2148	Homo sapiens	IC90	nM	160.0
	2615703	CHEMBL1026509	Inhibition of JAK3	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	IC50	nM	3880.0	CHEMBL2148	Homo sapiens	IC50	uM	3.88
	2615709	CHEMBL1026515	Inhibition of JAK3 expressed in mouse BAF3 cells assessed as cytotoxicity	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	uM	2.0
	2615721	CHEMBL1026509	Inhibition of JAK3	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL285063	=	IC50	nM	3140.0	CHEMBL2148	Homo sapiens	IC50	uM	3.14
	2615727	CHEMBL1026515	Inhibition of JAK3 expressed in mouse BAF3 cells assessed as cytotoxicity	B	C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL285063	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	2639175	CHEMBL1025472	Inhibition of JAK3	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	=	Ki	nM	2300.0	CHEMBL2148	Homo sapiens	Ki	nM	2300.0
	2639176	CHEMBL1025472	Inhibition of JAK3	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	>	Ki	nM	4000.0	CHEMBL2148	Homo sapiens	Ki	nM	4000.0
	2684761	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC[C@@H](O)[C@@H](O)CC3		CHEMBL558241	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	2684762	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C[C@@H](O)[C@@H](O)C3		CHEMBL559787	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	2684763	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC/C=C\CC3		CHEMBL558115	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	2684764	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C/C=C\C3		CHEMBL557709	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	2684765	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	C=CCn1c2ccccc2c2c3c(c4c5ccccc5n(CC=C)c4c21)C(=O)NC3		CHEMBL563795	>	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
	2684766	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	nM	61.0
	2684767	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	CN(C)C1CCN(C(=O)[C@]2(O)Cn3c4ccccc4c4c5c(c6c7ccccc7n(c6c43)C[C@H]2O)C(=O)NC5=O)C1		CHEMBL557559	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	2684768	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C[C@@](O)(C(=O)O)[C@H](O)C3		CHEMBL550791	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
	2684769	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	COC(=O)[C@]1(O)Cn2c3ccccc3c3c4c(c5c6ccccc6n(c5c32)C[C@H]1O)C(=O)NC4=O		CHEMBL564940	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	2684770	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	CC(=O)/C1=C/Cn2c3ccccc3c3c4c(c5c6ccccc6n(c5c32)C1)C(=O)NC4=O		CHEMBL557101	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	2684771	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C[C@@H](O)[C@@H](O)CC3		CHEMBL557846	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
	2684772	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C[C@@H](O)[C@@H](O)C3		CHEMBL563588	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	2684773	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(O)CCC3		CHEMBL565066	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	2684774	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1CC(O)CC3		CHEMBL562934	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	2684775	CHEMBL1053840	Inhibition of JAK3 expressed in insect Sf21 cells assessed as inhibition of biotinylated substrate phosphorylation	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	2721634	CHEMBL1057462	Inhibition of JAK3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	2722271	CHEMBL1063588	Inhibition of JAK3	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	30000.0	CHEMBL2148	Homo sapiens	Ki	uM	30.0
	2892466	CHEMBL1061988	Selectivity for JAK3 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Selectivity		0.0069	CHEMBL2148	Homo sapiens	Selectivity		0.0069
	2895845	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895846	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895847	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	260.0	CHEMBL2148	Homo sapiens	Kd	nM	260.0
	2895848	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895849	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895850	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895851	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	8700.0	CHEMBL2148	Homo sapiens	Kd	nM	8700.0
	2895852	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895853	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	630.0	CHEMBL2148	Homo sapiens	Kd	nM	630.0
	2895854	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	2.2	CHEMBL2148	Homo sapiens	Kd	nM	2.2
	2895855	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895856	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895857	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	25.0	CHEMBL2148	Homo sapiens	Kd	nM	25.0
	2895858	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	930.0	CHEMBL2148	Homo sapiens	Kd	nM	930.0
	2895859	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895860	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895861	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895862	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	6900.0	CHEMBL2148	Homo sapiens	Kd	nM	6900.0
	2895863	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895864	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	180.0	CHEMBL2148	Homo sapiens	Kd	nM	180.0
	2895865	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895866	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	420.0	CHEMBL2148	Homo sapiens	Kd	nM	420.0
	2895867	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895868	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895869	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895870	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	12.0	CHEMBL2148	Homo sapiens	Kd	nM	12.0
	2895871	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895872	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895873	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895874	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895875	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895876	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895877	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	10.0	CHEMBL2148	Homo sapiens	Kd	nM	10.0
	2895878	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	580.0	CHEMBL2148	Homo sapiens	Kd	nM	580.0
	2895879	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL2148	Homo sapiens	Kd	nM	1200.0
	2895880	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	630.0	CHEMBL2148	Homo sapiens	Kd	nM	630.0
	2895881	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2895882	CHEMBL1051335	Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	2921305	CHEMBL1049094	Inhibition of JAK3 kinase domain 2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	2938415	CHEMBL1038676	Inhibition of JAK3	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	>	Ki	nM	4000.0	CHEMBL2148	Homo sapiens	Ki	uM	4.0
	2947582	CHEMBL1047360	Inhibition of JAK3 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	2948183	CHEMBL1042392	Inhibition of recombinant JAK3	B	O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1	Outside typical range	CHEMBL584052	=	Ki	nM	0.006	CHEMBL2148	Homo sapiens	Ki	nM	0.006
	2948185	CHEMBL1042394	Inhibition of JAK3 in human HT2 cells assessed as inhibition of IL2-induced STAT5 phosphorylation by flow cytometry	B	O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1		CHEMBL584052	=	IC50	nM	1530.0	CHEMBL2148	Homo sapiens	IC50	microM	1.53
	2948188	CHEMBL1042392	Inhibition of recombinant JAK3	B	O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1	Outside typical range	CHEMBL584052	=	Ki	nM	0.0055	CHEMBL2148	Homo sapiens	Ki	nM	0.0055
	2981333	CHEMBL1043446	Inhibition of Tel-fused JAK3	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL570002	=	GI50	nM	1300.0	CHEMBL2148	Homo sapiens	GI50	uM	1.3
	2981334	CHEMBL1043446	Inhibition of Tel-fused JAK3	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL569720	=	GI50	nM	7400.0	CHEMBL2148	Homo sapiens	GI50	uM	7.4
	2981335	CHEMBL1043446	Inhibition of Tel-fused JAK3	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL578201	=	GI50	nM	2100.0	CHEMBL2148	Homo sapiens	GI50	uM	2.1
	2981336	CHEMBL1043446	Inhibition of Tel-fused JAK3	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL576257	=	GI50	nM	1100.0	CHEMBL2148	Homo sapiens	GI50	uM	1.1
	2981384	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL570002	=	IC50	nM	5030.0	CHEMBL2148	Homo sapiens	IC50	uM	5.03
	2981385	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2cnc(C#N)c(NC(C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL568788	=	IC50	nM	12770.0	CHEMBL2148	Homo sapiens	IC50	uM	12.77
	2981386	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL569720	=	IC50	nM	26480.0	CHEMBL2148	Homo sapiens	IC50	uM	26.48
	2981387	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(N[C@H](C)c3ncc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL569721	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	2981388	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL578201	=	IC50	nM	15670.0	CHEMBL2148	Homo sapiens	IC50	uM	15.67
	2981389	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(N[C@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL570230	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	2981390	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(NC(C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL568789	=	IC50	nM	25050.0	CHEMBL2148	Homo sapiens	IC50	uM	25.05
	2981391	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2cnc(C#N)c(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL576257	=	IC50	nM	5170.0	CHEMBL2148	Homo sapiens	IC50	uM	5.17
	2981392	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(O[C@@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL570192	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	2981393	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(O[C@H](C)c3ccc(F)cn3)c(C#N)nc2C)n[nH]1		CHEMBL571526	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	2981394	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	C[C@H](Nc1nc(Nc2cc(C3CC3)[nH]n2)cnc1C#N)c1ccc(F)cn1		CHEMBL578194	=	IC50	nM	26880.0	CHEMBL2148	Homo sapiens	IC50	uM	26.88
	2981395	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)cnc2C)n[nH]1		CHEMBL576068	=	IC50	nM	3660.0	CHEMBL2148	Homo sapiens	IC50	uM	3.66
	2981396	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	CC(C)Oc1cc(Nc2cncc(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL576286	=	IC50	nM	15220.0	CHEMBL2148	Homo sapiens	IC50	uM	15.22
	2981397	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2cncc(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL569738	=	IC50	nM	11710.0	CHEMBL2148	Homo sapiens	IC50	uM	11.71
	2981398	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	Cc1cc(Nc2cncc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL570899	=	IC50	nM	13730.0	CHEMBL2148	Homo sapiens	IC50	uM	13.73
Not Determined	2981399	CHEMBL1043453	Inhibition of JAK3 using 5 mM ATP as a substrate	B	COc1cc(Nc2cncc(N[C@@H](C)c3ccc(F)cn3)n2)n[nH]1		CHEMBL570464		IC50			CHEMBL2148	Homo sapiens	IC50		
	2981456	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CC(C)Nc1cc(-c2c(N)nn3cccnc23)ncn1		CHEMBL568790	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	uM	0.21
	2981457	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N2CCCCC2)ncn1		CHEMBL570668	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	uM	0.46
	2981458	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	NC(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL577944	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	uM	0.5
	2981459	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(CC)C(=O)C1CCCN(c2cc(-c3c(N)nn4cc(C)cnc34)ncn2)C1		CHEMBL568866	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	uM	2.1
	2981460	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N2CCOCC2)ncn1		CHEMBL576486	=	IC50	nM	1600.0	CHEMBL2148	Homo sapiens	IC50	uM	1.6
	2981461	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CN(C)C1CCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL585527	=	IC50	nM	4000.0	CHEMBL2148	Homo sapiens	IC50	uM	4.0
	2981462	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N2CCCC(O)C2)ncn1		CHEMBL570462	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	uM	0.42
	2981463	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	NC(=O)C1CCN(c2cc(-c3c(N)nn4cccnc34)ncn2)CC1		CHEMBL576272	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	2981464	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCCN(CCC)c1cc(-c2c(N)nn3cccnc23)ncn1		CHEMBL569948	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	uM	0.21
	2981465	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	COC(=O)C1CCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL571118	=	IC50	nM	600.0	CHEMBL2148	Homo sapiens	IC50	uM	0.6
	2981466	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCOC(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL571119	=	IC50	nM	570.0	CHEMBL2148	Homo sapiens	IC50	uM	0.57
	2981467	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCCN(CC)C(=O)C1CCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL570231	=	IC50	nM	2800.0	CHEMBL2148	Homo sapiens	IC50	uM	2.8
	2981468	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(CC)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1.Cl		CHEMBL1204012	=	Ki	nM	400.0	CHEMBL2148	Homo sapiens	Ki	uM	0.4
	2981469	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CN(C)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL569737	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	uM	2.1
	2981470	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCCN(CC)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL569757	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	uM	0.19
	2981471	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCCN(CCC)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL569091	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	uM	0.22
	2981472	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(CC(F)(F)F)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL569092	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	uM	0.17
	2981473	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCCN(CC(F)(F)F)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL569957	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	uM	0.067
	2981474	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(CCC(F)(F)F)C(=O)C1CCCN(c2cc(-c3c(N)nn4cccnc34)ncn2)C1		CHEMBL570456	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	uM	0.2
	2981475	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(NCc2ccccc2)ncn1		CHEMBL570890	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	uM	0.054
	2981476	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(Cc1ccccc1)c1cc(-c2c(N)nn3cccnc23)ncn1		CHEMBL584322	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	uM	0.23
	2981477	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCN(Cc1ccncc1)c1cc(-c2c(N)nn3cccnc23)ncn1		CHEMBL569739	=	IC50	nM	4400.0	CHEMBL2148	Homo sapiens	IC50	uM	4.4
	2981478	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(NCc2ccccn2)ncn1		CHEMBL576475	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	uM	0.16
	2981479	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(NCc2cccnc2)ncn1		CHEMBL583030	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	uM	0.049
	2981480	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(NCc2ccc(F)cc2)ncn1		CHEMBL570686	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	uM	0.039
	2981481	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(NCc2ccc(Cl)cc2)ncn1		CHEMBL569012	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	uM	0.025
	2981482	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(OCc2ccc(F)cc2)ncn1		CHEMBL568815	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	uM	0.18
	2981483	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	C[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccccc1		CHEMBL568816	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	uM	0.017
	2981484	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	C[C@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccccc1		CHEMBL576862	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	uM	0.29
	2981485	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	C[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(Cl)cc1		CHEMBL570206	=	IC50	nM	81.0	CHEMBL2148	Homo sapiens	IC50	uM	0.081
	2981486	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	C[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL583895	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	uM	0.007
	2981487	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N[C@H]2CCc3ccccc32)ncn1		CHEMBL576476	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	uM	0.24
	2981488	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N[C@@H]2CCc3ccccc32)ncn1		CHEMBL570229	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	uM	0.2
	2981489	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	Nc1nn2cccnc2c1-c1cc(N2CCCC2c2ccc(F)cc2)ncn1		CHEMBL582808	=	IC50	nM	86.0	CHEMBL2148	Homo sapiens	IC50	uM	0.086
	2981490	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CC[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL569966	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	uM	0.012
	2981491	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CCC[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL584944	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	uM	0.01
	2981492	CHEMBL1044319	Inhibition of JAK3 by radiometric assay	B	CC(C)[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL570217	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	uM	0.012
	2981513	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	C[C@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccccc1		CHEMBL576862	>	IC50	nM	20000.0	CHEMBL2148	Homo sapiens	IC50	uM	20.0
	2981514	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	C[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(Cl)cc1		CHEMBL570206	=	IC50	nM	11000.0	CHEMBL2148	Homo sapiens	IC50	uM	11.0
	2981515	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	C[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL583895	=	IC50	nM	3200.0	CHEMBL2148	Homo sapiens	IC50	uM	3.2
	2981516	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	Nc1nn2cccnc2c1-c1cc(N[C@@H]2CCc3ccccc32)ncn1		CHEMBL570229	>	IC50	nM	20000.0	CHEMBL2148	Homo sapiens	IC50	uM	20.0
	2981517	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	Nc1nn2cccnc2c1-c1cc(N2CCCC2c2ccc(F)cc2)ncn1		CHEMBL582808	=	IC50	nM	3100.0	CHEMBL2148	Homo sapiens	IC50	uM	3.1
	2981518	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	CC[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL569966	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	uM	1.9
	2981519	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	CCC[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL584944	=	IC50	nM	2400.0	CHEMBL2148	Homo sapiens	IC50	uM	2.4
	2981520	CHEMBL1044321	Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human HT2 cells	B	CC(C)[C@@H](Nc1cc(-c2c(N)nn3cccnc23)ncn1)c1ccc(F)cc1		CHEMBL570217	=	IC50	nM	4100.0	CHEMBL2148	Homo sapiens	IC50	uM	4.1
	2992215	CHEMBL1044518	Inhibition of human JAK3 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	4.0	CHEMBL2148	Homo sapiens	INH	%	4.0
	2992486	CHEMBL1040118	Inhibition of human recombinant JAK3	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	1500.0	CHEMBL2148	Homo sapiens	IC50	nM	1500.0
	3021229	CHEMBL1038362	Inhibition of Jak3	B	CNc1ccn(-c2ccccc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cn1		CHEMBL585927	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	3052639	CHEMBL1041126	Residual activity of JAK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	92.0	CHEMBL2148	Homo sapiens	Residual activity	%	92.0
	3053948	CHEMBL1047674	Residual activity of JAK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	53.0	CHEMBL2148	Homo sapiens	Residual activity	%	53.0
	3054200	CHEMBL1040668	Residual activity of JAK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	95.0	CHEMBL2148	Homo sapiens	Residual activity	%	95.0
	3055487	CHEMBL1041126	Residual activity of JAK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	101.0	CHEMBL2148	Homo sapiens	Residual activity	%	101.0
	3056792	CHEMBL1047674	Residual activity of JAK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	63.0	CHEMBL2148	Homo sapiens	Residual activity	%	63.0
	3057044	CHEMBL1040668	Residual activity of JAK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL2148	Homo sapiens	Residual activity	%	98.0
	3058364	CHEMBL1041126	Residual activity of JAK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL2148	Homo sapiens	Residual activity	%	93.0
	3058616	CHEMBL1047674	Residual activity of JAK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	68.0	CHEMBL2148	Homo sapiens	Residual activity	%	68.0
	3062473	CHEMBL1037960	Binding affinity to human JAK3 kinase domain 2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	4.6	CHEMBL2148	Homo sapiens	Activity	%	4.6
	3063608	CHEMBL1074874	Binding affinity to human JAK3 kinase domain 2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	3.6	CHEMBL2148	Homo sapiens	Activity	%	3.6
	3063698	CHEMBL1047850	Binding affinity to human JAK3 kinase domain 2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	16.0	CHEMBL2148	Homo sapiens	Activity	%	16.0
Not Evaluated	3063755	CHEMBL1048623	Ratio of compound to staurosporine binding affinity to human JAK3 in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546		Selectivity ratio			CHEMBL2148	Homo sapiens	Selectivity ratio		
	3066855	CHEMBL1070658	Inhibition of JAK3 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	3066945	CHEMBL1070658	Inhibition of JAK3 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	38.0	CHEMBL2148	Homo sapiens	INH	%	38.0
	3072962	CHEMBL1040668	Residual activity of JAK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL2148	Homo sapiens	Residual activity	%	90.0
	3084417	CHEMBL1073280	Inhibition of JAK3	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	5300.0	CHEMBL2148	Homo sapiens	IC50	uM	5.3
	3098432	CHEMBL1067029	Inhibition of human JAK3 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3117931	CHEMBL1072207	Inhibition of JAK3	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3117984	CHEMBL1072207	Inhibition of JAK3	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3118037	CHEMBL1072207	Inhibition of JAK3	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3127297	CHEMBL1074375	Inhibition of JAK3 at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	3127316	CHEMBL1074375	Inhibition of JAK3 at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	-3.0	CHEMBL2148	Homo sapiens	INH	%	-3.0
	3127335	CHEMBL1074375	Inhibition of JAK3 at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	47.0	CHEMBL2148	Homo sapiens	INH	%	47.0
	3130810	CHEMBL1073729	Inhibition of JAK3 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3191059	CHEMBL1101926	Inhibition of JAK3 at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	0.21	CHEMBL2148	Homo sapiens	INH	%	0.21
	3203126	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccccn4)c3o2)cc(OC)c1OC		CHEMBL1081443	=	IC50	nM	450.0	CHEMBL2148	Homo sapiens	IC50	uM	0.45
	3203130	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC		CHEMBL1081290	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3203134	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4cccc(Cl)c4)c3o2)cc(OC)c1OC		CHEMBL1081291	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3203138	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1ccc(-c2cccc3nc(Nc4cc(OC)c(OC)c(OC)c4)oc23)cc1		CHEMBL1081292	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3203142	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccc5ncccc5c4)c3o2)cc(OC)c1OC		CHEMBL1081975	=	IC50	nM	670.0	CHEMBL2148	Homo sapiens	IC50	uM	0.67
	3203147	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4cccc(NS(C)(=O)=O)c4)c3o2)cc(OC)c1OC		CHEMBL1081976	=	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	uM	2.0
	3203151	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccc(NS(C)(=O)=O)cc4)c3o2)cc(OC)c1OC		CHEMBL1081977	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	uM	0.13
	3203156	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc(OC)c1OC		CHEMBL1081978	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	uM	0.4
	3203165	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	COc1cc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc(OC)c1OC		CHEMBL1081485	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	uM	0.3
	3203170	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	CN(C)C(=O)c1ccc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc1		CHEMBL1081663	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	uM	0.62
	3203177	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)N(C)C		CHEMBL1080159	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	uM	0.16
	3203182	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	CNC(=O)c1ccc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)cc1C		CHEMBL1082022	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	uM	0.19
	3203187	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	Cc1cc(-c2cccc3nc(Nc4ccc(N5CCN(C)CC5)cc4)oc23)ccc1C(=O)N1CCOCC1		CHEMBL1082023	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	uM	0.17
	3203192	CHEMBL1102772	Inhibition of GST-tagged JAK3 assessed as inhibition of biotinylated JAK3tide peptide phosphorylation after 60 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)NCCCN(C)C		CHEMBL1076700	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	uM	0.22
	3213832	CHEMBL1111201	Inhibition of JAK3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	3214163	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOCC1		CHEMBL1087235	=	IC50	nM	115.0	CHEMBL2148	Homo sapiens	IC50	nM	115.0
	3214164	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4cc(C(F)(F)F)ccc43)nc2n1C1CCOCC1		CHEMBL1087236	=	IC50	nM	245.0	CHEMBL2148	Homo sapiens	IC50	nM	245.0
	3214165	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(C(F)(F)F)cc43)nc2n1C1CCOCC1		CHEMBL1088423	=	IC50	nM	68.0	CHEMBL2148	Homo sapiens	IC50	nM	68.0
	3214166	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOCC1		CHEMBL1088424	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	3214167	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(Cl)cc43)nc2n1C1CCOCC1		CHEMBL1080322	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	3214168	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	N#Cc1ccc2ncn(-c3ncc4[nH]c(=O)n(C5CCOCC5)c4n3)c2c1		CHEMBL1080323	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	3214169	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1Cc1cccc(F)c1F		CHEMBL1081846	=	IC50	nM	108.0	CHEMBL2148	Homo sapiens	IC50	nM	108.0
	3214170	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	N#Cc1ccc2ncn(-c3ncc4[nH]c(=O)n(Cc5cccc(F)c5F)c4n3)c2c1		CHEMBL1080332	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	3214171	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1Cc1c(F)cccc1F		CHEMBL1080333	=	IC50	nM	70.0	CHEMBL2148	Homo sapiens	IC50	nM	70.0
	3214172	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	N#Cc1ccc2ncn(-c3ncc4[nH]c(=O)n(Cc5c(F)cccc5F)c4n3)c2c1		CHEMBL1079523	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	3214173	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	N#Cc1ccc2ncn(-c3ncc4[nH]c(=O)n(Cc5c(Cl)cccc5Cl)c4n3)c2c1		CHEMBL1079524	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
	3214174	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2ccccc21		CHEMBL1079525	=	IC50	nM	95.0	CHEMBL2148	Homo sapiens	IC50	nM	95.0
	3214175	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2cccc(F)c21		CHEMBL1079526	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
	3214176	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2ccc(F)cc21		CHEMBL1081190	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	3214177	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2ccc(Cl)cc21		CHEMBL1076221	=	IC50	nM	365.0	CHEMBL2148	Homo sapiens	IC50	nM	365.0
	3214178	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2cc(F)ccc21		CHEMBL1080110	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
	3214179	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL1080111	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
	3214180	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1C1CCOc2c(Cl)cccc21		CHEMBL1081376	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
	3214181	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1[C@@H]1CCOc2c(F)cccc21		CHEMBL1081377	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	3214182	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccccc43)nc2n1[C@H]1CCOc2c(F)cccc21		CHEMBL1081378	=	IC50	nM	540.0	CHEMBL2148	Homo sapiens	IC50	nM	540.0
	3214183	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(Cl)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21		CHEMBL1081379	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	3214184	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21		CHEMBL1079593	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	3214185	CHEMBL1102455	Inhibition of human JAK3 (508-1124) by time resolved fluorescence assay	B	N#Cc1ccc2ncn(-c3ncc4[nH]c(=O)n([C@@H]5CCOc6c(F)cccc65)c4n3)c2c1		CHEMBL1079594	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	3224853	CHEMBL1100371	Inhibition of JAK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3225103	CHEMBL1100371	Inhibition of JAK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3227754	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	COc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)ccc1O		CHEMBL1078274	=	IC50	nM	62.0	CHEMBL2148	Homo sapiens	IC50	nM	62.0
	3227755	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3cccc(CN4CCCC4)c3)n2)cc1		CHEMBL1078275	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
	3227756	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(CN4CCCCC4)cc3)n2)cc1		CHEMBL1078276	=	IC50	nM	538.0	CHEMBL2148	Homo sapiens	IC50	nM	538.0
	3227757	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3cccc(CN4CCOCC4)c3)n2)cc1		CHEMBL1078277	=	IC50	nM	930.0	CHEMBL2148	Homo sapiens	IC50	nM	930.0
	3227758	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3cccc(CN4CCC(O)CC4)c3)n2)cc1		CHEMBL1078688	=	IC50	nM	636.0	CHEMBL2148	Homo sapiens	IC50	nM	636.0
	3227759	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(CN4CCOCC4)cc3)n2)cc1		CHEMBL1078689	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	3227760	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(CN4CCC(O)CC4)cc3)n2)cc1		CHEMBL1078767	=	IC50	nM	1619.0	CHEMBL2148	Homo sapiens	IC50	nM	1619.0
	3227761	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CN1CCN(Cc2cccc(Nc3nccc(-c4ccc(NS(C)(=O)=O)cc4)n3)c2)CC1		CHEMBL1078866	=	IC50	nM	960.0	CHEMBL2148	Homo sapiens	IC50	nM	960.0
	3227762	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CN1CCN(Cc2ccc(Nc3nccc(-c4ccc(NS(C)(=O)=O)cc4)n3)cc2)CC1		CHEMBL1078971	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	3227763	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(CN4CCS(=O)(=O)CC4)cc3)n2)cc1		CHEMBL1078889	=	IC50	nM	587.0	CHEMBL2148	Homo sapiens	IC50	nM	587.0
	3227764	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1079077	=	IC50	nM	351.0	CHEMBL2148	Homo sapiens	IC50	nM	351.0
	3227765	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCC(O)CC4)cc3)n2)cc1		CHEMBL1079078	=	IC50	nM	149.0	CHEMBL2148	Homo sapiens	IC50	nM	149.0
	3227766	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1078159	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	3227767	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCC(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1077575	=	IC50	nM	1760.0	CHEMBL2148	Homo sapiens	IC50	nM	1760.0
	3227768	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNCc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1078165	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	3227769	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078166	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	3227770	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	IC50	nM	155.0	CHEMBL2148	Homo sapiens	IC50	nM	155.0
	3227771	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)ccc1C(=O)NCC#N		CHEMBL1078363	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	3227772	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	COc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)ccc1C(=O)NCC#N		CHEMBL1078364	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
	3227773	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CC(C)(C#N)NC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078453	=	IC50	nM	3910.0	CHEMBL2148	Homo sapiens	IC50	nM	3910.0
	3227774	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CN(CC#N)C(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078370	=	IC50	nM	1418.0	CHEMBL2148	Homo sapiens	IC50	nM	1418.0
	3227775	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1ccc(C(=O)NCC#N)cc1		CHEMBL1078005	=	IC50	nM	85.0	CHEMBL2148	Homo sapiens	IC50	nM	85.0
	3227776	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	COc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1ccc(C(=O)NCC#N)cc1		CHEMBL1079120	=	IC50	nM	2310.0	CHEMBL2148	Homo sapiens	IC50	nM	2310.0
	3227777	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)c(C(F)(F)F)c3)n2)cc1		CHEMBL1079121	=	IC50	nM	2020.0	CHEMBL2148	Homo sapiens	IC50	nM	2020.0
	3227778	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CCN(CC)CCCOc1ccc(Nc2nccc(-c3ccc(C(=O)NCC#N)cc3)n2)cc1		CHEMBL1078720	=	IC50	nM	362.0	CHEMBL2148	Homo sapiens	IC50	nM	362.0
	3227779	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(CN4CCOCC4)cc3)n2)cc1		CHEMBL1078721	=	IC50	nM	1450.0	CHEMBL2148	Homo sapiens	IC50	nM	1450.0
	3227780	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)c(F)c3)n2)cc1		CHEMBL1078228	=	IC50	nM	274.0	CHEMBL2148	Homo sapiens	IC50	nM	274.0
	3227781	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1		CHEMBL1078229	=	IC50	nM	1876.0	CHEMBL2148	Homo sapiens	IC50	nM	1876.0
	3227782	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCSCC4)cc3)n2)cc1		CHEMBL1077841	=	IC50	nM	364.0	CHEMBL2148	Homo sapiens	IC50	nM	364.0
	3227783	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(CN4CCS(=O)(=O)CC4)cc3)n2)cc1		CHEMBL1077842	=	IC50	nM	364.0	CHEMBL2148	Homo sapiens	IC50	nM	364.0
	3227784	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CCN1CCN(Cc2ccc(Nc3nccc(-c4ccc(C(=O)NCC#N)cc4)n3)cc2)CC1		CHEMBL1078933	=	IC50	nM	152.0	CHEMBL2148	Homo sapiens	IC50	nM	152.0
	3227785	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	CN1CCN(c2ccc(Nc3nccc(-c4ccc(C(=O)NCC#N)cc4)n3)cc2)CC1		CHEMBL1078934	=	IC50	nM	192.0	CHEMBL2148	Homo sapiens	IC50	nM	192.0
	3227786	CHEMBL1107755	Inhibition of GST-tagged JAK3 kinase	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	3240813	CHEMBL1109691	Inhibition of JAK3	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	3247744	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	CNS(=O)(=O)c1ccc(-c2cccc3ncc(-c4cc(OC)c(OC)c(OC)c4)nc23)cc1		CHEMBL1093749	=	IC50	nM	1300.0	CHEMBL2148	Homo sapiens	IC50	nM	1300.0
	3247745	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1093191	=	IC50	nM	1300.0	CHEMBL2148	Homo sapiens	IC50	nM	1300.0
	3247746	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1093468	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
	3247747	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1089833	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
	3247748	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cc(C)cc(-c4ccc(CC(=O)N5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1091190	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3247749	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cc(F)cc(-c4ccc(CC(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1091191	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3247750	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1091565	=	IC50	nM	2500.0	CHEMBL2148	Homo sapiens	IC50	nM	2500.0
	3247751	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4)c3n2)cc(OC)c1OC		CHEMBL1092588	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3247752	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC		CHEMBL1093454	=	IC50	nM	8300.0	CHEMBL2148	Homo sapiens	IC50	nM	8300.0
	3247753	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC		CHEMBL1088856	=	IC50	nM	1500.0	CHEMBL2148	Homo sapiens	IC50	nM	1500.0
	3247754	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)cc(OC)c1OC		CHEMBL1088857	=	IC50	nM	4900.0	CHEMBL2148	Homo sapiens	IC50	nM	4900.0
	3247755	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4C)c3n2)cc(OC)c1OC		CHEMBL1089813	=	IC50	nM	2700.0	CHEMBL2148	Homo sapiens	IC50	nM	2700.0
	3247756	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4F)c3n2)cc(OC)c1OC		CHEMBL1089814	=	IC50	nM	9900.0	CHEMBL2148	Homo sapiens	IC50	nM	9900.0
	3247757	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)ccc1C(=O)N1CCN(C)CC1		CHEMBL1092063	=	IC50	nM	232.0	CHEMBL2148	Homo sapiens	IC50	nM	232.0
	3247758	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	Cc1cc(-c2cccc3ncc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)nc23)ccc1CN1CCOCC1		CHEMBL1089815	=	IC50	nM	408.0	CHEMBL2148	Homo sapiens	IC50	nM	408.0
	3247759	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1		CHEMBL1092840	=	IC50	nM	630.0	CHEMBL2148	Homo sapiens	IC50	nM	630.0
	3247760	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	Cc1cc(-c2cnc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1		CHEMBL1093119	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
	3247761	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cc2)CC1		CHEMBL1089773	=	IC50	nM	166.0	CHEMBL2148	Homo sapiens	IC50	nM	166.0
	3247762	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCS(=O)(=O)CC6)c(F)c5)c4n3)cn2)CC1		CHEMBL1092925	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	3247763	CHEMBL1116985	Inhibition of recombinant GST tagged JAK3 protein after 60 mins using FITC-GGEEEEYFELVKKKK-NH2 substrate	B	Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1		CHEMBL1092926	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
	3294620	CHEMBL1103932	Inhibition of JAK3	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL2148	Homo sapiens	INH	%	40.0
	3315899	CHEMBL1120245	Inhibition of JAK3	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3316788	CHEMBL1120347	Inhibition of JAK3 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	17.0	CHEMBL2148	Homo sapiens	INH	%	17.0
	3326165	CHEMBL1168292	Inhibition of JAK3 at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3331984	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	86.4	CHEMBL2148	Homo sapiens	INH	%	86.4
	3333399	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Inhibition	%	75.0	CHEMBL2148	Homo sapiens	INH	%	75.0
	3334804	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	=	Inhibition	%	73.0	CHEMBL2148	Homo sapiens	INH	%	73.0
	3336224	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	83.0	CHEMBL2148	Homo sapiens	INH	%	83.0
	3337556	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	3337807	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	=	Inhibition	%	79.3	CHEMBL2148	Homo sapiens	INH	%	79.3
	3339141	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	=	Inhibition	%	93.2	CHEMBL2148	Homo sapiens	INH	%	93.2
	3340444	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	98.7	CHEMBL2148	Homo sapiens	INH	%	98.7
	3340752	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	88.0	CHEMBL2148	Homo sapiens	INH	%	88.0
	3342168	CHEMBL1166034	Inhibition of JAK3 JH1 catalytic domain at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	88.0	CHEMBL2148	Homo sapiens	INH	%	88.0
Not Active	3352225	CHEMBL1175401	Inhibition of JAK3 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	3352226	CHEMBL1175401	Inhibition of JAK3 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	3352227	CHEMBL1175401	Inhibition of JAK3 at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	3358621	CHEMBL1174801	Inhibition of JAK3 JH1 catalytic domain at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	2.3	CHEMBL2148	Homo sapiens	INH	%	2.3
	3359063	CHEMBL1174801	Inhibition of JAK3 JH1 catalytic domain at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	3.5	CHEMBL2148	Homo sapiens	INH	%	3.5
	3423099	CHEMBL1227371	Inhibition of recombinant JAK3 after 1 hr	B	O=C(CCc1cn(Cc2ccc(Cl)cc2)c2ccccc12)Nc1ccc([N+](=O)[O-])cc1		CHEMBL1221633	=	IC50	nM	34200.0	CHEMBL2148	Homo sapiens	IC50	uM	34.2
	3423100	CHEMBL1227371	Inhibition of recombinant JAK3 after 1 hr	B	O=C(CCc1cn(Cc2ccc(Cl)cc2)c2ccccc12)Nc1ccncc1		CHEMBL185140	=	IC50	nM	52000.0	CHEMBL2148	Homo sapiens	IC50	uM	52.0
	3439122	CHEMBL1247969	Inhibition of Jak3 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	>	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	nM	8000.0
	3439189	CHEMBL1247969	Inhibition of Jak3 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1		CHEMBL1243200	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	3439202	CHEMBL1247969	Inhibition of Jak3 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	nM	25000.0
	3443425	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	3443642	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	3444797	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	3445157	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2.3	CHEMBL2148	Homo sapiens	Kd	nM	2.3
	3445421	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	3445638	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	3445842	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	8.0	CHEMBL2148	Homo sapiens	INH	%	8.0
	3446032	CHEMBL1244191	Inhibition of JAK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	3447701	CHEMBL1250000	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Ki	nM	1.0	CHEMBL2148	Homo sapiens	Ki	nM	1.0
	3448467	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	3449082	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	12.0	CHEMBL2148	Homo sapiens	Kd	nM	12.0
	3449230	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	37.0	CHEMBL2148	Homo sapiens	Kd	nM	37.0
	3449445	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL2148	Homo sapiens	Kd	nM	1200.0
	3449702	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	3450109	CHEMBL1244468	Binding affinity to JH1 catalytic domain of JAK3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	uM	10.0
	3463259	CHEMBL1252462	Inhibition of JAK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	3463803	CHEMBL1252462	Inhibition of JAK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	-1.0	CHEMBL2148	Homo sapiens	INH	%	-1.0
	3464022	CHEMBL1252462	Inhibition of JAK3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	89.0	CHEMBL2148	Homo sapiens	INH	%	89.0
	3504208	CHEMBL1260177	Inhibition of JAK3	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	3710.0	CHEMBL2148	Homo sapiens	IC50	uM	3.71
	3526981	CHEMBL1275102	Inhibition of JAK3	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3590873	CHEMBL1292171	Inhibition of Jak3	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290746	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	3605047	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	3605048	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
	3605049	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Nc1nc(Nc2cccc(S(N)(=O)=O)c2)nn1C(=O)c1c(F)cccc1F		CHEMBL1287883	=	IC50	nM	1250.0	CHEMBL2148	Homo sapiens	IC50	nM	1250.0
	3605050	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1		CHEMBL1287812	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3605051	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Nc1nc(Nc2cccc(C(=O)O)c2)nn1C(=O)c1c(F)cccc1F		CHEMBL1287910	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3605052	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	COC(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL1287940	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	3605053	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Nc1nc(Nc2ccc(C(=O)O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL1287941	=	IC50	nM	1470.0	CHEMBL2148	Homo sapiens	IC50	nM	1470.0
Not Determined	3605054	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)nn2C(=O)c2c(F)cccc2F)c1		CHEMBL1287970		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	3605055	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2n[nH]c(N)n2)c1		CHEMBL1288769		IC50			CHEMBL2148	Homo sapiens	IC50		
	3605056	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Nc1nc(Nc2ccccc2)nn1C(=O)c1c(F)cccc1F		CHEMBL1287971	=	IC50	nM	3250.0	CHEMBL2148	Homo sapiens	IC50	nM	3250.0
	3605057	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CN(C)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1		CHEMBL1288001	=	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	nM	2000.0
	3605058	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CN(C)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL1288002	=	IC50	nM	850.0	CHEMBL2148	Homo sapiens	IC50	nM	850.0
	3605059	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	Nc1nc(Nc2cccnc2)nn1C(=O)c1c(F)cccc1F		CHEMBL1288032	=	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
Not Determined	3605060	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccccc3)n2)c1		CHEMBL1288033		IC50			CHEMBL2148	Homo sapiens	IC50		
	3605061	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccccc3F)n2)c1		CHEMBL1288062	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
Not Determined	3605062	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccc(C(F)(F)F)cc3)n2)c1		CHEMBL1288063		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	3605063	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccc(N(C)C)cc3)n2)c1		CHEMBL1288093		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	3605064	CHEMBL1292867	Inhibition of human recombinant JAK3 by TR-FRET assay	B	CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccco3)n2)c1		CHEMBL1288094		IC50			CHEMBL2148	Homo sapiens	IC50		
	3605087	CHEMBL1292872	Binding affinity to JAK3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	180.0	CHEMBL2148	Homo sapiens	Kd	nM	180.0
	3605088	CHEMBL1292872	Binding affinity to JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	2.2	CHEMBL2148	Homo sapiens	Kd	nM	2.2
	5109056	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	5109062	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C=C(C)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630782	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	5109069	CHEMBL1641121	Inhibition of JAK3 by solution phase kinase assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	3.2	CHEMBL2148	Homo sapiens	IC50	nM	3.2
	5109070	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
	5109071	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C=C(C)[C@H]1CCC(C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630781	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	5109092	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H](COCC(=O)NCc1ccccc1)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630786	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	5109093	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC(C#N)C(=O)N1CCC(C)C(N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630803	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	5109096	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(S(=O)(=O)CC(F)(F)F)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630788	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	5109108	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CC(F)(F)F)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630801	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	5109112	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCC(C)C(N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630774	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	5109113	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H](CO)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630783	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	5109114	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CC2CC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630800	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	5109129	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	Cc1cc(NC(=O)N2CC[C@@H](C)[C@@H](N(C)c3ncnc4[nH]ccc34)C2)sn1		CHEMBL1630789	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	nM	26.0
	5109136	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)C2CCC(=O)C2)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630795	=	IC50	nM	29.0	CHEMBL2148	Homo sapiens	IC50	nM	29.0
	5109141	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CCN(CC)C(=O)COC[C@H](C)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630784	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	5109142	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CO)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630791	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	5109145	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CNC(=O)COC[C@H](C)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630785	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	5109146	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)C2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630798	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	5109147	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)C2CCOC2)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630797	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
	5109149	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(Cc2cccc(F)c2F)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630790	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
	5109150	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459769	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
	5109160	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CN(c1ncnc2[nH]ccc12)C1CCCCCCC1		CHEMBL1630771	=	IC50	nM	58.0	CHEMBL2148	Homo sapiens	IC50	nM	58.0
	5109162	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CCC1CCCCC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630775	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	nM	61.0
	5109164	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCCCC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630773	=	IC50	nM	65.0	CHEMBL2148	Homo sapiens	IC50	nM	65.0
	5109170	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CN(c1ncnc2[nH]ccc12)C1CCCCCC1		CHEMBL1630764	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
	5109172	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)C(C)(C)C#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630802	=	IC50	nM	113.0	CHEMBL2148	Homo sapiens	IC50	nM	113.0
	5109173	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)C2CCN(Cc3ccccc3)C2=O)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630793	=	IC50	nM	117.0	CHEMBL2148	Homo sapiens	IC50	nM	117.0
	5109178	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCCC(N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630765	=	IC50	nM	138.0	CHEMBL2148	Homo sapiens	IC50	nM	138.0
	5109180	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)c2ccsc2)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630796	=	IC50	nM	143.0	CHEMBL2148	Homo sapiens	IC50	nM	143.0
	5109181	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCN(C(=O)CS(C)(=O)=O)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630799	=	IC50	nM	147.0	CHEMBL2148	Homo sapiens	IC50	nM	147.0
	5109182	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CCN(CC)C(=O)OC[C@H](C)[C@H]1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630787	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
	5109184	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CN(c1ncnc2[nH]ccc12)C1CCCCC1		CHEMBL1630770	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
	5109187	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	c1ccc2c(c1)C1CCCCC1N2c1ncnc2[nH]ccc12		CHEMBL463821	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	5109188	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	c1nc(N2CCCCC2)c2cc[nH]c2n1		CHEMBL1630766	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	5109191	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CN(c1ncnc2[nH]ccc12)C1CCCCC1(C)C		CHEMBL1630778	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	5109192	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)CC2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630794	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	5109194	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCC(C)N1c1ncnc2[nH]ccc12		CHEMBL1630767	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
	5109203	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	c1nc(N2CCC3CCCCC32)c2cc[nH]c2n1		CHEMBL1630768	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
	5109204	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC1CCC(N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL1630772	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
	5109205	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CN(c1ncnc2[nH]ccc12)C1CCCC1		CHEMBL1630769	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
	5109211	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C[C@@H]1CCN(C(=O)C2Cc3cc(Cl)ccc3O2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL1630792	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
	5109215	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	COC1CCCCC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630779	=	IC50	nM	540.0	CHEMBL2148	Homo sapiens	IC50	nM	540.0
	5109225	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CCCCCC1CCCCC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630776	=	IC50	nM	800.0	CHEMBL2148	Homo sapiens	IC50	nM	800.0
	5109229	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	C=C(C)[C@@H]1CCC(C)[C@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL1630780	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	nM	1200.0
	5109241	CHEMBL1641115	Inhibition of GST-tagged human JAK3 catalytic domain expressed in Sf9 cells by ELISA	B	CC(C)CCC1CCC(C)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1630777	=	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	nM	2000.0
	5121175	CHEMBL1646174	Inhibition of human JAK3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	147.0	CHEMBL2148	Homo sapiens	INH	%	147.0
Active	5131836	CHEMBL1645702	Inhibition of Jak3 transfected with TEL fusion in mouse BA/F3 cells	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL1229592		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	5144096	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1		CHEMBL1650723	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
Not Determined	5144097	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	C[C@H](Nc1ncc(Cl)c(Nc2cc(C3CC3)[nH]n2)n1)c1ncc(F)cn1		CHEMBL1650724		IC50			CHEMBL2148	Homo sapiens	IC50		
	5144098	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2F)n[nH]1		CHEMBL1650697	=	IC50	nM	5250.0	CHEMBL2148	Homo sapiens	IC50	uM	5.25
Not Determined	5144099	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	C[C@H](Nc1ncc(F)c(Nc2cc(C3CC3)[nH]n2)n1)c1ncc(F)cn1		CHEMBL1650698		IC50			CHEMBL2148	Homo sapiens	IC50		
	5144100	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	IC50	nM	1360.0	CHEMBL2148	Homo sapiens	IC50	uM	1.36
	5144101	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2C)n[nH]1		CHEMBL1650725	=	IC50	nM	8350.0	CHEMBL2148	Homo sapiens	IC50	uM	8.35
	5144102	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(O[C@@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1		CHEMBL1650726	=	IC50	nM	12730.0	CHEMBL2148	Homo sapiens	IC50	uM	12.73
	5144103	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(O[C@H](C)c3ncc(F)cn3)ncc2Cl)n[nH]1		CHEMBL1650727	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	5144104	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Br)n[nH]1		CHEMBL1650728	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	5144105	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Br)n[nH]1		CHEMBL1650729	=	IC50	nM	4590.0	CHEMBL2148	Homo sapiens	IC50	uM	4.59
	5144106	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	C[C@H](Nc1ncc(Cl)c(Nc2cc(N(C)C)[nH]n2)n1)c1ncc(F)cn1		CHEMBL1650730	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	5144107	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	C[C@H](Nc1ncc(F)c(Nc2cc(N(C)C)[nH]n2)n1)c1ncc(F)cn1		CHEMBL1650731	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	5144108	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2cc(N3CCOCC3)nc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL1650732	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	uM	0.03
	5144109	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N3CCOCC3)c2F)n[nH]1		CHEMBL1650733	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	5144110	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N3CCOCC3)c2Cl)n[nH]1		CHEMBL1650734	=	IC50	nM	11800.0	CHEMBL2148	Homo sapiens	IC50	uM	11.8
	5144111	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	COc1cc(Nc2cc(N3CCOCC3)nc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1		CHEMBL1650735	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	uM	0.2
	5144112	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N3CCOCC3)c2F)n[nH]1		CHEMBL1650736	=	IC50	nM	30500.0	CHEMBL2148	Homo sapiens	IC50	uM	30.5
	5144113	CHEMBL1656590	Inhibition of JAK3 using 5 mM of ATP	B	COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N3CCOCC3)c2Cl)n[nH]1		CHEMBL1650737	=	IC50	nM	2960.0	CHEMBL2148	Homo sapiens	IC50	uM	2.96
	5146668	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	5146669	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(F)ccc1C(F)(F)F		CHEMBL1650952	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	5146670	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCNCC2)ccc1C(F)(F)F		CHEMBL1650953	=	IC50	nM	133.0	CHEMBL2148	Homo sapiens	IC50	nM	133.0
	5146671	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	CN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL1650954	=	IC50	nM	423.0	CHEMBL2148	Homo sapiens	IC50	nM	423.0
	5146672	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	O=CN1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650955	=	IC50	nM	36.0	CHEMBL2148	Homo sapiens	IC50	nM	36.0
	5146673	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCOCC2)ccc1C(F)(F)F		CHEMBL1650956	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	nM	460.0
	5146674	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	O=C1CCN(c2ncc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1		CHEMBL1235315	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	5146675	CHEMBL1657304	Inhibition of GST-tagged Jak3 expressed in insect cells using 18 uM ATP	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	5146686	CHEMBL1657307	Inhibition of Jak3-mediated IL15-induced Stat5 phosphorylation in human MO7 cells by cell-based assay	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	525.0	CHEMBL2148	Homo sapiens	IC50	nM	525.0
	5146687	CHEMBL1657307	Inhibition of Jak3-mediated IL15-induced Stat5 phosphorylation in human MO7 cells by cell-based assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	5152488	CHEMBL1656533	Inhibition of JAK3 by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	5152513	CHEMBL1656533	Inhibition of JAK3 by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
Not Active	5239588	CHEMBL1686874	Inhibition of JAK3 up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	5240349	CHEMBL1685410	Inhibition of JAK3 after 60 mins	B	Cc1nnc(Nc2nc(N3CCN(C(=O)Cc4ccccc4)CC3)nn3cccc23)s1		CHEMBL1682361	=	IC50	nM	18000.0	CHEMBL2148	Homo sapiens	IC50	uM	18.0
	5243722	CHEMBL1685685	Inhibition of JAK3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	52.0	CHEMBL2148	Homo sapiens	INH	%	52.0
	5243830	CHEMBL1685934	Inhibition of JAK3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	5243943	CHEMBL1685685	Inhibition of JAK3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	25.0	CHEMBL2148	Homo sapiens	INH	%	25.0
	5244051	CHEMBL1685934	Inhibition of JAK3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	8.0	CHEMBL2148	Homo sapiens	INH	%	8.0
	5244924	CHEMBL1685685	Inhibition of JAK3 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	84.0	CHEMBL2148	Homo sapiens	INH	%	84.0
	5245032	CHEMBL1685934	Inhibition of JAK3 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	28.0	CHEMBL2148	Homo sapiens	INH	%	28.0
	5245183	CHEMBL1685685	Inhibition of JAK3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	76.0	CHEMBL2148	Homo sapiens	INH	%	76.0
	5246013	CHEMBL1685934	Inhibition of JAK3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	26.0	CHEMBL2148	Homo sapiens	INH	%	26.0
	5249794	CHEMBL1687340	inhibition of JAK3 at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	5249810	CHEMBL1687366	inhibition of JAK3	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	5293781	CHEMBL1696434	Inhibition of JAK3	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	990.0	CHEMBL2148	Homo sapiens	IC50	uM	0.99
	6167568	CHEMBL1769041	Binding affinity to human Jak3 domain 1 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	6167584	CHEMBL1769227	Binding affinity to human Jak3 domain 10 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	6167652	CHEMBL1769193	Inhibition of JAK3	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	=	Ki	nM	350.0	CHEMBL2148	Homo sapiens	Ki	uM	0.35
	6196657	CHEMBL1776839	Inhibition of JAK3 after 60 min	B	C[C@H](Nc1nc(Nc2cc(C3CC3)[nH]n2)c(F)cc1C#N)c1ccc(F)cc1		CHEMBL1774053	=	IC50	nM	183.0	CHEMBL2148	Homo sapiens	IC50	uM	0.183
	6196658	CHEMBL1776839	Inhibition of JAK3 after 60 min	B	CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1		CHEMBL1774054	=	IC50	nM	1735.0	CHEMBL2148	Homo sapiens	IC50	uM	1.735
	6196659	CHEMBL1776839	Inhibition of JAK3 after 60 min	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1		CHEMBL1774055	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	uM	0.009
	6196660	CHEMBL1776839	Inhibition of JAK3 after 60 min	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	uM	0.007
	6196661	CHEMBL1776839	Inhibition of JAK3 after 60 min	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2Cl)n[nH]1		CHEMBL1773082	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	uM	0.021
	6196667	CHEMBL1776841	Inhibition of TEL-fused JAK3-induced proliferative activity against mouse BA/F3 cells	B	C[C@H](Nc1nc(Nc2cc(C3CC3)[nH]n2)c(F)cc1C#N)c1ccc(F)cc1		CHEMBL1774053	=	GI50	nM	1000.0	CHEMBL2148	Homo sapiens	GI50	uM	1.0
Not Determined	6196668	CHEMBL1776841	Inhibition of TEL-fused JAK3-induced proliferative activity against mouse BA/F3 cells	B	CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1		CHEMBL1774054		GI50			CHEMBL2148	Homo sapiens	GI50		
	6196669	CHEMBL1776841	Inhibition of TEL-fused JAK3-induced proliferative activity against mouse BA/F3 cells	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1		CHEMBL1774055	=	GI50	nM	350.0	CHEMBL2148	Homo sapiens	GI50	uM	0.35
	6196670	CHEMBL1776841	Inhibition of TEL-fused JAK3-induced proliferative activity against mouse BA/F3 cells	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	=	GI50	nM	1300.0	CHEMBL2148	Homo sapiens	GI50	uM	1.3
	6196671	CHEMBL1776841	Inhibition of TEL-fused JAK3-induced proliferative activity against mouse BA/F3 cells	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2Cl)n[nH]1		CHEMBL1773082	=	GI50	nM	430.0	CHEMBL2148	Homo sapiens	GI50	uM	0.43
	6196674	CHEMBL1776844	Inhibition of human JAK3	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	uM	0.015
	6198126	CHEMBL1776217	Inhibition of JAK3 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	6210058	CHEMBL1781095	Inhibition of JAK3 at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	9.0	CHEMBL2148	Homo sapiens	INH	%	9.0
	6219903	CHEMBL1785331	Inhibition of human JAK3 using GEEEEYFELVKKKK peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	57.5	CHEMBL2148	Homo sapiens	IC50	nM	57.5
	6267513	CHEMBL1799029	Inhibition of JAK3 at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	6267514	CHEMBL1799029	Inhibition of JAK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	6299682	CHEMBL1811579	Inhibition of JAK3	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	6325317	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	78.0	CHEMBL2148	Homo sapiens	INH	%	78.0
	6325346	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	36.0	CHEMBL2148	Homo sapiens	INH	%	36.0
	6325378	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	53.0	CHEMBL2148	Homo sapiens	INH	%	53.0
	6325410	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	29.0	CHEMBL2148	Homo sapiens	INH	%	29.0
	6325442	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	54.0	CHEMBL2148	Homo sapiens	INH	%	54.0
	6325471	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	72.0	CHEMBL2148	Homo sapiens	INH	%	72.0
	6325500	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	54.0	CHEMBL2148	Homo sapiens	INH	%	54.0
	6325529	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	6325872	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	74.0	CHEMBL2148	Homo sapiens	INH	%	74.0
	6325902	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6325932	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6325961	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6325990	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6326019	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6326048	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6326077	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	6326106	CHEMBL1819995	Inhibition of JAK3 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	6339928	CHEMBL1826611	Activity of JAK3 JH1 catalytic domain kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	74.0	CHEMBL2148	Homo sapiens	Activity	%	74.0
	6360090	CHEMBL1832348	Inhibition of Jak3 at 5 uM assessed as remaining activity	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	Activity	%	128.0	CHEMBL2148	Homo sapiens	Activity	%	128.0
	6375147	CHEMBL1838159	Inhibition of JAK3 at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	29.5	CHEMBL2148	Homo sapiens	INH	%	29.5
	6375151	CHEMBL1838159	Inhibition of JAK3 at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	43.3	CHEMBL2148	Homo sapiens	INH	%	43.3
	6382485	CHEMBL1837889	Inhibition of JAK3	B	Cc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835071	=	IC50	nM	1995.26	CHEMBL2148	Homo sapiens	pIC50		5.7
	6386368	CHEMBL1839847	Inhibition of recombinant JAK3	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	6389943	CHEMBL1840116	Inhibition of JAK3	B	CCNc1ncc(C(N)=O)c2[nH]c3ccc(F)cc3c12		CHEMBL1835014	=	IC50	nM	6800.0	CHEMBL2148	Homo sapiens	IC50	nM	6800.0
	6389944	CHEMBL1840116	Inhibition of JAK3	B	O=c1[nH]ccc2c1c1cc(F)ccc1n2-c1ccccc1		CHEMBL1834949	=	IC50	nM	720.0	CHEMBL2148	Homo sapiens	IC50	nM	720.0
	6389945	CHEMBL1840116	Inhibition of JAK3	B	O=c1[nH]ccc2c3[nH]c(-c4ccccc4Cl)nc3c3ccc(F)cc3c12		CHEMBL261386	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	nM	77.0
	6390012	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	C[C@H](Nc1ccc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C(C)(C)C		CHEMBL1835039	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
	6390013	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	C[C@H](Nc1ncc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C1CC1		CHEMBL1835137	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	nM	140.0
	6390014	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	C[C@@H](Nc1ncc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C1CC1		CHEMBL1835138	=	IC50	nM	740.0	CHEMBL2148	Homo sapiens	IC50	nM	740.0
	6390015	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	CCC(Nc1ncc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C1CC1		CHEMBL1835139	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
	6390016	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	CC(C)C(Nc1ncc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C1CC1		CHEMBL1835140	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	6390017	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(NC(C4CC4)C4CC4)c23)cn1		CHEMBL1835141	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
	6390018	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(N[C@H](C4CC4)C(F)(F)F)c23)cn1		CHEMBL1835142	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	6390019	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(N[C@@H](C4CC4)C(F)(F)F)c23)cn1		CHEMBL1835143	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	nM	1900.0
	6390020	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	CC(C)[C@@H](Nc1ncc(C(N)=O)c2[nH]c3cc(-c4cnn(C)c4)ccc3c12)C(F)(F)F		CHEMBL1835144	=	IC50	nM	560.0	CHEMBL2148	Homo sapiens	IC50	nM	560.0
	6390021	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	Cn1cc(-c2ccc3c(c2)[nH]c2c(C(N)=O)cnc(N[C@H](C4CCC4)C(F)(F)F)c23)cn1		CHEMBL1835145	=	IC50	nM	1700.0	CHEMBL2148	Homo sapiens	IC50	nM	1700.0
	6390022	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cn[nH]c3)ccc12		CHEMBL1835146	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
	6390023	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cccnn3)ccc12		CHEMBL1835147	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
	6390024	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cnc(N)cn3)ccc12		CHEMBL1835148	=	IC50	nM	640.0	CHEMBL2148	Homo sapiens	IC50	nM	640.0
	6390025	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(NC(C2CC2)C2CC2)c2c1[nH]c1cc(-c3cnc(N)nc3)ccc12		CHEMBL1833986	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
	6390026	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3cn[nH]c3)ccc12		CHEMBL1835149	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
	6390027	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3ccc(N)nc3)ccc12		CHEMBL1835150	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
	6390028	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3cnc(N4CCOCC4)nc3)ccc12		CHEMBL1835151	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
	6390029	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3ccc(N4CCS(=O)(=O)CC4)nn3)ccc12		CHEMBL1835152	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
	6390030	CHEMBL1840263	Inhibition of JAK3 using biotin-EQEDEPEGDYFEWLE- NH2 as substrate	B	NC(=O)c1cnc(N[C@H](C2CC2)C(F)(F)F)c2c1[nH]c1cc(-c3cnc(N)nc3)ccc12		CHEMBL1835153	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	nM	300.0
	7567179	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7567638	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	0.16	CHEMBL2148	Homo sapiens	Kd	nM	0.16
	7568109	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7568577	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	470.0	CHEMBL2148	Homo sapiens	Kd	nM	470.0
	7569009	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL2148	Homo sapiens	Kd	nM	1200.0
	7569152	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7569612	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	200.0	CHEMBL2148	Homo sapiens	Kd	nM	200.0
	7570084	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	2.0	CHEMBL2148	Homo sapiens	Kd	nM	2.0
	7571128	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7571585	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	640.0	CHEMBL2148	Homo sapiens	Kd	nM	640.0
	7572061	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	18.0	CHEMBL2148	Homo sapiens	Kd	nM	18.0
	7572082	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7572498	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	17.0	CHEMBL2148	Homo sapiens	Kd	nM	17.0
	7573109	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	8.2	CHEMBL2148	Homo sapiens	Kd	nM	8.2
	7573566	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	700.0	CHEMBL2148	Homo sapiens	Kd	nM	700.0
	7574069	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	12.0	CHEMBL2148	Homo sapiens	Kd	nM	12.0
	7574477	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7575087	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7575577	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7576042	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7576450	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	74.0	CHEMBL2148	Homo sapiens	Kd	nM	74.0
	7577078	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7577556	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	39.0	CHEMBL2148	Homo sapiens	Kd	nM	39.0
	7578026	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	86.0	CHEMBL2148	Homo sapiens	Kd	nM	86.0
	7578431	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7578627	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1500.0	CHEMBL2148	Homo sapiens	Kd	nM	1500.0
	7579001	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7579451	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1600.0	CHEMBL2148	Homo sapiens	Kd	nM	1600.0
	7579925	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7580394	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7580797	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	630.0	CHEMBL2148	Homo sapiens	Kd	nM	630.0
	7580985	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7581370	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7581815	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7582286	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	1700.0	CHEMBL2148	Homo sapiens	Kd	nM	1700.0
	7582750	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	36.0	CHEMBL2148	Homo sapiens	Kd	nM	36.0
	7583150	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7583331	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7583728	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7584173	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7584644	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1200.0	CHEMBL2148	Homo sapiens	Kd	nM	1200.0
	7585106	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7585661	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7586069	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7586515	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7586986	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7587622	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	3100.0	CHEMBL2148	Homo sapiens	Kd	nM	3100.0
	7588041	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2.3	CHEMBL2148	Homo sapiens	Kd	nM	2.3
	7588494	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	4700.0	CHEMBL2148	Homo sapiens	Kd	nM	4700.0
	7588974	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7589587	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7590011	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	410.0	CHEMBL2148	Homo sapiens	Kd	nM	410.0
	7590510	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7590961	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7591560	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	260.0	CHEMBL2148	Homo sapiens	Kd	nM	260.0
	7591982	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7592012	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7592485	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7592938	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1200.0	CHEMBL2148	Homo sapiens	Kd	nM	1200.0
	7593527	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7593992	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7594465	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7594917	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7300.0	CHEMBL2148	Homo sapiens	Kd	nM	7300.0
	7595497	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	630.0	CHEMBL2148	Homo sapiens	Kd	nM	630.0
	7595971	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7596442	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	6900.0	CHEMBL2148	Homo sapiens	Kd	nM	6900.0
	7596889	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	12.0	CHEMBL2148	Homo sapiens	Kd	nM	12.0
	7597025	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7597478	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	7597951	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	2000.0	CHEMBL2148	Homo sapiens	Kd	nM	2000.0
	7598421	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	510.0	CHEMBL2148	Homo sapiens	Kd	nM	510.0
	7598863	CHEMBL1908482	Binding constant for JAK3(JH1domain-catalytic) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	580.0	CHEMBL2148	Homo sapiens	Kd	nM	580.0
	7931102	CHEMBL1919277	Inhibition of JAK3 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	-4.0	CHEMBL2148	Homo sapiens	INH	%	-4.0
	7939644	CHEMBL1919604	Inhibition of human JAK3	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	7943739	CHEMBL1919759	Inhibition of JAK3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	7943779	CHEMBL1921547	Inhibition of JAK3 at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	7959811	CHEMBL1932880	Inhibition of JAK3	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	7959812	CHEMBL1932880	Inhibition of JAK3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	7992168	CHEMBL1935988	Inhibition of JAK3	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	IC50	nM	2.9	CHEMBL2148	Homo sapiens	IC50	nM	2.9
	7992195	CHEMBL1935883	Inhibition of JAK3 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	102.0	CHEMBL2148	Homo sapiens	INH	%	102.0
	7996703	CHEMBL1944034	Inhibition of JAK3 (Kin.Dom.2) at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	96.0	CHEMBL2148	Homo sapiens	INH	%	96.0
	8002116	CHEMBL1942188	Inhibition of JAK3 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	16.0	CHEMBL2148	Homo sapiens	INH	%	16.0
	8002117	CHEMBL1942188	Inhibition of JAK3 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	8002118	CHEMBL1942188	Inhibition of JAK3 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	INH	%	-2.0
	8009749	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938642	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	uM	0.018
	8009750	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938643	=	IC50	nM	1340.0	CHEMBL2148	Homo sapiens	IC50	uM	1.34
	8009751	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CCNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938644	=	IC50	nM	967.0	CHEMBL2148	Homo sapiens	IC50	uM	0.967
	8009752	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	Nc1ncc(C(=O)Nc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12		CHEMBL1938645	=	IC50	nM	2870.0	CHEMBL2148	Homo sapiens	IC50	uM	2.87
	8009753	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	Nc1ncc(C(=O)NCc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12	Outside typical range	CHEMBL1938646	>	IC50	nM	125000.0	CHEMBL2148	Homo sapiens	IC50	uM	125.0
	8009754	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CC(C)(C)NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938647	=	IC50	nM	10300.0	CHEMBL2148	Homo sapiens	IC50	uM	10.3
	8009755	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CN(C)C(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938648	=	IC50	nM	1660.0	CHEMBL2148	Homo sapiens	IC50	uM	1.66
	8009756	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccccc3)sc12		CHEMBL1938649	=	IC50	nM	767.0	CHEMBL2148	Homo sapiens	IC50	uM	0.767
	8009757	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C)cc3)sc12		CHEMBL1938650	=	IC50	nM	545.0	CHEMBL2148	Homo sapiens	IC50	uM	0.545
	8009758	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C)cc3)sc12		CHEMBL1938651	=	IC50	nM	188.0	CHEMBL2148	Homo sapiens	IC50	uM	0.188
	8009759	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(OC(F)(F)F)cc3)sc12		CHEMBL1938652	=	IC50	nM	365.0	CHEMBL2148	Homo sapiens	IC50	uM	0.365
	8009760	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C#N)cc3)sc12		CHEMBL1938653	=	IC50	nM	118.0	CHEMBL2148	Homo sapiens	IC50	uM	0.118
	8009761	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938654	=	IC50	nM	307.0	CHEMBL2148	Homo sapiens	IC50	uM	0.307
	8009762	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	uM	0.0006
	8009763	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCO)c3s2)cc1		CHEMBL1938655	=	IC50	nM	434.0	CHEMBL2148	Homo sapiens	IC50	uM	0.434
	8009764	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	COCCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938656	=	IC50	nM	1280.0	CHEMBL2148	Homo sapiens	IC50	uM	1.28
	8009765	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CN(C)CCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938657	=	IC50	nM	3330.0	CHEMBL2148	Homo sapiens	IC50	uM	3.33
	8009766	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCCCC4)c3s2)cc1		CHEMBL1938658	=	IC50	nM	2380.0	CHEMBL2148	Homo sapiens	IC50	uM	2.38
	8009767	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1		CHEMBL1938659	=	IC50	nM	963.0	CHEMBL2148	Homo sapiens	IC50	uM	0.963
	8009768	CHEMBL1941385	Inhibition of human recombinant N-terminal GST-tagged JAK3 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCCN4CCOCC4)c3s2)cc1		CHEMBL1938660	=	IC50	nM	645.0	CHEMBL2148	Homo sapiens	IC50	uM	0.645
	8009869	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938642	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009870	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938643	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009871	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccccc3)sc12		CHEMBL1938649	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009872	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C)cc3)sc12		CHEMBL1938650	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009873	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C)cc3)sc12		CHEMBL1938651	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009874	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(OC(F)(F)F)cc3)sc12		CHEMBL1938652	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009875	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C#N)cc3)sc12		CHEMBL1938653	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009876	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938654	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009877	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	uM	0.054
	8009878	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCO)c3s2)cc1		CHEMBL1938655	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009879	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	COCCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938656	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009880	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CN(C)CCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12		CHEMBL1938657	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009881	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCCCC4)c3s2)cc1		CHEMBL1938658	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009882	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1		CHEMBL1938659	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
	8009883	CHEMBL1941392	Inhibition of TEL-fused JAK3 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCCN4CCOCC4)c3s2)cc1		CHEMBL1938660	>	IC50	nM	25000.0	CHEMBL2148	Homo sapiens	IC50	uM	25.0
Not Active	8012251	CHEMBL1941644	Inhibition of JAK3 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	8012252	CHEMBL1941644	Inhibition of JAK3 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	8012253	CHEMBL1941644	Inhibition of JAK3 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	8012254	CHEMBL1941644	Inhibition of JAK3 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	8013109	CHEMBL1948128	Inhibition of JAK3 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	8018807	CHEMBL1948941	Inhibition of JAK3 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	96.0	CHEMBL2148	Homo sapiens	Activity	%	96.0
	8018808	CHEMBL1948941	Inhibition of JAK3 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	101.0	CHEMBL2148	Homo sapiens	Activity	%	101.0
	8018809	CHEMBL1948941	Inhibition of JAK3 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	95.0	CHEMBL2148	Homo sapiens	Activity	%	95.0
	8059496	CHEMBL1958988	Inhibition of Jak3	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	280.0	CHEMBL2148	Homo sapiens	Ki	uM	0.28
	8061573	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.71	CHEMBL2148	Homo sapiens	Inhibition	%	3.71
	8061680	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.54	CHEMBL2148	Homo sapiens	Inhibition	%	-0.54
	8061904	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.46	CHEMBL2148	Homo sapiens	Inhibition	%	1.46
	8062095	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.5	CHEMBL2148	Homo sapiens	Inhibition	%	-0.5
	8062211	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.54	CHEMBL2148	Homo sapiens	Inhibition	%	0.54
	8062435	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-1.06	CHEMBL2148	Homo sapiens	Inhibition	%	-1.06
	8062597	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-2.24	CHEMBL2148	Homo sapiens	Inhibition	%	-2.24
	8062919	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.73	CHEMBL2148	Homo sapiens	Inhibition	%	2.73
	8063051	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.4	CHEMBL2148	Homo sapiens	Inhibition	%	1.4
	8063275	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.41	CHEMBL2148	Homo sapiens	Inhibition	%	1.41
	8063442	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.77	CHEMBL2148	Homo sapiens	Inhibition	%	-0.77
	8063774	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-1.26	CHEMBL2148	Homo sapiens	Inhibition	%	-1.26
	8063956	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.53	CHEMBL2148	Homo sapiens	Inhibition	%	4.53
	8064295	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-0.29	CHEMBL2148	Homo sapiens	Inhibition	%	-0.29
	8064505	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.14	CHEMBL2148	Homo sapiens	Inhibition	%	0.14
	8064867	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.88	CHEMBL2148	Homo sapiens	Inhibition	%	0.88
	8065033	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.67	CHEMBL2148	Homo sapiens	Inhibition	%	-0.67
	8065373	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.2	CHEMBL2148	Homo sapiens	Inhibition	%	0.2
	8065548	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.61	CHEMBL2148	Homo sapiens	Inhibition	%	-0.61
	8065887	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.01	CHEMBL2148	Homo sapiens	Inhibition	%	-0.01
	8066097	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.09	CHEMBL2148	Homo sapiens	Inhibition	%	2.09
	8066457	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	10.7	CHEMBL2148	Homo sapiens	Inhibition	%	10.7
	8066623	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-1.0	CHEMBL2148	Homo sapiens	Inhibition	%	-1.0
	8066847	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.12	CHEMBL2148	Homo sapiens	Inhibition	%	0.12
	8066971	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.45	CHEMBL2148	Homo sapiens	Inhibition	%	-0.45
	8067146	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.66	CHEMBL2148	Homo sapiens	Inhibition	%	0.66
	8067370	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-1.12	CHEMBL2148	Homo sapiens	Inhibition	%	-1.12
	8067491	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	Inhibition	%	-1.1
	8067701	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	Inhibition	%	0.0
	8067925	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.61	CHEMBL2148	Homo sapiens	Inhibition	%	0.61
	8068060	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	7.71	CHEMBL2148	Homo sapiens	Inhibition	%	7.71
	8068448	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-1.06	CHEMBL2148	Homo sapiens	Inhibition	%	-1.06
	8068573	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.27	CHEMBL2148	Homo sapiens	Inhibition	%	1.27
	8068971	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.84	CHEMBL2148	Homo sapiens	Inhibition	%	0.84
	8069096	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.48	CHEMBL2148	Homo sapiens	Inhibition	%	-0.48
	8069320	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.18	CHEMBL2148	Homo sapiens	Inhibition	%	0.18
	8069391	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	60.48	CHEMBL2148	Homo sapiens	Inhibition	%	60.48
	8069615	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	8.31	CHEMBL2148	Homo sapiens	Inhibition	%	8.31
	8069776	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.94	CHEMBL2148	Homo sapiens	Inhibition	%	-0.94
	8069902	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.53	CHEMBL2148	Homo sapiens	Inhibition	%	0.53
	8070126	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.52	CHEMBL2148	Homo sapiens	Inhibition	%	2.52
	8070298	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-0.93	CHEMBL2148	Homo sapiens	Inhibition	%	-0.93
	8070647	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.23	CHEMBL2148	Homo sapiens	Inhibition	%	0.23
	8070945	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	49.24	CHEMBL2148	Homo sapiens	Inhibition	%	49.24
	8071102	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.31	CHEMBL2148	Homo sapiens	Inhibition	%	-0.31
	8071452	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.65	CHEMBL2148	Homo sapiens	Inhibition	%	0.65
	8071625	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.05	CHEMBL2148	Homo sapiens	Inhibition	%	0.05
	8071974	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.8	CHEMBL2148	Homo sapiens	Inhibition	%	0.8
	8072288	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.1	CHEMBL2148	Homo sapiens	Inhibition	%	1.1
	8072445	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.84	CHEMBL2148	Homo sapiens	Inhibition	%	0.84
	8072794	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.06	CHEMBL2148	Homo sapiens	Inhibition	%	3.06
	8072961	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-1.04	CHEMBL2148	Homo sapiens	Inhibition	%	-1.04
	8073185	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.18	CHEMBL2148	Homo sapiens	Inhibition	%	1.18
	8073310	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.26	CHEMBL2148	Homo sapiens	Inhibition	%	-0.26
	8073653	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.33	CHEMBL2148	Homo sapiens	Inhibition	%	0.33
	8073886	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.02	CHEMBL2148	Homo sapiens	Inhibition	%	2.02
	8074038	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-1.68	CHEMBL2148	Homo sapiens	Inhibition	%	-1.68
	8074262	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.28	CHEMBL2148	Homo sapiens	Inhibition	%	-0.28
	8074392	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.48	CHEMBL2148	Homo sapiens	Inhibition	%	-0.48
	8074773	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	Inhibition	%	-1.1
	8074900	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.75	CHEMBL2148	Homo sapiens	Inhibition	%	0.75
	8075235	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.38	CHEMBL2148	Homo sapiens	Inhibition	%	4.38
	8075472	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.46	CHEMBL2148	Homo sapiens	Inhibition	%	0.46
	8075837	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.9	CHEMBL2148	Homo sapiens	Inhibition	%	-0.9
	8075979	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	14.65	CHEMBL2148	Homo sapiens	Inhibition	%	14.65
	8076203	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.5	CHEMBL2148	Homo sapiens	Inhibition	%	0.5
	8076351	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.74	CHEMBL2148	Homo sapiens	Inhibition	%	0.74
	8076485	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.35	CHEMBL2148	Homo sapiens	Inhibition	%	1.35
	8076709	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.57	CHEMBL2148	Homo sapiens	Inhibition	%	1.57
	8076811	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.1	CHEMBL2148	Homo sapiens	Inhibition	%	0.1
	8077058	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.49	CHEMBL2148	Homo sapiens	Inhibition	%	1.49
	8077282	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.59	CHEMBL2148	Homo sapiens	Inhibition	%	0.59
	8077410	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	9.29	CHEMBL2148	Homo sapiens	Inhibition	%	9.29
	8077785	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	6.44	CHEMBL2148	Homo sapiens	Inhibition	%	6.44
	8077928	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.27	CHEMBL2148	Homo sapiens	Inhibition	%	-0.27
	8078291	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.11	CHEMBL2148	Homo sapiens	Inhibition	%	0.11
	8078393	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.07	CHEMBL2148	Homo sapiens	Inhibition	%	1.07
	8078617	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.58	CHEMBL2148	Homo sapiens	Inhibition	%	-1.58
	8078867	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.54	CHEMBL2148	Homo sapiens	Inhibition	%	3.54
	8078983	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-1.17	CHEMBL2148	Homo sapiens	Inhibition	%	-1.17
	8079365	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.17	CHEMBL2148	Homo sapiens	Inhibition	%	-0.17
	8079507	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.4	CHEMBL2148	Homo sapiens	Inhibition	%	-0.4
	8079731	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.01	CHEMBL2148	Homo sapiens	Inhibition	%	0.01
	8079870	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.25	CHEMBL2148	Homo sapiens	Inhibition	%	8.25
	8080199	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.17	CHEMBL2148	Homo sapiens	Inhibition	%	3.17
	8080451	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.41	CHEMBL2148	Homo sapiens	Inhibition	%	2.41
	8080566	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.29	CHEMBL2148	Homo sapiens	Inhibition	%	1.29
	8080790	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.27	CHEMBL2148	Homo sapiens	Inhibition	%	0.27
	8080954	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	19.66	CHEMBL2148	Homo sapiens	Inhibition	%	19.66
	8081313	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.11	CHEMBL2148	Homo sapiens	Inhibition	%	-0.11
	8081457	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	-0.92	CHEMBL2148	Homo sapiens	Inhibition	%	-0.92
	8081784	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.49	CHEMBL2148	Homo sapiens	Inhibition	%	3.49
	8082036	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	45.55	CHEMBL2148	Homo sapiens	Inhibition	%	45.55
	8082373	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.67	CHEMBL2148	Homo sapiens	Inhibition	%	0.67
	8082546	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.47	CHEMBL2148	Homo sapiens	Inhibition	%	0.47
	8082893	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-1.22	CHEMBL2148	Homo sapiens	Inhibition	%	-1.22
	8083049	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.07	CHEMBL2148	Homo sapiens	Inhibition	%	0.07
	8083273	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	Inhibition	%	-2.0
	8083372	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	51.44	CHEMBL2148	Homo sapiens	Inhibition	%	51.44
	8083626	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.04	CHEMBL2148	Homo sapiens	Inhibition	%	-0.04
	8083960	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.36	CHEMBL2148	Homo sapiens	Inhibition	%	-0.36
	8084145	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.72	CHEMBL2148	Homo sapiens	Inhibition	%	2.72
	8084369	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	14.15	CHEMBL2148	Homo sapiens	Inhibition	%	14.15
	8084487	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.06	CHEMBL2148	Homo sapiens	Inhibition	%	1.06
	8084872	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	18.79	CHEMBL2148	Homo sapiens	Inhibition	%	18.79
	8084970	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.13	CHEMBL2148	Homo sapiens	Inhibition	%	-0.13
	8085194	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.96	CHEMBL2148	Homo sapiens	Inhibition	%	2.96
	8085226	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.98	CHEMBL2148	Homo sapiens	Inhibition	%	3.98
	8085450	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.38	CHEMBL2148	Homo sapiens	Inhibition	%	0.38
	8085558	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-2.05	CHEMBL2148	Homo sapiens	Inhibition	%	-2.05
	8085971	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	67.72	CHEMBL2148	Homo sapiens	Inhibition	%	67.72
	8086086	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.53	CHEMBL2148	Homo sapiens	Inhibition	%	-0.53
	8086472	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-3.69	CHEMBL2148	Homo sapiens	Inhibition	%	-3.69
	8086795	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.14	CHEMBL2148	Homo sapiens	Inhibition	%	-1.14
	8087006	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-4.61	CHEMBL2148	Homo sapiens	Inhibition	%	-4.61
	8087164	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-1.89	CHEMBL2148	Homo sapiens	Inhibition	%	-1.89
	8087388	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-1.95	CHEMBL2148	Homo sapiens	Inhibition	%	-1.95
	8087502	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-1.6	CHEMBL2148	Homo sapiens	Inhibition	%	-1.6
	8087864	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-1.79	CHEMBL2148	Homo sapiens	Inhibition	%	-1.79
	8088006	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.41	CHEMBL2148	Homo sapiens	Inhibition	%	-0.41
	8088378	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.01	CHEMBL2148	Homo sapiens	Inhibition	%	-0.01
	8088506	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-2.17	CHEMBL2148	Homo sapiens	Inhibition	%	-2.17
	8088730	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-3.05	CHEMBL2148	Homo sapiens	Inhibition	%	-3.05
	8088823	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.66	CHEMBL2148	Homo sapiens	Inhibition	%	-0.66
	8089175	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.62	CHEMBL2148	Homo sapiens	Inhibition	%	0.62
	8089323	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.79	CHEMBL2148	Homo sapiens	Inhibition	%	1.79
	8089547	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.65	CHEMBL2148	Homo sapiens	Inhibition	%	5.65
	8089667	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.4	CHEMBL2148	Homo sapiens	Inhibition	%	2.4
	8090071	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.29	CHEMBL2148	Homo sapiens	Inhibition	%	-0.29
	8090236	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.64	CHEMBL2148	Homo sapiens	Inhibition	%	0.64
	8090403	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-0.27	CHEMBL2148	Homo sapiens	Inhibition	%	-0.27
	8090627	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-2.38	CHEMBL2148	Homo sapiens	Inhibition	%	-2.38
	8090766	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.21	CHEMBL2148	Homo sapiens	Inhibition	%	-0.21
	8090971	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.01	CHEMBL2148	Homo sapiens	Inhibition	%	-0.01
	8091195	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	Inhibition	%	-2.0
	8091332	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-3.71	CHEMBL2148	Homo sapiens	Inhibition	%	-3.71
	8091711	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.85	CHEMBL2148	Homo sapiens	Inhibition	%	-0.85
	8091827	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-3.6	CHEMBL2148	Homo sapiens	Inhibition	%	-3.6
	8092051	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-1.96	CHEMBL2148	Homo sapiens	Inhibition	%	-1.96
	8092188	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-6.39	CHEMBL2148	Homo sapiens	Inhibition	%	-6.39
	8092339	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.7	CHEMBL2148	Homo sapiens	Inhibition	%	-0.7
	8092563	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-2.63	CHEMBL2148	Homo sapiens	Inhibition	%	-2.63
	8092711	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.58	CHEMBL2148	Homo sapiens	Inhibition	%	0.58
	8093064	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.97	CHEMBL2148	Homo sapiens	Inhibition	%	1.97
	8093152	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.16	CHEMBL2148	Homo sapiens	Inhibition	%	1.16
	8093376	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.08	CHEMBL2148	Homo sapiens	Inhibition	%	0.08
	8093516	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.56	CHEMBL2148	Homo sapiens	Inhibition	%	1.56
	8093879	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	54.42	CHEMBL2148	Homo sapiens	Inhibition	%	54.42
	8093999	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.9	CHEMBL2148	Homo sapiens	Inhibition	%	0.9
	8094223	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.04	CHEMBL2148	Homo sapiens	Inhibition	%	4.04
	8094403	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.94	CHEMBL2148	Homo sapiens	Inhibition	%	-1.94
	8094578	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.68	CHEMBL2148	Homo sapiens	Inhibition	%	6.68
	8094958	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.04	CHEMBL2148	Homo sapiens	Inhibition	%	0.04
	8095098	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-2.38	CHEMBL2148	Homo sapiens	Inhibition	%	-2.38
	8095322	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-1.69	CHEMBL2148	Homo sapiens	Inhibition	%	-1.69
	8095525	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-1.45	CHEMBL2148	Homo sapiens	Inhibition	%	-1.45
	8095666	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-1.04	CHEMBL2148	Homo sapiens	Inhibition	%	-1.04
	8096038	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-1.67	CHEMBL2148	Homo sapiens	Inhibition	%	-1.67
	8096379	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-4.57	CHEMBL2148	Homo sapiens	Inhibition	%	-4.57
	8096518	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-5.72	CHEMBL2148	Homo sapiens	Inhibition	%	-5.72
	8096898	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.49	CHEMBL2148	Homo sapiens	Inhibition	%	-0.49
	8097045	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.46	CHEMBL2148	Homo sapiens	Inhibition	%	1.46
	8097356	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-5.28	CHEMBL2148	Homo sapiens	Inhibition	%	-5.28
	8097576	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.33	CHEMBL2148	Homo sapiens	Inhibition	%	1.33
	8097726	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.24	CHEMBL2148	Homo sapiens	Inhibition	%	1.24
	8098083	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.56	CHEMBL2148	Homo sapiens	Inhibition	%	-3.56
	8098427	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.45	CHEMBL2148	Homo sapiens	Inhibition	%	-1.45
	8098607	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.31	CHEMBL2148	Homo sapiens	Inhibition	%	0.31
	8098792	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.12	CHEMBL2148	Homo sapiens	Inhibition	%	0.12
	8099016	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	11.55	CHEMBL2148	Homo sapiens	Inhibition	%	11.55
	8099160	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-1.53	CHEMBL2148	Homo sapiens	Inhibition	%	-1.53
	8099526	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-2.98	CHEMBL2148	Homo sapiens	Inhibition	%	-2.98
	8099720	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.62	CHEMBL2148	Homo sapiens	Inhibition	%	-1.62
	8099867	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	0.49	CHEMBL2148	Homo sapiens	Inhibition	%	0.49
	8100091	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.38	CHEMBL2148	Homo sapiens	Inhibition	%	-0.38
	8100237	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.82	CHEMBL2148	Homo sapiens	Inhibition	%	1.82
	8100577	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.36	CHEMBL2148	Homo sapiens	Inhibition	%	2.36
	8100717	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.01	CHEMBL2148	Homo sapiens	Inhibition	%	-1.01
	8100941	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.24	CHEMBL2148	Homo sapiens	Inhibition	%	-0.24
	8101101	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	Inhibition	%	-2.0
	8101243	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.31	CHEMBL2148	Homo sapiens	Inhibition	%	1.31
	8101467	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.1	CHEMBL2148	Homo sapiens	Inhibition	%	-0.1
	8101652	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-7.0	CHEMBL2148	Homo sapiens	Inhibition	%	-7.0
	8101905	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.32	CHEMBL2148	Homo sapiens	Inhibition	%	0.32
	8102060	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	4.39	CHEMBL2148	Homo sapiens	Inhibition	%	4.39
	8102284	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.54	CHEMBL2148	Homo sapiens	Inhibition	%	0.54
	8102415	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.66	CHEMBL2148	Homo sapiens	Inhibition	%	0.66
	8102759	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.13	CHEMBL2148	Homo sapiens	Inhibition	%	-1.13
	8102937	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-2.56	CHEMBL2148	Homo sapiens	Inhibition	%	-2.56
	8103357	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	Inhibition	%	-2.0
	8103495	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.54	CHEMBL2148	Homo sapiens	Inhibition	%	0.54
	8103869	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-1.59	CHEMBL2148	Homo sapiens	Inhibition	%	-1.59
	8104054	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.11	CHEMBL2148	Homo sapiens	Inhibition	%	-1.11
	8104426	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.11	CHEMBL2148	Homo sapiens	Inhibition	%	1.11
	8104572	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-4.76	CHEMBL2148	Homo sapiens	Inhibition	%	-4.76
	8104796	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	24.05	CHEMBL2148	Homo sapiens	Inhibition	%	24.05
	8104910	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-3.92	CHEMBL2148	Homo sapiens	Inhibition	%	-3.92
	8105274	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.38	CHEMBL2148	Homo sapiens	Inhibition	%	0.38
	8105440	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.37	CHEMBL2148	Homo sapiens	Inhibition	%	0.37
	8105802	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	12.65	CHEMBL2148	Homo sapiens	Inhibition	%	12.65
	8106082	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.59	CHEMBL2148	Homo sapiens	Inhibition	%	0.59
	8106247	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	24.85	CHEMBL2148	Homo sapiens	Inhibition	%	24.85
	8106627	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	25.18	CHEMBL2148	Homo sapiens	Inhibition	%	25.18
	8106756	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.47	CHEMBL2148	Homo sapiens	Inhibition	%	-0.47
	8106980	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.16	CHEMBL2148	Homo sapiens	Inhibition	%	2.16
	8107101	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.38	CHEMBL2148	Homo sapiens	Inhibition	%	-1.38
	8107273	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.1	CHEMBL2148	Homo sapiens	Inhibition	%	-0.1
	8107497	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-1.17	CHEMBL2148	Homo sapiens	Inhibition	%	-1.17
	8107698	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-0.34	CHEMBL2148	Homo sapiens	Inhibition	%	-0.34
	8107833	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.62	CHEMBL2148	Homo sapiens	Inhibition	%	-1.62
	8108057	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.72	CHEMBL2148	Homo sapiens	Inhibition	%	2.72
	8108215	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-2.82	CHEMBL2148	Homo sapiens	Inhibition	%	-2.82
	8108390	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.87	CHEMBL2148	Homo sapiens	Inhibition	%	-0.87
	8108614	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.3	CHEMBL2148	Homo sapiens	Inhibition	%	-0.3
	8108761	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-1.46	CHEMBL2148	Homo sapiens	Inhibition	%	-1.46
	8109127	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.16	CHEMBL2148	Homo sapiens	Inhibition	%	0.16
	8109241	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.56	CHEMBL2148	Homo sapiens	Inhibition	%	1.56
	8109595	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.37	CHEMBL2148	Homo sapiens	Inhibition	%	-0.37
	8109766	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-5.38	CHEMBL2148	Homo sapiens	Inhibition	%	-5.38
	8109990	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	13.47	CHEMBL2148	Homo sapiens	Inhibition	%	13.47
	8110122	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-3.48	CHEMBL2148	Homo sapiens	Inhibition	%	-3.48
	8110401	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.13	CHEMBL2148	Homo sapiens	Inhibition	%	4.13
	8110567	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.83	CHEMBL2148	Homo sapiens	Inhibition	%	-2.83
	8110791	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.89	CHEMBL2148	Homo sapiens	Inhibition	%	-1.89
	8110949	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.62	CHEMBL2148	Homo sapiens	Inhibition	%	5.62
	8111296	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-1.05	CHEMBL2148	Homo sapiens	Inhibition	%	-1.05
	8111423	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.25	CHEMBL2148	Homo sapiens	Inhibition	%	-0.25
	8111813	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.71	CHEMBL2148	Homo sapiens	Inhibition	%	0.71
	8112018	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-0.81	CHEMBL2148	Homo sapiens	Inhibition	%	-0.81
	8112379	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.14	CHEMBL2148	Homo sapiens	Inhibition	%	-1.14
	8112547	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-0.34	CHEMBL2148	Homo sapiens	Inhibition	%	-0.34
	8112943	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.19	CHEMBL2148	Homo sapiens	Inhibition	%	-0.19
	8113095	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	29.26	CHEMBL2148	Homo sapiens	Inhibition	%	29.26
	8113455	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.6	CHEMBL2148	Homo sapiens	Inhibition	%	2.6
	8113579	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-2.52	CHEMBL2148	Homo sapiens	Inhibition	%	-2.52
	8113803	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.16	CHEMBL2148	Homo sapiens	Inhibition	%	-0.16
	8113919	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.4	CHEMBL2148	Homo sapiens	Inhibition	%	-0.4
	8114319	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-1.49	CHEMBL2148	Homo sapiens	Inhibition	%	-1.49
	8114451	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-1.92	CHEMBL2148	Homo sapiens	Inhibition	%	-1.92
	8114727	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.78	CHEMBL2148	Homo sapiens	Inhibition	%	0.78
	8115117	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.84	CHEMBL2148	Homo sapiens	Inhibition	%	-0.84
	8115282	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.64	CHEMBL2148	Homo sapiens	Inhibition	%	4.64
	8115626	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.13	CHEMBL2148	Homo sapiens	Inhibition	%	1.13
	8115759	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-2.14	CHEMBL2148	Homo sapiens	Inhibition	%	-2.14
	8115983	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.33	CHEMBL2148	Homo sapiens	Inhibition	%	0.33
	8116142	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.67	CHEMBL2148	Homo sapiens	Inhibition	%	-0.67
	8116345	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-0.44	CHEMBL2148	Homo sapiens	Inhibition	%	-0.44
	8116703	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.38	CHEMBL2148	Homo sapiens	Inhibition	%	0.38
	8116875	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-2.63	CHEMBL2148	Homo sapiens	Inhibition	%	-2.63
	8117099	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.64	CHEMBL2148	Homo sapiens	Inhibition	%	-0.64
	8117270	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.82	CHEMBL2148	Homo sapiens	Inhibition	%	0.82
	8117428	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-2.54	CHEMBL2148	Homo sapiens	Inhibition	%	-2.54
	8117652	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-0.89	CHEMBL2148	Homo sapiens	Inhibition	%	-0.89
	8117782	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.91	CHEMBL2148	Homo sapiens	Inhibition	%	0.91
	8118144	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-5.49	CHEMBL2148	Homo sapiens	Inhibition	%	-5.49
	8118260	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.32	CHEMBL2148	Homo sapiens	Inhibition	%	-0.32
	8118484	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.08	CHEMBL2148	Homo sapiens	Inhibition	%	0.08
	8118656	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.32	CHEMBL2148	Homo sapiens	Inhibition	%	0.32
	8118792	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-3.93	CHEMBL2148	Homo sapiens	Inhibition	%	-3.93
	8119016	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-1.55	CHEMBL2148	Homo sapiens	Inhibition	%	-1.55
	8119063	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.02	CHEMBL2148	Homo sapiens	Inhibition	%	3.02
	8119287	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.71	CHEMBL2148	Homo sapiens	Inhibition	%	0.71
	8119446	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.36	CHEMBL2148	Homo sapiens	Inhibition	%	1.36
	8119613	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.07	CHEMBL2148	Homo sapiens	Inhibition	%	2.07
	8119837	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.66	CHEMBL2148	Homo sapiens	Inhibition	%	2.66
	8119956	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.02	CHEMBL2148	Homo sapiens	Inhibition	%	-0.02
	8120319	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-2.23	CHEMBL2148	Homo sapiens	Inhibition	%	-2.23
	8120479	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	13.47	CHEMBL2148	Homo sapiens	Inhibition	%	13.47
	8120680	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-2.24	CHEMBL2148	Homo sapiens	Inhibition	%	-2.24
	8120904	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-1.24	CHEMBL2148	Homo sapiens	Inhibition	%	-1.24
	8121032	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.51	CHEMBL2148	Homo sapiens	Inhibition	%	-0.51
	8121428	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-2.28	CHEMBL2148	Homo sapiens	Inhibition	%	-2.28
	8121595	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.74	CHEMBL2148	Homo sapiens	Inhibition	%	0.74
	8121982	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-2.53	CHEMBL2148	Homo sapiens	Inhibition	%	-2.53
	8122103	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.44	CHEMBL2148	Homo sapiens	Inhibition	%	2.44
	8122465	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.81	CHEMBL2148	Homo sapiens	Inhibition	%	-1.81
	8122809	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.75	CHEMBL2148	Homo sapiens	Inhibition	%	-0.75
	8122976	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-1.47	CHEMBL2148	Homo sapiens	Inhibition	%	-1.47
	8123342	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-6.46	CHEMBL2148	Homo sapiens	Inhibition	%	-6.46
	8123620	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-1.63	CHEMBL2148	Homo sapiens	Inhibition	%	-1.63
	8123770	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-0.33	CHEMBL2148	Homo sapiens	Inhibition	%	-0.33
	8124161	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.48	CHEMBL2148	Homo sapiens	Inhibition	%	-2.48
	8124280	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.43	CHEMBL2148	Homo sapiens	Inhibition	%	3.43
	8124504	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.03	CHEMBL2148	Homo sapiens	Inhibition	%	2.03
	8124643	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.23	CHEMBL2148	Homo sapiens	Inhibition	%	1.23
	8124808	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.78	CHEMBL2148	Homo sapiens	Inhibition	%	-0.78
	8125032	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.24	CHEMBL2148	Homo sapiens	Inhibition	%	1.24
	8125233	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-1.25	CHEMBL2148	Homo sapiens	Inhibition	%	-1.25
	8125363	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.08	CHEMBL2148	Homo sapiens	Inhibition	%	1.08
	8125587	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.15	CHEMBL2148	Homo sapiens	Inhibition	%	-0.15
	8125755	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.16	CHEMBL2148	Homo sapiens	Inhibition	%	-1.16
	8125919	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.91	CHEMBL2148	Homo sapiens	Inhibition	%	5.91
	8126307	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.23	CHEMBL2148	Homo sapiens	Inhibition	%	0.23
	8126422	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.28	CHEMBL2148	Homo sapiens	Inhibition	%	0.28
	8126646	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	Inhibition	%	1.0
	8126782	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.45	CHEMBL2148	Homo sapiens	Inhibition	%	6.45
	8127128	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.04	CHEMBL2148	Homo sapiens	Inhibition	%	1.04
	8127295	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-1.15	CHEMBL2148	Homo sapiens	Inhibition	%	-1.15
	8127661	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.61	CHEMBL2148	Homo sapiens	Inhibition	%	-2.61
	8127949	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.02	CHEMBL2148	Homo sapiens	Inhibition	%	0.02
	8128101	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.39	CHEMBL2148	Homo sapiens	Inhibition	%	4.39
	8128325	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.76	CHEMBL2148	Homo sapiens	Inhibition	%	-0.76
	8128492	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.19	CHEMBL2148	Homo sapiens	Inhibition	%	-2.19
	8128835	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	44.17	CHEMBL2148	Homo sapiens	Inhibition	%	44.17
	8128972	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-2.64	CHEMBL2148	Homo sapiens	Inhibition	%	-2.64
	8129367	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.61	CHEMBL2148	Homo sapiens	Inhibition	%	-0.61
	8129556	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.22	CHEMBL2148	Homo sapiens	Inhibition	%	-0.22
	8129919	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.02	CHEMBL2148	Homo sapiens	Inhibition	%	0.02
	8130080	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.54	CHEMBL2148	Homo sapiens	Inhibition	%	-1.54
	8130252	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.12	CHEMBL2148	Homo sapiens	Inhibition	%	0.12
	8130476	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.09	CHEMBL2148	Homo sapiens	Inhibition	%	1.09
	8130636	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-3.13	CHEMBL2148	Homo sapiens	Inhibition	%	-3.13
	8130976	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-3.03	CHEMBL2148	Homo sapiens	Inhibition	%	-3.03
	8131115	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	54.36	CHEMBL2148	Homo sapiens	Inhibition	%	54.36
	8131339	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-1.33	CHEMBL2148	Homo sapiens	Inhibition	%	-1.33
	8131459	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.1	CHEMBL2148	Homo sapiens	Inhibition	%	0.1
	8131626	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	-1.97	CHEMBL2148	Homo sapiens	Inhibition	%	-1.97
	8131850	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.45	CHEMBL2148	Homo sapiens	Inhibition	%	0.45
	8131991	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-4.17	CHEMBL2148	Homo sapiens	Inhibition	%	-4.17
	8132277	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.74	CHEMBL2148	Homo sapiens	Inhibition	%	1.74
	8132648	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.31	CHEMBL2148	Homo sapiens	Inhibition	%	1.31
	8132816	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.51	CHEMBL2148	Homo sapiens	Inhibition	%	1.51
	8133161	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.04	CHEMBL2148	Homo sapiens	Inhibition	%	-0.04
	8133299	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	24.46	CHEMBL2148	Homo sapiens	Inhibition	%	24.46
	8133523	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-2.12	CHEMBL2148	Homo sapiens	Inhibition	%	-2.12
	8133695	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.8	CHEMBL2148	Homo sapiens	Inhibition	%	1.8
	8133875	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-1.34	CHEMBL2148	Homo sapiens	Inhibition	%	-1.34
	8134247	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.88	CHEMBL2148	Homo sapiens	Inhibition	%	-0.88
	8134407	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.63	CHEMBL2148	Homo sapiens	Inhibition	%	-1.63
	8134815	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.43	CHEMBL2148	Homo sapiens	Inhibition	%	0.43
	8134975	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	14.2	CHEMBL2148	Homo sapiens	Inhibition	%	14.2
	8135314	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-2.29	CHEMBL2148	Homo sapiens	Inhibition	%	-2.29
	8135679	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.46	CHEMBL2148	Homo sapiens	Inhibition	%	4.46
	8135800	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-3.84	CHEMBL2148	Homo sapiens	Inhibition	%	-3.84
	8136192	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-1.99	CHEMBL2148	Homo sapiens	Inhibition	%	-1.99
	8136336	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-2.01	CHEMBL2148	Homo sapiens	Inhibition	%	-2.01
	8136560	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-2.3	CHEMBL2148	Homo sapiens	Inhibition	%	-2.3
	8136626	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.43	CHEMBL2148	Homo sapiens	Inhibition	%	-3.43
	8136985	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.78	CHEMBL2148	Homo sapiens	Inhibition	%	0.78
	8137148	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.32	CHEMBL2148	Homo sapiens	Inhibition	%	2.32
	8137372	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-1.09	CHEMBL2148	Homo sapiens	Inhibition	%	-1.09
	8137492	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.94	CHEMBL2148	Homo sapiens	Inhibition	%	2.94
	8137864	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.45	CHEMBL2148	Homo sapiens	Inhibition	%	1.45
	8138030	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.04	CHEMBL2148	Homo sapiens	Inhibition	%	-1.04
	8138209	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	26.24	CHEMBL2148	Homo sapiens	Inhibition	%	26.24
	8138433	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.8	CHEMBL2148	Homo sapiens	Inhibition	%	-0.8
	8138581	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.39	CHEMBL2148	Homo sapiens	Inhibition	%	0.39
	8138739	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-1.84	CHEMBL2148	Homo sapiens	Inhibition	%	-1.84
	8138963	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.47	CHEMBL2148	Homo sapiens	Inhibition	%	-0.47
	8139148	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	8.16	CHEMBL2148	Homo sapiens	Inhibition	%	8.16
	8139307	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.16	CHEMBL2148	Homo sapiens	Inhibition	%	0.16
	8139531	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.72	CHEMBL2148	Homo sapiens	Inhibition	%	0.72
	8139645	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-4.36	CHEMBL2148	Homo sapiens	Inhibition	%	-4.36
	8140010	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-1.66	CHEMBL2148	Homo sapiens	Inhibition	%	-1.66
	8140133	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-5.11	CHEMBL2148	Homo sapiens	Inhibition	%	-5.11
	8140357	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.39	CHEMBL2148	Homo sapiens	Inhibition	%	0.39
	8140516	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-2.7	CHEMBL2148	Homo sapiens	Inhibition	%	-2.7
	8140883	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-2.01	CHEMBL2148	Homo sapiens	Inhibition	%	-2.01
	8140961	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.47	CHEMBL2148	Homo sapiens	Inhibition	%	-3.47
	8141185	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.19	CHEMBL2148	Homo sapiens	Inhibition	%	0.19
	8141315	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	17.99	CHEMBL2148	Homo sapiens	Inhibition	%	17.99
	8141699	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	8.21	CHEMBL2148	Homo sapiens	Inhibition	%	8.21
	8141818	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.28	CHEMBL2148	Homo sapiens	Inhibition	%	-3.28
	8142203	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.66	CHEMBL2148	Homo sapiens	Inhibition	%	-1.66
	8142371	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.45	CHEMBL2148	Homo sapiens	Inhibition	%	2.45
	8142771	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.6	CHEMBL2148	Homo sapiens	Inhibition	%	1.6
	8142920	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.73	CHEMBL2148	Homo sapiens	Inhibition	%	0.73
	8143299	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-2.62	CHEMBL2148	Homo sapiens	Inhibition	%	-2.62
	8143486	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.81	CHEMBL2148	Homo sapiens	Inhibition	%	-0.81
	8143869	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-1.71	CHEMBL2148	Homo sapiens	Inhibition	%	-1.71
	8143983	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-1.51	CHEMBL2148	Homo sapiens	Inhibition	%	-1.51
	8144207	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-5.54	CHEMBL2148	Homo sapiens	Inhibition	%	-5.54
	8144346	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-0.12	CHEMBL2148	Homo sapiens	Inhibition	%	-0.12
	8144700	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-1.13	CHEMBL2148	Homo sapiens	Inhibition	%	-1.13
	8144853	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-1.74	CHEMBL2148	Homo sapiens	Inhibition	%	-1.74
	8145214	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-3.52	CHEMBL2148	Homo sapiens	Inhibition	%	-3.52
	8145527	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.18	CHEMBL2148	Homo sapiens	Inhibition	%	0.18
	8145651	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.01	CHEMBL2148	Homo sapiens	Inhibition	%	0.01
	8146036	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.53	CHEMBL2148	Homo sapiens	Inhibition	%	0.53
	8146156	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.59	CHEMBL2148	Homo sapiens	Inhibition	%	-0.59
	8146380	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.15	CHEMBL2148	Homo sapiens	Inhibition	%	-1.15
	8146540	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.04	CHEMBL2148	Homo sapiens	Inhibition	%	-0.04
	8146707	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.8	CHEMBL2148	Homo sapiens	Inhibition	%	-0.8
	8146931	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	30.11	CHEMBL2148	Homo sapiens	Inhibition	%	30.11
	8147100	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-1.35	CHEMBL2148	Homo sapiens	Inhibition	%	-1.35
	8147242	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.51	CHEMBL2148	Homo sapiens	Inhibition	%	1.51
	8147466	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-1.84	CHEMBL2148	Homo sapiens	Inhibition	%	-1.84
	8147619	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.39	CHEMBL2148	Homo sapiens	Inhibition	%	-0.39
	8147806	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-3.69	CHEMBL2148	Homo sapiens	Inhibition	%	-3.69
	8148030	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.39	CHEMBL2148	Homo sapiens	Inhibition	%	1.39
	8148188	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-2.26	CHEMBL2148	Homo sapiens	Inhibition	%	-2.26
	8148526	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-5.98	CHEMBL2148	Homo sapiens	Inhibition	%	-5.98
	8148665	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-3.07	CHEMBL2148	Homo sapiens	Inhibition	%	-3.07
	8149027	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-0.36	CHEMBL2148	Homo sapiens	Inhibition	%	-0.36
	8149186	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.38	CHEMBL2148	Homo sapiens	Inhibition	%	-0.38
	8149410	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-5.68	CHEMBL2148	Homo sapiens	Inhibition	%	-5.68
	8149544	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-1.28	CHEMBL2148	Homo sapiens	Inhibition	%	-1.28
	8149866	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.21	CHEMBL2148	Homo sapiens	Inhibition	%	0.21
	8149991	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.11	CHEMBL2148	Homo sapiens	Inhibition	%	2.11
	8150215	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.43	CHEMBL2148	Homo sapiens	Inhibition	%	-3.43
	8150375	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.77	CHEMBL2148	Homo sapiens	Inhibition	%	2.77
	8150719	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.49	CHEMBL2148	Homo sapiens	Inhibition	%	2.49
	8150884	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.19	CHEMBL2148	Homo sapiens	Inhibition	%	-2.19
	8151271	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.08	CHEMBL2148	Homo sapiens	Inhibition	%	1.08
	8151448	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.59	CHEMBL2148	Homo sapiens	Inhibition	%	0.59
	8151810	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.12	CHEMBL2148	Homo sapiens	Inhibition	%	-0.12
	8151964	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-3.85	CHEMBL2148	Homo sapiens	Inhibition	%	-3.85
	8152376	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.25	CHEMBL2148	Homo sapiens	Inhibition	%	7.25
	8152534	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-1.29	CHEMBL2148	Homo sapiens	Inhibition	%	-1.29
	8152872	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-1.93	CHEMBL2148	Homo sapiens	Inhibition	%	-1.93
	8153011	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.98	CHEMBL2148	Homo sapiens	Inhibition	%	-0.98
	8153235	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-2.47	CHEMBL2148	Homo sapiens	Inhibition	%	-2.47
	8153372	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-0.92	CHEMBL2148	Homo sapiens	Inhibition	%	-0.92
	8153753	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-5.16	CHEMBL2148	Homo sapiens	Inhibition	%	-5.16
	8153886	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-3.8	CHEMBL2148	Homo sapiens	Inhibition	%	-3.8
	8154207	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.11	CHEMBL2148	Homo sapiens	Inhibition	%	-1.11
	8154557	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.59	CHEMBL2148	Homo sapiens	Inhibition	%	-2.59
	8154716	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.04	CHEMBL2148	Homo sapiens	Inhibition	%	-1.04
	8155060	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.07	CHEMBL2148	Homo sapiens	Inhibition	%	0.07
	8155236	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.7	CHEMBL2148	Homo sapiens	Inhibition	%	-1.7
	8155460	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.7	CHEMBL2148	Homo sapiens	Inhibition	%	-1.7
	8155621	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.55	CHEMBL2148	Homo sapiens	Inhibition	%	2.55
	8155799	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-2.87	CHEMBL2148	Homo sapiens	Inhibition	%	-2.87
	8156161	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-1.95	CHEMBL2148	Homo sapiens	Inhibition	%	-1.95
	8156373	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.42	CHEMBL2148	Homo sapiens	Inhibition	%	4.42
	8156747	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.72	CHEMBL2148	Homo sapiens	Inhibition	%	1.72
	8156890	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-0.66	CHEMBL2148	Homo sapiens	Inhibition	%	-0.66
	8157114	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.55	CHEMBL2148	Homo sapiens	Inhibition	%	3.55
	8157234	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	15.61	CHEMBL2148	Homo sapiens	Inhibition	%	15.61
	8157599	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.52	CHEMBL2148	Homo sapiens	Inhibition	%	-0.52
	8157729	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	9.29	CHEMBL2148	Homo sapiens	Inhibition	%	9.29
	8158114	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.61	CHEMBL2148	Homo sapiens	Inhibition	%	3.61
	8158364	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-0.93	CHEMBL2148	Homo sapiens	Inhibition	%	-0.93
	8158522	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.85	CHEMBL2148	Homo sapiens	Inhibition	%	-2.85
	8158746	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.32	CHEMBL2148	Homo sapiens	Inhibition	%	2.32
	8158915	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.26	CHEMBL2148	Homo sapiens	Inhibition	%	-0.26
	8159274	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.56	CHEMBL2148	Homo sapiens	Inhibition	%	-0.56
	8159394	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	42.3	CHEMBL2148	Homo sapiens	Inhibition	%	42.3
	8159749	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.25	CHEMBL2148	Homo sapiens	Inhibition	%	1.25
	8159890	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.19	CHEMBL2148	Homo sapiens	Inhibition	%	-0.19
	8160114	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.04	CHEMBL2148	Homo sapiens	Inhibition	%	-0.04
	8160251	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-0.09	CHEMBL2148	Homo sapiens	Inhibition	%	-0.09
	8160401	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.66	CHEMBL2148	Homo sapiens	Inhibition	%	2.66
	8160625	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.29	CHEMBL2148	Homo sapiens	Inhibition	%	1.29
	8160695	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-0.9	CHEMBL2148	Homo sapiens	Inhibition	%	-0.9
	8160919	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.42	CHEMBL2148	Homo sapiens	Inhibition	%	2.42
	8161069	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.77	CHEMBL2148	Homo sapiens	Inhibition	%	-0.77
	8161436	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.94	CHEMBL2148	Homo sapiens	Inhibition	%	1.94
	8161561	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	68.75	CHEMBL2148	Homo sapiens	Inhibition	%	68.75
	8161923	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.91	CHEMBL2148	Homo sapiens	Inhibition	%	4.91
	8162053	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.12	CHEMBL2148	Homo sapiens	Inhibition	%	6.12
	8162277	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	53.93	CHEMBL2148	Homo sapiens	Inhibition	%	53.93
	8162437	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.58	CHEMBL2148	Homo sapiens	Inhibition	%	-2.58
	8162690	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.95	CHEMBL2148	Homo sapiens	Inhibition	%	-0.95
	8163062	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	22.74	CHEMBL2148	Homo sapiens	Inhibition	%	22.74
	8163231	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.99	CHEMBL2148	Homo sapiens	Inhibition	%	-0.99
	8163589	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-2.5	CHEMBL2148	Homo sapiens	Inhibition	%	-2.5
	8163712	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-3.51	CHEMBL2148	Homo sapiens	Inhibition	%	-3.51
	8163936	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.02	CHEMBL2148	Homo sapiens	Inhibition	%	2.02
	8164070	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-1.48	CHEMBL2148	Homo sapiens	Inhibition	%	-1.48
	8164434	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.01	CHEMBL2148	Homo sapiens	Inhibition	%	-0.01
	8164589	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.28	CHEMBL2148	Homo sapiens	Inhibition	%	1.28
	8164957	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.69	CHEMBL2148	Homo sapiens	Inhibition	%	2.69
	8165251	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.81	CHEMBL2148	Homo sapiens	Inhibition	%	2.81
	8165392	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.15	CHEMBL2148	Homo sapiens	Inhibition	%	7.15
	8165759	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	45.97	CHEMBL2148	Homo sapiens	Inhibition	%	45.97
	8165885	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.39	CHEMBL2148	Homo sapiens	Inhibition	%	0.39
	8166109	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	21.82	CHEMBL2148	Homo sapiens	Inhibition	%	21.82
	8166247	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-1.55	CHEMBL2148	Homo sapiens	Inhibition	%	-1.55
	8166601	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.73	CHEMBL2148	Homo sapiens	Inhibition	%	0.73
	8166702	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.48	CHEMBL2148	Homo sapiens	Inhibition	%	1.48
	8166926	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	27.75	CHEMBL2148	Homo sapiens	Inhibition	%	27.75
	8167014	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.29	CHEMBL2148	Homo sapiens	Inhibition	%	-0.29
	8167379	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	63.69	CHEMBL2148	Homo sapiens	Inhibition	%	63.69
	8167543	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-0.84	CHEMBL2148	Homo sapiens	Inhibition	%	-0.84
	8167767	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.51	CHEMBL2148	Homo sapiens	Inhibition	%	1.51
	8167900	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-1.62	CHEMBL2148	Homo sapiens	Inhibition	%	-1.62
	8168248	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.07	CHEMBL2148	Homo sapiens	Inhibition	%	1.07
	8168389	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-3.27	CHEMBL2148	Homo sapiens	Inhibition	%	-3.27
	8168749	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.6	CHEMBL2148	Homo sapiens	Inhibition	%	-0.6
	8168913	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.73	CHEMBL2148	Homo sapiens	Inhibition	%	5.73
	8169137	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	36.18	CHEMBL2148	Homo sapiens	Inhibition	%	36.18
	8169279	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.85	CHEMBL2148	Homo sapiens	Inhibition	%	-0.85
	8169583	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.89	CHEMBL2148	Homo sapiens	Inhibition	%	0.89
	8169717	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-1.06	CHEMBL2148	Homo sapiens	Inhibition	%	-1.06
	8169941	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	10.08	CHEMBL2148	Homo sapiens	Inhibition	%	10.08
	8170086	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.06	CHEMBL2148	Homo sapiens	Inhibition	%	0.06
	8170435	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	Inhibition	%	0.0
	8170575	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.11	CHEMBL2148	Homo sapiens	Inhibition	%	1.11
	8170799	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-4.99	CHEMBL2148	Homo sapiens	Inhibition	%	-4.99
	8170934	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.09	CHEMBL2148	Homo sapiens	Inhibition	%	9.09
	8171131	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.29	CHEMBL2148	Homo sapiens	Inhibition	%	0.29
	8171348	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.31	CHEMBL2148	Homo sapiens	Inhibition	%	0.31
	8171572	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.45	CHEMBL2148	Homo sapiens	Inhibition	%	-0.45
	8171713	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	0.41	CHEMBL2148	Homo sapiens	Inhibition	%	0.41
	8172090	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-4.29	CHEMBL2148	Homo sapiens	Inhibition	%	-4.29
	8172222	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-1.23	CHEMBL2148	Homo sapiens	Inhibition	%	-1.23
	8172574	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	30.77	CHEMBL2148	Homo sapiens	Inhibition	%	30.77
	8172716	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	-1.31	CHEMBL2148	Homo sapiens	Inhibition	%	-1.31
	8172940	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	-0.86	CHEMBL2148	Homo sapiens	Inhibition	%	-0.86
	8173076	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.5	CHEMBL2148	Homo sapiens	Inhibition	%	-0.5
	8173465	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	-0.96	CHEMBL2148	Homo sapiens	Inhibition	%	-0.96
	8173606	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.11	CHEMBL2148	Homo sapiens	Inhibition	%	1.11
	8173917	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	0.03	CHEMBL2148	Homo sapiens	Inhibition	%	0.03
	8174273	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-1.76	CHEMBL2148	Homo sapiens	Inhibition	%	-1.76
	8174421	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.78	CHEMBL2148	Homo sapiens	Inhibition	%	0.78
	8174767	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.14	CHEMBL2148	Homo sapiens	Inhibition	%	4.14
	8175134	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-3.39	CHEMBL2148	Homo sapiens	Inhibition	%	-3.39
	8175270	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.01	CHEMBL2148	Homo sapiens	Inhibition	%	0.01
	8175526	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	Inhibition	%	-1.1
	8175913	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-0.24	CHEMBL2148	Homo sapiens	Inhibition	%	-0.24
	8176066	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.42	CHEMBL2148	Homo sapiens	Inhibition	%	1.42
	8176439	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.79	CHEMBL2148	Homo sapiens	Inhibition	%	0.79
	8176571	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-1.44	CHEMBL2148	Homo sapiens	Inhibition	%	-1.44
	8176795	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.66	CHEMBL2148	Homo sapiens	Inhibition	%	8.66
	8176925	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.46	CHEMBL2148	Homo sapiens	Inhibition	%	-0.46
	8177291	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-4.63	CHEMBL2148	Homo sapiens	Inhibition	%	-4.63
	8177429	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.58	CHEMBL2148	Homo sapiens	Inhibition	%	1.58
	8177653	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-1.14	CHEMBL2148	Homo sapiens	Inhibition	%	-1.14
	8177817	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	10.56	CHEMBL2148	Homo sapiens	Inhibition	%	10.56
	8177957	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	Inhibition	%	-1.1
	8178181	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	15.85	CHEMBL2148	Homo sapiens	Inhibition	%	15.85
	8178269	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.43	CHEMBL2148	Homo sapiens	Inhibition	%	3.43
	8178620	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.99	CHEMBL2148	Homo sapiens	Inhibition	%	0.99
	8178769	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.66	CHEMBL2148	Homo sapiens	Inhibition	%	-0.66
	8178993	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.07	CHEMBL2148	Homo sapiens	Inhibition	%	0.07
	8179116	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-1.24	CHEMBL2148	Homo sapiens	Inhibition	%	-1.24
	8179484	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-0.81	CHEMBL2148	Homo sapiens	Inhibition	%	-0.81
	8179621	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.19	CHEMBL2148	Homo sapiens	Inhibition	%	6.19
	8179845	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.2	CHEMBL2148	Homo sapiens	Inhibition	%	0.2
	8179878	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.49	CHEMBL2148	Homo sapiens	Inhibition	%	6.49
	8180102	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-1.09	CHEMBL2148	Homo sapiens	Inhibition	%	-1.09
	8180256	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	27.29	CHEMBL2148	Homo sapiens	Inhibition	%	27.29
	8180412	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	-0.04	CHEMBL2148	Homo sapiens	Inhibition	%	-0.04
	8180636	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.57	CHEMBL2148	Homo sapiens	Inhibition	%	1.57
	8180784	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-0.16	CHEMBL2148	Homo sapiens	Inhibition	%	-0.16
	8181141	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	-1.23	CHEMBL2148	Homo sapiens	Inhibition	%	-1.23
	8181272	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.76	CHEMBL2148	Homo sapiens	Inhibition	%	4.76
	8181496	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.45	CHEMBL2148	Homo sapiens	Inhibition	%	-0.45
	8181636	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-3.88	CHEMBL2148	Homo sapiens	Inhibition	%	-3.88
	8181999	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	12.76	CHEMBL2148	Homo sapiens	Inhibition	%	12.76
	8182162	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-0.98	CHEMBL2148	Homo sapiens	Inhibition	%	-0.98
	8182526	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-1.12	CHEMBL2148	Homo sapiens	Inhibition	%	-1.12
	8182618	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.68	CHEMBL2148	Homo sapiens	Inhibition	%	-0.68
	8182842	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.63	CHEMBL2148	Homo sapiens	Inhibition	%	1.63
	8182964	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-1.52	CHEMBL2148	Homo sapiens	Inhibition	%	-1.52
	8183337	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-1.19	CHEMBL2148	Homo sapiens	Inhibition	%	-1.19
	8183466	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.79	CHEMBL2148	Homo sapiens	Inhibition	%	1.79
	8183690	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.03	CHEMBL2148	Homo sapiens	Inhibition	%	6.03
	8183832	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.2	CHEMBL2148	Homo sapiens	Inhibition	%	6.2
	8184192	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.79	CHEMBL2148	Homo sapiens	Inhibition	%	2.79
	8184458	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-0.3	CHEMBL2148	Homo sapiens	Inhibition	%	-0.3
	8184605	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-3.97	CHEMBL2148	Homo sapiens	Inhibition	%	-3.97
	8184986	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.15	CHEMBL2148	Homo sapiens	Inhibition	%	-0.15
	8185135	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	20.42	CHEMBL2148	Homo sapiens	Inhibition	%	20.42
	8185490	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	0.26	CHEMBL2148	Homo sapiens	Inhibition	%	0.26
	8185845	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.44	CHEMBL2148	Homo sapiens	Inhibition	%	6.44
	8185984	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-1.69	CHEMBL2148	Homo sapiens	Inhibition	%	-1.69
	8186349	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-1.36	CHEMBL2148	Homo sapiens	Inhibition	%	-1.36
	8186513	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.8	CHEMBL2148	Homo sapiens	Inhibition	%	1.8
	8186737	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-0.7	CHEMBL2148	Homo sapiens	Inhibition	%	-0.7
	8186876	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.59	CHEMBL2148	Homo sapiens	Inhibition	%	0.59
	8187198	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.77	CHEMBL2148	Homo sapiens	Inhibition	%	-0.77
	8187322	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.02	CHEMBL2148	Homo sapiens	Inhibition	%	1.02
	8187546	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-0.93	CHEMBL2148	Homo sapiens	Inhibition	%	-0.93
	8187694	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.85	CHEMBL2148	Homo sapiens	Inhibition	%	5.85
	8188047	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.36	CHEMBL2148	Homo sapiens	Inhibition	%	4.36
	8188190	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-2.01	CHEMBL2148	Homo sapiens	Inhibition	%	-2.01
	8188549	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-4.07	CHEMBL2148	Homo sapiens	Inhibition	%	-4.07
	8188823	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.74	CHEMBL2148	Homo sapiens	Inhibition	%	-0.74
	8188971	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.5	CHEMBL2148	Homo sapiens	Inhibition	%	-1.5
	8189195	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.75	CHEMBL2148	Homo sapiens	Inhibition	%	0.75
	8189351	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-1.41	CHEMBL2148	Homo sapiens	Inhibition	%	-1.41
	8189500	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.21	CHEMBL2148	Homo sapiens	Inhibition	%	-0.21
	8189724	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	4.46	CHEMBL2148	Homo sapiens	Inhibition	%	4.46
	8189856	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-4.71	CHEMBL2148	Homo sapiens	Inhibition	%	-4.71
	8190212	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.19	CHEMBL2148	Homo sapiens	Inhibition	%	-0.19
	8190352	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.16	CHEMBL2148	Homo sapiens	Inhibition	%	0.16
	8190576	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-1.25	CHEMBL2148	Homo sapiens	Inhibition	%	-1.25
	8190713	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.8	CHEMBL2148	Homo sapiens	Inhibition	%	0.8
	8191101	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.63	CHEMBL2148	Homo sapiens	Inhibition	%	1.63
	8191239	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-1.47	CHEMBL2148	Homo sapiens	Inhibition	%	-1.47
	8191559	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.29	CHEMBL2148	Homo sapiens	Inhibition	%	1.29
	8191905	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.75	CHEMBL2148	Homo sapiens	Inhibition	%	2.75
	8192054	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-1.8	CHEMBL2148	Homo sapiens	Inhibition	%	-1.8
	8192407	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.7	CHEMBL2148	Homo sapiens	Inhibition	%	1.7
	8192551	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.21	CHEMBL2148	Homo sapiens	Inhibition	%	1.21
	8192775	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-0.66	CHEMBL2148	Homo sapiens	Inhibition	%	-0.66
	8192911	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	5.53	CHEMBL2148	Homo sapiens	Inhibition	%	5.53
	8193183	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.23	CHEMBL2148	Homo sapiens	Inhibition	%	-0.23
	8193552	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.25	CHEMBL2148	Homo sapiens	Inhibition	%	3.25
	8193709	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	Inhibition	%	-2.0
	8194082	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.2	CHEMBL2148	Homo sapiens	Inhibition	%	-0.2
	8194213	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-3.57	CHEMBL2148	Homo sapiens	Inhibition	%	-3.57
	8194437	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	-1.17	CHEMBL2148	Homo sapiens	Inhibition	%	-1.17
	8194568	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.39	CHEMBL2148	Homo sapiens	Inhibition	%	5.39
	8194935	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	Inhibition	%	-1.1
	8195068	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-2.19	CHEMBL2148	Homo sapiens	Inhibition	%	-2.19
	8195456	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	12.69	CHEMBL2148	Homo sapiens	Inhibition	%	12.69
	8195595	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.17	CHEMBL2148	Homo sapiens	Inhibition	%	-0.17
	8195819	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-1.9	CHEMBL2148	Homo sapiens	Inhibition	%	-1.9
	8195917	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.58	CHEMBL2148	Homo sapiens	Inhibition	%	0.58
	8196258	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-1.75	CHEMBL2148	Homo sapiens	Inhibition	%	-1.75
	8196408	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.86	CHEMBL2148	Homo sapiens	Inhibition	%	0.86
	8196632	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-0.48	CHEMBL2148	Homo sapiens	Inhibition	%	-0.48
	8196760	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.0	CHEMBL2148	Homo sapiens	Inhibition	%	3.0
	8197125	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.49	CHEMBL2148	Homo sapiens	Inhibition	%	0.49
	8197262	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.66	CHEMBL2148	Homo sapiens	Inhibition	%	0.66
	8197486	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	9.24	CHEMBL2148	Homo sapiens	Inhibition	%	9.24
	8197537	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-0.87	CHEMBL2148	Homo sapiens	Inhibition	%	-0.87
	8197901	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.35	CHEMBL2148	Homo sapiens	Inhibition	%	0.35
	8198058	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.9	CHEMBL2148	Homo sapiens	Inhibition	%	0.9
	8198282	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-4.98	CHEMBL2148	Homo sapiens	Inhibition	%	-4.98
	8198420	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.23	CHEMBL2148	Homo sapiens	Inhibition	%	2.23
	8198774	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.14	CHEMBL2148	Homo sapiens	Inhibition	%	2.14
	8198905	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-1.28	CHEMBL2148	Homo sapiens	Inhibition	%	-1.28
	8199277	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-1.29	CHEMBL2148	Homo sapiens	Inhibition	%	-1.29
	8199411	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-0.11	CHEMBL2148	Homo sapiens	Inhibition	%	-0.11
	8199635	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-1.12	CHEMBL2148	Homo sapiens	Inhibition	%	-1.12
	8199798	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	66.91	CHEMBL2148	Homo sapiens	Inhibition	%	66.91
	8200160	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.74	CHEMBL2148	Homo sapiens	Inhibition	%	0.74
	8200264	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.34	CHEMBL2148	Homo sapiens	Inhibition	%	1.34
	8200488	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.42	CHEMBL2148	Homo sapiens	Inhibition	%	0.42
	8200603	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.4	CHEMBL2148	Homo sapiens	Inhibition	%	2.4
	8200977	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.61	CHEMBL2148	Homo sapiens	Inhibition	%	2.61
	8201107	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.77	CHEMBL2148	Homo sapiens	Inhibition	%	-2.77
	8201466	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.75	CHEMBL2148	Homo sapiens	Inhibition	%	-0.75
	8201823	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.51	CHEMBL2148	Homo sapiens	Inhibition	%	0.51
	8201878	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-2.1	CHEMBL2148	Homo sapiens	Inhibition	%	-2.1
	8202102	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.58	CHEMBL2148	Homo sapiens	Inhibition	%	-0.58
	8202242	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.86	CHEMBL2148	Homo sapiens	Inhibition	%	4.86
	8202633	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-4.14	CHEMBL2148	Homo sapiens	Inhibition	%	-4.14
	8202758	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.89	CHEMBL2148	Homo sapiens	Inhibition	%	-0.89
	8203112	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-0.46	CHEMBL2148	Homo sapiens	Inhibition	%	-0.46
	8203243	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.36	CHEMBL2148	Homo sapiens	Inhibition	%	1.36
	8203467	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-4.75	CHEMBL2148	Homo sapiens	Inhibition	%	-4.75
	8203613	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-1.24	CHEMBL2148	Homo sapiens	Inhibition	%	-1.24
	8203971	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.1	CHEMBL2148	Homo sapiens	Inhibition	%	0.1
	8204137	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.72	CHEMBL2148	Homo sapiens	Inhibition	%	0.72
	8204498	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-1.06	CHEMBL2148	Homo sapiens	Inhibition	%	-1.06
	8204827	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.99	CHEMBL2148	Homo sapiens	Inhibition	%	2.99
	8204942	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	-1.64	CHEMBL2148	Homo sapiens	Inhibition	%	-1.64
	8205166	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.59	CHEMBL2148	Homo sapiens	Inhibition	%	2.59
	8205315	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-1.14	CHEMBL2148	Homo sapiens	Inhibition	%	-1.14
	8205451	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.29	CHEMBL2148	Homo sapiens	Inhibition	%	-0.29
	8205675	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.47	CHEMBL2148	Homo sapiens	Inhibition	%	0.47
	8205814	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-1.27	CHEMBL2148	Homo sapiens	Inhibition	%	-1.27
	8206170	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.61	CHEMBL2148	Homo sapiens	Inhibition	%	0.61
	8206446	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.15	CHEMBL2148	Homo sapiens	Inhibition	%	-0.15
	8206589	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.19	CHEMBL2148	Homo sapiens	Inhibition	%	1.19
	8206813	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.02	CHEMBL2148	Homo sapiens	Inhibition	%	2.02
	8206993	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-1.68	CHEMBL2148	Homo sapiens	Inhibition	%	-1.68
	8207119	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-3.5	CHEMBL2148	Homo sapiens	Inhibition	%	-3.5
	8207343	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-2.58	CHEMBL2148	Homo sapiens	Inhibition	%	-2.58
	8207473	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.64	CHEMBL2148	Homo sapiens	Inhibition	%	11.64
	8207829	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.05	CHEMBL2148	Homo sapiens	Inhibition	%	0.05
	8207974	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-1.85	CHEMBL2148	Homo sapiens	Inhibition	%	-1.85
	8208198	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-2.75	CHEMBL2148	Homo sapiens	Inhibition	%	-2.75
	8208330	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-1.18	CHEMBL2148	Homo sapiens	Inhibition	%	-1.18
	8208496	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.16	CHEMBL2148	Homo sapiens	Inhibition	%	6.16
	8208720	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.88	CHEMBL2148	Homo sapiens	Inhibition	%	0.88
	8208853	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.79	CHEMBL2148	Homo sapiens	Inhibition	%	0.79
	8209182	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.2	CHEMBL2148	Homo sapiens	Inhibition	%	1.2
	8209522	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-1.07	CHEMBL2148	Homo sapiens	Inhibition	%	-1.07
	8209672	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-0.05	CHEMBL2148	Homo sapiens	Inhibition	%	-0.05
	8210032	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.71	CHEMBL2148	Homo sapiens	Inhibition	%	4.71
	8210173	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.78	CHEMBL2148	Homo sapiens	Inhibition	%	-0.78
	8210397	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.17	CHEMBL2148	Homo sapiens	Inhibition	%	2.17
	8210533	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.48	CHEMBL2148	Homo sapiens	Inhibition	%	0.48
	8210792	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-4.26	CHEMBL2148	Homo sapiens	Inhibition	%	-4.26
	8211160	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.11	CHEMBL2148	Homo sapiens	Inhibition	%	0.11
	8211330	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-0.27	CHEMBL2148	Homo sapiens	Inhibition	%	-0.27
	8211677	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-0.69	CHEMBL2148	Homo sapiens	Inhibition	%	-0.69
	8211806	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.86	CHEMBL2148	Homo sapiens	Inhibition	%	11.86
	8212030	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	62.18	CHEMBL2148	Homo sapiens	Inhibition	%	62.18
	8212162	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	-0.33	CHEMBL2148	Homo sapiens	Inhibition	%	-0.33
	8212527	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-0.91	CHEMBL2148	Homo sapiens	Inhibition	%	-0.91
	8212660	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-0.62	CHEMBL2148	Homo sapiens	Inhibition	%	-0.62
	8213054	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	30.89	CHEMBL2148	Homo sapiens	Inhibition	%	30.89
	8213183	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.13	CHEMBL2148	Homo sapiens	Inhibition	%	4.13
	8213407	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.66	CHEMBL2148	Homo sapiens	Inhibition	%	4.66
	8213511	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	13.9	CHEMBL2148	Homo sapiens	Inhibition	%	13.9
	8213848	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.57	CHEMBL2148	Homo sapiens	Inhibition	%	-0.57
	8213995	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.06	CHEMBL2148	Homo sapiens	Inhibition	%	-0.06
	8214219	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.45	CHEMBL2148	Homo sapiens	Inhibition	%	2.45
	8214356	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.32	CHEMBL2148	Homo sapiens	Inhibition	%	0.32
	8214714	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-4.07	CHEMBL2148	Homo sapiens	Inhibition	%	-4.07
	8214866	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.19	CHEMBL2148	Homo sapiens	Inhibition	%	2.19
	8215117	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-4.85	CHEMBL2148	Homo sapiens	Inhibition	%	-4.85
	8215494	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	10.72	CHEMBL2148	Homo sapiens	Inhibition	%	10.72
	8215658	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-1.37	CHEMBL2148	Homo sapiens	Inhibition	%	-1.37
	8216001	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-5.03	CHEMBL2148	Homo sapiens	Inhibition	%	-5.03
	8216344	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-1.41	CHEMBL2148	Homo sapiens	Inhibition	%	-1.41
	8216480	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.81	CHEMBL2148	Homo sapiens	Inhibition	%	0.81
	8216842	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-0.96	CHEMBL2148	Homo sapiens	Inhibition	%	-0.96
	8216976	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-1.21	CHEMBL2148	Homo sapiens	Inhibition	%	-1.21
	8217200	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.46	CHEMBL2148	Homo sapiens	Inhibition	%	0.46
	8217374	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.5	CHEMBL2148	Homo sapiens	Inhibition	%	-0.5
	8217729	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.19	CHEMBL2148	Homo sapiens	Inhibition	%	5.19
	8217830	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.01	CHEMBL2148	Homo sapiens	Inhibition	%	0.01
	8218169	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-1.43	CHEMBL2148	Homo sapiens	Inhibition	%	-1.43
	8218520	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.22	CHEMBL2148	Homo sapiens	Inhibition	%	0.22
	8218663	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	25.86	CHEMBL2148	Homo sapiens	Inhibition	%	25.86
	8219018	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	14.0	CHEMBL2148	Homo sapiens	Inhibition	%	14.0
	8219178	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.96	CHEMBL2148	Homo sapiens	Inhibition	%	6.96
	8219402	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.88	CHEMBL2148	Homo sapiens	Inhibition	%	5.88
	8219428	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.85	CHEMBL2148	Homo sapiens	Inhibition	%	-0.85
	8219652	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.57	CHEMBL2148	Homo sapiens	Inhibition	%	-0.57
	8219813	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-1.56	CHEMBL2148	Homo sapiens	Inhibition	%	-1.56
	8219982	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.4	CHEMBL2148	Homo sapiens	Inhibition	%	0.4
	8220206	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.43	CHEMBL2148	Homo sapiens	Inhibition	%	-0.43
	8220335	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-8.11	CHEMBL2148	Homo sapiens	Inhibition	%	-8.11
	8220673	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.92	CHEMBL2148	Homo sapiens	Inhibition	%	0.92
	8220811	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-0.09	CHEMBL2148	Homo sapiens	Inhibition	%	-0.09
	8221035	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	13.33	CHEMBL2148	Homo sapiens	Inhibition	%	13.33
	8221171	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-4.12	CHEMBL2148	Homo sapiens	Inhibition	%	-4.12
	8221528	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-1.39	CHEMBL2148	Homo sapiens	Inhibition	%	-1.39
	8221693	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.13	CHEMBL2148	Homo sapiens	Inhibition	%	4.13
	8222048	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	55.0	CHEMBL2148	Homo sapiens	Inhibition	%	55.0
	8222146	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.64	CHEMBL2148	Homo sapiens	Inhibition	%	2.64
	8222370	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-1.13	CHEMBL2148	Homo sapiens	Inhibition	%	-1.13
	8222504	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.64	CHEMBL2148	Homo sapiens	Inhibition	%	0.64
	8222846	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	15.45	CHEMBL2148	Homo sapiens	Inhibition	%	15.45
	8222990	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.04	CHEMBL2148	Homo sapiens	Inhibition	%	1.04
	8223214	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.12	CHEMBL2148	Homo sapiens	Inhibition	%	3.12
	8223343	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.16	CHEMBL2148	Homo sapiens	Inhibition	%	-0.16
	8223728	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.12	CHEMBL2148	Homo sapiens	Inhibition	%	2.12
	8223978	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-0.96	CHEMBL2148	Homo sapiens	Inhibition	%	-0.96
	8224140	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.35	CHEMBL2148	Homo sapiens	Inhibition	%	2.35
	8224534	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.27	CHEMBL2148	Homo sapiens	Inhibition	%	0.27
	8224669	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-1.53	CHEMBL2148	Homo sapiens	Inhibition	%	-1.53
	8224893	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-1.26	CHEMBL2148	Homo sapiens	Inhibition	%	-1.26
	8225007	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.49	CHEMBL2148	Homo sapiens	Inhibition	%	2.49
	8225365	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	-1.44	CHEMBL2148	Homo sapiens	Inhibition	%	-1.44
	8225503	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-3.11	CHEMBL2148	Homo sapiens	Inhibition	%	-3.11
	8225862	CHEMBL1962121	GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.51	CHEMBL2148	Homo sapiens	Inhibition	%	0.51
	8226020	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.86	CHEMBL2148	Homo sapiens	Inhibition	%	0.86
	8226369	CHEMBL1962120	GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.41	CHEMBL2148	Homo sapiens	Inhibition	%	0.41
active	9617016	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9617017	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617018	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617019	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9617020	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617021	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	6.31	CHEMBL2148	Homo sapiens	pKi		8.2
inactive	9617022	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617023	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617024	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9617025	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617026	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9617027	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617028	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	19.95	CHEMBL2148	Homo sapiens	pKi		7.7
inactive	9617029	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617030	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617031	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9617032	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9617033	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617034	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617035	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9617036	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617037	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617038	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	31622.78	CHEMBL2148	Homo sapiens	pKi		4.5
inactive	9617039	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617040	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617041	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	10.0	CHEMBL2148	Homo sapiens	pKi		8.0
inactive	9617042	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617043	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617044	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9617045	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
inactive	9617046	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9617047	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617048	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617049	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9617050	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617051	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617052	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617053	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9617054	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617055	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617056	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617057	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9617058	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617059	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617060	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617061	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9617062	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617063	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	100000.0	CHEMBL2148	Homo sapiens	pKi		4.0
active	9617064	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	31622.78	CHEMBL2148	Homo sapiens	pKi		4.5
inactive	9617065	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617066	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9617067	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9617068	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	19.95	CHEMBL2148	Homo sapiens	pKi		7.7
active	9617069	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9617070	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9617071	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617072	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617073	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617074	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617075	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617076	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617077	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9617078	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9617079	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9617080	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617081	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9617082	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9617083	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617084	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9617085	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617086	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617087	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617088	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617089	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9617090	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617091	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
active	9617092	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9617093	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617094	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9617095	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617096	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9617097	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617098	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617099	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617100	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617101	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617102	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617103	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617104	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617105	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617106	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617107	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617108	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617109	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617110	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617111	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617112	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9617113	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9617114	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617115	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9617116	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617117	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617118	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1cccc(Br)c1c2=O		CHEMBL1976158	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9617119	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617120	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617121	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617122	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9617123	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617124	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
inactive	9617125	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617126	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9617127	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617128	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617129	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617130	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617131	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617132	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617133	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9617134	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9617135	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617136	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617137	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617138	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9617139	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617140	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617141	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617142	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617143	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9617144	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9617145	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9617146	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9617147	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617148	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617149	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617150	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617151	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617152	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617153	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9617154	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617155	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617156	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617157	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617158	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617159	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617160	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617161	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617162	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
active	9617163	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9617164	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9617165	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617166	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9617167	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617168	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617169	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9617170	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9617171	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9620728	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620729	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620730	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9620731	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620732	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620733	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9620734	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620735	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620736	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620737	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620738	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620739	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620740	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620741	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620742	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620743	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620744	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	7.943	CHEMBL2148	Homo sapiens	pKi		8.1
inactive	9620745	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620746	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620747	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9620748	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620749	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620750	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620751	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620752	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620753	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9620754	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9620755	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620756	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620757	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620758	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620759	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620760	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9620761	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620762	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620763	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620764	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620765	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
active	9620766	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
inactive	9620767	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620768	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620769	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620770	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	79.43	CHEMBL2148	Homo sapiens	pKi		7.1
inactive	9620771	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620772	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620773	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
active	9620774	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	100.0	CHEMBL2148	Homo sapiens	pKi		7.0
inactive	9620775	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620776	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620777	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9620778	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9620779	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9620780	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	100000.0	CHEMBL2148	Homo sapiens	pKi		4.0
inactive	9620781	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620782	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620783	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620784	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620785	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9620786	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620787	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620788	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
active	9620789	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	125.89	CHEMBL2148	Homo sapiens	pKi		6.9
inactive	9620790	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620791	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9620792	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9620793	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620794	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	100000.0	CHEMBL2148	Homo sapiens	pKi		4.0
active	9620795	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9620796	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9620797	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620798	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620799	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620800	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620801	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
active	9620802	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620803	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620804	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620805	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620806	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	1.995	CHEMBL2148	Homo sapiens	pKi		8.7
inactive	9620807	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620808	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9620809	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620810	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9620811	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620812	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620813	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620814	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620815	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620816	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620817	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	19952.62	CHEMBL2148	Homo sapiens	pKi		4.7
inactive	9620818	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620819	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620820	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620821	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9620822	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620823	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9620824	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620825	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620826	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620827	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620828	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620829	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620830	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
active	9620831	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	pKi		5.0
active	9620832	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
inactive	9620833	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620834	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620835	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620836	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620837	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL2148	Homo sapiens	pKi		5.0
inactive	9620838	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620839	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	=	Ki	nM	31.62	CHEMBL2148	Homo sapiens	pKi		7.5
inactive	9620840	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620841	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9620842	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620843	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620844	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620845	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620846	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620847	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
inactive	9620848	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620849	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620850	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620851	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620852	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9620853	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620854	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620855	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9620856	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	100.0	CHEMBL2148	Homo sapiens	pKi		7.0
active	9620857	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620858	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620859	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9620860	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9620861	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9620862	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620863	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9620864	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620865	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620866	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9620867	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620868	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620869	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620870	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9620871	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620872	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620873	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620874	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620875	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9620876	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620877	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9620878	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620879	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	3.162	CHEMBL2148	Homo sapiens	pKi		8.5
inactive	9620880	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620881	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620882	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9620883	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620884	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620885	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620886	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620887	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9620888	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620889	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620890	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620891	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620892	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620893	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620894	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620895	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620896	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	125.89	CHEMBL2148	Homo sapiens	pKi		6.9
active	9620897	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
active	9620898	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	31.62	CHEMBL2148	Homo sapiens	pKi		7.5
inactive	9620899	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620900	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9620901	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620902	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620903	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620904	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620905	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620906	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9620907	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620908	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9620909	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620910	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620911	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	25.12	CHEMBL2148	Homo sapiens	pKi		7.6
inactive	9620912	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620913	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620914	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620915	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9620916	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620917	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620918	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620919	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620920	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620921	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620922	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9620923	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620924	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620925	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
active	9620926	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	25118.86	CHEMBL2148	Homo sapiens	pKi		4.6
active	9620927	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9620928	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620929	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620930	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9620931	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620932	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620933	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620934	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9620935	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9620936	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
inactive	9620937	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620938	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620939	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620940	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620941	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620942	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]cnc2ccc(Br)cc12		CHEMBL562488	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
active	9620943	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9620944	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620945	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620946	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620947	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620948	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620949	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9620950	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9620951	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620952	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620953	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620954	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620955	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	39810.72	CHEMBL2148	Homo sapiens	pKi		4.4
active	9620956	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9620957	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620958	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620959	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9620960	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620961	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9620962	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620963	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9620964	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9620965	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9624507	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624508	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624509	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624510	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9624511	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9624512	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624513	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624514	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624515	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624516	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624517	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624518	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624519	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624520	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624521	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624522	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624523	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624524	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624525	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624526	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624527	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9624528	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	10.0	CHEMBL2148	Homo sapiens	pKi		8.0
active	9624529	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	39.81	CHEMBL2148	Homo sapiens	pKi		7.4
active	9624530	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9624531	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624532	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624533	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624534	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624535	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624536	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624537	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624538	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624539	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
active	9624540	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	19952.62	CHEMBL2148	Homo sapiens	pKi		4.7
inactive	9624541	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624542	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624543	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9624544	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
inactive	9624545	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624546	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624547	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624548	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624549	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624550	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624551	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624552	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9624553	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624554	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624555	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624556	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(NC(=O)CC2Nc3ccccc3NC2=O)cc1		CHEMBL1985469	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624557	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624558	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624559	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624560	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9624561	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624562	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9624563	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9624564	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
active	9624565	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	79.43	CHEMBL2148	Homo sapiens	pKi		7.1
inactive	9624566	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624567	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624568	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624569	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9624570	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624571	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624572	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9624573	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624574	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624575	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624576	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9624577	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624578	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624579	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624580	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9624581	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624582	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9624583	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
active	9624584	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	19.95	CHEMBL2148	Homo sapiens	pKi		7.7
active	9624585	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624586	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624587	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624588	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624589	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624590	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	39.81	CHEMBL2148	Homo sapiens	pKi		7.4
inactive	9624591	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624592	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624593	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624594	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624595	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624596	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624597	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9624598	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624599	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624600	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
inactive	9624601	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9624602	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9624603	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624604	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624605	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624606	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)CC(NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1)C(N)=O		CHEMBL1965469	=	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624607	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9624608	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9624609	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624610	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624611	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624612	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624613	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624614	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624615	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624616	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624617	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	125.89	CHEMBL2148	Homo sapiens	pKi		6.9
inactive	9624618	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624619	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624620	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624621	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624622	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624623	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624624	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624625	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624626	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624627	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	25.12	CHEMBL2148	Homo sapiens	pKi		7.6
active	9624628	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
active	9624629	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9624630	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624631	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624632	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624633	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624634	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624635	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624636	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624637	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624638	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624639	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624640	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2002660	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624641	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624642	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9624643	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	100.0	CHEMBL2148	Homo sapiens	pKi		7.0
active	9624644	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
inactive	9624645	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624646	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9624647	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	125.89	CHEMBL2148	Homo sapiens	pKi		6.9
active	9624648	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9624649	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9624650	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1cc(S(=O)(=O)NC(=O)c2ccc(-c3ccc(F)cc3)cc2)ccc1NC1CCCCC1		CHEMBL1996795	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624651	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624652	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624653	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9624654	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624655	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624656	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9624657	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624658	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	125.89	CHEMBL2148	Homo sapiens	pKi		6.9
inactive	9624659	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624660	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624661	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624662	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624663	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9624664	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9624665	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624666	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624667	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624668	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624669	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624670	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624671	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624672	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624673	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624674	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624675	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624676	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9624677	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624678	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
inactive	9624679	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624680	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624681	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624682	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9624683	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624684	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624685	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624686	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624687	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624688	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624689	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
active	9624690	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624691	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9624692	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624693	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624694	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624695	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624696	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624697	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624698	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624699	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9624700	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624701	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624702	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624703	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624704	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624705	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9624706	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624707	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
active	9624708	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624709	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624710	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9624711	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	79432.82	CHEMBL2148	Homo sapiens	pKi		4.1
inactive	9624712	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624713	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	100.0	CHEMBL2148	Homo sapiens	pKi		7.0
inactive	9624714	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624715	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624716	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624717	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624718	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9624719	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624720	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9624721	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624722	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9624723	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9624724	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624725	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	63095.73	CHEMBL2148	Homo sapiens	pKi		4.2
active	9624726	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9624727	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624728	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624729	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9624730	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624731	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624732	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624733	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624734	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624735	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624736	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624737	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9624738	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624739	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624740	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624741	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9624742	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9624743	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9624744	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628295	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628296	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628297	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628298	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628299	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628300	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
active	9628301	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
inactive	9628302	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628303	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628304	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628305	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
active	9628306	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9628307	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628308	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628309	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628310	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628311	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9628312	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628313	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628314	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628315	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628316	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628317	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628318	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628319	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	7.943	CHEMBL2148	Homo sapiens	pKi		8.1
inactive	9628320	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628321	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
active	9628322	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	3.981	CHEMBL2148	Homo sapiens	pKi		8.4
inactive	9628323	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628324	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628325	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628326	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628327	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	79432.82	CHEMBL2148	Homo sapiens	pKi		4.1
inactive	9628328	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628329	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628330	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628331	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628332	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9628333	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628334	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628335	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	5.012	CHEMBL2148	Homo sapiens	pKi		8.3
inactive	9628336	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628337	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9628338	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628339	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628340	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628341	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628342	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628343	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628344	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628345	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9628346	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628347	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9628348	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
inactive	9628349	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9628350	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628351	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628352	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628353	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628354	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628355	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628356	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628357	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628358	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	100.0	CHEMBL2148	Homo sapiens	pKi		7.0
inactive	9628359	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628360	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628361	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628362	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	19.95	CHEMBL2148	Homo sapiens	pKi		7.7
inactive	9628363	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628364	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628365	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628366	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628367	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628368	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9628369	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628370	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628371	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628372	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628373	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(OCc2cccc(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1966501	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
active	9628374	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	12.59	CHEMBL2148	Homo sapiens	pKi		7.9
inactive	9628375	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628376	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628377	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628378	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9628379	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	=	Ki	nM	3.162	CHEMBL2148	Homo sapiens	pKi		8.5
inactive	9628380	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628381	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628382	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
active	9628383	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9628384	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628385	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628386	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
active	9628387	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9628388	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628389	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628390	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9628391	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628392	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9628393	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628394	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
inactive	9628395	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9628396	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628397	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628398	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628399	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628400	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628401	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628402	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628403	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628404	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628405	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
inactive	9628406	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9628407	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628408	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628409	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628410	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9628411	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628412	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628413	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9628414	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628415	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628416	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628417	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628418	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
active	9628419	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cccc(Nc2nc(N3CCOCC3)nc(-n3cccn3)n2)c1		CHEMBL1940137	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9628420	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628421	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
active	9628422	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9628423	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628424	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628425	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9628426	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628427	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628428	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	=	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
active	9628429	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	79.43	CHEMBL2148	Homo sapiens	pKi		7.1
active	9628430	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL2148	Homo sapiens	pKi		7.3
active	9628431	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	19.95	CHEMBL2148	Homo sapiens	pKi		7.7
active	9628432	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	=	Ki	nM	5.012	CHEMBL2148	Homo sapiens	pKi		8.3
inactive	9628433	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628434	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9628435	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	79.43	CHEMBL2148	Homo sapiens	pKi		7.1
inactive	9628436	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628437	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628438	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
active	9628439	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	0.631	CHEMBL2148	Homo sapiens	pKi		9.2
active	9628440	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
active	9628441	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	501.19	CHEMBL2148	Homo sapiens	pKi		6.3
active	9628442	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1258.93	CHEMBL2148	Homo sapiens	pKi		5.9
inactive	9628443	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628444	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628445	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9628446	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628447	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628448	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628449	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628450	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628451	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628452	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628453	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628454	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628455	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
active	9628456	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	158.49	CHEMBL2148	Homo sapiens	pKi		6.8
inactive	9628457	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628458	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9628459	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628460	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
inactive	9628461	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628462	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628463	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628464	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
active	9628465	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9628466	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628467	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	1000.0	CHEMBL2148	Homo sapiens	pKi		6.0
active	9628468	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9628469	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628470	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628471	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628472	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628473	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628474	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628475	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9628476	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	15848.93	CHEMBL2148	Homo sapiens	pKi		4.8
active	9628477	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
inactive	9628478	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628479	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628480	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628481	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628482	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628483	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628484	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628485	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9628486	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628487	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628488	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628489	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628490	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628491	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628492	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628493	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)Nc1ccc(Nc2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1988872	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628494	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628495	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628496	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628497	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628498	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628499	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	630.96	CHEMBL2148	Homo sapiens	pKi		6.2
active	9628500	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	794.33	CHEMBL2148	Homo sapiens	pKi		6.1
inactive	9628501	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	2511.89	CHEMBL2148	Homo sapiens	pKi		5.6
inactive	9628502	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628503	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628504	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628505	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628506	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628507	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628508	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628509	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628510	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628511	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628512	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628513	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	63095.73	CHEMBL2148	Homo sapiens	pKi		4.2
active	9628514	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	3162.28	CHEMBL2148	Homo sapiens	pKi		5.5
inactive	9628515	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628516	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628517	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628518	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628519	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628520	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9628521	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	63.1	CHEMBL2148	Homo sapiens	pKi		7.2
inactive	9628522	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628523	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
inactive	9628524	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628525	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628526	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9628527	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628528	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9628529	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	199.53	CHEMBL2148	Homo sapiens	pKi		6.7
active	9628530	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	1995.26	CHEMBL2148	Homo sapiens	pKi		5.7
inactive	9628531	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9628532	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632095	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632096	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9632097	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632098	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9632099	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	251.19	CHEMBL2148	Homo sapiens	pKi		6.6
inactive	9632100	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9632101	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632102	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9632103	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	398.11	CHEMBL2148	Homo sapiens	pKi		6.4
inactive	9632104	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632105	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632106	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632107	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632108	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9632109	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632110	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9632111	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
active	9632112	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	316.23	CHEMBL2148	Homo sapiens	pKi		6.5
inactive	9632113	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9632114	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632115	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632116	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	5011.87	CHEMBL2148	Homo sapiens	pKi		5.3
inactive	9632117	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
inactive	9632118	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9632119	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	25.12	CHEMBL2148	Homo sapiens	pKi		7.6
inactive	9632120	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL2148	Homo sapiens	pKi		5.4
inactive	9632121	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
active	9632122	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	6.31	CHEMBL2148	Homo sapiens	pKi		8.2
active	9632123	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	79.43	CHEMBL2148	Homo sapiens	pKi		7.1
inactive	9632124	CHEMBL1963742	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1584.89	CHEMBL2148	Homo sapiens	pKi		5.8
	10838604	CHEMBL2014444	Inhibition of JAK3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	4.0	CHEMBL2148	Homo sapiens	INH	%	4.0
Not Active	10842744	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	10842745	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	10842746	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	10842747	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	10842748	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	10842749	CHEMBL2016350	Inhibition of JAK3 at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	10849606	CHEMBL2019649	Inhibition of JAK3 assessed as remaining activity at 0.1 uM by radiolabeled kinase assay relative to control	B	CCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O		CHEMBL2017007	=	Activity	%	94.04	CHEMBL2148	Homo sapiens	Activity	%	94.04
	10850684	CHEMBL2019804	Inhibition of human JAK3 at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	10863755	CHEMBL2024910	Inhibition of JAK3 by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
Active	10884065	CHEMBL2033674	Binding affinity to JAK3	B	C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL2029436		Activity			CHEMBL2148	Homo sapiens	Activity		
	10886512	CHEMBL2033417	Inhibition of JAK3 in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	10889047	CHEMBL2032468	Inhibition of JAK3	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	10889074	CHEMBL2032468	Inhibition of JAK3	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910576	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCC2CCCN(C2)c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035041	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910577	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/CCn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035042	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910578	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035043	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910579	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/CCOc2cc(ccn2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035044	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910580	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035045	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910581	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035046	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910582	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL2035047	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910583	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)COC/1		CHEMBL2035048	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910584	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)COC/1		CHEMBL2035049	=	IC50	nM	1140.0	CHEMBL2148	Homo sapiens	IC50	uM	1.14
	10910585	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	Cc1cnc2nc1-c1ccc3ccn(c3c1)C/C=C/COCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2035050	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910586	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cncc(c2)COC/1		CHEMBL2035051	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	10910587	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccnc(c2)OCC/1		CHEMBL2035052	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	uM	1.4
	10910588	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	Cc1cnc2nc1-c1ccnc(c1)OCC/C=C/COCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2035053	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	10910589	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1		CHEMBL2035054	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910590	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	CN1C/C=C/COCc2ccc(s2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1		CHEMBL2035055	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910591	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(o1)-c1ccnc(n1)N2		CHEMBL2035056	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910592	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(s1)-c1ccnc(n1)N2		CHEMBL2035182	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10910593	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(s2)COC/1		CHEMBL2035183	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	uM	0.65
	10910594	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2csc(c2)COC/1		CHEMBL2035184	=	IC50	nM	680.0	CHEMBL2148	Homo sapiens	IC50	uM	0.68
	10910595	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1		CHEMBL2035185	=	IC50	nM	4300.0	CHEMBL2148	Homo sapiens	IC50	uM	4.3
	10910596	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2coc(c2)COC/1		CHEMBL2035186	=	IC50	nM	8800.0	CHEMBL2148	Homo sapiens	IC50	uM	8.8
	10910597	CHEMBL2040120	Inhibition of recombinant JAK3 using poly(Glu,Ala,Tyr) as substrate after 2 hrs by luminometric assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cc(co2)COC/1		CHEMBL2035181	=	IC50	nM	9200.0	CHEMBL2148	Homo sapiens	IC50	uM	9.2
	10936279	CHEMBL2050072	Inhibition of human JAK3	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	10965880	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1ccccc1-c1cccn2nc(N)nc12		CHEMBL2062787	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	10965882	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	Nc1nc2c(-c3cccnc3)cccn2n1		CHEMBL2062788	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	10965884	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1ccc(-c2cccn3nc(N)nc23)cn1		CHEMBL2062789	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	10965886	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	Nc1nc2c(-c3ccncc3)cccn2n1		CHEMBL2062790	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	10965888	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1cccc(-c2cccn3nc(N)nc23)c1		CHEMBL2062791	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	10965890	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(N)nc23)cc1		CHEMBL2062792	>	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	nM	2000.0
	10965892	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	Nc1nc2c(-c3ccc(C(F)(F)F)cc3)cccn2n1		CHEMBL2062793	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	10965894	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1ccccc1-c1cccn2nc(Nc3ccccc3)nc12		CHEMBL2062794	=	IC50	nM	834.0	CHEMBL2148	Homo sapiens	IC50	nM	834.0
	10965898	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccccc4)nc23)cc1		CHEMBL2062796	=	IC50	nM	95.0	CHEMBL2148	Homo sapiens	IC50	nM	95.0
	10965899	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1cccc(-c2cccn3nc(Nc4ccccc4)nc23)c1		CHEMBL2062795	=	IC50	nM	475.0	CHEMBL2148	Homo sapiens	IC50	nM	475.0
	10965925	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1ccccc1Nc1nc2c(-c3ccc(S(C)(=O)=O)cc3)cccn2n1		CHEMBL2062797	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	10965926	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1cccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)c1		CHEMBL2062798	=	IC50	nM	89.0	CHEMBL2148	Homo sapiens	IC50	nM	89.0
	10965927	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	COc1ccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)cc1		CHEMBL2062799	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
	10965928	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(S(C)(=O)=O)c4)nc23)cc1		CHEMBL2062800	=	IC50	nM	598.0	CHEMBL2148	Homo sapiens	IC50	nM	598.0
	10965929	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)cc1		CHEMBL2062801	=	IC50	nM	105.0	CHEMBL2148	Homo sapiens	IC50	nM	105.0
	10965930	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCOCC5)c4)nc23)cc1		CHEMBL2062802	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	10965931	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)cc1		CHEMBL2062803	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	10965932	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062804	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
	10965933	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL2062805	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	10965934	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(Cc2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062806	=	IC50	nM	146.0	CHEMBL2148	Homo sapiens	IC50	nM	146.0
	10965935	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(CN5CCS(=O)(=O)CC5)c4)nc23)cc1		CHEMBL2062807	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	10965936	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCC(N6CCOCC6)CC5)c4)nc23)cc1		CHEMBL2062808	=	IC50	nM	60.0	CHEMBL2148	Homo sapiens	IC50	nM	60.0
	10965937	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(C2CCN(c3cccc(Nc4nc5c(-c6ccc(S(C)(=O)=O)cc6)cccn5n4)c3)CC2)CC1		CHEMBL2062529	=	IC50	nM	122.0	CHEMBL2148	Homo sapiens	IC50	nM	122.0
	10965938	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCC(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062809	=	IC50	nM	72.0	CHEMBL2148	Homo sapiens	IC50	nM	72.0
	10966895	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CC(C)S(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCN(C)CC5)c4)nc23)cc1		CHEMBL2062810	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	10966896	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(C(F)(F)F)cc5)cccn4n3)c2)CC1		CHEMBL2062811	=	IC50	nM	218.0	CHEMBL2148	Homo sapiens	IC50	nM	218.0
	10966897	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(F)cc5)cccn4n3)c2)CC1		CHEMBL2062812	=	IC50	nM	547.0	CHEMBL2148	Homo sapiens	IC50	nM	547.0
	10966898	CHEMBL2067181	Inhibition of human JAK3 expressed in baculovirus using biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide as substrate preincubated for 1 hr measured after 20 mins by time resolved fluorescence assay	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(P(C)(C)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062813	=	IC50	nM	286.0	CHEMBL2148	Homo sapiens	IC50	nM	286.0
	10975677	CHEMBL2064936	Inhibition of Jak3 in presence of 10 uM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	IC50	nM	8140.0	CHEMBL2148	Homo sapiens	IC50	nM	8140.0
	10978462	CHEMBL2066245	Inhibition of human recombinant JAK3 using ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2148	Homo sapiens	Activity	%	80.0
	11003682	CHEMBL2090810	Inhibition of JAK3	B	c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)[nH]c3ncnc(NCC4SCCS4)c23)cc1		CHEMBL2087875	=	Ki	nM	6.5	CHEMBL2148	Homo sapiens	Ki	nM	6.5
	12046339	CHEMBL2157151	Inhibition of JAK3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.5	CHEMBL2148	Homo sapiens	INH	%	4.5
	12062097	CHEMBL2155754	Inhibition of human recombinant JAK3 kinase domain using FITC-KGGEEEEYFELVKK as substrate by peptide mobility shift assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Ki	nM	0.24	CHEMBL2148	Homo sapiens	Ki	nM	0.24
	12062101	CHEMBL2155750	Inhibition of human JAK3 kinase domain expressed in Sf21 cells using EQEDEPEGDYFEWLE as substrate after 1 hr by HTRF assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	428.0	CHEMBL2148	Homo sapiens	IC50	nM	428.0
	12063038	CHEMBL2155760	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Ki	nM	0.4	CHEMBL2148	Homo sapiens	Ki	nM	0.4
	12063039	CHEMBL2155760	Inhibition of JAK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1n1cnc2cnc3[nH]ccc3c21		CHEMBL2152297	=	Ki	nM	0.9	CHEMBL2148	Homo sapiens	Ki	nM	0.9
	12063040	CHEMBL2155760	Inhibition of JAK3	B	C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL2152298	=	Ki	nM	120.0	CHEMBL2148	Homo sapiens	Ki	nM	120.0
	12063041	CHEMBL2155760	Inhibition of JAK3	B	C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1n1cnc2cnc3[nH]ccc3c21		CHEMBL2152299	=	Ki	nM	22.0	CHEMBL2148	Homo sapiens	Ki	nM	22.0
	12063042	CHEMBL2155760	Inhibition of JAK3	B	N#CCC(=O)N1CCC[C@@H](n2cnc3cnc4[nH]ccc4c32)C1		CHEMBL2152300	=	Ki	nM	3.8	CHEMBL2148	Homo sapiens	Ki	nM	3.8
	12063043	CHEMBL2155760	Inhibition of JAK3	B	c1ccc(CN2CCC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1		CHEMBL2152301	=	Ki	nM	130.0	CHEMBL2148	Homo sapiens	Ki	nM	130.0
	12063044	CHEMBL2155760	Inhibition of JAK3	B	c1ccc(CN2CCC[C@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1		CHEMBL2152302	=	Ki	nM	220.0	CHEMBL2148	Homo sapiens	Ki	nM	220.0
	12063045	CHEMBL2155760	Inhibition of JAK3	B	c1ccc(CN2CC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1		CHEMBL2152303	=	Ki	nM	130.0	CHEMBL2148	Homo sapiens	Ki	nM	130.0
	12063046	CHEMBL2155760	Inhibition of JAK3	B	c1ccc(CN2CC(n3cnc4cnc5[nH]ccc5c43)C2)cc1		CHEMBL2152304	=	Ki	nM	200.0	CHEMBL2148	Homo sapiens	Ki	nM	200.0
	12063047	CHEMBL2155760	Inhibition of JAK3	B	c1ccc(CN2CCC(n3cnc4cnc5[nH]ccc5c43)CC2)cc1		CHEMBL2152305	=	Ki	nM	33.0	CHEMBL2148	Homo sapiens	Ki	nM	33.0
	12063048	CHEMBL2155760	Inhibition of JAK3	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O		CHEMBL1795071	=	IC50	nM	810.0	CHEMBL2148	Homo sapiens	IC50	nM	810.0
	12068094	CHEMBL2160362	Inhibition of JAK3 kinase domain using N-terminal 5-carboxyfluorescein-tagged Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins	B	Cc1nc2cnc3[nH]ccc3c2n1[C@@H]1CCC[C@@H](O)C1		CHEMBL2159210	=	Ki	nM	22.0	CHEMBL2148	Homo sapiens	Ki	nM	22.0
	12069215	CHEMBL2160362	Inhibition of JAK3 kinase domain using N-terminal 5-carboxyfluorescein-tagged Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Ki	nM	3.2	CHEMBL2148	Homo sapiens	Ki	nM	3.2
	12138161	CHEMBL2186172	Inhibition of purified JAK3 incubated for 30 mins	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Ki	nM	3.22	CHEMBL2148	Homo sapiens	Ki	nM	3.22
	12150588	CHEMBL2188524	Inhibition of human recombinant JAK3 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	2600.0	CHEMBL2148	Homo sapiens	IC50	uM	2.6
	12153161	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Fc1ccc2cc1COCC=CCOCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1		CHEMBL2181314	=	IC50	nM	720.0	CHEMBL2148	Homo sapiens	IC50	uM	0.72
	12153162	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1ccc2cc1COCC=CCOCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1		CHEMBL2181313	=	IC50	nM	890.0	CHEMBL2148	Homo sapiens	IC50	uM	0.89
Not Determined	12153163	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Fc1cc2cc(c1)-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2		CHEMBL2181312		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153164	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1ccc2cc1-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2		CHEMBL2181311	=	IC50	nM	7200.0	CHEMBL2148	Homo sapiens	IC50	uM	7.2
	12153165	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Fc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2181310	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	12153166	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Cc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL2181088	=	IC50	nM	89.0	CHEMBL2148	Homo sapiens	IC50	uM	0.089
Not Determined	12153167	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1cc2cc(c1OCCN1CCCC1)COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181087		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153168	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CCN(CC)CCC(=O)Nc1cc2cc(c1)Nc1nccc(n1)-c1cccc(c1)COCC=CCOC2		CHEMBL2181086	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	uM	0.39
Not Determined	12153169	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Nc1cc2cc(c1)Nc1nccc(n1)-c1cccc(c1)COCC=CCOC2		CHEMBL2181085		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153170	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCOCC3)c2)COC1		CHEMBL2181084	=	IC50	nM	3300.0	CHEMBL2148	Homo sapiens	IC50	uM	3.3
	12153171	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCCC3)c2)COC1		CHEMBL2181083	=	IC50	nM	830.0	CHEMBL2148	Homo sapiens	IC50	uM	0.83
	12153172	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	O=C1CCN(CCOc2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)C1		CHEMBL2181082	=	IC50	nM	380.0	CHEMBL2148	Homo sapiens	IC50	uM	0.38
	12153173	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	O=C1CCCN1CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181332	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	uM	0.5
	12153174	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOCc2cc(ccc2OCCN2CCCCC2)Nc2nccc(n2)-c2cccc(c2)COC1		CHEMBL2181331	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	uM	0.75
	12153175	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	uM	0.52
	12153176	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CCN(CC)CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181329	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	uM	0.62
	12153177	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	ClCCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181328	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
Not Determined	12153178	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CN(C)CCN(C)c1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181327		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153179	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CCS(=O)(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1		CHEMBL2181326	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	12153180	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CC(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1		CHEMBL2181325	=	IC50	nM	6000.0	CHEMBL2148	Homo sapiens	IC50	uM	6.0
	12153181	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	OCCN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1		CHEMBL2181324	=	IC50	nM	2500.0	CHEMBL2148	Homo sapiens	IC50	uM	2.5
Not Determined	12153182	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	CN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1		CHEMBL2181323		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153183	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOCc2cc(ccc2N2CCNCC2)Nc2nccc(n2)-c2cccc(c2)COC1		CHEMBL2181322	=	IC50	nM	1600.0	CHEMBL2148	Homo sapiens	IC50	uM	1.6
Not Determined	12153184	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOCc2cc(ccc2N2CCOCC2)Nc2nccc(n2)-c2cccc(c2)COC1		CHEMBL2181321		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153185	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	Oc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181320	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	uM	1.1
	12153186	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181319	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	uM	1.2
Not Determined	12153187	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1ccc2cc1COCC=CCOc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181318		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	12153188	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	COc1ccc2cc1COCC=CCCOc1cccc(c1)-c1ccnc(n1)N2		CHEMBL2181317		IC50			CHEMBL2148	Homo sapiens	IC50		
	12153189	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCOc2cccc(c2)Nc2nccc(n2)-c2cccc(c2)OCC1		CHEMBL2181316	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	12153190	CHEMBL2183782	Inhibition of recombinant JAK3 using Poly (Glu,Ala,Tyr) as substrate after 2 hrs by luminescence assay	B	C1=CCCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)OCC1		CHEMBL2181315	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	12173567	CHEMBL2211065	Inhibition of JAK3 JH1catalytic domain assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	12193919	CHEMBL2214786	Inhibition of JAK3	B	CCN1CCC[C@@H]1C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2207760	=	IC50	nM	557.3	CHEMBL2148	Homo sapiens	IC50	nM	557.3
	12193920	CHEMBL2214786	Inhibition of JAK3	B	CN1CCC[C@@H]1C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2207759	=	IC50	nM	483.8	CHEMBL2148	Homo sapiens	IC50	nM	483.8
	12193921	CHEMBL2214786	Inhibition of JAK3	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCNC1		CHEMBL2207758	=	IC50	nM	368.1	CHEMBL2148	Homo sapiens	IC50	nM	368.1
	12193922	CHEMBL2214786	Inhibition of JAK3	B	O=C1CC[C@H](C(=O)Nc2ccc(-c3ccnc(Nc4ccc(N5CCOCC5)cc4)n3)cc2)N1		CHEMBL2208035	=	IC50	nM	61.7	CHEMBL2148	Homo sapiens	IC50	nM	61.7
	12193923	CHEMBL2214786	Inhibition of JAK3	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1		CHEMBL2208034	=	IC50	nM	214.2	CHEMBL2148	Homo sapiens	IC50	nM	214.2
	12193924	CHEMBL2214786	Inhibition of JAK3	B	N[C@H](CO)C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2208033	=	IC50	nM	159.8	CHEMBL2148	Homo sapiens	IC50	nM	159.8
	12193925	CHEMBL2214786	Inhibition of JAK3	B	C[C@@H](N)C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2208032	=	IC50	nM	306.8	CHEMBL2148	Homo sapiens	IC50	nM	306.8
	12193926	CHEMBL2214786	Inhibition of JAK3	B	C[C@H](N)C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2208031	=	IC50	nM	298.3	CHEMBL2148	Homo sapiens	IC50	nM	298.3
	12193927	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2cc(C)nc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL2208030	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193928	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2C(F)(F)F)cc1		CHEMBL2208029	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193929	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2C)cc1		CHEMBL2208028	=	IC50	nM	104.5	CHEMBL2148	Homo sapiens	IC50	nM	104.5
	12193930	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2F)cc1		CHEMBL2208027	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193931	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL2208026	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193932	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1077458	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193933	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1		CHEMBL2208025	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193934	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(N4CCCCC4)c3)n2)cc1		CHEMBL2208024	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193935	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL2208023	=	IC50	nM	1149.3	CHEMBL2148	Homo sapiens	IC50	nM	1149.3
	12193936	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(NC(=O)c4ccccc4)c3)n2)cc1		CHEMBL2207767	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193937	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(NC(=O)c4ccccc4Cl)c3)n2)cc1		CHEMBL2207766	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193938	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(NC(=O)c4c(Cl)cccc4Cl)n3)n2)cc1		CHEMBL2207765	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193939	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(Nc3cccc(NC(=O)c4c(Cl)cccc4Cl)c3)n2)cc1		CHEMBL2207764	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193940	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(NCC3CN(C(=O)c4c(Cl)cccc4Cl)C3)n2)cc1		CHEMBL2207763	=	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	12193941	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(NC3CCCC(NC(=O)c4c(Cl)cccc4Cl)C3)n2)cc1		CHEMBL2207762	>	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	nM	980.0
	12193942	CHEMBL2214786	Inhibition of JAK3	B	CC(=O)Nc1ccc(-c2ccnc(NCCCNC(=O)c3c(Cl)cccc3Cl)n2)cc1		CHEMBL2207761	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	12195496	CHEMBL2210060	Inhibition of recombinant JAK3 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	1700.0	CHEMBL2148	Homo sapiens	Ki	nM	1700.0
	12195606	CHEMBL2212385	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	67.3	CHEMBL2148	Homo sapiens	Activity	%	67.3
	12240154	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12240155	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	43.0	CHEMBL2148	Homo sapiens	Residual Activity	%	43.0
	12240156	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12240157	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12240158	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	96.0	CHEMBL2148	Homo sapiens	Residual Activity	%	96.0
	12240159	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12240160	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	45.0	CHEMBL2148	Homo sapiens	Residual Activity	%	45.0
	12240161	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12240162	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12240163	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240164	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	51.0	CHEMBL2148	Homo sapiens	Residual Activity	%	51.0
	12240165	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	85.0	CHEMBL2148	Homo sapiens	Residual Activity	%	85.0
	12240166	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	99.0	CHEMBL2148	Homo sapiens	Residual Activity	%	99.0
	12240167	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	99.0	CHEMBL2148	Homo sapiens	Residual Activity	%	99.0
	12240168	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	116.0	CHEMBL2148	Homo sapiens	Residual Activity	%	116.0
	12240169	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12240170	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	118.0	CHEMBL2148	Homo sapiens	Residual Activity	%	118.0
	12240171	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	91.0	CHEMBL2148	Homo sapiens	Residual Activity	%	91.0
	12240172	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL2148	Homo sapiens	Residual Activity	%	99.0
	12240173	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12240174	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240175	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12240176	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12240177	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12240178	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12240179	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12240180	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	64.0	CHEMBL2148	Homo sapiens	Residual Activity	%	64.0
	12240181	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	93.0	CHEMBL2148	Homo sapiens	Residual Activity	%	93.0
	12240182	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12240183	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	15.0	CHEMBL2148	Homo sapiens	Residual Activity	%	15.0
	12240184	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12240185	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12240186	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12240187	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12240188	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12240189	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	78.0	CHEMBL2148	Homo sapiens	Residual Activity	%	78.0
	12240190	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240191	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12240192	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12240193	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12240194	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12240195	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240196	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12240197	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	6.0	CHEMBL2148	Homo sapiens	Residual Activity	%	6.0
	12240198	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12240199	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12240200	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12240201	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	98.0	CHEMBL2148	Homo sapiens	Residual Activity	%	98.0
	12240202	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12240203	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12240204	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240205	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	91.0	CHEMBL2148	Homo sapiens	Residual Activity	%	91.0
	12240206	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	16.0	CHEMBL2148	Homo sapiens	Residual Activity	%	16.0
	12240207	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12240208	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12240209	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12240210	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12240211	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12240212	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12240213	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12240214	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL2148	Homo sapiens	Residual Activity	%	75.0
	12240215	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12240216	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12240217	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL2148	Homo sapiens	Residual Activity	%	91.0
	12240218	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL2148	Homo sapiens	Residual Activity	%	98.0
	12240219	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12240220	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12240221	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12240222	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12240223	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	93.0	CHEMBL2148	Homo sapiens	Residual Activity	%	93.0
	12240224	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	98.0	CHEMBL2148	Homo sapiens	Residual Activity	%	98.0
	12240225	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	76.0	CHEMBL2148	Homo sapiens	Residual Activity	%	76.0
	12240226	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12240227	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12240228	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	99.0	CHEMBL2148	Homo sapiens	Residual Activity	%	99.0
	12242830	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	54.0	CHEMBL2148	Homo sapiens	Residual Activity	%	54.0
	12242831	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12242832	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	62.0	CHEMBL2148	Homo sapiens	Residual Activity	%	62.0
	12242833	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12242834	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2148	Homo sapiens	Residual Activity	%	0.0
	12242835	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242836	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	7.0	CHEMBL2148	Homo sapiens	Residual Activity	%	7.0
	12242837	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12242838	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12242839	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	66.0	CHEMBL2148	Homo sapiens	Residual Activity	%	66.0
	12242840	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242841	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242842	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12242843	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12242844	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	21.0	CHEMBL2148	Homo sapiens	Residual Activity	%	21.0
	12242845	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12242846	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12242847	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	41.0	CHEMBL2148	Homo sapiens	Residual Activity	%	41.0
	12242848	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12242849	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	116.0	CHEMBL2148	Homo sapiens	Residual Activity	%	116.0
	12242850	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL2148	Homo sapiens	Residual Activity	%	98.0
	12242851	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12242852	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12242853	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242854	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242855	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	83.0	CHEMBL2148	Homo sapiens	Residual Activity	%	83.0
	12242856	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2148	Homo sapiens	Residual Activity	%	0.0
	12242857	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242858	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	8.0	CHEMBL2148	Homo sapiens	Residual Activity	%	8.0
	12242859	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242860	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	111.0	CHEMBL2148	Homo sapiens	Residual Activity	%	111.0
	12242861	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12242862	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12242863	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12242864	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242865	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	118.0	CHEMBL2148	Homo sapiens	Residual Activity	%	118.0
	12242866	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12242867	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242868	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12242869	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12242870	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12242871	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	42.0	CHEMBL2148	Homo sapiens	Residual Activity	%	42.0
	12242872	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	116.0	CHEMBL2148	Homo sapiens	Residual Activity	%	116.0
	12242873	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	120.0	CHEMBL2148	Homo sapiens	Residual Activity	%	120.0
	12242874	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242875	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	80.0	CHEMBL2148	Homo sapiens	Residual Activity	%	80.0
	12242876	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12242877	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	111.0	CHEMBL2148	Homo sapiens	Residual Activity	%	111.0
	12242878	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12242879	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	13.0	CHEMBL2148	Homo sapiens	Residual Activity	%	13.0
	12242880	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	98.0	CHEMBL2148	Homo sapiens	Residual Activity	%	98.0
	12242881	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12242882	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	95.0	CHEMBL2148	Homo sapiens	Residual Activity	%	95.0
	12242883	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	81.0	CHEMBL2148	Homo sapiens	Residual Activity	%	81.0
	12242884	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2148	Homo sapiens	Residual Activity	%	0.0
	12242885	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12242886	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL2148	Homo sapiens	Residual Activity	%	93.0
	12242887	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	57.0	CHEMBL2148	Homo sapiens	Residual Activity	%	57.0
	12242888	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12242889	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	83.0	CHEMBL2148	Homo sapiens	Residual Activity	%	83.0
	12242890	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12242891	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242892	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL2148	Homo sapiens	Residual Activity	%	7.0
	12242893	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	20.0	CHEMBL2148	Homo sapiens	Residual Activity	%	20.0
	12242894	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242895	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242896	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12242897	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	46.0	CHEMBL2148	Homo sapiens	Residual Activity	%	46.0
	12242898	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12242899	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12242900	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12242901	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	75.0	CHEMBL2148	Homo sapiens	Residual Activity	%	75.0
	12242902	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	95.0	CHEMBL2148	Homo sapiens	Residual Activity	%	95.0
	12242903	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242904	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242905	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	48.0	CHEMBL2148	Homo sapiens	Residual Activity	%	48.0
	12242906	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12242907	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12242908	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242909	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242910	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12242911	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242912	CHEMBL2219229	Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	82.0	CHEMBL2148	Homo sapiens	Residual Activity	%	82.0
	12242913	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	95.0	CHEMBL2148	Homo sapiens	Residual Activity	%	95.0
	12242914	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	6.0	CHEMBL2148	Homo sapiens	Residual Activity	%	6.0
	12242915	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	115.0	CHEMBL2148	Homo sapiens	Residual Activity	%	115.0
	12242916	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	145.0	CHEMBL2148	Homo sapiens	Residual Activity	%	145.0
	12242917	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	78.0	CHEMBL2148	Homo sapiens	Residual Activity	%	78.0
	12242918	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12242919	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	11.0	CHEMBL2148	Homo sapiens	Residual Activity	%	11.0
	12242920	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	118.0	CHEMBL2148	Homo sapiens	Residual Activity	%	118.0
	12242921	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12242922	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242923	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	59.0	CHEMBL2148	Homo sapiens	Residual Activity	%	59.0
	12242924	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	69.0	CHEMBL2148	Homo sapiens	Residual Activity	%	69.0
	12242925	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12242926	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12242927	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12242928	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	110.0	CHEMBL2148	Homo sapiens	Residual Activity	%	110.0
	12242929	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	149.0	CHEMBL2148	Homo sapiens	Residual Activity	%	149.0
	12242930	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	67.0	CHEMBL2148	Homo sapiens	Residual Activity	%	67.0
	12242931	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12242932	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12242933	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	109.0	CHEMBL2148	Homo sapiens	Residual Activity	%	109.0
	12242934	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	68.0	CHEMBL2148	Homo sapiens	Residual Activity	%	68.0
	12242935	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242936	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12242937	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242938	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	87.0	CHEMBL2148	Homo sapiens	Residual Activity	%	87.0
	12242939	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	17.0	CHEMBL2148	Homo sapiens	Residual Activity	%	17.0
	12242940	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	57.0	CHEMBL2148	Homo sapiens	Residual Activity	%	57.0
	12242941	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	124.0	CHEMBL2148	Homo sapiens	Residual Activity	%	124.0
	12242942	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL2148	Homo sapiens	Residual Activity	%	2.0
	12242943	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12242944	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	48.0	CHEMBL2148	Homo sapiens	Residual Activity	%	48.0
	12242945	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	126.0	CHEMBL2148	Homo sapiens	Residual Activity	%	126.0
	12242946	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12242947	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12242948	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	45.0	CHEMBL2148	Homo sapiens	Residual Activity	%	45.0
	12242949	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12242950	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	124.0	CHEMBL2148	Homo sapiens	Residual Activity	%	124.0
	12242951	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12242952	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242953	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	142.0	CHEMBL2148	Homo sapiens	Residual Activity	%	142.0
	12242954	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12242955	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	2.0	CHEMBL2148	Homo sapiens	Residual Activity	%	2.0
	12242956	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12242957	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12242958	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	128.0	CHEMBL2148	Homo sapiens	Residual Activity	%	128.0
	12242959	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12242960	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	56.0	CHEMBL2148	Homo sapiens	Residual Activity	%	56.0
	12242961	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12242962	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242963	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	50.0	CHEMBL2148	Homo sapiens	Residual Activity	%	50.0
	12242964	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	65.0	CHEMBL2148	Homo sapiens	Residual Activity	%	65.0
	12242965	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	3.0	CHEMBL2148	Homo sapiens	Residual Activity	%	3.0
	12242966	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12242967	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242968	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12242969	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	117.0	CHEMBL2148	Homo sapiens	Residual Activity	%	117.0
	12242970	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12242971	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	70.0	CHEMBL2148	Homo sapiens	Residual Activity	%	70.0
	12242972	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12242973	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	28.0	CHEMBL2148	Homo sapiens	Residual Activity	%	28.0
	12242974	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12242975	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL2148	Homo sapiens	Residual Activity	%	94.0
	12242976	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	82.0	CHEMBL2148	Homo sapiens	Residual Activity	%	82.0
	12242977	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242978	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	32.0	CHEMBL2148	Homo sapiens	Residual Activity	%	32.0
	12242979	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	63.0	CHEMBL2148	Homo sapiens	Residual Activity	%	63.0
	12242980	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	78.0	CHEMBL2148	Homo sapiens	Residual Activity	%	78.0
	12242981	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	67.0	CHEMBL2148	Homo sapiens	Residual Activity	%	67.0
	12242982	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12242983	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	81.0	CHEMBL2148	Homo sapiens	Residual Activity	%	81.0
	12242984	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	23.0	CHEMBL2148	Homo sapiens	Residual Activity	%	23.0
	12242985	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	26.0	CHEMBL2148	Homo sapiens	Residual Activity	%	26.0
	12242986	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12242987	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	66.0	CHEMBL2148	Homo sapiens	Residual Activity	%	66.0
	12242988	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	10.0	CHEMBL2148	Homo sapiens	Residual Activity	%	10.0
	12242989	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	63.0	CHEMBL2148	Homo sapiens	Residual Activity	%	63.0
	12242990	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	16.0	CHEMBL2148	Homo sapiens	Residual Activity	%	16.0
	12242991	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	58.0	CHEMBL2148	Homo sapiens	Residual Activity	%	58.0
	12242992	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2148	Homo sapiens	Residual Activity	%	0.0
	12242993	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	83.0	CHEMBL2148	Homo sapiens	Residual Activity	%	83.0
	12242994	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12242995	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	96.0	CHEMBL2148	Homo sapiens	Residual Activity	%	96.0
	12242996	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	122.0	CHEMBL2148	Homo sapiens	Residual Activity	%	122.0
	12242997	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	48.0	CHEMBL2148	Homo sapiens	Residual Activity	%	48.0
	12242998	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12242999	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	121.0	CHEMBL2148	Homo sapiens	Residual Activity	%	121.0
	12243000	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12243001	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	113.0	CHEMBL2148	Homo sapiens	Residual Activity	%	113.0
	12243002	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL2148	Homo sapiens	Residual Activity	%	2.0
	12243003	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL2148	Homo sapiens	Residual Activity	%	97.0
	12243004	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12243005	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	5.0	CHEMBL2148	Homo sapiens	Residual Activity	%	5.0
	12243006	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	82.0	CHEMBL2148	Homo sapiens	Residual Activity	%	82.0
	12243007	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12243008	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	119.0	CHEMBL2148	Homo sapiens	Residual Activity	%	119.0
	12243009	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	78.0	CHEMBL2148	Homo sapiens	Residual Activity	%	78.0
	12243010	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12243011	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12243012	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12243013	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	58.0	CHEMBL2148	Homo sapiens	Residual Activity	%	58.0
	12243014	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2148	Homo sapiens	Residual Activity	%	0.0
	12243015	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12243016	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	9.0	CHEMBL2148	Homo sapiens	Residual Activity	%	9.0
	12243017	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12243018	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12243019	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12243020	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	102.0	CHEMBL2148	Homo sapiens	Residual Activity	%	102.0
	12243021	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	100.0	CHEMBL2148	Homo sapiens	Residual Activity	%	100.0
	12243022	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	71.0	CHEMBL2148	Homo sapiens	Residual Activity	%	71.0
	12243023	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12243024	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	114.0	CHEMBL2148	Homo sapiens	Residual Activity	%	114.0
	12243025	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	66.0	CHEMBL2148	Homo sapiens	Residual Activity	%	66.0
	12243026	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	85.0	CHEMBL2148	Homo sapiens	Residual Activity	%	85.0
	12243027	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	117.0	CHEMBL2148	Homo sapiens	Residual Activity	%	117.0
	12243028	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL2148	Homo sapiens	Residual Activity	%	92.0
	12243029	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	5.0	CHEMBL2148	Homo sapiens	Residual Activity	%	5.0
	12243030	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	104.0	CHEMBL2148	Homo sapiens	Residual Activity	%	104.0
	12243031	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	118.0	CHEMBL2148	Homo sapiens	Residual Activity	%	118.0
	12243032	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12243033	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	26.0	CHEMBL2148	Homo sapiens	Residual Activity	%	26.0
	12243034	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	119.0	CHEMBL2148	Homo sapiens	Residual Activity	%	119.0
	12243035	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	81.0	CHEMBL2148	Homo sapiens	Residual Activity	%	81.0
	12243036	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	89.0	CHEMBL2148	Homo sapiens	Residual Activity	%	89.0
	12243037	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12243038	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	91.0	CHEMBL2148	Homo sapiens	Residual Activity	%	91.0
	12243039	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	96.0	CHEMBL2148	Homo sapiens	Residual Activity	%	96.0
	12243040	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	122.0	CHEMBL2148	Homo sapiens	Residual Activity	%	122.0
	12243041	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12243042	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL2148	Homo sapiens	Residual Activity	%	2.0
	12243043	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	107.0	CHEMBL2148	Homo sapiens	Residual Activity	%	107.0
	12243044	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	81.0	CHEMBL2148	Homo sapiens	Residual Activity	%	81.0
	12243045	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	9.0	CHEMBL2148	Homo sapiens	Residual Activity	%	9.0
	12243046	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL2148	Homo sapiens	Residual Activity	%	89.0
	12243047	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	21.0	CHEMBL2148	Homo sapiens	Residual Activity	%	21.0
	12243048	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	87.0	CHEMBL2148	Homo sapiens	Residual Activity	%	87.0
	12243049	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	85.0	CHEMBL2148	Homo sapiens	Residual Activity	%	85.0
	12243050	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	1.0	CHEMBL2148	Homo sapiens	Residual Activity	%	1.0
	12243051	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	21.0	CHEMBL2148	Homo sapiens	Residual Activity	%	21.0
	12243052	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	70.0	CHEMBL2148	Homo sapiens	Residual Activity	%	70.0
	12243053	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL2148	Homo sapiens	Residual Activity	%	101.0
	12243054	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	112.0	CHEMBL2148	Homo sapiens	Residual Activity	%	112.0
	12243055	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	9.0	CHEMBL2148	Homo sapiens	Residual Activity	%	9.0
	12243056	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	108.0	CHEMBL2148	Homo sapiens	Residual Activity	%	108.0
	12243057	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	99.0	CHEMBL2148	Homo sapiens	Residual Activity	%	99.0
	12243058	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	106.0	CHEMBL2148	Homo sapiens	Residual Activity	%	106.0
	12243059	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	26.0	CHEMBL2148	Homo sapiens	Residual Activity	%	26.0
	12243060	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	48.0	CHEMBL2148	Homo sapiens	Residual Activity	%	48.0
	12243061	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL2148	Homo sapiens	Residual Activity	%	90.0
	12243062	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL2148	Homo sapiens	Residual Activity	%	103.0
	12243063	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	10.0	CHEMBL2148	Homo sapiens	Residual Activity	%	10.0
	12243064	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	34.0	CHEMBL2148	Homo sapiens	Residual Activity	%	34.0
	12243065	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL2148	Homo sapiens	Residual Activity	%	105.0
	12245667	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL2148	Homo sapiens	Residual Activity	%	86.0
	12245668	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	96.0	CHEMBL2148	Homo sapiens	Residual Activity	%	96.0
	12245669	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	124.0	CHEMBL2148	Homo sapiens	Residual Activity	%	124.0
	12245670	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	93.0	CHEMBL2148	Homo sapiens	Residual Activity	%	93.0
	12245671	CHEMBL2219230	Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	81.0	CHEMBL2148	Homo sapiens	Residual Activity	%	81.0
	12626734	CHEMBL2317003	Inhibition of JAK3 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	12631667	CHEMBL2317770	Inhibition of JAK3 (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	5300.0	CHEMBL2148	Homo sapiens	IC50	uM	5.3
	12631668	CHEMBL2317770	Inhibition of JAK3 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	12631669	CHEMBL2317770	Inhibition of JAK3 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
Not Determined	12631670	CHEMBL2317770	Inhibition of JAK3 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	12631671	CHEMBL2317770	Inhibition of JAK3 (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645		IC50			CHEMBL2148	Homo sapiens	IC50		
	12647768	CHEMBL2329039	Binding affinity to JAK3 (unknown origin)	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Kd	nM	0.12	CHEMBL2148	Homo sapiens	Kd	nM	0.12
	12649732	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	2.2	CHEMBL2148	Homo sapiens	IC50	nM	2.2
	12649733	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	N#C[C@H]1CCN(C(=O)[C@H](NC(=O)c2c[nH]c3ncc(C4CC4)nc23)C2CC2)C1		CHEMBL2325898	=	IC50	nM	0.44	CHEMBL2148	Homo sapiens	IC50	nM	0.44
	12649734	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	N#C[C@@H]1CCN(C(=O)[C@H](NC(=O)c2c[nH]c3ncc(C4CC4)nc23)C2CC2)C1		CHEMBL2325897	<	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	12649735	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	N#CC1CN(C(=O)[C@H](NC(=O)c2c[nH]c3ncc(C4CC4)nc23)C2CC2)C1		CHEMBL2325896	<	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	12649736	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	IC50	nM	0.26	CHEMBL2148	Homo sapiens	IC50	nM	0.26
	12649737	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	IC50	nM	8.2	CHEMBL2148	Homo sapiens	IC50	nM	8.2
	12649738	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC1CCN(C(=O)[C@@H](C)NC(=O)c2c[nH]c3ncc(C4CC4)nc23)C1		CHEMBL2325913	=	IC50	nM	80.6	CHEMBL2148	Homo sapiens	IC50	nM	80.6
	12649739	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CCC(C#N)C1		CHEMBL2325912	=	IC50	nM	8.7	CHEMBL2148	Homo sapiens	IC50	nM	8.7
	12649740	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CCC1		CHEMBL2325911	=	IC50	nM	148.0	CHEMBL2148	Homo sapiens	IC50	nM	148.0
	12649741	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CCCC1		CHEMBL2325910	=	IC50	nM	48.5	CHEMBL2148	Homo sapiens	IC50	nM	48.5
	12649742	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CCCCC1		CHEMBL2325909	=	IC50	nM	68.9	CHEMBL2148	Homo sapiens	IC50	nM	68.9
	12649743	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N(C)C		CHEMBL2325908	=	IC50	nM	104.4	CHEMBL2148	Homo sapiens	IC50	nM	104.4
	12649744	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C1CCCCC1		CHEMBL2325907	=	IC50	nM	43.6	CHEMBL2148	Homo sapiens	IC50	nM	43.6
	12649745	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
	12649746	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325905	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	12649747	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	12649748	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
	12649749	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C1CC1		CHEMBL2325900	=	IC50	nM	8.6	CHEMBL2148	Homo sapiens	IC50	nM	8.6
	12649750	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@H](C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325899	=	IC50	nM	7.8	CHEMBL2148	Homo sapiens	IC50	nM	7.8
	12649751	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC[C@H](C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325902	=	IC50	nM	9.6	CHEMBL2148	Homo sapiens	IC50	nM	9.6
	12649752	CHEMBL2327061	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 30 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	IC50	nM	44.5	CHEMBL2148	Homo sapiens	IC50	nM	44.5
	12679742	CHEMBL2345854	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	1.75	CHEMBL2148	Homo sapiens	INH	%	1.75
	12700125	CHEMBL2344138	Inhibition of recombinant JAK3 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	15.0	CHEMBL2148	Homo sapiens	INH	%	15.0
	12728798	CHEMBL2351427	Inhibition of JAK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	85.0	CHEMBL2148	Homo sapiens	Activity	%	85.0
	12729042	CHEMBL2351948	Inhibition of JAK3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL2148	Homo sapiens	Activity	%	105.0
	12729925	CHEMBL2350070	Inhibition of JAK3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL2148	Homo sapiens	Activity	%	94.0
	12730185	CHEMBL2351427	Inhibition of JAK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL2148	Homo sapiens	Activity	%	105.0
	13281250	CHEMBL2378199	Binding affinity to JAK3 (unknown origin) by ligand displacement assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Kd	nM	1.4	CHEMBL2148	Homo sapiens	Kd	nM	1.4
	13282625	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cnc4cc(Cl)ccn34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376159	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
	13282626	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	13282627	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376157	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	13282628	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-n3ncc4cc(Cl)ccc43)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376156	=	IC50	nM	10.5	CHEMBL2148	Homo sapiens	IC50	nM	10.5
	13282629	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C(C)(C)C)c3n2)c2ccc(Cl)cc21		CHEMBL2376155	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	13282630	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	13282631	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	<	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	13282632	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
	13282633	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(C(C)(C)C)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376151	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	13282634	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(C5CC5)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376150	=	IC50	nM	3.1	CHEMBL2148	Homo sapiens	IC50	nM	3.1
	13282635	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	COc1ccc2c(-c3cnc4[nH]cc(C(=O)N[C@H](C)C(=O)N5CC(C#N)C5)c4n3)nn(C)c2c1		CHEMBL2376149	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
	13282636	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(C#N)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376148	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
	13282637	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(F)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376147	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	13282638	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4ccccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376146	=	IC50	nM	2.9	CHEMBL2148	Homo sapiens	IC50	nM	2.9
	13282639	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4ccc(Cl)cc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376145	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	13282640	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	13282641	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	13283418	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	CCn1cc(-c2cnc3[nH]cc(C(=O)N[C@H](C)C(=O)N4CC(C#N)C4)c3n2)cn1		CHEMBL2376142	=	IC50	nM	5.2	CHEMBL2148	Homo sapiens	IC50	nM	5.2
	13283419	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	COc1cc(-c2cnc3[nH]cc(C(=O)N[C@H](C)C(=O)N4CC(C#N)C4)c3n2)cc(OC)c1OC		CHEMBL2376040	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	13283420	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	IC50	nM	8.2	CHEMBL2148	Homo sapiens	IC50	nM	8.2
	13283421	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	13283422	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	10.7	CHEMBL2148	Homo sapiens	IC50	nM	10.7
	13283423	CHEMBL2378516	Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVKD as substrate incubated for 10 mins prior to substrate addition measured after 30 mins by filtration assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	2.2	CHEMBL2148	Homo sapiens	IC50	nM	2.2
	13284841	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	uM	0.002
	13284842	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)N[C@@H](C(=O)N5CC(C#N)C5)C(C)(C)C)c4n3)cc21		CHEMBL2376440	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	uM	0.057
	13284843	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)N[C@@H](C(=O)N5CC(C#N)C5)C5CC5)c4n3)cc21		CHEMBL2376439	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	uM	0.005
	13284844	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)N[C@H](C)C(=O)N5CC(C#N)C5)c4n3)cc21		CHEMBL2376438	=	IC50	nM	112.0	CHEMBL2148	Homo sapiens	IC50	uM	0.112
	13284845	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)N[C@H](C)C5CC5)c4n3)cc21		CHEMBL2376437	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	uM	0.014
	13284846	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)N[C@@H](C)C5CC5)c4n3)cc21		CHEMBL2376436	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	uM	0.022
	13284847	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)NC(C)C)c4n3)cc21		CHEMBL2376340	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	uM	0.14
	13284848	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(=O)N[C@H]1CCc2ccc(Oc3cnc4[nH]cc(C(=O)NC(C)C)c4n3)cc21		CHEMBL2376339	=	IC50	nM	340.0	CHEMBL2148	Homo sapiens	IC50	uM	0.34
	13284849	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(C)NC(=O)c1c[nH]c2ncc(Oc3ccc4c(c3)CCC4)nc12		CHEMBL2376338	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	uM	0.37
	13284850	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(NC(=O)c1c[nH]c2ncc(Oc3ccccc3)nc12)C1CC1		CHEMBL2376337	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	uM	0.03
	13284851	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	Cc1ccccc1Oc1cnc2[nH]cc(C(=O)NC(C)C)c2n1		CHEMBL2376336	=	IC50	nM	1380.0	CHEMBL2148	Homo sapiens	IC50	uM	1.38
	13284852	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(C)NC(=O)c1c[nH]c2ncc(Oc3ccc(C#N)cc3)nc12		CHEMBL2376335	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	uM	0.42
	13284853	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(C)NC(=O)c1c[nH]c2ncc(Oc3cccc(C#N)c3)nc12		CHEMBL2376334	=	IC50	nM	970.0	CHEMBL2148	Homo sapiens	IC50	uM	0.97
	13284854	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	COc1cc(OC)cc(Oc2cnc3[nH]cc(C(=O)NC(C)C)c3n2)c1		CHEMBL2376333	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	uM	0.4
	13284855	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CCc1cccc(Oc2cnc3[nH]cc(C(=O)NC(C)C)c3n2)c1		CHEMBL2376332	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	uM	0.47
	13284856	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	Cc1cccc(Oc2cnc3[nH]cc(C(=O)NC(C)C)c3n2)c1		CHEMBL2376331	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	uM	0.28
	13284857	CHEMBL2378978	Inhibition of JAK3 (unknown origin) using Biotin-KAIETDKEYYTVKD as substrate and [33Pgamma]ATP incubated for 10 mins prior to substrate addition measured after 30 mins by Topcount analysis	B	CC(C)NC(=O)c1c[nH]c2ncc(Oc3ccccc3)nc12		CHEMBL2376330	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	uM	0.21
	13307748	CHEMBL2383799	Inhibition of JAK3 TEL domain (unknown origin) transfected in mouse Ba/F3 cells	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cc3F)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381983	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	uM	0.37
	13307816	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCN(C)CC3)n2)n[nH]1		CHEMBL2381987	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	uM	0.015
	13307817	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCS(=O)(=O)CC3)n2)n[nH]1		CHEMBL2381986	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	uM	0.004
	13307819	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(Cl)c(N3CCOCC3)n2)n[nH]1		CHEMBL2380329	=	IC50	nM	262.0	CHEMBL2148	Homo sapiens	IC50	uM	0.262
	13307820	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)cc(N3CCOCC3)n2)n[nH]1		CHEMBL2381985	=	IC50	nM	95.0	CHEMBL2148	Homo sapiens	IC50	uM	0.095
	13307821	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(O[C@@H](C)c3ncc(F)cc3F)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381984	=	IC50	nM	45.0	CHEMBL2148	Homo sapiens	IC50	uM	0.045
	13307822	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cc3F)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381983	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	uM	0.008
	13307823	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(O[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381982	=	IC50	nM	87.0	CHEMBL2148	Homo sapiens	IC50	uM	0.087
	13307824	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381981	=	IC50	nM	262.0	CHEMBL2148	Homo sapiens	IC50	uM	0.262
	13307825	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(O[C@@H](C)c3ncc(F)cn3)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381980	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	uM	0.02
	13307826	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381979	=	IC50	nM	229.0	CHEMBL2148	Homo sapiens	IC50	uM	0.229
	13307827	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	COc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(F)c(N3CCOCC3)n2)n[nH]1		CHEMBL2381978	=	IC50	nM	11230.0	CHEMBL2148	Homo sapiens	IC50	uM	11.23
	13307828	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cnc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc(N3CCOCC3)c2F)s1		CHEMBL1080151	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	13307829	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cnc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)c(F)c(N3CCOCC3)n2)s1		CHEMBL2381977	=	IC50	nM	16400.0	CHEMBL2148	Homo sapiens	IC50	uM	16.4
	13307832	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCN(S(C)(=O)=O)CC3)n2)n[nH]1		CHEMBL2381975	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	uM	0.02
	13307844	CHEMBL2383937	Inhibition of JAK3 (unknown origin) using biotinylated poly-EY peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(F)c(N3CCNCC3)n2)n[nH]1		CHEMBL2381976	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	uM	0.03
	13315827	CHEMBL2389265	Inhibition of JAK3 (unknown origin)	B	O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl		CHEMBL2387224	=	Ki	nM	253.0	CHEMBL2148	Homo sapiens	Ki	nM	253.0
	13317340	CHEMBL2389431	Inhibition of human JAK3 (781-1124) expressed in baculovirus-infected Sf9 cells using EQEDEPEGDYFEWLE as substrate after 1 hr by HTRF assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Ki	nM	3.2	CHEMBL2148	Homo sapiens	Ki	nM	3.2
	13317434	CHEMBL2389439	Inhibition of human GST-fused JAK3 catalytic domain expressed in baculovirus-infected Sf9 cells using polyglutamic acid-tyrosine as substrate after 30 mins by ELISA	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Ki	nM	0.4	CHEMBL2148	Homo sapiens	Ki	nM	0.4
	13327660	CHEMBL2389825	Inhibition of JAK3 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	27.0	CHEMBL2148	Homo sapiens	INH	%	27.0
Not Determined	13327661	CHEMBL2389825	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	13328769	CHEMBL2388492	Inhibition of JAK3 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	13329994	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CCC#N)CC1		CHEMBL2386636	=	Ki	nM	7.8	CHEMBL2148	Homo sapiens	Ki	nM	7.8
	13329995	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1		CHEMBL2386635	=	Ki	nM	5.9	CHEMBL2148	Homo sapiens	Ki	nM	5.9
	13329996	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1		CHEMBL2386633	=	Ki	nM	280.0	CHEMBL2148	Homo sapiens	Ki	nM	280.0
	13329997	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@@H](NCC(F)(F)F)C1		CHEMBL2385096	=	Ki	nM	53.0	CHEMBL2148	Homo sapiens	Ki	nM	53.0
	13329998	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](NCC(F)(F)F)CC1		CHEMBL2386629	=	Ki	nM	76.0	CHEMBL2148	Homo sapiens	Ki	nM	76.0
	13329999	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CCCOC1		CHEMBL2386653	=	Ki	nM	110.0	CHEMBL2148	Homo sapiens	Ki	nM	110.0
	13330000	CHEMBL2390366	Inhibition of JAK3 (unknown origin) using Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg as substrate after 30 mins in presence of ATP	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Ki	nM	0.4	CHEMBL2148	Homo sapiens	Ki	nM	0.4
	13343207	CHEMBL2394947	Inhibition of JAK3 (unknown origin)	B	CC1(n2nnc3cnc4[nH]ccc4c32)CCN(S(C)(=O)=O)CC1		CHEMBL2392493	=	Ki	nM	369.0	CHEMBL2148	Homo sapiens	Ki	nM	369.0
	13343220	CHEMBL2394947	Inhibition of JAK3 (unknown origin)	B	N#CCCN[C@H]1CC[C@H](n2nnc3cnc4[nH]ccc4c32)CC1		CHEMBL2392480	=	Ki	nM	122.0	CHEMBL2148	Homo sapiens	Ki	nM	122.0
	13343248	CHEMBL2394947	Inhibition of JAK3 (unknown origin)	B	N#CCC(=O)N1CCC[C@@H](n2nnc3cnc4[nH]ccc4c32)C1		CHEMBL2392500	=	Ki	nM	24.0	CHEMBL2148	Homo sapiens	Ki	nM	24.0
	13367177	CHEMBL2406334	Inhibition of JAK3 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	7920.0	CHEMBL2148	Homo sapiens	IC50	uM	7.92
	13375829	CHEMBL2404342	Inhibition of JAK3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL2148	Homo sapiens	INH	%	-1.0
Active	13376816	CHEMBL2404404	Inhibition of JAK3 (unknown origin) at 0.5 uM	B	COc1cc(Nc2ncc(Br)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)[C@@H](C)C1		CHEMBL2403079		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	13418821	CHEMBL2422670	Inhibition of JAK3 (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	IC50	nM	63.1	CHEMBL2148	Homo sapiens	pIC50		7.2
	13418843	CHEMBL2422670	Inhibition of JAK3 (unknown origin)	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	501.19	CHEMBL2148	Homo sapiens	pIC50		6.3
	13418844	CHEMBL2422670	Inhibition of JAK3 (unknown origin)	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	pIC50		6.0
	13431974	CHEMBL2421806	Inhibition of JAK3 (unknown origin)	B	O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl		CHEMBL2387224	=	Ki	nM	253.0	CHEMBL2148	Homo sapiens	Ki	nM	253.0
	13433623	CHEMBL2421806	Inhibition of JAK3 (unknown origin)	B	O=C(Nc1ccncc1)c1c(Cl)cccc1Cl		CHEMBL1327969	>	Ki	nM	5000.0	CHEMBL2148	Homo sapiens	Ki	uM	5.0
	13439721	CHEMBL2427770	Competitive binding affinity to JAK3 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	13445554	CHEMBL2427770	Competitive binding affinity to JAK3 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	13451541	CHEMBL2427770	Competitive binding affinity to JAK3 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	13468705	CHEMBL2433184	Inhibition of JAK3 JH1 domain (unknown origin) assessed as residual activity at 5 uM relative to control	B	Cc1ccc(S(=O)(=O)N(CC(=O)N(Cc2ccc(C3CCCCC3)cc2)c2ccc(C(=O)O)c(O)c2)Cc2ccccc2C(F)(F)F)cc1		CHEMBL2431993	=	Activity	%	84.0	CHEMBL2148	Homo sapiens	Activity	%	84.0
	13475220	CHEMBL2438689	Inhibition of JAK3 (unknown origin)	B	CCc1nc(N[C@@H]2CCC[C@@H]2C#N)c2cc[nH]c(=O)c2n1		CHEMBL2436945	=	Ki	nM	37.0	CHEMBL2148	Homo sapiens	Ki	nM	37.0
	13483405	CHEMBL2439329	Inhibition of JAK3 JH1 catalytic domain (unknown origin) at 1 uM after 1 hr relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL2437469	<	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	13507571	CHEMBL2443998	Inhibition of JAK3 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	13507572	CHEMBL2443998	Inhibition of JAK3 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	13507573	CHEMBL2443998	Inhibition of JAK3 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	13507574	CHEMBL2443998	Inhibition of JAK3 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
Not Active	13508480	CHEMBL2447355	Inhibition of JAK3 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	13826422	CHEMBL3088490	Binding affinity to JAK3 (unknown origin)	B	C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1		CHEMBL3086102		Activity			CHEMBL2148	Homo sapiens	Activity		
	13872117	CHEMBL3101742	Inhibition of human JAK3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	85.0	CHEMBL2148	Homo sapiens	Activity	%	85.0
	13882551	CHEMBL3106994	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	10.9	CHEMBL2148	Homo sapiens	IC50	nM	10.9
	13882575	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Inhibition	%	12.6	CHEMBL2148	Homo sapiens	INH	%	12.6
	13882576	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2c(C#CCCO)n[nH]c12		CHEMBL3105874	=	Inhibition	%	48.1	CHEMBL2148	Homo sapiens	INH	%	48.1
	13882577	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2c(C#CCCO)n[nH]c12		CHEMBL3105873	=	Inhibition	%	32.3	CHEMBL2148	Homo sapiens	INH	%	32.3
	13882578	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2c(C#CCO)n[nH]c12		CHEMBL3105872	=	Inhibition	%	38.1	CHEMBL2148	Homo sapiens	INH	%	38.1
	13882579	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2c(C#CCO)n[nH]c12		CHEMBL3105871	=	Inhibition	%	24.9	CHEMBL2148	Homo sapiens	INH	%	24.9
	13882580	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cc(N)cc3[nH]ncc23)cc2cn[nH]c12		CHEMBL3105870	=	Inhibition	%	15.7	CHEMBL2148	Homo sapiens	INH	%	15.7
	13882581	CHEMBL3107000	Inhibition of JAK3 (unknown origin) at 10 uM	B	NC(=O)c1cc(-c2cccc3[nH]ncc23)cc2cn[nH]c12		CHEMBL3105869	=	Inhibition	%	22.5	CHEMBL2148	Homo sapiens	INH	%	22.5
	13901942	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CN(c3ccnc(F)c3)C2)c1		CHEMBL3114765	=	IC50	nM	576.0	CHEMBL2148	Homo sapiens	IC50	nM	576.0
	13901943	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CCN(c3ccnc(F)c3)CC2)c1		CHEMBL3114764	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	13901944	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(C2CCN(c3ccnc(F)c3)C2)c1		CHEMBL3114763	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	13901945	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(O[C@@H]2CCN(c3ccnc(F)c3)C2)c1		CHEMBL3114762	=	IC50	nM	497.0	CHEMBL2148	Homo sapiens	IC50	nM	497.0
	13901946	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(O[C@H]2CCN(c3ccnc(F)c3)C2)c1		CHEMBL3114761	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	13901947	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCN(c3ccnc(F)c3)C2)c1		CHEMBL3114786	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	13901948	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CN(c3ccnc(F)c3)C2)c1		CHEMBL3114785	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
	13901949	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCCN(c3ccnc(F)c3)C2)c1		CHEMBL3114784	=	IC50	nM	163.0	CHEMBL2148	Homo sapiens	IC50	nM	163.0
	13901950	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCN(c3ccnc(F)c3)CC2)c1		CHEMBL3114783	=	IC50	nM	625.0	CHEMBL2148	Homo sapiens	IC50	nM	625.0
	13901951	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1C=C(Nc2cccc(OCCNc3ccnc(F)c3)c2)C(=O)N1		CHEMBL3114782	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	13901952	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(OCCNc2ccnc(F)c2)c1		CHEMBL3114781	=	IC50	nM	576.0	CHEMBL2148	Homo sapiens	IC50	nM	576.0
	13901953	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2cc(F)cc(F)c2)c1		CHEMBL3114780	=	IC50	nM	1387.0	CHEMBL2148	Homo sapiens	IC50	nM	1387.0
	13901954	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2ccccc2)c1		CHEMBL3114779	=	IC50	nM	1380.0	CHEMBL2148	Homo sapiens	IC50	nM	1380.0
	13901955	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2cnccn2)c1		CHEMBL3114778	=	IC50	nM	408.0	CHEMBL2148	Homo sapiens	IC50	nM	408.0
	13901956	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2ccccn2)c1		CHEMBL3114777	=	IC50	nM	1499.0	CHEMBL2148	Homo sapiens	IC50	nM	1499.0
	13901957	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	CN(CCOc1cccc(NC2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1)c1ccnc(F)c1		CHEMBL3114776	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	13901958	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	Cn1cc(C2=C(Nc3cccc(OCCNc4ccnc(F)c4)c3)C(=O)NC2=O)c2ccccc21		CHEMBL3114775	=	IC50	nM	179.0	CHEMBL2148	Homo sapiens	IC50	nM	179.0
	13901959	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCNc2ccnc(F)c2)c1		CHEMBL3114774	=	IC50	nM	29.0	CHEMBL2148	Homo sapiens	IC50	nM	29.0
	13901960	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccccc1OCCNc1ccnc(F)c1		CHEMBL3114773	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	13901961	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCNc2ccnc(F)c2)cc1		CHEMBL3114772	=	IC50	nM	201.0	CHEMBL2148	Homo sapiens	IC50	nM	201.0
	13901962	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCCNc2ccnc(F)c2)cc1		CHEMBL3114771	=	IC50	nM	135.0	CHEMBL2148	Homo sapiens	IC50	nM	135.0
	13901963	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccccc1OCCn1ccnc1		CHEMBL3114770	=	IC50	nM	9367.0	CHEMBL2148	Homo sapiens	IC50	nM	9367.0
	13901964	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCCn2ccnc2)cc1		CHEMBL3114769	=	IC50	nM	1148.0	CHEMBL2148	Homo sapiens	IC50	nM	1148.0
	13901965	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCn2ccnc2)cc1		CHEMBL3114768	=	IC50	nM	278.0	CHEMBL2148	Homo sapiens	IC50	nM	278.0
	13901966	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCn2ccnc2)c1		CHEMBL3114767	=	IC50	nM	1790.0	CHEMBL2148	Homo sapiens	IC50	nM	1790.0
	13901967	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OCCCn2ccnc2)c1		CHEMBL3114766	=	IC50	nM	128.0	CHEMBL2148	Homo sapiens	IC50	nM	128.0
	13901968	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	13901969	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	13901970	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	14.6	CHEMBL2148	Homo sapiens	IC50	nM	14.6
	13901971	CHEMBL3118992	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
Not Active	13907187	CHEMBL3118663	Inhibition of JAK3 (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	13918702	CHEMBL3118222	Inhibition of human JAK3	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	uM	0.035
	13918741	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	Cc1csc2c(Nc3cn(C)cn3)nc(N[C@@H](C)c3ncc(F)cn3)nc12		CHEMBL3116056	=	IC50	nM	3930.0	CHEMBL2148	Homo sapiens	IC50	uM	3.93
	13918745	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	CC(Nc1nc(Nc2cn(C)cn2)c2[nH]ccc2n1)c1ncc(F)cn1		CHEMBL3116055	=	IC50	nM	5880.0	CHEMBL2148	Homo sapiens	IC50	uM	5.88
	13918749	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cnn(C)c2n1)c1ncc(F)cn1		CHEMBL3116054	=	IC50	nM	1440.0	CHEMBL2148	Homo sapiens	IC50	uM	1.44
	13918753	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	CC(Nc1nc(Nc2cn(C)cn2)c2cn[nH]c2n1)c1ncc(F)cn1		CHEMBL3116053	=	IC50	nM	4620.0	CHEMBL2148	Homo sapiens	IC50	uM	4.62
	13918757	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2ccn(C3CC3)c2n1)c1ncc(F)cn1		CHEMBL3116052	=	IC50	nM	2460.0	CHEMBL2148	Homo sapiens	IC50	uM	2.46
	13919076	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2ccn(C)c2n1)c1ncc(F)cn1		CHEMBL3116051	=	IC50	nM	7560.0	CHEMBL2148	Homo sapiens	IC50	uM	7.56
	13919080	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	uM	0.22
	13919084	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2ccncc2n1)c1ncc(F)cn1		CHEMBL3116065	=	IC50	nM	1820.0	CHEMBL2148	Homo sapiens	IC50	uM	1.82
	13919088	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2nccnc2n1)c1ncc(F)cn1		CHEMBL3116064	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	13919092	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	CC(Nc1nc(Nc2cn(C)cn2)c2ccc(Cl)nc2n1)c1ncc(F)cn1		CHEMBL3116063	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	13919096	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc(F)cnc2n1)c1ncc(F)cn1		CHEMBL3116062	=	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	13919100	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	CC(Nc1nc(Nc2cn(C)cn2)c2cccnc2n1)c1ncc(F)cn1		CHEMBL3116061	=	IC50	nM	3780.0	CHEMBL2148	Homo sapiens	IC50	uM	3.78
	13919104	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	COc1ccc2c(Nc3cn(C)cn3)nc(NC(C)c3ncc(F)cn3)nc2c1		CHEMBL3116060	=	IC50	nM	13150.0	CHEMBL2148	Homo sapiens	IC50	uM	13.15
	13919108	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	COc1ccc2nc(NC(C)c3ncc(F)cn3)nc(Nc3cn(C)cn3)c2c1		CHEMBL3116059	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	13919112	CHEMBL3118239	Inhibition of Jak3 (unknown origin)	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2ccccc2n1)c1ncc(F)cn1		CHEMBL3116058	=	IC50	nM	14830.0	CHEMBL2148	Homo sapiens	IC50	uM	14.83
	13939650	CHEMBL3132142	Inhibition of JAK3 (unknown origin) at 10 uM	B	COCCNc1nc2ccc(C#CC(C)(C)O)cc2n1-c1ccnc(N)n1		CHEMBL3128041	=	Inhibition	%	31.0	CHEMBL2148	Homo sapiens	INH	%	31.0
	13941102	CHEMBL3132148	Inhibition of JAK3 (unknown origin) at 1 uM	B	COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1		CHEMBL3128042	=	Inhibition	%	-1.0	CHEMBL2148	Homo sapiens	INH	%	-1.0
	13941103	CHEMBL3132148	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ncnc(N)n1		CHEMBL3128050	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	INH	%	-2.0
	13941104	CHEMBL3132148	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cc1nc2ccc(C#CC(C)(C)O)cc2n1-c1ncnc(N)n1		CHEMBL3128044	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	13946514	CHEMBL3131077	Inhibition of JAK3 (unknown origin) after 20 mins	B	NS(=O)(=O)OCCn1cnc2c(Nc3ccc(F)cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21		CHEMBL3125667	=	IC50	nM	10500.0	CHEMBL2148	Homo sapiens	IC50	uM	10.5
	13946517	CHEMBL3131075	Inhibition of JAK3 (unknown origin) at 50 uM after 20 mins	B	NS(=O)(=O)OCCn1cnc2c(Nc3ccc(F)cc3)nc(NCc3ccc(C4CCCCC4)cc3)nc21		CHEMBL3125667	=	Inhibition	%	85.0	CHEMBL2148	Homo sapiens	INH	%	85.0
	13953291	CHEMBL3130701	Inhibition of human JAK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	96.0	CHEMBL2148	Homo sapiens	Activity	%	96.0
	13953306	CHEMBL3130701	Inhibition of human JAK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	94.0	CHEMBL2148	Homo sapiens	Activity	%	94.0
	13953330	CHEMBL3130701	Inhibition of human JAK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	91.0	CHEMBL2148	Homo sapiens	Activity	%	91.0
Not Active	13973374	CHEMBL3134665	Inhibition of JAK3 (unknown origin) using poly(Ala,Glu,Lsy,Tyr) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	14537722	CHEMBL3223754	Inhibition of JAK3 in KL-2 EBV-transformed human lymphoblastoid B cells by immune complex kinase assay	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	IC50	nM	9100.0	CHEMBL2148	Homo sapiens	IC50	uM	9.1
	14567130	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	NC(=O)Nc1sc(-c2ccccc2)cc1C(N)=O		CHEMBL404609	=	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	uM	2.0
	14567132	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)sc1Nc1ccccn1		CHEMBL3234894	=	IC50	nM	5200.0	CHEMBL2148	Homo sapiens	IC50	uM	5.2
	14567136	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)sc1Nc1ccccc1		CHEMBL3234893	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	14567138	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)sc1Nc1cccnc1		CHEMBL3234892	=	IC50	nM	28500.0	CHEMBL2148	Homo sapiens	IC50	uM	28.5
	14567140	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)sc1Nc1ccncc1		CHEMBL3234891	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	14569851	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	CC(C)(O)c1ccc(-c2cc(C(N)=O)c(Nc3cccc(CN4CCOCC4)n3)s2)cc1		CHEMBL3234873	=	IC50	nM	1350.0	CHEMBL2148	Homo sapiens	IC50	nM	1350.0
	14569862	CHEMBL3239500	Inhibition of JAK3 (unknown origin)	B	CC(C)(O)COCc1cccc(Nc2sc(-c3c(F)cc(C(C)(C)O)cc3F)cc2C(N)=O)n1		CHEMBL3234895	=	IC50	nM	763.0	CHEMBL2148	Homo sapiens	IC50	nM	763.0
	14582530	CHEMBL3242531	Inhibition of human JAK3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	99.0	CHEMBL2148	Homo sapiens	Activity	%	99.0
	14590404	CHEMBL3241991	Inhibition of JAK3 (unknown origin) at 5 uM	B	Clc1nc(Cl)c2sccc2n1		CHEMBL3236403	<	Inhibition	%	40.0	CHEMBL2148	Homo sapiens	INH	%	40.0
	14593789	CHEMBL3242878	Inhibition of human JAK3	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	14645927	CHEMBL3270968	Inhibition of JAK3 (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	33740.0	CHEMBL2148	Homo sapiens	IC50	uM	33.74
	14659365	CHEMBL3267571	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	9.0	CHEMBL2148	Homo sapiens	INH	%	9.0
	14659366	CHEMBL3267571	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	14730376	CHEMBL3292442	Inhibition of Jak3 (unknown origin) after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142	=	IC50	nM	2680.0	CHEMBL2148	Homo sapiens	IC50	nM	2680.0
	14730377	CHEMBL3292442	Inhibition of Jak3 (unknown origin) after 1 hr by HTRF assay	B	C=CC(=O)NCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290148	=	IC50	nM	6370.0	CHEMBL2148	Homo sapiens	IC50	nM	6370.0
	14746162	CHEMBL3292188	Inhibition of human JAK3 assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	121.0	CHEMBL2148	Homo sapiens	Activity	%	121.0
	14746163	CHEMBL3292188	Inhibition of human JAK3 assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	112.0	CHEMBL2148	Homo sapiens	Activity	%	112.0
	14751775	CHEMBL3300959	Inhibition of JAK3 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	14751776	CHEMBL3300959	Inhibition of JAK3 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	14751947	CHEMBL3299214	Inhibition of recombinant JAK3 kinase domain (unknown origin) using FITC-KGGEEEEYFELVKK as substrate assessed as inhibition of substrate phosphorylation by peptide mobility shift assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	14751960	CHEMBL3299319	Inhibition of JAK3 (unknown origin) using poly(Glu)4Tyr as substrate assessed as 33P incorporation after 20 mins by scintillation counting analysis in presence of radiolabelled ATP	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	14751975	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
	14751980	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	IC50	nM	74.4	CHEMBL2148	Homo sapiens	IC50	nM	74.4
	14751997	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	487.0	CHEMBL2148	Homo sapiens	IC50	nM	487.0
	14752001	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	IC50	nM	787.0	CHEMBL2148	Homo sapiens	IC50	nM	787.0
	14752019	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	14752026	CHEMBL3299202	Inhibition of JAK3 (unknown origin)	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Ki	nM	2.5	CHEMBL2148	Homo sapiens	Ki	nM	2.5
	14926977	CHEMBL3391350	Inhibition of JAK3 (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(C(=O)NCCc4cccnc4)c3)ccc12		CHEMBL3347513	=	Inhibition	%	60.0	CHEMBL2148	Homo sapiens	INH	%	60.0
	14926978	CHEMBL3391350	Inhibition of JAK3 (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(C(=O)NCC(=O)N4CCOCC4)c3)ccc12		CHEMBL3347694	=	Inhibition	%	65.0	CHEMBL2148	Homo sapiens	INH	%	65.0
	14926979	CHEMBL3391350	Inhibition of JAK3 (unknown origin) at 1 uM	B	CN1CCN(C(=O)Nc2cccc(-c3ccc4c(c3)sc3c(N)ncnc34)c2)CC1		CHEMBL3347683	=	Inhibition	%	53.0	CHEMBL2148	Homo sapiens	INH	%	53.0
	14926980	CHEMBL3391350	Inhibition of JAK3 (unknown origin) at 1 uM	B	Nc1ncnc2c1sc1cc(-c3cccc(NC(=O)N4CCCC4)c3)ccc12		CHEMBL3347669	=	Inhibition	%	56.0	CHEMBL2148	Homo sapiens	INH	%	56.0
	14979418	CHEMBL3372980	Inhibition of Jak3 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	14983193	CHEMBL3385006	Inhibition of JAK3 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	11.0	CHEMBL2148	Homo sapiens	INH	%	11.0
	14984435	CHEMBL3382492	Inhibition of JAK3 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	-7.0	CHEMBL2148	Homo sapiens	INH	%	-7.0
	14984618	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359922	=	IC50	nM	69.0	CHEMBL2148	Homo sapiens	IC50	nM	69.0
	14984619	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359923	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
	14984620	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359924	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	14984621	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359925	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	nM	140.0
	14984622	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359926	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	14984623	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3352892	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
	14984624	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359927	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	14984625	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@]1(F)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359928	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
	14984626	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359929	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
	14984645	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C		CHEMBL3359907	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	14984646	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359908	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	14984647	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	C[C@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C		CHEMBL3359909	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
	14984648	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359910	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	14984649	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	NC(=O)c1cnn2cccc2c1NC1CCCC1		CHEMBL3359911	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	nM	57.0
	14984650	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359912	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	14984651	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359913	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	14984652	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)O		CHEMBL3359914	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	14984653	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)O		CHEMBL3359915	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	14984654	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)C[C@@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359916	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
	14984655	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)C[C@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359917	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	14984656	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359918	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	14984657	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12		CHEMBL3359919	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	14984658	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)N		CHEMBL3359920	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	14984659	CHEMBL3377593	Inhibition of JAK3 (unknown origin) by filter assay	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)N		CHEMBL3359921	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	15009765	CHEMBL3361643	Inhibition of JAK3 (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	15018622	CHEMBL3366846	Inhibition of JAK3 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	0.1	CHEMBL2148	Homo sapiens	INH	%	0.1
	15036833	CHEMBL3381082	Inhibition of JAK3 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15036834	CHEMBL3381082	Inhibition of JAK3 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15036835	CHEMBL3381082	Inhibition of JAK3 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15036836	CHEMBL3381082	Inhibition of JAK3 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15036837	CHEMBL3381082	Inhibition of JAK3 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15040743	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040744	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2c[nH]nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120960	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040745	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3ccc(C(=O)O)cc3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120995	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040746	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3cccc(C(=O)O)c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120983	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040747	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120963	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040748	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2cn([C@H]3[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3314270	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040749	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn([C@H]3CCNC[C@@H]3F)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120986	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040750	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1)OCC		CHEMBL3120969	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040751	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCP(=O)([O-])[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120985	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040752	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1)c1ccccc1		CHEMBL3120970	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040753	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1		CHEMBL3314271	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040754	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	C#Cc1ccn2c(-c3ccnc(SC)n3)c(-c3ccc(F)cc3)nc2n1		CHEMBL3314272	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040755	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CC(=O)[O-])nn4)ccn23)n1.[Na+]		CHEMBL3314273	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040756	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccn3c(-c4ccnc(SC)n4)c(-c4ccc(F)cc4)nc3n2)nn1)OCC		CHEMBL3314274	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	10'-4M	1.0
	15040757	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CCP(=O)([O-])[O-])nn4)ccn23)n1.[Na+].[Na+]		CHEMBL3314275	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	15040758	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1		CHEMBL3314276	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	10'-4M	1.0
	15040759	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCO)nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314277	=	IC50	nM	10600.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	1.06
	15040760	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CCOC(=O)Cn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1		CHEMBL3314278	=	IC50	nM	3030.0	CHEMBL2148	Homo sapiens	IC50	10'-6M	3.03
	15040761	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1)OCC		CHEMBL3314279	=	IC50	nM	37400.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	3.74
	15040762	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCP(=O)([O-])[O-])nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[Na+].[Na+]		CHEMBL3314280	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	10'-4M	1.0
	15040763	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281	=	IC50	nM	14400.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	1.44
	15040764	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935	=	IC50	nM	3900.0	CHEMBL2148	Homo sapiens	IC50	10'-6M	3.9
	15040765	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282	=	IC50	nM	21400.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	2.14
	15040766	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283	=	IC50	nM	11800.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	1.18
	15040767	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4nnn[n-]4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[K+]		CHEMBL3314284	=	IC50	nM	783.0	CHEMBL2148	Homo sapiens	IC50	10'-7M	7.83
	15040768	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	CSc1nccc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)n1		CHEMBL3314285	=	IC50	nM	78300.0	CHEMBL2148	Homo sapiens	IC50	10'-5M	7.83
	15040769	CHEMBL3363475	Inhibition of JAK3 (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc(SC)n3)[nH]2)cc1		CHEMBL3314286	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	10'-4M	1.0
	15082397	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CN(C(=O)N[C@H]1CCCN(S(C)(=O)=O)C1)c1cnc2[nH]ccc2n1		CHEMBL3357977	=	IC50	nM	334.0	CHEMBL2148	Homo sapiens	IC50	nM	334.0
	15082400	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2nccnc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3357978	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	15082402	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	O=C(Nc1cnc2[nH]ccc2n1)NC1CCCCC1		CHEMBL3335676	=	IC50	nM	268.0	CHEMBL2148	Homo sapiens	IC50	nM	268.0
	15082403	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(=O)N1CCC(NC(=O)Nc2cnc3[nH]ccc3n2)CC1		CHEMBL3335677	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	15082404	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	O=C(Nc1cnc2[nH]ccc2n1)NC1CCCN(CC(F)(F)F)C1		CHEMBL3335678	=	IC50	nM	29.0	CHEMBL2148	Homo sapiens	IC50	nM	29.0
	15082405	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC(NC(=O)Nc2cnc3[nH]ccc3n2)CC1		CHEMBL3335679	=	IC50	nM	1083.0	CHEMBL2148	Homo sapiens	IC50	nM	1083.0
	15082406	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(=O)N1CCCC(NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335680	=	IC50	nM	82.0	CHEMBL2148	Homo sapiens	IC50	nM	82.0
	15082407	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	N#CCC(=O)N1CCCC(NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335681	=	IC50	nM	695.0	CHEMBL2148	Homo sapiens	IC50	nM	695.0
	15082408	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCCC(NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335682	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	15082409	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335683	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	15082410	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CCCS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335684	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	15082411	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335685	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	15082412	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)(C)CS(=O)(=O)N1CCC[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335686	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	15082413	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](NC(=O)Nc2cnc3[nH]ccc3n2)C1		CHEMBL3335687	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	15082437	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335689	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	15082439	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335688	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	15082440	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335690	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	15082441	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	N#CCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335691	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	15082442	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335692	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	15082443	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	15082489	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2ncncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335693	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
	15082490	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335694	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	15082491	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2[nH]c(=O)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335695	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	15082492	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CC[C@H](CO)Nc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3335696	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	15082493	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC[C@@H](O)C3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335697	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	15082494	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCOCC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335698	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	15082495	CHEMBL3374009	Inhibition of JAK3 (unknown origin)-mediated phosphorylation of Biotin-KAIETDKEYYTVKD incubated for 10 mins prior to substrate addition measured after 1 hr in presence of [gamma-33P]ATP by scintillation counting analysis	B	CN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3335699	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	15091087	CHEMBL3381542	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	52.0	CHEMBL2148	Homo sapiens	Activity	%	52.0
	15101415	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O		CHEMBL3343033	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101416	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O		CHEMBL3343034	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101417	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO		CHEMBL3343037	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101418	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O		CHEMBL3343038	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101419	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O		CHEMBL3343039	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101420	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O		CHEMBL3343040	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101421	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O		CHEMBL3343042	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101422	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O		CHEMBL3343044	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101423	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1		CHEMBL3343045	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101424	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O		CHEMBL3343046	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101425	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O		CHEMBL3343047	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101426	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O		CHEMBL3343048	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101427	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3341771	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101428	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343051	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101429	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O		CHEMBL3343052	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101430	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1		CHEMBL3343055	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101431	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1		CHEMBL3343057	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15101432	CHEMBL3380805	Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay	B	CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1		CHEMBL3343058	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	15112133	CHEMBL3388145	Inhibition of human recombinant JAK3	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	=	IC50	nM	528.0	CHEMBL2148	Homo sapiens	IC50	nM	528.0
Not Active	15151637	CHEMBL3396721	Inhibition of JAK3 (JH1 domain-catalytic) (unknown origin) at 1 uM	B	CN(C)c1ncnc2[nH]cc(-c3cccc(C#N)c3)c12		CHEMBL3393346		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	15151638	CHEMBL3396721	Inhibition of JAK3 (JH1 domain-catalytic) (unknown origin) at 1 uM	B	N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOCC4)c23)c1		CHEMBL3393348		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	15151641	CHEMBL3396724	Inhibition of JAK3 (unknown origin)	B	C[C@H]1CCCN(c2ncnc3[nH]cc(-c4cccc(C#N)c4)c23)C1		CHEMBL3393341	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
Active	15178856	CHEMBL3405532	Inhibition of JAK3 in human DERL7 cells assessed as inhibition of STAT5 phosphorylation after 2 hrs by SDS-PAGE analysis in presence of human IL-2	B	CCc1ccc(Cl)cc1-n1cc(-c2cc(N)ncn2)cc1C(N)=O		CHEMBL3403543		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	15639990	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12		CHEMBL3589164	=	IC50	nM	139.0	CHEMBL2148	Homo sapiens	IC50	nM	139.0
	15639991	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12		CHEMBL3589165	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
	15639992	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1		CHEMBL3589166	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	15639993	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccc(Cl)cc2Cl)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12		CHEMBL3589167	=	IC50	nM	119.0	CHEMBL2148	Homo sapiens	IC50	nM	119.0
	15639994	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CCCOc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1		CHEMBL3589168	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
	15639995	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)cc5)cc4c3c2)CC1		CHEMBL3589169	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	15639996	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN(C)[C@H]1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)c(Cl)c5)cc4c3c2)C1		CHEMBL3589170	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
	15639997	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c3c2)c1		CHEMBL3589171	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	15639998	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(Cc2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12		CHEMBL3589172	=	IC50	nM	123.0	CHEMBL2148	Homo sapiens	IC50	nM	123.0
	15639999	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c3c([nH]c12)CCC(C(=O)N1CCOCC1)C3		CHEMBL3589173	=	IC50	nM	2021.0	CHEMBL2148	Homo sapiens	IC50	nM	2021.0
	15640000	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(C(=O)N3CCOCC3)ccc12		CHEMBL3589174	=	IC50	nM	246.0	CHEMBL2148	Homo sapiens	IC50	nM	246.0
	15640001	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)c1		CHEMBL3589175	=	IC50	nM	193.0	CHEMBL2148	Homo sapiens	IC50	nM	193.0
	15640002	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)cc1F		CHEMBL3589176	=	IC50	nM	311.0	CHEMBL2148	Homo sapiens	IC50	nM	311.0
	15640003	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CC[C@H](N(C)C)C5)ccc4c3c2)c1		CHEMBL3589177	=	IC50	nM	225.0	CHEMBL2148	Homo sapiens	IC50	nM	225.0
	15640004	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(NC(=O)C5CCOCC5)ccc4c3c2)c1		CHEMBL3589178	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
	15640005	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(N3CCOCC3)ccc12		CHEMBL3589179	=	IC50	nM	990.0	CHEMBL2148	Homo sapiens	IC50	nM	990.0
	15640006	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccccc4)cc23)CC1		CHEMBL3589325	=	IC50	nM	264.0	CHEMBL2148	Homo sapiens	IC50	nM	264.0
	15640007	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4cccc(Cl)c4)cc23)CC1		CHEMBL3589326	=	IC50	nM	197.0	CHEMBL2148	Homo sapiens	IC50	nM	197.0
	15640008	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc(CN5CCOCC5)c(Cl)c4)cc23)CC1		CHEMBL3589327	=	IC50	nM	242.0	CHEMBL2148	Homo sapiens	IC50	nM	242.0
	15640009	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	Cc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(N5CCOCC5)ccc4c3c2)cn1		CHEMBL3589328	=	IC50	nM	442.0	CHEMBL2148	Homo sapiens	IC50	nM	442.0
	15640010	CHEMBL3592851	Inhibition of JAK3 (unknown origin)	B	CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc5c(cnn5C)c4)cc23)CC1		CHEMBL3589329	=	IC50	nM	324.0	CHEMBL2148	Homo sapiens	IC50	nM	324.0
	15648403	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1n1c(=O)[nH]c2cnc3[nH]ccc3c21		CHEMBL3593591	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	15648406	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CS(=O)(=O)N1CCC(n2c(=O)[nH]c3cnc4[nH]ccc4c32)CC1		CHEMBL3593587	=	IC50	nM	710.0	CHEMBL2148	Homo sapiens	IC50	nM	710.0
	15648411	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	15648417	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1n1c(=O)n(C)c2cnc3[nH]ccc3c21		CHEMBL3593592	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	15648429	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CN(c1ccnc2[nH]ccc12)C1CCCCC1		CHEMBL3593427	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	nM	1100.0
	15648430	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	N#CCC(=O)N1CCC[C@@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1		CHEMBL3593590	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	15648434	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CS(=O)(=O)N1CCC[C@@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1		CHEMBL3593588	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
	15648440	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CS(=O)(=O)N1CCC[C@H](n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1		CHEMBL3593589	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	nM	460.0
	15648446	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1C1CCCCC1		CHEMBL3593428	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
	15648451	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1C1CCCC1		CHEMBL3593429	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
	15648456	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1C1CCCCCC1		CHEMBL3856117	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	15648461	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1CC1CCCCC1		CHEMBL3593578	=	IC50	nM	60.0	CHEMBL2148	Homo sapiens	IC50	nM	60.0
	15648466	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	C[C@@H]1CCCC[C@@H]1n1c(=O)[nH]c2cnc3[nH]ccc3c21		CHEMBL3593579	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	15648473	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	C[C@H]1CCCC[C@H]1n1c(=O)[nH]c2cnc3[nH]ccc3c21		CHEMBL3593580	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	15648478	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CC1CCCC(n2c(=O)[nH]c3cnc4[nH]ccc4c32)C1		CHEMBL3593581	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	15648483	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CC1CCC(n2c(=O)[nH]c3cnc4[nH]ccc4c32)CC1		CHEMBL3593582	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
	15648488	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CC1(C)CCCCC1n1c(=O)[nH]c2cnc3[nH]ccc3c21.O=C(O)C(=O)O		CHEMBL3593583	=	IC50	nM	69.0	CHEMBL2148	Homo sapiens	IC50	nM	69.0
	15648493	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	CC[C@@H]1CCCC[C@@H]1n1c(=O)[nH]c2cnc3[nH]ccc3c21.Cl		CHEMBL3593584	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	15648498	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1C1CCOCC1		CHEMBL3593585	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
	15648504	CHEMBL3594575	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method	B	O=c1[nH]c2cnc3[nH]ccc3c2n1C1CCNCC1		CHEMBL3593586	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	nM	1200.0
	15649073	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	C[C@H]1CN(c2ccc(C#N)cn2)CC[C@H]1Nc1c(C(N)=O)cnc2[nH]ccc12		CHEMBL3593779	=	IC50	nM	0.78	CHEMBL2148	Homo sapiens	IC50	nM	0.78
	15649074	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1ccc(N2CC[C@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@H](F)C2)nc1		CHEMBL3593778	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	15649075	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	15649076	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nn1		CHEMBL3593776	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	15649077	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1cnc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)cn1		CHEMBL3593775	=	IC50	nM	3.6	CHEMBL2148	Homo sapiens	IC50	nM	3.6
	15649078	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1cnc2[nH]ccc2c1NC1CCN(c2ccc(CO)cn2)CC1		CHEMBL3593774	=	IC50	nM	9.2	CHEMBL2148	Homo sapiens	IC50	nM	9.2
	15649079	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nc1		CHEMBL3593773	=	IC50	nM	5.2	CHEMBL2148	Homo sapiens	IC50	nM	5.2
	15649080	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1cnc2[nH]ccc2c1NC1CCN(c2ccc(C(F)(F)F)cn2)CC1		CHEMBL3593772	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
	15649081	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nc1		CHEMBL3593771	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	15649082	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)cc1		CHEMBL3593770	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
	15649083	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#Cc1cccc(CN2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)c1		CHEMBL3593769	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
	15649084	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	N#CCC(=O)N1CCC(Nc2c(C(N)=O)cnc3[nH]ccc23)CC1		CHEMBL3593768	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	15649085	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCCN(Cc2ccccc2)C1		CHEMBL3593767	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
	15649086	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCCN(Cc2ccccc2)C1		CHEMBL3593766	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
	15649087	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	NC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1		CHEMBL3593765	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	15649088	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	CS(=O)(=O)N1CCC(Nc2c(C(N)=O)cnc3[nH]ccc23)CC1		CHEMBL3593764	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
	15649089	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	CC(=O)N1CCC(Nc2c(C(N)=O)cnc3[nH]ccc23)CC1		CHEMBL3593763	=	IC50	nM	340.0	CHEMBL2148	Homo sapiens	IC50	nM	340.0
	15649090	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	CN1CCC(Nc2c(C(N)=O)cnc3[nH]ccc23)CC1		CHEMBL3593762	=	IC50	nM	90.0	CHEMBL2148	Homo sapiens	IC50	nM	90.0
	15649091	CHEMBL3594792	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA method	B	C[C@@H]1CCCC[C@@H]1Nc1c(C(N)=O)cnc2[nH]ccc12		CHEMBL3593761	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
	15666940	CHEMBL3603229	Inhibition of JAK3 (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
Active	15666949	CHEMBL3602077	Irreversible inhibition of recombinant JAK3 kinase domain (unknown origin) assessed as addition of expected molecular weight by electrospray ionization mass spectrometry analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666950	CHEMBL3602077	Irreversible inhibition of recombinant JAK3 kinase domain (unknown origin) assessed as addition of expected molecular weight by electrospray ionization mass spectrometry analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666951	CHEMBL3602077	Irreversible inhibition of recombinant JAK3 kinase domain (unknown origin) assessed as addition of expected molecular weight by electrospray ionization mass spectrometry analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	15666952	CHEMBL3602076	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells at 300 nM preincubated for 3 hrs followed by pulldown with streptavidin beads by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	15666953	CHEMBL3602076	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells at 300 nM preincubated for 3 hrs followed by pulldown with streptavidin beads by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666954	CHEMBL3602075	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells at 1 uM preincubated for 3 hrs followed by pulldown with streptavidin beads by immunoblotting analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	15666955	CHEMBL3602075	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells at 1 uM preincubated for 3 hrs followed by pulldown with streptavidin beads by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666956	CHEMBL3602074	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells at 1 uM preincubated for 1 hr followed by pulldown with streptavidin beads by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)c3)ncc2Cl)c1		CHEMBL3601862		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	15666957	CHEMBL3602073	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM incubated for 3 hrs followed by washout measured after 4 hrs by immunoblotting analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666958	CHEMBL3602073	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM incubated for 3 hrs followed by washout measured after 4 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666959	CHEMBL3602073	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM incubated for 3 hrs followed by washout measured after 4 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666960	CHEMBL3602073	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM incubated for 3 hrs followed by washout measured after 4 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666961	CHEMBL3602072	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 100 nM after 3 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666962	CHEMBL3602072	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 100 nM after 3 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666963	CHEMBL3602071	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM after 3 hrs by immunoblotting analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15666964	CHEMBL3602071	Inhibition of JAK3 (unknown origin) expressed in mouse BA/F3 cells assessed as reduction of STAT5 phosphorylation at 300 nM after 3 hrs by immunoblotting analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	15666967	CHEMBL3603338	Inhibition of JAK3 (unknown origin) assessed as residual enzyme activity at 100 nM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	15666978	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)c3)ncc2Cl)c1		CHEMBL3601862	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
	15666979	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15666980	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15666981	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(C)c3)ncc2Cl)c1		CHEMBL3601242	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	15666982	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCOCC4)c(F)c3)ncc2Cl)c1		CHEMBL3601235	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	15666983	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2Cl)c1		CHEMBL3601231	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	15666984	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	IC50	nM	4.8	CHEMBL2148	Homo sapiens	IC50	nM	4.8
Active	15667043	CHEMBL3602083	Inhibition of JAK3 in human TALL-1 cells assessed as inhibition of IL-2 induced STAT5 phosphorylation at 1 uM preincubated for 3 hrs followed by IL-2 induction measured after 30 mins by immunoblotting	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15667044	CHEMBL3602084	Inhibition of JAK3 in human TALL-1 cells assessed as inhibition of IL-2 induced STAT5 phosphorylation at 100 nM preincubated for 3 hrs followed by IL-2 induction measured after 30 mins by immunoblotting	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15667045	CHEMBL3602084	Inhibition of JAK3 in human TALL-1 cells assessed as inhibition of IL-2 induced STAT5 phosphorylation at 100 nM preincubated for 3 hrs followed by IL-2 induction measured after 30 mins by immunoblotting	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	15667333	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601224	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	15667334	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(C)c(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601225	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
	15667335	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1		CHEMBL3601226	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	15667336	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2Cl)c1		CHEMBL3601227	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	15667337	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)c(Cl)c3)ncc2Cl)c1		CHEMBL3601228	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	15667338	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(Cl)c(N4CCN(C)CC4)c(Cl)c3)ncc2Cl)c1		CHEMBL3601229	=	IC50	nM	20.0	CHEMBL2148	Homo sapiens	IC50	nM	20.0
	15667339	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCN(C)CC4)cc3F)ncc2Cl)c1		CHEMBL3601230	=	IC50	nM	4.6	CHEMBL2148	Homo sapiens	IC50	nM	4.6
	15667340	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCOCC4)cc3F)ncc2Cl)c1		CHEMBL3601232	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
	15667341	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCOCC4)c(F)c3)ncc2Cl)c1		CHEMBL3601233	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	15667342	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCOCC4)cc3F)ncc2Cl)c1		CHEMBL3601234	=	IC50	nM	5.2	CHEMBL2148	Homo sapiens	IC50	nM	5.2
	15667343	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCN(C(C)=O)CC4)c(F)c3)ncc2Cl)c1		CHEMBL3601236	=	IC50	nM	3.6	CHEMBL2148	Homo sapiens	IC50	nM	3.6
	15667344	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(N4CCC(O)CC4)c(F)c3)ncc2Cl)c1		CHEMBL3601237	=	IC50	nM	7.4	CHEMBL2148	Homo sapiens	IC50	nM	7.4
	15667345	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cc(F)c(OCCN4CCOCC4)c(F)c3)ncc2Cl)c1		CHEMBL3601238	=	IC50	nM	6.2	CHEMBL2148	Homo sapiens	IC50	nM	6.2
	15667346	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(NCCCCN(CC)CC)ncc2Cl)c1		CHEMBL3601239	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	15667347	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(N[C@@H]3CCN(C(C)=O)C3)ncc2Cl)c1		CHEMBL3601240	=	IC50	nM	99.0	CHEMBL2148	Homo sapiens	IC50	nM	99.0
	15667348	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(N[C@H]3CCN(C(C)=O)C3)ncc2Cl)c1		CHEMBL3601241	=	IC50	nM	1600.0	CHEMBL2148	Homo sapiens	IC50	nM	1600.0
	15667349	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cn(C)nc3C)ncc2Cl)c1		CHEMBL3601243	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	15667350	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnoc3)ncc2Cl)c1		CHEMBL3601244	=	IC50	nM	2.9	CHEMBL2148	Homo sapiens	IC50	nM	2.9
	15667351	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(C(F)F)c3)ncc2Cl)c1		CHEMBL3601106	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
	15667352	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(F)F)c3)ncc2Cl)c1		CHEMBL3601107	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667353	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(C4CCOCC4)c3)ncc2Cl)c1		CHEMBL3601108	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	15667354	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(C4CCN(C(C)=O)CC4)c3)ncc2Cl)c1		CHEMBL3600393	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667355	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(=O)NC)c3)ncc2Cl)c1		CHEMBL3601109	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667356	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(=O)NCC(F)(F)F)c3)ncc2Cl)c1		CHEMBL3601110	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667357	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(=O)N(C)C)c3)ncc2Cl)c1		CHEMBL3601111	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	15667358	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(=O)N4CCOCC4)c3)ncc2Cl)c1		CHEMBL3601112	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	15667359	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCN(C)C)c3)ncc2Cl)c1		CHEMBL3601113	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667360	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCN4CCOCC4)c3)ncc2Cl)c1		CHEMBL3601114	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667361	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOCC)c3)ncc2Cl)c1		CHEMBL3601116	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667362	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC(C)C)c3)ncc2Cl)c1		CHEMBL3601117	<	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	15667363	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC(F)F)c3)ncc2Cl)c1		CHEMBL3601118	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	15667364	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(C(C)(C)COC)c3)ncc2Cl)c1		CHEMBL3601119	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	15667365	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CC(C)(C)O)c3)ncc2Cl)c1		CHEMBL3601121	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	15667366	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	CCC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601122	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
	15667367	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=C(C)C(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601123	=	IC50	nM	7.8	CHEMBL2148	Homo sapiens	IC50	nM	7.8
	15667368	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(NCc2cccc(NC(=O)/C=C/CO)c2)n1		CHEMBL3601124	=	IC50	nM	245.0	CHEMBL2148	Homo sapiens	IC50	nM	245.0
	15667369	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(NCc2cccc(NC(=O)/C=C/CN)c2)n1		CHEMBL3601125	=	IC50	nM	64.0	CHEMBL2148	Homo sapiens	IC50	nM	64.0
	15667370	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(NCc2cccc(NC(=O)/C=C/CN(C)C)c2)n1		CHEMBL3601126	=	IC50	nM	258.0	CHEMBL2148	Homo sapiens	IC50	nM	258.0
	15667371	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cc(CNc2nc(Nc3cnn(C)c3)ncc2Cl)ccc1F		CHEMBL3601127	=	IC50	nM	4.4	CHEMBL2148	Homo sapiens	IC50	nM	4.4
	15667372	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1ccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)cc1		CHEMBL3601704	=	IC50	nM	83.0	CHEMBL2148	Homo sapiens	IC50	nM	83.0
	15667373	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1ccc(CNc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2Cl)cc1		CHEMBL3601705	=	IC50	nM	0.87	CHEMBL2148	Homo sapiens	IC50	nM	0.87
	15667374	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1ccc(CNc2nc(Nc3cnn(C)c3)ncc2Cl)cc1		CHEMBL3601706	=	IC50	nM	0.58	CHEMBL2148	Homo sapiens	IC50	nM	0.58
	15667375	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1ccc(CNc2nc(Nc3cnn(CC(=O)NC)c3)ncc2Cl)cc1		CHEMBL3601707	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	15667376	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1ccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)cc1		CHEMBL3601708	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	15667377	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C(C)Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601709	=	IC50	nM	6.6	CHEMBL2148	Homo sapiens	IC50	nM	6.6
	15667378	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C(C)Nc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601710	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	15667379	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CSc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601711	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	15667380	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CSc2nc(Nc3cnn(C)c3)ncc2Cl)c1		CHEMBL3601712	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	15667381	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN(C)c2nc(Nc3cnn(C)c3)ncc2Cl)c1		CHEMBL3601713	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	15667382	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2F)c1		CHEMBL3601714	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
	15667383	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Br)c1		CHEMBL3601715	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
	15667384	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3601716	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	15667385	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2C#N)c1		CHEMBL3601717	=	IC50	nM	2570.0	CHEMBL2148	Homo sapiens	IC50	nM	2570.0
	15667386	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2C)c1		CHEMBL3601718	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	15667387	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2OC)c1		CHEMBL3601719	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	15667388	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCNCC4)cc3OC)ncc2C2CC2)c1		CHEMBL3601720	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
	15667389	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3OC)n2)c1		CHEMBL3601721	=	IC50	nM	222.0	CHEMBL2148	Homo sapiens	IC50	nM	222.0
	15667390	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL3601722	=	IC50	nM	9.9	CHEMBL2148	Homo sapiens	IC50	nM	9.9
	15667391	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cn2ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3601723	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	15667392	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cn2cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3601724	=	IC50	nM	101.0	CHEMBL2148	Homo sapiens	IC50	nM	101.0
	15667393	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)C(C)(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3601725	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	15667394	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)NCc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3601726	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	15667395	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3601727	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	15667396	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc(N)c2Cl)c1		CHEMBL3601728	=	IC50	nM	499.0	CHEMBL2148	Homo sapiens	IC50	nM	499.0
	15667397	CHEMBL3603326	Inhibition of JAK3 (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc3[nH]ccc23)c1		CHEMBL3601861	=	IC50	nM	2720.0	CHEMBL2148	Homo sapiens	IC50	nM	2720.0
Active	15668061	CHEMBL3602083	Inhibition of JAK3 in human TALL-1 cells assessed as inhibition of IL-2 induced STAT5 phosphorylation at 1 uM preincubated for 3 hrs followed by IL-2 induction measured after 30 mins by immunoblotting	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15668062	CHEMBL3602083	Inhibition of JAK3 in human TALL-1 cells assessed as inhibition of IL-2 induced STAT5 phosphorylation at 1 uM preincubated for 3 hrs followed by IL-2 induction measured after 30 mins by immunoblotting	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	15668063	CHEMBL3602163	Binding affinity to Cys909 in human JAK3 (900 to 911) by LC/MS/MS analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223		Activity			CHEMBL2148	Homo sapiens	Activity		
Active	15668064	CHEMBL3602163	Binding affinity to Cys909 in human JAK3 (900 to 911) by LC/MS/MS analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115		Activity			CHEMBL2148	Homo sapiens	Activity		
Active	15668065	CHEMBL3602163	Binding affinity to Cys909 in human JAK3 (900 to 911) by LC/MS/MS analysis	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1		CHEMBL3601120		Activity			CHEMBL2148	Homo sapiens	Activity		
	15668074	CHEMBL3602169	Binding affinity to JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL1229592	=	Kd	nM	150.0	CHEMBL2148	Homo sapiens	Kd	nM	150.0
	15685894	CHEMBL3607970	Inhibition of human JAK3	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15687009	CHEMBL3607490	Inhibition of JAK3 (unknown origin) using poly (Glu-Tyr, 4:1) substrate incubated for 60 mins by ELISA method	B	CNC(=O)Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1		CHEMBL3605107	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	15687010	CHEMBL3607490	Inhibition of JAK3 (unknown origin) using poly (Glu-Tyr, 4:1) substrate incubated for 60 mins by ELISA method	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(Oc5ccccc5)cc4)csc23)cn1		CHEMBL3605102	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	15709808	CHEMBL3615455	Inhibition of JAK3 (unknown origin) at 10 uM	B	CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1		CHEMBL3613597	>	Inhibition	%	90.0	CHEMBL2148	Homo sapiens	INH	%	90.0
	15709949	CHEMBL3614377	Inhibition of JAK3 (unknown origin) after 1 hr by ELISA based assay	B	Nc1ncc(-c2cnn(CC(=O)N3CCOCC3)c2)c2scc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL3612840	=	IC50	nM	3068.0	CHEMBL2148	Homo sapiens	IC50	nM	3068.0
	15722659	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12	Non standard unit for type	CHEMBL221959	=	INH	uM	0.003	CHEMBL2148	Homo sapiens	INH	uM	0.003
	15722660	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1	Non standard unit for type	CHEMBL2105759	=	INH	uM	0.18	CHEMBL2148	Homo sapiens	INH	uM	0.18
	15722661	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1	Non standard unit for type	CHEMBL2322141	=	INH	uM	3.23	CHEMBL2148	Homo sapiens	INH	uM	3.23
	15722662	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	N#CCC(=O)N1CCC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1	Non standard unit for type	CHEMBL3618145	=	INH	uM	1.02	CHEMBL2148	Homo sapiens	INH	uM	1.02
	15722663	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	O=S(=O)(C1CC1)N1CCC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1	Non standard unit for type	CHEMBL3618146	=	INH	uM	5.65	CHEMBL2148	Homo sapiens	INH	uM	5.65
	15722664	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	N#CCC(=O)N1CC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1	Non standard unit for type	CHEMBL3618147	=	INH	uM	10.8	CHEMBL2148	Homo sapiens	INH	uM	10.8
	15722665	CHEMBL3619027	Inhibition of JAK3 (unknown origin) using biotin-TYR2 peptide as substrate after 60 mins by HTRF assay	B	O=S(=O)(C1CC1)N1CC[C@@H](c2nnc3cnc4[nH]ccc4n23)C1	Non standard unit for type	CHEMBL3618148	=	INH	uM	20.4	CHEMBL2148	Homo sapiens	INH	uM	20.4
	15723397	CHEMBL3620003	Inhibition of Jak3 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
Not Active	15723398	CHEMBL3620003	Inhibition of Jak3 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	15723443	CHEMBL3620033	Inhibition of Jak3 (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	15735701	CHEMBL3627022	Inhibition of JAK3 (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1cc(C)cc(Nc2nccc(-n3cc(C)c(CN4CC[C@@H](O)C4)c3)n2)c1		CHEMBL3622924	=	IC50	nM	349.1	CHEMBL2148	Homo sapiens	IC50	nM	349.1
	15735702	CHEMBL3627022	Inhibition of JAK3 (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	=	IC50	nM	78.12	CHEMBL2148	Homo sapiens	IC50	nM	78.12
	15735703	CHEMBL3627022	Inhibition of JAK3 (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC[C@@H](O)C1		CHEMBL3622957	=	IC50	nM	478.1	CHEMBL2148	Homo sapiens	IC50	nM	478.1
	15735704	CHEMBL3627022	Inhibition of JAK3 (unknown origin) pre-incubated for 30 mins at room temperature before substrate addition and measured 1 hr after substrate addition by cell free kinase assay	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(C)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622958	=	IC50	nM	418.2	CHEMBL2148	Homo sapiens	IC50	nM	418.2
	15735995	CHEMBL3624355	Inhibition of human recombinant JAK3	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	15743062	CHEMBL3626581	Inhibition of JAK3 (unknown origin) after 20 mins by radiometric analysis in presence of [gamma33P]-ATP	B	c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1		CHEMBL3622376	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	15745606	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3ncc(C)s3)nc21		CHEMBL3622136	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	nM	77.0
	15745607	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)cs3)nc21		CHEMBL3622135	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	15745608	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nccs3)nc21		CHEMBL3622134	=	IC50	nM	62.0	CHEMBL2148	Homo sapiens	IC50	nM	62.0
	15745609	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)NCCOC)nc21		CHEMBL3622133	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
	15745610	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)OCCOC)nc21		CHEMBL3622132	>	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	nM	2000.0
	15745611	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NCCCOC)nc21		CHEMBL3622131	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	nM	1400.0
	15745612	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC)nc21		CHEMBL3622130	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
	15745613	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(C(=O)N(C3CC3)C3CC3)n2C[C@@H](C)O)c2c1ncn2C		CHEMBL3622129	=	IC50	nM	510.0	CHEMBL2148	Homo sapiens	IC50	nM	510.0
	15745614	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(C(=O)N(C3CC3)C3CC3)n2CCCO)c2c1ncn2C		CHEMBL3622128	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
	15745615	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(C(=O)N(C3CC3)C3CC3)n2C[C@H](O)CO)c2c1ncn2C		CHEMBL3622127	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	15745631	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21		CHEMBL3622137	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
	15745632	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(-c3nnnn3C3CC3)n2C[C@H](O)CO)c2c1ncn2C		CHEMBL3622138	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
	15745633	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(C(=O)NC3CC3)n2C[C@H](O)CO)c2c1ncn2C		CHEMBL3622139	=	IC50	nM	2900.0	CHEMBL2148	Homo sapiens	IC50	nM	2900.0
	15745634	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CCN(C(=O)c1cc2c3c(ncn3C)c(NC)nc2n1C[C@H](O)CO)C(C)C		CHEMBL3622140	=	IC50	nM	670.0	CHEMBL2148	Homo sapiens	IC50	nM	670.0
	15745635	CHEMBL3625475	Inhibition of recombinant JAK3 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay	B	CNc1nc2c(cc(C(=O)N(C)C3CC3)n2C[C@H](O)CO)c2c1ncn2C		CHEMBL3622141	=	IC50	nM	5800.0	CHEMBL2148	Homo sapiens	IC50	nM	5800.0
	15745725	CHEMBL3625654	Binding affinity to JAK3 (unknown origin) assessed as dissociation constant	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	=	Kd	nM	360.0	CHEMBL2148	Homo sapiens	Kd	nM	360.0
	15746504	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)[nH]n3)nc21		CHEMBL3622150	=	IC50	nM	87.0	CHEMBL2148	Homo sapiens	IC50	nM	87.0
	15746505	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)nn3C)nc21		CHEMBL3622149	=	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	15746506	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1nc(Nc2nc3c(cc(C(=O)N(C4CC4)C4CC4)n3CC)c3c2ncn3C)cc1C		CHEMBL3622148	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	15746507	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
	15746508	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)n(C)n3)nc21		CHEMBL3622147	=	IC50	nM	3800.0	CHEMBL2148	Homo sapiens	IC50	nM	3800.0
	15746509	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C(=O)N4CCS(=O)(=O)CC4)s3)nc21		CHEMBL3622146	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	15746510	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(S(C)(=O)=O)s3)nc21		CHEMBL3622145	=	IC50	nM	52.0	CHEMBL2148	Homo sapiens	IC50	nM	52.0
	15746511	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C(=O)NC)c(C)s3)nc21		CHEMBL3622144	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	15746512	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C(=O)NC)s3)nc21		CHEMBL3622143	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	15746513	CHEMBL3625646	Inhibition of recombinant JAK3 (unknown origin) using 5-FAM-KKKKEEIYFFFG-OH substrate and ATP incubated for 180 mins by scintillation counting method	B	CCc1nc(Nc2nc3c(cc(C(=O)N(C4CC4)C4CC4)n3CC)c3c2ncn3C)sc1C		CHEMBL3622142	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	nM	460.0
	15747164	CHEMBL3625891	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2		CHEMBL3137308	=	IC50	nM	0.71	CHEMBL2148	Homo sapiens	IC50	nM	0.71
	15747165	CHEMBL3625891	Inhibition of JAK3 (unknown origin)	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	810.0	CHEMBL2148	Homo sapiens	IC50	nM	810.0
	15747166	CHEMBL3625891	Inhibition of JAK3 (unknown origin)	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	IC50	nM	2.5	CHEMBL2148	Homo sapiens	IC50	nM	2.5
	15747167	CHEMBL3625891	Inhibition of JAK3 (unknown origin)	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
	15747201	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCCn1c(CCN)nc2cc(C(N)=O)ccc21		CHEMBL3622822	=	IC50	nM	1500.0	CHEMBL2148	Homo sapiens	IC50	uM	1.5
	15747202	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21		CHEMBL3622823	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	15747203	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCc1nc2cc(C(N)=O)ccc2n1CCN		CHEMBL3622824	=	IC50	nM	1500.0	CHEMBL2148	Homo sapiens	IC50	uM	1.5
	15747204	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCCc1nc2cc(C(N)=O)ccc2n1CCN		CHEMBL3622825	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	uM	1.1
	15747205	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	=	IC50	nM	1260.0	CHEMBL2148	Homo sapiens	IC50	uM	1.26
	15747206	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(C2CCCCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622827	=	IC50	nM	2500.0	CHEMBL2148	Homo sapiens	IC50	uM	2.5
	15747207	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21		CHEMBL3622828	=	IC50	nM	14100.0	CHEMBL2148	Homo sapiens	IC50	uM	14.1
	15747208	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(Cc2ccccc2)nc2cc(C(N)=O)ccc21		CHEMBL3622829	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	uM	2.1
	15747209	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	N#Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1		CHEMBL3622830	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	uM	1.9
	15747210	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1		CHEMBL3622831	=	IC50	nM	2300.0	CHEMBL2148	Homo sapiens	IC50	uM	2.3
	15747211	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	CC(C)c1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1		CHEMBL3622832	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	uM	1.9
	15747212	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2ccc(C(F)(F)F)cc2)nc2cc(C(N)=O)ccc21		CHEMBL3622833	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	uM	2.1
	15747213	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2ccc(O)cc2)nc2cc(C(N)=O)ccc21		CHEMBL3622834	=	IC50	nM	2400.0	CHEMBL2148	Homo sapiens	IC50	uM	2.4
	15747214	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2ccc(O)cc2O)nc2cc(C(N)=O)ccc21		CHEMBL3622835	=	IC50	nM	2900.0	CHEMBL2148	Homo sapiens	IC50	uM	2.9
	15747215	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2ccncc2)nc2cc(C(N)=O)ccc21		CHEMBL3622836	=	IC50	nM	10500.0	CHEMBL2148	Homo sapiens	IC50	uM	10.5
	15747216	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2cccnc2N)nc2cc(C(N)=O)ccc21		CHEMBL3622837	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	uM	1.9
	15747217	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(-c2cncnc2)nc2cc(C(N)=O)ccc21		CHEMBL3622838	=	IC50	nM	2500.0	CHEMBL2148	Homo sapiens	IC50	uM	2.5
	15747218	CHEMBL3625899	Inhibition of JAK3 (unknown origin) using 16 uM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	uM	0.01
	15747295	CHEMBL3625906	Inhibition of JAK3 (unknown origin) using 1 mM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21	Outside typical range	CHEMBL3622826	=	IC50	nM	232500.0	CHEMBL2148	Homo sapiens	IC50	uM	232.5
	15747296	CHEMBL3625906	Inhibition of JAK3 (unknown origin) using 1 mM of ATP and Tyr6 peptide by Z'-LYTE kinase assay	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	900.0	CHEMBL2148	Homo sapiens	IC50	uM	0.9
	15747307	CHEMBL3625913	Ratio of IC50 for JAK3 (unknown origin) using 16 uM of ATP to IC50 for JAK3 (unknown origin) using 1 mM of ATP	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	=	Ratio IC50		114.0	CHEMBL2148	Homo sapiens	Ratio IC50		114.0
	15747309	CHEMBL3625915	Inhibition of JAK3 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL2148	Homo sapiens	Activity	%	65.0
	15754941	CHEMBL3631833	Inhibition of JAK3 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	12.5	CHEMBL2148	Homo sapiens	INH	%	12.5
	15755889	CHEMBL3630666	Inhibition of JAK3 JH1 catalytic domain (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	61.0	CHEMBL2148	Homo sapiens	Activity	%	61.0
	15756946	CHEMBL3631264	Inhibition of JAK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-20.3	CHEMBL2148	Homo sapiens	INH	%	-20.3
	15757777	CHEMBL3631264	Inhibition of JAK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	15.91	CHEMBL2148	Homo sapiens	INH	%	15.91
	15758756	CHEMBL3631264	Inhibition of JAK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-7.14	CHEMBL2148	Homo sapiens	INH	%	-7.14
	15771607	CHEMBL3635832	Competitive binding affinity to human JAK3 in presence of immobilized ligand	B	C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1		CHEMBL3633152	=	Kd	nM	30.0	CHEMBL2148	Homo sapiens	Kd	nM	30.0
226330	16258115	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=S(=O)(Nc1cccc(-c2cnc3ccccc3n2)c1)c1cccs1		CHEMBL3645543	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216769	16258150	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(C(F)(F)F)ccc1-c1cccc2nc(Nc3ccc4c(c3)CCNCC4)nn12		CHEMBL3644975	=	IC50	nM	52.76	CHEMBL2148	Homo sapiens	IC50	nM	52.76
234442	16258233	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(COCC3CC3)CC2)CC1		CHEMBL3652328	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
233640	16258347	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665133	=	IC50	nM	0.1919	CHEMBL2148	Homo sapiens	IC50	nM	0.19188
216610	16258633	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1-c1cccn2nc(Nc3cccc(N4CCN(C)CC4)c3)nc12		CHEMBL3642292	=	IC50	nM	219.7	CHEMBL2148	Homo sapiens	IC50	nM	219.7
233736	16258774	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)CN(S(=O)(=O)CC#N)C1	Outside typical range	CHEMBL3665216	=	Ki	nM	0.00207	CHEMBL2148	Homo sapiens	Ki	nM	0.00207
233650	16258857	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335692	=	IC50	nM	0.006695	CHEMBL2148	Homo sapiens	IC50	nM	0.006695
234524	16258862	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COCCOC1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652408	=	IC50	nM	0.0368	CHEMBL2148	Homo sapiens	IC50	nM	0.0368
216821	16258873	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645033	=	IC50	nM	173.78	CHEMBL2148	Homo sapiens	IC50	nM	173.78
216802	16259029	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	O=c1[nH]cccc1-c1cccn2nc(Nc3ccc4ncccc4c3)nc12		CHEMBL3645008	=	IC50	nM	434.11	CHEMBL2148	Homo sapiens	IC50	nM	434.11
234520	16259036	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@H]1CN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C[C@@H]1CO		CHEMBL3652404	=	IC50	nM	0.198	CHEMBL2148	Homo sapiens	IC50	nM	0.198
233666	16259068	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335691	=	Ki	nM	0.000748	CHEMBL2148	Homo sapiens	Ki	nM	0.000748
216644	16259153	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3cccc(-c4ccc(S(C)(=O)=O)cc4)n3n2)cc1		CHEMBL3642320	=	IC50	nM	63.9	CHEMBL2148	Homo sapiens	IC50	nM	63.9
216697	16259160	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1C(=O)Cc2cc(Nc3nc4c(NCc5cccnc5N(C)S(C)(=O)=O)cccn4n3)ccc21		CHEMBL3642369	=	IC50	nM	286.66	CHEMBL2148	Homo sapiens	IC50	nM	286.66
216687	16259225	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5cccnc5N(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642359	=	IC50	nM	646.76	CHEMBL2148	Homo sapiens	IC50	nM	646.76
233706	16259256	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3335699	=	IC50	nM	0.01559	CHEMBL2148	Homo sapiens	IC50	nM	0.015593
294026	16259293	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1S(C)(=O)=O		CHEMBL3651008	=	IC50	nM	0.087	CHEMBL2148	Homo sapiens	IC50	nM	0.087
216754	16259306	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCC(n2cc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cn2)CC1		CHEMBL3644960	=	IC50	nM	20.92	CHEMBL2148	Homo sapiens	IC50	nM	20.92
234503	16259472	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COC(=O)NC1CN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652387	=	IC50	nM	382.0	CHEMBL2148	Homo sapiens	IC50	nM	382.0
294007	16259491	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(CC)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650990	=	IC50	nM	0.61	CHEMBL2148	Homo sapiens	IC50	nM	0.61
226324	16259658	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(Cn1cncn1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645539	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
233660	16259712	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(=O)(=O)CC(C)(C)C)C2)n1	Outside typical range	CHEMBL3665150	=	Ki	nM	0.008383	CHEMBL2148	Homo sapiens	Ki	nM	0.008383
234391	16259754	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCC1(NC(=O)OCc2ccccc2)CCCN(S(=O)(=O)CC2CCC(N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3927234	=	IC50	nM	846.0	CHEMBL2148	Homo sapiens	IC50	nM	846.0
293997	16259811	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4cc[nH]c4c3)c12		CHEMBL3650981	=	IC50	nM	9.7	CHEMBL2148	Homo sapiens	IC50	nM	9.7
216869	16259872	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	FC(F)COc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645079	=	IC50	nM	832.18	CHEMBL2148	Homo sapiens	IC50	nM	832.18
233675	16260141	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665162	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
234392	16260258	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC(=O)C1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652279	=	IC50	nM	339.0	CHEMBL2148	Homo sapiens	IC50	nM	339.0
216638	16260317	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4ccc(CN5CCOCC5)cc4)nn23)cc1		CHEMBL3642314	=	IC50	nM	36.8	CHEMBL2148	Homo sapiens	IC50	nM	36.8
216781	16260399	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3cccc(N4CCN(C)CC4)c3)nc12		CHEMBL3644987	=	IC50	nM	2827.84	CHEMBL2148	Homo sapiens	IC50	nM	2827.84
294009	16260425	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1C		CHEMBL3650992	=	IC50	nM	0.15	CHEMBL2148	Homo sapiens	IC50	nM	0.15
233713	16260730	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(O)CNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665195	=	IC50	nM	0.03959	CHEMBL2148	Homo sapiens	IC50	nM	0.03959
234491	16260961	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCN1CCN(C[C@H]2CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)C2)C(=O)C1=O		CHEMBL3652376	=	IC50	nM	755.0	CHEMBL2148	Homo sapiens	IC50	nM	755.0
294014	16261089	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1F		CHEMBL3650996	=	IC50	nM	0.07	CHEMBL2148	Homo sapiens	IC50	nM	0.07
216588	16261140	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(C4=CCN(S(C)(=O)=O)CC4)cccn3n2)cc1		CHEMBL3642274	=	IC50	nM	68.0	CHEMBL2148	Homo sapiens	IC50	nM	68.0
233655	16261457	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(C)(=O)=O)C2)n1	Outside typical range	CHEMBL3665146	=	Ki	nM	0.009688	CHEMBL2148	Homo sapiens	Ki	nM	0.009688
294073	16261706	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	COC(=O)Cc1ccc(OC)c(-c2c[nH]c3ncnc(-c4ccccc4)c23)c1		CHEMBL3651056	=	IC50	nM	3.1	CHEMBL2148	Homo sapiens	IC50	nM	3.1
216689	16261818	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5ccccc5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642361	=	IC50	nM	97.39	CHEMBL2148	Homo sapiens	IC50	nM	97.39
233684	16261819	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(C#N)c3n2)C1	Outside typical range	CHEMBL3665171	=	Ki	nM	0.00867	CHEMBL2148	Homo sapiens	Ki	nM	0.00867
216566	16261865	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(OCCN5CCCC5)cc4)nc23)cc1		CHEMBL3642256	=	IC50	nM	40.3	CHEMBL2148	Homo sapiens	IC50	nM	40.3
216758	16262033	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	FC(F)(F)c1ccc(-c2cccn3nc(Nc4cnn(CCN5CCCC5)c4)nc23)cc1		CHEMBL3644964	=	IC50	nM	193.88	CHEMBL2148	Homo sapiens	IC50	nM	193.88
233630	16262133	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665123	=	Ki	nM	0.006572	CHEMBL2148	Homo sapiens	Ki	nM	0.006572
233643	16262290	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665136	=	IC50	nM	1.157	CHEMBL2148	Homo sapiens	IC50	nM	1.1565
233632	16262485	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665125	=	Ki	nM	0.3103	CHEMBL2148	Homo sapiens	Ki	nM	0.310324
302611	16262640	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CCCS(=O)(=O)N[C@H]1CC[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655092	=	IC50	nM	5950.0	CHEMBL2148	Homo sapiens	IC50	nM	5950.0
302624	16262794	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@H]3C[C@@]3(C#N)C2)C1		CHEMBL3658853	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234438	16262831	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCN(CC)C(=O)C1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652324	=	IC50	nM	1240.0	CHEMBL2148	Homo sapiens	IC50	nM	1240.0
216773	16262864	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3644979	=	IC50	nM	628.38	CHEMBL2148	Homo sapiens	IC50	nM	628.38
234453	16262872	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](CS(C)(=O)=O)C2)CC1		CHEMBL3652338	=	IC50	nM	573.0	CHEMBL2148	Homo sapiens	IC50	nM	573.0
198764	16262929	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C(C)=C/CN(C)C)c3)c12		CHEMBL3651061	=	IC50	nM	6.6	CHEMBL2148	Homo sapiens	IC50	nM	6.6
216593	16262957	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(-c4cn[nH]c4)cccn3n2)cc1		CHEMBL3642278	=	IC50	nM	510.3	CHEMBL2148	Homo sapiens	IC50	nM	510.3
233680	16263202	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nccnc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665167	=	IC50	nM	0.02299	CHEMBL2148	Homo sapiens	IC50	nM	0.02299
234473	16263235	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](c3ncccn3)C2)CC1		CHEMBL3652358	=	IC50	nM	55.7	CHEMBL2148	Homo sapiens	IC50	nM	55.7
293989	16263465	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(N(C)C)cc3)c12		CHEMBL3703503	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
234410	16263568	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(C)(O)CC2)CC1		CHEMBL3652296	=	IC50	nM	243.0	CHEMBL2148	Homo sapiens	IC50	nM	243.0
293993	16263682	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4c(c3)CCN4)c12		CHEMBL3650977	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
226343	16263904	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CC(=O)C(F)(F)F)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648432	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233668	16264161	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665155	=	IC50	nM	2.37	CHEMBL2148	Homo sapiens	IC50	nM	2.37006
294063	16264163	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ccc(F)cc4)c23)c1		CHEMBL3651046	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
294038	16264358	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/COC)c3)c12		CHEMBL3651019	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
216777	16264389	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3644983	=	IC50	nM	556.95	CHEMBL2148	Homo sapiens	IC50	nM	556.95
216603	16264541	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCC(N6CCOCC6)CC5)cc4)nc23)cc1		CHEMBL3642286	=	IC50	nM	59.5	CHEMBL2148	Homo sapiens	IC50	nM	59.5
233713	16264586	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(O)CNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665195	=	Ki	nM	0.01979	CHEMBL2148	Homo sapiens	Ki	nM	0.01979
216567	16264732	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1cc(-c2ccncc2)c2nc(Nc3ccc(N4CCOCC4)cc3)nn2c1		CHEMBL3642257	=	IC50	nM	174.3	CHEMBL2148	Homo sapiens	IC50	nM	174.3
234475	16264756	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COc1ccccc1CS(=O)(=O)[C@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652360	=	IC50	nM	96.6	CHEMBL2148	Homo sapiens	IC50	nM	96.6
216672	16264836	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4cccc(CN5CCS(=O)(=O)CC5)c4)nn23)cc1		CHEMBL3642344	=	IC50	nM	42.12	CHEMBL2148	Homo sapiens	IC50	nM	42.12
216822	16264861	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nc12		CHEMBL3645034	=	IC50	nM	189.05	CHEMBL2148	Homo sapiens	IC50	nM	189.05
216833	16264870	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	FC(F)COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645045	=	IC50	nM	2870.92	CHEMBL2148	Homo sapiens	IC50	nM	2870.92
234434	16264876	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1ccc(CC2CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)CC2)nn1		CHEMBL3652320	=	IC50	nM	753.0	CHEMBL2148	Homo sapiens	IC50	nM	753.0
255701	16264913	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCCc1cccc(c1)OCCCc1cccc(c1)N2		CHEMBL3694588	=	IC50	nM	315.0	CHEMBL2148	Homo sapiens	IC50	nM	315.0
233644	16265058	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665137	=	IC50	nM	0.1948	CHEMBL2148	Homo sapiens	IC50	nM	0.194845
226318	16265232	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CCl)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL1427221	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
233656	16265308	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335690	=	IC50	nM	0.0024	CHEMBL2148	Homo sapiens	IC50	nM	0.0024
233711	16265435	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCOCC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335698	=	IC50	nM	0.01863	CHEMBL2148	Homo sapiens	IC50	nM	0.01863
233668	16265546	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665155	=	Ki	nM	1.185	CHEMBL2148	Homo sapiens	Ki	nM	1.18503
216815	16265555	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cc1ccc(-n2cc(-c3cccn4nc(Nc5ccc(C6CCNCC6)cc5)nc34)cn2)cc1		CHEMBL3645021	=	IC50	nM	82.56	CHEMBL2148	Homo sapiens	IC50	nM	82.56
216715	16265651	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(Nc5ccccc5CS(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642385	=	IC50	nM	452.9	CHEMBL2148	Homo sapiens	IC50	nM	452.9
294062	16265787	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ccccc4F)c23)c1		CHEMBL3651045	=	IC50	nM	0.96	CHEMBL2148	Homo sapiens	IC50	nM	0.96
216763	16265792	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1ccc2c(c1)CCCN2c1nc2cccc(N3CCCc4ccccc43)n2n1		CHEMBL3644969	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216853	16265831	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)c1F		CHEMBL3645064	=	IC50	nM	1649.49	CHEMBL2148	Homo sapiens	IC50	nM	1649.49
216857	16266114	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)c1OC		CHEMBL3645068	=	IC50	nM	184.67	CHEMBL2148	Homo sapiens	IC50	nM	184.67
233631	16266481	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665124	=	Ki	nM	0.1604	CHEMBL2148	Homo sapiens	Ki	nM	0.160445
216868	16266640	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(F)cc5)cccn4n3)c2)CC1		CHEMBL2062812	=	IC50	nM	494.04	CHEMBL2148	Homo sapiens	IC50	nM	494.04
255694	16266684	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cccc(c1)OCCCc1cccc(c1)N2		CHEMBL3694581	=	IC50	nM	2.4	CHEMBL2148	Homo sapiens	IC50	nM	2.4
216562	16266714	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1-c1cccn2nc(Nc3ccc(N4CCOCC4)cc3)nc12		CHEMBL3642253	=	IC50	nM	88.3	CHEMBL2148	Homo sapiens	IC50	nM	88.3
216746	16266848	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(OCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642416	=	IC50	nM	134.76	CHEMBL2148	Homo sapiens	IC50	nM	134.76
216760	16267132	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cnn(CCN5CCCC5)c4)nc23)cc1		CHEMBL3644966	=	IC50	nM	475.64	CHEMBL2148	Homo sapiens	IC50	nM	475.64
216796	16267141	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Fc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645002	=	IC50	nM	137.2	CHEMBL2148	Homo sapiens	IC50	nM	137.2
302635	16267617	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@H]2CC[C@H](C#N)C2)C1		CHEMBL3658864	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233685	16267655	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1c[nH]c2ncc(-c3cccnc3N[C@H]3CCCN(S(C)(=O)=O)C3)nc12	Outside typical range	CHEMBL3665172	=	Ki	nM	0.00587	CHEMBL2148	Homo sapiens	Ki	nM	0.00587
216586	16267774	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL2062805	=	IC50	nM	30.7	CHEMBL2148	Homo sapiens	IC50	nM	30.7
216803	16267839	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCN(C(=O)OC(C)(C)C)CC4)cc3)nc12		CHEMBL3645009	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
293980	16268043	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(CO)c(N)c3)c12		CHEMBL3703494	=	IC50	nM	8.3	CHEMBL2148	Homo sapiens	IC50	nM	8.3
234422	16268087	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](CC#N)C2)CC1		CHEMBL3652308	=	IC50	nM	447.0	CHEMBL2148	Homo sapiens	IC50	nM	447.0
302629	16268258	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@@H](C#N)C2)C1		CHEMBL3658858	=	IC50	nM	5270.0	CHEMBL2148	Homo sapiens	IC50	nM	5270.0
234486	16268303	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](c3ccccc3)C2)CC1		CHEMBL3652371	=	IC50	nM	414.0	CHEMBL2148	Homo sapiens	IC50	nM	414.0
216622	16268402	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(Nc5ccccc5S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642300	=	IC50	nM	612.0	CHEMBL2148	Homo sapiens	IC50	nM	612.0
216571	16268409	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1cccc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)c1		CHEMBL3642261	=	IC50	nM	415.2	CHEMBL2148	Homo sapiens	IC50	nM	415.2
216836	16268482	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(Cl)ccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)C4)nc12		CHEMBL3645048	=	IC50	nM	93.0	CHEMBL2148	Homo sapiens	IC50	nM	93.0
226328	16268544	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CNC(=S)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL1537091	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216685	16268577	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ncccc1CNc1cccn2nc(Nc3ccc(S(C)(=O)=O)cc3)nc12)S(C)(=O)=O		CHEMBL3642357	=	IC50	nM	273.97	CHEMBL2148	Homo sapiens	IC50	nM	273.97
233731	16268725	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)CCNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665211	=	IC50	nM	0.03268	CHEMBL2148	Homo sapiens	IC50	nM	0.032685
233687	16268747	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(Cl)c3n2)C1	Outside typical range	CHEMBL3665174	=	IC50	nM	0.00773	CHEMBL2148	Homo sapiens	IC50	nM	0.00773
294061	16268859	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cccc(F)c4)c23)c1		CHEMBL3651044	=	IC50	nM	0.59	CHEMBL2148	Homo sapiens	IC50	nM	0.59
234506	16269033	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCN(c3ccccn3)CC2)CC1		CHEMBL3652390	=	IC50	nM	208.0	CHEMBL2148	Homo sapiens	IC50	nM	208.0
226333	16269144	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCN(c2ccccc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645545	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
233694	16269146	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665180	=	IC50	nM	0.001155	CHEMBL2148	Homo sapiens	IC50	nM	0.001155
233672	16269861	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665159	=	Ki	nM	0.5293	CHEMBL2148	Homo sapiens	Ki	nM	0.52926
233705	16269952	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(Cl)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665190	=	IC50	nM	0.05241	CHEMBL2148	Homo sapiens	IC50	nM	0.05241
302600	16270196	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655081	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234495	16270237	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC2)CC1		CHEMBL3652380	=	IC50	nM	289.0	CHEMBL2148	Homo sapiens	IC50	nM	289.0
234492	16270238	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1cccc(C[C@H]2CCCN2S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)n1		CHEMBL3652377	=	IC50	nM	322.0	CHEMBL2148	Homo sapiens	IC50	nM	322.0
233691	16270319	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(C)NS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665178	=	IC50	nM	0.0647	CHEMBL2148	Homo sapiens	IC50	nM	0.0647
233661	16270580	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665151	=	Ki	nM	0.01969	CHEMBL2148	Homo sapiens	Ki	nM	0.01969
233738	16270623	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1C[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1		CHEMBL3665218	=	Ki	nM	0.1955	CHEMBL2148	Homo sapiens	Ki	nM	0.19549
233632	16270661	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665125	=	IC50	nM	0.6049	CHEMBL2148	Homo sapiens	IC50	nM	0.604935
216598	16270676	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(Cc2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL3642282	=	IC50	nM	58.6	CHEMBL2148	Homo sapiens	IC50	nM	58.6
226319	16270711	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CN(C)CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645535	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216681	16270838	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2cccc(Nc3nc4c(-c5ccccc5N(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642353	=	IC50	nM	830.05	CHEMBL2148	Homo sapiens	IC50	nM	830.05
294030	16270895	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c[nH]c1=O		CHEMBL3651012	=	IC50	nM	0.47	CHEMBL2148	Homo sapiens	IC50	nM	0.47
216731	16270902	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCC(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642401	=	IC50	nM	216.19	CHEMBL2148	Homo sapiens	IC50	nM	216.19
234419	16270914	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](CC#N)C2)CC1		CHEMBL3652305	=	IC50	nM	355.0	CHEMBL2148	Homo sapiens	IC50	nM	355.0
216707	16270990	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642379	=	IC50	nM	576.56	CHEMBL2148	Homo sapiens	IC50	nM	576.56
233700	16271061	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)c1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665186	=	IC50	nM	0.05674	CHEMBL2148	Homo sapiens	IC50	nM	0.05674
226326	16271131	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCCCC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645541	=	IC50	nM	175.0	CHEMBL2148	Homo sapiens	IC50	nM	175.0
294072	16271167	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cncs4)c23)c1		CHEMBL3651055	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
233730	16271438	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(Nc3ccncc3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665210	=	Ki	nM	0.07654	CHEMBL2148	Homo sapiens	Ki	nM	0.07654
234460	16271647	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC[C@@]1(CO)CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652345	=	IC50	nM	495.0	CHEMBL2148	Homo sapiens	IC50	nM	495.0
233698	16271651	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCOCC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665184	=	IC50	nM	0.01051	CHEMBL2148	Homo sapiens	IC50	nM	0.010505
233711	16271725	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCOCC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335698	=	Ki	nM	0.00931	CHEMBL2148	Homo sapiens	Ki	nM	0.00931
233638	16271745	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665131	=	Ki	nM	0.05062	CHEMBL2148	Homo sapiens	Ki	nM	0.050622
226342	16271774	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CSCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648431	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216827	16271820	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nc12		CHEMBL3645039	=	IC50	nM	133.14	CHEMBL2148	Homo sapiens	IC50	nM	133.14
216563	16271846	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)cc1		CHEMBL2062803	=	IC50	nM	22.5	CHEMBL2148	Homo sapiens	IC50	nM	22.5
233676	16271952	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665163	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
233654	16271963	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665145	=	Ki	nM	0.03037	CHEMBL2148	Homo sapiens	Ki	nM	0.030373
233737	16272003	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)CN(S(C)(=O)=O)C1		CHEMBL3665217	=	IC50	nM	0.02678	CHEMBL2148	Homo sapiens	IC50	nM	0.02678
279125	16272478	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	NC(=O)c1cnc(Nc2ccc(N3CCC[C@@H](C(N)=O)C3)cc2)nc1NC1CC1		CHEMBL3645122	=	Kd	nM	4.1	CHEMBL2148	Homo sapiens	Kd	nM	4.1
233730	16272644	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(Nc3ccncc3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665210	=	IC50	nM	0.1531	CHEMBL2148	Homo sapiens	IC50	nM	0.153085
234464	16272685	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@@H](F)[C@H](F)C2)CC1		CHEMBL3652349	=	IC50	nM	275.0	CHEMBL2148	Homo sapiens	IC50	nM	275.0
233645	16272740	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665138	=	IC50	nM	0.7003	CHEMBL2148	Homo sapiens	IC50	nM	0.7003
233667	16272973	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cn1ccc2ncc(-c3cccnc3N[C@H]3CCCN(S(C)(=O)=O)C3)nc21		CHEMBL3665154	=	Ki	nM	1.627	CHEMBL2148	Homo sapiens	Ki	nM	1.62743
234488	16272996	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](Cc3cnccn3)C2)CC1		CHEMBL3652373	=	IC50	nM	283.0	CHEMBL2148	Homo sapiens	IC50	nM	283.0
233708	16272999	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCOc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665191	=	Ki	nM	0.01631	CHEMBL2148	Homo sapiens	Ki	nM	0.01631
216696	16273056	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc5c(c4)CCC(N4CCOCC4)CC5)nc23)cc1		CHEMBL3642368	=	IC50	nM	43.02	CHEMBL2148	Homo sapiens	IC50	nM	43.02
302609	16273160	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C(C)(C)O)c2)C1		CHEMBL3655090	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
293985	16273272	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(F)c3)c12		CHEMBL3703499	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
234489	16273365	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@](O)(c3ccccn3)C2)CC1		CHEMBL3652374	=	IC50	nM	294.0	CHEMBL2148	Homo sapiens	IC50	nM	294.0
234411	16273408	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(O)(c3ccccc3)CC2)CC1		CHEMBL3652297	=	IC50	nM	37.4	CHEMBL2148	Homo sapiens	IC50	nM	37.4
216661	16273628	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(Nc5cccc(S(C)(=O)=O)c5)cccn4n3)c2)CC1		CHEMBL3642337	=	IC50	nM	8249.0	CHEMBL2148	Homo sapiens	IC50	nM	8249.0
234526	16273673	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@@H](OP(=O)(O)O)C2)CC1		CHEMBL3652410	=	IC50	nM	0.768	CHEMBL2148	Homo sapiens	IC50	nM	0.768
216742	16273726	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc([C@@H]5CCN(CC(N)=O)C[C@@H]5O)c4)nc23)cc1		CHEMBL3642412	=	IC50	nM	13.23	CHEMBL2148	Homo sapiens	IC50	nM	13.23
302636	16273746	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@@H]2CC[C@@H](C#N)C2)C1		CHEMBL3658865	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233644	16273790	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665137	=	Ki	nM	0.09995	CHEMBL2148	Homo sapiens	Ki	nM	0.099953
234426	16273949	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@@H](O)C2)CC1		CHEMBL3652312	=	IC50	nM	105.0	CHEMBL2148	Homo sapiens	IC50	nM	105.0
233709	16273998	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NCCO)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665192	=	Ki	nM	0.00402	CHEMBL2148	Homo sapiens	Ki	nM	0.00402
233727	16274042	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NC3CCC(C#N)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665207	=	IC50	nM	0.01359	CHEMBL2148	Homo sapiens	IC50	nM	0.013595
233737	16274212	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)CN(S(C)(=O)=O)C1		CHEMBL3665217	=	Ki	nM	0.01339	CHEMBL2148	Homo sapiens	Ki	nM	0.01339
302605	16274230	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2COC2)C1		CHEMBL3655086	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
294015	16274318	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1OC		CHEMBL3650997	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
216573	16274550	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)cc1		CHEMBL2062799	=	IC50	nM	41.3	CHEMBL2148	Homo sapiens	IC50	nM	41.3
216741	16274591	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)CCN1CCC(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642411	=	IC50	nM	27.33	CHEMBL2148	Homo sapiens	IC50	nM	27.33
234507	16274612	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCN(c3ncccc3C(=O)NC3CC3)CC2)CC1		CHEMBL3652391	=	IC50	nM	595.0	CHEMBL2148	Homo sapiens	IC50	nM	595.0
216692	16274638	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccccc1CNc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3642364	=	IC50	nM	193.78	CHEMBL2148	Homo sapiens	IC50	nM	193.78
217556	16274709	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	COCC(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645119	=	Kd	nM	2.9	CHEMBL2148	Homo sapiens	Kd	nM	2.9
234398	16274722	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(N)CC2)CC1		CHEMBL3652284	=	IC50	nM	2270.0	CHEMBL2148	Homo sapiens	IC50	nM	2270.0
216721	16274804	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCC5CCCN5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642391	=	IC50	nM	160.34	CHEMBL2148	Homo sapiens	IC50	nM	160.34
294052	16274961	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C/C=C/S(=O)(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651033	=	IC50	nM	8.2	CHEMBL2148	Homo sapiens	IC50	nM	8.2
216727	16275079	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5cccc(CN(C)S(C)(=O)=O)c5)cccn4n3)c2)CC1		CHEMBL3642397	=	IC50	nM	247.06	CHEMBL2148	Homo sapiens	IC50	nM	247.06
216698	16275351	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642370	=	IC50	nM	224.57	CHEMBL2148	Homo sapiens	IC50	nM	224.57
234496	16275404	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(c3ncccn3)C2)CC1		CHEMBL3652381	=	IC50	nM	294.0	CHEMBL2148	Homo sapiens	IC50	nM	294.0
233724	16275463	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC[C@H](O)C3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665205	=	IC50	nM	0.04262	CHEMBL2148	Homo sapiens	IC50	nM	0.04262
233712	16275509	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(C(=O)CC#N)C2)n1		CHEMBL3665194	=	IC50	nM	0.8445	CHEMBL2148	Homo sapiens	IC50	nM	0.84448
233649	16275764	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665142	=	IC50	nM	0.00776	CHEMBL2148	Homo sapiens	IC50	nM	0.00776
221726	16275767	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	189.3	CHEMBL2148	Homo sapiens	IC50	nM	189.3
294058	16275830	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(CO)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651041	=	IC50	nM	0.02	CHEMBL2148	Homo sapiens	IC50	nM	0.02
293996	16275910	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(N)cc3)c12		CHEMBL3650980	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
233628	16276067	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665121	=	Ki	nM	0.1723	CHEMBL2148	Homo sapiens	Ki	nM	0.172341
233642	16276173	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665135	=	Ki	nM	0.413	CHEMBL2148	Homo sapiens	Ki	nM	0.413034
294008	16276198	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1Cl		CHEMBL3650991	=	IC50	nM	0.013	CHEMBL2148	Homo sapiens	IC50	nM	0.013
234514	16276242	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@@H]1C[C@@H](CS(=O)(=O)N2CCC[C@@H](O)C2)CC[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL3652398	=	IC50	nM	19.4	CHEMBL2148	Homo sapiens	IC50	nM	19.4
216666	16276332	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4ccc(CN5CCS(=O)(=O)CC5)cc4)nn23)cc1		CHEMBL3642340	=	IC50	nM	26.08	CHEMBL2148	Homo sapiens	IC50	nM	26.08
233721	16276373	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(=O)(=O)CCC(C)(C)C)C3)n2)CC1	Outside typical range	CHEMBL3665202	=	Ki	nM	0.00109	CHEMBL2148	Homo sapiens	Ki	nM	0.00109
293973	16276741	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(OC)cc3)c12		CHEMBL3703487	=	IC50	nM	5.7	CHEMBL2148	Homo sapiens	IC50	nM	5.7
216657	16276836	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cc(F)cn4n3)cc2)CC1		CHEMBL3642333	=	IC50	nM	932.9	CHEMBL2148	Homo sapiens	IC50	nM	932.9
233673	16277074	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3ccn(C)c3n2)C1		CHEMBL3665160	=	Ki	nM	1.026	CHEMBL2148	Homo sapiens	Ki	nM	1.02631
293992	16277139	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL3703506	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
216861	16277152	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5ccc(C#N)cc5)cccn4n3)cc2)CC1		CHEMBL3645072	=	IC50	nM	143.36	CHEMBL2148	Homo sapiens	IC50	nM	143.36
233739	16277234	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1		CHEMBL3665219	=	Ki	nM	0.06732	CHEMBL2148	Homo sapiens	Ki	nM	0.06732
255702	16277235	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCCCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694589	=	IC50	nM	62.0	CHEMBL2148	Homo sapiens	IC50	nM	62.0
216734	16277281	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCN(CC(N)=O)CC5)c4)nc23)cc1		CHEMBL3642404	=	IC50	nM	28.6	CHEMBL2148	Homo sapiens	IC50	nM	28.6
216846	16277655	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(C(F)F)ccc1-c1cccn2nc(Nc3ccc(C4CCN(CC(=O)N(C)C)CC4)cc3)nc12		CHEMBL3645057	=	IC50	nM	91.06	CHEMBL2148	Homo sapiens	IC50	nM	91.06
234428	16278032	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(C#N)CC2)CC1		CHEMBL3652314	=	IC50	nM	431.0	CHEMBL2148	Homo sapiens	IC50	nM	431.0
302614	16278050	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC2)C1		CHEMBL3655095	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
226322	16278067	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CCCCl)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645538	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216709	16278078	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(Cc1ccccc1CNc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642381	=	IC50	nM	1782.92	CHEMBL2148	Homo sapiens	IC50	nM	1782.92
233629	16278083	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665122	=	IC50	nM	0.01047	CHEMBL2148	Homo sapiens	IC50	nM	0.010465
233656	16278159	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335690	=	Ki	nM	0.0012	CHEMBL2148	Homo sapiens	Ki	nM	0.0012
233646	16278485	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)C(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665139	=	Ki	nM	0.1763	CHEMBL2148	Homo sapiens	Ki	nM	0.176251
233693	16278502	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665179	=	IC50	nM	0.00196	CHEMBL2148	Homo sapiens	IC50	nM	0.00196
233670	16278756	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665157	=	IC50	nM	0.1269	CHEMBL2148	Homo sapiens	IC50	nM	0.126905
216601	16278940	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(Nc4ccccc4S(C)(=O)=O)cccn3n2)cc1		CHEMBL3642284	=	IC50	nM	111.7	CHEMBL2148	Homo sapiens	IC50	nM	111.7
216814	16279071	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5cnn(-c6ccc(F)cc6)c5)cccn4n3)c2)CC1		CHEMBL3645020	=	IC50	nM	152.93	CHEMBL2148	Homo sapiens	IC50	nM	152.93
216599	16279159	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc4)nc23)cc1		CHEMBL3642283	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233642	16279168	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665135	=	IC50	nM	0.8052	CHEMBL2148	Homo sapiens	IC50	nM	0.805155
233625	16279230	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335688	=	IC50	nM	0.03082	CHEMBL2148	Homo sapiens	IC50	nM	0.03082
294005	16279275	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650988	=	IC50	nM	0.04	CHEMBL2148	Homo sapiens	IC50	nM	0.04
234497	16279295	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(c3cccnc3)C2)CC1		CHEMBL3639512	=	IC50	nM	346.0	CHEMBL2148	Homo sapiens	IC50	nM	346.0
216607	16279503	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)S(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCN(C)CC5)c4)nc23)cc1		CHEMBL2062810	=	IC50	nM	37.8	CHEMBL2148	Homo sapiens	IC50	nM	37.8
294025	16279515	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1C(=O)N(C)C		CHEMBL3651007	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
216866	16279518	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)c1cccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)c1		CHEMBL3645077	=	IC50	nM	82.16	CHEMBL2148	Homo sapiens	IC50	nM	82.16
216578	16279708	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CNC(=O)c1ccc(-c2cccn3nc(Nc4ccccc4OC)nc23)cc1		CHEMBL3642267	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216873	16279718	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCc2ccc(Nc3nc4c(-c5cc(C(F)F)ccc5OCC(F)F)cccn4n3)cc2CC1		CHEMBL3645092	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
234417	16279807	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](CO)C2)CC1		CHEMBL3652303	=	IC50	nM	112.0	CHEMBL2148	Homo sapiens	IC50	nM	112.0
234490	16279858	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](Cc3ccccc3)C2)CC1		CHEMBL3652375	=	IC50	nM	721.0	CHEMBL2148	Homo sapiens	IC50	nM	721.0
2953	16279879	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cn1ncc2c(-c3cccn4nc(Nc5ccc6c(c5)CCN(C(=O)OC(C)(C)C)CC6)nc34)cccc21		CHEMBL3642250	=	IC50	nM	226.9	CHEMBL2148	Homo sapiens	IC50	nM	226.9
293976	16279917	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(C3=CCCCC3)c12		CHEMBL3703490	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
216584	16279924	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(N4CCN(C)CC4)cccn3n2)cc1		CHEMBL3642271	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216845	16280111	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(C(F)F)ccc1-c1cccn2nc(Nc3ccc(C4CCNCC4)cc3)nc12		CHEMBL3645056	=	IC50	nM	201.78	CHEMBL2148	Homo sapiens	IC50	nM	201.78
294012	16280289	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1Cl		CHEMBL3650995	=	IC50	nM	0.066	CHEMBL2148	Homo sapiens	IC50	nM	0.066
216785	16280356	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3644991	=	IC50	nM	805.87	CHEMBL2148	Homo sapiens	IC50	nM	805.87
233627	16280363	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665120	=	Ki	nM	0.02511	CHEMBL2148	Homo sapiens	Ki	nM	0.025109
216834	16280397	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCc2ccc(Nc3nc4c(-c5cc(C(F)(F)F)ccc5OCC(F)F)cccn4n3)cc2CC1		CHEMBL3645046	=	IC50	nM	1667.36	CHEMBL2148	Homo sapiens	IC50	nM	1667.36
216676	16280468	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(Nc5ccccc5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642348	=	IC50	nM	140.87	CHEMBL2148	Homo sapiens	IC50	nM	140.87
233697	16280481	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(=O)(=O)CC(C)C)C2)n1	Outside typical range	CHEMBL3665183	=	Ki	nM	0.00448	CHEMBL2148	Homo sapiens	Ki	nM	0.00448
294023	16280594	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(C)cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651005	=	IC50	nM	0.19	CHEMBL2148	Homo sapiens	IC50	nM	0.19
216820	16280781	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cn1ncc2c(-c3cccn4nc(Nc5ccc6c(c5)CCNCC6)nc34)cccc21		CHEMBL3645026	=	IC50	nM	226.9	CHEMBL2148	Homo sapiens	IC50	nM	226.9
294065	16280848	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ccccc4C)c23)c1		CHEMBL3651048	=	IC50	nM	5.2	CHEMBL2148	Homo sapiens	IC50	nM	5.2
233717	16280924	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCC(CC(N)=O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665199	=	IC50	nM	0.0053	CHEMBL2148	Homo sapiens	IC50	nM	0.0053
216745	16281199	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(CCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642415	=	IC50	nM	655.75	CHEMBL2148	Homo sapiens	IC50	nM	655.75
233636	16281500	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665129	=	IC50	nM	0.1074	CHEMBL2148	Homo sapiens	IC50	nM	0.10739
294027	16281563	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1CN(C)C		CHEMBL3651009	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
216784	16281612	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(OCCN4CCOCC4)cc3)nc12		CHEMBL3644990	=	IC50	nM	1041.68	CHEMBL2148	Homo sapiens	IC50	nM	1041.68
216872	16281669	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	FC(F)COc1ccc(C(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645091	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
279119	16281770	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	COCC(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645119	=	Kd	nM	2.9	CHEMBL2148	Homo sapiens	Kd	nM	2.9
233690	16282017	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)S(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665177	=	IC50	nM	0.04782	CHEMBL2148	Homo sapiens	IC50	nM	0.04782
216675	16282031	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ncccc1CNc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642347	=	IC50	nM	838.05	CHEMBL2148	Homo sapiens	IC50	nM	838.05
216654	16282103	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cc(C(F)(F)F)cn4n3)cc2)CC1		CHEMBL3642330	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233677	16282124	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665164	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
233722	16282136	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)C1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665203	=	Ki	nM	0.01291	CHEMBL2148	Homo sapiens	Ki	nM	0.01291
216642	16282240	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(NC(=O)Nc3nc4cccc(-c5cccc(S(C)(=O)=O)c5)n4n3)cc2)CC1		CHEMBL3642318	=	IC50	nM	2353.8	CHEMBL2148	Homo sapiens	IC50	nM	2353.8
293987	16282472	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(O)c3)c12		CHEMBL3703501	=	IC50	nM	5.6	CHEMBL2148	Homo sapiens	IC50	nM	5.6
216608	16282574	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(=O)(=O)N(C)C)cc5)cccn4n3)cc2)CC1		CHEMBL3642290	=	IC50	nM	33.3	CHEMBL2148	Homo sapiens	IC50	nM	33.3
233696	16282714	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(S(C)(=O)=O)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665182	=	Ki	nM	0.00094	CHEMBL2148	Homo sapiens	Ki	nM	0.00094
216606	16282724	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)S(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCN(C)CC5)cc4)nc23)cc1		CHEMBL3642289	=	IC50	nM	42.4	CHEMBL2148	Homo sapiens	IC50	nM	42.4
216778	16282766	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)CCN1CCc2ccc(Nc3nc4c(-c5cccc6c5OC(F)(F)O6)cccn4n3)cc2CC1		CHEMBL3644984	=	IC50	nM	222.96	CHEMBL2148	Homo sapiens	IC50	nM	222.96
216732	16282862	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCNCC5)c4)nc23)cc1		CHEMBL3642402	=	IC50	nM	52.56	CHEMBL2148	Homo sapiens	IC50	nM	52.56
233715	16283198	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665197	=	Ki	nM	0.01504	CHEMBL2148	Homo sapiens	Ki	nM	0.01504
216639	16283221	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(Cc2ccc(Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)cc2)CC1		CHEMBL3642315	=	IC50	nM	76.1	CHEMBL2148	Homo sapiens	IC50	nM	76.1
233709	16283226	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NCCO)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665192	=	IC50	nM	0.008045	CHEMBL2148	Homo sapiens	IC50	nM	0.008045
255695	16283437	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	C[C@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2		CHEMBL3694582	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	nM	140.0
216627	16283525	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4ccc(OCCN5CCCC5)cc4)nn23)cc1		CHEMBL3642305	=	IC50	nM	71.0	CHEMBL2148	Homo sapiens	IC50	nM	71.0
216753	16283583	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCn1cc(Nc2nc3c(Oc4ccc(S(C)(=O)=O)cc4)cccn3n2)cn1		CHEMBL3644959	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
233626	16283762	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665119	=	IC50	nM	0.00837	CHEMBL2148	Homo sapiens	IC50	nM	0.00837
216643	16283814	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(NC(=O)Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)cc2)CC1		CHEMBL3642319	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233643	16284067	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665136	=	Ki	nM	0.5933	CHEMBL2148	Homo sapiens	Ki	nM	0.593269
234480	16284453	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCc1ccc(COC[C@H]2CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)C2)nc1		CHEMBL3652365	=	IC50	nM	678.0	CHEMBL2148	Homo sapiens	IC50	nM	678.0
233639	16284632	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665132	=	Ki	nM	0.3997	CHEMBL2148	Homo sapiens	Ki	nM	0.399728
216665	16284699	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(CN5CCS(=O)(=O)CC5)cc4)nc23)cc1		CHEMBL3642339	=	IC50	nM	30.27	CHEMBL2148	Homo sapiens	IC50	nM	30.27
234443	16284731	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(C)S(=O)(=O)C[C@H]1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652329	=	IC50	nM	453.0	CHEMBL2148	Homo sapiens	IC50	nM	453.0
294003	16284788	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cncc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650986	=	IC50	nM	0.085	CHEMBL2148	Homo sapiens	IC50	nM	0.085
233714	16284796	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCS(=O)(=O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665196	=	Ki	nM	0.02491	CHEMBL2148	Homo sapiens	Ki	nM	0.02491
234402	16284871	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(COc3ccc(F)cc3)C2)CC1		CHEMBL3652288	=	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233715	16284973	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665197	=	IC50	nM	0.03009	CHEMBL2148	Homo sapiens	IC50	nM	0.030085
294076	16285017	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	COc1ccc(F)cc1-c1c[nH]c2ncnc(-c3ccccc3)c12		CHEMBL3651059	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
255699	16285090	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCCCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694586	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
216693	16285287	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	C[C@H](O)CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642365	=	IC50	nM	77.87	CHEMBL2148	Homo sapiens	IC50	nM	77.87
216825	16285387	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nc12		CHEMBL3645037	=	IC50	nM	3384.89	CHEMBL2148	Homo sapiens	IC50	nM	3384.89
234447	16285520	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@H]1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652332	=	IC50	nM	851.0	CHEMBL2148	Homo sapiens	IC50	nM	851.0
234449	16285707	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@@](C)(CO)C2)CC1		CHEMBL3652334	=	IC50	nM	554.0	CHEMBL2148	Homo sapiens	IC50	nM	554.0
233721	16285795	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(=O)(=O)CCC(C)(C)C)C3)n2)CC1	Outside typical range	CHEMBL3665202	=	IC50	nM	0.002185	CHEMBL2148	Homo sapiens	IC50	nM	0.002185
216823	16285950	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645035	=	IC50	nM	749.57	CHEMBL2148	Homo sapiens	IC50	nM	749.57
216561	16286109	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1ccc(Nc2nc3ccccn3n2)cc1		CHEMBL3642252	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
234396	16286356	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(O)CC2)CC1		CHEMBL3639511	=	IC50	nM	342.0	CHEMBL2148	Homo sapiens	IC50	nM	342.0
216640	16286661	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1cccc(-c2cccc3nc(Nc4ccc(CN5CCOCC5)cc4)nn23)c1		CHEMBL3642316	=	IC50	nM	105.6	CHEMBL2148	Homo sapiens	IC50	nM	105.6
216660	16286823	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(Nc5cccc(S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642336	=	IC50	nM	3049.69	CHEMBL2148	Homo sapiens	IC50	nM	3049.69
216794	16286869	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)CCN1CCc2ccc(Nc3nc4c(-c5cc(C(F)(F)F)ccc5Cl)cccn4n3)cc2CC1		CHEMBL3645000	=	IC50	nM	359.53	CHEMBL2148	Homo sapiens	IC50	nM	359.53
216708	16286909	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642380	=	IC50	nM	2575.04	CHEMBL2148	Homo sapiens	IC50	nM	2575.04
216783	16286988	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3cccc(C4CCNCC4)c3)nc12		CHEMBL3644989	=	IC50	nM	705.92	CHEMBL2148	Homo sapiens	IC50	nM	705.92
279117	16287060	CHEMBL3707514	Time-Resolved Fluorescence Resonance Energy Transfer Assay (TR-FRET): SYK tyrosine phosphorylation activity is measured using the LANCE Technology developed by Perkin Elmer Life and Analytical Sciences (Boston, Mass.). LANCE refers to homogeneous time resolved fluorometry applications using techniques such as time-resolved fluorescence resonance energy transfer assay (TR-FRET) (see generally for procedures in Perkin Elmer Application Note How to Optimize a Tyrosine Kinase Assay Using Time Resolved Fluorescence-Based LANCE Detection, wwww.perkinelmer.com/lifesciences). The assay principle involves detection of a phosphorylated substrate using energy transfer from a phosphospecific europium-labeled antibody to streptavidin-allophycocyanin as an acceptor.To test the ability of candidate molecules to inhibit SYK tyrosine phosphorylation activity, molecules are reconstituted in 30% DMSO and serially diluted 1:3 with the final dilution containing DMSO in the absence of the candidate molecule. The final DMSO concentration in the assay is 3%.	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
233724	16287168	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC[C@H](O)C3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665205	=	Ki	nM	0.02131	CHEMBL2148	Homo sapiens	Ki	nM	0.02131
233707	16287463	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2[nH]c(=O)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335695	=	Ki	nM	0.0086	CHEMBL2148	Homo sapiens	Ki	nM	0.0086
216680	16287532	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2cccc(Nc3nc4c(-c5cccc(N(C)S(C)(=O)=O)c5)cccn4n3)c2)CC1		CHEMBL3642352	=	IC50	nM	211.35	CHEMBL2148	Homo sapiens	IC50	nM	211.35
216605	16287782	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(C2CCN(c3ccc(Nc4nc5c(-c6ccc(S(C)(=O)=O)cc6)cccn5n4)cc3)CC2)CC1		CHEMBL3642288	=	IC50	nM	31.2	CHEMBL2148	Homo sapiens	IC50	nM	31.2
221729	16287860	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCC(F)(F)CC4)cc3)n2n1)C1CC1		CHEMBL3360356	=	IC50	nM	194.6	CHEMBL2148	Homo sapiens	IC50	nM	194.6
216838	16287900	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCN(C(=O)OC(C)(C)C)CC4)cc3)nc12		CHEMBL3645050	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233669	16288204	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665156	=	Ki	nM	0.1258	CHEMBL2148	Homo sapiens	Ki	nM	0.12585
216706	16288252	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ncccc1CNc1cccn2nc(Nc3ccc(N4CCN(CCO)CC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642378	=	IC50	nM	406.91	CHEMBL2148	Homo sapiens	IC50	nM	406.91
226350	16288362	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCN(c2ccncc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648439	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234401	16288526	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](O)C2)CC1		CHEMBL3652287	=	IC50	nM	169.0	CHEMBL2148	Homo sapiens	IC50	nM	169.0
226340	16288628	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	C=CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648429	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216577	16288703	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CNC(=O)c1cccc(-c2cccn3nc(Nc4ccccc4OC)nc23)c1		CHEMBL3642266	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216876	16288712	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCN1CCP(=O)(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL3645118	=	IC50	nM	57.86	CHEMBL2148	Homo sapiens	IC50	nM	57.86
234458	16288766	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@@H](O)[C@H](O)C2)CC1		CHEMBL3652343	=	IC50	nM	173.0	CHEMBL2148	Homo sapiens	IC50	nM	173.0
233699	16288818	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665185	=	Ki	nM	0.02368	CHEMBL2148	Homo sapiens	Ki	nM	0.02368
293979	16288988	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4c(c3)NCC4)c12		CHEMBL3703493	=	IC50	nM	4.6	CHEMBL2148	Homo sapiens	IC50	nM	4.6
302606	16289070	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@](C)(CC#N)C2)C1		CHEMBL3655087	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216641	16289096	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(Cc2ccc(Nc3nc4cccc(-c5cccc(S(C)(=O)=O)c5)n4n3)cc2)CC1		CHEMBL3642317	=	IC50	nM	219.6	CHEMBL2148	Homo sapiens	IC50	nM	219.6
216594	16289136	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)c1		CHEMBL2062798	=	IC50	nM	60.8	CHEMBL2148	Homo sapiens	IC50	nM	60.8
302615	16289180	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CN(C3CC3)C2)C1		CHEMBL3655096	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
294035	16289288	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CC#CC(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651016	=	IC50	nM	0.072	CHEMBL2148	Homo sapiens	IC50	nM	0.072
233690	16289291	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)S(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665177	=	Ki	nM	0.02391	CHEMBL2148	Homo sapiens	Ki	nM	0.02391
234456	16289320	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](F)C2)CC1		CHEMBL3652341	=	IC50	nM	319.0	CHEMBL2148	Homo sapiens	IC50	nM	319.0
234466	16289377	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@H](F)[C@@H](CO)C2)CC1		CHEMBL3652351	=	IC50	nM	205.0	CHEMBL2148	Homo sapiens	IC50	nM	205.0
216855	16289428	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCN(CC(=O)N(C)C)CC5)cc4)nc23)c1F		CHEMBL3645066	=	IC50	nM	96.1	CHEMBL2148	Homo sapiens	IC50	nM	96.1
233700	16289516	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)c1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665186	=	Ki	nM	0.02837	CHEMBL2148	Homo sapiens	Ki	nM	0.02837
226339	16289548	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	C=CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3639444	=	IC50	nM	45.0	CHEMBL2148	Homo sapiens	IC50	nM	45.0
216858	16289593	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCN(CC(=O)N(C)C)CC5)cc4)nc23)c1OC		CHEMBL3645069	=	IC50	nM	123.71	CHEMBL2148	Homo sapiens	IC50	nM	123.71
216678	16289619	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5cccc(N(C)S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642350	=	IC50	nM	173.06	CHEMBL2148	Homo sapiens	IC50	nM	173.06
233683	16289635	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665170	=	IC50	nM	4.678	CHEMBL2148	Homo sapiens	IC50	nM	4.678085
216621	16289891	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccccc5S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642299	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
294070	16289928	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C4=CCOCC4)c23)c1		CHEMBL3651053	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
233652	16290288	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665144	=	Ki	nM	0.01517	CHEMBL2148	Homo sapiens	Ki	nM	0.015169
233683	16290334	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2ncccc2-c2cnc3nc[nH]c3n2)C1		CHEMBL3665170	=	Ki	nM	2.339	CHEMBL2148	Homo sapiens	Ki	nM	2.33904
216704	16290454	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5cccnc5)cccn4n3)c2)CC1		CHEMBL3642376	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
216628	16291088	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCN(c2ccc(Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)cc2)CC1		CHEMBL3642306	=	IC50	nM	50.2	CHEMBL2148	Homo sapiens	IC50	nM	50.2
234517	16291115	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@@H]1C[C@@H](CS(=O)(=O)N2CC[C@@H](CO)C2)CC[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL3652401	=	IC50	nM	51.2	CHEMBL2148	Homo sapiens	IC50	nM	51.2
234516	16291163	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@@H]1C[C@@H](CS(=O)(=O)N2CCC[C@H](O)C2)CC[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL3652400	=	IC50	nM	32.5	CHEMBL2148	Homo sapiens	IC50	nM	32.5
255696	16291194	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cccc(c1)OCCOc1cccc(c1)N2		CHEMBL3694583	=	IC50	nM	6.4	CHEMBL2148	Homo sapiens	IC50	nM	6.4
216808	16291333	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Fc1ccc(-n2cc(-c3cccn4nc(Nc5ccc(C6CCNCC6)cc5)nc34)cn2)cc1		CHEMBL3645014	=	IC50	nM	119.79	CHEMBL2148	Homo sapiens	IC50	nM	119.79
233728	16291372	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCN(c4ccccn4)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665208	=	IC50	nM	0.06487	CHEMBL2148	Homo sapiens	IC50	nM	0.064865
216805	16291516	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCN(CC(=O)N(C)C)CC4)cc3)nc12		CHEMBL3645011	=	IC50	nM	2243.29	CHEMBL2148	Homo sapiens	IC50	nM	2243.29
293986	16291567	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL3703500	=	IC50	nM	4.2	CHEMBL2148	Homo sapiens	IC50	nM	4.2
293998	16291631	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(-n4cccn4)cc3)c12		CHEMBL3650982	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
221727	16291702	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	194.7	CHEMBL2148	Homo sapiens	IC50	nM	194.7
234432	16291741	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(Cc3ncccn3)CC2)CC1		CHEMBL3652318	=	IC50	nM	167.0	CHEMBL2148	Homo sapiens	IC50	nM	167.0
302625	16291850	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@@H]3C[C@]3(C#N)C2)C1		CHEMBL3904533	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
302612	16292438	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC(F)(F)C2)C1		CHEMBL3655093	>	IC50	nM	9670.0	CHEMBL2148	Homo sapiens	IC50	nM	9670.0
221725	16292529	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	187.3	CHEMBL2148	Homo sapiens	IC50	nM	187.3
294042	16292533	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/c4ccccn4)c3)c12		CHEMBL3651023	=	IC50	nM	6.6	CHEMBL2148	Homo sapiens	IC50	nM	6.6
233667	16292565	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cn1ccc2ncc(-c3cccnc3N[C@H]3CCCN(S(C)(=O)=O)C3)nc21		CHEMBL3665154	=	IC50	nM	3.255	CHEMBL2148	Homo sapiens	IC50	nM	3.254865
233671	16292849	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665158	=	IC50	nM	0.2906	CHEMBL2148	Homo sapiens	IC50	nM	0.290615
302620	16292957	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@@H]3C[C@H](C2)O3)C1		CHEMBL3655101	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234397	16293105	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(F)C2)CC1		CHEMBL3652283	=	IC50	nM	234.0	CHEMBL2148	Homo sapiens	IC50	nM	234.0
293978	16293193	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4c(F)n(C)nc4c3)c12		CHEMBL3703492	=	IC50	nM	8.1	CHEMBL2148	Homo sapiens	IC50	nM	8.1
233743	16293347	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCC(N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1)C(F)(F)F		CHEMBL3665223	=	IC50	nM	0.3222	CHEMBL2148	Homo sapiens	IC50	nM	0.3222
216579	16293395	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1Nc1nc2c(-c3ccc(S(C)(=O)=O)cc3)cccn2n1		CHEMBL2062797	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
293981	16293416	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(O)cc3)c12		CHEMBL3703495	=	IC50	nM	5.7	CHEMBL2148	Homo sapiens	IC50	nM	5.7
234513	16293442	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC3(CNC(=O)C3)C2)CC1		CHEMBL3652397	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
217553	16293531	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
233726	16293599	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC(C#N)C3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665206	=	IC50	nM	0.01251	CHEMBL2148	Homo sapiens	IC50	nM	0.012505
216723	16293750	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(Nc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642393	=	IC50	nM	3180.14	CHEMBL2148	Homo sapiens	IC50	nM	3180.14
233650	16293759	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335692	=	Ki	nM	0.003435	CHEMBL2148	Homo sapiens	Ki	nM	0.003435
216786	16293826	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(OCc5cccc(Cl)c5)cccn4n3)cc2)CC1		CHEMBL3644992	=	IC50	nM	796.85	CHEMBL2148	Homo sapiens	IC50	nM	796.85
234407	16293892	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC(=O)NCC1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652293	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
216629	16294019	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1ccc(-c2cccc3nc(Nc4ccc(OCCN5CCCC5)cc4)nn23)cc1		CHEMBL3642307	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
234415	16294027	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCOCCO[C@@H]1CCN(S(=O)(=O)CC2CCC(N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3929066	=	IC50	nM	249.0	CHEMBL2148	Homo sapiens	IC50	nM	249.0
294002	16294063	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650985	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
234481	16294449	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@](CO)(CCO)C2)CC1		CHEMBL3652366	=	IC50	nM	612.0	CHEMBL2148	Homo sapiens	IC50	nM	612.0
294053	16294503	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OC)c23)ccc1F		CHEMBL3651034	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
226325	16294546	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	N#CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645540	=	IC50	nM	136.0	CHEMBL2148	Homo sapiens	IC50	nM	136.0
226347	16294814	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CC(=O)SCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648436	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
279123	16294956	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	COCC(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645119	=	Kd	nM	2.9	CHEMBL2148	Homo sapiens	Kd	nM	2.9
216662	16294975	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(Nc5cccnc5N(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642338	=	IC50	nM	1036.1	CHEMBL2148	Homo sapiens	IC50	nM	1036.1
294059	16295295	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)C4(C)CO4)c3)c12		CHEMBL3651042	=	IC50	nM	0.056	CHEMBL2148	Homo sapiens	IC50	nM	0.056
233734	16295395	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665214	=	IC50	nM	0.006755	CHEMBL2148	Homo sapiens	IC50	nM	0.006755
233722	16295637	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)C1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665203	=	IC50	nM	0.02582	CHEMBL2148	Homo sapiens	IC50	nM	0.02582
233631	16295749	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665124	=	IC50	nM	0.3128	CHEMBL2148	Homo sapiens	IC50	nM	0.312765
234433	16295786	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(C(C)(C)O)CC2)CC1		CHEMBL3652319	=	IC50	nM	397.0	CHEMBL2148	Homo sapiens	IC50	nM	397.0
233723	16295800	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(C#N)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665204	=	Ki	nM	0.08035	CHEMBL2148	Homo sapiens	Ki	nM	0.08035
216645	16295894	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)c2)CC1		CHEMBL3642321	=	IC50	nM	121.9	CHEMBL2148	Homo sapiens	IC50	nM	121.9
216790	16296085	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(O)cccn4n3)cc2)CC1		CHEMBL3644996	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
217553	16296111	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	Kd	nM	2.7	CHEMBL2148	Homo sapiens	Kd	nM	2.7
233629	16296141	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665122	=	Ki	nM	0.005369	CHEMBL2148	Homo sapiens	Ki	nM	0.005369
216770	16296212	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccc2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nn12		CHEMBL3644976	=	IC50	nM	342.23	CHEMBL2148	Homo sapiens	IC50	nM	342.23
216768	16296398	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccc2nc(Nc3ccc4c(c3)CCN(CCSC)CC4)nn12		CHEMBL3644974	=	IC50	nM	410.53	CHEMBL2148	Homo sapiens	IC50	nM	410.53
216806	16296466	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCC(c2ccc(Nc3nc4c(-c5cnn(-c6ccc(F)cc6)c5)cccn4n3)cc2)CC1		CHEMBL3645012	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216779	16296646	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCc2ccc(Nc3nc4c(-c5cccc6c5OC(F)(F)O6)cccn4n3)cc2CC1		CHEMBL3644985	=	IC50	nM	350.32	CHEMBL2148	Homo sapiens	IC50	nM	350.32
302604	16296752	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2(CC#N)COC2)C1		CHEMBL3655085	=	IC50	nM	8090.0	CHEMBL2148	Homo sapiens	IC50	nM	8090.0
216755	16297022	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cnn(C5CCNCC5)c4)nc23)cc1		CHEMBL3644961	=	IC50	nM	59.57	CHEMBL2148	Homo sapiens	IC50	nM	59.57
294011	16297317	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1C		CHEMBL3650994	=	IC50	nM	0.19	CHEMBL2148	Homo sapiens	IC50	nM	0.19
216671	16297427	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(CN5CCS(=O)(=O)CC5)c4)nc23)cc1		CHEMBL2062807	=	IC50	nM	38.78	CHEMBL2148	Homo sapiens	IC50	nM	38.78
216860	16297653	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	N#Cc1ccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)cc1		CHEMBL3645071	=	IC50	nM	249.4	CHEMBL2148	Homo sapiens	IC50	nM	249.4
216703	16298055	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCN(CCO)CC5)c4)nc23)cc1		CHEMBL3642375	=	IC50	nM	168.37	CHEMBL2148	Homo sapiens	IC50	nM	168.37
233719	16298285	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC[C@H](CO)Nc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1	Outside typical range	CHEMBL3335696	=	Ki	nM	0.00429	CHEMBL2148	Homo sapiens	Ki	nM	0.00429
234515	16298557	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@@H]1C[C@@H](CS(=O)(=O)N2CCC(CO)CC2)CC[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL3652399	=	IC50	nM	42.9	CHEMBL2148	Homo sapiens	IC50	nM	42.9
226351	16298600	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCC(O)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648440	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234485	16298614	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@](C)(O)C2)CC1		CHEMBL3652370	=	IC50	nM	322.0	CHEMBL2148	Homo sapiens	IC50	nM	322.0
216670	16298748	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ccc(-c2cccn3nc(Nc4ccc(CN5CCS(=O)(=O)CC5)cc4)nc23)cc1)S(C)(=O)=O		CHEMBL3642343	=	IC50	nM	11.01	CHEMBL2148	Homo sapiens	IC50	nM	11.01
234474	16298764	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](Oc3ccccc3C#N)C2)CC1		CHEMBL3652359	=	IC50	nM	413.0	CHEMBL2148	Homo sapiens	IC50	nM	413.0
302610	16298791	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@H](NS(=O)(=O)CC2CC2)C1		CHEMBL3655091	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
226341	16299002	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CBr)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648430	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
233626	16299199	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665119	=	Ki	nM	0.004294	CHEMBL2148	Homo sapiens	Ki	nM	0.004294
216716	16299415	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(Nc5ccccc5CS(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642386	=	IC50	nM	820.91	CHEMBL2148	Homo sapiens	IC50	nM	820.91
216871	16299468	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCc2ccc(Nc3nc4c(-c5cc(Cl)ccc5OCC(F)F)cccn4n3)cc2CC1		CHEMBL3645089	=	IC50	nM	1024.27	CHEMBL2148	Homo sapiens	IC50	nM	1024.27
216874	16299551	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1CNc1cccn2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc12		CHEMBL3645094	=	IC50	nM	154.54	CHEMBL2148	Homo sapiens	IC50	nM	154.54
293982	16299618	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(Cl)c3)c12		CHEMBL3703496	=	IC50	nM	8.4	CHEMBL2148	Homo sapiens	IC50	nM	8.4
233732	16299732	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665212	=	IC50	nM	0.04856	CHEMBL2148	Homo sapiens	IC50	nM	0.048555
233640	16299835	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665133	=	Ki	nM	0.09843	CHEMBL2148	Homo sapiens	Ki	nM	0.098432
302637	16299962	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CC(C)N1CCC(S(=O)(=O)C[C@H]2C[C@@H](N(C)c3ncnc4[nH]ccc34)C2)C1		CHEMBL3658866	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216677	16300036	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccccc1Nc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL3642349	=	IC50	nM	239.34	CHEMBL2148	Homo sapiens	IC50	nM	239.34
233688	16300245	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CC[C@@H](O)[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665175	=	IC50	nM	0.004205	CHEMBL2148	Homo sapiens	IC50	nM	0.004205
233734	16300397	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665214	=	Ki	nM	0.00337	CHEMBL2148	Homo sapiens	Ki	nM	0.00337
302638	16300577	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2ccc(F)c(Cl)c2)C1		CHEMBL3658867	=	IC50	nM	3190.0	CHEMBL2148	Homo sapiens	IC50	nM	3190.0
216667	16300662	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(Cc2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062806	=	IC50	nM	149.68	CHEMBL2148	Homo sapiens	IC50	nM	149.68
234409	16300673	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](O)[C@H](O)C2)CC1		CHEMBL3652295	=	IC50	nM	138.0	CHEMBL2148	Homo sapiens	IC50	nM	138.0
233740	16300740	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCC1(N2CCC[C@H](Nc3ncccc3-c3cnc4[nH]ccc4n3)C2)COC1		CHEMBL3665220	=	IC50	nM	0.09996	CHEMBL2148	Homo sapiens	IC50	nM	0.09996
216842	16300766	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCNC4)nc12		CHEMBL3645054	=	IC50	nM	674.98	CHEMBL2148	Homo sapiens	IC50	nM	674.98
234461	16300823	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](NC(=O)C(F)(F)F)C2)CC1		CHEMBL3652346	=	IC50	nM	399.0	CHEMBL2148	Homo sapiens	IC50	nM	399.0
234519	16300906	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@@H](OC(=O)C(C)(C)C)C2)CC1		CHEMBL3652403	=	IC50	nM	3.89	CHEMBL2148	Homo sapiens	IC50	nM	3.89
226331	16301049	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C1CC1		CHEMBL3645544	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216725	16301228	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(Nc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642395	=	IC50	nM	679.34	CHEMBL2148	Homo sapiens	IC50	nM	679.34
216613	16301232	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5cccc(S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642293	=	IC50	nM	89.4	CHEMBL2148	Homo sapiens	IC50	nM	89.4
217549	16301384	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	NC(=O)c1cnc(Nc2ccc(N3CCC[C@@H](C(N)=O)C3)cc2)nc1NC1CC1		CHEMBL3645122	=	Kd	nM	4.1	CHEMBL2148	Homo sapiens	Kd	nM	4.1
233648	16301426	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(S(C)(=O)=O)C1		CHEMBL3665141	=	IC50	nM	0.03714	CHEMBL2148	Homo sapiens	IC50	nM	0.03714
216792	16301591	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(OCc5ccccc5C(N)=O)cccn4n3)c2)CC1		CHEMBL3644998	=	IC50	nM	2359.82	CHEMBL2148	Homo sapiens	IC50	nM	2359.82
294066	16301916	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ccc(C)cc4)c23)c1		CHEMBL3651049	=	IC50	nM	5.4	CHEMBL2148	Homo sapiens	IC50	nM	5.4
216859	16301920	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCC(c2ccc(Nc3nc4c(-c5ccc(C#N)cc5)cccn4n3)cc2)CC1		CHEMBL3645070	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
234459	16301971	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COC[C@@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652344	=	IC50	nM	138.0	CHEMBL2148	Homo sapiens	IC50	nM	138.0
216766	16302264	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COCc1ccccc1-c1cccc2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nn12		CHEMBL3644972	=	IC50	nM	133.32	CHEMBL2148	Homo sapiens	IC50	nM	133.32
216589	16302303	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062804	=	IC50	nM	84.7	CHEMBL2148	Homo sapiens	IC50	nM	84.7
294047	16302337	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/c4nccs4)c3)c12		CHEMBL3651028	=	IC50	nM	3.9	CHEMBL2148	Homo sapiens	IC50	nM	3.9
221728	16302348	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCOCC4)cc3)n2n1)C1CC1		CHEMBL3360353	=	IC50	nM	2843.0	CHEMBL2148	Homo sapiens	IC50	nM	2843.0
233660	16302361	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(=O)(=O)CC(C)(C)C)C2)n1		CHEMBL3665150	=	IC50	nM	0.01676	CHEMBL2148	Homo sapiens	IC50	nM	0.016765
198766	16302604	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ncco4)c23)c1		CHEMBL3651062	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
216648	16302679	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)n3n2)cc1		CHEMBL3642324	=	IC50	nM	25.3	CHEMBL2148	Homo sapiens	IC50	nM	25.3
216583	16302753	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1cccc(-c2cccn3nc(Nc4cccc(N5CCOCC5)c4)nc23)c1		CHEMBL3642270	=	IC50	nM	183.0	CHEMBL2148	Homo sapiens	IC50	nM	183.0
234437	16302942	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652323	=	IC50	nM	781.0	CHEMBL2148	Homo sapiens	IC50	nM	781.0
302608	16303024	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cc(C#N)ccn2)C1		CHEMBL3655089	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
255703	16303027	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cc(ccc1Br)OCCCc1cccc(c1)N2		CHEMBL3694590	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	nM	57.0
216850	16303087	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5ccc(F)cc5)cccn4n3)cc2)CC1		CHEMBL3645061	=	IC50	nM	254.31	CHEMBL2148	Homo sapiens	IC50	nM	254.31
233637	16303251	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665130	=	Ki	nM	0.02529	CHEMBL2148	Homo sapiens	Ki	nM	0.025293
216591	16303490	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4ccc(-c5ccc(S(C)(=O)=O)cc5)cn4n3)cc2)CC1		CHEMBL3642276	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233639	16303659	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665132	=	IC50	nM	0.7792	CHEMBL2148	Homo sapiens	IC50	nM	0.779215
233641	16303824	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665134	=	IC50	nM	0.542	CHEMBL2148	Homo sapiens	IC50	nM	0.542035
255708	16304141	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	N#Cc1ccccc1S(=O)(=O)Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2		CHEMBL3694595	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
294067	16304310	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4ccccc4)c23)c1		CHEMBL3651050	=	IC50	nM	0.016	CHEMBL2148	Homo sapiens	IC50	nM	0.016
216712	16304554	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5cccc(S(C)(=O)=O)c5)cccn4n3)c2)CC1		CHEMBL3642383	=	IC50	nM	6499.0	CHEMBL2148	Homo sapiens	IC50	nM	6499.0
216646	16304565	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(Nc2nc3cccc(-c4ccc(S(C)(=O)=O)cc4)n3n2)cc1		CHEMBL3642322	=	IC50	nM	69.9	CHEMBL2148	Homo sapiens	IC50	nM	69.9
233692	16304609	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335693	=	Ki	nM	0.01878	CHEMBL2148	Homo sapiens	Ki	nM	0.01878
216756	16304783	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(Oc5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3644962	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216809	16305041	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5cnn(-c6ccc(F)cc6)c5)cccn4n3)cc2)CC1		CHEMBL3645015	=	IC50	nM	46.05	CHEMBL2148	Homo sapiens	IC50	nM	46.05
234416	16305064	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@@H](O)[C@H](c3ccccc3)C2)CC1		CHEMBL3652302	=	IC50	nM	151.0	CHEMBL2148	Homo sapiens	IC50	nM	151.0
216609	16305128	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1-c1cccn2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc12		CHEMBL3642291	=	IC50	nM	100.5	CHEMBL2148	Homo sapiens	IC50	nM	100.5
234414	16305160	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCN[C@@H](C)[C@@H]1CCN(S(=O)(=O)CC2CCC(N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3969771	=	IC50	nM	1190.0	CHEMBL2148	Homo sapiens	IC50	nM	1190.0
234463	16305250	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(C)C(=O)CO[C@@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652348	=	IC50	nM	644.0	CHEMBL2148	Homo sapiens	IC50	nM	644.0
216702	16305280	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5cccnc5)cccn4n3)cc2)CC1		CHEMBL3642374	=	IC50	nM	4197.95	CHEMBL2148	Homo sapiens	IC50	nM	4197.95
302640	16305292	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	Cc1ncc(S(=O)(=O)N[C@H]2C[C@@H](N(C)c3ncnc4[nH]ccc34)C2)s1		CHEMBL3658869	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
294017	16305454	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(F)cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650999	=	IC50	nM	0.05	CHEMBL2148	Homo sapiens	IC50	nM	0.05
234440	16305468	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CNC(=O)C1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652326	=	IC50	nM	377.0	CHEMBL2148	Homo sapiens	IC50	nM	377.0
216572	16305503	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(N5CCCCC5)cc4)nc23)cc1		CHEMBL3642262	=	IC50	nM	26.8	CHEMBL2148	Homo sapiens	IC50	nM	26.8
226345	16305532	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CC(=O)OCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1	Outside typical range	CHEMBL3648434	=	IC50	nM	150000.0	CHEMBL2148	Homo sapiens	IC50	nM	150000.0
294016	16305927	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1ccc(F)c(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650998	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
294040	16306046	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(F)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1F		CHEMBL3651021	=	IC50	nM	0.013	CHEMBL2148	Homo sapiens	IC50	nM	0.013
216695	16306150	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(O)CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642367	=	IC50	nM	110.46	CHEMBL2148	Homo sapiens	IC50	nM	110.46
233716	16306215	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NCCN)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665198	=	IC50	nM	0.05038	CHEMBL2148	Homo sapiens	IC50	nM	0.050375
234390	16306248	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCOC1CCCN(S(=O)(=O)CC2CCC(N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652277	=	IC50	nM	31.7	CHEMBL2148	Homo sapiens	IC50	nM	31.7
234393	16306477	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(C(F)(F)F)C2)CC1		CHEMBL3652280	=	IC50	nM	604.0	CHEMBL2148	Homo sapiens	IC50	nM	604.0
216867	16306481	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5cccc(N(C)C)c5)cccn4n3)cc2)CC1		CHEMBL3645078	=	IC50	nM	89.07	CHEMBL2148	Homo sapiens	IC50	nM	89.07
234445	16306610	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](C(N)=O)C2)CC1		CHEMBL3652330	=	IC50	nM	222.0	CHEMBL2148	Homo sapiens	IC50	nM	222.0
216620	16306687	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccccc5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642298	=	IC50	nM	6499.0	CHEMBL2148	Homo sapiens	IC50	nM	6499.0
233637	16306703	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665130	=	IC50	nM	0.04931	CHEMBL2148	Homo sapiens	IC50	nM	0.049305
233719	16306773	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC[C@H](CO)Nc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1	Outside typical range	CHEMBL3335696	=	IC50	nM	0.00858	CHEMBL2148	Homo sapiens	IC50	nM	0.00858
233653	16306781	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335689	=	Ki	nM	0.01046	CHEMBL2148	Homo sapiens	Ki	nM	0.010455
216617	16306984	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(N(C)S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642296	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	nM	26.0
216747	16307035	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(P(C)(C)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062813	=	IC50	nM	191.96	CHEMBL2148	Homo sapiens	IC50	nM	191.96
255690	16307036	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694577	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
294046	16307148	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)C4=CC(=O)CC4)c3)c12		CHEMBL3651027	=	IC50	nM	0.14	CHEMBL2148	Homo sapiens	IC50	nM	0.14
234395	16307180	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(CN3CCCC3)C2)CC1		CHEMBL3652282	=	IC50	nM	3280.0	CHEMBL2148	Homo sapiens	IC50	nM	3280.0
216764	16307230	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COCc1ccccc1-c1cccc2nc(Nc3ccc4c(c3)CCNCC4)nn12		CHEMBL3644970	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216824	16307399	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645036	=	IC50	nM	1114.57	CHEMBL2148	Homo sapiens	IC50	nM	1114.57
216615	16307409	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL2062809	=	IC50	nM	52.1	CHEMBL2148	Homo sapiens	IC50	nM	52.1
216830	16307413	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(Cl)ccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645042	=	IC50	nM	31.82	CHEMBL2148	Homo sapiens	IC50	nM	31.82
234431	16307453	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COCCC1(C(N)=O)CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652317	=	IC50	nM	39.6	CHEMBL2148	Homo sapiens	IC50	nM	39.6
216635	16307482	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4cccc(-c5cccc(S(C)(=O)=O)c5)n4n3)cc2)CC1		CHEMBL2414545	=	IC50	nM	137.9	CHEMBL2148	Homo sapiens	IC50	nM	137.9
216632	16307554	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(Nc2nc3cccc(-c4cccc(S(C)(=O)=O)c4)n3n2)c1		CHEMBL3642310	=	IC50	nM	197.0	CHEMBL2148	Homo sapiens	IC50	nM	197.0
216647	16307777	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4cccc(S(C)(=O)=O)c4)nn23)cc1		CHEMBL3642323	=	IC50	nM	718.9	CHEMBL2148	Homo sapiens	IC50	nM	718.9
216782	16307810	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3cccc(C4CCN(C(=O)OC(C)(C)C)CC4)c3)nc12		CHEMBL3644988	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
293999	16308199	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(N4CCS(=O)(=O)CC4)cc3)c12		CHEMBL3650983	=	IC50	nM	6.8	CHEMBL2148	Homo sapiens	IC50	nM	6.8
233654	16308272	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665145	=	IC50	nM	0.06075	CHEMBL2148	Homo sapiens	IC50	nM	0.060745
234479	16308288	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](c3ccccc3F)C2)CC1		CHEMBL3652364	=	IC50	nM	286.0	CHEMBL2148	Homo sapiens	IC50	nM	286.0
216576	16308372	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1Nc1nc2c(-c3ccccc3)cccn2n1		CHEMBL3642265	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216844	16308401	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(C(F)F)ccc1-c1cccn2nc(Nc3ccc(C4CCN(C(=O)OC(C)(C)C)CC4)cc3)nc12		CHEMBL3639439	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
302617	16308622	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@@H](C#N)C2)C1		CHEMBL3655098	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
226353	16308760	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	NS(=O)(=O)CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648442	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233661	16309049	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)CC1		CHEMBL3665151	=	IC50	nM	0.03938	CHEMBL2148	Homo sapiens	IC50	nM	0.03938
234430	16309096	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCC1(C(N)=O)CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652316	=	IC50	nM	353.0	CHEMBL2148	Homo sapiens	IC50	nM	353.0
216776	16309135	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nc12		CHEMBL3644982	=	IC50	nM	249.52	CHEMBL2148	Homo sapiens	IC50	nM	249.52
216875	16309318	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3cccc(C4CCN(CC(=O)N(C)C)CC4)c3)nc12		CHEMBL3645117	=	IC50	nM	1118.93	CHEMBL2148	Homo sapiens	IC50	nM	1118.93
216780	16309321	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc12		CHEMBL3644986	=	IC50	nM	420.74	CHEMBL2148	Homo sapiens	IC50	nM	420.74
294050	16309468	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(Nc4nc(Cl)ns4)c3)c12		CHEMBL3651031	=	IC50	nM	9.2	CHEMBL2148	Homo sapiens	IC50	nM	9.2
234518	16309502	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@@H]1C[C@@H](CS(=O)(=O)N2CC[C@H](CO)C2)CC[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL3652402	=	IC50	nM	0.0421	CHEMBL2148	Homo sapiens	IC50	nM	0.0421
216592	16309928	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(Nc4ccc(S(C)(=O)=O)cc4)cccn3n2)cc1		CHEMBL3642277	=	IC50	nM	6499.0	CHEMBL2148	Homo sapiens	IC50	nM	6499.0
293991	16310059	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cc4ccccc4s3)c12		CHEMBL3703505	=	IC50	nM	4.8	CHEMBL2148	Homo sapiens	IC50	nM	4.8
234439	16310372	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC[C@H](O)C1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652325	=	IC50	nM	673.0	CHEMBL2148	Homo sapiens	IC50	nM	673.0
216759	16310385	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(Oc2cccn3nc(Nc4cnn(CCN5CCCC5)c4)nc23)cc1		CHEMBL3644965	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
294010	16310393	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1C		CHEMBL3650993	=	IC50	nM	0.033	CHEMBL2148	Homo sapiens	IC50	nM	0.033
216738	16310405	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCN(CCCF)CC5)c4)nc23)cc1		CHEMBL3642408	=	IC50	nM	164.57	CHEMBL2148	Homo sapiens	IC50	nM	164.57
294060	16310537	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cccc(C)c4)c23)c1		CHEMBL3651043	=	IC50	nM	0.17	CHEMBL2148	Homo sapiens	IC50	nM	0.17
217546	16310614	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	COCC(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645119	=	Kd	nM	2.9	CHEMBL2148	Homo sapiens	Kd	nM	2.9
216841	16310709	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(C(=O)OC(C)(C)C)C4)nc12		CHEMBL3645053	=	IC50	nM	6499.0	CHEMBL2148	Homo sapiens	IC50	nM	6499.0
216651	16311229	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	NC1CCN(c2nc3c(NCc4cccnc4)cccn3n2)CC1		CHEMBL3642327	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216788	16311433	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(OCc5ccccc5C#N)cccn4n3)cc2)CC1		CHEMBL3644994	=	IC50	nM	323.81	CHEMBL2148	Homo sapiens	IC50	nM	323.81
233636	16311470	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665129	=	Ki	nM	0.05509	CHEMBL2148	Homo sapiens	Ki	nM	0.05509
294043	16311895	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/c4ccncc4)c3)c12		CHEMBL3651024	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
226323	16312044	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL1446198	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
233652	16312319	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)S(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665144	=	IC50	nM	0.02957	CHEMBL2148	Homo sapiens	IC50	nM	0.02957
255704	16312327	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cc(ccc1-c1ccccc1)OCCCc1cccc(c1)N2		CHEMBL3694591	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
217548	16312345	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	Kd	nM	2.7	CHEMBL2148	Homo sapiens	Kd	nM	2.7
234418	16312458	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](CO)C2)CC1		CHEMBL3652304	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
216658	16312668	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4cncc(-c5ccc(S(C)(=O)=O)cc5)n4n3)c2)CC1		CHEMBL3642334	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233687	16312675	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(Cl)c3n2)C1	Outside typical range	CHEMBL3665174	=	Ki	nM	0.00386	CHEMBL2148	Homo sapiens	Ki	nM	0.00386
226336	16312712	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CCCl)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645548	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
216624	16312720	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4cccc(-c5ccc(CN6CCS(=O)(=O)CC6)cc5)n4n3)cc2)CC1		CHEMBL3642302	=	IC50	nM	14.7	CHEMBL2148	Homo sapiens	IC50	nM	14.7
216564	16312737	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1cncc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)c1		CHEMBL3642254	=	IC50	nM	1223.2	CHEMBL2148	Homo sapiens	IC50	nM	1223.2
233634	16312848	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665127	=	Ki	nM	0.1128	CHEMBL2148	Homo sapiens	Ki	nM	0.112752
216828	16312888	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645040	=	IC50	nM	150.09	CHEMBL2148	Homo sapiens	IC50	nM	150.09
233720	16312956	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCC(Nc2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665201	=	Ki	nM	0.01253	CHEMBL2148	Homo sapiens	Ki	nM	0.01253
233743	16313074	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCC(N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1)C(F)(F)F		CHEMBL3665223	=	Ki	nM	0.1611	CHEMBL2148	Homo sapiens	Ki	nM	0.1611
279120	16313171	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	CNC(=O)[C@H]1CCCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)C1		CHEMBL3645120	=	Kd	nM	3.0	CHEMBL2148	Homo sapiens	Kd	nM	3.0
302626	16313245	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@H](NS(=O)(=O)N2CCC(C#N)C2)C1		CHEMBL3658855	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216580	16313351	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(OCCN5CCOCC5)cc4)nc23)cc1		CHEMBL3642268	=	IC50	nM	38.5	CHEMBL2148	Homo sapiens	IC50	nM	38.5
216835	16313650	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(Cl)ccc1-c1cccn2nc(Nc3ccc(C4CCN(CC(=O)N(C)C)CC4)cc3)nc12		CHEMBL3645047	=	IC50	nM	104.39	CHEMBL2148	Homo sapiens	IC50	nM	104.39
216679	16313808	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1cccc(-c2cccn3nc(Nc4ccc(OCCN5CCCC5)cc4)nc23)c1)S(C)(=O)=O		CHEMBL3642351	=	IC50	nM	320.76	CHEMBL2148	Homo sapiens	IC50	nM	320.76
293977	16313847	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(Cl)c(N)c3)c12		CHEMBL3703491	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
233669	16313905	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665156	=	IC50	nM	0.2484	CHEMBL2148	Homo sapiens	IC50	nM	0.248435
293984	16313964	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccccc3F)c12		CHEMBL3703498	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
216840	16314083	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCN(CC(=O)N(C)C)CC4)cc3)nc12		CHEMBL3645052	=	IC50	nM	415.06	CHEMBL2148	Homo sapiens	IC50	nM	415.06
234408	16314109	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(Cc3ccccn3)C2)CC1		CHEMBL3652294	=	IC50	nM	592.0	CHEMBL2148	Homo sapiens	IC50	nM	592.0
216631	16314123	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1cccc(-c2cccc3nc(Nc4ccc(N5CCOCC5)cc4)nn23)c1		CHEMBL3642309	=	IC50	nM	52.6	CHEMBL2148	Homo sapiens	IC50	nM	52.6
233635	16314249	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665128	=	IC50	nM	0.01794	CHEMBL2148	Homo sapiens	IC50	nM	0.01794
216848	16314337	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Fc1ccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)cc1		CHEMBL3645059	=	IC50	nM	252.09	CHEMBL2148	Homo sapiens	IC50	nM	252.09
216744	16314471	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1Cc2ccc(Nc3nc4c(C#Cc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2C1		CHEMBL3642414	=	IC50	nM	398.3	CHEMBL2148	Homo sapiens	IC50	nM	398.3
294036	16314479	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(Br)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651017	=	IC50	nM	0.043	CHEMBL2148	Homo sapiens	IC50	nM	0.043
233710	16314683	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COCCNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665193	=	IC50	nM	0.01071	CHEMBL2148	Homo sapiens	IC50	nM	0.01071
233681	16314735	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665168	=	Ki	nM	0.5656	CHEMBL2148	Homo sapiens	Ki	nM	0.56561
216568	16314768	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4ccc(N5CCOCC5)cc4)nn23)cc1		CHEMBL3642258	=	IC50	nM	17.7	CHEMBL2148	Homo sapiens	IC50	nM	17.7
234413	16314948	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](NC(=O)OC(C)(C)C)C2)CC1		CHEMBL3652299	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
216807	16315052	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(=O)Nc1ccc(Sc2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)cc1		CHEMBL3645013	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216772	16315095	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(C(=O)OC(C)(C)C)CC4)nc12		CHEMBL3644978	=	IC50	nM	2388.36	CHEMBL2148	Homo sapiens	IC50	nM	2388.36
255706	16315124	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2		CHEMBL3694593	=	IC50	nM	114.0	CHEMBL2148	Homo sapiens	IC50	nM	114.0
216688	16315154	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nc2c(NCc3cccnc3N(C)S(C)(=O)=O)cccn2n1		CHEMBL3642360	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233688	16315250	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CC[C@@H](O)[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665175	=	Ki	nM	0.0021	CHEMBL2148	Homo sapiens	Ki	nM	0.0021
233702	16315447	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)c1ncc(-c2cnc3[nH]cc(C#N)c3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665187	=	Ki	nM	0.2242	CHEMBL2148	Homo sapiens	Ki	nM	0.22419
233635	16315492	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665128	=	Ki	nM	0.009203	CHEMBL2148	Homo sapiens	Ki	nM	0.009203
294054	16315532	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OC)c23)c1		CHEMBL3651035	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
233738	16315746	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1C[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1		CHEMBL3665218	=	IC50	nM	0.391	CHEMBL2148	Homo sapiens	IC50	nM	0.39098
294075	16315769	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	COc1ccccc1-c1c[nH]c2ncnc(-c3ccc4cn(C)nc4c3)c12		CHEMBL3651058	=	IC50	nM	6.9	CHEMBL2148	Homo sapiens	IC50	nM	6.9
294033	16315860	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(F)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651015	=	IC50	nM	0.024	CHEMBL2148	Homo sapiens	IC50	nM	0.024
293990	16316012	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4c(c3)OCO4)c12		CHEMBL3703504	=	IC50	nM	3.8	CHEMBL2148	Homo sapiens	IC50	nM	3.8
234420	16316125	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@H]1CN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C[C@H]1S(C)(=O)=O		CHEMBL3652306	=	IC50	nM	275.0	CHEMBL2148	Homo sapiens	IC50	nM	275.0
216701	16316199	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ccccc1CNc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642373	=	IC50	nM	345.16	CHEMBL2148	Homo sapiens	IC50	nM	345.16
255692	16316322	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	O=S1(=O)Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2		CHEMBL3694579	=	IC50	nM	325.0	CHEMBL2148	Homo sapiens	IC50	nM	325.0
233716	16316719	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NCCN)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665198	=	Ki	nM	0.02518	CHEMBL2148	Homo sapiens	Ki	nM	0.02518
234403	16316897	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(C(=O)O)C2)CC1		CHEMBL3652289	=	IC50	nM	74.3	CHEMBL2148	Homo sapiens	IC50	nM	74.3
233686	16316934	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(C4CC4)c3n2)C1		CHEMBL3665173	=	IC50	nM	0.0215	CHEMBL2148	Homo sapiens	IC50	nM	0.021495
234476	16317005	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@](O)(Cn3cccn3)C2)CC1		CHEMBL3652361	=	IC50	nM	82.3	CHEMBL2148	Homo sapiens	IC50	nM	82.3
216663	16317154	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)cc1		CHEMBL2062801	=	IC50	nM	81.28	CHEMBL2148	Homo sapiens	IC50	nM	81.28
216735	16317172	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(C5CCN(CC(N)=O)CC5)c4)nc23)cc1		CHEMBL3642405	=	IC50	nM	20.2	CHEMBL2148	Homo sapiens	IC50	nM	20.2
216711	16317247	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5cccc(S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3639412	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
216582	16317462	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC1(C)CCC(C)(C)c2cc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)ccc21		CHEMBL3642269	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216743	16317504	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(C#Cc5ccccc5N(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642413	=	IC50	nM	548.03	CHEMBL2148	Homo sapiens	IC50	nM	548.03
233707	16317562	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2[nH]c(=O)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335695	=	IC50	nM	0.01721	CHEMBL2148	Homo sapiens	IC50	nM	0.01721
216751	16317665	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCn1cc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)cn1		CHEMBL3644957	=	IC50	nM	99.92	CHEMBL2148	Homo sapiens	IC50	nM	99.92
294028	16317803	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1O		CHEMBL3651010	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
279124	16317815	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	Kd	nM	2.7	CHEMBL2148	Homo sapiens	Kd	nM	2.7
233684	16317992	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(C#N)c3n2)C1		CHEMBL3665171	=	IC50	nM	0.01735	CHEMBL2148	Homo sapiens	IC50	nM	0.01735
233678	16318021	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665165	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
302607	16318050	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@](C)(CC#N)C2)C1		CHEMBL3655088	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216829	16318051	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(F)ccc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645041	=	IC50	nM	292.28	CHEMBL2148	Homo sapiens	IC50	nM	292.28
217559	16318152	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	NC(=O)c1cnc(Nc2ccc(N3CCC[C@@H](C(N)=O)C3)cc2)nc1NC1CC1		CHEMBL3645122	=	Kd	nM	4.1	CHEMBL2148	Homo sapiens	Kd	nM	4.1
191788	16318168	CHEMBL3705679	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ulÂ prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK1 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ulÂ of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, MA) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assays was: ATP, 100 uM; fluoresceinated peptide.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(NS(C)(=O)=O)cc23)CC[C@@]1(C)O		CHEMBL3671832	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
233735	16318253	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665215	=	IC50	nM	0.005185	CHEMBL2148	Homo sapiens	IC50	nM	0.005185
234502	16318597	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(S(=O)(=O)CC3CC3)C2)CC1		CHEMBL3652386	=	IC50	nM	298.0	CHEMBL2148	Homo sapiens	IC50	nM	298.0
233689	16318825	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@@H](O)[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665176	=	IC50	nM	0.007615	CHEMBL2148	Homo sapiens	IC50	nM	0.007615
233664	16319020	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]cc(Cl)c3n2)c(NC2CCCN(S(=O)(=O)CC3CC3)C2)n1		CHEMBL3665153	=	Ki	nM	0.01754	CHEMBL2148	Homo sapiens	Ki	nM	0.01754
216668	16319216	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccc3nc(Nc4cccc(CN5CCOCC5)c4)nn23)cc1		CHEMBL3642341	=	IC50	nM	52.26	CHEMBL2148	Homo sapiens	IC50	nM	52.26
216590	16319243	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2ccc3nc(Nc4ccc(N5CCOCC5)cc4)nn3c2)cc1		CHEMBL3642275	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216720	16319314	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5cccc(N(C)S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642390	=	IC50	nM	3238.72	CHEMBL2148	Homo sapiens	IC50	nM	3238.72
233710	16319317	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COCCNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1	Outside typical range	CHEMBL3665193	=	Ki	nM	0.00535	CHEMBL2148	Homo sapiens	Ki	nM	0.00535
216614	16319353	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5cccc(S(C)(=O)=O)c5)cccn4n3)c2)CC1		CHEMBL3642294	=	IC50	nM	206.7	CHEMBL2148	Homo sapiens	IC50	nM	206.7
216870	16319618	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCc2ccc(Nc3nc4c(-c5ccccc5OCC(F)F)cccn4n3)cc2CC1		CHEMBL3645080	=	IC50	nM	1094.94	CHEMBL2148	Homo sapiens	IC50	nM	1094.94
226329	16319651	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)c1ccco1		CHEMBL1572928	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
234505	16319808	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1ccc(N2CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)CC2)nc1C		CHEMBL3652389	=	IC50	nM	88.9	CHEMBL2148	Homo sapiens	IC50	nM	88.9
233729	16319982	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCC(CC(=O)O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665209	=	IC50	nM	0.02336	CHEMBL2148	Homo sapiens	IC50	nM	0.023355
234510	16320022	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCSC2)CC1		CHEMBL3652394	=	IC50	nM	122.0	CHEMBL2148	Homo sapiens	IC50	nM	122.0
216623	16320113	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccccc1Nc1nc2c(Nc3ccccc3S(C)(=O)=O)cccn2n1		CHEMBL3642301	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
294057	16320249	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(CF)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651040	=	IC50	nM	0.024	CHEMBL2148	Homo sapiens	IC50	nM	0.024
293983	16320465	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4ccccc4c3)c12		CHEMBL3703497	=	IC50	nM	8.8	CHEMBL2148	Homo sapiens	IC50	nM	8.8
294064	16320681	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cccc(F)c4Cl)c23)c1		CHEMBL3651047	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
302599	16320703	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC(F)(F)F)C1		CHEMBL3655080	>	IC50	nM	9220.0	CHEMBL2148	Homo sapiens	IC50	nM	9220.0
226321	16320767	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCN(c2ccc(Cl)cc2)CC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645537	=	IC50	nM	2700.0	CHEMBL2148	Homo sapiens	IC50	nM	2700.0
233663	16320807	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]cc(Cl)c3n2)C1		CHEMBL3639640	=	IC50	nM	0.06878	CHEMBL2148	Homo sapiens	IC50	nM	0.06878
216634	16321262	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)cc2)CC1		CHEMBL2414547	=	IC50	nM	99.2	CHEMBL2148	Homo sapiens	IC50	nM	99.2
216719	16321401	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1Cc2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2C1		CHEMBL3642389	=	IC50	nM	77.56	CHEMBL2148	Homo sapiens	IC50	nM	77.56
233689	16321435	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CC[C@@H](O)[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665176	=	Ki	nM	0.0038	CHEMBL2148	Homo sapiens	Ki	nM	0.0038
233685	16321456	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1c[nH]c2ncc(-c3cccnc3N[C@H]3CCCN(S(C)(=O)=O)C3)nc12		CHEMBL3665172	=	IC50	nM	0.01175	CHEMBL2148	Homo sapiens	IC50	nM	0.011745
198772	16321488	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cnco4)c23)c1		CHEMBL3651065	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
234394	16322086	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(OCC(N)=O)C2)CC1		CHEMBL3652281	=	IC50	nM	173.0	CHEMBL2148	Homo sapiens	IC50	nM	173.0
216813	16322251	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cc1ccc(-n2cc(-c3cccn4nc(Nc5ccc(C6CCN(C(=O)OC(C)(C)C)CC6)cc5)nc34)cn2)cc1		CHEMBL3645019	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
302639	16322284	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2cc(C#N)ccn2)C1		CHEMBL3658868	>	IC50	nM	8880.0	CHEMBL2148	Homo sapiens	IC50	nM	8880.0
255697	16322392	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694584	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	nM	300.0
302622	16322423	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CCC(c3cc[nH]n3)CC2)C1		CHEMBL3655103	=	IC50	nM	3120.0	CHEMBL2148	Homo sapiens	IC50	nM	3120.0
293975	16322474	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc(C)c(N)c3)c12		CHEMBL3703489	=	IC50	nM	4.6	CHEMBL2148	Homo sapiens	IC50	nM	4.6
294055	16322491	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)N(C)c1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651036	=	IC50	nM	0.13	CHEMBL2148	Homo sapiens	IC50	nM	0.13
216710	16322936	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(NCc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642382	=	IC50	nM	1445.13	CHEMBL2148	Homo sapiens	IC50	nM	1445.13
216633	16323012	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1Nc1nc2cccc(-c3cccc(S(C)(=O)=O)c3)n2n1		CHEMBL3642311	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216674	16323139	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(NCc5cccnc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642346	=	IC50	nM	835.51	CHEMBL2148	Homo sapiens	IC50	nM	835.51
233729	16323219	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCC(CC(=O)O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665209	=	Ki	nM	0.01167	CHEMBL2148	Homo sapiens	Ki	nM	0.01167
233666	16323413	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335691	=	IC50	nM	0.00149	CHEMBL2148	Homo sapiens	IC50	nM	0.00149
233725	16323483	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC[C@@H](O)C3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335697	=	IC50	nM	0.01512	CHEMBL2148	Homo sapiens	IC50	nM	0.01512
216682	16323487	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(Nc5cccnc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642354	=	IC50	nM	78.92	CHEMBL2148	Homo sapiens	IC50	nM	78.92
233671	16323494	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665158	=	Ki	nM	0.1491	CHEMBL2148	Homo sapiens	Ki	nM	0.14908
216581	16323613	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCOCC5)c4)nc23)cc1		CHEMBL2062802	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
293995	16324205	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4[nH]ncc4c3)c12		CHEMBL3650979	=	IC50	nM	6.5	CHEMBL2148	Homo sapiens	IC50	nM	6.5
216565	16324225	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(-c2cccn3nc(Nc4ccc(N5CCOCC5)cc4)nc23)cn1		CHEMBL3642255	=	IC50	nM	517.9	CHEMBL2148	Homo sapiens	IC50	nM	517.9
233735	16324271	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665215	=	Ki	nM	0.01631	CHEMBL2148	Homo sapiens	Ki	nM	0.01631
293988	16324485	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(C)c3)c12		CHEMBL3703502	=	IC50	nM	7.6	CHEMBL2148	Homo sapiens	IC50	nM	7.6
216612	16324488	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(C2CCN(c3cccc(Nc4nc5c(-c6ccc(S(C)(=O)=O)cc6)cccn5n4)c3)CC2)CC1		CHEMBL2062529	=	IC50	nM	81.3	CHEMBL2148	Homo sapiens	IC50	nM	81.3
226334	16324545	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CN1CCN(CC(=O)Nc2cccc(-c3cnc4ccccc4n3)c2)CC1		CHEMBL3645546	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
234389	16324599	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)C1CCC(CS(=O)(=O)N2CCC(CO)CC2)CC1		CHEMBL3916507	=	IC50	nM	453.0	CHEMBL2148	Homo sapiens	IC50	nM	453.0
216669	16324687	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(Cc2cccc(Nc3nc4cccc(-c5ccc(S(C)(=O)=O)cc5)n4n3)c2)CC1		CHEMBL3642342	=	IC50	nM	66.86	CHEMBL2148	Homo sapiens	IC50	nM	66.86
234525	16324689	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCOP(=O)(OCC)O[C@@H]1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652409	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
302630	16324804	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@H](C#N)C2)C1		CHEMBL3658859	>	IC50	nM	9930.0	CHEMBL2148	Homo sapiens	IC50	nM	9930.0
233698	16324864	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCOCC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665184	=	Ki	nM	0.00525	CHEMBL2148	Homo sapiens	Ki	nM	0.00525
233727	16325145	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(NC3CCC(C#N)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665207	=	Ki	nM	0.00679	CHEMBL2148	Homo sapiens	Ki	nM	0.00679
233701	16325161	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335694	=	IC50	nM	0.01787	CHEMBL2148	Homo sapiens	IC50	nM	0.017875
233701	16325337	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335694	=	Ki	nM	0.00893	CHEMBL2148	Homo sapiens	Ki	nM	0.00893
216569	16325375	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1cccc(-c2cccn3nc(Nc4ccc(OCCN5CCCC5)cc4)nc23)c1		CHEMBL3642259	=	IC50	nM	111.5	CHEMBL2148	Homo sapiens	IC50	nM	111.5
294029	16325400	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)cnc1OC		CHEMBL3651011	=	IC50	nM	0.68	CHEMBL2148	Homo sapiens	IC50	nM	0.68
233628	16325509	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665121	=	IC50	nM	0.336	CHEMBL2148	Homo sapiens	IC50	nM	0.335955
234424	16325581	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC1CN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CCN1C		CHEMBL3652310	=	IC50	nM	1920.0	CHEMBL2148	Homo sapiens	IC50	nM	1920.0
216804	16325720	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCNCC4)cc3)nc12		CHEMBL3645010	=	IC50	nM	574.34	CHEMBL2148	Homo sapiens	IC50	nM	574.34
216585	16325749	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(N4CCS(=O)(=O)CC4)cccn3n2)cc1		CHEMBL3642272	=	IC50	nM	6499.0	CHEMBL2148	Homo sapiens	IC50	nM	6499.0
234446	16325811	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CO[C@@H]1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652331	=	IC50	nM	203.0	CHEMBL2148	Homo sapiens	IC50	nM	203.0
234462	16325818	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](S(C)(=O)=O)C2)CC1		CHEMBL3652347	=	IC50	nM	125.0	CHEMBL2148	Homo sapiens	IC50	nM	125.0
255705	16325932	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cc(Br)cc(c1)OCCCc1cccc(c1)N2		CHEMBL3694592	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
226337	16326015	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCOCC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645549	=	IC50	nM	34000.0	CHEMBL2148	Homo sapiens	IC50	nM	34000.0
234509	16326222	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCN(Cc3ccccn3)CC2)CC1		CHEMBL3652393	=	IC50	nM	323.0	CHEMBL2148	Homo sapiens	IC50	nM	323.0
216761	16326410	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Oc1cccn2nc(Nc3ccc(C(F)(F)F)cc3)nc12		CHEMBL3644967	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216618	16326497	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(C(F)(F)F)cc5)cccn4n3)cc2)CC1		CHEMBL3642297	=	IC50	nM	69.9	CHEMBL2148	Homo sapiens	IC50	nM	69.9
216843	16326529	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)C4)nc12		CHEMBL3645055	=	IC50	nM	533.77	CHEMBL2148	Homo sapiens	IC50	nM	533.77
216717	16326602	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1Cc2ccc(Nc3nc4c(NCc5cccnc5N(C)S(C)(=O)=O)cccn4n3)cc2C1		CHEMBL3642387	=	IC50	nM	306.37	CHEMBL2148	Homo sapiens	IC50	nM	306.37
226344	16327064	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CS(=O)(=O)OCC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648433	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
234478	16327157	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(C(=O)OC(C)(C)C)[C@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652363	=	IC50	nM	488.0	CHEMBL2148	Homo sapiens	IC50	nM	488.0
226349	16327443	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CCOC(=O)CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648438	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234412	16327462	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](O)C2)CC1		CHEMBL3652298	=	IC50	nM	335.0	CHEMBL2148	Homo sapiens	IC50	nM	335.0
216616	16327658	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(N(C)S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL3642295	=	IC50	nM	11.9	CHEMBL2148	Homo sapiens	IC50	nM	11.9
216655	16327664	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cc(C(F)(F)F)cn4n3)cn2)CC1		CHEMBL3642331	=	IC50	nM	3440.6	CHEMBL2148	Homo sapiens	IC50	nM	3440.6
302634	16327811	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CC2CC(F)(F)C2)C1		CHEMBL3658863	=	IC50	nM	6570.0	CHEMBL2148	Homo sapiens	IC50	nM	6570.0
216762	16327815	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COCc1ccccc1-c1cccc2nc(Nc3ccc4c(c3)CCN(C(=O)OC(C)(C)C)CC4)nn12		CHEMBL3644968	=	IC50	nM	2540.53	CHEMBL2148	Homo sapiens	IC50	nM	2540.53
233706	16327848	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3335699	=	Ki	nM	0.01055	CHEMBL2148	Homo sapiens	Ki	nM	0.01055
216863	16328256	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)c(F)c1		CHEMBL3645074	=	IC50	nM	58.06	CHEMBL2148	Homo sapiens	IC50	nM	58.06
234405	16328289	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1nnc(C2CCCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)C2)o1		CHEMBL3652291	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
294021	16328637	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(C#N)cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651003	=	IC50	nM	0.068	CHEMBL2148	Homo sapiens	IC50	nM	0.068
226348	16328713	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	C/C(Nc1cccc(-c2cnc3ccccc3n2)c1)=C1/CCOC1=O		CHEMBL3648437	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216705	16328951	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1cncc(CNc2cccn3nc(Nc4ccc(OCCN5CCCC5)cc4)nc23)c1		CHEMBL3642377	=	IC50	nM	2793.21	CHEMBL2148	Homo sapiens	IC50	nM	2793.21
216600	16329016	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(CN5CCOCC5)c4)nc23)cc1		CHEMBL3639411	=	IC50	nM	14.8	CHEMBL2148	Homo sapiens	IC50	nM	14.8
216699	16329060	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642371	=	IC50	nM	527.19	CHEMBL2148	Homo sapiens	IC50	nM	527.19
216595	16329103	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(NC4CCN(S(C)(=O)=O)CC4)cccn3n2)cc1		CHEMBL3642279	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
234448	16329188	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](CO)C2)CC1		CHEMBL3652333	=	IC50	nM	233.0	CHEMBL2148	Homo sapiens	IC50	nM	233.0
216637	16329541	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4cccc(-c5ccc(NS(C)(=O)=O)cc5)n4n3)cc2)CC1		CHEMBL3642313	=	IC50	nM	67.6	CHEMBL2148	Homo sapiens	IC50	nM	67.6
234429	16329711	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COCC1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652315	=	IC50	nM	434.0	CHEMBL2148	Homo sapiens	IC50	nM	434.0
233691	16329830	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)(C)NS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665178	=	Ki	nM	0.03235	CHEMBL2148	Homo sapiens	Ki	nM	0.03235
233733	16329879	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)[C@@H]1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)C1		CHEMBL3665213	=	Ki	nM	0.01081	CHEMBL2148	Homo sapiens	Ki	nM	0.01081
216812	16329936	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cnc(-c2cccn3nc(Nc4ccc(C5CCN(CC(=O)N(C)C)CC5)cc4)nc23)cn1		CHEMBL3645018	=	IC50	nM	449.05	CHEMBL2148	Homo sapiens	IC50	nM	449.05
234499	16329953	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(c3nnn[nH]3)C2)CC1		CHEMBL3652383	=	IC50	nM	111.0	CHEMBL2148	Homo sapiens	IC50	nM	111.0
216722	16329955	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(Nc5ccccc5CN(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642392	=	IC50	nM	541.65	CHEMBL2148	Homo sapiens	IC50	nM	541.65
294041	16330310	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/C(C)=O)c3)c12		CHEMBL3651022	=	IC50	nM	5.3	CHEMBL2148	Homo sapiens	IC50	nM	5.3
294022	16330359	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1CO		CHEMBL3651004	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
255698	16330389	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694585	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
234471	16330662	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1cc(CC[C@]2(O)CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)C2)on1		CHEMBL3652356	=	IC50	nM	286.0	CHEMBL2148	Homo sapiens	IC50	nM	286.0
302616	16330719	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCC2CC2)C1		CHEMBL3655097	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233634	16330729	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COC(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665127	=	IC50	nM	0.2198	CHEMBL2148	Homo sapiens	IC50	nM	0.219795
233694	16330733	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665180	=	Ki	nM	0.000578	CHEMBL2148	Homo sapiens	Ki	nM	0.000578
234465	16330856	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@@](C)(CO)[C@@](C)(CO)C2)CC1		CHEMBL3652350	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
234400	16330896	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](O)[C@@H](O)C2)CC1		CHEMBL3652286	=	IC50	nM	275.0	CHEMBL2148	Homo sapiens	IC50	nM	275.0
226332	16331047	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CS(=O)(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL1553519	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
233659	16331085	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(=O)(=O)CC3CC3)C2)n1		CHEMBL3665149	=	IC50	nM	0.03977	CHEMBL2148	Homo sapiens	IC50	nM	0.039765
216650	16331159	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	O=[N+]([O-])c1cccc(CNc2cccn3nc(N4CCOCC4)nc23)c1		CHEMBL3642326	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233662	16331183	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	O=S(=O)(CC1CC1)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665152	=	Ki	nM	0.00373	CHEMBL2148	Homo sapiens	Ki	nM	0.00373
293974	16331273	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(OCC(F)(F)F)c3)c12		CHEMBL3703488	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
233699	16331468	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665185	=	IC50	nM	0.04737	CHEMBL2148	Homo sapiens	IC50	nM	0.04737
233720	16331469	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN1CCC(Nc2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665201	=	IC50	nM	0.02507	CHEMBL2148	Homo sapiens	IC50	nM	0.025065
216865	16331490	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(-c2cccn3nc(Nc4ccc(C5CCN(CC(=O)N(C)C)CC5)cc4)nc23)c(F)c1		CHEMBL3645076	=	IC50	nM	36.42	CHEMBL2148	Homo sapiens	IC50	nM	36.42
216854	16331515	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)c1F		CHEMBL3645065	=	IC50	nM	183.25	CHEMBL2148	Homo sapiens	IC50	nM	183.25
302621	16331674	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC(C#N)C2)C1		CHEMBL3655102	=	IC50	nM	5500.0	CHEMBL2148	Homo sapiens	IC50	nM	5500.0
234450	16331836	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](C#N)C2)CC1		CHEMBL3652335	=	IC50	nM	263.0	CHEMBL2148	Homo sapiens	IC50	nM	263.0
234388	16331903	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)C1CCC(CS(=O)(=O)N2CC[C@@H](O)C2)CC1		CHEMBL3953856	=	IC50	nM	163.0	CHEMBL2148	Homo sapiens	IC50	nM	163.0
216684	16331952	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(Nc5cccnc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642356	=	IC50	nM	166.83	CHEMBL2148	Homo sapiens	IC50	nM	166.83
233630	16332277	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665123	=	IC50	nM	0.01281	CHEMBL2148	Homo sapiens	IC50	nM	0.01281
302618	16332291	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@H](C#N)C2)C1		CHEMBL3655099	>	IC50	nM	9770.0	CHEMBL2148	Homo sapiens	IC50	nM	9770.0
216630	16332449	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCN(c2ccc(Nc3nc4cccc(-c5ccccc5)n4n3)cc2)CC1		CHEMBL3642308	=	IC50	nM	100.9	CHEMBL2148	Homo sapiens	IC50	nM	100.9
216771	16332630	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(C(F)(F)F)ccc1-c1cccc2nc(Nc3ccc4c(c3)CCN(CCS(C)(=O)=O)CC4)nn12		CHEMBL3644977	=	IC50	nM	43.74	CHEMBL2148	Homo sapiens	IC50	nM	43.74
294001	16332701	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650985	=	IC50	nM	0.15	CHEMBL2148	Homo sapiens	IC50	nM	0.15
234427	16333023	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COC1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652313	=	IC50	nM	634.0	CHEMBL2148	Homo sapiens	IC50	nM	634.0
233741	16333058	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(C2(CC#N)COC2)C1		CHEMBL3665221	=	IC50	nM	0.1897	CHEMBL2148	Homo sapiens	IC50	nM	0.18972
216686	16333182	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ncccc1CNc1cccn2nc(Nc3cccc(S(C)(=O)=O)c3)nc12)S(C)(=O)=O		CHEMBL3642358	=	IC50	nM	919.83	CHEMBL2148	Homo sapiens	IC50	nM	919.83
216625	16333184	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4cccc(-c5ccc(CN6CCS(=O)(=O)CC6)cc5)n4n3)c2)CC1		CHEMBL3642303	=	IC50	nM	37.8	CHEMBL2148	Homo sapiens	IC50	nM	37.8
234451	16333228	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@@](C)(O)C2)CC1		CHEMBL3652336	=	IC50	nM	431.0	CHEMBL2148	Homo sapiens	IC50	nM	431.0
233742	16333234	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(S(=O)(=O)CC#N)C1	Outside typical range	CHEMBL3665222	=	Ki	nM	0.0026	CHEMBL2148	Homo sapiens	Ki	nM	0.0026
233673	16333285	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3ccn(C)c3n2)C1		CHEMBL3665160	=	IC50	nM	1.281	CHEMBL2148	Homo sapiens	IC50	nM	1.28077
279121	16333447	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	CS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL3645121	=	Kd	nM	2.7	CHEMBL2148	Homo sapiens	Kd	nM	2.7
216750	16333819	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(P(C)(C)=O)cc5)cccn4n3)c2)C(=O)C1		CHEMBL3644956	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
233679	16333835	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3ccn(C)c3n2)C1		CHEMBL3665166	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
233695	16333836	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N(C)C)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665181	=	Ki	nM	0.00248	CHEMBL2148	Homo sapiens	Ki	nM	0.00248
294045	16333877	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C(/C)C(F)(F)F)c3)c12		CHEMBL3651026	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
294024	16333879	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1C#N		CHEMBL3651006	=	IC50	nM	0.14	CHEMBL2148	Homo sapiens	IC50	nM	0.14
216831	16333990	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)Oc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645043	=	IC50	nM	3248.21	CHEMBL2148	Homo sapiens	IC50	nM	3248.21
233655	16334013	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665146	=	IC50	nM	0.01937	CHEMBL2148	Homo sapiens	IC50	nM	0.019375
234469	16334062	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](S(=O)(=O)CCc3ccccc3)C2)CC1		CHEMBL3652354	=	IC50	nM	133.0	CHEMBL2148	Homo sapiens	IC50	nM	133.0
216636	16334164	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4cccc(-c5cccc(NS(C)(=O)=O)c5)n4n3)cc2)CC1		CHEMBL3642312	=	IC50	nM	497.5	CHEMBL2148	Homo sapiens	IC50	nM	497.5
216752	16334269	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cc1nn(C)c(C)c1Nc1nc2c(-c3ccc(S(C)(=O)=O)cc3)cccn2n1		CHEMBL3644958	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216726	16334290	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5cccc(CN(C)S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642396	=	IC50	nM	126.92	CHEMBL2148	Homo sapiens	IC50	nM	126.92
234470	16334617	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@](O)(COc3cccc(F)c3)C2)CC1		CHEMBL3652355	=	IC50	nM	132.0	CHEMBL2148	Homo sapiens	IC50	nM	132.0
216849	16334683	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc5c(c4)CNC5)nc23)c1		CHEMBL3645060	=	IC50	nM	159.62	CHEMBL2148	Homo sapiens	IC50	nM	159.62
233662	16334715	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	O=S(=O)(CC1CC1)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665152	=	IC50	nM	0.00747	CHEMBL2148	Homo sapiens	IC50	nM	0.00747
233733	16334906	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)[C@@H]1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)C1		CHEMBL3665213	=	IC50	nM	0.02164	CHEMBL2148	Homo sapiens	IC50	nM	0.021635
233702	16334979	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)c1ncc(-c2cnc3[nH]cc(C#N)c3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665187	=	IC50	nM	0.4484	CHEMBL2148	Homo sapiens	IC50	nM	0.44839
255707	16335001	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	O=C(Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2)c1ccccc1		CHEMBL3694594	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
234441	16335079	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(CC(N)=O)CC2)CC1		CHEMBL3652327	=	IC50	nM	681.0	CHEMBL2148	Homo sapiens	IC50	nM	681.0
302602	16335126	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@H](CC#N)C2)C1		CHEMBL3655083	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234454	16335205	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CO[C@@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652339	=	IC50	nM	468.0	CHEMBL2148	Homo sapiens	IC50	nM	468.0
294074	16335269	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	COc1ccccc1-c1c[nH]c2ncnc(-c3ccccc3)c12		CHEMBL3651057	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
216787	16335276	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(OCc5cccc(Cl)c5)cccn4n3)c2)CC1		CHEMBL3644993	=	IC50	nM	1677.38	CHEMBL2148	Homo sapiens	IC50	nM	1677.38
216653	16335310	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cc(C(F)(F)F)cn4n3)c2)CC1		CHEMBL3642329	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233665	16335525	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nccnc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3357978	=	IC50	nM	0.04936	CHEMBL2148	Homo sapiens	IC50	nM	0.04936
233718	16335725	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC[C@@H](CO)Nc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1	Outside typical range	CHEMBL3665200	=	Ki	nM	0.00548	CHEMBL2148	Homo sapiens	Ki	nM	0.00548
233680	16335785	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nccnc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665167	=	Ki	nM	0.01179	CHEMBL2148	Homo sapiens	Ki	nM	0.01179
255693	16335909	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	O=C1Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2		CHEMBL3694580	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
233708	16335915	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCOc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665191	=	IC50	nM	0.03263	CHEMBL2148	Homo sapiens	IC50	nM	0.032625
233682	16336170	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665169	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
293994	16336413	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cc4ccccc4o3)c12		CHEMBL3650978	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
216810	16336472	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cnc(-c2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)cn1		CHEMBL3645016	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216724	16336514	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(Cc1ccccc1Nc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642394	=	IC50	nM	1171.33	CHEMBL2148	Homo sapiens	IC50	nM	1171.33
233647	16336587	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665140	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
294006	16336785	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C/C=C/C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650989	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
255691	16336940	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	Clc1cnc2nc1NCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694578	=	IC50	nM	9.2	CHEMBL2148	Homo sapiens	IC50	nM	9.2
216797	16337135	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncccc1-c1cccn2nc(Nc3ccc(C4CCN(C(=O)OC(C)(C)C)CC4)cc3)nc12		CHEMBL3645003	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
234472	16337205	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	C[C@H]1CCCN1S(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL3652357	=	IC50	nM	457.0	CHEMBL2148	Homo sapiens	IC50	nM	457.0
302631	16337256	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CCCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3658860	>	IC50	nM	6710.0	CHEMBL2148	Homo sapiens	IC50	nM	6710.0
216597	16337361	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc(CN5CCOCC5)cc4)nc23)cc1		CHEMBL3642281	=	IC50	nM	67.6	CHEMBL2148	Homo sapiens	IC50	nM	67.6
234425	16337389	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@@H](CS(=O)(=O)N2CCC[C@H](C#N)C2)CC1		CHEMBL3652311	=	IC50	nM	393.0	CHEMBL2148	Homo sapiens	IC50	nM	393.0
216659	16337574	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cncc(Nc3nc4cncc(-c5ccc(S(C)(=O)=O)cc5)n4n3)c2)CC1		CHEMBL3642335	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233732	16337588	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCN1CCN(c2ncc(-c3cnc4[nH]ccc4n3)c(N[C@H]3CCCN(S(C)(=O)=O)C3)n2)CC1		CHEMBL3665212	=	Ki	nM	0.02427	CHEMBL2148	Homo sapiens	Ki	nM	0.02427
233686	16337923	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]cc(C4CC4)c3n2)C1		CHEMBL3665173	=	Ki	nM	0.01074	CHEMBL2148	Homo sapiens	Ki	nM	0.01074
233728	16337982	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCN(c4ccccn4)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665208	=	Ki	nM	0.03243	CHEMBL2148	Homo sapiens	Ki	nM	0.03243
233692	16338012	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335693	=	IC50	nM	0.03661	CHEMBL2148	Homo sapiens	IC50	nM	0.03661
216739	16338028	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc([C@@H]5CCNC[C@@H]5O)c4)nc23)cc1		CHEMBL3642409	=	IC50	nM	59.54	CHEMBL2148	Homo sapiens	IC50	nM	59.54
233674	16338067	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3ccn(C)c3n2)C1		CHEMBL3665161	=	IC50	nM	0.7523	CHEMBL2148	Homo sapiens	IC50	nM	0.75233
233645	16338315	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665138	=	Ki	nM	0.3592	CHEMBL2148	Homo sapiens	Ki	nM	0.359245
226346	16338361	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CO)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648435	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
302628	16338385	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(O)(C(F)(F)F)CC2)C1		CHEMBL3658857	=	IC50	nM	1880.0	CHEMBL2148	Homo sapiens	IC50	nM	1880.0
233672	16338405	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665159	=	IC50	nM	1.032	CHEMBL2148	Homo sapiens	IC50	nM	1.031735
216619	16338499	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(C(F)(F)F)cc5)cccn4n3)c2)CC1		CHEMBL2062811	=	IC50	nM	208.1	CHEMBL2148	Homo sapiens	IC50	nM	208.1
233633	16338536	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665126	=	IC50	nM	0.06345	CHEMBL2148	Homo sapiens	IC50	nM	0.063455
216795	16338614	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCc2ccc(Nc3nc4c(-c5cc(C(F)(F)F)ccc5F)cccn4n3)cc2CC1		CHEMBL3645001	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
234423	16338635	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@@H](O)[C@H](C#N)C2)CC1		CHEMBL3652309	=	IC50	nM	123.0	CHEMBL2148	Homo sapiens	IC50	nM	123.0
226335	16338766	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C(Cl)Cl		CHEMBL3645547	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
233740	16338785	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	N#CCC1(N2CCC[C@H](Nc3ncccc3-c3cnc4[nH]ccc4n3)C2)COC1		CHEMBL3665220	=	Ki	nM	0.04998	CHEMBL2148	Homo sapiens	Ki	nM	0.04998
294051	16339040	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CS(=O)(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651032	=	IC50	nM	0.037	CHEMBL2148	Homo sapiens	IC50	nM	0.037
216656	16339306	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(N(c3cccc(N4CCN(C)CC4)c3)c3nc4c(-c5ccc(S(C)(=O)=O)cc5)cc(F)cn4n3)c2)CC1		CHEMBL3642332	=	IC50	nM	2138.4	CHEMBL2148	Homo sapiens	IC50	nM	2138.4
233648	16339520	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(S(C)(=O)=O)C1		CHEMBL3665141	=	Ki	nM	0.01905	CHEMBL2148	Homo sapiens	Ki	nM	0.019053
233697	16339604	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(=O)(=O)CC(C)C)C2)n1	Outside typical range	CHEMBL3665183	=	IC50	nM	0.00897	CHEMBL2148	Homo sapiens	IC50	nM	0.00897
294020	16339642	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)n1ccc2ccc(-c3ncnc4[nH]cc(C(=O)OCC)c34)cc21		CHEMBL3651002	=	IC50	nM	0.34	CHEMBL2148	Homo sapiens	IC50	nM	0.34
216683	16339739	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(c1ncccc1Nc1cccn2nc(Nc3ccc(OCCN4CCCC4)cc3)nc12)S(C)(=O)=O		CHEMBL3642355	=	IC50	nM	266.92	CHEMBL2148	Homo sapiens	IC50	nM	266.92
234512	16339882	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCS(=O)(=O)CC2)CC1		CHEMBL3652396	=	IC50	nM	587.0	CHEMBL2148	Homo sapiens	IC50	nM	587.0
216799	16339917	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncccc1-c1cccn2nc(Nc3ccc(C4CCN(CC(=O)N(C)C)CC4)cc3)nc12		CHEMBL3645005	=	IC50	nM	1685.1	CHEMBL2148	Homo sapiens	IC50	nM	1685.1
216798	16340166	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncccc1-c1cccn2nc(Nc3ccc(C4CCNCC4)cc3)nc12		CHEMBL3645004	=	IC50	nM	2351.49	CHEMBL2148	Homo sapiens	IC50	nM	2351.49
233703	16340181	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(=O)(=O)CCC(C)(C)C)C2)n1	Outside typical range	CHEMBL3665188	=	IC50	nM	0.00242	CHEMBL2148	Homo sapiens	IC50	nM	0.00242
234511	16340226	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC[C@H]1CCCCC1NS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL3652395	=	IC50	nM	1490.0	CHEMBL2148	Homo sapiens	IC50	nM	1490.0
216800	16340290	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ncccc1-c1cccn2nc(Nc3ccc4ncccc4c3)nc12		CHEMBL3645006	=	IC50	nM	1346.05	CHEMBL2148	Homo sapiens	IC50	nM	1346.05
216652	16340325	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1cncc(CNc2cccn3nc(NCCN4CCOCC4)nc23)c1		CHEMBL3642328	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
3072	16340514	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	C=Cc1nc(NC(=O)Nc2ccc(N3CCNCC3)cc2)nn1C(=C)c1ccc(S(C)(=O)=O)cc1		CHEMBL3642251	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233664	16340515	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]cc(Cl)c3n2)c(NC2CCCN(S(=O)(=O)CC3CC3)C2)n1		CHEMBL3665153	=	IC50	nM	0.03508	CHEMBL2148	Homo sapiens	IC50	nM	0.03508
234477	16340747	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@](O)(c3ccccc3)C2)CC1		CHEMBL3652362	=	IC50	nM	76.6	CHEMBL2148	Homo sapiens	IC50	nM	76.6
233681	16340798	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3cc[nH]c3n2)C1		CHEMBL3665168	=	IC50	nM	1.103	CHEMBL2148	Homo sapiens	IC50	nM	1.102595
233718	16341032	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC[C@@H](CO)Nc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665200	=	IC50	nM	0.01096	CHEMBL2148	Homo sapiens	IC50	nM	0.01096
233739	16341047	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1C[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C[C@H](C(F)(F)F)C1		CHEMBL3665219	=	IC50	nM	0.1347	CHEMBL2148	Homo sapiens	IC50	nM	0.134655
302601	16341187	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CC(C)CS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655082	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216649	16341349	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2nc3c(NCc4cccc([N+](=O)[O-])c4)cccn3n2)CC1		CHEMBL3642325	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233649	16341377	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1C[C@@H](C)C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665142	=	Ki	nM	0.003981	CHEMBL2148	Homo sapiens	Ki	nM	0.003981
302613	16342005	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CC(F)(F)C2)C1		CHEMBL3655094	=	IC50	nM	8840.0	CHEMBL2148	Homo sapiens	IC50	nM	8840.0
216730	16342051	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642400	=	IC50	nM	297.04	CHEMBL2148	Homo sapiens	IC50	nM	297.04
216728	16342067	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(Cc1cccc(-c2cccn3nc(Nc4ccc(OCCN5CCCC5)cc4)nc23)c1)S(C)(=O)=O		CHEMBL3642398	=	IC50	nM	287.19	CHEMBL2148	Homo sapiens	IC50	nM	287.19
216818	16342102	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)COc1cccc(-c2cccn3nc(Nc4ccc5c(c4)CCNCC5)nc23)c1		CHEMBL3645024	=	IC50	nM	342.21	CHEMBL2148	Homo sapiens	IC50	nM	342.21
234435	16342152	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(CS(=O)(=O)CC3CC3)CC2)CC1		CHEMBL3652321	=	IC50	nM	491.0	CHEMBL2148	Homo sapiens	IC50	nM	491.0
216604	16342186	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL3642287	=	IC50	nM	34.6	CHEMBL2148	Homo sapiens	IC50	nM	34.6
233674	16342193	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3ccn(C)c3n2)C1		CHEMBL3665161	=	Ki	nM	0.3859	CHEMBL2148	Homo sapiens	Ki	nM	0.38593
234500	16342194	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(S(=O)(=O)c3ccccc3)C2)CC1		CHEMBL3652384	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
216570	16342229	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	c1cc(-c2ccncc2)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nn2c1		CHEMBL3642260	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216664	16342566	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(S(C)(=O)=O)c4)nc23)cc1		CHEMBL2062800	=	IC50	nM	607.13	CHEMBL2148	Homo sapiens	IC50	nM	607.13
216793	16342636	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(=O)Nc1cccc(Nc2nc3c(-c4ccc(S(C)(=O)=O)cc4)cccn3n2)c1		CHEMBL3644999	=	IC50	nM	162.03	CHEMBL2148	Homo sapiens	IC50	nM	162.03
234468	16342664	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](S(=O)(=O)Cc3ccccc3)C2)CC1		CHEMBL3652353	=	IC50	nM	146.0	CHEMBL2148	Homo sapiens	IC50	nM	146.0
233651	16342703	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665143	=	IC50	nM	0.5467	CHEMBL2148	Homo sapiens	IC50	nM	0.546745
233742	16342762	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(S(=O)(=O)CC#N)C1	Outside typical range	CHEMBL3665222	=	IC50	nM	0.005205	CHEMBL2148	Homo sapiens	IC50	nM	0.005205
234521	16342807	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)CC1		CHEMBL3652405	=	IC50	nM	1.29	CHEMBL2148	Homo sapiens	IC50	nM	1.29
234498	16342838	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(F)C2)CC1		CHEMBL3652382	=	IC50	nM	143.0	CHEMBL2148	Homo sapiens	IC50	nM	143.0
217547	16343131	CHEMBL3707561	Binding Assay: ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.	B	CNC(=O)[C@H]1CCCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)C1		CHEMBL3645120	=	Kd	nM	3.0	CHEMBL2148	Homo sapiens	Kd	nM	3.0
234455	16343299	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	COC[C@H]1CCCN1S(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL3652340	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
216862	16343537	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(-c2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)c(F)c1		CHEMBL3645073	=	IC50	nM	999.0	CHEMBL2148	Homo sapiens	IC50	nM	999.0
234501	16343625	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC(O)C2)CC1		CHEMBL3652385	=	IC50	nM	303.0	CHEMBL2148	Homo sapiens	IC50	nM	303.0
216673	16343628	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCc5cccnc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642345	=	IC50	nM	514.95	CHEMBL2148	Homo sapiens	IC50	nM	514.95
216574	16343753	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1Nc1nc2c(-c3ccc(C(F)(F)F)cc3)cccn2n1		CHEMBL3642263	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233658	16343834	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCS(=O)(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665148	=	IC50	nM	0.05099	CHEMBL2148	Homo sapiens	IC50	nM	0.050985
234399	16343910	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](O)[C@H](O)C2)CC1		CHEMBL3652285	=	IC50	nM	119.0	CHEMBL2148	Homo sapiens	IC50	nM	119.0
216575	16343943	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccccc1Nc1nc2c(-c3cccc(C(F)(F)F)c3)cccn2n1		CHEMBL3642264	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233736	16343978	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2nc(N3CCN(C)CC3)ncc2-c2cnc3[nH]ccc3n2)CN(S(=O)(=O)CC#N)C1	Outside typical range	CHEMBL3665216	=	IC50	nM	0.00415	CHEMBL2148	Homo sapiens	IC50	nM	0.00415
234421	16344120	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@H](F)C2)CC1		CHEMBL3652307	=	IC50	nM	217.0	CHEMBL2148	Homo sapiens	IC50	nM	217.0
234406	16344394	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCCC(O)(COc3cccc(F)c3)C2)CC1		CHEMBL3652292	=	IC50	nM	492.0	CHEMBL2148	Homo sapiens	IC50	nM	492.0
216602	16344475	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(-c5ccc(CS(C)(=O)=O)cc5)cccn4n3)cc2)CC1		CHEMBL3642285	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
216767	16344520	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccc2nc(Nc3ccc4c(c3)CCNCC4)nn12		CHEMBL3644973	=	IC50	nM	351.41	CHEMBL2148	Homo sapiens	IC50	nM	351.41
233696	16344558	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(S(C)(=O)=O)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665182	=	IC50	nM	0.00188	CHEMBL2148	Homo sapiens	IC50	nM	0.00188
216587	16344575	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(N4CCN(S(C)(=O)=O)CC4)cccn3n2)cc1		CHEMBL3642273	=	IC50	nM	1506.5	CHEMBL2148	Homo sapiens	IC50	nM	1506.5
234444	16344663	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](O)C2)CC1		CHEMBL3652287	=	IC50	nM	175.0	CHEMBL2148	Homo sapiens	IC50	nM	175.0
226327	16344769	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	COc1ccc(NC(=O)Nc2cccc(-c3cnc4ccccc4n3)c2)cc1		CHEMBL3645542	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	nM	50000.0
234522	16344861	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(C)(O)C2)CC1		CHEMBL3652406	=	IC50	nM	0.302	CHEMBL2148	Homo sapiens	IC50	nM	0.302
216851	16344884	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)c1		CHEMBL3645062	=	IC50	nM	218.66	CHEMBL2148	Homo sapiens	IC50	nM	218.66
233714	16344888	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCS(=O)(=O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665196	=	IC50	nM	0.04983	CHEMBL2148	Homo sapiens	IC50	nM	0.049835
216700	16345081	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(NCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642372	=	IC50	nM	268.58	CHEMBL2148	Homo sapiens	IC50	nM	268.58
234508	16345362	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCN(c3ncccc3C#N)CC2)CC1		CHEMBL3652392	=	IC50	nM	271.0	CHEMBL2148	Homo sapiens	IC50	nM	271.0
293972	16345428	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccc4cn(C)nc4c3)c12		CHEMBL3703486	=	IC50	nM	7.2	CHEMBL2148	Homo sapiens	IC50	nM	7.2
294019	16345454	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)N1CCc2ccc(-c3ncnc4[nH]cc(C(=O)OCC)c34)cc21		CHEMBL3651001	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
234494	16345478	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H]2CN2CCCC2)CC1		CHEMBL3652379	=	IC50	nM	813.0	CHEMBL2148	Homo sapiens	IC50	nM	813.0
198768	16345549	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C4CCOCC4)c23)c1		CHEMBL3651063	=	IC50	nM	8.3	CHEMBL2148	Homo sapiens	IC50	nM	8.3
216801	16345638	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5ccc[nH]c5=O)cccn4n3)cc2)CC1		CHEMBL3645007	=	IC50	nM	344.88	CHEMBL2148	Homo sapiens	IC50	nM	344.88
302623	16346078	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(CCC#N)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655104	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216694	16346162	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	C[C@@H](O)CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1		CHEMBL3642366	=	IC50	nM	53.19	CHEMBL2148	Homo sapiens	IC50	nM	53.19
216832	16346258	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)C(=O)CN1CCC(c2ccc(Nc3nc4c(-c5cc(C(F)(F)F)ccc5OCC(F)F)cccn4n3)cc2)CC1		CHEMBL3645044	=	IC50	nM	1622.78	CHEMBL2148	Homo sapiens	IC50	nM	1622.78
216749	16346354	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)C(=O)C1		CHEMBL3642425	=	IC50	nM	147.29	CHEMBL2148	Homo sapiens	IC50	nM	147.29
226320	16346376	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCCC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645536	>	IC50	nM	20000.0	CHEMBL2148	Homo sapiens	IC50	nM	20000.0
216839	16346411	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc(C4CCNCC4)cc3)nc12		CHEMBL3645051	=	IC50	nM	740.39	CHEMBL2148	Homo sapiens	IC50	nM	740.39
294039	16346516	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C/C=C\C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651020	=	IC50	nM	8.3	CHEMBL2148	Homo sapiens	IC50	nM	8.3
216774	16346528	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCc2ccc(Nc3nc4c(-c5cccc6c5OC(F)(F)O6)cccn4n3)cc2CC1		CHEMBL3644980	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233659	16346600	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	Cc1ccc(-c2cnc3[nH]ccc3n2)c(NC2CCCN(S(=O)(=O)CC3CC3)C2)n1		CHEMBL3665149	=	Ki	nM	0.01988	CHEMBL2148	Homo sapiens	Ki	nM	0.019883
216736	16346886	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(N(C)Cc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642406	=	IC50	nM	432.96	CHEMBL2148	Homo sapiens	IC50	nM	432.96
234493	16346924	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](c3ccccn3)C2)CC1		CHEMBL3652378	=	IC50	nM	36.3	CHEMBL2148	Homo sapiens	IC50	nM	36.3
216791	16347018	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cc1cccn2nc(Nc3ccc(S(C)(=O)=O)cc3)nc12		CHEMBL3644997	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
302627	16347110	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(F)(F)CC2)C1		CHEMBL3658856	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233703	16347116	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(=O)(=O)CCC(C)(C)C)C2)n1	Outside typical range	CHEMBL3665188	=	Ki	nM	0.00121	CHEMBL2148	Homo sapiens	Ki	nM	0.00121
294032	16347210	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccn1		CHEMBL3651014	=	IC50	nM	0.049	CHEMBL2148	Homo sapiens	IC50	nM	0.049
294068	16347472	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cnc[nH]4)c23)c1		CHEMBL3651051	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
234404	16347952	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCCS(=O)(=O)CC1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652290	=	IC50	nM	745.0	CHEMBL2148	Homo sapiens	IC50	nM	745.0
233657	16347959	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	FC(F)(F)CN1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665147	=	Ki	nM	0.1029	CHEMBL2148	Homo sapiens	Ki	nM	0.102895
233641	16348057	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665134	=	Ki	nM	0.2781	CHEMBL2148	Homo sapiens	Ki	nM	0.278057
234523	16348129	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CC(C)COC1CCCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652407	=	IC50	nM	0.132	CHEMBL2148	Homo sapiens	IC50	nM	0.132
216856	16348133	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)c1OC		CHEMBL3645067	=	IC50	nM	1105.66	CHEMBL2148	Homo sapiens	IC50	nM	1105.66
216714	16348208	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(NCC5CCN(C(=O)OC(C)(C)C)C5)cccn4n3)cc2)CC1		CHEMBL3642384	=	IC50	nM	3256.6	CHEMBL2148	Homo sapiens	IC50	nM	3256.6
234452	16348271	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC[C@H](CS(N)(=O)=O)C2)CC1		CHEMBL3652337	=	IC50	nM	128.0	CHEMBL2148	Homo sapiens	IC50	nM	128.0
216847	16348404	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CCC(c2ccc(Nc3nc4c(-c5ccc(F)cc5)cccn4n3)cc2)CC1		CHEMBL3645058	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216748	16348537	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)C(=O)C1		CHEMBL3642424	=	IC50	nM	138.13	CHEMBL2148	Homo sapiens	IC50	nM	138.13
233705	16348658	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(Cl)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665190	=	Ki	nM	0.0262	CHEMBL2148	Homo sapiens	Ki	nM	0.0262
294037	16348965	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(Cl)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651018	=	IC50	nM	0.22	CHEMBL2148	Homo sapiens	IC50	nM	0.22
216737	16349180	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)(C)OC(=O)N1CC[C@@H](c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)[C@@H](O)C1		CHEMBL3642407	=	IC50	nM	71.14	CHEMBL2148	Homo sapiens	IC50	nM	71.14
233657	16349182	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	FC(F)(F)CN1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665147	=	IC50	nM	0.2058	CHEMBL2148	Homo sapiens	IC50	nM	0.20579
233693	16349324	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665179	=	Ki	nM	0.00098	CHEMBL2148	Homo sapiens	Ki	nM	0.00098
279122	16349371	CHEMBL3707906	Ambit KinomeScan Assay: This assay is an ATP-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag (T7 bacteriophage). The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound. Ambit's JAK assays use kinase domains and not full-length proteins. The domain used for JAK1 binding is the pseudo kinase domain while that for JAK3 binding is the catalytic domain (Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, et. al. A Quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology, 2008, Volume 26, No. 1, Page 127-132).	B	NC(=O)c1cnc(Nc2ccc(N3CCC[C@@H](C(N)=O)C3)cc2)nc1NC1CC1		CHEMBL3645122	=	Kd	nM	4.1	CHEMBL2148	Homo sapiens	Kd	nM	4.1
294018	16349377	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)N1CCc2ccc(-c3ncnc4[nH]cc(C(=O)OCC)c34)cc21		CHEMBL3651000	=	IC50	nM	0.081	CHEMBL2148	Homo sapiens	IC50	nM	0.081
216817	16349448	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CC(C)COc1ccccc1-c1cccn2nc(Nc3ccc4c(c3)CCNCC4)nc12		CHEMBL3645023	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
233695	16349711	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2nc(N(C)C)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665181	=	IC50	nM	0.004965	CHEMBL2148	Homo sapiens	IC50	nM	0.004965
233665	16350019	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nccnc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3357978	=	Ki	nM	0.02468	CHEMBL2148	Homo sapiens	Ki	nM	0.02468
216596	16350148	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(Nc2nc3c(-c4cnn(S(C)(=O)=O)c4)cccn3n2)cc1		CHEMBL3642280	=	IC50	nM	56.3	CHEMBL2148	Homo sapiens	IC50	nM	56.3
216729	16350520	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(-c5cccc(CN(C)S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3642399	=	IC50	nM	215.49	CHEMBL2148	Homo sapiens	IC50	nM	215.49
234482	16350548	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](COCc3cccnc3)C2)CC1		CHEMBL3652367	=	IC50	nM	462.0	CHEMBL2148	Homo sapiens	IC50	nM	462.0
216789	16350648	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(OCc5ccccc5C#N)cccn4n3)c2)CC1		CHEMBL3644995	=	IC50	nM	1758.94	CHEMBL2148	Homo sapiens	IC50	nM	1758.94
233725	16350673	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC[C@@H](O)C3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3335697	=	Ki	nM	0.00756	CHEMBL2148	Homo sapiens	Ki	nM	0.00756
216864	16350791	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN(C)c1cccc(-c2cccn3nc(Nc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4)nc23)c1		CHEMBL3645075	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
294069	16350883	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cccnc4)c23)c1		CHEMBL3651052	=	IC50	nM	9.7	CHEMBL2148	Homo sapiens	IC50	nM	9.7
302619	16350938	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	Cn1cc2c(n1)CN(S(=O)(=O)N[C@H]1C[C@@H](N(C)c3ncnc4[nH]ccc34)C1)C2		CHEMBL3655100	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
216819	16351137	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	Cc1ccc(-c2cccn3nc(Nc4ccc5c(c4)CCNCC5)nc23)c(OCC(C)C)c1		CHEMBL3645025	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
216826	16351179	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCOc1ccc(C(F)(F)F)cc1-c1cccn2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nc12		CHEMBL3645038	=	IC50	nM	1435.57	CHEMBL2148	Homo sapiens	IC50	nM	1435.57
216733	16351336	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(C5CCNCC5)c4)nc23)cc1		CHEMBL3642403	=	IC50	nM	37.93	CHEMBL2148	Homo sapiens	IC50	nM	37.93
294056	16351378	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(CNS(C)(=O)=O)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651037	=	IC50	nM	0.052	CHEMBL2148	Homo sapiens	IC50	nM	0.052
233663	16351382	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]cc(Cl)c3n2)C1		CHEMBL3639640	=	Ki	nM	0.03528	CHEMBL2148	Homo sapiens	Ki	nM	0.03528
233704	16351406	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665189	=	Ki	nM	0.01356	CHEMBL2148	Homo sapiens	Ki	nM	0.01356
216611	16351714	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4cccc(N5CCC(N6CCOCC6)CC5)c4)nc23)cc1		CHEMBL2062808	=	IC50	nM	47.6	CHEMBL2148	Homo sapiens	IC50	nM	47.6
216816	16351761	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1ccc(C(F)(F)F)cc1Nc1cccn2nc(Nc3cccc(N4CCN(C)CC4)c3)nc12		CHEMBL3645022	=	IC50	nM	9999.0	CHEMBL2148	Homo sapiens	IC50	nM	9999.0
221724	16351799	CHEMBL3707912	Inhibition Assay: In vitro inhibition assay using various enzyme.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	149.35	CHEMBL2148	Homo sapiens	IC50	nM	149.35
294013	16351800	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=CC(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)ccc1OC		CHEMBL3639498	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
216757	16351953	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CCn1cc(Nc2nc3c(-c4ccc(C(F)(F)F)cc4)cccn3n2)cn1		CHEMBL3644963	=	IC50	nM	70.19	CHEMBL2148	Homo sapiens	IC50	nM	70.19
216811	16352006	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cnc(-c2cccn3nc(Nc4ccc(C5CCNCC5)cc4)nc23)cn1		CHEMBL3645017	=	IC50	nM	391.68	CHEMBL2148	Homo sapiens	IC50	nM	391.68
198762	16352010	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/CN(C)C)c3)c12		CHEMBL3651060	=	IC50	nM	0.02	CHEMBL2148	Homo sapiens	IC50	nM	0.02
294000	16352024	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCCOC(=O)c1c[nH]c2ncnc(-c3ccc4cn(C)nc4c3)c12		CHEMBL3650984	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
233627	16352074	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665120	=	IC50	nM	0.04895	CHEMBL2148	Homo sapiens	IC50	nM	0.048945
255700	16352108	CHEMBL3707616	In Vitro Kinase Assay: One or more compounds herein were tested for inhibitory activity of JAK targets according to the following in vitro assay described in Park et al., Analytical Biochemistry 1999, 269, 94-104. The catalytic domains of human JAK1 (a.a. 837-1142), JAK2 (a.a. 828-1132) and JAK3 (a.a. 781-1124) with an N-terminal His tag were expressed using baculovirus in insect cells and purified. The catalytic activity of JAK1, JAK2 or JAK3 was assayed by measuring the phosphorylation of a biotinylated peptide. The phosphorylated peptide was detected by homogenous time resolved fluorescence (HTRF). IC50s of compounds were measured for each kinase in the reactions that contain the enzyme, ATP and 500 nM peptide in 50 mM Tris (pH 7.8) buffer with 100 mM NaCl, 5 mM DTT, and 0.1 mg/mL (0.01%) BSA. The ATP concentration in the reactions was 90 uM for JAK1, 30 uM for JAK2 and 3 uM for JAK3. Reactions were carried out at room temperature for 1 hr and then stopped with 20 uL 45 mM EDTA.	B	C[C@@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2		CHEMBL3694587	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
294004	16352118	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)cc(OC)n1		CHEMBL3650987	=	IC50	nM	0.049	CHEMBL2148	Homo sapiens	IC50	nM	0.049
294031	16352186	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cc(-c2ncnc3[nH]cc(C(=O)OCC)c23)cn(C)c1=O		CHEMBL3651013	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
294044	16352188	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)/C=C/c4c[nH]c5ccccc45)c3)c12		CHEMBL3651025	=	IC50	nM	2.4	CHEMBL2148	Homo sapiens	IC50	nM	2.4
216765	16352289	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COCc1ccccc1-c1cccc2nc(Nc3ccc4c(c3)CCN(CC(=O)N(C)C)CC4)nn12		CHEMBL3644971	=	IC50	nM	166.82	CHEMBL2148	Homo sapiens	IC50	nM	166.82
233651	16352388	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CCS(=O)(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665143	=	Ki	nM	0.2805	CHEMBL2148	Homo sapiens	Ki	nM	0.280473
216626	16352437	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(Nc5ccccc5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642304	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
233712	16352566	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CSc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(C(=O)CC#N)C2)n1		CHEMBL3665194	=	Ki	nM	0.4222	CHEMBL2148	Homo sapiens	Ki	nM	0.42224
293971	16352716	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	CCOC(=O)c1c[nH]c2ncnc(-c3ccccc3)c12		CHEMBL3703485	=	IC50	nM	5.5	CHEMBL2148	Homo sapiens	IC50	nM	5.5
234504	16352989	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	Cc1ccc(N2CCN(S(=O)(=O)C[C@H]3CC[C@H](N(C)c4ncnc5[nH]ccc45)CC3)CC2)nc1		CHEMBL3652388	=	IC50	nM	255.0	CHEMBL2148	Homo sapiens	IC50	nM	255.0
216690	16353150	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2cccc(Nc3nc4c(NCc5ccccc5S(C)(=O)=O)cccn4n3)c2)CC1		CHEMBL3642362	=	IC50	nM	184.7	CHEMBL2148	Homo sapiens	IC50	nM	184.7
233741	16353323	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	C[C@H]1C[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)CN(C2(CC#N)COC2)C1		CHEMBL3665221	=	Ki	nM	0.09486	CHEMBL2148	Homo sapiens	Ki	nM	0.09486
226338	16353328	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	CC(Cl)C(=O)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3645550	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
233726	16353342	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CC(C#N)C3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665206	=	Ki	nM	0.00625	CHEMBL2148	Homo sapiens	Ki	nM	0.00625
234467	16353462	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CNS(=O)(=O)[C@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652352	=	IC50	nM	90.6	CHEMBL2148	Homo sapiens	IC50	nM	90.6
233646	16353698	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)C(=O)N1CC[C@@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665139	=	IC50	nM	0.22	CHEMBL2148	Homo sapiens	IC50	nM	0.21995
233723	16353813	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(C#N)ncc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665204	=	IC50	nM	0.1607	CHEMBL2148	Homo sapiens	IC50	nM	0.1607
233653	16353883	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(C)CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335689	=	IC50	nM	0.02038	CHEMBL2148	Homo sapiens	IC50	nM	0.02038
216691	16354291	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(NCc5ccccc5S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642363	=	IC50	nM	244.39	CHEMBL2148	Homo sapiens	IC50	nM	244.39
216837	16354310	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cc(Cl)ccc1-c1cccn2nc(Nc3cccc(C4CCN(CC(=O)N(C)C)CC4)c3)nc12		CHEMBL3645049	=	IC50	nM	128.16	CHEMBL2148	Homo sapiens	IC50	nM	128.16
226352	16354424	CHEMBL3705159	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	B	O=C(CN1CCNCC1)Nc1cccc(-c2cnc3ccccc3n2)c1		CHEMBL3648441	=	IC50	nM	13000.0	CHEMBL2148	Homo sapiens	IC50	nM	13000.0
216718	16354486	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1Cc2ccc(Nc3nc4c(NCc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2C1		CHEMBL3642388	=	IC50	nM	109.77	CHEMBL2148	Homo sapiens	IC50	nM	109.77
294049	16354524	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(COC)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651030	=	IC50	nM	0.025	CHEMBL2148	Homo sapiens	IC50	nM	0.025
233670	16354576	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCCS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ncc3n2)C1		CHEMBL3665157	=	Ki	nM	0.0651	CHEMBL2148	Homo sapiens	Ki	nM	0.0651
233717	16354751	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2nc(N3CCC(CC(N)=O)CC3)ncc2-c2cnc3[nH]ccc3n2)C1	Outside typical range	CHEMBL3665199	=	Ki	nM	0.00265	CHEMBL2148	Homo sapiens	Ki	nM	0.00265
233638	16354795	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCCCC(Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665131	=	IC50	nM	0.09868	CHEMBL2148	Homo sapiens	IC50	nM	0.09868
233704	16354809	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	COc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665189	=	IC50	nM	0.02712	CHEMBL2148	Homo sapiens	IC50	nM	0.02712
216852	16355171	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	COc1cccc(-c2cccn3nc(Nc4ccc(C5CCN(CC(=O)N(C)C)CC5)cc4)nc23)c1		CHEMBL3645063	=	IC50	nM	180.27	CHEMBL2148	Homo sapiens	IC50	nM	180.27
234484	16355206	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@H](OCC(=O)N3CCCC3)C2)CC1		CHEMBL3652369	=	IC50	nM	386.0	CHEMBL2148	Homo sapiens	IC50	nM	386.0
233625	16355266	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CS(=O)(=O)N1CCC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3335688	=	Ki	nM	0.01553	CHEMBL2148	Homo sapiens	Ki	nM	0.015529
302603	16355475	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@H](CC#N)C2)C1		CHEMBL3655084	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
233633	16355495	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CC(=O)N1CC[C@H](Nc2ncccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665126	=	Ki	nM	0.03255	CHEMBL2148	Homo sapiens	Ki	nM	0.032552
216740	16355505	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCN(c2ccc(Nc3nc4c(C#Cc5ccccc5N(C)S(C)(=O)=O)cccn4n3)cc2)CC1		CHEMBL3642410	=	IC50	nM	69.6	CHEMBL2148	Homo sapiens	IC50	nM	69.6
234487	16355707	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CCN(CC)C(=O)CO[C@@H]1CCN(S(=O)(=O)C[C@H]2CC[C@H](N(C)c3ncnc4[nH]ccc34)CC2)C1		CHEMBL3652372	=	IC50	nM	584.0	CHEMBL2148	Homo sapiens	IC50	nM	584.0
216775	16355772	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	FC1(F)Oc2cccc(-c3cccn4nc(Nc5ccc6c(c5)CCNCC6)nc34)c2O1		CHEMBL3644981	=	IC50	nM	657.36	CHEMBL2148	Homo sapiens	IC50	nM	657.36
302633	16355914	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CCC2CC2)C1		CHEMBL3658862	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
234457	16356231	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2C[C@H](O)[C@H](O)C2)CC1		CHEMBL3652342	=	IC50	nM	80.8	CHEMBL2148	Homo sapiens	IC50	nM	80.8
294048	16356351	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(CN1CCOCC1)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3651029	=	IC50	nM	0.66	CHEMBL2148	Homo sapiens	IC50	nM	0.66
234483	16356527	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CC[C@@](O)(CSc3ccccn3)C2)CC1		CHEMBL3652368	=	IC50	nM	85.6	CHEMBL2148	Homo sapiens	IC50	nM	85.6
233658	16356539	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CCS(=O)(=O)N1CCCC(Nc2nc(C)ccc2-c2cnc3[nH]ccc3n2)C1		CHEMBL3665148	=	Ki	nM	0.02549	CHEMBL2148	Homo sapiens	Ki	nM	0.025493
302632	16356546	CHEMBL3707974	Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, 1 mM ATP and 1 μM peptide substrate. The JAK1 and TYK2 assays contained 1 μM of the IRStide peptide (5FAMKKSRGDYMTMQID) and the JAK2 and JAK3 assays contained 1 μM of the JAKtide peptide (FITC-KGGEEEEYFELVKK). The assays were initiated by the addition of 20 nM JAK1, 1 nM JAK2, 1 nM JAK3 or 1 nM TYK2 enzyme and were incubated at room temperature for three hours for JAK1, 60 minutes for JAK2, 75 minutes for JAK3 or 135 minutes for TYK2. Enzyme concentrations and incubation times were optimized for each new enzyme preps and were modified slightly over time to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.	B	CCCS(=O)(=O)C[C@H]1C[C@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3658861	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
294071	16356582	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(-c4cnc(C)s4)c23)c1		CHEMBL3651054	=	IC50	nM	10.3	CHEMBL2148	Homo sapiens	IC50	nM	10.3
234436	16356586	CHEMBL3706146	Enzymatic Assay: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)N2CCC(c3nc(CS(C)(=O)=O)no3)CC2)CC1		CHEMBL3652322	=	IC50	nM	581.0	CHEMBL2148	Homo sapiens	IC50	nM	581.0
233731	16356775	CHEMBL3705847	Inhibition Assay: The kinase activity of all three JAK kinases is measured using a radioactive, end-point assay and with trace amounts of 33P-ATP.	B	CN(C)CCNc1ncc(-c2cnc3[nH]ccc3n2)c(N[C@H]2CCCN(S(C)(=O)=O)C2)n1		CHEMBL3665211	=	Ki	nM	0.01634	CHEMBL2148	Homo sapiens	Ki	nM	0.01634
	16379617	CHEMBL3738537	Inhibition of JAK3 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	1.5	CHEMBL2148	Homo sapiens	INH	%	1.5
	16379618	CHEMBL3738537	Inhibition of JAK3 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	4.4	CHEMBL2148	Homo sapiens	INH	%	4.4
	16413464	CHEMBL3742716	Inhibition of JAK3 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16417205	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16417206	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	55.0	CHEMBL2148	Homo sapiens	INH	%	55.0
	16417207	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16417208	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	41.0	CHEMBL2148	Homo sapiens	INH	%	41.0
	16417209	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16417210	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	16417211	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16417212	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	16417213	CHEMBL3750764	Inhibition of JAK3 (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16421923	CHEMBL3750405	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16424289	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3747205	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424290	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1cccc(-c2nc3c(NCC4CCN(C)CC4)c(Cl)cnc3[nH]2)c1		CHEMBL3746531	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424291	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccccc1-c1nc2c(NCC3CCN(C)CC3)c(Cl)cnc2[nH]1		CHEMBL3746249	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424292	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	CN1CCC(CNc2c(Cl)cnc3[nH]c(-c4cccc(F)c4)nc23)CC1		CHEMBL3746045	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424293	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	CN1CCC(CNc2c(Cl)cnc3[nH]c(-c4ccc(S(C)(=O)=O)cc4)nc23)CC1		CHEMBL3746351	=	IC50	nM	27600.0	CHEMBL2148	Homo sapiens	IC50	uM	27.6
	16424294	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	CN1CCC(CNc2c(Cl)cnc3[nH]c(-c4cccc(S(C)(=O)=O)c4)nc23)CC1		CHEMBL3746976	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424295	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(Cl)cnc3[nH]2)cc1OC		CHEMBL3745829	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424296	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(Cl)cnc3[nH]2)c(C)c1		CHEMBL3746783	=	IC50	nM	6600.0	CHEMBL2148	Homo sapiens	IC50	uM	6.6
	16424297	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(F)c(-c2nc3c(NCC4CCN(C)CC4)c(Cl)cnc3[nH]2)c1		CHEMBL3745993	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424898	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	CNc1c(Cl)cnc2[nH]c(-c3ccc(OC)cc3)nc12		CHEMBL3746486	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424899	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCCO)c(Cl)cnc3[nH]2)cc1		CHEMBL3745933	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424900	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COCCNc1c(Cl)cnc2[nH]c(-c3ccc(OC)cc3)nc12		CHEMBL3747542	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424901	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NC4CCN(C)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3746743	=	IC50	nM	16900.0	CHEMBL2148	Homo sapiens	IC50	uM	16.9
	16424902	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NC4CCN(C(C)=O)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3747111	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424903	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3746067	=	IC50	nM	1130.0	CHEMBL2148	Homo sapiens	IC50	uM	1.13
	16424904	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(OCC4CCNCC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3745960	=	IC50	nM	2780.0	CHEMBL2148	Homo sapiens	IC50	uM	2.78
	16424905	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COCCN1CCC(CNc2c(Cl)cnc3[nH]c(-c4ccc(OC)cc4)nc23)CC1		CHEMBL3746186	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424906	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCCNC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3746882	=	IC50	nM	5750.0	CHEMBL2148	Homo sapiens	IC50	uM	5.75
	16424907	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(N(C)CC4CCNCC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3747199	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424908	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNC4)c(Cl)cnc3[nH]2)cc1		CHEMBL3747681	>	IC50	nM	22000.0	CHEMBL2148	Homo sapiens	IC50	uM	22.0
	16424909	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL3746341	=	IC50	nM	19200.0	CHEMBL2148	Homo sapiens	IC50	uM	19.2
	16424910	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)ccnc3[nH]2)cc1		CHEMBL3745777	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424911	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(C#N)cnc3[nH]2)cc1		CHEMBL3747452	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	16424912	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCN(C)CC4)c(C(N)=O)cnc3[nH]2)cc1		CHEMBL3746397	=	IC50	nM	4500.0	CHEMBL2148	Homo sapiens	IC50	uM	4.5
	16424913	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC		CHEMBL3747305	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	uM	1.2
	16424914	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c(F)c1		CHEMBL3746074	=	IC50	nM	6900.0	CHEMBL2148	Homo sapiens	IC50	uM	6.9
	16424915	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c(C)c1		CHEMBL3746766	=	IC50	nM	1540.0	CHEMBL2148	Homo sapiens	IC50	uM	1.54
	16424916	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1ccc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c1		CHEMBL3745954	=	IC50	nM	6140.0	CHEMBL2148	Homo sapiens	IC50	uM	6.14
	16424917	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1F		CHEMBL3747077	=	IC50	nM	7470.0	CHEMBL2148	Homo sapiens	IC50	uM	7.47
	16424918	CHEMBL3751002	Inhibition of N-terminal GST-fused recombinant JAK3 (781 to 1124 residues) (unknown origin) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate by microfluidic capillary electrophoresis method	B	COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC		CHEMBL3746463	=	IC50	nM	8300.0	CHEMBL2148	Homo sapiens	IC50	uM	8.3
	16425947	CHEMBL3748757	Inhibition of JAK3 (unknown origin) expressed in BaF3 cells assessed as inhibition of cell proliferation after 72 hrs by CelltiterGlo assay	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	GI50	nM	2500.0	CHEMBL2148	Homo sapiens	GI50	uM	2.5
	16426135	CHEMBL3750462	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	Outside typical range	CHEMBL3746293	=	Inhibition	%	-13.6	CHEMBL2148	Homo sapiens	INH	%	-13.6
	16429060	CHEMBL3750798	Inhibition of JAK3 (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	16431872	CHEMBL3748226	Inhibition of human JAK3 using [GEEEEYFELVKKKK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16450882	CHEMBL3762898	Inhibition of JAK3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	2.7	CHEMBL2148	Homo sapiens	INH	%	2.7
	16465891	CHEMBL3767839	Inhibition of human JAK3 at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	16480276	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CCC(C(C)C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3763184	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
	16480277	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)Cn1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3763697	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16480278	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CCC(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3764167	=	IC50	nM	52.0	CHEMBL2148	Homo sapiens	IC50	nM	52.0
	16480279	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)C(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3764637	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	16480280	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Cc1ccccc1-n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3763864	=	IC50	nM	82.0	CHEMBL2148	Homo sapiens	IC50	nM	82.0
	16480281	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Cc1ccccc1-n1cc(-c2ccccc2)c2[nH]nc(N)c2c1=O		CHEMBL3763833	=	IC50	nM	2200.0	CHEMBL2148	Homo sapiens	IC50	nM	2200.0
	16480282	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Nc1n[nH]c2c(-c3ccccn3)cn(-c3ccccc3Cl)c(=O)c12		CHEMBL3764463	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	16480283	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Cn1ccc(-c2cn(-c3ccccc3Cl)c(=O)c3c(N)n[nH]c23)n1		CHEMBL3765131	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	16480284	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Nc1n[nH]c2ccn(-c3ccccc3Cl)c(=O)c12		CHEMBL3763289	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	nM	1900.0
	16480285	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	Nc1n[nH]c2ccc(-c3ccccc3Cl)cc12		CHEMBL498859	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
	16480286	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	O=C(O)Cc1cnc(Nc2n[nH]c3ccc(-c4ncccc4Cl)cc23)s1		CHEMBL3763310	=	IC50	nM	3400.0	CHEMBL2148	Homo sapiens	IC50	nM	3400.0
	16481326	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
	16481327	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@@H](C)n1cc(-c2cc(C(C)(C)O)n(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3765822	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
	16481328	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3765517	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	16481329	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@H](C)n1cc(-c2cc(C3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3764277	=	IC50	nM	4.6	CHEMBL2148	Homo sapiens	IC50	nM	4.6
	16481330	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@H](C)n1cc(-c2cc(N3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3763213	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	16481331	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@H](C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O		CHEMBL3764030	=	IC50	nM	6.4	CHEMBL2148	Homo sapiens	IC50	nM	6.4
	16481332	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O		CHEMBL3764383	=	IC50	nM	85.0	CHEMBL2148	Homo sapiens	IC50	nM	85.0
	16481333	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)[C@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O		CHEMBL3763991	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	16481334	CHEMBL3766654	Inhibition of JAK3 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	B	CC(C)C(C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O		CHEMBL3763252	=	IC50	nM	5.3	CHEMBL2148	Homo sapiens	IC50	nM	5.3
	16485734	CHEMBL3771583	Inhibition of human recombinant JAK3 (JH1 domain-catalytic) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	16495109	CHEMBL3776227	Inhibition of N-terminal His6-tagged recombinant human JAK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	9.0	CHEMBL2148	Homo sapiens	Activity	%	9.0
	16496028	CHEMBL3776227	Inhibition of N-terminal His6-tagged recombinant human JAK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	2.0	CHEMBL2148	Homo sapiens	Activity	%	2.0
	16508215	CHEMBL3776227	Inhibition of N-terminal His6-tagged recombinant human JAK3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-4.0	CHEMBL2148	Homo sapiens	Activity	%	-4.0
Not Active	16514133	CHEMBL3782181	Inhibition of partial length human JAK3 JH1 catalytic domain expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	16515197	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.35	CHEMBL2148	Homo sapiens	IC50	nM	0.35
	16515198	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	16515199	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	COC(=O)C1CCc2[nH]c(-c3c(N[C@H]4CC[C@@H](N)CC4)cc[nH]c3=O)nc2C1		CHEMBL3780467	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	16515200	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1		CHEMBL3780091	=	IC50	nM	2.5	CHEMBL2148	Homo sapiens	IC50	nM	2.5
	16515201	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	O=c1[nH]ccc(NC2CCOCC2)c1-c1nc2ccccc2[nH]1		CHEMBL3781427	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	16515202	CHEMBL3784140	Inhibition of JAK3 (unknown origin)	B	CS(=O)(=O)c1ccc(Nc2nn(C3CCOCC3)cc2C(N)=O)cc1		CHEMBL3782012	>	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	nM	1400.0
	16540827	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16540828	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16540829	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	7200.0	CHEMBL2148	Homo sapiens	IC50	uM	7.2
	16540830	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16540831	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16540832	CHEMBL3789995	Inhibition of JAK3 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16559643	CHEMBL3794770	Inhibition of human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	51.9	CHEMBL2148	Homo sapiens	INH	%	51.9
	16559644	CHEMBL3794770	Inhibition of human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	26.4	CHEMBL2148	Homo sapiens	INH	%	26.4
	16559645	CHEMBL3794770	Inhibition of human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	9.0	CHEMBL2148	Homo sapiens	INH	%	9.0
	16581330	CHEMBL3802365	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Z'-LYTE Try6 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cn1c(C(=O)NCCN2CCCC2)cc2c(-c3ccc(NC(=O)C(C)(C)C)cc3)ncnc21		CHEMBL3799882	=	IC50	nM	953.0	CHEMBL2148	Homo sapiens	IC50	nM	953.0
	16581331	CHEMBL3802365	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Z'-LYTE Try6 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cn1c(C(=O)NCCN2CCCC2)cc2c(-c3ccc(NC(=O)[C@@H]4CCCN4C(=O)OC(C)(C)C)cc3)ncnc21		CHEMBL3797831	=	IC50	nM	716.0	CHEMBL2148	Homo sapiens	IC50	nM	716.0
	16581332	CHEMBL3802365	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Z'-LYTE Try6 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cn1c(C(=O)NCCCN2CCOCC2)cc2c(-c3ccc(NC(=O)C(C)(C)C)cc3)ncnc21		CHEMBL3798482	=	IC50	nM	584.0	CHEMBL2148	Homo sapiens	IC50	nM	584.0
	16581333	CHEMBL3802365	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Z'-LYTE Try6 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	Cn1c(C(=O)NCCCN2CCOCC2)cc2c(-c3ccc(NC(=O)[C@@H]4CCCN4C(=O)OC(C)(C)C)cc3)ncnc21		CHEMBL3798618	=	IC50	nM	507.0	CHEMBL2148	Homo sapiens	IC50	nM	507.0
	16581334	CHEMBL3802365	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Z'-LYTE Try6 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	16582268	CHEMBL3804598	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	uM	0.3
	16582273	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CCC1(n2cc(Nc3ncnc4[nH]ccc34)cn2)CCCC1		CHEMBL3798782	=	Inhibition	%	40.0	CHEMBL2148	Homo sapiens	INH	%	40.0
	16582276	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CCC1(n2cc(Nc3ncnc4[nH]ccc34)cn2)CCCCC1		CHEMBL3800034	=	Inhibition	%	26.0	CHEMBL2148	Homo sapiens	INH	%	26.0
	16582279	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CCC(C1CCCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3797903	=	Inhibition	%	31.0	CHEMBL2148	Homo sapiens	INH	%	31.0
	16582282	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CCC(C1CCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3800564	=	Inhibition	%	61.0	CHEMBL2148	Homo sapiens	INH	%	61.0
	16582285	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3798518	=	Inhibition	%	36.0	CHEMBL2148	Homo sapiens	INH	%	36.0
	16582288	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3798298	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	16582291	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC1(n2cc(Nc3ncnc4[nH]ccc34)cn2)CCCCC1		CHEMBL3799477	=	Inhibition	%	32.0	CHEMBL2148	Homo sapiens	INH	%	32.0
	16582294	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC1(n2cc(Nc3ncnc4[nH]ccc34)cn2)CCCC1		CHEMBL3797754	=	Inhibition	%	15.0	CHEMBL2148	Homo sapiens	INH	%	15.0
	16582297	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CCCNC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3797856	=	Inhibition	%	66.0	CHEMBL2148	Homo sapiens	INH	%	66.0
	16582300	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CC(C)CNC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3[nH]ccc23)cn1		CHEMBL3797805	=	Inhibition	%	44.0	CHEMBL2148	Homo sapiens	INH	%	44.0
	16582303	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3ccccc23)cn1		CHEMBL3800101	=	Inhibition	%	36.0	CHEMBL2148	Homo sapiens	INH	%	36.0
	16582306	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3[nH]cnc23)cn1		CHEMBL3798220	=	Inhibition	%	68.0	CHEMBL2148	Homo sapiens	INH	%	68.0
	16582309	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3sccc23)cn1		CHEMBL3799937	=	Inhibition	%	17.0	CHEMBL2148	Homo sapiens	INH	%	17.0
	16582312	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3[nH]ncc23)cn1		CHEMBL3798654	=	Inhibition	%	58.0	CHEMBL2148	Homo sapiens	INH	%	58.0
	16582315	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncc3cc[nH]c3n2)cn1		CHEMBL3797755	=	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	16582318	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CNc1nc(Nc2cnn(C(CC(N)=O)C3CCCCC3)c2)ncc1Cl		CHEMBL3800622	=	Inhibition	%	98.0	CHEMBL2148	Homo sapiens	INH	%	98.0
	16582321	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CNc1nc(Nc2cnn(C(CC(N)=O)C3CCCCC3)c2)ncc1C(F)(F)F		CHEMBL3797207	=	Inhibition	%	100.0	CHEMBL2148	Homo sapiens	INH	%	100.0
	16582324	CHEMBL3804598	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CNc1nc(Nc2cnn(C(CC(N)=O)C3CCCCC3)c2)ncc1C(F)(F)F		CHEMBL3797207	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	uM	0.039
	16582328	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	NC(=O)CC(C1CCCCC1)n1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1		CHEMBL3799967	=	Inhibition	%	94.0	CHEMBL2148	Homo sapiens	INH	%	94.0
	16582332	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CC(C)CNC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3sccc23)cn1		CHEMBL3799565	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	16582335	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CC(C)CNC(=O)CC(C1CCCCC1)n1cc(Nc2ncnc3ccccc23)cn1		CHEMBL3799208	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	16582338	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CNc1nc(Nc2cnn(C(CC(N)=O)C3CCCC3)c2)ncc1Cl		CHEMBL3798939	=	Inhibition	%	83.0	CHEMBL2148	Homo sapiens	INH	%	83.0
	16582341	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CCCNC(=O)CC(C1CCCCC1)n1cc(Nc2ncc(Cl)c(NC)n2)cn1		CHEMBL3799123	=	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	16582344	CHEMBL3803217	Inhibition of JAK3 (unknown origin)	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	IC50	nM	787.0	CHEMBL2148	Homo sapiens	IC50	nM	787.0
	16582348	CHEMBL3803217	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	487.0	CHEMBL2148	Homo sapiens	IC50	nM	487.0
	16582349	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Inhibition	%	85.0	CHEMBL2148	Homo sapiens	INH	%	85.0
	16582354	CHEMBL3804595	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation at 10 uM pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	98.0	CHEMBL2148	Homo sapiens	INH	%	98.0
	16582357	CHEMBL3804598	Inhibition of human recombinant JAK3 assessed as reduction in Ulight-CAGAGAIETDKEYYTVKD phosphorylation pre-incubated before substrate addition and measured after 60 mins by LANCE detection method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	uM	0.001
	16582360	CHEMBL3803217	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
	16587008	CHEMBL3807420	Inhibition of JAK3 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	349.0	CHEMBL2148	Homo sapiens	IC50	uM	0.349
	16593499	CHEMBL3812353	Inhibition of GST-tagged human recombinant JAK3 (781 to 1124 residues) expressed in baculovirus using GFP-ST AT1 as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2148	Homo sapiens	INH	%	40.0
	16594881	CHEMBL3812437	Inhibition of human JAK3 JH1 catalytic domain (781 to 1124 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	61.0	CHEMBL2148	Homo sapiens	Activity	%	61.0
	16609984	CHEMBL3817144	Inhibition of human JAK3 at 1 uM	B	C=CC(=O)Nc1cccc(-n2c(-c3nc(-c4cnn(C5CCN(C)CC5)c4)cnc3N)nc3ccccc32)c1		CHEMBL3814825	>	Inhibition	%	75.0	CHEMBL2148	Homo sapiens	INH	%	75.0
	16614513	CHEMBL3816711	Inhibition of human JAK3 at 1 uM using [GEEEEYFELVKKKK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	8.0	CHEMBL2148	Homo sapiens	INH	%	8.0
	16617245	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	NCCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3814195	=	IC50	nM	14300.0	CHEMBL2148	Homo sapiens	IC50	uM	14.3
	16617246	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	CNCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3814934	=	IC50	nM	1500.0	CHEMBL2148	Homo sapiens	IC50	uM	1.5
	16617247	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	NCCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1		CHEMBL3814099	=	IC50	nM	12400.0	CHEMBL2148	Homo sapiens	IC50	uM	12.4
	16617248	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	CNCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1		CHEMBL3815154	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	uM	1.9
	16617249	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	C[C@@H](O)Cn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1		CHEMBL3814406	=	IC50	nM	8500.0	CHEMBL2148	Homo sapiens	IC50	uM	8.5
	16617250	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCCO		CHEMBL3814951	=	IC50	nM	20600.0	CHEMBL2148	Homo sapiens	IC50	uM	20.6
	16617251	CHEMBL3817414	Inhibition of JAK3 (unknown origin) using tyrosine 6 peptide as substrate by z'-lyte assay	B	NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCO		CHEMBL3814293	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	16617270	CHEMBL3817422	Inhibition of FLAG-tagged human JAK3 expressed in insect Sf9 cells using biotin-EQEDEPEGDYFEWLE-NH2 as substrate by HTRF assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	=	IC50	nM	1300.0	CHEMBL2148	Homo sapiens	IC50	uM	1.3
	16618183	CHEMBL3817249	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16621518	CHEMBL3820656	Inhibition of JAK3 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	nM	30000.0
	16622225	CHEMBL3820656	Inhibition of JAK3 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	16668114	CHEMBL3854812	Inhibition of JAK3 (unknown origin)	B	Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12		CHEMBL3911320	=	IC50	nM	219.0	CHEMBL2148	Homo sapiens	IC50	nM	219.0
	16668138	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12		CHEMBL3911320	=	Inhibition	%	79.0	CHEMBL2148	Homo sapiens	INH	%	79.0
	16668139	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12		CHEMBL3939280	=	Inhibition	%	76.0	CHEMBL2148	Homo sapiens	INH	%	76.0
	16668140	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12		CHEMBL3975326	=	Inhibition	%	58.0	CHEMBL2148	Homo sapiens	INH	%	58.0
	16668141	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12		CHEMBL3964636	=	Inhibition	%	21.0	CHEMBL2148	Homo sapiens	INH	%	21.0
	16668142	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12	Outside typical range	CHEMBL3984494	=	Inhibition	%	-14.0	CHEMBL2148	Homo sapiens	INH	%	-14.0
	16668143	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12		CHEMBL3955876	=	Inhibition	%	15.0	CHEMBL2148	Homo sapiens	INH	%	15.0
	16668144	CHEMBL3854819	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12		CHEMBL3895703	=	Inhibition	%	37.0	CHEMBL2148	Homo sapiens	INH	%	37.0
	16668494	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL3932176	=	IC50	nM	6880.0	CHEMBL2148	Homo sapiens	IC50	uM	6.88
	16668495	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN(C(C)C)C(C)C		CHEMBL3950966	=	IC50	nM	8150.0	CHEMBL2148	Homo sapiens	IC50	uM	8.15
	16668496	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3923228	=	IC50	nM	4960.0	CHEMBL2148	Homo sapiens	IC50	uM	4.96
	16668497	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL3942228	=	IC50	nM	7150.0	CHEMBL2148	Homo sapiens	IC50	uM	7.15
	16668498	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1[C@@H](C)CCC[C@H]1C		CHEMBL3914227	=	IC50	nM	7670.0	CHEMBL2148	Homo sapiens	IC50	uM	7.67
	16668499	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCOCC1		CHEMBL3907533	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668500	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1		CHEMBL3921129	=	IC50	nM	8750.0	CHEMBL2148	Homo sapiens	IC50	uM	8.75
	16668501	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1C[C@H](C)N[C@H](C)C1		CHEMBL3941823	=	IC50	nM	6940.0	CHEMBL2148	Homo sapiens	IC50	uM	6.94
	16668502	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1[C@@H](C)CNC[C@H]1C		CHEMBL3971413	=	IC50	nM	8880.0	CHEMBL2148	Homo sapiens	IC50	uM	8.88
	16668503	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C(C)C)C(C)C		CHEMBL3950549	=	IC50	nM	7400.0	CHEMBL2148	Homo sapiens	IC50	uM	7.4
	16668504	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	=	IC50	nM	3570.0	CHEMBL2148	Homo sapiens	IC50	uM	3.57
	16668505	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL3959248	=	IC50	nM	7100.0	CHEMBL2148	Homo sapiens	IC50	uM	7.1
	16668506	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3890186	=	IC50	nM	4800.0	CHEMBL2148	Homo sapiens	IC50	uM	4.8
	16668507	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1		CHEMBL3970330	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668508	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(ccn4S(=O)(=O)c4ccccc4)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL3899132	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668509	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(ccn4S(=O)(=O)c4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3890751	=	IC50	nM	3790.0	CHEMBL2148	Homo sapiens	IC50	uM	3.79
	16668510	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc4c(ccn4S(=O)(=O)c4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCOCC1		CHEMBL3933895	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668511	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL3958482	=	IC50	nM	7100.0	CHEMBL2148	Homo sapiens	IC50	uM	7.1
	16668512	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(Cc4ccccn4)cc3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3930965	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668513	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3962365	=	IC50	nM	6450.0	CHEMBL2148	Homo sapiens	IC50	uM	6.45
	16668514	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1		CHEMBL3939985	=	IC50	nM	3690.0	CHEMBL2148	Homo sapiens	IC50	uM	3.69
	16668515	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)cc3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3977926	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668516	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)cc3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1		CHEMBL3922922	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668517	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(NS(=O)(=O)c4ccccc4)cc3)c2cc1NC(=O)/C=C/CN1CCCC1		CHEMBL3986103	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668518	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(NS(=O)(=O)c4ccccc4)cc3)c2cc1NC(=O)/C=C/CN1CCOCC1		CHEMBL3957416	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668519	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CCOc1cc2ncnc(Nc3ccc(NS(=O)(=O)c4ccccc4)cc3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1		CHEMBL3936505	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668520	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL3968417	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668521	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL3930506	=	IC50	nM	793.0	CHEMBL2148	Homo sapiens	IC50	uM	0.793
	16668522	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL3958006	=	IC50	nM	1710.0	CHEMBL2148	Homo sapiens	IC50	uM	1.71
	16668523	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cn2)CC1		CHEMBL3921555	=	IC50	nM	2420.0	CHEMBL2148	Homo sapiens	IC50	uM	2.42
	16668524	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL3949347	=	IC50	nM	7440.0	CHEMBL2148	Homo sapiens	IC50	uM	7.44
	16668525	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCCC1)Nc1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL3948267	=	IC50	nM	7620.0	CHEMBL2148	Homo sapiens	IC50	uM	7.62
	16668526	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2cn1		CHEMBL3977504	=	IC50	nM	8010.0	CHEMBL2148	Homo sapiens	IC50	uM	8.01
	16668527	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCCC1)Nc1cc2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2cn1		CHEMBL3896779	=	IC50	nM	5970.0	CHEMBL2148	Homo sapiens	IC50	uM	5.97
	16668528	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cc4ccccn4)cc3)ncnc2cn1		CHEMBL3969056	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668529	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCCC1)Nc1cc2c(Nc3ccc(Cc4ccccn4)cc3)ncnc2cn1		CHEMBL3967962	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668530	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(Cc5ccccn5)cc4)ncnc3cn2)CC1		CHEMBL3921446	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	16668531	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cn1		CHEMBL3981551	=	IC50	nM	1220.0	CHEMBL2148	Homo sapiens	IC50	uM	1.22
	16668532	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	O=C(/C=C/CN1CCCC1)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cn1		CHEMBL3904257	=	IC50	nM	3490.0	CHEMBL2148	Homo sapiens	IC50	uM	3.49
	16668533	CHEMBL3854874	Irreversible inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in polyglutamic acid-tyrosine phosphorylation after 30 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	16772241	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2c(=O)[nH]c3cnc(Nc4ccc(N5CCOCC5)cc4OC)nc32)c1		CHEMBL3973451	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16772242	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2c(=O)[nH]c3cnc(Nc4ccc(N5CCN(CC)CC5)cc4)nc32)c1		CHEMBL3963986	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16772243	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(OC)cc4)nc32)c1		CHEMBL3962478	=	IC50	nM	67.2	CHEMBL2148	Homo sapiens	IC50	nM	67.2
	16772244	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(OCCCN5CCOCC5)cc4)nc32)c1		CHEMBL3893465	=	IC50	nM	72.6	CHEMBL2148	Homo sapiens	IC50	nM	72.6
	16772245	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(C(C)=O)C(C)C5)cc4)nc32)c1		CHEMBL3953720	=	IC50	nM	61.2	CHEMBL2148	Homo sapiens	IC50	nM	61.2
	16772246	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(S(C)(=O)=O)C(C)C5)cc4)nc32)c1		CHEMBL3982421	=	IC50	nM	83.1	CHEMBL2148	Homo sapiens	IC50	nM	83.1
	16772247	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(S(C)(=O)=O)CC5)cc4OC)nc32)c1		CHEMBL3946985	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16772248	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(S(C)(=O)=O)CC5)cc4)nc32)c1		CHEMBL3919900	=	IC50	nM	70.1	CHEMBL2148	Homo sapiens	IC50	nM	70.1
	16772249	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(CC)CC5)cc4OC)nc32)c1		CHEMBL3895185	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16772250	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(CC)CC5)cc4)nc32)c1		CHEMBL3966494	=	IC50	nM	67.5	CHEMBL2148	Homo sapiens	IC50	nM	67.5
	16772251	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL3904111	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16772252	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL3975003	=	IC50	nM	67.1	CHEMBL2148	Homo sapiens	IC50	nM	67.1
	16772253	CHEMBL3864053	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-n2cnc3cnc(Nc4ccc(N5CCOCC5)cc4)nc32)c1		CHEMBL3975962	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	16796978	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2ccccc2o1		CHEMBL3907087	=	IC50	nM	183.2	CHEMBL2148	Homo sapiens	IC50	nM	183.2
	16796979	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CCOC(=O)COc1ccc(Nc2ncc(C)c(-c3cc4ccccc4o3)n2)cc1		CHEMBL3934182	=	IC50	nM	1195.4	CHEMBL2148	Homo sapiens	IC50	nM	1195.4
	16796980	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CCOC(=O)COc1cccc(Nc2ncc(C)c(-c3cc4ccccc4o3)n2)c1		CHEMBL3895231	=	IC50	nM	87.6	CHEMBL2148	Homo sapiens	IC50	nM	87.6
	16796981	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(OCC(=O)O)cc2)nc1-c1cc2ccccc2o1		CHEMBL3912973	=	IC50	nM	359.4	CHEMBL2148	Homo sapiens	IC50	nM	359.4
	16796982	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(/C=C/C(=O)NO)cc2)nc1-c1cc2ccccc2o1		CHEMBL3974845	=	IC50	nM	1580.6	CHEMBL2148	Homo sapiens	IC50	nM	1580.6
	16796983	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2cc(COCC(F)(F)F)ccc2o1		CHEMBL3903955	=	IC50	nM	836.5	CHEMBL2148	Homo sapiens	IC50	nM	836.5
	16796984	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2cc(C#N)ccc2o1		CHEMBL3966342	=	IC50	nM	364.4	CHEMBL2148	Homo sapiens	IC50	nM	364.4
	16796985	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	N#Cc1ccc2oc(-c3nc(Nc4ccc(N5CCNCC5)cc4)ncc3C(F)(F)F)cc2c1		CHEMBL3895028	=	IC50	nM	201.8	CHEMBL2148	Homo sapiens	IC50	nM	201.8
	16796986	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CC1CC(C)CN(c2ccc(Nc3ncc(C(F)(F)F)c(-c4cc5ccc(C#N)cc5o4)n3)cc2)C1		CHEMBL3955194	=	IC50	nM	5174.0	CHEMBL2148	Homo sapiens	IC50	nM	5174.0
	16796987	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	16796988	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CS(=O)(=O)N1CCc2oc(-c3ccnc(Nc4ccc(N5CCOCC5)cc4)n3)cc2C1		CHEMBL3920857	=	IC50	nM	226.1	CHEMBL2148	Homo sapiens	IC50	nM	226.1
	16796989	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	N#CCC(=O)N1CCc2oc(-c3ccnc(Nc4ccc(N5CCOCC5)cc4)n3)cc2C1		CHEMBL3948663	=	IC50	nM	140.5	CHEMBL2148	Homo sapiens	IC50	nM	140.5
	16796990	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cc5c(o4)CCN(S(C)(=O)=O)C5)n3)cc2)CC1		CHEMBL3950301	=	IC50	nM	204.2	CHEMBL2148	Homo sapiens	IC50	nM	204.2
	16796991	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cc5c(o4)CCN(C(=O)CC#N)C5)n3)cc2)CC1		CHEMBL3922588	=	IC50	nM	136.1	CHEMBL2148	Homo sapiens	IC50	nM	136.1
	16796992	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CS(=O)(=O)N1CCc2oc(-c3ccnc(Nc4ccc(OCCN5CCCC5)cc4)n3)cc2C1		CHEMBL3941571	=	IC50	nM	500.5	CHEMBL2148	Homo sapiens	IC50	nM	500.5
	16796993	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	CS(=O)(=O)N1CCc2oc(-c3nc(Nc4ccc(OCCN5CCCC5)cc4)ncc3F)cc2C1		CHEMBL3913592	=	IC50	nM	175.8	CHEMBL2148	Homo sapiens	IC50	nM	175.8
	16796994	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	COc1cc(Nc2ncc(F)c(-c3cc4c(o3)CCN(S(C)(=O)=O)C4)n2)cc(OC)c1OC		CHEMBL3970092	=	IC50	nM	178.1	CHEMBL2148	Homo sapiens	IC50	nM	178.1
	16796995	CHEMBL3868064	Inhibition of GST-tagged recombinant human cytoplasmic JAK3 expressed in baculovirus using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition after 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL3940537	=	IC50	nM	23.2	CHEMBL2148	Homo sapiens	IC50	nM	23.2
	16804130	CHEMBL3869722	Inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus expression system using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 as substrate after 1 hr in presence of ATP by electrophoretic mobility shift assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	IC50	nM	114.0	CHEMBL2148	Homo sapiens	IC50	nM	114.0
	16804171	CHEMBL3869762	Inhibition of human recombinant GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	56.0	CHEMBL2148	Homo sapiens	INH	%	56.0
	16835836	CHEMBL3875839	Inhibition of human JAK3 using poly (Glu:Tyr) as substrate	B	Cc1cc(Nc2ncc(C#N)c(Nc3cccc(S(=O)(=O)NC(C)(C)C)c3)n2)ccc1N1CCN(C)CC1		CHEMBL3885292	>	IC50	nM	100000.0	CHEMBL2148	Homo sapiens	IC50	uM	100.0
	16835837	CHEMBL3875839	Inhibition of human JAK3 using poly (Glu:Tyr) as substrate	B	Cc1cc(Nc2nccc(Nc3cccc(S(N)(=O)=O)c3)n2)ccc1N1CCN(C)CC1		CHEMBL3884104	=	IC50	nM	4100.0	CHEMBL2148	Homo sapiens	IC50	uM	4.1
	16835839	CHEMBL3875839	Inhibition of human JAK3 using poly (Glu:Tyr) as substrate	B	Cc1cccc(Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1		CHEMBL3883652	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	uM	2.1
	16835840	CHEMBL3875839	Inhibition of human JAK3 using poly (Glu:Tyr) as substrate	B	NS(=O)(=O)c1cccc(Nc2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL3884240	=	IC50	nM	7100.0	CHEMBL2148	Homo sapiens	IC50	uM	7.1
	16835844	CHEMBL3875839	Inhibition of human JAK3 using poly (Glu:Tyr) as substrate	B	Cc1cccc(Nc2ccnc(Nc3ccc(N4CCN(C)CC4)c(C)c3)n2)c1		CHEMBL3884848	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	16837418	CHEMBL3876089	Inhibition of human recombinant GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	3162.0	CHEMBL2148	Homo sapiens	IC50	nM	3162.0
	16844274	CHEMBL3877348	Inhibition of JAK3 (unknown origin) at 0.1 uM preincubated for 20 mins followed by [33P]ATP addition measured after 120 mins by Hotspot assay relative to control	B	O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO		CHEMBL3917405	=	Inhibition	%	55.0	CHEMBL2148	Homo sapiens	INH	%	55.0
	16844323	CHEMBL3877392	Inhibition of human JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by KINOMEScan assay relative to control	B	O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO		CHEMBL3917405	=	Activity	%	7.9	CHEMBL2148	Homo sapiens	Activity	%	7.9
	16844413	CHEMBL3877409	Inhibition of human JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system by KINOMEScan assay	B	O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO		CHEMBL3917405	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	16880216	CHEMBL3880812	Inhibition of JAK3 (unknown origin) using poly(Glu)4Tyr substrate and and [gamma-33P]-ATP incubated for 20 mins by Top-count assay	B	Cc1cc(Nc2cc(N3CCC3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3936298	<	Ki	nM	500.0	CHEMBL2148	Homo sapiens	Ki	uM	0.5
	16880217	CHEMBL3880812	Inhibition of JAK3 (unknown origin) using poly(Glu)4Tyr substrate and and [gamma-33P]-ATP incubated for 20 mins by Top-count assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3905298	<	Ki	nM	500.0	CHEMBL2148	Homo sapiens	Ki	uM	0.5
	16880218	CHEMBL3880812	Inhibition of JAK3 (unknown origin) using poly(Glu)4Tyr substrate and and [gamma-33P]-ATP incubated for 20 mins by Top-count assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1		CHEMBL3545378	<	Ki	nM	250.0	CHEMBL2148	Homo sapiens	Ki	uM	0.25
	16910531	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(N[C@@H](C)c3ccccc3)n2)ccc1O		CHEMBL538630	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910532	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CC[C@H](Nc1cncc(-c2ccc(O)c(OC)c2)n1)c1ccccc1		CHEMBL560480	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910533	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(NC(C)c3cccc(NC(=O)c4ccncc4)c3)n2)ccc1O		CHEMBL3951278	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910534	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(NC(C)c3cccc(NC(=O)[C@H]4CCCN4)c3)n2)ccc1O		CHEMBL3948658	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910535	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(NC(C)c3ccc(-c4cccnc4)cc3)n2)ccc1O		CHEMBL3913514	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910536	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(NC(C)c3cccc(NC(=O)c4cccnc4)c3)n2)ccc1O		CHEMBL473487	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910537	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cc(N[C@@H](C)c3ccccc3)ncn2)ccc1O		CHEMBL3894434	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910538	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1ccnc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cccnc1		CHEMBL562472	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910539	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2nc(N[C@H](C)c3ccccc3)nnc2C)ccc1O		CHEMBL3955686	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910540	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1nnc(C)c(-c2cc(OC)c(OC)c(OC)c2)n1)c1ccccc1		CHEMBL3958313	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910541	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CC[C@H](Nc1nc(-c2ccc(O)c(OC)c2)ncc1C)c1cccnc1		CHEMBL3936405	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910542	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2ncc(C)c(N[C@@H](CC)c3cccnc3)n2)cc1OC		CHEMBL3933664	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910543	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1nc(-c2ccc(O)c(OC)c2)ncc1C)c1cccnc1		CHEMBL3947792	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910544	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1		CHEMBL552212	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910545	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cc(-c2ccc(O)c(OC)c2)ncn1)c1cccnc1		CHEMBL3986224	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910546	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2cncc(N[C@@H](COCC)c3ccccc3)n2)cc1OC		CHEMBL3966343	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910547	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2cncc(N[C@@H](COC)c3ccccc3)n2)cc1OC		CHEMBL3961856	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910548	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2ncc(C)c(NC(CCO)c3ccccc3)n2)ccc1O		CHEMBL3959121	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910549	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cc(-c2ccc(NC(=O)NCC)c(OC)c2)ncn1)c1cccnc1		CHEMBL556641	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910550	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2cncc(NC(CCOC)c3ccccc3)n2)cc1OC		CHEMBL3900141	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910551	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)cnc1C)c1ccccc1		CHEMBL3979712	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910552	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)NC)c(OC)c2)n1)c1ccccn1		CHEMBL3963186	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910553	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)NCCCCCN)c(C)c2)n1)c1cccnc1		CHEMBL3907438	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910554	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cccnc1C		CHEMBL3910249	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910555	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1ccccn1		CHEMBL3900028	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910556	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)CN(C)C)c(OC)c2)n1)c1cccnc1		CHEMBL3971231	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910557	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(C)c2)n1)c1cnccc1C		CHEMBL3937228	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910558	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cnccc1C		CHEMBL3926960	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910559	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1ccccn1		CHEMBL3932763	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910560	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(C)c2)n1)c1ccccn1		CHEMBL3954857	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910561	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CO)c(OC)c2)n1)c1cccnc1		CHEMBL3971563	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910562	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)NCC)c(C)c2)n1)c1cccnc1		CHEMBL3901168	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910563	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cccnc1		CHEMBL550664	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910564	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cncc(C)c1		CHEMBL3915558	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910565	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(CC)c2)n1)c1cccnc1		CHEMBL551814	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910566	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCCCN(CC)CC)c(OC)c2)n1)c1cccnc1		CHEMBL3953292	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910567	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCCN(C)C)c(OC)c2)n1)c1cccnc1		CHEMBL551531	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910568	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCCCN3CCOCC3)c(OC)c2)n1)c1cccnc1		CHEMBL3901133	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910569	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCOCC3)c(OC)c2)n1)c1cccnc1		CHEMBL3908354	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910570	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCCC3)c(OC)c2)n1)c1cccnc1		CHEMBL3911106	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910571	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCN(C)CC3)c(OC)c2)n1)c1cccnc1		CHEMBL3925257	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910572	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(C)c2)n1)c1cccnc1		CHEMBL3947629	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910573	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2cncc(NC(C)c3cccnc3)n2)cc1OC		CHEMBL3924906	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910574	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)N3CCOCC3)cc2)n1)c1ccccc1		CHEMBL3941408	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910575	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)N3CCN(C)CC3)cc2)n1)c1ccccc1		CHEMBL3906054	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910576	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1)c1ccccc1		CHEMBL3922971	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910577	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN(CC)CC)cc2)n1)c1ccccc1		CHEMBL3901583	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910578	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(C(=O)NCCN(C)C)cc2)n1)c1ccccc1		CHEMBL3898817	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910579	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)C3CCNCC3)c(OC)c2)n1)c1cccnc1		CHEMBL3891656	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910580	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2cc(C)c(O)c(C)c2)c1)c1ccccc1		CHEMBL3964021	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910581	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(O)c(OC)c2)c1)c1ccccc1		CHEMBL3923926	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910582	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2cncc(N[C@@H](C)c3ccccc3)c2)ccc1O		CHEMBL3926651	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910583	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2cc(OC)c(OC)c(OC)c2)c1)c1ccccc1		CHEMBL3939818	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910584	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2nccc(N[C@@H](C)c3ccccc3)n2)ccc1O		CHEMBL3942468	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910585	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCNC(=O)Nc1ccc(-c2cncc(N[C@@H](CC)c3cccnc3)n2)cc1OC		CHEMBL3894712	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910586	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN)c(OC)c2)n1)c1cccnc1		CHEMBL3937095	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910587	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCCC3)cc2)n1)c1ccccc1		CHEMBL3906792	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910588	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	COc1cc(-c2nc(N[C@H](C)c3ccccc3)nnc2C)cc(OC)c1OC		CHEMBL3956459	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910589	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1nnc(C)c(-c2ccc(O)c(OC)c2)n1)c1ccccc1		CHEMBL3916149	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910590	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CNC(=O)C3CCNCC3)cc2)n1)c1ccccc1		CHEMBL3918917	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910591	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)c3cccnc3)c(OC)c2)n1)c1cccnc1		CHEMBL3941803	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910592	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)cc2)n1)c1cccnc1		CHEMBL3939099	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910593	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCC(O)CC3)cc2)n1)c1ccccc1		CHEMBL3925999	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910594	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCC[C@H]3CO)cc2)n1)c1ccccc1		CHEMBL3923221	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910595	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN(C)C)cc2)n1)c1ccccc1		CHEMBL3965862	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910596	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN)c(OC)c2)n1)c1ccccc1		CHEMBL3960703	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910597	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN3CCN(C)CC3)c(OC)c2)n1)c1ccccc1		CHEMBL3911575	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910598	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN(CC)CC)c(OC)c2)n1)c1ccccc1		CHEMBL3929853	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910599	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN3CCCC3)c(OC)c2)n1)c1ccccc1		CHEMBL3980501	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910600	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN3CCCCC3)c(OC)c2)n1)c1ccccc1		CHEMBL3976134	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910601	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCN3CCOCC3)c(OC)c2)n1)c1ccccc1		CHEMBL3926456	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910602	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CNC(=O)C3CCCNC3)cc2)n1)c1ccccc1		CHEMBL3929126	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910603	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CNC(=O)C3CCC(=O)N3)cc2)n1)c1ccccc1		CHEMBL3902836	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910604	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCn3ccnc3)c(OC)c2)n1)c1ccccc1		CHEMBL3956414	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910605	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCN(C)CC3)c(OC)c2)n1)c1ccccc1		CHEMBL3960626	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910606	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN(CC)CC)c(OC)c2)n1)c1ccccc1		CHEMBL3950356	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910607	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCCC3)c(OC)c2)n1)c1ccccc1		CHEMBL3929482	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910608	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)N3CCN(C)CC3)c(OC)c2)n1)c1cccnc1		CHEMBL3898827	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910609	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN)cc2)n1)c1ccccc1		CHEMBL3934145	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910610	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCN3CCOCC3)c(OC)c2)n1)c1ccccc1		CHEMBL3936924	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910611	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCCO)c(OC)c2)n1)c1ccccc1		CHEMBL3905994	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910612	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cccnc1		CHEMBL551815	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910613	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCN(C)CC3)cc2)n1)c1ccccc1		CHEMBL3967252	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910614	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCOCC3)cc2)n1)c1ccccc1		CHEMBL3962305	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910615	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCC[C@H](Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1ccccc1		CHEMBL3899329	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910616	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCN(CC)CC)c(OC)c2)n1)c1ccccc1		CHEMBL3917756	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910617	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCCO)c(OC)c2)n1)c1ccccc1		CHEMBL3951579	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910618	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CN3CCCCC3)cc2)n1)c1ccccc1		CHEMBL3948968	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910619	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(CO)cc2)n1)c1ccccc1		CHEMBL3913805	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910620	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(OCCN(CC)CC)c(OC)c2)n1)c1cncc(C)c1		CHEMBL3955621	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	16910621	CHEMBL3883123	Inhibition of TEL-fused JAK3 kinase domain (2520 to 3469 nucleotide) (unknown origin) expressed in mouse BaF3 cells assessed as decrease in cell growth at 20 uM after 40 hrs by MTT assay relative to control	B	CCCC(Nc1cncc(-c2ccc(NC(=O)NCC)c(OC)c2)n1)c1cccc(F)c1		CHEMBL3909347	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
191725	17602023	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(Cl)cn3)CC4)n[nH]c2c1		CHEMBL3644641	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
191727	17602025	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4cc(C(=O)c5ccc(Oc6ccccc6F)cc5OCC(C)NN)cnc4[nH]3)n[nH]c2c1		CHEMBL3644642	=	IC50	nM	3.6	CHEMBL2148	Homo sapiens	IC50	nM	3.6
191729	17602027	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4cc(Cc5ccc(N6C=CC=CC6)nc5)cnc4[nH]3)n[nH]c2c1		CHEMBL3644643	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
191731	17602029	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4cc(Cc5ccc6c(n5)NCC=C6)cnc4[nH]3)n[nH]c2c1		CHEMBL3644644	=	IC50	nM	10.9	CHEMBL2148	Homo sapiens	IC50	nM	10.9
191733	17602031	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	O=C(c1cnc2[nH]c(-c3n[nH]c4cc(-c5cc(F)c(O)cc5CC(F)(F)F)ccc34)nc2c1)c1cnc(N2CCCCC2)cn1		CHEMBL3644645	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
216713	17605851	CHEMBL3707951	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	B	CN1CCC(c2ccc(Nc3nc4c(NCc5cccc(S(C)(=O)=O)c5)cccn4n3)cc2)CC1		CHEMBL3935745	=	IC50	nM	2999.0	CHEMBL2148	Homo sapiens	IC50	nM	2999.0
230509	17618648	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
230510	17618649	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	4.7	CHEMBL2148	Homo sapiens	IC50	nM	4.7
230511	17618650	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689515	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
230512	17618651	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CC(F)(F)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689516	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
230513	17618652	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689517	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
230514	17618653	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689518	=	IC50	nM	7.1	CHEMBL2148	Homo sapiens	IC50	nM	7.1
230515	17618654	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689519	=	IC50	nM	5.8	CHEMBL2148	Homo sapiens	IC50	nM	5.8
230516	17618655	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CN(CCC#N)C(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689520	=	IC50	nM	730.0	CHEMBL2148	Homo sapiens	IC50	nM	730.0
230517	17618656	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CC2(CCCN(c3ncnc4[nH]ccc34)C2)N1C(=O)CC#N		CHEMBL3689521	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
230518	17618657	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	7.1	CHEMBL2148	Homo sapiens	IC50	nM	7.1
230519	17618658	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(c2ncnc3[nH]ccc23)CC2(CCN2C(=O)CC#N)C1		CHEMBL3689522	=	IC50	nM	58.0	CHEMBL2148	Homo sapiens	IC50	nM	58.0
230520	17618659	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689523	=	IC50	nM	87.0	CHEMBL2148	Homo sapiens	IC50	nM	87.0
230521	17618660	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CCC2(CCN2C(=O)CC#N)CN1c1ncnc2[nH]ccc12		CHEMBL3689524	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
230522	17618661	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689518	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
230523	17618662	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CC2(CCCN(c3ncnc4[nH]ccc34)C2)N1C(=O)CC#N		CHEMBL3689521	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
230524	17618663	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689518	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
230525	17618664	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
230526	17618665	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1N(c2ncnc3[nH]ccc23)CCC12CCN2C(=O)CC#N		CHEMBL3689525	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
230527	17618666	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689515	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
230528	17618667	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CC(F)(F)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689516	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
230529	17618668	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689517	=	IC50	nM	88.0	CHEMBL2148	Homo sapiens	IC50	nM	88.0
230530	17618669	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1(C)CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689526	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
230531	17618670	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	C=CCOCCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689527	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
230532	17618671	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(O)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689528	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
230533	17618672	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CN(c1ncnc3[nH]ccc13)CCC2(F)F		CHEMBL3689529	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
230534	17618673	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CN(c1ncnc3[nH]ccc13)CC2(F)F		CHEMBL3689530	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
230535	17618674	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CC2(CCCN2C(=O)CC#N)CN1c1ncnc2[nH]ccc12		CHEMBL3689531	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
230536	17618675	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1N(c2ncnc3[nH]ccc23)CCC12CCCN2C(=O)CC#N		CHEMBL3689532	=	IC50	nM	36.0	CHEMBL2148	Homo sapiens	IC50	nM	36.0
230537	17618676	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(O)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689528	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
230538	17618677	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(O)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689528	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
230539	17618678	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689517	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
230540	17618679	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1(C)CN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689533	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
230541	17618680	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	COCCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689534	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
230542	17618681	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CCN(C(=O)CC#N)C12CN(c1ncnc3[nH]ccc13)CC2(F)F		CHEMBL3689535	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	nM	140.0
230543	17618682	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1(C)CCN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689536	=	IC50	nM	90.0	CHEMBL2148	Homo sapiens	IC50	nM	90.0
230544	17618683	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CC2(CCCN2C(=O)CC#N)CN1c1ncnc2[nH]ccc12		CHEMBL3689531	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
230545	17618684	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	C[C@H](O)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689537	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
230546	17618685	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	O=C(CO)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693592	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
230547	17618686	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CO[C@@H](C)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693593	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
230548	17618687	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CO[C@H](C)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693594	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
230549	17618688	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(=O)O[C@@H](C)C(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693595	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
230550	17618689	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	COCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693596	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
230551	17618690	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CCNC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693597	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
230552	17618691	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(=O)OCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693598	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
230553	17618692	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCNC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693599	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
230554	17618693	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCCN1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693600	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
230555	17618694	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CCN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693601	=	IC50	nM	5.9	CHEMBL2148	Homo sapiens	IC50	nM	5.9
230556	17618695	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC(F)(F)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693602	=	IC50	nM	6.6	CHEMBL2148	Homo sapiens	IC50	nM	6.6
230557	17618696	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693603	=	IC50	nM	6.8	CHEMBL2148	Homo sapiens	IC50	nM	6.8
230558	17618697	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC12CCCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693604	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
230559	17618698	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCCNC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693605	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
230560	17618699	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689515	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
230561	17618700	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CCN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693606	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
230562	17618701	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	COC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693607	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	nM	650.0
230563	17618702	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCNC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693608	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
230564	17618703	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CN(CC#N)C(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693609	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
230565	17618704	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#Cc1cccc(C(=O)N2CCCC23CCN(c2ncnc4[nH]ccc24)C3)c1		CHEMBL3693610	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
230566	17618705	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#Cc1ccc(C(=O)N2CCCC23CCN(c2ncnc4[nH]ccc24)C3)cc1		CHEMBL3693611	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
230567	17618706	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC1CCN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693601	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
230568	17618707	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCCNC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693612	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
230569	17618708	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CCCNC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693613	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
230570	17618709	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	COC(=O)CCC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693614	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
230571	17618710	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	COC(=O)CCC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693614	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	nM	300.0
230572	17618711	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693615	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	nM	250.0
230573	17618712	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	O=C(CO)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693616	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
230574	17618713	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CC1(C(=O)N2CCCC23CCN(c2ncnc4[nH]ccc24)C3)CC1		CHEMBL3693617	=	IC50	nM	73.0	CHEMBL2148	Homo sapiens	IC50	nM	73.0
230575	17618714	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693618	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
230576	17618715	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(C)(C)OC(=O)N1CCCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693619	=	IC50	nM	760.0	CHEMBL2148	Homo sapiens	IC50	nM	760.0
230577	17618716	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693620	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
230578	17618717	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(=O)N1CCCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693621	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
230579	17618718	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(C)(C)OC(=O)N1CCCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693622	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
230580	17618719	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(=O)N1CCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693623	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	nM	460.0
230581	17618720	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693624	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
230582	17618721	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693625	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	nM	250.0
230583	17618722	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689519	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
230584	17618723	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CC(C)C(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693626	=	IC50	nM	570.0	CHEMBL2148	Homo sapiens	IC50	nM	570.0
230585	17618724	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	CCC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693627	=	IC50	nM	450.0	CHEMBL2148	Homo sapiens	IC50	nM	450.0
230586	17618725	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693628	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
230587	17618726	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	c1nc(N2CCC3(CCCN3)C2)c2cc[nH]c2n1		CHEMBL3693629	=	IC50	nM	8600.0	CHEMBL2148	Homo sapiens	IC50	nM	8600.0
230588	17618727	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	c1ccc(CN2CCCC23CCN(c2ncnc4[nH]ccc24)C3)cc1		CHEMBL3693630	=	IC50	nM	550.0	CHEMBL2148	Homo sapiens	IC50	nM	550.0
230589	17618728	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CCN(c1c(Cl)cnc3[nH]ncc13)C2		CHEMBL3693631	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
230590	17618729	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCCC12CCN(c1c(Cl)cnc3[nH]ncc13)C2		CHEMBL3693632	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
230591	17618730	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCC12CCCN(c1ncnc3nc[nH]c13)C2		CHEMBL3693633	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
230592	17618731	CHEMBL3705640	Inhibition Assay: In the kinase reactions, fused proteins (6His tag-fused hJAK3 kinase domain (aa781-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NTA agarose were used.	B	N#CCC(=O)N1CCCCC12CCN(c1ncnc3nc[nH]c13)C2		CHEMBL3693634	=	IC50	nM	78.0	CHEMBL2148	Homo sapiens	IC50	nM	78.0
241634	17625129	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Cc1ccc(C)c(-c2nn(C)cc2NC(=O)c2cnn3ccc(N)nc23)c1		CHEMBL2178803	=	Ki	nM	2.9	CHEMBL2148	Homo sapiens	Ki	nM	2.9
241635	17625130	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2cc(Cl)ccc2C)n1		CHEMBL3670390	=	Ki	nM	15.7	CHEMBL2148	Homo sapiens	Ki	nM	15.7
241636	17625131	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Cc1nc(-c2ccccc2C)c(NC(=O)c2cnn3ccc(N)nc23)s1		CHEMBL3670391	=	Ki	nM	12.4	CHEMBL2148	Homo sapiens	Ki	nM	12.4
241637	17625132	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Cc1cc(NC(=O)c2cnn3ccc(Nc4cccc(C(F)(F)F)c4)nc23)on1		CHEMBL3670392	=	Ki	nM	95.1	CHEMBL2148	Homo sapiens	Ki	nM	95.1
241638	17625133	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Nc1ccn2ncc(C(=O)Nc3c[nH]nc3-c3cc(Cl)ccc3Cl)c2n1		CHEMBL3670393	=	Ki	nM	1.7	CHEMBL2148	Homo sapiens	Ki	nM	1.7
241639	17625134	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Nc1ccn2ncc(C(=O)Nc3conc3-c3cccc(Cl)c3)c2n1		CHEMBL2178257	=	Ki	nM	55.6	CHEMBL2148	Homo sapiens	Ki	nM	55.6
241640	17625135	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Nc1ccn2ncc(C(=O)Nc3ccnn3-c3cc(Cl)ccc3Cl)c2n1		CHEMBL3670394	=	Ki	nM	25.4	CHEMBL2148	Homo sapiens	Ki	nM	25.4
241641	17625136	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	O=C(NC1CCOCC1)c1cnn2ccc(NC3Cc4ccccc4C3)nc12		CHEMBL3670395	=	Ki	nM	39.7	CHEMBL2148	Homo sapiens	Ki	nM	39.7
241642	17625137	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	O=C(NC1CCC(O)CC1)c1cnn2ccc(NC3CCc4ccccc43)nc12		CHEMBL3960901	=	Ki	nM	14.5	CHEMBL2148	Homo sapiens	Ki	nM	14.5
241643	17625138	CHEMBL3706325	JAK3 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer's specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979)).	B	Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2ccccc2C)n1		CHEMBL3670397	=	Ki	nM	28.6	CHEMBL2148	Homo sapiens	Ki	nM	28.6
258545	17641313	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12		CHEMBL3675908	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258546	17641314	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	O=C(NC1CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12		CHEMBL3675929	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258547	17641315	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	COc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)NC3CCC(O)CC3)c2n1		CHEMBL3904952	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258548	17641316	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	CC(C)NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12		CHEMBL3675968	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258549	17641317	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	O=C(NCC1CC1)c1cnn2ccc(N3CCCC3c3cncc(F)c3)nc12		CHEMBL3675980	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258550	17641318	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	CNC(=O)c1cnn2ccc(N3CCCC3c3cncc(F)c3)nc12		CHEMBL3675988	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258551	17641319	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	Cc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)NC3CC3)c2n1		CHEMBL3676049	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258552	17641320	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	CC1(NC(=O)c2cnn3ccc(N4CCC[C@@H]4c4cncc(F)c4)nc23)CC1		CHEMBL3675966	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258553	17641321	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	C[C@@H](NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12)C1CC1		CHEMBL3675997	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258554	17641322	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	C[C@H](NC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12)C1CC1		CHEMBL3675998	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258555	17641323	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	Cc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NC3(C)CC3)c2n1		CHEMBL3676058	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258556	17641324	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	O=C(NC1(C(F)(F)F)CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12		CHEMBL3675973	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
258557	17641325	CHEMBL3705390	Inhibition Assay: Compounds of Formula I were screened for their ability to inhibit Jak3 using the general enzyme inhibition assay method, in which the assay mixture contained 500 μM ATP, 10 μM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 1.5 nM Jak3 in a total volume of 20 μL. GST-tagged human Jak3 kinase domain comprising amino acids 781-1124 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV3855).	B	Cc1ncc(F)cc1C1CCCN1c1ccn2ncc(C(=O)NC3CCC(O)CC3)c2n1		CHEMBL3955007	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
274076	17656376	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(F)cc3)C4)n[nH]c2c1		CHEMBL3644618	<	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
274077	17656377	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccsn3)C4)n[nH]c2c1		CHEMBL3644619	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
274078	17656378	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccsn3)C4)n[nH]c2c1		CHEMBL3644619	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
274079	17656379	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1		CHEMBL3644620	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
274080	17656380	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(S(=O)(=O)c3ccc(N5CCOCC5)nc3)C4)n[nH]c2c1		CHEMBL3644621	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
274081	17656381	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(S(=O)(=O)c3ccc(Oc5ccccc5)nc3)C4)n[nH]c2c1		CHEMBL3644622	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
274082	17656382	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cc(C#N)ccn3)CC4)n[nH]c2c1		CHEMBL3644623	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
274083	17656383	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(F)cc3)CC4)n[nH]c2c1		CHEMBL3644624	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
274084	17656384	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccsn3)CC4)n[nH]c2c1		CHEMBL3644625	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
274085	17656385	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(S(=O)(=O)c3ccc(F)cc3)C4)n[nH]c2c1		CHEMBL3644626	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
274086	17656386	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3ccccc3)CC4)n[nH]c2c1		CHEMBL3644627	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
274087	17656387	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(Cl)cn3)C4)n[nH]c2c1		CHEMBL3644628	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
274088	17656388	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(C#N)nc3)C4)n[nH]c2c1		CHEMBL3644629	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
274089	17656389	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(C#N)nc3)CC4)n[nH]c2c1		CHEMBL3644630	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
274090	17656390	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3ccc5ncccc5c3)C4)n[nH]c2c1		CHEMBL3644631	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
274091	17656391	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3ccc(O)cc3)C4)n[nH]c2c1		CHEMBL3644632	=	IC50	nM	2.2	CHEMBL2148	Homo sapiens	IC50	nM	2.2
274092	17656392	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3cccc(O)c3)C4)n[nH]c2c1		CHEMBL3644633	=	IC50	nM	5.6	CHEMBL2148	Homo sapiens	IC50	nM	5.6
274093	17656393	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3ccnc(C#N)c3)C4)n[nH]c2c1		CHEMBL3644634	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
274094	17656394	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3cccc(OC)c3)C4)n[nH]c2c1		CHEMBL3644635	=	IC50	nM	2.6	CHEMBL2148	Homo sapiens	IC50	nM	2.6
274095	17656395	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3cnc5ccccc5c3)C4)n[nH]c2c1		CHEMBL3644636	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
274096	17656396	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3ccc(Oc5ccccc5)nc3)C4)n[nH]c2c1		CHEMBL3644637	=	IC50	nM	2.4	CHEMBL2148	Homo sapiens	IC50	nM	2.4
274097	17656397	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(Cc3cccnc3C#N)C4)n[nH]c2c1		CHEMBL3644638	=	IC50	nM	4.1	CHEMBL2148	Homo sapiens	IC50	nM	4.1
274098	17656398	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	O=C(c1ccc(F)cc1)N1CCc2[nH]c(-c3n[nH]c4cc(-c5cc(F)c(O)cc5CC(F)(F)F)ccc34)nc2C1		CHEMBL3644639	=	IC50	nM	6.7	CHEMBL2148	Homo sapiens	IC50	nM	6.7
274099	17656399	CHEMBL3705592	High ATP Caliper Endpoint Assay: JAK3 enzyme (Invitrogen) stock solution is made up at 4.1 uM in sterile water. JAK3 enzyme stock is diluted to 2 nM in assay buffer (10 mM HEPES free acid pH 7.5, 10 mM HEPES free base pH 7.5, 10 mM MgCL2, 0.0005% Tween-20, 0.01% BSA) containing 2 mM DTT (all supplied by Sigma). ATP is made up at 10 mM stock in sterile water and diluted to 800 uM in assay buffer. Peptide (American peptide company) is made up at 30 mM in 100% DMSO and diluted to 3 uM in assay buffer. Stop buffer comprises 140 mM HEPES, 22.5 mM EDTA (Sigma) and 0.15% coating reagent (Caliper Life Sciences).Assays are performed in Greiner polypropylene 384 well plates. Following compound preparation within the plate 10 ul of enzyme in assay buffer containing DTT is added using a Multidrop Micro. Final assay concentration of enzyme is 1 nM. Compound and enzyme are pre-incubated for 60 minutes at room temperature using low evaporation lids before addition of 10 ul ATP/peptide mixture in assay buffer.	B	Oc1cc(CC(F)(F)F)c(-c2ccc3c(-c4nc5c([nH]4)CCN(Cc4ccccc4)C5)n[nH]c3c2)cc1F		CHEMBL3644640	=	IC50	nM	186.0	CHEMBL2148	Homo sapiens	IC50	nM	186.0
276771	17659110	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC(=O)Nc1cc2c(N[C@@H]3CC[C@@](C)(O)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3666882	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
276772	17659111	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(NS(=O)(=O)c4ccccc4)cc23)CC[C@@]1(C)O		CHEMBL3666883	=	IC50	nM	22.1	CHEMBL2148	Homo sapiens	IC50	nM	22.1
276773	17659112	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(NS(=O)(=O)c4ccc(Cl)cc4)cc23)CC[C@@]1(C)O		CHEMBL3666884	=	IC50	nM	23.4	CHEMBL2148	Homo sapiens	IC50	nM	23.4
276774	17659113	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1ccc(S(=O)(=O)Nc2cc3c(N[C@@H]4CC[C@@](C)(O)C4(C)C)c(C(N)=O)cnn3c2)cc1		CHEMBL3666885	=	IC50	nM	34.2	CHEMBL2148	Homo sapiens	IC50	nM	34.2
276775	17659114	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CCS(=O)(=O)Nc1cc2c(N[C@@H]3CC[C@@](C)(O)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3666886	=	IC50	nM	8.1	CHEMBL2148	Homo sapiens	IC50	nM	8.1
276776	17659115	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC(C)c1ccccc1-c1cc2c(N[C@@H]3CCC[C@]3(C)F)c(C(N)=O)cnn2c1		CHEMBL3666887	=	IC50	nM	135.6	CHEMBL2148	Homo sapiens	IC50	nM	135.6
276777	17659116	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cncc4ccccc34)cc12		CHEMBL3666888	=	IC50	nM	46.4	CHEMBL2148	Homo sapiens	IC50	nM	46.4
276778	17659117	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cc1cccc(-c2cc3c(N[C@@H]4CCC[C@]4(C)F)c(C(N)=O)cnn3c2)c1		CHEMBL3666889	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
276779	17659118	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cccc(C(N)=O)c3)cc12		CHEMBL3666890	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
276780	17659119	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)cc4)cc23)CC[C@@]1(C)N		CHEMBL3666891	=	IC50	nM	9.4	CHEMBL2148	Homo sapiens	IC50	nM	9.4
276781	17659120	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C#N)CCCC1Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL3671790	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
276782	17659121	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)NS(C)(=O)=O		CHEMBL3671791	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
276783	17659122	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cn1nccc1-c1cc2c(N[C@@H]3C[C@@H](O)[C@@H](O)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3671792	=	IC50	nM	5.6	CHEMBL2148	Homo sapiens	IC50	nM	5.6
276784	17659123	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cn1nccc1-c1cc2c(N[C@@H]3CC[C@](C)(O)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3671793	=	IC50	nM	25.2	CHEMBL2148	Homo sapiens	IC50	nM	25.2
276785	17659124	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CCCC3=O)cc12		CHEMBL3671794	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
276786	17659125	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cn1nccc1-c1cc2c(N[C@H]3CC[C@@](C)(O)CC3)c(C(N)=O)cnn2c1		CHEMBL3671795	=	IC50	nM	62.7	CHEMBL2148	Homo sapiens	IC50	nM	62.7
276787	17659126	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(O)CC[C@@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4C(N)=O)cc23)CC1		CHEMBL3671796	=	IC50	nM	33.6	CHEMBL2148	Homo sapiens	IC50	nM	33.6
276788	17659127	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	[C-]#[N+]c1ccc(-c2cc3c(N[C@H]4CC[C@@](C)(O)CC4)c(C(N)=O)cnn3c2)cc1		CHEMBL3671797	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
276789	17659128	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(O)CC[C@@H](Nc2c(C(N)=O)cnn3cc(-c4cncnc4)cc23)CC1		CHEMBL3671798	=	IC50	nM	17.1	CHEMBL2148	Homo sapiens	IC50	nM	17.1
276790	17659129	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1cccc(-c2cc3c(NC4C5CC6CC4CC(O)(C6)C5)c(C(N)=O)cnn3c2)c1		CHEMBL3671799	=	IC50	nM	8.9	CHEMBL2148	Homo sapiens	IC50	nM	8.9
276791	17659130	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cc1cccc(C)c1-c1cc2c(NC3C4CC5CC3CC(O)(C5)C4)c(C(N)=O)cnn2c1		CHEMBL3671800	=	IC50	nM	524.2	CHEMBL2148	Homo sapiens	IC50	nM	524.2
276792	17659131	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1ccccc1-c1cc2c(NC3C4CC5CC3CC(O)(C5)C4)c(C(N)=O)cnn2c1		CHEMBL3671801	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
276793	17659132	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cn1nccc1-c1cc2c(NC3C4CC5CC3CC(O)(C5)C4)c(C(N)=O)cnn2c1		CHEMBL3671802	=	IC50	nM	6.2	CHEMBL2148	Homo sapiens	IC50	nM	6.2
276794	17659133	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cc1ccc(-c2cc3c(NC4C5CC6CC4CC(O)(C6)C5)c(C(N)=O)cnn3c2)cc1		CHEMBL3671803	=	IC50	nM	6.1	CHEMBL2148	Homo sapiens	IC50	nM	6.1
276795	17659134	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccnc4)cc23)CC[C@]1(C)N		CHEMBL3671804	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
276796	17659135	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	Cc1ccncc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3671805	=	IC50	nM	6.1	CHEMBL2148	Homo sapiens	IC50	nM	6.1
276797	17659136	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(N5CCCC5)nc4)cc23)CC[C@]1(C)N		CHEMBL3671806	=	IC50	nM	9.5	CHEMBL2148	Homo sapiens	IC50	nM	9.5
276798	17659137	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C(=O)NC5CC5)cc4)cc23)CC[C@]1(C)N		CHEMBL3671807	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
276799	17659138	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4C(N)=O)cc23)CC[C@]1(C)N		CHEMBL3671808	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
276800	17659139	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC(=O)Nc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3671809	=	IC50	nM	36.9	CHEMBL2148	Homo sapiens	IC50	nM	36.9
276801	17659140	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CN(C)C(=O)c1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1		CHEMBL3671810	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
276802	17659141	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(CO)cc4)cc23)CC[C@]1(C)N		CHEMBL3671811	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
276803	17659142	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc5ncccc45)cc23)CC[C@]1(C)N		CHEMBL3671812	=	IC50	nM	13.8	CHEMBL2148	Homo sapiens	IC50	nM	13.8
276804	17659143	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncc(C(=O)O)c4)cc23)CC[C@]1(C)N		CHEMBL3671813	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
276805	17659144	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1ncc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL3671814	=	IC50	nM	8.4	CHEMBL2148	Homo sapiens	IC50	nM	8.4
276806	17659145	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1cncc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1		CHEMBL3671815	=	IC50	nM	5.5	CHEMBL2148	Homo sapiens	IC50	nM	5.5
276807	17659146	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@@]1(C)O		CHEMBL3671816	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
276808	17659147	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	NC(=O)c1cnn2cc(-c3ccc(F)cc3)cc2c1NC12CC3CC(O)(CC(O)(C3)C1)C2		CHEMBL3671817	=	IC50	nM	4.7	CHEMBL2148	Homo sapiens	IC50	nM	4.7
276809	17659148	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	NC(=O)c1cnn2cc(-c3ccc4scnc4c3)cc2c1NC12CC3CC(O)(CC(O)(C3)C1)C2		CHEMBL3671818	=	IC50	nM	7.3	CHEMBL2148	Homo sapiens	IC50	nM	7.3
276810	17659149	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL3671819	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
276811	17659150	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(N4CCOCC4=O)cc23)CC[C@]1(C)N		CHEMBL3671820	=	IC50	nM	44.2	CHEMBL2148	Homo sapiens	IC50	nM	44.2
276812	17659151	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(O)CCCC[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL3671821	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
276813	17659152	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(O)CC[C@@H](Nc2c(C(N)=O)cnn3cc(-c4cncnc4N)cc23)CC1		CHEMBL3671822	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
276814	17659153	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CCOC3=O)cc12		CHEMBL3671823	=	IC50	nM	6.8	CHEMBL2148	Homo sapiens	IC50	nM	6.8
276815	17659154	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CCOCC3=O)cc12		CHEMBL3671824	=	IC50	nM	7.1	CHEMBL2148	Homo sapiens	IC50	nM	7.1
276816	17659155	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(N4CCCC4=O)cc23)CC[C@]1(C)N		CHEMBL3671825	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
276817	17659156	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(N4CCC4=O)cc23)CC[C@]1(C)N		CHEMBL3671826	=	IC50	nM	8.8	CHEMBL2148	Homo sapiens	IC50	nM	8.8
276818	17659157	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(NS(C)(=O)=O)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL3671827	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
276819	17659158	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)C(N)=O		CHEMBL3671828	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
276820	17659159	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(C(N)=O)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL3671829	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
276821	17659160	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)nc4)cc23)CC[C@]1(C)C(N)=O		CHEMBL3671830	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
276822	17659161	CHEMBL3706068	Kinase Assay: Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH 8.0, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT). Reactions were incubated for 30 minutes at room temperature and stopped by the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. TCA precipitates were collected onto 384 well phosphocellulose filters (Millipore) using a Platemate to transfer the reaction mixture, washed on an EMBLA plate washer and the filters were quantitated using a TopCount 384-well liquid scintillation counter. Dose response curves were generated to determine the concentration required inhibiting 50% of kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at six concentrations, each in triplicate. The final concentration of DMSO in the assay equaled 2%.	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)nc4)cc23)CC[C@]1(C)C(N)=O		CHEMBL3671831	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
290566	17672803	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3ccc(F)cc3)cc2c1NC1CCOCC1		CHEMBL3667453	=	IC50	nM	7.6	CHEMBL2148	Homo sapiens	IC50	nM	7.6
290567	17672804	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3cncc(F)c3)cc2c1NC1CCOCC1		CHEMBL3667454	=	IC50	nM	70.0	CHEMBL2148	Homo sapiens	IC50	nM	70.0
290568	17672805	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	Cn1nccc1-c1cc2c(NC3CCOCC3)c(C(N)=O)cnn2c1		CHEMBL3667455	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
290569	17672806	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3cccnc3)cc2c1NC1CCOCC1		CHEMBL3667456	=	IC50	nM	70.0	CHEMBL2148	Homo sapiens	IC50	nM	70.0
290570	17672807	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3cncnc3)cc2c1NC1CCOCC1		CHEMBL3667457	=	IC50	nM	148.4	CHEMBL2148	Homo sapiens	IC50	nM	148.4
290571	17672808	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	N#Cc1ccccc1-c1cc2c(NC3CCOCC3)c(C(N)=O)cnn2c1		CHEMBL3667458	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
290572	17672809	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3ccccc3F)cc2c1NC1CCOCC1		CHEMBL3667459	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
290573	17672810	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3cnc4ccccc4c3)cc2c1NC1CCOCC1		CHEMBL3667460	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
290574	17672811	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC1(F)COCC1Nc1c(C(N)=O)cnn2cc(N3CCCC3=O)cc12		CHEMBL3667461	=	IC50	nM	15.1	CHEMBL2148	Homo sapiens	IC50	nM	15.1
290575	17672812	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CS(=O)(=O)N1CCC[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)C1		CHEMBL3667462	=	IC50	nM	20.9	CHEMBL2148	Homo sapiens	IC50	nM	20.9
290576	17672813	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	NC(=O)c1cnn2cc(-c3ccccc3)cc2c1N[C@@H]1CCCNC1		CHEMBL3667463	=	IC50	nM	57.1	CHEMBL2148	Homo sapiens	IC50	nM	57.1
290577	17672814	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CCOC(=O)N1CCC[C@@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)C1		CHEMBL3667464	=	IC50	nM	284.6	CHEMBL2148	Homo sapiens	IC50	nM	284.6
290578	17672815	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@@H]4CN(C(=O)CC#N)C[C@@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3667465	=	IC50	nM	2.2	CHEMBL2148	Homo sapiens	IC50	nM	2.2
290579	17672816	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@@H]4CN(C(=O)CC#N)C[C@@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3667465	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290580	17672817	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@H]4CN(C(=O)CC#N)C[C@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3672470	=	IC50	nM	133.4	CHEMBL2148	Homo sapiens	IC50	nM	133.4
290581	17672818	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@@H]4CCN(C(=O)C(N)=O)CC4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL3667466	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
290582	17672819	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@H]4CCN(C(=O)[C@H](C)O)CC4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL3672471	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	nM	3.3
290583	17672820	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(S(C)(=O)=O)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnc(N)nc3)cc12		CHEMBL3667467	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
290584	17672821	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC(=O)N1CCN(c2cc3c(N[C@@H]4C[C@@H]5CN(S(C)(=O)=O)C[C@@H]5[C@H]4C)c(C(N)=O)cnn3c2)C1=O		CHEMBL3667468	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
290585	17672822	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(C(=O)CO)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(C(N)=O)cc3)cc12		CHEMBL3667469	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290586	17672823	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(C(=O)C(C)(C)O)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnc(N)nc3)cc12		CHEMBL3667470	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
290587	17672824	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CNC(=O)c1ccc(-c2cc3c(N[C@@H]4C[C@@H]5CN(C(=O)C(C)(C)O)C[C@@H]5[C@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3667471	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
290588	17672825	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(S(C)(=O)=O)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3nnn(C)n3)cc12		CHEMBL3667472	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290589	17672826	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(C(=O)CF)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnc(N)c(F)c3)cc12		CHEMBL3667473	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290590	17672827	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(C(=O)CO)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(C(=O)NC4CC4)cc3)cc12		CHEMBL3667474	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290591	17672828	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@@H]1[C@H]2CN(C(=O)C(C)(C)O)C[C@H]2C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)cc12		CHEMBL3667475	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290592	17672829	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC(=O)N1C[C@H]2C[C@@H](Nc3c(C(N)=O)cnn4cc(-c5cnn(C)c5)cc34)[C@H](C)[C@H]2C1		CHEMBL3667476	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290593	17672830	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CCC(=O)N1C[C@H]2C[C@@H](Nc3c(C(N)=O)cnn4cc(-c5ccc(F)nc5)cc34)[C@H](C)[C@H]2C1		CHEMBL3667477	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290594	17672831	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC1(C)CN(c2ccc(C#N)cn2)CC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CC[C@@H](O)C3=O)cc12		CHEMBL3667478	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
290595	17672832	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC1(C)CN(c2ccc(C#N)cn2)CC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CC(c4ccccc4)CC3=O)cc12		CHEMBL3667479	=	IC50	nM	11.4	CHEMBL2148	Homo sapiens	IC50	nM	11.4
290596	17672833	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC1(C)CN(c2ncc(C#N)cn2)CC[C@H]1Nc1c(C(N)=O)cnn2cc(N3CCC(CCCC(=O)O)C3=O)cc12		CHEMBL3667480	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290597	17672834	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(S(C)(=O)=O)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CCC#N)c3)cc12		CHEMBL3667481	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290598	17672835	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H](O)C(=O)N1CC[C@@H](Nc2c(C(N)=O)cnn3cc(-c4cnn(C)c4)cc23)[C@H](CC)C1		CHEMBL3667482	=	IC50	nM	5.6	CHEMBL2148	Homo sapiens	IC50	nM	5.6
290599	17672836	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(C(=O)C(C)(C)O)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnc(C)c3)cc12		CHEMBL3667483	=	IC50	nM	7.1	CHEMBL2148	Homo sapiens	IC50	nM	7.1
290600	17672837	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(C(=O)[C@H](C)O)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnc(OC)c3)cc12		CHEMBL3667484	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
290601	17672838	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(C(=O)[C@H](C)O)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)C)c3)cc12		CHEMBL3667485	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290602	17672839	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(C(=O)CC(F)(F)F)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)cc12		CHEMBL3667486	=	IC50	nM	6.7	CHEMBL2148	Homo sapiens	IC50	nM	6.7
290603	17672840	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@@H]1CN(C(=O)[C@@H](C)O)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)cc12		CHEMBL3672450	=	IC50	nM	7.8	CHEMBL2148	Homo sapiens	IC50	nM	7.8
290604	17672841	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(c2ccc(C#N)cn2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(=O)n(C)c3)cc12		CHEMBL3672451	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290605	17672842	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(c2ccc(C#N)cn2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)cc12		CHEMBL3672452	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290606	17672843	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(c2ncc(C#N)s2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)cc12		CHEMBL3672472	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
290607	17672844	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(c2ncc(C#N)s2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)C)c3)cc12		CHEMBL3672473	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
290608	17672845	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@H]1CN(c2ccc(C#N)cn2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(=O)N4CC(F)(F)C4)c3)cc12		CHEMBL3672453	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
290609	17672846	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@H]1CN(c2ccc(C#N)cn2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(=O)N4CCC(F)(F)C4)c3)cc12		CHEMBL3672454	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
290610	17672847	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CNC(=O)Cn1cc(-c2cc3c(N[C@@H]4CN(c5ccc(Cl)cn5)C[C@@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3672474	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
290611	17672848	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@H]1CN(C(=O)CC#N)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(F)nc3)cc12		CHEMBL3672455	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290612	17672849	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	C[C@H]1CN(C(=O)CC#N)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnc(F)c3)cc12		CHEMBL3672456	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290613	17672850	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CNC(=O)c1ccc(-c2cc3c(N[C@@H]4CN(C(=O)OC)C[C@@H]4C)c(C(N)=O)cnn3c2)cn1		CHEMBL3672457	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
290614	17672851	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cn(C)nc3C)cc12		CHEMBL3672458	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290615	17672852	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(C)nc3)cc12		CHEMBL3672459	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
290616	17672853	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(S(C)(=O)=O)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)C)c3)cc12		CHEMBL3672460	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
290617	17672854	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CCNC(=O)c1ccc(-c2cc3c(N[C@@H]4CN(C(=O)C(C)(C)C#N)C[C@@H]4CC)c(C(N)=O)cnn3c2)cn1		CHEMBL3672461	=	IC50	nM	8.6	CHEMBL2148	Homo sapiens	IC50	nM	8.6
290618	17672855	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(C(=O)C2(C#N)CCC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnc(Cl)c3)cc12		CHEMBL3672462	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
290619	17672856	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CS(=O)(=O)N1C[C@H](CF)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C(F)(F)F)nc4)cc23)C1		CHEMBL3672475	=	IC50	nM	9.7	CHEMBL2148	Homo sapiens	IC50	nM	9.7
290620	17672857	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ncc(-c2cc3c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4CF)c(C(N)=O)cnn3c2)cn1		CHEMBL3672463	=	IC50	nM	8.9	CHEMBL2148	Homo sapiens	IC50	nM	8.9
290621	17672858	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CCOc1ncc(-c2cc3c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4CF)c(C(N)=O)cnn3c2)cn1		CHEMBL3672464	=	IC50	nM	11.8	CHEMBL2148	Homo sapiens	IC50	nM	11.8
290622	17672859	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CC[C@H]1CN(C(=O)OC(C)(C)C)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cc(C)no3)cc12		CHEMBL3672465	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
290623	17672860	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CNC(=O)c1cccc(-c2cc3c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4OC)c(C(N)=O)cnn3c2)c1		CHEMBL3672466	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290624	17672861	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CO[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(F)cc3)cc12		CHEMBL3672467	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
290625	17672862	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	CO[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc(C#N)cc3)cc12		CHEMBL3672468	=	IC50	nM	6.6	CHEMBL2148	Homo sapiens	IC50	nM	6.6
290626	17672863	CHEMBL3706183	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2,25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 ul of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 uM; fluoresceinated peptide, 1.5 uM.	B	COc1ccc(-c2cc3c(N[C@@H]4CN(S(C)(=O)=O)C[C@@H]4OC)c(C(N)=O)cnn3c2)cn1		CHEMBL3672469	=	IC50	nM	8.9	CHEMBL2148	Homo sapiens	IC50	nM	8.9
294034	17675715	CHEMBL3705687	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	B	C=C(C)C(=O)Nc1ccc(F)c(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650998	=	IC50	nM	0.11	CHEMBL2148	Homo sapiens	IC50	nM	0.11
294990	17676346	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	O=C(Nc1ccncc1-c1cccc(F)c1)c1cnn2cccnc12		CHEMBL3667514	=	Ki	nM	200.0	CHEMBL2148	Homo sapiens	Ki	nM	200.0
294991	17676347	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2C)n1		CHEMBL3667508	=	Ki	nM	152.0	CHEMBL2148	Homo sapiens	Ki	nM	152.0
294992	17676348	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	O=C(Nc1c[nH]nc1-n1cc(Cl)ccc1=O)c1cnn2cccnc12		CHEMBL3667520	=	Ki	nM	4100.0	CHEMBL2148	Homo sapiens	Ki	nM	4100.0
294993	17676349	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccccc2Br)n1		CHEMBL3667511	=	Ki	nM	140.0	CHEMBL2148	Homo sapiens	Ki	nM	140.0
294994	17676350	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1c(NC(=O)c2c(N)nn3cccnc23)cnn1CC(N)=O		CHEMBL3667521	=	Ki	nM	5.5	CHEMBL2148	Homo sapiens	Ki	nM	5.5
294995	17676351	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	CC1CCCCN1c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667526	=	Ki	nM	240.0	CHEMBL2148	Homo sapiens	Ki	nM	240.0
294996	17676352	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ncc(C#N)cc1-c1n[nH]cc1NC(=O)c1cnn2cccnc12		CHEMBL3667518	=	Ki	nM	53.0	CHEMBL2148	Homo sapiens	Ki	nM	53.0
294997	17676353	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(C#N)cc1-c1nn(Cc2nncn2C)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667517	=	Ki	nM	210.0	CHEMBL2148	Homo sapiens	Ki	nM	210.0
294998	17676354	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(F)cc1-c1nn(CC2(O)CCOCC2)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667525	=	Ki	nM	710.0	CHEMBL2148	Homo sapiens	Ki	nM	710.0
294999	17676355	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1nn(CC(=O)N2CCCC2C)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667522	=	Ki	nM	270.0	CHEMBL2148	Homo sapiens	Ki	nM	270.0
295000	17676356	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(C#N)cc1-c1nn(CC2(O)CCCC2)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667524	=	Ki	nM	690.0	CHEMBL2148	Homo sapiens	Ki	nM	690.0
295001	17676357	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1nn(CC(O)(C(F)(F)F)C(F)(F)F)cc1NC(=O)c1cnn2cccnc12		CHEMBL3639663	=	Ki	nM	570.0	CHEMBL2148	Homo sapiens	Ki	nM	570.0
295002	17676358	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1nn(CC(=O)N2CC=CCC2)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667523	=	Ki	nM	170.0	CHEMBL2148	Homo sapiens	Ki	nM	170.0
295003	17676359	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1nc(C)sc1NC(=O)c1cnn2cccnc12		CHEMBL3667519	=	Ki	nM	13.0	CHEMBL2148	Homo sapiens	Ki	nM	13.0
295004	17676360	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ncc(Cl)cc1-c1nn(CC(=O)N(C)C)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667529	=	Ki	nM	780.0	CHEMBL2148	Homo sapiens	Ki	nM	780.0
295005	17676361	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	CCOc1ccc(Cl)cc1-c1nn([C@H]2CCCC[C@@H]2O)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667528	=	Ki	nM	210.0	CHEMBL2148	Homo sapiens	Ki	nM	210.0
295006	17676362	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1cnc(C(F)(F)F)cc1-c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12		CHEMBL3667516	=	Ki	nM	1500.0	CHEMBL2148	Homo sapiens	Ki	nM	1500.0
295007	17676363	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2Cl)n1		CHEMBL3667510	=	Ki	nM	73.9	CHEMBL2148	Homo sapiens	Ki	nM	73.9
295008	17676364	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(C#N)ccc2C)n1		CHEMBL3667509	=	Ki	nM	102.0	CHEMBL2148	Homo sapiens	Ki	nM	102.0
295009	17676365	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2Cl)n1		CHEMBL2178799	=	Ki	nM	135.0	CHEMBL2148	Homo sapiens	Ki	nM	135.0
295010	17676366	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	O=C(Nc1ccnn1-c1ccccc1Cl)c1cnn2cccnc12		CHEMBL3667512	=	Ki	nM	150.0	CHEMBL2148	Homo sapiens	Ki	nM	150.0
295011	17676367	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	COc1ccc(Cl)cc1-c1c(NC(=O)c2cnn3cccnc23)cnn1CCO		CHEMBL3667515	=	Ki	nM	18.0	CHEMBL2148	Homo sapiens	Ki	nM	18.0
295012	17676368	CHEMBL3706194	Inhibition Assay: The activity of the isolated JAK3 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, Mass.). To determine the inhibition constants (Ki) of Examples 1-508, compounds were diluted serially in DMSO and added to 50 uL kinase reactions containing 5 nM purified JAK3 enzyme, 100 mM Hepes pH7.2, 0.015% Brij-35, 1.5 uM peptide substrate, 5 uM ATP, 10 mM MgCl2, 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22Â° C. in 384-well polypropylene microtiter plates for 30 minutes and then stopped by addition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.	B	N#CC1CCN(c2n[nH]cc2NC(=O)c2cnn3cccnc23)CC1		CHEMBL3667527	=	Ki	nM	390.0	CHEMBL2148	Homo sapiens	Ki	nM	390.0
312370	17692587	CHEMBL3887153	Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.	B	Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL3545241	=	Kd	nM	10500.0	CHEMBL2148	Homo sapiens	Kd	nM	10500.0
312374	17692591	CHEMBL3887153	Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.	B	Cc1cc(Nc2nc([C@@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1	Potential transcription error	CHEMBL3939800	=	Kd	nM	5000.0	CHEMBL2148	Homo sapiens	Kd	nM	5000.0
312378	17692595	CHEMBL3887153	Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at room temperature to generate affinity resins. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific binding. Binding reactions were assembled by combining kinase, liganded affinity beads, and test compounds in 1x binding buffer (20% SeaBlock, 0.17xPBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 100x stocks in DMSO and rapidly diluted into the aqueous environment. DMSO was added to control assays lacking a test compound. Primary screen interactions were performed in polypropylene 384-well plates in a final volume of 34 uL, while Kd determinations were performed in polystyrene 96-well plates in a final volume of 135 uL. The assay plates were incubated at room temperature with shaking for 1 hr, long enough for binding reactions to reach equilibrium, and the affinity beads were washed extensively with wash buffer (1xPBS, 0.05% Tween 20) to remove unbound protein. The beads were then resuspended in elution buffer (1xPBS, 0.05% Tween 20, 2 uM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.	B	Cc1cc(Nc2nc([C@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL3962269	=	Kd	nM	21000.0	CHEMBL2148	Homo sapiens	Kd	nM	21000.0
335041	17713259	CHEMBL3887374	Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.	B	CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL2103874	=	IC50	nM	95.1	CHEMBL2148	Homo sapiens	IC50	nM	95.1
335042	17713260	CHEMBL3887374	Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)NC2CCC2)CC1		CHEMBL3925083	=	IC50	nM	742.0	CHEMBL2148	Homo sapiens	IC50	nM	742.0
342620	17720011	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	10.4	CHEMBL2148	Homo sapiens	IC50	nM	10.4
342641	17720032	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	8278.0	CHEMBL2148	Homo sapiens	IC50	nM	8278.0
342731	17720122	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	10.4	CHEMBL2148	Homo sapiens	IC50	nM	10.4
342732	17720123	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3917698	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342733	17720124	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	8278.0	CHEMBL2148	Homo sapiens	IC50	nM	8278.0
342734	17720125	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3912266	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342735	17720126	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3903870	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342736	17720127	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3903249	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342737	17720128	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL4109796	=	IC50	nM	12980.0	CHEMBL2148	Homo sapiens	IC50	nM	12980.0
342738	17720129	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3910496	=	IC50	nM	1456.0	CHEMBL2148	Homo sapiens	IC50	nM	1456.0
342739	17720130	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL4107879	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342740	17720131	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3905432	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342741	17720132	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4106607	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342742	17720133	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3893004	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342743	17720134	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3921017	=	IC50	nM	5997.0	CHEMBL2148	Homo sapiens	IC50	nM	5997.0
342744	17720135	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C(=O)/C=C/CN2CCOCC2)CC1		CHEMBL3982014	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342745	17720136	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@@H]1CCCN1C(=O)/C=C/CN1CCOCC1		CHEMBL3915538	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342746	17720137	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3921655	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
342747	17720138	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3894938	=	IC50	nM	3306.0	CHEMBL2148	Homo sapiens	IC50	nM	3306.0
342748	17720139	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1		CHEMBL4110614	=	IC50	nM	9077.0	CHEMBL2148	Homo sapiens	IC50	nM	9077.0
342749	17720140	CHEMBL3887548	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1		CHEMBL3894102	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
344952	17721722	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)C(N)=O		CHEMBL3899920	=	IC50	nM	304.9	CHEMBL2148	Homo sapiens	IC50	nM	304.9
344953	17721723	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)C(=O)N1CCC1		CHEMBL3985250	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
344954	17721724	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)C(=O)N1CCOCC1		CHEMBL3901999	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344955	17721725	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C4/SC(=O)NC4=O)cc3)nc12		CHEMBL3969640	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
344956	17721726	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1F)C(=O)N(C)C		CHEMBL3926863	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344957	17721727	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)s1)C(=O)N(C)C		CHEMBL3965484	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344958	17721728	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CCN1C(=O)S/C(=C/c2ccc(Nc3cnc4[nH]cc(C(=O)C(C)(C)C)c4n3)cc2)C1=O		CHEMBL3895215	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
344959	17721729	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)c1nccs1		CHEMBL3921931	=	IC50	nM	2200.0	CHEMBL2148	Homo sapiens	IC50	nM	2200.0
344960	17721730	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)C(=O)N1CCCCC1		CHEMBL3952461	=	IC50	nM	1270.0	CHEMBL2148	Homo sapiens	IC50	nM	1270.0
344961	17721731	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	[C-]#[N+]/C(=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)C(=O)NCC		CHEMBL3904490	=	IC50	nM	1770.0	CHEMBL2148	Homo sapiens	IC50	nM	1770.0
344962	17721732	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N4CCNCC4)cc3)nc12		CHEMBL3971092	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
344963	17721733	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1cccc(-c2cnc3[nH]ccc3n2)c1		CHEMBL3944789	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344964	17721734	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1cccc(Nc2cnc3[nH]ccc3n2)c1		CHEMBL3929650	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344965	17721735	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1cccc(Oc2cnc3[nH]ccc3n2)c1		CHEMBL3979275	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
344966	17721736	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Oc2cnc3[nH]ccc3n2)cc1		CHEMBL3964283	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
344967	17721737	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)C(=O)c1c[nH]c2ncc(-c3cccc(/C=C(\C#N)C(=O)N(C)C)c3)nc12		CHEMBL3902997	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
344968	17721738	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)NC(=O)c1c[nH]c2ncc(-c3cccc(/C=C(\C#N)C(=O)N(C)C)c3)nc12		CHEMBL3967007	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
344969	17721739	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)NC(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N(C)C)cc3)nc12		CHEMBL3910244	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
344970	17721740	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)NC(=O)c1c[nH]c2ncc(Oc3cccc(/C=C(\C#N)C(=O)N(C)C)c3)nc12		CHEMBL3914716	=	IC50	nM	1153.0	CHEMBL2148	Homo sapiens	IC50	nM	1153.0
344971	17721741	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1		CHEMBL3890245	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
344972	17721742	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(/C#N)C(N)=O)cc3)nc12		CHEMBL4114664	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
344973	17721743	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N4CCC4)cc3)nc12		CHEMBL3976465	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
344974	17721744	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN1CCN(C(=O)/C(C#N)=C/c2ccc(Nc3cnc4[nH]cc(C(=O)C(C)(C)C)c4n3)cc2)CC1		CHEMBL3900351	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
344975	17721745	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1F		CHEMBL3967948	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
344976	17721746	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1Cl		CHEMBL3891319	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
344977	17721747	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)c(F)c1		CHEMBL3960370	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
344978	17721748	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cn1		CHEMBL3977489	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
344979	17721749	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)NC(C)(C)C)c3n2)cc1		CHEMBL3951665	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
344980	17721750	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)s1		CHEMBL3929221	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
344981	17721751	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N4CCCCC4)cc3)nc12		CHEMBL3956776	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
344982	17721752	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CCNC(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1		CHEMBL3934694	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
344983	17721753	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CCN1C(=O)S/C(=C\c2ccc(Nc3cnc4[nH]cc(C(=O)C(C)(C)C)c4n3)cc2)C1=O		CHEMBL3967819	=	IC50	nM	33.5	CHEMBL2148	Homo sapiens	IC50	nM	33.5
344984	17721754	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CCOC(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1		CHEMBL4114729	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
344985	17721755	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)NC(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N4CCOCC4)cc3)nc12		CHEMBL3973173	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
344986	17721756	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(/C#N)S(C)(=O)=O)cc3)nc12		CHEMBL3955783	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
344987	17721757	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)c4nccs4)cc3)nc12		CHEMBL3963697	=	IC50	nM	38.3	CHEMBL2148	Homo sapiens	IC50	nM	38.3
344988	17721758	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)NC(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)C(=O)N4CCNCC4)cc3)nc12		CHEMBL3921536	=	IC50	nM	0.2	CHEMBL2148	Homo sapiens	IC50	nM	0.2
344989	17721759	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1)c1ccccc1		CHEMBL3949322	=	IC50	nM	5.5	CHEMBL2148	Homo sapiens	IC50	nM	5.5
344990	17721760	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C(\C#N)c4ccno4)cc3)nc12		CHEMBL3938057	=	IC50	nM	35.1	CHEMBL2148	Homo sapiens	IC50	nM	35.1
344991	17721761	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)CCN1C(=O)S/C(=C\c2ccc(Nc3cnc4[nH]cc(C(=O)C(C)(C)C)c4n3)cc2)C1=O		CHEMBL3950608	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
344992	17721762	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C4\SC(=O)N(CCN)C4=O)cc3)nc12		CHEMBL3959163	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
344993	17721763	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1ccc(-c2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1		CHEMBL3935183	=	IC50	nM	679.9	CHEMBL2148	Homo sapiens	IC50	nM	679.9
344994	17721764	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1cccc(-c2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)c1		CHEMBL3966232	=	IC50	nM	104.0	CHEMBL2148	Homo sapiens	IC50	nM	104.0
344995	17721765	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CN(C)C(=O)/C(C#N)=C/c1cccc(Oc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)c1		CHEMBL3936422	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
344996	17721766	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(-c3cccc(NC(=O)/C(C#N)=C/C4CC4)c3)nc12		CHEMBL3974727	=	IC50	nM	345.0	CHEMBL2148	Homo sapiens	IC50	nM	345.0
344997	17721767	CHEMBL3887612	Phosphorylation Assay: Phosphorylation of the appropriate peptide substrate (fluorescently labeled Srctide) by recombinant JAK3 (catalytic domain, aa 781-1124) was measured in the presence and absence of different concentrations of test compounds. Test compound, enzyme, fluorescently labeled substrate, and cofactors (ATP and Mg2+) were combined in a well of a microtiter plate and incubated for 2 hours at 25° C. The composition of the reaction buffer was 100 mM HEPES pH 7.5, 5 mM MgCl2, 0.01% Triton-X 100, 0.1% Bovine Serum Albumin, and 1% DMSO. Enzyme concentration in the final reaction mixture was 0.5 nM while peptide substrate was at 1 uM. ATP was used at 1xKm concentration corresponding to 2 uM. Serial dilutions (3-fold steps) of compounds were prepared in DMSO. At the end of the incubation, the reaction was stopped by the addition of 20 mM EDTA. Substrate and product (i.e. phosphorylated substrate) were separated electrophoretically and both were quantified by fluorescence intensity.	B	CC(C)(C)C(=O)c1c[nH]c2ncc(Nc3ccc(/C=C4\SC(=O)NC4=O)cc3)nc12		CHEMBL3941879	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
348446	17724823	CHEMBL3887685	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine series of compounds and analogues in Table 3B were synthesized and tested in 10-dose IC50 mode with 3 fold serial dilutions starting at 100 μM. The reactions were carried out at 10 μM ATP for JAK3 and ITK. The compounds 5, 7, 8, 16, 19-33, 48-51, 57-60, 66, 75, 77-92 and 133-153 exhibited biochemical IC50=between 0.1 to 1 μM against JAK3 and ITK respectively.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
348615	17724992	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3n2)c1		CHEMBL3984768	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348616	17724993	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3963521	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348617	17724994	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1		CHEMBL3902509	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348618	17724995	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC1(C(=O)Nc2cccc(-c3cnc4[nH]cc(Cl)c4c3)c2)CC1		CHEMBL3901385	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348619	17724996	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3919260	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348620	17724997	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3915825	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348621	17724998	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3926317	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348622	17724999	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	O=C(CF)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3953949	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348623	17725000	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1		CHEMBL3938761	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348624	17725001	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)c1		CHEMBL3962690	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348625	17725002	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	Cc1c[nH]c2ncc(-c3cccc(NC(=O)CF)c3)cc12		CHEMBL3911910	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348626	17725003	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(F)c4OC)c3c2)c1		CHEMBL3939895	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348627	17725004	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3c2)c1		CHEMBL3917327	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348628	17725005	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(CC)CC)c4)c3c2)c1		CHEMBL3948653	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348629	17725006	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(C(=O)OCC)c4)c3c2)c1		CHEMBL3918545	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348630	17725007	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc(F)cc(F)c4OC)c3c2)c1		CHEMBL3946420	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348631	17725008	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cc(-c2cnc3[nH]cc(C)c3c2)ccc1F		CHEMBL3909234	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348632	17725009	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3c2)c1		CHEMBL3979472	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348633	17725010	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3n2)c1		CHEMBL3918168	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348634	17725011	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	Cc1n[nH]c2ncc(-c3cccc(NC(=O)/C=C/N(C)C)c3)cc12		CHEMBL3979809	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348635	17725012	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	Cc1n[nH]c2ncc(-c3ccc(Cl)c(NC(=O)/C=C/N(C)C)c3)cc12		CHEMBL3942125	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348636	17725013	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cc(-c2cnc3[nH]nc(C)c3c2)ccc1Cl		CHEMBL3968188	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348637	17725014	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC/C=C/C(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL3967741	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348638	17725015	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1		CHEMBL3976245	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348639	17725016	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1		CHEMBL3964955	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348640	17725017	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F		CHEMBL3904442	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348641	17725018	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F		CHEMBL3907847	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348642	17725019	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3c2)c1		CHEMBL3958574	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348643	17725020	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(C)cc5[nH]4)c3c2)c1		CHEMBL3914851	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348644	17725021	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1		CHEMBL3920364	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348645	17725022	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1		CHEMBL3951591	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348646	17725023	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1		CHEMBL3937076	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348647	17725024	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1		CHEMBL3966831	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348648	17725025	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cccc(-c2cnc3[nH]ccc3c2)n1		CHEMBL3968455	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348649	17725026	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)n1		CHEMBL3962931	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348650	17725027	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F		CHEMBL3986267	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348651	17725028	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F		CHEMBL3957567	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348652	17725029	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F		CHEMBL3981782	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348653	17725030	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F		CHEMBL3956377	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348654	17725031	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cc(-c2cnc3[nH]ccc3c2)ccc1F		CHEMBL3973770	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348655	17725032	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cc(-c2cnc3[nH]cc(Cl)c3c2)ccc1F		CHEMBL3944305	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348656	17725033	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1		CHEMBL3958612	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348657	17725034	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CCC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1		CHEMBL3927614	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348658	17725035	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CC#CC(=O)Nc1cccc(-c2cnc3[nH]cc(C)c3c2)n1		CHEMBL3967872	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348659	17725036	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C#CC(=O)Nc1cc(-c2cnc3[nH]cc(C)c3c2)ccc1F		CHEMBL3893228	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348660	17725037	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	COc1c(F)cc(F)cc1-c1c[nH]c2ncc(-c3cc(NC(=O)/C=C/CN(C)C)ccc3F)cc12		CHEMBL3925725	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348661	17725038	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	COc1cc(F)c(C)cc1-c1c[nH]c2ncc(-c3cccc(NC(=O)/C=C/CN(C)C)c3)cc12		CHEMBL3948029	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348662	17725039	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc(C)c(F)cc4OC)c3c2)c1		CHEMBL3920230	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348663	17725040	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	Cc1cccc(-c2c[nH]c3ncc(-c4cccc(NC(=O)/C=C/CN(C)C)c4)cc23)c1F		CHEMBL3943435	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348664	17725041	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(C)c4F)c3c2)c1		CHEMBL3919033	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348665	17725042	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	C=CC(=O)Nc1cccc(-c2cnc3c(c2)CC(=O)N3)c1		CHEMBL3934456	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348666	17725043	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	Cc1c[nH]c2ncc(-c3cccc(NC(=O)/C=C/CN(C)C)c3)cc12		CHEMBL3906494	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
348667	17725044	CHEMBL3887690	Biochemical Inhibition Assay: 1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Janus and TEC family of kinases except for the BMX and TXK it had activity of 30 and 45 nM respectively.	B	CN(C)C/C=C/C(=O)Nc1cccc(-c2cnc3[nH]cc(Cl)c3c2)c1		CHEMBL3921295	<	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
351795	17727797	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1nc(C2CCCCC2)c2c3cc[nH]c3ncn12		CHEMBL3963532	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	nM	1400.0
351796	17727798	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3cnc(C4CCCCC4)c23)[nH]1		CHEMBL3948605	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	nM	61.0
351797	17727799	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCCC(c2ncn3cnc4[nH]ccc4c23)C1		CHEMBL3924291	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	nM	1400.0
351798	17727800	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC(=O)N1CCCC(c2ncn3cnc4[nH]ccc4c23)C1		CHEMBL3898786	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	nM	290.0
351799	17727801	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccccc1-c1nnn2cnc3[nH]ccc3c12		CHEMBL3911874	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
351800	17727802	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCCCC4)c23)[nH]1		CHEMBL3969473	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
351801	17727803	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1CCCCC1c1nnn2cnc3[nH]ccc3c12		CHEMBL3936356	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
351802	17727804	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	S=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12		CHEMBL3935714	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
351803	17727805	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12		CHEMBL3955496	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
351804	17727806	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3906967	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
352735	17728737	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1CCN(C(=O)OC(C)(C)C)CC1c1nnn2cnc3[nH]ccc3c12		CHEMBL3963319	=	IC50	nM	440.0	CHEMBL2148	Homo sapiens	IC50	nM	440.0
352736	17728738	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1CCN(C(=O)CC#N)CC1c1nnn2cnc3[nH]ccc3c12		CHEMBL3915844	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
352737	17728739	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1		CHEMBL3955793	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352738	17728740	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1		CHEMBL3906872	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352739	17728741	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCCNC4)c23)[nH]1		CHEMBL3977496	=	IC50	nM	4300.0	CHEMBL2148	Homo sapiens	IC50	nM	4300.0
352740	17728742	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1		CHEMBL3896712	=	IC50	nM	5300.0	CHEMBL2148	Homo sapiens	IC50	nM	5300.0
352741	17728743	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CC(F)(F)F)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1		CHEMBL3971389	=	IC50	nM	2100.0	CHEMBL2148	Homo sapiens	IC50	nM	2100.0
352742	17728744	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cncc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)c1		CHEMBL3909793	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352743	17728745	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCCN(Cc5cncs5)C4)c23)[nH]1		CHEMBL3986686	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352744	17728746	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(Nc1nncs1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1		CHEMBL3896215	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
352745	17728747	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(NC(=O)N2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)sn1		CHEMBL3963555	=	IC50	nM	900.0	CHEMBL2148	Homo sapiens	IC50	nM	900.0
352746	17728748	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1		CHEMBL3902447	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352747	17728749	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1		CHEMBL3920352	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352748	17728750	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3985597	=	IC50	nM	6900.0	CHEMBL2148	Homo sapiens	IC50	nM	6900.0
352749	17728751	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3929096	=	IC50	nM	440.0	CHEMBL2148	Homo sapiens	IC50	nM	440.0
352750	17728752	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3933612	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352751	17728753	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCNCC4)c23)[nH]1		CHEMBL3974904	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352752	17728754	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3958797	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
352753	17728755	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CC(F)(F)F)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3931293	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352754	17728756	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(Nc1nncs1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3969865	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
352755	17728757	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(NC(=O)N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)sn1		CHEMBL3943768	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352756	17728758	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3944831	=	IC50	nM	380.0	CHEMBL2148	Homo sapiens	IC50	nM	380.0
352757	17728759	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3916915	=	IC50	nM	78.0	CHEMBL2148	Homo sapiens	IC50	nM	78.0
352758	17728760	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3953550	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
352759	17728761	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3892138	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
352760	17728762	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1noc(C)c1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3896798	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352761	17728763	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3918854	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
352762	17728764	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)Sc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3912192	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
352763	17728765	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3936616	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
352764	17728766	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1		CHEMBL3899634	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
352765	17728767	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3927649	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
352766	17728768	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3890660	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352767	17728769	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3922240	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
352768	17728770	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(Cc5cncs5)CC4)c23)[nH]1		CHEMBL3983078	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
352769	17728771	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3913228	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352770	17728772	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F		CHEMBL3975090	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352771	17728773	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc(C(F)(F)F)c1		CHEMBL3900724	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352772	17728774	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)n1		CHEMBL3981443	=	IC50	nM	440.0	CHEMBL2148	Homo sapiens	IC50	nM	440.0
352773	17728775	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3949285	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
352774	17728776	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(CC5CCCCC5)CC4)c23)[nH]1		CHEMBL3973453	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352775	17728777	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(C5CCCC5)CC4)c23)[nH]1		CHEMBL3943946	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352776	17728778	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1		CHEMBL3897798	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
352777	17728779	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(F)c(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1		CHEMBL3972475	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
352778	17728780	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3986618	=	IC50	nM	71.0	CHEMBL2148	Homo sapiens	IC50	nM	71.0
352779	17728781	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3957937	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
352780	17728782	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C1CCC(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3956311	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352781	17728783	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C1CCC(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3956311	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352782	17728784	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(Nc1cccc(C(F)(F)F)c1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3959789	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352783	17728785	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(c1ccc(C(F)(F)F)cc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3897131	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352784	17728786	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3903353	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352785	17728787	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)OCc1ccccc1		CHEMBL3927827	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352786	17728788	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3945787	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
352787	17728789	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3975158	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	nM	470.0
352788	17728790	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CO[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3951060	=	IC50	nM	780.0	CHEMBL2148	Homo sapiens	IC50	nM	780.0
352789	17728791	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3983127	=	IC50	nM	930.0	CHEMBL2148	Homo sapiens	IC50	nM	930.0
352790	17728792	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CC5CCC4C5)c23)[nH]1		CHEMBL3926766	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
352791	17728793	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCCCCC4)c23)[nH]1		CHEMBL3917774	=	IC50	nM	86.0	CHEMBL2148	Homo sapiens	IC50	nM	86.0
352792	17728794	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCC4)c23)[nH]1		CHEMBL3891204	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	nM	650.0
352793	17728795	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3900224	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352794	17728796	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(=O)SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3905627	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
352795	17728797	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(=O)OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3892296	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
352796	17728798	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3942741	=	IC50	nM	65.0	CHEMBL2148	Homo sapiens	IC50	nM	65.0
352797	17728799	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	BrC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3918308	=	IC50	nM	74.0	CHEMBL2148	Homo sapiens	IC50	nM	74.0
352798	17728800	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	ClC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3954894	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
352799	17728801	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3927252	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
352800	17728802	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3934580	=	IC50	nM	53.0	CHEMBL2148	Homo sapiens	IC50	nM	53.0
352801	17728803	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3967735	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
352802	17728804	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3929124	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
352803	17728805	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3984424	=	IC50	nM	640.0	CHEMBL2148	Homo sapiens	IC50	nM	640.0
352804	17728806	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3911186	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352805	17728807	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3943557	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352806	17728808	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCC(c2ncn3cnc4[nH]ccc4c23)CC1		CHEMBL3973060	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	nM	620.0
352807	17728809	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCC(c2[nH]c(=S)n3cnc4[nH]ccc4c23)CC1		CHEMBL3958601	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352808	17728810	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN2CCC(c3[nH]c(=S)n4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3932581	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
352809	17728811	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S1(=O)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3896777	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
352810	17728812	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3922488	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352811	17728813	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3894474	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
352812	17728814	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCOCC5)CC4)c23)[nH]1		CHEMBL3917030	=	IC50	nM	640.0	CHEMBL2148	Homo sapiens	IC50	nM	640.0
352813	17728815	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3983303	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352814	17728816	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3908040	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
352815	17728817	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	F[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3895546	=	IC50	nM	830.0	CHEMBL2148	Homo sapiens	IC50	nM	830.0
352816	17728818	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	F[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4112119	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352817	17728819	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1(C)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3970198	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352818	17728820	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3971898	=	IC50	nM	970.0	CHEMBL2148	Homo sapiens	IC50	nM	970.0
352819	17728821	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3900746	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	nM	300.0
352820	17728822	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3976885	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352821	17728823	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3909814	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
352822	17728824	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3984960	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
352823	17728825	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)cc1		CHEMBL3915165	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352824	17728826	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(C#N)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3899650	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352825	17728827	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(OC(F)(F)F)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3924171	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352826	17728828	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F		CHEMBL3937827	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352827	17728829	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3891947	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352828	17728830	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3972506	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352829	17728831	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C#N)cc1		CHEMBL3897849	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
352830	17728832	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)c(F)c1		CHEMBL3957990	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
352831	17728833	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)Oc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3986660	=	IC50	nM	510.0	CHEMBL2148	Homo sapiens	IC50	nM	510.0
352832	17728834	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3949323	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
352833	17728835	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F		CHEMBL3950680	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	nM	250.0
352834	17728836	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CS(=O)(=O)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3943994	=	IC50	nM	710.0	CHEMBL2148	Homo sapiens	IC50	nM	710.0
352835	17728837	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)Oc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3973486	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352836	17728838	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)Oc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)c1		CHEMBL3962689	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352837	17728839	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(F)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3919766	=	IC50	nM	560.0	CHEMBL2148	Homo sapiens	IC50	nM	560.0
352838	17728840	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c(C(F)(F)F)c1		CHEMBL3973017	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352839	17728841	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNc5ccc(N6CCOCC6)cc5)CC4)c23)[nH]1		CHEMBL3943501	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352840	17728842	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3980241	=	IC50	nM	590.0	CHEMBL2148	Homo sapiens	IC50	nM	590.0
352841	17728843	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC[C@@H]5CCCO5)CC4)c23)[nH]1		CHEMBL3934627	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352842	17728844	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3956611	=	IC50	nM	460.0	CHEMBL2148	Homo sapiens	IC50	nM	460.0
352843	17728845	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1		CHEMBL3978777	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352844	17728846	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3967682	=	IC50	nM	870.0	CHEMBL2148	Homo sapiens	IC50	nM	870.0
352845	17728847	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCC(N5CCOCC5)CC4)c23)[nH]1		CHEMBL3926748	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352846	17728848	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1cccc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3900189	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352847	17728849	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCC(NCCN5CCOCC5)CC4)c23)[nH]1		CHEMBL3927316	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352848	17728850	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1CCN(C2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3970109	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352849	17728851	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3898916	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352850	17728852	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1		CHEMBL3975250	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352851	17728853	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(c1ccc(F)cc1)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3907944	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352852	17728854	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3983231	=	IC50	nM	560.0	CHEMBL2148	Homo sapiens	IC50	nM	560.0
352853	17728855	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(C#N)ccc1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3913397	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352854	17728856	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cc(OC(F)(F)F)ccc1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3897850	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352855	17728857	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(N[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3922392	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352856	17728858	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3906857	=	IC50	nM	660.0	CHEMBL2148	Homo sapiens	IC50	nM	660.0
352857	17728859	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3934814	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352858	17728860	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3906263	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352859	17728861	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCCN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3980041	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352860	17728862	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3897300	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352861	17728863	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3968423	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352862	17728864	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3903790	=	IC50	nM	380.0	CHEMBL2148	Homo sapiens	IC50	nM	380.0
352863	17728865	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3957421	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352864	17728866	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3980979	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
352865	17728867	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@@H](NN5CCOCC5)CC4)c23)[nH]1		CHEMBL3952151	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
352866	17728868	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](NN5CCOCC5)CC4)c23)[nH]1		CHEMBL3984482	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352867	17728869	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCc1ccc(-c2nnn3cnc4[nH]ccc4c23)cc1		CHEMBL3945740	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
352868	17728870	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3906967	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
352869	17728871	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3945964	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
352870	17728872	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3909146	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
352871	17728873	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3937067	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
352872	17728874	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1		CHEMBL3965965	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	nM	26.0
352873	17728875	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1coc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3891030	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
352874	17728876	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Ic1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3923513	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
352875	17728877	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3951230	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
352876	17728878	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3979340	=	IC50	nM	60.0	CHEMBL2148	Homo sapiens	IC50	nM	60.0
352877	17728879	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3912553	=	IC50	nM	9.8	CHEMBL2148	Homo sapiens	IC50	nM	9.8
352878	17728880	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)[nH]n1		CHEMBL3922180	=	IC50	nM	630.0	CHEMBL2148	Homo sapiens	IC50	nM	630.0
352879	17728881	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(Cc5csnn5)CC4)c23)[nH]1		CHEMBL3894161	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
352880	17728882	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3931093	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
352881	17728883	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F		CHEMBL3899570	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	nM	620.0
352882	17728884	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl		CHEMBL3936565	=	IC50	nM	950.0	CHEMBL2148	Homo sapiens	IC50	nM	950.0
352883	17728885	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CS(=O)(=O)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3908624	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
352884	17728886	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(C(F)(F)F)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3974989	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
352885	17728887	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(Cl)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3949040	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
352886	17728888	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl		CHEMBL3986377	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
352887	17728889	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1		CHEMBL3957659	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
352888	17728890	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3940267	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
352889	17728891	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)nc1		CHEMBL3969811	=	IC50	nM	680.0	CHEMBL2148	Homo sapiens	IC50	nM	680.0
352890	17728892	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3981338	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
352891	17728893	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1		CHEMBL3907770	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
352892	17728894	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)c1		CHEMBL3925854	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
352893	17728895	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F		CHEMBL3953486	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
352894	17728896	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1C(F)(F)F		CHEMBL3931226	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
352895	17728897	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCOc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3962232	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352896	17728898	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)C(F)(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3906687	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
352897	17728899	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1		CHEMBL3934664	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
352898	17728900	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)NCCN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3949195	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352899	17728901	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F		CHEMBL3917860	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352900	17728902	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(c1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1)C(F)(F)F		CHEMBL3940421	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352901	17728903	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3912419	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
352902	17728904	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)c1nc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2[nH]1		CHEMBL3965670	=	IC50	nM	340.0	CHEMBL2148	Homo sapiens	IC50	nM	340.0
352903	17728905	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3939331	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352904	17728906	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3954454	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
352905	17728907	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3926817	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
352906	17728908	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3965520	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352907	17728909	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3951107	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
352908	17728910	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3921365	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352909	17728911	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3948691	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352910	17728912	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1cnc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cn1		CHEMBL3973302	=	IC50	nM	800.0	CHEMBL2148	Homo sapiens	IC50	nM	800.0
352911	17728913	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	C[C@H](O)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3902287	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
352912	17728914	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	C[C@@H](O)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4109199	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
352913	17728915	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3896784	=	IC50	nM	99.0	CHEMBL2148	Homo sapiens	IC50	nM	99.0
352914	17728916	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4107757	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
352915	17728917	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3978202	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
352916	17728918	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CS(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3894535	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
352917	17728919	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)S(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3919034	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352918	17728920	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1NCCN1CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3975439	=	IC50	nM	920.0	CHEMBL2148	Homo sapiens	IC50	nM	920.0
352919	17728921	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1nc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c[nH]1		CHEMBL3956418	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
352920	17728922	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3967397	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352921	17728923	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3941241	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352922	17728924	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3985363	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
352923	17728925	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3942424	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352924	17728926	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3980095	=	IC50	nM	560.0	CHEMBL2148	Homo sapiens	IC50	nM	560.0
352925	17728927	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F		CHEMBL3947742	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352926	17728928	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F		CHEMBL3963428	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	nM	290.0
352927	17728929	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3966425	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352928	17728930	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3904756	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
352929	17728931	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3940782	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
352930	17728932	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(Cl)cc1)C(F)(F)F		CHEMBL3978620	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
352931	17728933	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(F)cc1)C(F)(F)F		CHEMBL3946125	=	IC50	nM	76.0	CHEMBL2148	Homo sapiens	IC50	nM	76.0
352932	17728934	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3983447	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
352933	17728935	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3954819	=	IC50	nM	680.0	CHEMBL2148	Homo sapiens	IC50	nM	680.0
352934	17728936	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H](CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL4109603	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352935	17728937	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@@H](CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3898196	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352936	17728938	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3935174	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352937	17728939	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(Nc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3907227	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352938	17728940	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3938956	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352939	17728941	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCCc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3972033	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
352940	17728942	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC[C@H](F)C1		CHEMBL3933458	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352941	17728943	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3ncn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3960910	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	nM	77.0
352942	17728944	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(OCc1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)C1		CHEMBL3890951	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352943	17728945	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C(F)(F)F)cc1		CHEMBL3947711	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	nM	620.0
352944	17728946	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCOc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3947749	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352945	17728947	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1		CHEMBL3977017	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
352946	17728948	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	C(=C/c1ccco1)\CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3905358	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352947	17728949	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3936927	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352948	17728950	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1n[nH]c2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc12		CHEMBL3973429	=	IC50	nM	380.0	CHEMBL2148	Homo sapiens	IC50	nM	380.0
352949	17728951	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cnc2cc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)ccc2n1		CHEMBL3940483	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352950	17728952	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(Cc5cocn5)CC4)c23)[nH]1		CHEMBL3962451	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	nM	620.0
352951	17728953	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)Oc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3934943	=	IC50	nM	620.0	CHEMBL2148	Homo sapiens	IC50	nM	620.0
352952	17728954	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cn(-c2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2)cn1		CHEMBL3986588	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352953	17728955	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F		CHEMBL3961357	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
352954	17728956	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1F		CHEMBL3978366	=	IC50	nM	940.0	CHEMBL2148	Homo sapiens	IC50	nM	940.0
352955	17728957	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(C(F)(F)F)cc(F)c1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3949257	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
352956	17728958	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1COc2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2N1		CHEMBL3902770	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352957	17728959	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(CCC#N)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3975255	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352958	17728960	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)Oc2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1		CHEMBL3964008	=	IC50	nM	79.0	CHEMBL2148	Homo sapiens	IC50	nM	79.0
352959	17728961	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3979988	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
352960	17728962	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)Oc2cccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)c2O1		CHEMBL3894366	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352961	17728963	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C/C(=C\N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3918875	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352962	17728964	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)n1		CHEMBL3936877	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
352963	17728965	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc[n+]2cc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)sc2c1		CHEMBL4115251	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352964	17728966	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)sc1Br		CHEMBL3942304	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352965	17728967	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(Cc5cnc(N6CCOCC6)s5)CC4)c23)[nH]1		CHEMBL3975123	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352966	17728968	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C/C(=C\N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(Cl)cc1		CHEMBL3917783	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352967	17728969	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3945676	=	IC50	nM	450.0	CHEMBL2148	Homo sapiens	IC50	nM	450.0
352968	17728970	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1		CHEMBL3896566	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
352969	17728971	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1		CHEMBL3967749	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
352970	17728972	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1		CHEMBL3905498	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
352971	17728973	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc(C4CCN(Cc5cscn5)CC4)c23)[nH]1		CHEMBL3979388	=	IC50	nM	600.0	CHEMBL2148	Homo sapiens	IC50	nM	600.0
352972	17728974	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	NC(=O)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3980369	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352973	17728975	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C#N		CHEMBL3964133	=	IC50	nM	960.0	CHEMBL2148	Homo sapiens	IC50	nM	960.0
352974	17728976	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1C(F)(F)F		CHEMBL3900738	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352975	17728977	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F		CHEMBL3965217	=	IC50	nM	440.0	CHEMBL2148	Homo sapiens	IC50	nM	440.0
352976	17728978	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(c1ccccc1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3938277	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352977	17728979	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3902123	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
352978	17728980	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1Cl		CHEMBL3946824	=	IC50	nM	920.0	CHEMBL2148	Homo sapiens	IC50	nM	920.0
352979	17728981	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c2ccccc12		CHEMBL3972962	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352980	17728982	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1F		CHEMBL3934440	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
352981	17728983	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc(F)c1F		CHEMBL3937326	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352982	17728984	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F		CHEMBL3910680	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352983	17728985	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)ccc1F		CHEMBL3956550	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352984	17728986	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1SCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3920091	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	nM	140.0
352985	17728987	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCSC5)CC4)c23)[nH]1		CHEMBL3947889	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
352986	17728988	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3911142	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
352987	17728989	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3935532	=	IC50	nM	990.0	CHEMBL2148	Homo sapiens	IC50	nM	990.0
352988	17728990	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3966840	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
352989	17728991	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3940644	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352990	17728992	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3955720	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
352991	17728993	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCN1		CHEMBL3928091	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352992	17728994	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	NC(=O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3950399	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352993	17728995	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C#N		CHEMBL3969516	=	IC50	nM	590.0	CHEMBL2148	Homo sapiens	IC50	nM	590.0
352994	17728996	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1cc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl		CHEMBL3941680	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352995	17728997	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3913693	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352996	17728998	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC[C@H]1CCCN1C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4114436	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352997	17728999	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC[C@@H]1CCCN1C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3907076	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
352998	17729000	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4113620	=	IC50	nM	790.0	CHEMBL2148	Homo sapiens	IC50	nM	790.0
352999	17729001	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCN(Cc1ccccc1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3965307	=	IC50	nM	720.0	CHEMBL2148	Homo sapiens	IC50	nM	720.0
353000	17729002	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(Br)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3985243	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	nM	57.0
353001	17729003	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3919050	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	nM	750.0
353002	17729004	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3896461	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353003	17729005	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3904312	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
353004	17729006	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1COc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2N1		CHEMBL3909024	=	IC50	nM	570.0	CHEMBL2148	Homo sapiens	IC50	nM	570.0
353005	17729007	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1COc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2N1		CHEMBL3933397	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353006	17729008	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)Oc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1		CHEMBL3917954	=	IC50	nM	850.0	CHEMBL2148	Homo sapiens	IC50	nM	850.0
353007	17729009	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@@H](CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3896725	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
353008	17729010	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H](CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL4112919	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
353009	17729011	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(O)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3967880	=	IC50	nM	450.0	CHEMBL2148	Homo sapiens	IC50	nM	450.0
353010	17729012	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1OCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3960109	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
353011	17729013	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CC5)CC4)c23)[nH]1		CHEMBL3963443	=	IC50	nM	680.0	CHEMBL2148	Homo sapiens	IC50	nM	680.0
353012	17729014	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3939325	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
353013	17729015	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3911362	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
353014	17729016	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCC5)CC4)c23)[nH]1		CHEMBL3949461	=	IC50	nM	900.0	CHEMBL2148	Homo sapiens	IC50	nM	900.0
353015	17729017	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCCC5)CC4)c23)[nH]1		CHEMBL3923802	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353016	17729018	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNCC5CC5)CC4)c23)[nH]1		CHEMBL3957921	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
353017	17729019	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCC5)CC4)c23)[nH]1		CHEMBL3930431	=	IC50	nM	570.0	CHEMBL2148	Homo sapiens	IC50	nM	570.0
353018	17729020	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCCC5)CC4)c23)[nH]1		CHEMBL3900631	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353019	17729021	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C1NOC[C@H]1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4106456	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	nM	150.0
353020	17729022	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC[C@H]5CCCO5)CC4)c23)[nH]1		CHEMBL4110648	=	IC50	nM	850.0	CHEMBL2148	Homo sapiens	IC50	nM	850.0
353021	17729023	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1(C)CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3962117	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
353022	17729024	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3892159	=	IC50	nM	670.0	CHEMBL2148	Homo sapiens	IC50	nM	670.0
353023	17729025	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3916636	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
353024	17729026	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3978189	=	IC50	nM	940.0	CHEMBL2148	Homo sapiens	IC50	nM	940.0
353025	17729027	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5COC5)CC4)c23)[nH]1		CHEMBL3907648	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
353026	17729028	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3904186	=	IC50	nM	840.0	CHEMBL2148	Homo sapiens	IC50	nM	840.0
353027	17729029	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3935688	=	IC50	nM	730.0	CHEMBL2148	Homo sapiens	IC50	nM	730.0
353028	17729030	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3942120	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353029	17729031	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3971717	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353030	17729032	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4114175	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353031	17729033	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3909751	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	nM	750.0
353032	17729034	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3956911	=	IC50	nM	960.0	CHEMBL2148	Homo sapiens	IC50	nM	960.0
353033	17729035	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3934426	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
353034	17729036	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC12CC3CC(C1)C(NC[C@H]1CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC1)C(C3)C2		CHEMBL3899587	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353035	17729037	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC12CC3CC(C1)C(NC[C@H]1CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC1)C(C3)C2		CHEMBL3899587	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353036	17729038	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CC[C@H](NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3892562	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353037	17729039	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CCCCC1		CHEMBL3934192	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353038	17729040	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3947422	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353039	17729041	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Clc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1		CHEMBL3941925	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
353040	17729042	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3956966	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353041	17729043	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1(c2ccccc2)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3929398	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353042	17729044	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3951710	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353043	17729045	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CCCC[C@H]1CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3906776	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353044	17729046	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCCCC1		CHEMBL3914847	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353045	17729047	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3973072	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353046	17729048	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3902428	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353047	17729049	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC56CC(C5)C6)CC4)c23)[nH]1		CHEMBL3976587	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353048	17729050	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F		CHEMBL3916457	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	nM	470.0
353049	17729051	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(=O)N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4112922	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353050	17729052	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(=O)N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3903941	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353051	17729053	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(N[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1)C(F)(F)F		CHEMBL4112721	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353052	17729054	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(N[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1)C(F)(F)F		CHEMBL3931935	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353053	17729055	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1		CHEMBL3926516	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
353054	17729056	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CC2)cc1		CHEMBL3889588	=	IC50	nM	830.0	CHEMBL2148	Homo sapiens	IC50	nM	830.0
353055	17729057	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CCC2)cc1		CHEMBL3959692	=	IC50	nM	660.0	CHEMBL2148	Homo sapiens	IC50	nM	660.0
353056	17729058	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COCCN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3980992	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353057	17729059	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COCCN(CCOC)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3907394	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353058	17729060	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3939232	=	IC50	nM	790.0	CHEMBL2148	Homo sapiens	IC50	nM	790.0
353059	17729061	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3931713	=	IC50	nM	530.0	CHEMBL2148	Homo sapiens	IC50	nM	530.0
353060	17729062	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3948921	=	IC50	nM	800.0	CHEMBL2148	Homo sapiens	IC50	nM	800.0
353061	17729063	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3923711	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353062	17729064	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3906210	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353063	17729065	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3896766	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353064	17729066	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	C#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3959556	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353065	17729067	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCC(N6CCOCC6)CC5)CC4)c23)[nH]1		CHEMBL3902256	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353066	17729068	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N1CCC(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3905617	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353067	17729069	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)NCC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3976356	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353068	17729070	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N1CC[C@H](NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3954792	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353069	17729071	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3985390	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	nM	480.0
353070	17729072	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC1(F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3981130	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
353071	17729073	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)[C@@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4106545	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353072	17729074	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3916687	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
353073	17729075	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3972353	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
353074	17729076	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F		CHEMBL3949242	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
353075	17729077	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CSC5)CC4)c23)[nH]1		CHEMBL3963387	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
353076	17729078	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CCS(=O)(=O)N1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1		CHEMBL3893196	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353077	17729079	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCC(O)(c1ccccc1)C(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3921202	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353078	17729080	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCC(O)(c1ccc(F)cc1)C(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3917056	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	nM	650.0
353079	17729081	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	NC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3983344	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	nM	750.0
353080	17729082	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1		CHEMBL3908073	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353081	17729083	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3945378	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353082	17729084	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC(NC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1		CHEMBL3931435	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353083	17729085	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCCc1ccc(Cl)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3906986	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353084	17729086	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NC[C@@H](O)c1ccccc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4115208	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
353085	17729087	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCC(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3894516	=	IC50	nM	690.0	CHEMBL2148	Homo sapiens	IC50	nM	690.0
353086	17729088	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3981542	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353087	17729089	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3921442	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353088	17729090	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C[C@H]1CCN(C(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4107883	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353089	17729091	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC[C@H](O)C1		CHEMBL3973276	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353090	17729092	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3983856	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353091	17729093	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCCO)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3962300	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353092	17729094	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C([C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)N1CC(O)C1		CHEMBL3965485	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353093	17729095	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CCNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3986443	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353094	17729096	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1CN(C(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3955124	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353095	17729097	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCS(=O)(=O)c1ccccc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3928338	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
353096	17729098	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)cc1		CHEMBL3975088	=	IC50	nM	740.0	CHEMBL2148	Homo sapiens	IC50	nM	740.0
353097	17729099	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1		CHEMBL3907774	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
353098	17729100	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	IC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3934116	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
353099	17729101	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F		CHEMBL3968041	=	IC50	nM	370.0	CHEMBL2148	Homo sapiens	IC50	nM	370.0
353100	17729102	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	[N-]=[N+]=NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4111044	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
353101	17729103	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(O)c1cn(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)nn1		CHEMBL3963480	=	IC50	nM	590.0	CHEMBL2148	Homo sapiens	IC50	nM	590.0
353102	17729104	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3923184	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
353103	17729105	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3981393	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
353104	17729106	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CC(F)(F)F)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3920329	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
353105	17729107	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1c(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)nn1CC(F)(F)F		CHEMBL3927682	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353106	17729108	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CCN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3940316	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353107	17729109	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(N2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3963994	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353108	17729110	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]cc(Cl)c5c34)CC2)cc1		CHEMBL3954249	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
353109	17729111	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1Cc2ccccc2[C@H]1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3889789	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
353110	17729112	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@@H]1Cc2ccccc2[C@@H]1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL4111878	=	IC50	nM	660.0	CHEMBL2148	Homo sapiens	IC50	nM	660.0
353111	17729113	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCN(CCC#N)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3953229	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
353112	17729114	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(N[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3931001	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
353113	17729115	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3907565	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	nM	420.0
353114	17729116	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(Br)CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3973102	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	nM	750.0
353115	17729117	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(Br)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3943928	=	IC50	nM	70.0	CHEMBL2148	Homo sapiens	IC50	nM	70.0
353116	17729118	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C(F)(F)CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3981121	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353117	17729119	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3911096	=	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
353118	17729120	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3923030	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353119	17729121	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3965030	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353120	17729122	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1cccnc1)C(F)(F)F		CHEMBL3926894	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
353121	17729123	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CSc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1		CHEMBL3962138	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
353122	17729124	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cn1		CHEMBL3985391	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
353123	17729125	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1		CHEMBL3953381	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
353124	17729126	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Fc1ccc([C@@H]2C[C@H]2CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3922303	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353125	17729127	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1OC		CHEMBL3949248	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
353126	17729128	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#Cc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1		CHEMBL3958508	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353127	17729129	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](NC5CC5)CC4)c23)[nH]1		CHEMBL3941598	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
353128	17729130	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3941431	=	IC50	nM	790.0	CHEMBL2148	Homo sapiens	IC50	nM	790.0
353129	17729131	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCCN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3910017	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353130	17729132	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3932456	=	IC50	nM	610.0	CHEMBL2148	Homo sapiens	IC50	nM	610.0
353131	17729133	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@H](NCC5CC5)CC4)c23)[nH]1		CHEMBL3904453	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353132	17729134	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3897648	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353133	17729135	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3931368	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353134	17729136	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3946758	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353135	17729137	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F		CHEMBL3918943	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353136	17729138	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3902570	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
353137	17729139	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3934891	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
353138	17729140	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1CN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3890993	=	IC50	nM	440.0	CHEMBL2148	Homo sapiens	IC50	nM	440.0
353139	17729141	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@H]1CCN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3903493	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
353140	17729142	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O[C@@H]1CCN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL4114359	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353141	17729143	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	c1cc2c(ncn3nnc([C@H]4CC[C@@H](CNC5CC5)CC4)c23)[nH]1		CHEMBL3927961	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353142	17729144	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC(=O)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3975399	=	IC50	nM	310.0	CHEMBL2148	Homo sapiens	IC50	nM	310.0
353143	17729145	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC(=O)N(CC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3904571	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
353144	17729146	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC(=O)N(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1		CHEMBL3980246	=	IC50	nM	920.0	CHEMBL2148	Homo sapiens	IC50	nM	920.0
353145	17729147	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	Cc1ccc(CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(=O)CC#N)o1		CHEMBL3913565	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
353146	17729148	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(CC(F)(F)F)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3924572	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
353147	17729149	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(=O)CC(F)(F)F		CHEMBL3952261	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
353148	17729150	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CN(CC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3972067	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353149	17729151	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCN(CC1CC1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3942459	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353150	17729152	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)CN(CC1CC1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3980120	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353151	17729153	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3947782	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353152	17729154	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NC1CC1		CHEMBL3985119	=	IC50	nM	380.0	CHEMBL2148	Homo sapiens	IC50	nM	380.0
353153	17729155	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)S(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3956450	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
353154	17729156	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCNS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3896324	=	IC50	nM	69.0	CHEMBL2148	Homo sapiens	IC50	nM	69.0
353155	17729157	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3979623	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
353156	17729158	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	FC(F)(F)COC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3906460	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353157	17729159	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC1(O)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3977129	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353158	17729160	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CN(C)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3962364	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353159	17729161	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CCN(C)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3933671	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353160	17729162	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC1(C(F)(F)F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3956945	=	IC50	nM	82.0	CHEMBL2148	Homo sapiens	IC50	nM	82.0
353161	17729163	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(NCC(F)(F)F)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3985603	=	IC50	nM	870.0	CHEMBL2148	Homo sapiens	IC50	nM	870.0
353162	17729164	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CS(=O)(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3984562	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
353163	17729165	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C)(C)OC(=O)N1CC(CC#N)(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1		CHEMBL3911332	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353164	17729166	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O/N=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3973343	=	IC50	nM	790.0	CHEMBL2148	Homo sapiens	IC50	nM	790.0
353165	17729167	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3902333	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353166	17729168	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC(C#N)=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3898818	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	nM	290.0
353167	17729169	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC(C#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3930389	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
353168	17729170	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	C=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3907503	=	IC50	nM	710.0	CHEMBL2148	Homo sapiens	IC50	nM	710.0
353169	17729171	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3985220	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
353170	17729172	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3902992	=	IC50	nM	720.0	CHEMBL2148	Homo sapiens	IC50	nM	720.0
353171	17729173	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3900105	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
353172	17729174	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CCOC(=O)C=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3937822	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353173	17729175	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C#N)=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3935408	=	IC50	nM	570.0	CHEMBL2148	Homo sapiens	IC50	nM	570.0
353174	17729176	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CCOC(=O)CC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3938593	=	IC50	nM	340.0	CHEMBL2148	Homo sapiens	IC50	nM	340.0
353175	17729177	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C#N)[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3937456	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
353176	17729178	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	CC(C#N)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3945399	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	nM	330.0
353177	17729179	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#C/C=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3971373	=	IC50	nM	540.0	CHEMBL2148	Homo sapiens	IC50	nM	540.0
353178	17729180	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3944859	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
353179	17729181	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3974289	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
353180	17729182	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	O=C(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F		CHEMBL3950137	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
353181	17729183	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCNC(=O)C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3912503	=	IC50	nM	730.0	CHEMBL2148	Homo sapiens	IC50	nM	730.0
353182	17729184	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CCNC(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1		CHEMBL3889920	=	IC50	nM	340.0	CHEMBL2148	Homo sapiens	IC50	nM	340.0
353183	17729185	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	N#CC1CC12CCC(c1nnn3cnc4[nH]ccc4c13)CC2		CHEMBL3962051	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	nM	250.0
353184	17729186	CHEMBL3887756	Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer Co., Ltd. (PE)) was used. Dilute solutions of compounds and enzymes in assay buffer (50 mM HEPES pH7.5, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 0.01% Tween20) were dispensed into wells of a 384-well black plate. After 5 minutes of preincubation, dilute solutions of the substrate and ATP (adenosine triphosphate) were added at a final concentration of 100 μM, and the plate was incubated at room temperature for 2 hours. After addition of a termination reagent containing EDTA (ethylenediamine tetraacetic acid) at a final concentration of 10 mM, LANCE Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.	B	OC12CC3CC(C1)CC(c1nnn4cnc5[nH]ccc5c14)(C3)C2		CHEMBL3902431	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	nM	220.0
370426	17745292	CHEMBL3888065	JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.	B	CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1		CHEMBL2103874	=	IC50	nM	95.1	CHEMBL2148	Homo sapiens	IC50	nM	95.1
370427	17745293	CHEMBL3888065	JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 peptide (JAK-1 and Tyk-2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 microliter total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 micromolar for JAK-2 and JAK-3, 40 micromolar for JAK-1 and 7 micromolar for Tyk-2)), 2% DMSO and 1 micromolar peptide substrate (JAKtide for JAK-2 and JAK-3 or IRS-1 peptide for JAK-1 and Tyk-2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 microliter reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK-2, 1 nM JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.	B	CN(c1ncnc2[nH]ccc12)[C@H]1CC[C@H](CS(=O)(=O)NC2CCC2)CC1		CHEMBL3925083	=	IC50	nM	742.0	CHEMBL2148	Homo sapiens	IC50	nM	742.0
375852	17750076	CHEMBL3888139	JAK3 Enzymatic Assay: The assay has been performed using the JAK3 kinase domain (residues 781-1124 of the 1124 amino acid long full-length sequence, accession number P52333 of UniProtKB/Swiss-Prot databse). The JAK3 kinase domain showed a linear kinetic without prephosphorylation. The JAK3 kinase assay was run with a final enzyme concentration of 1 nM, in the presence of 22 uM ATP, 1 nM 33P-γ-ATP and 40 uM of substrate BioDBn*306 (Amino acid sequence: LPLDKDYYWREPGQ-SEQ ID NO: 1). The peptidic substrate was purchased from American Peptide Company (Sunnyvale, Calif.).	B	CCc1ccc(Cl)cc1-n1nc(-c2ccnc(N)n2)cc1C(N)=O		CHEMBL3953015	<	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
385012	17758434	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	10.4	CHEMBL2148	Homo sapiens	IC50	nM	10.4
385033	17758455	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	8278.0	CHEMBL2148	Homo sapiens	IC50	nM	8278.0
385123	17758545	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	10.4	CHEMBL2148	Homo sapiens	IC50	nM	10.4
385124	17758546	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3917698	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385125	17758547	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	8278.0	CHEMBL2148	Homo sapiens	IC50	nM	8278.0
385126	17758548	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3912266	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385127	17758549	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Cc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@H]1CCCN1C(=O)/C=C/CN(C)C		CHEMBL4107818	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385128	17758550	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3903249	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385129	17758551	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3910496	=	IC50	nM	12980.0	CHEMBL2148	Homo sapiens	IC50	nM	12980.0
385130	17758552	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3910496	=	IC50	nM	1456.0	CHEMBL2148	Homo sapiens	IC50	nM	1456.0
385131	17758553	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3905432	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385132	17758554	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3905432	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385133	17758555	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3929922	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385134	17758556	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CN(C)C/C=C/C(=O)NC1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3980550	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385135	17758557	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3921017	=	IC50	nM	5997.0	CHEMBL2148	Homo sapiens	IC50	nM	5997.0
385136	17758558	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C(=O)/C=C/CN2CCOCC2)CC1		CHEMBL3982014	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385137	17758559	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@@H]1CCCN1C(=O)/C=C/CN1CCOCC1		CHEMBL3915538	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385138	17758560	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	CC#CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3921655	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
385139	17758561	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL3894938	=	IC50	nM	3306.0	CHEMBL2148	Homo sapiens	IC50	nM	3306.0
385140	17758562	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1		CHEMBL3968716	=	IC50	nM	9077.0	CHEMBL2148	Homo sapiens	IC50	nM	9077.0
385141	17758563	CHEMBL3888254	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1		CHEMBL3894102	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
399541	17766378	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CNS(=O)(=O)N(C)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4115639	=	IC50	nM	157.0	CHEMBL2148	Homo sapiens	IC50	nM	157.0
399542	17766379	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)c(F)c1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4112580	=	IC50	nM	359.4	CHEMBL2148	Homo sapiens	IC50	nM	359.4
399543	17766380	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncc(C#N)cn1)[C@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3959421	=	IC50	nM	497.0	CHEMBL2148	Homo sapiens	IC50	nM	497.0
399544	17766381	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)Nc2nccs2)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4108070	=	IC50	nM	522.0	CHEMBL2148	Homo sapiens	IC50	nM	522.0
399545	17766382	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NC2c3ccccc3C[C@H]2O)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4108544	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
399546	17766383	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(S(N)(=O)=O)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4113706	=	IC50	nM	86.3	CHEMBL2148	Homo sapiens	IC50	nM	86.3
399744	17766553	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	COc1nc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)ccc1C#N		CHEMBL3951700	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399745	17766554	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccnc(Cl)n1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3941211	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399746	17766555	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(F)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3925605	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399747	17766556	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(Cl)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3920484	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399748	17766557	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccnc(C#N)c1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3937835	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399749	17766558	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CCN(c1ccc(C#N)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3893327	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399750	17766559	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	C#CCN(c1c(F)cc(C#N)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3930290	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399751	17766560	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1cnc(N2CCOCC2)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3942728	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399752	17766561	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	C#Cc1ccc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)nc1		CHEMBL3960416	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399753	17766562	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	C[C@@H](NC(=O)c1ccc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)c(F)c1)c1ccccc1		CHEMBL3951623	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399754	17766563	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1c(F)cc(C(=O)N[C@H](CO)c2ccccc2)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3890208	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399755	17766564	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	COC[C@@H](NC(=O)c1cc(F)c(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)c(F)c1)c1ccccc1		CHEMBL3956882	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399756	17766565	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(S(=O)(=O)NC2CC2)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3917906	=	IC50	nM	0.055	CHEMBL2148	Homo sapiens	IC50	nM	0.055
399757	17766566	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(C(=O)CC#N)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3955948	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399758	17766567	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(C(=O)Nc1ccc(C#N)cc1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3960213	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399759	17766568	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(C(=O)CC(F)(F)F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3910875	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399760	17766569	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	C=CCN(C1CCCC1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3955757	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399761	17766570	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	N#Cc1ccc(N(C2CC2)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)nc1		CHEMBL3984764	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399762	17766571	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CCS(=O)(=O)N(C)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3954558	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399763	17766572	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)nn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3926930	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399764	17766573	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(F)(F)F)nn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3925768	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399765	17766574	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(CCC#N)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3913220	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399766	17766575	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc([N+](=O)[O-])cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3952191	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399767	17766576	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3896481	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399768	17766577	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	Cc1cc(Cl)nc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)c1C#N		CHEMBL3973848	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399769	17766578	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	Cc1cc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)ncc1[N+](=O)[O-]		CHEMBL3890701	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399770	17766579	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1nc(Cl)nc2ccccc12)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3949963	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399771	17766580	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncnc2ccccc12)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3952555	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399772	17766581	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	N#Cc1ccc(NC2CCN(c3ncnc4[nH]ccc34)C2)nc1		CHEMBL3968548	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399773	17766582	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1cnc(C#N)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3937204	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399774	17766583	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	COc1cc2ncnc(N(C)[C@@H]3CCN(c4ncnc5[nH]ccc45)C3)c2cc1OC		CHEMBL3897417	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399775	17766584	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1nc(Cl)c(C#N)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3930750	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399776	17766585	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1cccc(C#N)n1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3961850	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399777	17766586	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3896481	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399778	17766587	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(C1NC(C#N)=CS1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3903286	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399779	17766588	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncc(Br)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3919799	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399780	17766589	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncc(C#N)cc1[N+](=O)[O-])[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3925815	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399781	17766590	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	N#Cc1cnc(NC2CCN(c3ncnc4[nH]ccc34)C2)c([N+](=O)[O-])c1		CHEMBL3975440	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399782	17766591	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CCCN(c1ccc(C#N)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3940099	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399783	17766592	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncc(C#N)cc1Br)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3906885	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399784	17766593	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cn1)[C@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3977509	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399785	17766594	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3915857	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399786	17766595	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cc1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3899672	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399787	17766596	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)cc1[N+](=O)[O-])[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3980318	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399788	17766597	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)c2ccccc12)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3982307	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399789	17766598	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C#N)c(Br)c1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3921320	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399790	17766599	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	C#CCN(c1ccc(C#N)cc1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3905748	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399791	17766600	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1cncc(-n2ccnc2)n1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3914739	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399792	17766601	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccccn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3920581	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399793	17766602	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ncccc1C#N)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3926059	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399794	17766603	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc2nc[nH]c2n1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3934942	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399795	17766604	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc2[nH]c(=O)[nH]c2n1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3962448	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399796	17766605	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	COC(=O)c1ccc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)nc1		CHEMBL3976708	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399797	17766606	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NC2CC2)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3902542	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399798	17766607	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)N[C@H](CO)c2ccccc2)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3984793	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399799	17766608	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)N[C@@H](CO)c2ccccc2)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3977452	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399800	17766609	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NC2c3ccccc3CC2O)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3939312	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399801	17766610	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NCc2ccccc2)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3933796	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399802	17766611	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NCCO)cn1)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3902351	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399803	17766612	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NC(CO)c2ccc(Cl)cc2)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3896837	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399804	17766613	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CN(c1ccc(C(=O)NC[C@H](O)c2ccccc2)cc1F)[C@@H]1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL3914438	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
399805	17766614	CHEMBL3888426	Enzymatic Assay: JAK1/2/3 kinase assay are performed in vitro using Kit-Tyr 6 Peptide (Invitrogen, Cat. No. PV4122). TYK2 kinase assay are performed in vitro using Z'-LYTE™ Kinase Assay Kit-Tyr 3 Peptide (Invitrogen, Cat. No. PV3192). Recombinant human JAK1/2/3 or TYK2 catalytic domains are from Invitrogen (Cat No. PV4774/PV4210/PV3855/PV4790); All reactions (20 μL) are started by adding 2.5 μL of the testing compound in 4% DMSO solution, 5 μL of Kinase/Peptide substrate Mixture (3.2, 0.04, 0.2 or 8 μg/mL for Recombinant human JAK1/2/3 catalytic domains, 4 μM for Z-LYTE™ Tyr 6 peptide or Z-LYTE™ Tyr 3 peptide) or Phospho-Peptide solution (Invitrogen, Cat. No. PV3192, diluted with 1.33× Kinase Buffer), 2.5 μL ATP Solution (300/100/40/100M, JAK1/JAK2/JAK3/TYK2) or 1.33× Kinase Buffer (Invitrogen, Cat. No. PV3189, 5× diluted with distilled water). The 384-well assay plate (Corning, Cat. No. 3575) is mixed and incubated at room temperature for 1 hour. 5 μL of the Development Solution (Dilute Development Reagent A (Cat. No. PV3297) is diluted to 1/64 with Development Buffer (Cat. No. PV3127) for JAK1, JAK2 and JAK3 assay; Development Reagent A (Cat. No. PV3297) is diluted to 1/2048 with Development Buffer (Cat. No. PV3127) for TYK2 assay. The diluted Development Solution is then added to each well, mixed and incubated at room temperature for another 1 hour. The kinase reaction is then stopped by adding 5 μL of the Stop Reagent (Invitrogen, Cat. No. PV3094), and the plate is read with Wallac 1420 VICTOR3 Multilabel Counter (PerkinElmer™) at 445 nm and 520 nm fluorescence. All compounds are initially tested at 8 different concentrations (1 μM down to 0.0003 μM) using a 1:3 serial dilution scheme.	B	CCS(=O)(=O)Nc1ccc(N(C)[C@@H]2CCN(c3ncnc4[nH]ccc34)C2)nc1		CHEMBL3982255	=	IC50	nM	0.55	CHEMBL2148	Homo sapiens	IC50	nM	0.55
412027	17776742	CHEMBL3888670	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
418596	17781839	CHEMBL3888835	Kinase Assay: JAK3 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 500 μM GGEEEEYFELVKKKK, 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(C(=O)CC#N)CC4C3)n2)cn1		CHEMBL3977718	=	IC50	nM	359.0	CHEMBL2148	Homo sapiens	IC50	nM	359.0
418597	17781840	CHEMBL3888835	Kinase Assay: JAK3 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 500 μM GGEEEEYFELVKKKK, 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3CCC4(CC3)CCN(C(=O)CC#N)C4)n2)cn1		CHEMBL3944322	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
418598	17781841	CHEMBL3888835	Kinase Assay: JAK3 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 500 μM GGEEEEYFELVKKKK, 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(=O)N1CCC2(CCC(Nc3nc(Nc4cnn(C)c4)ncc3Cl)CC2)CC1		CHEMBL3905686	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
418599	17781842	CHEMBL3888835	Kinase Assay: JAK3 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 500 μM GGEEEEYFELVKKKK, 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(S(C)(=O)=O)CC4C3)n2)cn1		CHEMBL3917073	=	IC50	nM	178.0	CHEMBL2148	Homo sapiens	IC50	nM	178.0
428312	17789982	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ccc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3900587	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
428313	17789983	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ccc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3900587	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428314	17789984	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3923936	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
428315	17789985	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(c2ccc(C#N)cn2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)(C)O)c3)nc12		CHEMBL3973511	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
428316	17789986	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3922873	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428317	17789987	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ccc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3914278	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428318	17789988	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3945733	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
428319	17789989	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(c2ncc(C#N)cn2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)(C)O)c3)nc12		CHEMBL3924656	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
428320	17789990	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(c2nnc(C(F)(F)F)s2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)(C)O)c3)nc12		CHEMBL3985826	=	IC50	nM	3.1	CHEMBL2148	Homo sapiens	IC50	nM	3.1
428321	17789991	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ccc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3899852	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
428322	17789992	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC(C)n1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3903685	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
428323	17789993	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	COC[C@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3975857	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
428324	17789994	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1nn(C)cc1-c1cn2ncc(C(N)=O)c(N[C@H]3CN(c4ncc(C#N)cn4)C[C@H]3C)c2n1		CHEMBL3949959	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
428325	17789995	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ncc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3965169	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
428326	17789996	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(c5ccc(C#N)cn5)C[C@H]4C)c3n2)cn1		CHEMBL3937711	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428327	17789997	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(c2ccc(C#N)cn2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C[C@H](O)C(F)(F)F)c3)nc12		CHEMBL3923801	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
428328	17789998	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3929793	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
428329	17789999	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)cn1		CHEMBL3950992	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
428330	17790000	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CCC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL4108712	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
428331	17790001	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)(C)O)c3)nc12		CHEMBL3958864	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
428332	17790002	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)cn1		CHEMBL3957457	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
428333	17790003	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)COC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL4110159	=	IC50	nM	8.4	CHEMBL2148	Homo sapiens	IC50	nM	8.4
428334	17790004	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnn3C)nc12		CHEMBL3943940	=	IC50	nM	2.5	CHEMBL2148	Homo sapiens	IC50	nM	2.5
428335	17790005	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	COC[C@H](O)Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)cn1		CHEMBL3921483	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
428336	17790006	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1nn(C)c(C)c1-c1cn2ncc(C(N)=O)c(N[C@H]3CN(C(=O)C4(C#N)CC4)C[C@H]3C)c2n1		CHEMBL4106494	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
428337	17790007	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1nn(C)cc1-c1cn2ncc(C(N)=O)c(N[C@H]3CN(C(=O)C4(C#N)CC4)C[C@H]3C)c2n1		CHEMBL3939580	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
428338	17790008	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C[C@@H](O)C(F)(F)F)c3)nc12		CHEMBL3957930	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
428339	17790009	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCCn1cc(-c2cn3ncc(C(N)=O)c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4C)c3n2)cn1		CHEMBL3942856	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
428340	17790010	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC(C)n1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)cn1		CHEMBL3968963	=	IC50	nM	2.9	CHEMBL2148	Homo sapiens	IC50	nM	2.9
428341	17790011	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc4c(cnn4C)c3)nc12		CHEMBL3951604	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
428342	17790012	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	COc1ccc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)cn1		CHEMBL3980515	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
428343	17790013	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4C)c3n2)ccn1		CHEMBL3980081	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
428344	17790014	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1nn(C)c(C)c1-c1cn2ncc(C(N)=O)c(N[C@H]3CN(C(=O)C(C)(C)C#N)C[C@H]3C)c2n1		CHEMBL3951139	=	IC50	nM	3.6	CHEMBL2148	Homo sapiens	IC50	nM	3.6
428345	17790015	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1nn(C)cc1-c1cn2ncc(C(N)=O)c(N[C@H]3CN(C(=O)C(C)(C)C#N)C[C@H]3C)c2n1		CHEMBL3890788	=	IC50	nM	4.4	CHEMBL2148	Homo sapiens	IC50	nM	4.4
428346	17790016	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	C[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C4CC4)c3)nc12		CHEMBL3956402	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
428347	17790017	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC)c3)nc12		CHEMBL3896264	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428348	17790018	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CCC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC)c3)nc12		CHEMBL4112225	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
428349	17790019	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CCC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL4115596	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428350	17790020	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3963792	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
428351	17790021	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc4ncccc4c3)nc12		CHEMBL3890332	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
428352	17790022	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnc(C)c3)nc12		CHEMBL3917516	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
428353	17790023	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccc4c(cnn4C)c3)nc12		CHEMBL3973287	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428354	17790024	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3c(C)nn(C)c3C)nc12		CHEMBL3905704	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
428355	17790025	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccnn3C)nc12		CHEMBL3960021	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
428356	17790026	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cn(C)nc3C)nc12		CHEMBL3896771	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
428357	17790027	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cn(CC(C)(C)O)nc3C)nc12		CHEMBL3966881	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
428358	17790028	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C4CC4)c3)nc12		CHEMBL3963248	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
428359	17790029	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4CC)c3n2)cn1		CHEMBL3949368	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
428360	17790030	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3ccn(C)n3)nc12		CHEMBL3922444	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428361	17790031	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3sc(C)nc3C)nc12		CHEMBL3980209	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
428362	17790032	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(C(=O)C2(C#N)CC2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C(C)C)c3)nc12		CHEMBL3936210	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428363	17790033	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(c2ccc(C#N)cn2)C[C@@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3914152	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
428364	17790034	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CCN(c5ccc(C#N)nn5)CC4(C)C)c3n2)cn1		CHEMBL3980778	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
428365	17790035	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CCN(c5ccc(C#N)nn5)CC4(C)C)c3n2)cn1		CHEMBL3905150	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
428366	17790036	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@@H]1CN(c2ccc(C#N)nn2)CC[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC)c3)nc12		CHEMBL3975940	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
428367	17790037	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4CF)c3n2)cn1		CHEMBL3928562	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
428368	17790038	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cn1cc(-c2cn3ncc(C(N)=O)c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4CF)c3n2)cn1		CHEMBL3904090	=	IC50	nM	4.5	CHEMBL2148	Homo sapiens	IC50	nM	4.5
428369	17790039	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CCCn1cc(-c2cn3ncc(C(N)=O)c(N[C@H]4CN(C(=O)C5(C#N)CC5)C[C@H]4CF)c3n2)cn1		CHEMBL3919654	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
428370	17790040	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC(C)n1cc(-c2cn3ncc(C(N)=O)c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4CF)c3n2)cn1		CHEMBL3891603	=	IC50	nM	2.5	CHEMBL2148	Homo sapiens	IC50	nM	2.5
428371	17790041	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	N#CC1(C(=O)N2C[C@H](CF)[C@H](Nc3c(C(N)=O)cnn4cc(-c5cnn(C6CC6)c5)nc34)C2)CC1		CHEMBL3906388	=	IC50	nM	3.7	CHEMBL2148	Homo sapiens	IC50	nM	3.7
428372	17790042	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	N#CC1(C(=O)N2C[C@H](CF)[C@H](Nc3c(C(N)=O)cnn4cc(-c5cnn(C(F)F)c5)nc34)C2)CC1		CHEMBL3973864	=	IC50	nM	13.7	CHEMBL2148	Homo sapiens	IC50	nM	13.7
428373	17790043	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cn1ncc2cc(-c3cn4ncc(C(N)=O)c(N[C@@H]5CN(C(=O)C6(C#N)CC6)C[C@@H]5CF)c4n3)ccc21		CHEMBL3899917	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
428374	17790044	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1cc(-c2cn3ncc(C(N)=O)c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4CF)c3n2)ccn1		CHEMBL3927910	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
428375	17790045	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	N#CC1(C(=O)N2C[C@H](CF)[C@H](Nc3c(C(N)=O)cnn4cc(-c5ccc6c(c5)NC(=O)C6)nc34)C2)CC1		CHEMBL3982270	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
428376	17790046	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C(F)F)c3)nc12		CHEMBL3908821	=	IC50	nM	2.3	CHEMBL2148	Homo sapiens	IC50	nM	2.3
428377	17790047	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C[C@H](O)C(F)(F)F)c3)nc12		CHEMBL3983334	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
428378	17790048	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(CC(C)(C)O)c3)nc12		CHEMBL3913520	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
428379	17790049	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C[C@H](C)O)c3)nc12		CHEMBL3938736	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
428380	17790050	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C[C@@H](C)O)c3)nc12		CHEMBL3890933	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
428381	17790051	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	COc1cccc(-c2cn3ncc(C(N)=O)c(N[C@@H]4CN(C(=O)C5(C#N)CC5)C[C@@H]4C)c3n2)n1		CHEMBL3922507	=	IC50	nM	2.2	CHEMBL2148	Homo sapiens	IC50	nM	2.2
428382	17790052	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC(C)(C#N)C(=O)N1C[C@H](CF)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cn[nH]c4)nc23)C1		CHEMBL3907704	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
428383	17790053	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cn[nH]c3)nc12		CHEMBL3935662	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
428384	17790054	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3952907	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
428385	17790055	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3952907	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
428386	17790056	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	CC[C@H]1CN(C(=O)C2(C#N)CC2)C[C@H]1Nc1c(C(N)=O)cnn2cc(-c3cnn(C)c3)nc12		CHEMBL3952907	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
428387	17790057	CHEMBL3888997	Kinase Assay: The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (100 mM HEPES pH 7.4, 10 mM MgCl2, 25 mM beta-glycerol phosphate 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of GST-JAK3 enzyme with substrates and test compounds. The reactions were incubated at room temperature for 3 hours and terminated by adding 60 μl of 35 mM EDTA to each sample. Each reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product Inhibition data were calculated by comparison with no enzyme control reactions for 100% inhibition, and vehicle-only treated reactions for 0% inhibition. The final concentration of reagents in the assay was: ATP, 8 μM; fluoresceinated peptide, 1.5 μM; GST-JAK3, 4.5 nM; and DMSO, 1.6%.	B	Cc1noc(C)c1-c1cn2ncc(C(N)=O)c(N[C@@H]3CN(C(=O)C4(C#N)CC4)C[C@@H]3CF)c2n1		CHEMBL3967441	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
443919	17803627	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1NCN(C2CCCCC2)c2c1cnc1[nH]ccc21		CHEMBL3906070	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
443920	17803628	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)Br)CC2)c2c1cnc1[nH]ccc21		CHEMBL3934061	=	IC50	nM	6.3	CHEMBL2148	Homo sapiens	IC50	nM	6.3
443921	17803629	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3954540	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
443922	17803630	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c1cnc1[nH]ccc21		CHEMBL3986613	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
443923	17803631	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3892634	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
443924	17803632	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3967370	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
443925	17803633	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)CN1CC(F)(F)F		CHEMBL3981673	=	IC50	nM	73.0	CHEMBL2148	Homo sapiens	IC50	nM	73.0
443926	17803634	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CO)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3952936	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	nM	57.0
443927	17803635	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCNC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3976846	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
443928	17803636	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3944182	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
443929	17803637	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCNC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3968326	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
443930	17803638	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3892672	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
443931	17803639	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](C(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3964946	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
443932	17803640	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3936358	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
443933	17803641	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1NCN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c1cnc1[nH]ccc21		CHEMBL3938113	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
443934	17803642	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3967688	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
443935	17803643	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC#N)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3943509	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
443936	17803644	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3976204	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
443937	17803645	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3952221	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
443938	17803646	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	COCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3981038	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
443939	17803647	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CSCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3966746	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
443940	17803648	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC(F)(F)F		CHEMBL3891913	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
443941	17803649	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	COCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3963389	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
443942	17803650	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3947499	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	nM	290.0
443943	17803651	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CC1		CHEMBL3944237	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
443944	17803652	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CCCO1		CHEMBL3916308	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
443945	17803653	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3981841	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
443946	17803654	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1C1CC1		CHEMBL3956439	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
443947	17803655	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3936693	=	IC50	nM	42.0	CHEMBL2148	Homo sapiens	IC50	nM	42.0
443948	17803656	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(C)C(=O)CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3901870	=	IC50	nM	4.9	CHEMBL2148	Homo sapiens	IC50	nM	4.9
443949	17803657	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O		CHEMBL3892991	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
443950	17803658	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O		CHEMBL3898972	=	IC50	nM	9.5	CHEMBL2148	Homo sapiens	IC50	nM	9.5
443951	17803659	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3910814	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
443952	17803660	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCCN1CCN(C[C@H]2CC[C@H](N3CN(C4CC4)C(=O)c4cnc5[nH]ccc5c43)CC2)CC1		CHEMBL3980883	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
443953	17803661	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3949226	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
443954	17803662	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3947242	=	IC50	nM	5.4	CHEMBL2148	Homo sapiens	IC50	nM	5.4
443955	17803663	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3919463	=	IC50	nM	8.9	CHEMBL2148	Homo sapiens	IC50	nM	8.9
443956	17803664	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3984749	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
443957	17803665	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(C)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3924902	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
443958	17803666	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3892444	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
443959	17803667	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	COCN1CN([C@H]2CC[C@H](CN(C)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3961430	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
443960	17803668	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3901392	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
443961	17803669	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3975691	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
443962	17803670	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1C1CC1		CHEMBL3911589	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
443963	17803671	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCNC[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3981587	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
443964	17803672	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3893247	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
443965	17803673	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3913622	=	IC50	nM	45.0	CHEMBL2148	Homo sapiens	IC50	nM	45.0
443966	17803674	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3985528	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
443967	17803675	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3949572	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
443968	17803676	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC#N)C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3942783	=	IC50	nM	350.0	CHEMBL2148	Homo sapiens	IC50	nM	350.0
443969	17803677	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(CC#N)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3968872	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
443970	17803678	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1NCN([C@H]2CC[C@H](CN3CC[C@@H](F)C3)CC2)c2c1cnc1[nH]ccc21		CHEMBL3893600	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	nM	410.0
443971	17803679	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](COCCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3896113	=	IC50	nM	4.9	CHEMBL2148	Homo sapiens	IC50	nM	4.9
443972	17803680	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNC3(C#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3932070	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
443973	17803681	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3903817	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
443974	17803682	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)F)CC2)CN1C1CC1		CHEMBL3933776	=	IC50	nM	50.0	CHEMBL2148	Homo sapiens	IC50	nM	50.0
443975	17803683	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3907106	=	IC50	nM	73.0	CHEMBL2148	Homo sapiens	IC50	nM	73.0
443976	17803684	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	COCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3894490	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
443977	17803685	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3983594	=	IC50	nM	34.0	CHEMBL2148	Homo sapiens	IC50	nM	34.0
443978	17803686	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3934831	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
443979	17803687	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC#N)C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3922146	=	IC50	nM	360.0	CHEMBL2148	Homo sapiens	IC50	nM	360.0
443980	17803688	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CCN1CN([C@H]2CC[C@H](CN(C)CC#N)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3896236	=	IC50	nM	540.0	CHEMBL2148	Homo sapiens	IC50	nM	540.0
443981	17803689	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	N#CCN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3913143	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	nM	240.0
443982	17803690	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CF)CC2)CN1C1CC1		CHEMBL3960523	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
443983	17803691	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN1CN([C@H]2CC[C@H](CN3CC(O)C3)CC2)c2c(cnc3[nH]ccc23)C1=O		CHEMBL3950208	=	IC50	nM	190.0	CHEMBL2148	Homo sapiens	IC50	nM	190.0
443984	17803692	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1		CHEMBL3930342	=	IC50	nM	8.5	CHEMBL2148	Homo sapiens	IC50	nM	8.5
443985	17803693	CHEMBL3889259	Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and Tyk2) were purchased from Carna Biosciences, Inc.As a substrate of the enzymes (hereinafter referred to as substrate), LANCE Ultra ULight-JAK-1 (Tyr1023) Peptide (manufactured by PerkinElmer Inc.) was used.As an antibody for detecting phosphorylation of the substrate, LANCE Ultra Europium-anti-phospho tyrosine antibody (PT66) (manufactured by PerkinElmer Inc.) was used.The other reagents were purchased from the following.Adenosine triphosphate (ATP): Sigma-Aldrich4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): DOJINDO LABORATORIESGlycol ether diamine tetraacetic acid (EGTA): DOJINDO LABORATORIES Magnesium chloride (MgCl2): Wako Pure Chemical Industries, Ltd.Dithiothreitol (DTT): Wako Pure Chemical Industries, Ltd.Tween 20: Sigma-AldrichEthylenediaminetetraacetic acid (EDTA): DOJINDO LABORATORIESThe compounds of the present invention, the enzymes (JAK1, JAK2, JAK3 and Tyk2), the substrate and ATP were used for assay as diluted with assay buffer.Â  As the assay buffer, one having the following composition was used.Â  HEPES (pH7.5): 50 mM EGTA: 1 mM MgCl2: 10 mM DTT: 2 mM Tween 20: 0.01% (wt/wt). The dilute concentration and the addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.	B	O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1CC(F)(F)F		CHEMBL3957838	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	17964911	CHEMBL3995020	Inhibition of human JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	17979254	CHEMBL3998059	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	-1.0	CHEMBL2148	Homo sapiens	INH	%	-1.0
	17996261	CHEMBL4001410	Inhibition of human wild type partial length JAK3 (I781 to S1124 residues) expressed in mammalian expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18007287	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1		CHEMBL3644620	=	IC50	nM	59.9	CHEMBL2148	Homo sapiens	IC50	nM	59.9
	18007288	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	C[C@@H]1CCN(C(=O)N2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL4068357	=	IC50	nM	139.3	CHEMBL2148	Homo sapiens	IC50	nM	139.3
	18007289	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	C[C@@H]1CCN(C(=O)N2CC[C@@H](S(=O)(=O)c3cccc(O)c3)C2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL4089515	=	IC50	nM	34.1	CHEMBL2148	Homo sapiens	IC50	nM	34.1
	18007290	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3928932	=	IC50	nM	8.3	CHEMBL2148	Homo sapiens	IC50	nM	8.3
	18007291	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	Oc1cccc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c1		CHEMBL3929865	=	IC50	nM	493.1	CHEMBL2148	Homo sapiens	IC50	nM	493.1
	18007292	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CC(C)c1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL4087076	=	IC50	nM	293.4	CHEMBL2148	Homo sapiens	IC50	nM	293.4
	18007293	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL4104931	=	IC50	nM	166.0	CHEMBL2148	Homo sapiens	IC50	nM	166.0
	18007294	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3914503	=	IC50	nM	43.5	CHEMBL2148	Homo sapiens	IC50	nM	43.5
	18007295	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL4103980	=	IC50	nM	16.7	CHEMBL2148	Homo sapiens	IC50	nM	16.7
	18007296	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3ncc[nH]3)n[nH]c2c1		CHEMBL4086057	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	18007297	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(C(N)=O)n[nH]c2c1		CHEMBL4096219	=	IC50	nM	4.3	CHEMBL2148	Homo sapiens	IC50	nM	4.3
	18007298	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(C(=O)NC)n[nH]c2c1		CHEMBL4078165	=	IC50	nM	125.0	CHEMBL2148	Homo sapiens	IC50	nM	125.0
	18007299	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(C(=O)N(C)C)n[nH]c2c1		CHEMBL4074855	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18007300	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(C(=O)Nc3ccc(C)nc3)n[nH]c2c1		CHEMBL4101534	=	IC50	nM	418.3	CHEMBL2148	Homo sapiens	IC50	nM	418.3
	18007301	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(C)CC4)n[nH]c2c1		CHEMBL4066236	=	IC50	nM	2.9	CHEMBL2148	Homo sapiens	IC50	nM	2.9
	18007302	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(C(C)=O)CC4)n[nH]c2c1		CHEMBL4093813	=	IC50	nM	7.1	CHEMBL2148	Homo sapiens	IC50	nM	7.1
	18007303	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(S(C)(=O)=O)CC4)n[nH]c2c1		CHEMBL4069951	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	18007304	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CN(Cc3ccccc3)CC4)n[nH]c2c1		CHEMBL4097152	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	18007305	CHEMBL4003452	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(F)cc3)C4)n[nH]c2c1		CHEMBL3644618	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	18007344	CHEMBL4003457	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus assessed as time taken for inhibition to reverse by 50% by dilution recovery based microfluidic mobility shift assay	B	C[C@@H]1CCN(C(=O)N2CC[C@@H](S(=O)(=O)c3cccc(O)c3)C2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL4089515	=	T1/2	hr	0.4667	CHEMBL2148	Homo sapiens	t1/2	min	28.0
	18007345	CHEMBL4003457	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus assessed as time taken for inhibition to reverse by 50% by dilution recovery based microfluidic mobility shift assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3928932	=	T1/2	hr	1.9	CHEMBL2148	Homo sapiens	t1/2	min	114.0
	18007365	CHEMBL4003460	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1		CHEMBL3644620	>	Inhibition	%	85.0	CHEMBL2148	Homo sapiens	INH	%	85.0
	18007366	CHEMBL4003460	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL4103980	>	Inhibition	%	85.0	CHEMBL2148	Homo sapiens	INH	%	85.0
	18007367	CHEMBL4003460	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCc1cc(O)ccc1-c1ccc2c(C(=O)NC)n[nH]c2c1		CHEMBL4078165	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18007368	CHEMBL4003460	Inhibition of JAK3 (unknown origin) at 1 uM	B	CCc1cc(O)ccc1-c1ccc2c(C(=O)Nc3ccc(C)nc3)n[nH]c2c1		CHEMBL4101534	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18007420	CHEMBL4003503	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus assessed as offset rate by dilution recovery based microfluidic mobility shift assay	B	C[C@@H]1CCN(C(=O)N2CC[C@@H](S(=O)(=O)c3cccc(O)c3)C2)C[C@@H]1N(C)c1ncnc2[nH]ccc12	Non standard unit for type	CHEMBL4089515	=	K	/min	0.024	CHEMBL2148	Homo sapiens	K	/min	0.024
	18007421	CHEMBL4003503	Inhibition of GST tagged human recombinant JAK3 catalytic domain expressed in baculovirus assessed as offset rate by dilution recovery based microfluidic mobility shift assay	B	CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1	Non standard unit for type	CHEMBL3928932	=	K	/min	0.006	CHEMBL2148	Homo sapiens	K	/min	0.006
	18008695	CHEMBL4003786	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18008696	CHEMBL4003786	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	Inhibition	%	4.0	CHEMBL2148	Homo sapiens	INH	%	4.0
	18008697	CHEMBL4003786	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18015573	CHEMBL4004931	Inhibition of human recombinant GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system incubated for 1 hr by FRET-based Z'-Lyte assay	B	O=CC1=CCC[C@@H](C(=O)O)[C@@]2(C1)Oc1ccc(O)cc1C2=O		CHEMBL4059880	=	IC50	nM	34800.0	CHEMBL2148	Homo sapiens	IC50	uM	34.8
	18015574	CHEMBL4004931	Inhibition of human recombinant GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system incubated for 1 hr by FRET-based Z'-Lyte assay	B	O=CC1=CCC[C@@H](C(=O)O)[C@]2(C1)Oc1ccc(O)cc1C2=O		CHEMBL4089667	=	IC50	nM	7000.0	CHEMBL2148	Homo sapiens	IC50	uM	7.0
Not Determined	18020258	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)N1CCC[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4090883		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020259	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062946	=	IC50	nM	107.0	CHEMBL2148	Homo sapiens	IC50	nM	107.0
Not Determined	18020260	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)N1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4083094		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020269	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4075230	=	IC50	nM	372.0	CHEMBL2148	Homo sapiens	IC50	nM	372.0
	18020270	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4064018	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18020271	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]ccc23)c1		CHEMBL4085582	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	18020272	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)N1CCC[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4090883	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	18020273	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062946	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	18020274	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4083094	=	IC50	nM	75.0	CHEMBL2148	Homo sapiens	IC50	nM	75.0
	18020299	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@@H](C)[C@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4083165	=	IC50	nM	7570.0	CHEMBL2148	Homo sapiens	IC50	nM	7570.0
	18020300	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@H](C)[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4069969	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
	18020301	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@@H](C)C[C@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4090950	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020302	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@@H](Nc2ncnc3[nH]ccc23)C[C@@H](C)C1		CHEMBL4084482	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020303	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@H](C)C[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062806	=	IC50	nM	2021.0	CHEMBL2148	Homo sapiens	IC50	nM	2021.0
	18020304	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@@H](C)C[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4074183	=	IC50	nM	60.0	CHEMBL2148	Homo sapiens	IC50	nM	60.0
	18020305	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4100944	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020306	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@@H](Nc2ncnc3[nH]ccc23)CC[C@H]1C		CHEMBL4065559	>	IC50	nM	2478.0	CHEMBL2148	Homo sapiens	IC50	nM	2478.0
	18020307	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@H]1C		CHEMBL4093219	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020308	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)[C@H]1C		CHEMBL4103378	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18020309	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	18020310	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C/C=C/C(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4095629	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020311	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4075230	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18020312	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4064018	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
	18020313	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]ccc23)c1		CHEMBL4085582	=	IC50	nM	29.0	CHEMBL2148	Homo sapiens	IC50	nM	29.0
	18020314	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CCC[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4090883	=	IC50	nM	3840.0	CHEMBL2148	Homo sapiens	IC50	nM	3840.0
	18020315	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062946	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
	18020316	CHEMBL4005716	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by microfluidic assay	B	C=CC(=O)N1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4083094	=	IC50	nM	1930.0	CHEMBL2148	Homo sapiens	IC50	nM	1930.0
	18020317	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	18020318	CHEMBL4005715	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by microfluidic assay	B	C/C=C/C(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4095629	=	IC50	nM	1610.0	CHEMBL2148	Homo sapiens	IC50	nM	1610.0
	18020319	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]ccc23)c1		CHEMBL4085582	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	18020320	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4064018	=	IC50	nM	116.0	CHEMBL2148	Homo sapiens	IC50	nM	116.0
Not Determined	18020321	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4075230		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18020322	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C/C=C/C(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4095629		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020323	CHEMBL4005721	Inhibition of JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 75 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometry	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	51.0	CHEMBL2148	Homo sapiens	IC50	nM	51.0
Not Determined	18020324	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1CC[C@@H](C)[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4083094		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020325	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062946	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
Not Determined	18020326	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1CCC[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4090883		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020327	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]ccc23)c1		CHEMBL4085582	=	IC50	nM	2280.0	CHEMBL2148	Homo sapiens	IC50	nM	2280.0
	18020328	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4064018	=	IC50	nM	399.0	CHEMBL2148	Homo sapiens	IC50	nM	399.0
Not Determined	18020329	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	CC(=O)N1CC[C@H]2CCN(c3ncnc4[nH]ccc34)[C@H]2C1		CHEMBL4075230		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18020330	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C/C=C/C(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4095629		IC50			CHEMBL2148	Homo sapiens	IC50		
	18020331	CHEMBL4005714	Inhibition of JAK3 in human whole blood assessed as inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	197.0	CHEMBL2148	Homo sapiens	IC50	nM	197.0
	18020375	CHEMBL4005753	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as inactivation rate by KT236 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Kinact	/s	2.32	CHEMBL2148	Homo sapiens	Kinact	/s	2.32
	18020382	CHEMBL4005760	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system by KT236 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Ki	nM	6310.0	CHEMBL2148	Homo sapiens	Ki	uM	6.31
	18020389	CHEMBL4005767	Ratio of Kinact to Ki for recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues)	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Ratio	10'5/M/s	3.68	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	3.68
	18020396	CHEMBL4005774	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by KT236 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	90.0	CHEMBL2148	Homo sapiens	IC50	nM	90.0
	18020407	CHEMBL4005785	Inhibition of JAK3 in human whole blood assessed as free drug concentration required for inhibition of IL-15 induced STAT5 phosphorylation preincubated for 45 mins followed by IL-15 addition and measured after 15 mins by Alexa Fluor 647 staining based flow cytometric analysis	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	106.0	CHEMBL2148	Homo sapiens	IC50	nM	106.0
	18020408	CHEMBL4005786	Ratio of IC50 for JAK3 in human whole blood assessed as free drug concentration required for inhibition of IL-15 induced STAT5 phosphorylation to IC50 for JAK3 in human PBMC assessed as inhibition of IL-15 induced STAT5 phosphorylation	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Ratio IC50		2.0	CHEMBL2148	Homo sapiens	Ratio IC50		2.0
	18020420	CHEMBL4005788	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as dissociation time by KT236 probe based TR-FRET assay	B	C=CC(=O)N1CCC[C@@H](Nc2ncnc3[nH]ccc23)C1		CHEMBL4062946	>	TIME	hr	8.0	CHEMBL2148	Homo sapiens	Time	hr	8.0
	18031742	CHEMBL4007716	Inhibition of JAK3 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	496.0	CHEMBL2148	Homo sapiens	IC50	uM	0.496
	18031743	CHEMBL4007716	Inhibition of JAK3 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18031744	CHEMBL4007716	Inhibition of JAK3 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18031745	CHEMBL4007716	Inhibition of JAK3 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18031746	CHEMBL4007716	Inhibition of JAK3 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18034715	CHEMBL4008326	Inhibition of recombinant TEL-fused JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4064566	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	18034716	CHEMBL4008326	Inhibition of recombinant TEL-fused JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4093840	=	GI50	nM	8300.0	CHEMBL2148	Homo sapiens	GI50	uM	8.3
	18034717	CHEMBL4008326	Inhibition of recombinant TEL-fused JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4066104	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	18034718	CHEMBL4008326	Inhibition of recombinant TEL-fused JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4087478	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	18040169	CHEMBL4009516	Inhibition of recombinant human GST-tagged cytoplasmic JAK3 (781 to 1124 amino acid residues) catalytic domain expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	C=CC(=O)Nc1cc(Nc2n[nH]c3cc(Nc4cccc(F)c4)ccc23)c(OC)cc1N(C)CCN(C)C		CHEMBL4068763	>	Inhibition	%	85.0	CHEMBL2148	Homo sapiens	INH	%	85.0
	18053024	CHEMBL4011871	Inhibition of JAK3 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-27.9	CHEMBL2148	Homo sapiens	INH	%	-27.9
	18064288	CHEMBL4013843	Inhibition of human JAK3 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	556.0	CHEMBL2148	Homo sapiens	IC50	nM	556.0
	18064302	CHEMBL4013857	Inhibition of human JAK3 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
Not Determined	18066685	CHEMBL4014519	Inhibition of human JAK3	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL2148	Homo sapiens	IC50		
	18066686	CHEMBL4014519	Inhibition of human JAK3	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	=	IC50	nM	4260.0	CHEMBL2148	Homo sapiens	IC50	uM	4.26
	18066687	CHEMBL4014520	Inhibition of human JAK3 at 10 uM relative to control	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18066688	CHEMBL4014520	Inhibition of human JAK3 at 10 uM relative to control	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18084577	CHEMBL4018338	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4089245	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18084609	CHEMBL4018331	Inhibition of human JAK3 at 10 uM using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	Inhibition	%	12.0	CHEMBL2148	Homo sapiens	INH	%	12.0
	18084616	CHEMBL4018338	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18084619	CHEMBL4018331	Inhibition of human JAK3 at 10 uM using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4089245	=	Inhibition	%	7.0	CHEMBL2148	Homo sapiens	INH	%	7.0
	18084669	CHEMBL4018331	Inhibition of human JAK3 at 10 uM using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4077859	=	Inhibition	%	9.0	CHEMBL2148	Homo sapiens	INH	%	9.0
	18084676	CHEMBL4018338	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4077859	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18084685	CHEMBL4018338	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	uM	0.1
	18086466	CHEMBL4018854	Binding affinity to human JAK3 JH1 domain assessed as dissociation constant by quantitative real-time PCR method	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Kd	nM	26.0	CHEMBL2148	Homo sapiens	Kd	nM	26.0
Not Active	18091340	CHEMBL4019849	Inhibition of JAK3 (unknown origin) at 10 uM	B	O/N=c1\cc(-c2cc3cccn3cn2)oc2ccc(OCCN3CCOCC3)cc12		CHEMBL4067875		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	18092345	CHEMBL4020201	Inhibition of JAK3 (unknown origin)	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18105573	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	CCOc1nn(C)cc1Nc1ncc(C)c(-c2c[nH]c3c(NC(=O)[C@@H](CC)N4CCN(C)CC4)cccc23)n1		CHEMBL4092807	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18105574	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	COC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cn(C)nc4C)ncc3F)c[nH]c12)N1CCN(C)CC1		CHEMBL4060528	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18105575	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	CC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cn(C)nc4C)ncc3F)c[nH]c12)N1CCN(C)CC1		CHEMBL4085905	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18105576	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	COc1nn(C)cc1Nc1ncc(Cl)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1		CHEMBL4064366	=	IC50	nM	19100.0	CHEMBL2148	Homo sapiens	IC50	uM	19.1
	18105577	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	CCOc1nn(C)cc1Nc1ncc(F)c(-c2c[nH]c3c(NC(=O)[C@H](C)N4CCN(C)C[C@@H]4C)cccc23)n1		CHEMBL4078025	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18105578	CHEMBL4022636	Inhibition of N-terminal GST fused recombinant JAK3 (781 to 1124 amino acids) (unknown origin) expressed in insect cells using ATP and peptide substrate (5FAM-GEEPLYWSFPAKKK-NH2	B	COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)C[C@@H]4C)cccc23)n1		CHEMBL4102286	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18107192	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107193	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107194	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107195	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2ccccc2)C1		CHEMBL4101374	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107196	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(C)(=O)=O)C1		CHEMBL4100431	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107197	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4092805	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107198	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CC(C)CS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655082	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107199	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC(F)(F)F)C1		CHEMBL3655080	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107200	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2ccc(F)cc2)C1		CHEMBL4103698	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107201	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)Cc2ccccc2)C1		CHEMBL4085011	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107202	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCNS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4071850	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107203	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCNS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4098094	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107204	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NC2CC2)C1		CHEMBL4078655	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107205	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCC2CC2)C1		CHEMBL3655097	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107206	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCCCC#N)C1		CHEMBL4082035	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107207	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4100048	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107208	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)C2CC2)C1		CHEMBL4075575	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107209	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4090590	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107210	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3658860	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107211	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2ccccc2)C1		CHEMBL4103586	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107212	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4089286	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107213	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4059894	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107214	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCCNS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4093643	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107215	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)NCC2CC2)C1		CHEMBL4066876	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107216	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655081	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18107217	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCS(=O)(=O)N[C@H]1C[C@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4101725	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107218	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4087961	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107219	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CC2)C1		CHEMBL4059667	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107220	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC2)C1		CHEMBL3655095	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107221	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CCC2)C1		CHEMBL4068319	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107222	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCC(F)(F)F)C1		CHEMBL4103435	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107223	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCCC(F)(F)F)C1		CHEMBL4079179	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107224	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	COCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4065613	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107225	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	COCCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4087044	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107226	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CCCC#N)C1		CHEMBL4099048	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107227	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2COC2)C1		CHEMBL3655086	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107228	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCN(C)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4085264	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107229	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(C1CC1)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4063642	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107230	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CCCCC2)C1		CHEMBL4077614	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107231	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(CCC#N)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655104	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107232	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CCCCN(C)S(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4066404	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107233	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(CC1CC1)S(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL4093955	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107234	CHEMBL4022976	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay	B	CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCCC2)C1		CHEMBL4104105	>=	IC50	nM	8000.0	CHEMBL2148	Homo sapiens	IC50	uM	8.0
	18107302	CHEMBL4022984	Inhibition of recombinant human JAK3 using FITC-KGGEEEEYFELVKK as substrate in presence of 4 uM ATP by mobility shift assay	B	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655081	=	IC50	nM	605.0	CHEMBL2148	Homo sapiens	IC50	nM	605.0
	18107303	CHEMBL4022985	Inhibition of recombinant GST-tagged human JAK3 catalytic/cytoplasmic domain expressed in Baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate at 1 uM in presence of 1 mM ATP by mobility shift assay relative to control	B	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655081	=	Inhibition	%	61.0	CHEMBL2148	Homo sapiens	INH	%	61.0
	18109320	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Inhibition	%	80.0	CHEMBL2148	Homo sapiens	INH	%	80.0
	18109321	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	Inhibition	%	89.0	CHEMBL2148	Homo sapiens	INH	%	89.0
	18109322	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4071161	=	Inhibition	%	-7.0	CHEMBL2148	Homo sapiens	INH	%	-7.0
	18109323	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	=	Inhibition	%	-3.0	CHEMBL2148	Homo sapiens	INH	%	-3.0
	18109324	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1		CHEMBL4065122	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	18109325	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18109326	CHEMBL4023732	Inhibition of recombinant human catalytic GST-tagged JAK3 expressed in baculovirus at 1 uM by Z'-LYTE assay	A	Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O		CHEMBL3952795	=	Inhibition	%	-2.0	CHEMBL2148	Homo sapiens	INH	%	-2.0
	18114303	CHEMBL4025191	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	79.0	CHEMBL2148	Homo sapiens	Activity	%	79.0
	18114698	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142	=	IC50	nM	1705.0	CHEMBL2148	Homo sapiens	IC50	nM	1705.0
	18114699	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1		CHEMBL2216827	=	IC50	nM	1533.0	CHEMBL2148	Homo sapiens	IC50	nM	1533.0
	18114700	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	1753.0	CHEMBL2148	Homo sapiens	IC50	nM	1753.0
	18114701	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21		CHEMBL4077064	=	IC50	nM	3336.0	CHEMBL2148	Homo sapiens	IC50	nM	3336.0
	18114702	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	146.0	CHEMBL2148	Homo sapiens	IC50	nM	146.0
	18114703	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4cc5c(s4)CCCC5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4096207	=	IC50	nM	1033.0	CHEMBL2148	Homo sapiens	IC50	nM	1033.0
	18114704	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4085868	=	IC50	nM	2014.0	CHEMBL2148	Homo sapiens	IC50	nM	2014.0
	18114705	CHEMBL4024933	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18141403	CHEMBL4031312	Inhibition of wild type human JAK3 (I781 to S1124 residues) expressed in mammalian cells assessed as residual activity at 1 uM by KINOMEscan assay relative to control	A	O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO		CHEMBL4060201	=	Activity	%	0.75	CHEMBL2148	Homo sapiens	Activity	%	0.75
	18141409	CHEMBL4031308	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of [gamma-33P]-ATP	A	CC(CCCCCC(=O)NO)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL4095596	=	IC50	nM	436.0	CHEMBL2148	Homo sapiens	IC50	uM	0.436
	18141410	CHEMBL4031308	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of [gamma-33P]-ATP	A	O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO		CHEMBL4060201	=	IC50	nM	569.0	CHEMBL2148	Homo sapiens	IC50	uM	0.569
	18143847	CHEMBL4031840	Inhibition of recombinant human JAK3 JH1 catalytic domain (781 to 1124 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1		CHEMBL3961632	>	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	18143877	CHEMBL4031865	Inhibition of JAK3 in human PBMC at 1 uM	B	Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1		CHEMBL3961632	>	Inhibition	%	60.0	CHEMBL2148	Homo sapiens	INH	%	60.0
	18143878	CHEMBL4031865	Inhibition of JAK3 in human PBMC at 1 uM	B	Cc1cccc(-c2cc(Nc3ccn(C)n3)nc3[nH]cc(C#N)c23)c1		CHEMBL3969077	=	Inhibition	%	53.0	CHEMBL2148	Homo sapiens	INH	%	53.0
	18147086	CHEMBL4032525	Inhibition of JAK3 (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	22.5	CHEMBL2148	Homo sapiens	INH	%	22.5
	18147087	CHEMBL4032525	Inhibition of JAK3 (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	31.9	CHEMBL2148	Homo sapiens	INH	%	31.9
	18147122	CHEMBL4032545	Inhibition of JAK3 (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	52.8	CHEMBL2148	Homo sapiens	INH	%	52.8
	18147123	CHEMBL4032545	Inhibition of JAK3 (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	14.6	CHEMBL2148	Homo sapiens	INH	%	14.6
	18148544	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.34	CHEMBL2148	Homo sapiens	IC50	nM	0.34
	18148545	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	CN(C)[C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1		CHEMBL3703085	=	IC50	nM	1226.0	CHEMBL2148	Homo sapiens	IC50	nM	1226.0
	18148546	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccccc2)n1		CHEMBL4100288	=	IC50	nM	361.0	CHEMBL2148	Homo sapiens	IC50	nM	361.0
	18148547	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(Cl)cc2)n1		CHEMBL4089234	=	IC50	nM	256.0	CHEMBL2148	Homo sapiens	IC50	nM	256.0
	18148548	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(F)cc2)n1		CHEMBL4104623	=	IC50	nM	304.0	CHEMBL2148	Homo sapiens	IC50	nM	304.0
	18148549	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(C3CC3)cc2)n1		CHEMBL4077886	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
	18148550	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(OC(F)F)cc2)n1		CHEMBL4102140	=	IC50	nM	196.0	CHEMBL2148	Homo sapiens	IC50	nM	196.0
	18148551	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	Cn1cc(-c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc2)cn1		CHEMBL4078799	=	IC50	nM	91.0	CHEMBL2148	Homo sapiens	IC50	nM	91.0
	18148552	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc(-n3ccnn3)cc2)n1		CHEMBL4096821	=	IC50	nM	116.0	CHEMBL2148	Homo sapiens	IC50	nM	116.0
	18148553	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccnc(F)c2)n1		CHEMBL4067915	=	IC50	nM	511.0	CHEMBL2148	Homo sapiens	IC50	nM	511.0
	18148554	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccc([C@H](O)C(F)(F)F)cc2)n1		CHEMBL4089118	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18148555	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1		CHEMBL4061128	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	18148556	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	C[C@@H]1NS(=O)(=O)c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc21		CHEMBL4066906	=	IC50	nM	315.0	CHEMBL2148	Homo sapiens	IC50	nM	315.0
	18148557	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1C#N		CHEMBL4072848	=	IC50	nM	391.0	CHEMBL2148	Homo sapiens	IC50	nM	391.0
	18148558	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1C1CC1		CHEMBL4098999	>	IC50	nM	1496.0	CHEMBL2148	Homo sapiens	IC50	nM	1496.0
	18148559	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1C#N		CHEMBL4064171	=	IC50	nM	656.0	CHEMBL2148	Homo sapiens	IC50	nM	656.0
	18148560	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1Cl		CHEMBL4085737	=	IC50	nM	556.0	CHEMBL2148	Homo sapiens	IC50	nM	556.0
	18148561	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1Cl		CHEMBL4071005	=	IC50	nM	397.0	CHEMBL2148	Homo sapiens	IC50	nM	397.0
	18148562	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	CN(C)c1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc(F)n1		CHEMBL4092626	=	IC50	nM	701.0	CHEMBL2148	Homo sapiens	IC50	nM	701.0
	18148563	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc(F)n1		CHEMBL4066193	=	IC50	nM	1130.0	CHEMBL2148	Homo sapiens	IC50	nM	1130.0
	18148564	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	COc1ccnc2c(F)cc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc12		CHEMBL4088262	>	IC50	nM	1496.0	CHEMBL2148	Homo sapiens	IC50	nM	1496.0
	18148565	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2cc(F)c3nccc(Cl)c3c2)n1		CHEMBL4076473	=	IC50	nM	1012.0	CHEMBL2148	Homo sapiens	IC50	nM	1012.0
	18148566	CHEMBL4033004	Inhibition of GST-tagged recombinant human JAK3 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay	B	Cc1ncnc2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc12		CHEMBL4079092	=	IC50	nM	783.0	CHEMBL2148	Homo sapiens	IC50	nM	783.0
Not Active	18156567	CHEMBL4035111	Inhibition of JAK3 (unknown origin) at 20 uM	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18203715	CHEMBL4044002	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	98.0	CHEMBL2148	Homo sapiens	Activity	%	98.0
	18211585	CHEMBL4045710	Inhibition of JAK3 domain2 conserved Lys1 (YDPLGDNTGALVAVKQLQHSGPDQQR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-0.9	CHEMBL2148	Homo sapiens	INH	%	-0.9
	18211600	CHEMBL4045709	Inhibition of JAK3 domain2 activation Loop (IADFGLAKLLPLDKDYYVVR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.8	CHEMBL2148	Homo sapiens	INH	%	7.8
	18211854	CHEMBL4045950	Inhibition of JAK3 domain2 activation Loop (IADFGLAKLLPLDKDYYVVR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	15.9	CHEMBL2148	Homo sapiens	INH	%	15.9
	18211855	CHEMBL4045951	Inhibition of JAK3 domain2 conserved Lys1 (YDPLGDNTGALVAVKQLQHSGPDQQR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-8.0	CHEMBL2148	Homo sapiens	INH	%	-8.0
	18214068	CHEMBL4046597	Inhibition of JAK3 (unknown origin)	B	Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1		CHEMBL4076947	=	Ki	nM	58.0	CHEMBL2148	Homo sapiens	Ki	nM	58.0
	18218947	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1		CHEMBL4072239	=	IC50	nM	4.5	CHEMBL2148	Homo sapiens	IC50	nM	4.5
	18218948	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	NC(=O)c1cnn2cc(-c3ccccc3)cc2c1NCc1ccccc1		CHEMBL4093318	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	18218949	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18218950	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	CCC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4071559	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18218951	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	C=CC(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1		CHEMBL4092337	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	18218952	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	C/C=C/C(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1		CHEMBL4062932	=	IC50	nM	175.0	CHEMBL2148	Homo sapiens	IC50	nM	175.0
	18218953	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	C=CS(=O)(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1		CHEMBL4084598	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
	18218954	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	N#CCC(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1		CHEMBL4066730	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	18218955	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	CN(C)/C=C(/C#N)C(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1		CHEMBL4088027	=	IC50	nM	942.0	CHEMBL2148	Homo sapiens	IC50	nM	942.0
	18218956	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	NC(=O)c1cnn2cccc2c1NCc1cccc(NC(=O)COc2c(F)c(F)c(F)c(F)c2F)c1		CHEMBL4084173	=	IC50	nM	743.0	CHEMBL2148	Homo sapiens	IC50	nM	743.0
	18218957	CHEMBL4047229	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	NC(=O)c1cnn2cccc2c1NCc1cccc(NC(=O)Cn2sc3ccccc3c2=O)c1		CHEMBL4062471	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
Active	18218968	CHEMBL4047231	Time-dependent inhibition of JAK3 (unknown origin) using CSKtide as substrate in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693		TDI			CHEMBL2148	Homo sapiens	TDI		
	18218969	CHEMBL4047232	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 15 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method relative to control	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	=	Inhibition	%	100.0	CHEMBL2148	Homo sapiens	INH	%	100.0
	18218983	CHEMBL4047238	Inhibition of JAK3 (unknown origin) assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	<	Activity	%	10.0	CHEMBL2148	Homo sapiens	Activity	%	10.0
	18219004	CHEMBL4047259	Ratio of Kinact to Ki for His-tagged JAK3 (unknown origin) by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	=	Ratio	/uM/s	0.3	CHEMBL2148	Homo sapiens	Ratio	/uM/s	0.3
Active	18219008	CHEMBL4047263	Inhibition of JAK3 (unknown origin) using CSKtide as substrate pretreated measured after 30 mins in presence of [gamma32P]ATP by top-count liquid scintillation counting method	B	CCC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4071559		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18220840	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1		CHEMBL4072239	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	18220841	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4099198	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18220842	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)c1ccccc1		CHEMBL4080656	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	18220843	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1NCc1ccccc1		CHEMBL4098698	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18220844	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1NCc1ccccc1		CHEMBL4088523	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
	18220845	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1ccc(Nc2cc(NCc3ccccc3)c(C(N)=O)cn2)cc1		CHEMBL4060298	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	18220846	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	CN1CCC(NC(=O)c2ccc(Nc3cc(NCc4ccccc4)c(C(N)=O)cn3)cc2)CC1		CHEMBL4096246	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18220847	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NCc1cc(F)ccc1F		CHEMBL4068975	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18220848	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4104005	=	IC50	nM	3500.0	CHEMBL2148	Homo sapiens	IC50	nM	3500.0
	18220849	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4079743	=	IC50	nM	1600.0	CHEMBL2148	Homo sapiens	IC50	nM	1600.0
	18220850	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	COCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4091863	=	IC50	nM	3400.0	CHEMBL2148	Homo sapiens	IC50	nM	3400.0
	18220851	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	CN(C)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4064106	=	IC50	nM	5400.0	CHEMBL2148	Homo sapiens	IC50	nM	5400.0
	18220852	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	O=C(NCC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4096937	=	IC50	nM	3600.0	CHEMBL2148	Homo sapiens	IC50	nM	3600.0
	18220853	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	O=C(NC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4091402	=	IC50	nM	8600.0	CHEMBL2148	Homo sapiens	IC50	nM	8600.0
	18220854	CHEMBL4047623	Inhibition of JAK3 (unknown origin) by caliper assay	B	CN(C)C(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1		CHEMBL4089510	=	IC50	nM	29000.0	CHEMBL2148	Homo sapiens	IC50	nM	29000.0
	18231697	CHEMBL4050189	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of [gamma-32P]ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.184	CHEMBL2148	Homo sapiens	IC50	10'-10M	1.84
Not Determined	18231727	CHEMBL4050189	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of [gamma-32P]ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		IC50			CHEMBL2148	Homo sapiens	IC50		
	18248603	CHEMBL4053886	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	89.0	CHEMBL2148	Homo sapiens	INH	%	89.0
	18252911	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)nc4)cc23)CC[C@]1(C)N		CHEMBL4096795	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18252912	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC(C)Oc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4070136	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	18252913	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CCOc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4091096	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	18252914	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	18252915	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)nc4)cc23)CC[C@]1(C)N		CHEMBL4098840	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18252916	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncc(F)c4)cc23)CC[C@]1(C)N		CHEMBL4088673	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
	18252917	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4060444	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	18252918	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1ccncc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL3671805	=	IC50	nM	6.1	CHEMBL2148	Homo sapiens	IC50	nM	6.1
	18252919	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	COc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1		CHEMBL4069127	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	18252920	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccnc(F)c4)cc23)CC[C@]1(C)N		CHEMBL4104127	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	18252921	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4F)cc23)CC[C@]1(C)N		CHEMBL4079880	=	IC50	nM	4.6	CHEMBL2148	Homo sapiens	IC50	nM	4.6
	18252922	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1		CHEMBL4073562	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	18252923	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1cnccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL4084341	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	18252924	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cc[nH]n4)cc23)CC[C@]1(C)N		CHEMBL4060984	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	18252925	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cncnc4)cc23)CC[C@]1(C)N		CHEMBL4089164	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18252926	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4)cc23)CC[C@]1(C)N		CHEMBL4063870	=	IC50	nM	6.7	CHEMBL2148	Homo sapiens	IC50	nM	6.7
	18252927	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccnc4)cc23)CC[C@]1(C)N		CHEMBL3671804	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	18252928	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(C#N)cc4)cc23)CC[C@]1(C)N		CHEMBL4091582	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18252929	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(C#N)c4)cc23)CC[C@]1(C)N		CHEMBL4070687	=	IC50	nM	3.8	CHEMBL2148	Homo sapiens	IC50	nM	3.8
	18252930	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4C#N)cc23)CC[C@]1(C)N		CHEMBL4083798	=	IC50	nM	1.9	CHEMBL2148	Homo sapiens	IC50	nM	1.9
	18252931	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(Cl)cc4)cc23)CC[C@]1(C)N		CHEMBL4062062	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	18252932	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(Cl)c4)cc23)CC[C@]1(C)N		CHEMBL4076823	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18252933	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4Cl)cc23)CC[C@]1(C)N		CHEMBL4105015	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	18252934	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(F)cc4)cc23)CC[C@]1(C)N		CHEMBL4077508	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	18252935	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(F)c4)cc23)CC[C@]1(C)N		CHEMBL4071806	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	18252936	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4F)cc23)CC[C@]1(C)N		CHEMBL4076191	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
	18252937	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1		CHEMBL4078773	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
	18252938	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	COc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1		CHEMBL4076794	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18252939	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	COc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL4071255	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	18252940	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1		CHEMBL4060536	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	18252941	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1cccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)c1		CHEMBL4087655	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	18252942	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	Cc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1		CHEMBL4068856	=	IC50	nM	1.8	CHEMBL2148	Homo sapiens	IC50	nM	1.8
	18252943	CHEMBL4054821	Inhibition of JAK3 (unknown origin) using CSKtide as substrate after 30 mins in presence of [gamma33P]ATP by liquid scintillation counting method	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	18253225	CHEMBL4054896	Inhibition of human JAK3 D2 domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	3.8	CHEMBL2148	Homo sapiens	Activity	%	3.8
	18253226	CHEMBL4054896	Inhibition of human JAK3 D2 domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	40.0	CHEMBL2148	Homo sapiens	Activity	%	40.0
	18265876	CHEMBL4057326	Inhibition of JAK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1	Outside typical range	CHEMBL4095072	=	Inhibition	%	-15.7	CHEMBL2148	Homo sapiens	INH	%	-15.7
	18266070	CHEMBL4057520	Inhibition of JAK3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-7.3	CHEMBL2148	Homo sapiens	INH	%	-7.3
	18268996	CHEMBL4058127	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	8160.0	CHEMBL2148	Homo sapiens	IC50	nM	8160.0
	18282068	CHEMBL4120023	Inhibition of recombinant GST-tagged human JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 1 uM by FRET relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	21.9	CHEMBL2148	Homo sapiens	INH	%	21.9
	18282387	CHEMBL4120023	Inhibition of recombinant GST-tagged human JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 1 uM by FRET relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	24.6	CHEMBL2148	Homo sapiens	INH	%	24.6
	18282873	CHEMBL4120458	Inhibition of JAK3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1	Outside typical range	CHEMBL4095072	=	Inhibition	%	-15.7	CHEMBL2148	Homo sapiens	INH	%	-15.7
	18283087	CHEMBL4120672	Inhibition of JAK3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1	Outside typical range	CHEMBL4125807	=	Inhibition	%	-10.3	CHEMBL2148	Homo sapiens	INH	%	-10.3
	18283302	CHEMBL4120887	Inhibition of JAK3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18286311	CHEMBL4121546	Inhibition of recombinant GST-tagged human JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-3.0	CHEMBL2148	Homo sapiens	INH	%	-3.0
	18298363	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
	18298364	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18298365	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4128005	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18298366	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)/C=C/c1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4125935	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	nM	470.0
	18298367	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4129249	=	IC50	nM	129.0	CHEMBL2148	Homo sapiens	IC50	nM	129.0
	18298368	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4127174	=	IC50	nM	226.0	CHEMBL2148	Homo sapiens	IC50	nM	226.0
	18298369	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)/C=C/c1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4125798	=	IC50	nM	548.0	CHEMBL2148	Homo sapiens	IC50	nM	548.0
	18298370	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128410	=	IC50	nM	51.0	CHEMBL2148	Homo sapiens	IC50	nM	51.0
	18298371	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#C/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4127032	=	IC50	nM	390.0	CHEMBL2148	Homo sapiens	IC50	nM	390.0
	18298372	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#C/C=C/c1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4129641	=	IC50	nM	135.0	CHEMBL2148	Homo sapiens	IC50	nM	135.0
	18298373	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#C/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128266	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	18298374	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4127332	=	IC50	nM	499.0	CHEMBL2148	Homo sapiens	IC50	nM	499.0
	18298375	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)CCc1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4128719	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
	18298376	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	NC(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4126097	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
	18298377	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4127480	=	IC50	nM	642.0	CHEMBL2148	Homo sapiens	IC50	nM	642.0
	18298378	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)CCc1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4129794	=	IC50	nM	678.0	CHEMBL2148	Homo sapiens	IC50	nM	678.0
	18298379	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4126514	=	IC50	nM	181.0	CHEMBL2148	Homo sapiens	IC50	nM	181.0
	18298380	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CCCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4128579	=	IC50	nM	436.0	CHEMBL2148	Homo sapiens	IC50	nM	436.0
	18298381	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CCCc1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4129943	=	IC50	nM	505.0	CHEMBL2148	Homo sapiens	IC50	nM	505.0
	18298382	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CCCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4127590	=	IC50	nM	129.0	CHEMBL2148	Homo sapiens	IC50	nM	129.0
	18298383	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4128988	=	IC50	nM	571.0	CHEMBL2148	Homo sapiens	IC50	nM	571.0
	18298384	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)C(C#N)=Cc1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4129559	=	IC50	nM	205.0	CHEMBL2148	Homo sapiens	IC50	nM	205.0
	18298385	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128181	=	IC50	nM	9.0	CHEMBL2148	Homo sapiens	IC50	nM	9.0
	18298386	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CNC(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128324	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	18298387	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CC(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)cc1		CHEMBL4126944	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
	18298388	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CC(C#N)=Cc1cccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)c1		CHEMBL4127091	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18298389	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	N#CC(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4125719	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	18298390	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN1CCN(C(=O)C(C#N)=Cc2ccc(-c3nc4cnc5[nH]ccc5c4n3C3CCCCC3)o2)CC1		CHEMBL4125861	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	18298391	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C)o1		CHEMBL4129159	=	IC50	nM	368.0	CHEMBL2148	Homo sapiens	IC50	nM	368.0
	18298392	CHEMBL4124177	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in baculovirus expression system assessed as reduction in polypeptide substrate phosphorylation in presence of ATP by ELISA	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4c(ccn4C)c3n2C2CCCCC2)o1		CHEMBL4129808	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18298420	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.29	CHEMBL2148	Homo sapiens	IC50	nM	0.29
	18298421	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18298422	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	CN(C)C(=O)/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128410	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	18298423	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	N#C/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128266	=	IC50	nM	0.21	CHEMBL2148	Homo sapiens	IC50	nM	0.21
	18298424	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	CN(C)C(=O)CCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4126514	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	nM	48.0
	18298425	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	N#CCCc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4127590	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	18298426	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128181	=	IC50	nM	0.13	CHEMBL2148	Homo sapiens	IC50	nM	0.13
	18298427	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	N#CC(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4125719	=	IC50	nM	0.39	CHEMBL2148	Homo sapiens	IC50	nM	0.39
	18298428	CHEMBL4124185	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 10 uM [gamma33P]ATP by radiometric method	B	CN1CCN(C(=O)C(C#N)=Cc2ccc(-c3nc4cnc5[nH]ccc5c4n3C3CCCCC3)o2)CC1		CHEMBL4125861	=	IC50	nM	0.74	CHEMBL2148	Homo sapiens	IC50	nM	0.74
	18298429	CHEMBL4124186	Inhibition of human JAK3 using GEEEEYFELVKKKK as substrate in presence of 200 uM [gamma33P]ATP by radiometric method	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128181	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18298461	CHEMBL4124195	Inhibition of kinase tracer-05 binding to C-terminal NanoLuc tagged full length JAK3 (unknown origin) expressed in HEK cells by NanoBRET assay	B	N#C/C=C/c1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128266	=	EC50	nM	740.0	CHEMBL2148	Homo sapiens	EC50	nM	740.0
	18298462	CHEMBL4124195	Inhibition of kinase tracer-05 binding to C-terminal NanoLuc tagged full length JAK3 (unknown origin) expressed in HEK cells by NanoBRET assay	B	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4128181	=	EC50	nM	237.0	CHEMBL2148	Homo sapiens	EC50	nM	237.0
	18298463	CHEMBL4124195	Inhibition of kinase tracer-05 binding to C-terminal NanoLuc tagged full length JAK3 (unknown origin) expressed in HEK cells by NanoBRET assay	B	N#CC(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1		CHEMBL4125719	=	EC50	nM	678.0	CHEMBL2148	Homo sapiens	EC50	nM	678.0
	18298464	CHEMBL4124195	Inhibition of kinase tracer-05 binding to C-terminal NanoLuc tagged full length JAK3 (unknown origin) expressed in HEK cells by NanoBRET assay	B	CN1CCN(C(=O)C(C#N)=Cc2ccc(-c3nc4cnc5[nH]ccc5c4n3C3CCCCC3)o2)CC1		CHEMBL4125861	=	EC50	nM	257.0	CHEMBL2148	Homo sapiens	EC50	nM	257.0
	18307202	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-n5cccn5)cc4c32)ccc1C		CHEMBL4166664	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18307206	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cnn(C)c5)cc4c32)ccc1C		CHEMBL4098453	=	IC50	nM	343.0	CHEMBL2148	Homo sapiens	IC50	nM	343.0
	18307210	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)c1		CHEMBL4161110	=	IC50	nM	224.0	CHEMBL2148	Homo sapiens	IC50	nM	224.0
	18307217	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cn[nH]c5)cc4c32)ccc1C		CHEMBL4075449	=	IC50	nM	38.1	CHEMBL2148	Homo sapiens	IC50	nM	38.1
	18307221	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccoc5)cc4c32)ccc1C		CHEMBL4159628	=	IC50	nM	17.4	CHEMBL2148	Homo sapiens	IC50	nM	17.4
	18307225	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccsc5)cc4c32)ccc1C		CHEMBL4173695	=	IC50	nM	38.6	CHEMBL2148	Homo sapiens	IC50	nM	38.6
	18307229	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccccc5)cc4c32)ccc1C		CHEMBL4162994	=	IC50	nM	25.3	CHEMBL2148	Homo sapiens	IC50	nM	25.3
	18307233	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cccnc5)cc4c32)ccc1C		CHEMBL4163399	=	IC50	nM	1520.0	CHEMBL2148	Homo sapiens	IC50	nM	1520.0
	18307237	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N)nc5)cc4c32)ccc1C		CHEMBL4077107	=	IC50	nM	177.0	CHEMBL2148	Homo sapiens	IC50	nM	177.0
	18307241	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N)nc5)cc4c32)c1		CHEMBL4166849	=	IC50	nM	654.0	CHEMBL2148	Homo sapiens	IC50	nM	654.0
	18307265	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	CCC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-n5cccn5)cc4c32)ccc1C		CHEMBL4174577	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18307315	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(/C=C/c5ccccc5)cc4c32)ccc1C		CHEMBL4170077	=	IC50	nM	5580.0	CHEMBL2148	Homo sapiens	IC50	nM	5580.0
	18307319	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NC(=O)NC)cc5)cc4c32)ccc1C		CHEMBL4159459	=	IC50	nM	218.0	CHEMBL2148	Homo sapiens	IC50	nM	218.0
	18307323	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(COc6cccc(C(F)(F)F)c6)cc5)cc4c32)ccc1C		CHEMBL4159852	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	nM	650.0
	18307327	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C		CHEMBL4091991	=	IC50	nM	175.0	CHEMBL2148	Homo sapiens	IC50	nM	175.0
	18307334	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc6c(c5)OCCO6)cc4c32)ccc1C		CHEMBL4163217	=	IC50	nM	192.0	CHEMBL2148	Homo sapiens	IC50	nM	192.0
	18307338	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5cnc6ccccc6c5)cc4c32)ccc1C		CHEMBL4071759	=	IC50	nM	983.0	CHEMBL2148	Homo sapiens	IC50	nM	983.0
	18307342	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21		CHEMBL4077064	=	IC50	nM	5180.0	CHEMBL2148	Homo sapiens	IC50	nM	5180.0
	18307349	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cn[nH]c6)cc5c43)cc21		CHEMBL4160923	=	IC50	nM	2150.0	CHEMBL2148	Homo sapiens	IC50	nM	2150.0
	18307353	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(N)nc6)cc5c43)cc21		CHEMBL4161149	=	IC50	nM	5640.0	CHEMBL2148	Homo sapiens	IC50	nM	5640.0
	18307357	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc21		CHEMBL4171756	=	IC50	nM	983.0	CHEMBL2148	Homo sapiens	IC50	nM	983.0
	18307361	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(S(=O)(=O)NC(C)(C)C)cc6)cc5c43)cc21		CHEMBL4068097	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18307365	CHEMBL4130923	Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 hr followed by substrate addition measured after 1 hr by ADP-glo assay	B	C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c43)cc21		CHEMBL4175202	=	IC50	nM	1560.0	CHEMBL2148	Homo sapiens	IC50	nM	1560.0
	18330829	CHEMBL4136273	Inhibition of recombinant JAK3 (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	89.0	CHEMBL2148	Homo sapiens	INH	%	89.0
	18378230	CHEMBL4145182	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	1940.0	CHEMBL2148	Homo sapiens	IC50	uM	1.94
	18378275	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CN1CCN(c2cc(Nc3nccc(Nc4ccc(F)c(Cl)c4F)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4173676	=	IC50	nM	464.0	CHEMBL2148	Homo sapiens	IC50	uM	0.464
	18378276	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)nc1Nc1cccc(CO)c1		CHEMBL4165758	=	IC50	nM	371.0	CHEMBL2148	Homo sapiens	IC50	uM	0.371
	18378277	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CN1CCN(c2cc(Nc3nccc(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4170235	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378278	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CN1CCN(c2cc(Nc3ncc(F)c(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4162314	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378279	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3CCN(C)CC3)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4171692	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378280	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CN1CCN(c2cc(Nc3ncc(Cl)c(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4163817	=	IC50	nM	12600.0	CHEMBL2148	Homo sapiens	IC50	uM	12.6
	18378281	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CN1CCN(c2cc(Nc3ncc(Br)c(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4162065	=	IC50	nM	6540.0	CHEMBL2148	Homo sapiens	IC50	uM	6.54
	18378282	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4169982	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378283	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cccc(N3CCN(C)CC3)c2)nc1Nc1cccc(CO)c1		CHEMBL4165506	=	IC50	nM	20300.0	CHEMBL2148	Homo sapiens	IC50	uM	20.3
	18378284	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3CCNCC3)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4173429	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378285	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@H](C)N[C@H](C)C3)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4173835	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378286	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CC(=O)N1CCN(c2cc(Nc3ncc(C)c(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4163122	=	IC50	nM	24600.0	CHEMBL2148	Homo sapiens	IC50	uM	24.6
	18378287	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3CCN(CCO)CC3)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4177188	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378288	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	COCCN1CCN(c2cc(Nc3ncc(C)c(Nc4cccc(CO)c4)n3)cc(S(C)(=O)=O)c2)CC1		CHEMBL4166565	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378289	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cc(S(C)(=O)=O)c2)nc1Nc1cccc(CO)c1		CHEMBL4166989	>	IC50	nM	27900.0	CHEMBL2148	Homo sapiens	IC50	uM	27.9
	18378290	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(C(F)F)cc(N3C[C@@H]4C[C@H]3CN4C)c2)nc1Nc1cccc(CO)c1		CHEMBL4174879	=	IC50	nM	18100.0	CHEMBL2148	Homo sapiens	IC50	uM	18.1
	18378291	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cc(C(F)F)c2F)nc1Nc1cccc(CO)c1		CHEMBL4175654	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378292	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)nc1Nc1cccc(CO)c1		CHEMBL4165365	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378293	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)ccc2F)nc1Nc1cccc(CO)c1		CHEMBL4159048	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378294	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	Cc1cnc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)nc1N[C@H](C)C(C)C		CHEMBL4175808	=	IC50	nM	18100.0	CHEMBL2148	Homo sapiens	IC50	uM	18.1
	18378295	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CCC(CC)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C		CHEMBL4168613	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378296	CHEMBL4145185	Inhibition of recombinant human JAK3 (781 to 1124 residues) expressed in insect cells using 5FAM-GEEPLYWSFPAKKK-NH2 as substrate after 10 mins by caliper assay	B	CC[C@@H](C)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C		CHEMBL4169221	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	18378349	CHEMBL4145194	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus at 1 uM	B	CC[C@@H](C)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C		CHEMBL4169221	=	Inhibition	%	46.0	CHEMBL2148	Homo sapiens	INH	%	46.0
	18379925	CHEMBL4145826	Inhibition of JAK3 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-8.59	CHEMBL2148	Homo sapiens	INH	%	-8.59
	18379977	CHEMBL4145878	Inhibition of JAK3 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.1	CHEMBL2148	Homo sapiens	IC50	nM	0.1
	18403653	CHEMBL4150599	Inhibition of JAK3 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCC(C(=O)Nc5ccc(/C=C/C(=O)NO)cc5)CC4)cc3)n2)cc1		CHEMBL4175555	=	IC50	nM	121.0	CHEMBL2148	Homo sapiens	IC50	nM	121.0
	18403654	CHEMBL4150599	Inhibition of JAK3 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP	B	CS(=O)(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCC(C(=O)NCCCCCCCC(=O)NO)CC4)cc3)n2)cc1		CHEMBL4159366	=	IC50	nM	144.0	CHEMBL2148	Homo sapiens	IC50	nM	144.0
	18403655	CHEMBL4150599	Inhibition of JAK3 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of ATP	B	O=C(NO)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4160840	=	IC50	nM	517.0	CHEMBL2148	Homo sapiens	IC50	nM	517.0
	18415117	CHEMBL4152881	Inhibition of JAK3 (unknown origin)	B	CC(C)(C)/C=C(/C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4167139	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	18440257	CHEMBL4157081	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	18443285	CHEMBL4157918	Inhibition of human JAK3 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	85.0	CHEMBL2148	Homo sapiens	Activity	%	85.0
	18450221	CHEMBL4178256	Inhibition of recombinant human JAK3 (781 to 1124 residues) preincubated for 10 mins followed by poly-[Glu-Tyr(4:1) substrate addition after 60 mins in presence of ATP by Kinase-Glo assay	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18450222	CHEMBL4178256	Inhibition of recombinant human JAK3 (781 to 1124 residues) preincubated for 10 mins followed by poly-[Glu-Tyr(4:1) substrate addition after 60 mins in presence of ATP by Kinase-Glo assay	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
Active	18450774	CHEMBL4178431	Inhibition of JAK3 (unknown origin) at 1 uM by cell based assay	B	C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F		CHEMBL3989970		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18453027	CHEMBL4179012	Inhibition of JAK3 (unknown origin) by ELISA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
	18453028	CHEMBL4179013	Time-dependent inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in sf21 cells using biotinylated peptide substrate after 1 hr by DELFIA	B	C=CC(=O)Nc1ccc2ncn(-c3cncc(NC(C)(C)C)n3)c2c1		CHEMBL4209458	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	18453030	CHEMBL4179015	Binding affinity to JAK3 (unknown origin) assessed as dissociation half life	B	CN(C)C(=O)/C(C#N)=C/c1ccc(Nc2cnc3[nH]cc(C(=O)C(C)(C)C)c3n2)cc1		CHEMBL3890245	=	T1/2	hr	9.0	CHEMBL2148	Homo sapiens	t1/2	hr	9.0
	18453031	CHEMBL4179016	Inhibition of JAK3 (unknown origin)	B	N#C/C(=C\c1cccc(-c2cccc3[nH]ncc23)c1)C(N)=O		CHEMBL4204801	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	18453032	CHEMBL4179016	Inhibition of JAK3 (unknown origin)	B	c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1		CHEMBL3622376	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	18453033	CHEMBL4179016	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1ccc(F)c(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL4209692	=	IC50	nM	0.43	CHEMBL2148	Homo sapiens	IC50	nM	0.43
	18453034	CHEMBL4179016	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	0.35	CHEMBL2148	Homo sapiens	IC50	nM	0.35
	18453041	CHEMBL4179023	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate by fluorescence caliper assay	B	C=C(C)C(=O)Nc1cccc(-c2ncnc3[nH]cc(C(=O)OCC)c23)c1		CHEMBL3650985	=	IC50	nM	0.15	CHEMBL2148	Homo sapiens	IC50	nM	0.15
	18464421	CHEMBL4181430	Inhibition of recombinant GST-tagged human JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 100 nM relative to control	B	CCOP(=O)(CCCOc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(=O)NC)n2)cc1)N1CCOCC1		CHEMBL4216755	=	Inhibition	%	26.0	CHEMBL2148	Homo sapiens	INH	%	26.0
	18484213	CHEMBL4185860	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	88.0	CHEMBL2148	Homo sapiens	Activity	%	88.0
	18484697	CHEMBL4185860	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	18489522	CHEMBL4187263	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	18499349	CHEMBL4188989	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP relative to control	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	Inhibition	%	98.0	CHEMBL2148	Homo sapiens	INH	%	98.0
Not Active	18504086	CHEMBL4189915	Inhibition of DNA-tagged human partial length JAK3 JH1 domain-catalytic expressed in mammalian expression system at 100 nM by qPCR method	B	CN1CCN(c2cc(Nc3cc(-c4cccc(F)c4)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4216563		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18506014	CHEMBL4190474	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus infected Sf9 insect cells using Poly(Ala,Glu,Lys,Tyr)6:2:5:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Non standard unit for type	CHEMBL1290072	>	INH	uM	100.0	CHEMBL2148	Homo sapiens	INH	uM	100.0
	18507744	CHEMBL4191018	Inhibition of recombinant human JAK3 (781 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	4.0	CHEMBL2148	Homo sapiens	INH	%	4.0
	18570767	CHEMBL4220899	Inhibition of recombinant human JAK3 (781-end residues) at 10 uM in presence of ATP relative to control	B	CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1		CHEMBL4224807	=	Inhibition	%	80.0	CHEMBL2148	Homo sapiens	INH	%	80.0
	18570768	CHEMBL4220900	Inhibition of recombinant human JAK3 (781-end residues) in presence of ATP	B	CN(c1ncnc2[nH]ccc12)[C@@H]1CCN(C(=O)CC#N)C1		CHEMBL4224807	=	IC50	nM	2800.0	CHEMBL2148	Homo sapiens	IC50	10'3nM	2.8
	18652259	CHEMBL4229649	Inhibition of JAK3 (unknown origin)	B	NC(=O)c1c[nH]c2nnnc(O)c12		CHEMBL4241245	<	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	18653575	CHEMBL4230116	Inhibition of JAK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	30.0	CHEMBL2148	Homo sapiens	INH	%	30.0
	18653576	CHEMBL4230116	Inhibition of JAK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	18655475	CHEMBL4230760	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2148	Homo sapiens	Activity	%	100.0
	18663918	CHEMBL4232902	Inhibition of human JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	73.0	CHEMBL2148	Homo sapiens	Activity	%	73.0
	18664015	CHEMBL4232999	Binding affinity to human JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2148	Homo sapiens	Kd	uM	5.0
	18665405	CHEMBL4233342	Inhibition of JAK3 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	18665479	CHEMBL4233342	Inhibition of JAK3 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	nM	5000.0
	18666966	CHEMBL4233699	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781-end residues) expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NCC(=O)O)cc3)ncc2Cl)c1		CHEMBL4251213	>	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
	18666967	CHEMBL4233699	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781-end residues) expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCCC4C(=O)OC)cc3)ncc2Cl)c1		CHEMBL4243975	=	IC50	nM	196.0	CHEMBL2148	Homo sapiens	IC50	nM	196.0
	18666968	CHEMBL4233699	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781-end residues) expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NC(C)C(=O)OC)cc3)ncc2Cl)c1		CHEMBL4247474	>	IC50	nM	500.0	CHEMBL2148	Homo sapiens	IC50	nM	500.0
	18666969	CHEMBL4233699	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781-end residues) expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)NCC(=O)OC)cc3)ncc2Cl)c1		CHEMBL4247870	=	IC50	nM	496.0	CHEMBL2148	Homo sapiens	IC50	nM	496.0
	18666970	CHEMBL4233699	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781-end residues) expressed in baculovirus infected Sf9 cells using poly (4:1 Glu, Tyr) peptide as substrate after 60 mins by ADP-Glo assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	<	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18674719	CHEMBL4235374	Inhibition of JAK3 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	=	Ki	nM	280.0	CHEMBL2148	Homo sapiens	Ki	nM	280.0
	18674720	CHEMBL4235374	Inhibition of JAK3 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	=	Ki	nM	1900.0	CHEMBL2148	Homo sapiens	Ki	nM	1900.0
	18674721	CHEMBL4235374	Inhibition of JAK3 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	=	Ki	nM	4800.0	CHEMBL2148	Homo sapiens	Ki	nM	4800.0
	18675718	CHEMBL4235705	Inhibition of JAK3 (unknown origin)	B	C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C		CHEMBL4248386	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18675719	CHEMBL4235705	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C		CHEMBL4237557	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	18675720	CHEMBL4235705	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C		CHEMBL4241958	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
	18675721	CHEMBL4235705	Inhibition of JAK3 (unknown origin)	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)cccc1-n1cnc2ccccc2c1=O		CHEMBL4237800	=	IC50	nM	15000.0	CHEMBL2148	Homo sapiens	IC50	nM	15000.0
	18679897	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(Cn2ncc3c(Nc4cnn(CCOC)c4)ncnc32)c1		CHEMBL4241559	=	IC50	nM	267.4	CHEMBL2148	Homo sapiens	IC50	nM	267.4
	18679898	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)c1		CHEMBL4239312	=	IC50	nM	154.2	CHEMBL2148	Homo sapiens	IC50	nM	154.2
	18679899	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1		CHEMBL4241272	=	IC50	nM	19.2	CHEMBL2148	Homo sapiens	IC50	nM	19.2
	18679900	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCCC(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1		CHEMBL4249872	=	IC50	nM	36.3	CHEMBL2148	Homo sapiens	IC50	nM	36.3
	18679901	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(CC3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1		CHEMBL4238357	=	IC50	nM	56.1	CHEMBL2148	Homo sapiens	IC50	nM	56.1
	18679902	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1		CHEMBL4244570	=	IC50	nM	87.4	CHEMBL2148	Homo sapiens	IC50	nM	87.4
	18679903	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	CN(C)CC(=O)N1CCCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1		CHEMBL4237694	=	IC50	nM	591.2	CHEMBL2148	Homo sapiens	IC50	nM	591.2
	18679904	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCCN(C(=O)CN(C)C)C3)c3ncnc(N)c23)cn1		CHEMBL4239990	=	IC50	nM	787.5	CHEMBL2148	Homo sapiens	IC50	nM	787.5
	18679905	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(CC3CCCN(C#N)C3)c3ncnc(N)c23)cn1		CHEMBL4244213	=	IC50	nM	189.3	CHEMBL2148	Homo sapiens	IC50	nM	189.3
	18679906	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCCN(C#N)C3)c3ncnc(N)c23)cn1		CHEMBL4242842	=	IC50	nM	143.2	CHEMBL2148	Homo sapiens	IC50	nM	143.2
	18679907	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1		CHEMBL4240238	=	IC50	nM	197.2	CHEMBL2148	Homo sapiens	IC50	nM	197.2
	18679908	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCC(Cn2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)CC1		CHEMBL4248256	=	IC50	nM	324.3	CHEMBL2148	Homo sapiens	IC50	nM	324.3
	18679909	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(CC3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4249784	=	IC50	nM	278.4	CHEMBL2148	Homo sapiens	IC50	nM	278.4
	18679910	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4237788	=	IC50	nM	315.3	CHEMBL2148	Homo sapiens	IC50	nM	315.3
	18679911	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	CN(C)CC(=O)N1CCC(Cn2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1		CHEMBL4247801	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679912	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCN(C(=O)CN(C)C)CC3)c3ncnc(N)c23)cn1		CHEMBL4241519	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679913	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(CC3CCN(C#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4237340	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679914	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(CC3CCN(C#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4248368	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679915	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	18679916	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1		CHEMBL4249310	=	IC50	nM	9.9	CHEMBL2148	Homo sapiens	IC50	nM	9.9
	18679917	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1		CHEMBL4245422	=	IC50	nM	15.6	CHEMBL2148	Homo sapiens	IC50	nM	15.6
	18679918	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1		CHEMBL4244148	=	IC50	nM	6.2	CHEMBL2148	Homo sapiens	IC50	nM	6.2
	18679919	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	C=CC(=O)N1CCCC(n2nc(-c3cnn(CCOC)c3)c3c(N)ncnc32)C1		CHEMBL4249492	=	IC50	nM	21.3	CHEMBL2148	Homo sapiens	IC50	nM	21.3
	18679920	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(C3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1		CHEMBL4248202	=	IC50	nM	32.3	CHEMBL2148	Homo sapiens	IC50	nM	32.3
	18679921	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cn1		CHEMBL4238190	=	IC50	nM	57.7	CHEMBL2148	Homo sapiens	IC50	nM	57.7
	18679922	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	CN(C)CC(=O)N1CCCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)C1		CHEMBL4239767	=	IC50	nM	582.6	CHEMBL2148	Homo sapiens	IC50	nM	582.6
	18679923	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCCN(C(=O)CN(C)C)C3)c3ncnc(N)c23)cn1		CHEMBL4241889	=	IC50	nM	756.3	CHEMBL2148	Homo sapiens	IC50	nM	756.3
	18679924	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(C3CCCN(C#N)C3)c3ncnc(N)c23)cn1		CHEMBL4240663	=	IC50	nM	115.4	CHEMBL2148	Homo sapiens	IC50	nM	115.4
	18679925	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCCN(C#N)C3)c3ncnc(N)c23)cn1		CHEMBL4244856	=	IC50	nM	144.2	CHEMBL2148	Homo sapiens	IC50	nM	144.2
	18679926	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(C3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4245633	=	IC50	nM	394.8	CHEMBL2148	Homo sapiens	IC50	nM	394.8
	18679927	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCN(C(=O)CC#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4245728	=	IC50	nM	373.7	CHEMBL2148	Homo sapiens	IC50	nM	373.7
	18679928	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	CN(C)CC(=O)N1CCC(n2nc(-c3cnn(C)c3)c3c(N)ncnc32)CC1		CHEMBL4245604	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679929	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCN(C(=O)CN(C)C)CC3)c3ncnc(N)c23)cn1		CHEMBL4251240	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18679930	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	Cn1cc(-c2nn(C3CCN(C#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4238436	=	IC50	nM	94.3	CHEMBL2148	Homo sapiens	IC50	nM	94.3
	18679931	CHEMBL4236382	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition measured after 30 mins by HTRF assay	B	COCCn1cc(-c2nn(C3CCN(C#N)CC3)c3ncnc(N)c23)cn1		CHEMBL4248451	=	IC50	nM	124.4	CHEMBL2148	Homo sapiens	IC50	nM	124.4
	18680381	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	COC12CC3CC(C1)C(Nc1c(C(N)=O)cnc4[nH]ccc14)C(C3)C2		CHEMBL4246788	=	IC50	nM	0.63	CHEMBL2148	Homo sapiens	IC50	nM	0.63
	18680382	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(F)(C3)C2		CHEMBL4247874	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	18680383	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	Br.NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2		CHEMBL4242999	=	IC50	nM	0.71	CHEMBL2148	Homo sapiens	IC50	nM	0.71
	18680384	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2		CHEMBL4238926	=	IC50	nM	0.43	CHEMBL2148	Homo sapiens	IC50	nM	0.43
	18680385	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC12CC3CC(CC(C3)C1)C2		CHEMBL4239361	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	18680386	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC(C2)CC1C3		CHEMBL4249444	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	18680387	CHEMBL4236467	Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using Biotin-Lyn-Substrate2 after 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1C[C@H]2CC[C@@H]1C2		CHEMBL4241916	=	IC50	nM	3.2	CHEMBL2148	Homo sapiens	IC50	nM	3.2
	18680389	CHEMBL4236465	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCCC[C@@H]1Nc1c(C(N)=O)cnc2[nH]ccc12		CHEMBL3593761	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
	18687153	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4289688	=	IC50	nM	1.39	CHEMBL2148	Homo sapiens	IC50	nM	1.39
	18687154	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4286900	=	IC50	nM	8.34	CHEMBL2148	Homo sapiens	IC50	nM	8.34
	18687155	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(OC)c3)ncc2Cl)c1		CHEMBL4278652	=	IC50	nM	21.59	CHEMBL2148	Homo sapiens	IC50	nM	21.59
	18687156	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(OC)c3)ncc2F)c1		CHEMBL4280709	=	IC50	nM	11.23	CHEMBL2148	Homo sapiens	IC50	nM	11.23
	18687157	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4290692	=	IC50	nM	0.83	CHEMBL2148	Homo sapiens	IC50	nM	0.83
	18687158	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4284156	=	IC50	nM	1.06	CHEMBL2148	Homo sapiens	IC50	nM	1.06
	18687159	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4294772	=	IC50	nM	0.91	CHEMBL2148	Homo sapiens	IC50	nM	0.91
	18687160	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)c(OC)c3)ncc2Cl)c1		CHEMBL4292468	=	IC50	nM	6.77	CHEMBL2148	Homo sapiens	IC50	nM	6.77
	18687161	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)cc3C)ncc2Cl)c1		CHEMBL4284578	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18687162	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)cc3C)ncc2F)c1		CHEMBL4277319	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18687163	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(C)CC4)cc3C)ncc2Cl)c1		CHEMBL4287960	=	IC50	nM	91.15	CHEMBL2148	Homo sapiens	IC50	nM	91.15
	18687164	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3C)ncc2Cl)c1		CHEMBL4279066	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18687165	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2Cl)c1		CHEMBL4289281	=	IC50	nM	0.69	CHEMBL2148	Homo sapiens	IC50	nM	0.69
	18687166	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2F)c1		CHEMBL4290449	=	IC50	nM	0.95	CHEMBL2148	Homo sapiens	IC50	nM	0.95
	18687167	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	22.5	CHEMBL2148	Homo sapiens	IC50	nM	22.5
	18687168	CHEMBL4252317	Inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly(4:1 Glu,Tyr) peptide substrate incubated for 60 mins by ADP-Glo luminescence assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	16.1	CHEMBL2148	Homo sapiens	IC50	nM	16.1
	18687219	CHEMBL4252321	Potency index, ratio of ibrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4290692	=	Ratio IC50		17.0	CHEMBL2148	Homo sapiens	Ratio IC50		17.0
	18687220	CHEMBL4252321	Potency index, ratio of ibrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4294772	=	Ratio IC50		17.0	CHEMBL2148	Homo sapiens	Ratio IC50		17.0
	18687221	CHEMBL4252321	Potency index, ratio of ibrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2Cl)c1		CHEMBL4289281	=	Ratio IC50		17.0	CHEMBL2148	Homo sapiens	Ratio IC50		17.0
	18687222	CHEMBL4252321	Potency index, ratio of ibrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2F)c1		CHEMBL4290449	=	Ratio IC50		17.0	CHEMBL2148	Homo sapiens	Ratio IC50		17.0
	18687223	CHEMBL4252322	Potency index, ratio of spebrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4290692	=	Ratio IC50		40.0	CHEMBL2148	Homo sapiens	Ratio IC50		40.0
	18687224	CHEMBL4252322	Potency index, ratio of spebrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCN(CC)CC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4294772	=	Ratio IC50		40.0	CHEMBL2148	Homo sapiens	Ratio IC50		40.0
	18687225	CHEMBL4252322	Potency index, ratio of spebrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2Cl)c1		CHEMBL4289281	=	Ratio IC50		40.0	CHEMBL2148	Homo sapiens	Ratio IC50		40.0
	18687226	CHEMBL4252322	Potency index, ratio of spebrutinib IC50 to compound IC50 for inhibition of recombinant N-terminal GST-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OCCCN4CCOCC4)c3)ncc2F)c1		CHEMBL4290449	=	Ratio IC50		40.0	CHEMBL2148	Homo sapiens	Ratio IC50		40.0
Dose-dependent effect	18687280	CHEMBL4252343	Inhibition of JAK3 in human NAMALWA cells assessed as reduction in STAT3 phosphorylation after 48 hrs by immunoblot analysis	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCC(=O)N4CCOCC4)c(Cl)c3)ncc2Cl)c1		CHEMBL4286900		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Dose-dependent effect	18687281	CHEMBL4252343	Inhibition of JAK3 in human NAMALWA cells assessed as reduction in STAT3 phosphorylation after 48 hrs by immunoblot analysis	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4290692		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18687291	CHEMBL4252349	Inhibition of JAK3 in human NAMALWA cells assessed as reduction in STAT3 phosphorylation at 10 uM after 48 hrs by immunoblot analysis	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18693949	CHEMBL4253402	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using ULight-JAK-1 peptide as substrate preincubated for 15 mins followed by ATP addition measured after 90 mins	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	IC50	nM	154.0	CHEMBL2148	Homo sapiens	IC50	nM	154.0
	18693996	CHEMBL4253449	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	56.0	CHEMBL2148	Homo sapiens	INH	%	56.0
	18694078	CHEMBL4253531	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	92.0	CHEMBL2148	Homo sapiens	INH	%	92.0
	18697647	CHEMBL4254320	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	98.0	CHEMBL2148	Homo sapiens	Activity	%	98.0
	18702492	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	-8.0	CHEMBL2148	Homo sapiens	INH	%	-8.0
	18702547	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1	Outside typical range	CHEMBL4282644	=	Inhibition	%	-16.0	CHEMBL2148	Homo sapiens	INH	%	-16.0
	18702591	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	12.0	CHEMBL2148	Homo sapiens	INH	%	12.0
	18702643	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	16.0	CHEMBL2148	Homo sapiens	INH	%	16.0
	18702687	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	3.0	CHEMBL2148	Homo sapiens	INH	%	3.0
	18702730	CHEMBL4255115	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	18706733	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(C)c1cc2c(cc1O)[C@@]1(C)CCC[C@@](C)(C=O)[C@@H]1CC2		CHEMBL1277662	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706734	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	COC(=O)C[C@@]1(C(=O)O)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12		CHEMBL4292650	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706735	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	COC(=O)C[C@@]1(C(=O)O)CCC[C@]2(C)c3ccc(C(C)=O)cc3CC[C@@H]12		CHEMBL4278579	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706736	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	COC(=O)C[C@@]1(C(=O)O)CCC[C@]2(C)c3ccc(O)cc3CC[C@@H]12		CHEMBL4289234	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706737	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	C=C(C)c1ccc2c(c1)CC[C@H]1[C@](CC(=O)OC)(C(=O)O)CCC[C@]21C		CHEMBL4293812	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706738	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	COC(=O)C[C@@]1(C(=O)O)CCC[C@]2(C)c3ccc(C(C)(C)O)cc3CC[C@@H]12		CHEMBL4285076	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706739	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	C=C(C)c1ccc2c(c1)CC[C@H]1[C@@](CO)(C(=O)O)CCC[C@]21C		CHEMBL4279751	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706740	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(C)c1ccc2c(c1)CC[C@H]1[C@@](CO)(C(=O)O)CCC[C@]21C		CHEMBL4286991	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706741	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(=O)c1ccc2c(c1)CC[C@H]1[C@@](CO)(C(=O)O)CCC[C@]21C		CHEMBL4294902	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706766	CHEMBL4256120	Inhibition of JAK3 (unknown origin) at 50 ug/ml by mobility shift assay relative to control	A	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	=	Inhibition	%	74.9	CHEMBL2148	Homo sapiens	INH	%	74.9
	18706773	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(C)(O)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL598566	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18706774	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	>	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
Not Determined	18706775	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)CO		CHEMBL12799		IC50			CHEMBL2148	Homo sapiens	IC50		
	18706776	CHEMBL4256133	Inhibition of JAK3 (unknown origin) by mobility shift assay	A	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.12	CHEMBL2148	Homo sapiens	IC50	uM	0.00012
	18722629	CHEMBL4258467	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method	B	CN(c1ncnc2[nH]ccc12)[C@H]1CN(C(=O)CC#N)CC12CC2		CHEMBL4279819	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	nM	1100.0
	18722630	CHEMBL4258467	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method	B	CN(c1ncnc2[nH]ccc12)[C@H]1CN(S(=O)(=O)c2cccc(C#N)c2)CC12CC2		CHEMBL4293578	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	nM	110.0
	18722631	CHEMBL4258467	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	810.0	CHEMBL2148	Homo sapiens	IC50	nM	810.0
	18722683	CHEMBL4258488	Inhibition of human JAK3 at 10 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P-ATP] by scintillation counting method relative to control	B	CN(c1ncnc2[nH]ccc12)[C@H]1CN(C(=O)CC#N)CC12CC2		CHEMBL4279819	=	Inhibition	%	90.0	CHEMBL2148	Homo sapiens	INH	%	90.0
Not Active	18723848	CHEMBL4258702	Inhibition of human JAK3 using GGEEEEYFELVKKKK as substrate at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Determined	18737036	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	CC[C@@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4289532		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737037	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	CC[C@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4278853		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737038	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	CC[C@H](C(=O)N1CC(C#N)C1)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4286103		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737039	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n([C@@H](C(=O)NCC(F)(F)F)C(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4294002		IC50			CHEMBL2148	Homo sapiens	IC50		
	18737040	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n([C@@H]3CCCN(C(=O)CC#N)C3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4290597	=	IC50	nM	1550.0	CHEMBL2148	Homo sapiens	IC50	uM	1.55
Not Determined	18737041	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COC(=O)[C@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4289375		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737042	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COC(=O)[C@@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4281492		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737043	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n([C@@H]3CCCNC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4287893		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737044	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n([C@@H]3CCNC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4279991		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737045	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(C3CCNCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4291298		IC50			CHEMBL2148	Homo sapiens	IC50		
	18737046	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(C3CCN(C)CC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4283458	=	IC50	nM	61570.0	CHEMBL2148	Homo sapiens	IC50	uM	61.57
	18737047	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(C3CCCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4281080	=	IC50	nM	28860.0	CHEMBL2148	Homo sapiens	IC50	uM	28.86
	18737048	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(C3CCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4291720	=	IC50	nM	18340.0	CHEMBL2148	Homo sapiens	IC50	uM	18.34
	18737049	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(CC3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4284499	=	IC50	nM	76900.0	CHEMBL2148	Homo sapiens	IC50	uM	76.9
	18737050	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(C3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4295151	=	IC50	nM	3720.0	CHEMBL2148	Homo sapiens	IC50	uM	3.72
Not Determined	18737051	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	CCOC(=O)C(CC)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4286762		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737052	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COC(=O)Cn1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4278842		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737053	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	COc1cc2c(=O)n(CC(=O)OC(C)(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4285332		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18737054	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	CN(C)CCCn1c(=O)c2ccccc2c2cnc3[nH]ccc3c21		CHEMBL4288673		IC50			CHEMBL2148	Homo sapiens	IC50		
	18737055	CHEMBL4261272	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by MSD assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1210.0	CHEMBL2148	Homo sapiens	IC50	uM	1.21
	18737083	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CC[C@@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4289532	=	IC50	nM	75.03	CHEMBL2148	Homo sapiens	IC50	nM	75.03
	18737084	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CC[C@H](C(=O)NCC(F)(F)F)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4278853	=	IC50	nM	87.03	CHEMBL2148	Homo sapiens	IC50	nM	87.03
	18737085	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CC[C@H](C(=O)N1CC(C#N)C1)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4286103	=	IC50	nM	114.4	CHEMBL2148	Homo sapiens	IC50	nM	114.4
	18737086	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n([C@@H](C(=O)NCC(F)(F)F)C(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4294002	=	IC50	nM	26.58	CHEMBL2148	Homo sapiens	IC50	nM	26.58
	18737087	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n([C@@H](C(=O)N3CC(C#N)C3)C(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4282720	=	IC50	nM	818.9	CHEMBL2148	Homo sapiens	IC50	nM	818.9
	18737088	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n([C@@H]3CCCN(C(=O)CC#N)C3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4290597	=	IC50	nM	2.55	CHEMBL2148	Homo sapiens	IC50	nM	2.55
	18737089	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COC(=O)[C@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4289375	=	IC50	nM	95.56	CHEMBL2148	Homo sapiens	IC50	nM	95.56
	18737090	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COC(=O)[C@@H](C(C)C)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4281492	=	IC50	nM	28.94	CHEMBL2148	Homo sapiens	IC50	nM	28.94
	18737091	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n([C@@H]3CCCNC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4287893	=	IC50	nM	23.45	CHEMBL2148	Homo sapiens	IC50	nM	23.45
	18737092	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n([C@@H]3CCNC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4279991	=	IC50	nM	143.7	CHEMBL2148	Homo sapiens	IC50	nM	143.7
	18737093	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(C3CCNCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4291298	=	IC50	nM	18.31	CHEMBL2148	Homo sapiens	IC50	nM	18.31
	18737094	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(C3CCN(C)CC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4283458	=	IC50	nM	124.1	CHEMBL2148	Homo sapiens	IC50	nM	124.1
	18737095	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(C3CCCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4281080	=	IC50	nM	1.01	CHEMBL2148	Homo sapiens	IC50	nM	1.01
	18737096	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(C3CCCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4291720	=	IC50	nM	1.09	CHEMBL2148	Homo sapiens	IC50	nM	1.09
	18737097	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(CC3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4284499	=	IC50	nM	1.65	CHEMBL2148	Homo sapiens	IC50	nM	1.65
	18737098	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(C3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4295151	=	IC50	nM	2.92	CHEMBL2148	Homo sapiens	IC50	nM	2.92
	18737099	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CCOC(=O)C(CC)n1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4286762	=	IC50	nM	27.5	CHEMBL2148	Homo sapiens	IC50	nM	27.5
	18737100	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COC(=O)Cn1c(=O)c2cc(OC)c(OC)cc2c2cnc3[nH]ccc3c21		CHEMBL4278842	=	IC50	nM	6.65	CHEMBL2148	Homo sapiens	IC50	nM	6.65
	18737101	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(CC(=O)OC(C)(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4285332	=	IC50	nM	9.94	CHEMBL2148	Homo sapiens	IC50	nM	9.94
	18737102	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CN(C)CCCn1c(=O)c2cc([N+](=O)[O-])ccc2c2cnc3[nH]ccc3c21		CHEMBL4277379	=	IC50	nM	1111.5	CHEMBL2148	Homo sapiens	IC50	nM	1111.5
	18737103	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	CN(C)CCCn1c(=O)c2ccccc2c2cnc3[nH]ccc3c21		CHEMBL4288673	=	IC50	nM	285.9	CHEMBL2148	Homo sapiens	IC50	nM	285.9
	18737104	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4280783	=	IC50	nM	129.75	CHEMBL2148	Homo sapiens	IC50	nM	129.75
	18737105	CHEMBL4261265	Inhibition of JAK3 (unknown origin) preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by filter-binding method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.24	CHEMBL2148	Homo sapiens	IC50	nM	0.24
	18737153	CHEMBL4261257	Binding affinity to JAK3 (unknown origin)	B	COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4280783	=	Kd	nM	20.0	CHEMBL2148	Homo sapiens	Kd	nM	20.0
	18737156	CHEMBL4261262	Binding affinity to JAK3 (unknown origin) assessed as remaining unbound target protein level at 10 uM relative to control	B	COc1cc2c(=O)n(CCCN(C)C)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4280783	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	18737182	CHEMBL4261274	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by Western blot analysis	B	COc1cc2c(=O)n(C3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4295151	=	IC50	nM	65.9	CHEMBL2148	Homo sapiens	IC50	nM	65.9
	18737183	CHEMBL4261274	Inhibition of JAK3 in human SZ4 cells assessed as reduction in IL2-stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL2 stimulation and measured after 15 mins by Western blot analysis	B	COc1cc2c(=O)n([C@@H]3CCCN(C(=O)CC#N)C3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4290597	=	IC50	nM	15.3	CHEMBL2148	Homo sapiens	IC50	nM	15.3
	18751016	CHEMBL4263834	Inhibition of JAK3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	18751554	CHEMBL4264349	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL2148	Homo sapiens	Activity	%	92.0
	18757623	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	18757624	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C=CC(=O)N1CCOc2ccc(-c3ncnc4[nH]cc(CCOC)c34)cc21		CHEMBL4280180	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	18757625	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CCO4)c12		CHEMBL4292612	=	IC50	nM	17.0	CHEMBL2148	Homo sapiens	IC50	nM	17.0
	18757626	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18757627	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CNC1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4292010	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	18757628	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18757629	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4276860	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	18757630	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CC4)c12		CHEMBL4284799	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	18757631	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	CN(C#N)C1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4280294	=	IC50	nM	230.0	CHEMBL2148	Homo sapiens	IC50	nM	230.0
	18757632	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CNC1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4288201	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	18757633	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4284952	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	18757634	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4282878	=	IC50	nM	26.0	CHEMBL2148	Homo sapiens	IC50	nM	26.0
	18757635	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C[C@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4278647	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	18757636	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C[C@@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4283198	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	18757637	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	CC1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4293778	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18757638	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	18757639	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C[C@@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4290377	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
	18757640	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18757641	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4286963	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	18757642	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@@H]1c2cc(-c3ncnc4[nH]ccc34)ccc2C[C@H]1O		CHEMBL4281693	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18757643	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	18757644	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COCCS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4288935	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
Not Determined	18757645	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	Cn1nccc1S(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4281035		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18757646	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18757647	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18757648	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193		IC50			CHEMBL2148	Homo sapiens	IC50		
	18757649	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	18757650	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	18757651	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	18757681	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	18757682	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C=CC(=O)N1CCOc2ccc(-c3ncnc4[nH]cc(CCOC)c34)cc21		CHEMBL4280180	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	18757683	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CCO4)c12		CHEMBL4292612	=	IC50	nM	1226.0	CHEMBL2148	Homo sapiens	IC50	nM	1226.0
	18757684	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	IC50	nM	456.0	CHEMBL2148	Homo sapiens	IC50	nM	456.0
	18757685	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CNC1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4292010	=	IC50	nM	711.0	CHEMBL2148	Homo sapiens	IC50	nM	711.0
	18757686	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	=	IC50	nM	256.0	CHEMBL2148	Homo sapiens	IC50	nM	256.0
	18757687	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4276860	>	IC50	nM	5820.0	CHEMBL2148	Homo sapiens	IC50	nM	5820.0
	18757688	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CC4)c12		CHEMBL4284799	=	IC50	nM	1592.0	CHEMBL2148	Homo sapiens	IC50	nM	1592.0
	18757689	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	CN(C#N)C1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4280294	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18757690	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CNC1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4288201	=	IC50	nM	1211.0	CHEMBL2148	Homo sapiens	IC50	nM	1211.0
	18757691	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4284952	=	IC50	nM	781.0	CHEMBL2148	Homo sapiens	IC50	nM	781.0
	18757692	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4282878	=	IC50	nM	6110.0	CHEMBL2148	Homo sapiens	IC50	nM	6110.0
	18757693	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C[C@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4278647	=	IC50	nM	603.0	CHEMBL2148	Homo sapiens	IC50	nM	603.0
	18757694	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C[C@@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4283198	=	IC50	nM	1530.0	CHEMBL2148	Homo sapiens	IC50	nM	1530.0
	18757695	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	CC1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4293778	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
	18757696	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
Not Determined	18757697	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C[C@@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4290377		IC50			CHEMBL2148	Homo sapiens	IC50		
	18757698	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	=	IC50	nM	163.0	CHEMBL2148	Homo sapiens	IC50	nM	163.0
	18757699	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4286963	=	IC50	nM	1338.0	CHEMBL2148	Homo sapiens	IC50	nM	1338.0
	18757700	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@@H]1c2cc(-c3ncnc4[nH]ccc34)ccc2C[C@H]1O		CHEMBL4281693	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
	18757701	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	18757702	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COCCS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4288935	=	IC50	nM	111.0	CHEMBL2148	Homo sapiens	IC50	nM	111.0
	18757703	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	Cn1nccc1S(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4281035	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	18757704	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	18757705	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18757706	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	18757707	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	18757708	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	=	IC50	nM	78.0	CHEMBL2148	Homo sapiens	IC50	nM	78.0
	18757709	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	18757797	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
Not Determined	18757798	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C=CC(=O)N1CCOc2ccc(-c3ncnc4[nH]cc(CCOC)c34)cc21		CHEMBL4280180		t1/2			CHEMBL2148	Homo sapiens	t1/2		
	18757799	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CCO4)c12		CHEMBL4292612	=	T1/2	hr	1.1	CHEMBL2148	Homo sapiens	t1/2	hr	1.1
	18757800	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	T1/2	hr	1.8	CHEMBL2148	Homo sapiens	t1/2	hr	1.8
	18757801	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CNC1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4292010	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757802	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757803	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4276860	=	T1/2	hr	0.3	CHEMBL2148	Homo sapiens	t1/2	hr	0.3
	18757804	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CC4)c12		CHEMBL4284799	=	T1/2	hr	6.5	CHEMBL2148	Homo sapiens	t1/2	hr	6.5
Not Determined	18757805	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	CN(C#N)C1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4280294		t1/2			CHEMBL2148	Homo sapiens	t1/2		
	18757806	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CNC1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4288201	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757807	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4284952	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757808	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4282878	=	T1/2	hr	6.5	CHEMBL2148	Homo sapiens	t1/2	hr	6.5
	18757809	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C[C@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4278647	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757810	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C[C@@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4283198	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757811	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	CC1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4293778	=	T1/2	hr	0.05	CHEMBL2148	Homo sapiens	t1/2	hr	0.05
	18757812	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720	<	T1/2	hr	0.05	CHEMBL2148	Homo sapiens	t1/2	hr	0.05
	18757813	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C[C@@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4290377	=	T1/2	hr	0.2	CHEMBL2148	Homo sapiens	t1/2	hr	0.2
	18757814	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757815	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4286963	=	T1/2	hr	7.6	CHEMBL2148	Homo sapiens	t1/2	hr	7.6
	18757816	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1c2cc(-c3ncnc4[nH]ccc34)ccc2C[C@H]1O		CHEMBL4281693	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757817	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757818	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COCCS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4288935	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757819	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	Cn1nccc1S(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4281035	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757820	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757821	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757822	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757823	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757824	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18757825	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	=	Ratio	10'6/M/s	1.1	CHEMBL2148	Homo sapiens	Ratio	10'6/M/s	1.1
Not Determined	18757826	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C=CC(=O)N1CCOc2ccc(-c3ncnc4[nH]cc(CCOC)c34)cc21		CHEMBL4280180		Ratio			CHEMBL2148	Homo sapiens	Ratio		
	18757827	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CCO4)c12		CHEMBL4292612	=	Ratio	10'4/M/s	2.3	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	2.3
	18757828	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	Ratio	10'4/M/s	4.8	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	4.8
	18757829	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CNC1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4292010	=	Ratio	10'4/M/s	1.3	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.3
	18757830	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	=	Ratio	10'4/M/s	5.7	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	5.7
	18757831	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4276860	=	Ratio	10'4/M/s	1.1	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.1
	18757832	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CC4)c12		CHEMBL4284799	=	Ratio	10'4/M/s	1.6	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.6
Not Determined	18757833	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	CN(C#N)C1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4280294		Ratio			CHEMBL2148	Homo sapiens	Ratio		
	18757834	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CNC1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4288201	=	Ratio	10'3/M/s	9.5	CHEMBL2148	Homo sapiens	Ratio	10'3/M/s	9.5
	18757835	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4284952	=	Ratio	10'4/M/s	1.6	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.6
	18757836	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1CCOc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4282878	=	Ratio	10'3/M/s	3.4	CHEMBL2148	Homo sapiens	Ratio	10'3/M/s	3.4
	18757837	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C[C@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4278647	=	Ratio	10'4/M/s	2.8	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	2.8
	18757838	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C[C@@H]1Cc2ccc(-c3ncnc4[nH]ccc34)cc2[C@@H]1NC#N		CHEMBL4283198	=	Ratio	10'4/M/s	1.0	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.0
Not Determined	18757839	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	CC1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4293778		Ratio			CHEMBL2148	Homo sapiens	Ratio		
Not Determined	18757840	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720		Ratio			CHEMBL2148	Homo sapiens	Ratio		
Not Determined	18757841	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	C[C@@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4290377		Ratio			CHEMBL2148	Homo sapiens	Ratio		
	18757842	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	=	Ratio	10'5/M/s	1.5	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	1.5
	18757843	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4286963	=	Ratio	10'4/M/s	1.9	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	1.9
	18757844	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@@H]1c2cc(-c3ncnc4[nH]ccc34)ccc2C[C@H]1O		CHEMBL4281693	=	Ratio	10'4/M/s	4.6	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	4.6
	18757845	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320	=	Ratio	10'5/M/s	2.8	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	2.8
	18757846	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COCCS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4288935	=	Ratio	10'5/M/s	1.3	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	1.3
	18757847	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	Cn1nccc1S(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4281035	=	Ratio	10'5/M/s	1.2	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	1.2
	18757848	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555	=	Ratio	10'4/M/s	5.4	CHEMBL2148	Homo sapiens	Ratio	10'4/M/s	5.4
	18757849	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	=	Ratio	10'5/M/s	1.9	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	1.9
	18757850	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193	=	Ratio	10'5/M/s	2.4	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	2.4
	18757851	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	=	Ratio	10'5/M/s	2.2	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	2.2
	18757852	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	=	Ratio	10'3/M/s	7.7	CHEMBL2148	Homo sapiens	Ratio	10'3/M/s	7.7
	18757898	CHEMBL4265564	Irreversible inhibition of human GST-tagged JAK3 assessed as pKa of Cys909 at pH 5.1 to 9.7	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	=	pKa		6.2	CHEMBL2148	Homo sapiens	pKa		6.2
	18757899	CHEMBL4265564	Irreversible inhibition of human GST-tagged JAK3 assessed as pKa of Cys909 at pH 5.1 to 9.7	B	C=CC(=O)N1CC[C@@H]2OCCN(c3ncnc4[nH]ccc34)[C@@H]2C1		CHEMBL4286219	=	pKa		6.3	CHEMBL2148	Homo sapiens	pKa		6.3
	18757933	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	nM	63.0
	18757934	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	IC50	nM	162.0	CHEMBL2148	Homo sapiens	IC50	nM	162.0
	18757935	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	=	IC50	nM	598.0	CHEMBL2148	Homo sapiens	IC50	nM	598.0
	18757936	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
	18757937	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	=	IC50	nM	1728.0	CHEMBL2148	Homo sapiens	IC50	nM	1728.0
	18757938	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320	=	IC50	nM	2240.0	CHEMBL2148	Homo sapiens	IC50	nM	2240.0
	18757939	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555	=	IC50	nM	468.0	CHEMBL2148	Homo sapiens	IC50	nM	468.0
	18757940	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	=	IC50	nM	331.0	CHEMBL2148	Homo sapiens	IC50	nM	331.0
	18757941	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193	=	IC50	nM	947.0	CHEMBL2148	Homo sapiens	IC50	nM	947.0
	18757942	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	=	IC50	nM	458.0	CHEMBL2148	Homo sapiens	IC50	nM	458.0
	18757943	CHEMBL4265577	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	=	IC50	nM	498.0	CHEMBL2148	Homo sapiens	IC50	nM	498.0
	18757955	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	C=CC(=O)Nc1cccc(-c2ncnc3[nH]cc(CCOC)c23)c1		CHEMBL4288086	=	IC50	nM	953.0	CHEMBL2148	Homo sapiens	IC50	nM	953.0
	18757956	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	=	IC50	nM	7252.0	CHEMBL2148	Homo sapiens	IC50	nM	7252.0
	18757957	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18757958	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	C[C@]1(NC#N)CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4279720	=	IC50	nM	5480.0	CHEMBL2148	Homo sapiens	IC50	nM	5480.0
Not Determined	18757959	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18757960	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	CS(=O)(=O)N[C@@H]1C[C@H](NC#N)c2cc(-c3ncnc4[nH]ccc34)ccc21		CHEMBL4292320		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18757961	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C#N)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4285555		IC50			CHEMBL2148	Homo sapiens	IC50		
	18757962	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
Not Determined	18757963	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	COc1ccc(S(=O)(=O)N[C@@H]2C[C@H](NC#N)c3cc(-c4ncnc5[nH]ccc45)ccc32)cc1		CHEMBL4277193		IC50			CHEMBL2148	Homo sapiens	IC50		
	18757964	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5ccccc5)c34)cc21		CHEMBL4287845	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18757965	CHEMBL4265579	Inhibition of JAK3 in human whole blood assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 75 mins followed by IL15 addition and measured after 15 mins by FACS analysis	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18758028	CHEMBL4265609	Inhibition of recombinant human JAK3 JH1 domain at 1 uM in presence of 1 mM ATP by kinomescan assay relative to control	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)N(C#N)CC(F)(F)O4)c12		CHEMBL4284396	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18758029	CHEMBL4265609	Inhibition of recombinant human JAK3 JH1 domain at 1 uM in presence of 1 mM ATP by kinomescan assay relative to control	B	N#CN[C@H]1C[C@@H](O)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4294868	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18758030	CHEMBL4265609	Inhibition of recombinant human JAK3 JH1 domain at 1 uM in presence of 1 mM ATP by kinomescan assay relative to control	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18758031	CHEMBL4265609	Inhibition of recombinant human JAK3 JH1 domain at 1 uM in presence of 1 mM ATP by kinomescan assay relative to control	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18758032	CHEMBL4265552	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of ATP at Km concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CCO4)c12		CHEMBL4286562	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	18758034	CHEMBL4265554	Inhibition of recombinant human GST-tagged JAK3 JH1 domain using KAIETDKEYYTVKD-NH2 as substrate in presence of 1 mM ATP concentration by coupled PK/LDH assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CCO4)c12		CHEMBL4286562	=	IC50	nM	5828.0	CHEMBL2148	Homo sapiens	IC50	nM	5828.0
	18758038	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CCO4)c12		CHEMBL4286562	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18758039	CHEMBL4265560	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as kinact/Ki ratio by kinase tracer-178 based TR-FRET assay	B	COCCc1c[nH]c2ncnc(-c3ccc4c(c3)C(NC#N)CCO4)c12		CHEMBL4286562	=	Ratio	10'3/M/s	4.5	CHEMBL2148	Homo sapiens	Ratio	10'3/M/s	4.5
	18758043	CHEMBL4265558	Irreversible inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as half life by kinase tracer-178 based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	>	T1/2	hr	8.0	CHEMBL2148	Homo sapiens	t1/2	hr	8.0
	18761526	CHEMBL4266579	Inhibition of human JAK3 at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	10.0	CHEMBL2148	Homo sapiens	INH	%	10.0
	18761797	CHEMBL4266579	Inhibition of human JAK3 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	18761960	CHEMBL4266579	Inhibition of human JAK3 at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-3.0	CHEMBL2148	Homo sapiens	INH	%	-3.0
	18763063	CHEMBL4266860	Inhibition of JAK3 (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	54.64	CHEMBL2148	Homo sapiens	INH	%	54.64
	18763094	CHEMBL4266891	Inhibition of JAK3 (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	99.63	CHEMBL2148	Homo sapiens	INH	%	99.63
	18770426	CHEMBL4268226	Inhibition of human JAK3 using poly(Glu:Tyr)(4:1) as substrate preincubated for 20 mins followed by [gamma33P]ATP addition measured after 120 mins by ion exchange filter paper method	B	O=C(CCCCCCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)NO		CHEMBL4286867	=	IC50	nM	80.1	CHEMBL2148	Homo sapiens	IC50	nM	80.1
	18789042	CHEMBL4272392	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18789043	CHEMBL4272392	Inhibition of JAK3 (unknown origin)	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	18789044	CHEMBL4272392	Inhibition of JAK3 (unknown origin)	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1		CHEMBL4116008	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
Not Active	18847309	CHEMBL4304911	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18858013	CHEMBL4307859	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	81.0	CHEMBL2148	Homo sapiens	Activity	%	81.0
	18863588	CHEMBL4309410	Inhibition of recombinant JAK3 (unknown origin) by alpha-screen assay	B	CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12		CHEMBL3622821	=	IC50	nM	2300.0	CHEMBL2148	Homo sapiens	IC50	nM	2300.0
	18863591	CHEMBL4309407	Inhibition of human JAK3	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Ki	nM	1002.0	CHEMBL2148	Homo sapiens	Ki	nM	1002.0
	18863595	CHEMBL4309403	Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate incubated for 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(C2)C3O		CHEMBL4446102	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18892888	CHEMBL4314854	Inhibition of recombinant human JAK3 (781 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	90.0	CHEMBL2148	Homo sapiens	Activity	%	90.0
	18916351	CHEMBL4322090	Inhibition of human JAK3 using GGEEEEYFELVKKKK substrate preincubated for 20 mis followed by addition of ATP and measured after 120 mins in presence of 33P-gamma ATP by hotspot kinase assay	B	c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1		CHEMBL3622376	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	18919505	CHEMBL4322862	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged JAK3 (unknown origin) (795 to 1124 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	14.0	CHEMBL2148	Homo sapiens	Kd	nM	14.0
	18919693	CHEMBL4322862	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged JAK3 (unknown origin) (795 to 1124 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	13.0	CHEMBL2148	Homo sapiens	Kd	nM	13.0
Not Determined	18923047	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCn1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)cc3F)ncc2F)cn1		CHEMBL4438945		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923048	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCn1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2F)cn1		CHEMBL4591278	=	Activity	%	69.0	CHEMBL2148	Homo sapiens	Activity	%	69.0
Not Determined	18923049	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCn1cc(-c2nc(Nc3ccc(N4CCN(CC)CC4)cc3F)ncc2F)cn1		CHEMBL4450462		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923050	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCn1cc(-c2nc(Nc3ccc(N4CCN(CC)CC4)c(F)c3)ncc2F)cn1		CHEMBL4440541	=	Activity	%	52.0	CHEMBL2148	Homo sapiens	Activity	%	52.0
	18923051	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCCn1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2F)cn1		CHEMBL4470429	=	Activity	%	41.0	CHEMBL2148	Homo sapiens	Activity	%	41.0
Not Determined	18923052	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CN1CCN(c2ccc(Nc3ncc(F)c(-c4cnn(C5CCCC5)c4)n3)cc2F)CC1		CHEMBL4466451		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923053	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCN1CCN(c2ccc(Nc3ncc(F)c(-c4cnn(C5CCCC5)c4)n3)cc2F)CC1		CHEMBL4541604	=	Activity	%	68.0	CHEMBL2148	Homo sapiens	Activity	%	68.0
Not Determined	18923054	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCN1CCC(n2cc(-c3nc(Nc4ccc(N5CCN(C)CC5)c(F)c4)ncc3F)cn2)CC1		CHEMBL4524731		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923055	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCCN1CCC(n2cc(-c3nc(Nc4ccc(N5CCN(C)CC5)c(F)c4)ncc3F)cn2)CC1		CHEMBL4593344	=	Activity	%	32.0	CHEMBL2148	Homo sapiens	Activity	%	32.0
Not Determined	18923056	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CC(C)n1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)cc3F)ncc2F)cn1		CHEMBL4476204		Activity			CHEMBL2148	Homo sapiens	Activity		
Not Determined	18923057	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CC(C)n1cc(-c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2F)cn1		CHEMBL4554165		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923058	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCN1CCN(c2ccc(Nc3ncc(F)c(-c4cnn(C(C)C)c4)n3)cc2)CC1		CHEMBL4475198	=	Activity	%	77.0	CHEMBL2148	Homo sapiens	Activity	%	77.0
	18923059	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCN1CCN(c2ccc(Nc3ncc(F)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4530057	=	Activity	%	66.0	CHEMBL2148	Homo sapiens	Activity	%	66.0
	18923060	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CC(C)n1cc(-c2nc(Nc3ccc(N4CCN(C5CCN(C)CC5)CC4)c(F)c3)ncc2F)cn1		CHEMBL4531300	=	Activity	%	44.0	CHEMBL2148	Homo sapiens	Activity	%	44.0
	18923061	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CC(C)n1cc(-c2nc(Nc3ccc(N4CCC(N5CCCCC5)CC4)c(F)c3)ncc2F)cn1		CHEMBL4584426	=	Activity	%	47.0	CHEMBL2148	Homo sapiens	Activity	%	47.0
	18923062	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4458621	=	Activity	%	40.0	CHEMBL2148	Homo sapiens	Activity	%	40.0
Not Determined	18923063	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCN1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4466750		Activity			CHEMBL2148	Homo sapiens	Activity		
Not Determined	18923064	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CN(C)C1CCN(c2ccc(Nc3ncc(F)c(-c4cnn(C5CCCC5)c4)n3)cc2F)CC1		CHEMBL4466959		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923065	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CC(C)n1cc(-c2nc(Nc3ccc(N4CCC(N(C)C)CC4)c(F)c3)ncc2F)cn1		CHEMBL4536451	=	Activity	%	48.0	CHEMBL2148	Homo sapiens	Activity	%	48.0
Not Determined	18923066	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(CO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4475684		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923067	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)C)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4592536	=	Activity	%	23.0	CHEMBL2148	Homo sapiens	Activity	%	23.0
	18923068	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	Activity	%	36.0	CHEMBL2148	Homo sapiens	Activity	%	36.0
	18923069	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4560698	=	Activity	%	31.0	CHEMBL2148	Homo sapiens	Activity	%	31.0
Not Determined	18923070	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCCCCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4470352		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923071	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCN(C)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4549541	=	Activity	%	9.0	CHEMBL2148	Homo sapiens	Activity	%	9.0
	18923072	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCCN(C)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4436572	=	Activity	%	33.0	CHEMBL2148	Homo sapiens	Activity	%	33.0
	18923073	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCCCCN(C)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4528737	=	Activity	%	44.0	CHEMBL2148	Homo sapiens	Activity	%	44.0
	18923074	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCOCCN(C)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4466078	=	Activity	%	28.0	CHEMBL2148	Homo sapiens	Activity	%	28.0
	18923075	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CC4CC4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4583451	=	Activity	%	31.0	CHEMBL2148	Homo sapiens	Activity	%	31.0
	18923076	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CC4CCCO4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4532008	=	Activity	%	36.0	CHEMBL2148	Homo sapiens	Activity	%	36.0
	18923077	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCN4CCOCC4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4437166	=	Activity	%	37.0	CHEMBL2148	Homo sapiens	Activity	%	37.0
	18923078	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCN4CCCCC4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4513659	=	Activity	%	38.0	CHEMBL2148	Homo sapiens	Activity	%	38.0
	18923079	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCN4CCN(C)CC4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4461809	=	Activity	%	44.0	CHEMBL2148	Homo sapiens	Activity	%	44.0
	18923080	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCN(CCN1CCOCC1)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4538575	=	Activity	%	33.0	CHEMBL2148	Homo sapiens	Activity	%	33.0
	18923081	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	CCCN(CCN1CCOCC1)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4439816	=	Activity	%	9.0	CHEMBL2148	Homo sapiens	Activity	%	9.0
Not Determined	18923082	CHEMBL4323927	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 100 nM using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay relative to control	B	Cc1cnc(Nc2ccc(N3CCC(NCCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4527967		Activity			CHEMBL2148	Homo sapiens	Activity		
	18923127	CHEMBL4323931	Inhibition of human JAK3 (781 to end residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	18923128	CHEMBL4323931	Inhibition of human JAK3 (781 to end residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4560698	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	18923129	CHEMBL4323931	Inhibition of human JAK3 (781 to end residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay	B	CCCCN(C)C1CCN(c2ccc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)cc2F)CC1		CHEMBL4436572	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	18923130	CHEMBL4323931	Inhibition of human JAK3 (781 to end residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometric assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCN4CCN(C)CC4)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4461809	=	IC50	nM	103.0	CHEMBL2148	Homo sapiens	IC50	nM	103.0
	18929212	CHEMBL4325218	Inhibition of human JAK3 at 1 uM relative to control	A	c1cncc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4436808	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	18938011	CHEMBL4327732	Inhibition of human JAK3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.16	CHEMBL2148	Homo sapiens	Activity	%	94.16
	18938012	CHEMBL4327732	Inhibition of human JAK3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.18	CHEMBL2148	Homo sapiens	Activity	%	95.18
	18938577	CHEMBL4328096	Inhibition of human JAK3 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Activity	%	65.0	CHEMBL2148	Homo sapiens	Activity	%	65.0
	18938956	CHEMBL4328460	Inhibition of human JAK3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.138	CHEMBL2148	Homo sapiens	IC50	10'-10M	1.38
	18952516	CHEMBL4331754	Inhibition of JAK3 in human Jurkat cells assessed as reduction in IFN-alpha stimulated JAK3 phosphorylation by caspase3/7 reagent-based Western blot analysis	B	NC(=O)c1nc(-c2c(F)cccc2Cl)oc1Nc1ccc(C(=O)N2CCOCC2)cc1		CHEMBL4476770	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
	18957298	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664	=	Ki	nM	1.0	CHEMBL2148	Homo sapiens	Ki	nM	1.0
	18957299	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCC(Nc2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4533508	=	Ki	nM	27.0	CHEMBL2148	Homo sapiens	Ki	nM	27.0
	18957300	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N[C@@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4444559	=	Ki	nM	201.0	CHEMBL2148	Homo sapiens	Ki	nM	201.0
	18957301	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4454565	=	Ki	nM	9.4	CHEMBL2148	Homo sapiens	Ki	nM	9.4
	18957302	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C#CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4543011	=	Ki	nM	55.0	CHEMBL2148	Homo sapiens	Ki	nM	55.0
	18957303	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4445411	=	Ki	nM	51.0	CHEMBL2148	Homo sapiens	Ki	nM	51.0
	18957304	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4470305	=	Ki	nM	3.3	CHEMBL2148	Homo sapiens	Ki	nM	3.3
	18957305	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	Ki	nM	1.1	CHEMBL2148	Homo sapiens	Ki	nM	1.1
	18957306	CHEMBL4332981	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot analysis	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	EC50	nM	1042.0	CHEMBL2148	Homo sapiens	EC50	nM	1042.0
	18957307	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	18957308	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18957309	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18957310	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
	18957311	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCC(Nc2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4533508	=	IC50	nM	6.4	CHEMBL2148	Homo sapiens	IC50	nM	6.4
	18957312	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4513304	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	nM	41.0
	18957313	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N(C)C1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4464446	=	IC50	nM	4.4	CHEMBL2148	Homo sapiens	IC50	nM	4.4
	18957314	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N[C@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4463237	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	18957315	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N[C@@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4444559	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	18957316	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4454565	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	18957317	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4578121	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	18957318	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCCCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4461660	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	18957319	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	CN(C)C/C=C/C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4520141	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	18957320	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C/C=C/C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4544861	=	IC50	nM	104.0	CHEMBL2148	Homo sapiens	IC50	nM	104.0
	18957321	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCN(C(=O)CCl)CC2)ccc1C(F)(F)F		CHEMBL4463109	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18957322	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCN(C(=O)CBr)CC2)ccc1C(F)(F)F		CHEMBL4439785	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	18957323	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C#CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4543011	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	18957324	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4461890	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18957325	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5cc(F)ccc45)C(=O)NC3=O)c2)CC1		CHEMBL4444087	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	18957326	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccc(F)cc45)C(=O)NC3=O)c2)CC1		CHEMBL4441142	=	IC50	nM	5.4	CHEMBL2148	Homo sapiens	IC50	nM	5.4
	18957327	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5cc(C)ccc45)C(=O)NC3=O)c2)CC1		CHEMBL4459688	=	IC50	nM	7.5	CHEMBL2148	Homo sapiens	IC50	nM	7.5
	18957328	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ncccc45)C(=O)NC3=O)c2)CC1		CHEMBL4522075	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	18957329	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4ccc(Cl)cc4)C(=O)NC3=O)c2)CC1		CHEMBL4457521	=	IC50	nM	4000.0	CHEMBL2148	Homo sapiens	IC50	nM	4000.0
	18957330	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)cc(C(F)(F)F)c2)CC1		CHEMBL4461593	=	IC50	nM	894.0	CHEMBL2148	Homo sapiens	IC50	nM	894.0
	18957331	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)ccc2F)CC1		CHEMBL4537868	=	IC50	nM	873.0	CHEMBL2148	Homo sapiens	IC50	nM	873.0
	18957332	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4557507	=	IC50	nM	232.0	CHEMBL2148	Homo sapiens	IC50	nM	232.0
	18957333	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(OC)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4463762	=	IC50	nM	52.0	CHEMBL2148	Homo sapiens	IC50	nM	52.0
	18957334	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4445411	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	nM	21.0
	18957335	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4470305	=	IC50	nM	4.3	CHEMBL2148	Homo sapiens	IC50	nM	4.3
	18957336	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)NCCCN(C)c1ccc([N+](=O)[O-])c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4464668	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18957337	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	18957338	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C#CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4473956	<	IC50	nM	0.1	CHEMBL2148	Homo sapiens	IC50	nM	0.1
	18957339	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	C=CC(=O)N1CCC(NC2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)CC1		CHEMBL4526325	=	IC50	nM	1777.0	CHEMBL2148	Homo sapiens	IC50	nM	1777.0
	18957340	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	CCC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4554336	=	IC50	nM	27.0	CHEMBL2148	Homo sapiens	IC50	nM	27.0
	18957341	CHEMBL4332968	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 6 uM ATP by HTRF assay	B	CCC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4541648	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	18957342	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	50.0	CHEMBL2148	Homo sapiens	IC50	nM	50.0
	18957343	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	685.0	CHEMBL2148	Homo sapiens	IC50	nM	685.0
	18957344	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	202.0	CHEMBL2148	Homo sapiens	IC50	nM	202.0
	18957345	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664	=	IC50	nM	520.0	CHEMBL2148	Homo sapiens	IC50	nM	520.0
	18957346	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCC(Nc2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4533508	=	IC50	nM	3456.0	CHEMBL2148	Homo sapiens	IC50	nM	3456.0
Not Determined	18957347	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)NCC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4513304		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957348	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N(C)C1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4464446		IC50			CHEMBL2148	Homo sapiens	IC50		
	18957349	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N[C@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4463237	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	nM	30000.0
	18957350	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N[C@@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4444559	=	IC50	nM	3690.0	CHEMBL2148	Homo sapiens	IC50	nM	3690.0
Not Determined	18957351	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)NCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4454565		IC50			CHEMBL2148	Homo sapiens	IC50		
	18957352	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)NCCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4578121	=	IC50	nM	1276.0	CHEMBL2148	Homo sapiens	IC50	nM	1276.0
Not Determined	18957353	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)NCCCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4461660		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957354	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	CN(C)C/C=C/C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4520141		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957355	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C/C=C/C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4544861		IC50			CHEMBL2148	Homo sapiens	IC50		
	18957356	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCN(C(=O)CCl)CC2)ccc1C(F)(F)F		CHEMBL4463109	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	18957357	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1cc(N2CCN(C(=O)CBr)CC2)ccc1C(F)(F)F		CHEMBL4439785	=	IC50	nM	709.0	CHEMBL2148	Homo sapiens	IC50	nM	709.0
	18957358	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C#CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4543011	=	IC50	nM	212.0	CHEMBL2148	Homo sapiens	IC50	nM	212.0
	18957359	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4461890	=	IC50	nM	584.0	CHEMBL2148	Homo sapiens	IC50	nM	584.0
	18957360	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5cc(F)ccc45)C(=O)NC3=O)c2)CC1		CHEMBL4444087	=	IC50	nM	817.0	CHEMBL2148	Homo sapiens	IC50	nM	817.0
	18957361	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccc(F)cc45)C(=O)NC3=O)c2)CC1		CHEMBL4441142	=	IC50	nM	895.0	CHEMBL2148	Homo sapiens	IC50	nM	895.0
	18957362	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5cc(C)ccc45)C(=O)NC3=O)c2)CC1		CHEMBL4459688	=	IC50	nM	650.0	CHEMBL2148	Homo sapiens	IC50	nM	650.0
	18957363	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ncccc45)C(=O)NC3=O)c2)CC1		CHEMBL4522075	=	IC50	nM	750.0	CHEMBL2148	Homo sapiens	IC50	nM	750.0
Not Determined	18957364	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4ccc(Cl)cc4)C(=O)NC3=O)c2)CC1		CHEMBL4457521		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957365	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)cc(C(F)(F)F)c2)CC1		CHEMBL4461593		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957366	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)ccc2F)CC1		CHEMBL4537868		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957367	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4557507		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957368	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(OC)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4463762		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	18957369	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4445411		IC50			CHEMBL2148	Homo sapiens	IC50		
	18957370	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4470305	=	IC50	nM	450.0	CHEMBL2148	Homo sapiens	IC50	nM	450.0
	18957371	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)NCCCN(C)c1ccc([N+](=O)[O-])c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4464668	=	IC50	nM	332.0	CHEMBL2148	Homo sapiens	IC50	nM	332.0
	18957372	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
	18957373	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C#CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4473956	=	IC50	nM	90.0	CHEMBL2148	Homo sapiens	IC50	nM	90.0
Not Determined	18957374	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	C=CC(=O)N1CCC(NC2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)CC1		CHEMBL4526325		IC50			CHEMBL2148	Homo sapiens	IC50		
	18957375	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	CCC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4554336	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	18957376	CHEMBL4332969	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system in presence of 1 mM ATP by HTRF assay	B	CCC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4541648	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	nM	210.0
	18957377	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664	=	Kinact	/min	0.21	CHEMBL2148	Homo sapiens	Kinact	/min	0.21
	18957378	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N1CCC(Nc2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4533508	=	Kinact	/min	0.21	CHEMBL2148	Homo sapiens	Kinact	/min	0.21
	18957379	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N[C@@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4444559	=	Kinact	/min	0.26	CHEMBL2148	Homo sapiens	Kinact	/min	0.26
	18957380	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)NCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4454565	=	Kinact	/min	0.25	CHEMBL2148	Homo sapiens	Kinact	/min	0.25
	18957381	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C#CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4543011	=	Kinact	/min	1.2	CHEMBL2148	Homo sapiens	Kinact	/min	1.2
	18957382	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4445411	=	Kinact	/min	0.17	CHEMBL2148	Homo sapiens	Kinact	/min	0.17
	18957383	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4470305	=	Kinact	/min	0.07	CHEMBL2148	Homo sapiens	Kinact	/min	0.07
	18957384	CHEMBL4332970	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as Kinact by HTRF assay	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	Kinact	/min	0.41	CHEMBL2148	Homo sapiens	Kinact	/min	0.41
	18957385	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664	=	Ratio	10'5/M/s	35.0	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	35.0
	18957386	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N1CCC(Nc2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4533508	=	Ratio	10'5/M/s	1.3	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	1.3
	18957387	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N[C@@H]1CCCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)C1		CHEMBL4444559	=	Ratio	10'5/M/s	0.22	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	0.22
	18957388	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)NCCN(C)c1ccc(C(F)(F)F)c(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL4454565	=	Ratio	10'5/M/s	4.4	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	4.4
	18957389	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C#CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4543011	=	Ratio	10'5/M/s	3.6	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	3.6
	18957390	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4445411	=	Ratio	10'5/M/s	0.56	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	0.56
	18957391	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4470305	=	Ratio	10'5/M/s	3.5	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	3.5
	18957392	CHEMBL4332971	Inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system assessed as ratio of Kinact to Ki by HTRF assay	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	Ratio	10'5/M/s	62.0	CHEMBL2148	Homo sapiens	Ratio	10'5/M/s	62.0
Active	18957393	CHEMBL4332972	Binding affinity to recombinant JAK3 kinase domain (unknown origin) assessed as enzyme-compound covalent adduct formation via Cys909 residue at protein to compound molar ratio of 1:10 preincubated for 2 hrs followed by overnight trypsin digestion by LC-MS/MS analysis	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664		Activity			CHEMBL2148	Homo sapiens	Activity		
	18957399	CHEMBL4332978	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL2-induced STAT5 phosphorylation preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot analysis	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	EC50	nM	1999.0	CHEMBL2148	Homo sapiens	EC50	nM	1999.0
	18957400	CHEMBL4332978	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL2-induced STAT5 phosphorylation preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	EC50	nM	305.0	CHEMBL2148	Homo sapiens	EC50	nM	305.0
Active	18957401	CHEMBL4332979	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL2-induced STAT5 phosphorylation at 0.6 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957402	CHEMBL4332980	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL2-induced STAT5 phosphorylation at 6 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot analysis	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18957403	CHEMBL4332981	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	=	EC50	nM	141.0	CHEMBL2148	Homo sapiens	EC50	nM	141.0
Active	18957404	CHEMBL4332982	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL2-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957405	CHEMBL4332983	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957406	CHEMBL4332984	Inhibition of JAK3 in human PBMC assessed as reduction in IL2-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957407	CHEMBL4332984	Inhibition of JAK3 in human PBMC assessed as reduction in IL2-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL2 stimulation measured after 30 mins by Western blot	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957408	CHEMBL4332985	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957409	CHEMBL4332985	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation up to 10 uM preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957410	CHEMBL4332986	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation at 300 nM preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957411	CHEMBL4332986	Inhibition of JAK3 in human PBMC assessed as reduction in IL15-induced STAT5 phosphorylation at 300 nM preincubated for 2 hrs followed by IL15 stimulation measured after 30 mins by Western blot	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957416	CHEMBL4332989	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation at 1 uM preincubated for 2 hrs followed by compound washout with PBS and IL15 stimulation measured after 30 mins by Western blot analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957417	CHEMBL4332989	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation at 1 uM preincubated for 2 hrs followed by compound washout with PBS and IL15 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957418	CHEMBL4332989	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation at 1 uM preincubated for 2 hrs followed by compound washout with PBS and IL15 stimulation measured after 30 mins by Western blot analysis	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957419	CHEMBL4332990	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation at 6 uM preincubated for 2 hrs followed by compound washout with PBS and IL15 stimulation measured after 30 mins by Western blot analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957420	CHEMBL4332990	Inhibition of JAK3 in human CTLL2 cells assessed as reduction in IL15-induced STAT5 phosphorylation at 6 uM preincubated for 2 hrs followed by compound washout with PBS and IL15 stimulation measured after 30 mins by Western blot analysis	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	18957446	CHEMBL4333010	Irreversible inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system preincubated up to 40 mins followed by substrate/6 to 1000 uM ATP addition by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957447	CHEMBL4333010	Irreversible inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system preincubated up to 40 mins followed by substrate/6 to 1000 uM ATP addition by HTRF assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	18957448	CHEMBL4333010	Irreversible inhibition of human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system preincubated up to 40 mins followed by substrate/6 to 1000 uM ATP addition by HTRF assay	B	C=CC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4435664		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	18958925	CHEMBL4333447	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	80.0	CHEMBL2148	Homo sapiens	Activity	%	80.0
	18964385	CHEMBL4335130	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	102.0	CHEMBL2148	Homo sapiens	Activity	%	102.0
	18964386	CHEMBL4335130	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL2148	Homo sapiens	Activity	%	104.0
	18971947	CHEMBL4336957	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	43.0	CHEMBL2148	Homo sapiens	Activity	%	43.0
	18984236	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	CC(C)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4539805	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	18984237	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	CC(C)CNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4440261	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	nM	4.0
	18984238	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	CC(C)CCNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4471290	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	18984239	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	CC(C)(C)CNc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4461011	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	18984240	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	NC(=O)c1cnn2cc(-c3ccccc3)cc2c1NC1CCCC1		CHEMBL4472924	=	IC50	nM	5.0	CHEMBL2148	Homo sapiens	IC50	nM	5.0
	18984241	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(N[C@H](CO)CC(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4467881	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18984242	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(N[C@H](CO)CC4CC4)c(C(N)=O)cnn3c2)cn1		CHEMBL4549451	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	18984243	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(NC(CO)[C@H](O)C4CC4)c(C(N)=O)cnn3c2)cn1		CHEMBL4440767	=	IC50	nM	100.0	CHEMBL2148	Homo sapiens	IC50	nM	100.0
	18984244	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(NC(CO)[C@H](O)C4CC4)c(C(N)=O)cnn3c2)cn1		CHEMBL4440767	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18984245	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(NC(CO)CO)c(C(N)=O)cnn3c2)cn1		CHEMBL4568896	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	nM	38.0
	18984246	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	COc1ccc(-c2cc3c(N[C@H](CO)[C@@H](C)O)c(C(N)=O)cnn3c2)cn1		CHEMBL4547761	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	nM	2.0
	18984247	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	C[C@@H](O)[C@@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4447360	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	18984248	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	C[C@H](O)[C@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4463195	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
	18984249	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	C[C@H](O)[C@@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4450347	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	nM	13.0
	18984250	CHEMBL4339744	Inhibition of GST-tagged JAK3 (unknown origin) using fluoresceinated peptide as substrate measured after 3 hrs by electrophoresis method	B	C[C@@H](O)[C@H](CO)Nc1c(C(N)=O)cnn2cc(-c3ccccc3)cc12		CHEMBL4469583	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
	18985693	CHEMBL4339992	Inhibition of JAK3 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	18991818	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(F)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4471390	=	IC50	nM	95.7	CHEMBL2148	Homo sapiens	IC50	nM	95.7
	18991819	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccccc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4583532	=	IC50	nM	94.7	CHEMBL2148	Homo sapiens	IC50	nM	94.7
	18991820	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2cccc(N3CCN(C)CC3)c2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4452803	=	IC50	nM	751.0	CHEMBL2148	Homo sapiens	IC50	nM	751.0
	18991821	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2cc(F)c(N3CCOCC3)c(F)c2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4456396	=	IC50	nM	195.1	CHEMBL2148	Homo sapiens	IC50	nM	195.1
	18991822	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(-n3ccnc3)cc2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4466925	=	IC50	nM	91.3	CHEMBL2148	Homo sapiens	IC50	nM	91.3
	18991823	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4521339	=	IC50	nM	56.7	CHEMBL2148	Homo sapiens	IC50	nM	56.7
	18991824	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(F)cc2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4569551	=	IC50	nM	5083.0	CHEMBL2148	Homo sapiens	IC50	nM	5083.0
	18991825	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccccc2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4453064	=	IC50	nM	153.1	CHEMBL2148	Homo sapiens	IC50	nM	153.1
	18991849	CHEMBL4341339	Inhibition of recombinant epitope tagged JAK3 kinase domain (718 to 1124 residues) (unknown origin) using peptide substrate by fluorescence based assay	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
	18991853	CHEMBL4341335	Inhibition of human JAK3 kinase-domain using Biotin-Lyn-Substrate-2 as substrate incubated for 1 hr by ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2		CHEMBL4238926	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	18991856	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc([N+](=O)[O-])cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4549680	=	IC50	nM	274.9	CHEMBL2148	Homo sapiens	IC50	nM	274.9
	18991857	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4590082	=	IC50	nM	7.6	CHEMBL2148	Homo sapiens	IC50	nM	7.6
	18991858	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4524343	=	IC50	nM	33.7	CHEMBL2148	Homo sapiens	IC50	nM	33.7
	18991859	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4552039	=	IC50	nM	52.0	CHEMBL2148	Homo sapiens	IC50	nM	52.0
	18991860	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2cc(F)c(N3CCOCC3)c(F)c2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4449906	=	IC50	nM	88.1	CHEMBL2148	Homo sapiens	IC50	nM	88.1
	18991861	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	COc1cc(Nc2ncc(C)c(-c3cc4c(o3)CCN(C(=O)CC#N)C4)n2)cc(OC)c1OC		CHEMBL4440795	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	18991862	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	CCC(=O)N1CCc2oc(-c3nc(Nc4ccc(N5CCOCC5)cc4)ncc3C)cc2C1		CHEMBL4464597	=	IC50	nM	111.8	CHEMBL2148	Homo sapiens	IC50	nM	111.8
	18991863	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)c1ccc(C#N)cc1)C2		CHEMBL4537207	=	IC50	nM	430.7	CHEMBL2148	Homo sapiens	IC50	nM	430.7
	18991864	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)c1cccc(C#N)c1)C2		CHEMBL4462728	=	IC50	nM	552.4	CHEMBL2148	Homo sapiens	IC50	nM	552.4
	18991865	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)C(C)C)C2		CHEMBL4524537	=	IC50	nM	32.4	CHEMBL2148	Homo sapiens	IC50	nM	32.4
	18991866	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	18991867	CHEMBL4341344	Inhibition of JAK3 (unknown origin) using TK-substrate-biotin as substrate preincubated for 5 mins followed by substrate addition and measured by 30 mins by HTRF assay	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	IC50	nM	560.0	CHEMBL2148	Homo sapiens	IC50	nM	560.0
	18991887	CHEMBL4341351	Inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	Cc1cnc(Nc2cc(F)c(N3CCOCC3)c(F)c2)nc1-c1cc2c(o1)CCN(S(C)(=O)=O)C2		CHEMBL4456396	=	IC50	nM	1096.0	CHEMBL2148	Homo sapiens	IC50	nM	1096.0
	18991888	CHEMBL4341351	Inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4590082	=	IC50	nM	543.3	CHEMBL2148	Homo sapiens	IC50	nM	543.3
	18991889	CHEMBL4341351	Inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	Cc1cnc(Nc2cc(F)c(N3CCOCC3)c(F)c2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4449906	=	IC50	nM	622.7	CHEMBL2148	Homo sapiens	IC50	nM	622.7
	18991890	CHEMBL4341351	Inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	COc1cc(Nc2ncc(C)c(-c3cc4c(o3)CCN(C(=O)CC#N)C4)n2)cc(OC)c1OC		CHEMBL4440795	=	IC50	nM	200.3	CHEMBL2148	Homo sapiens	IC50	nM	200.3
	18991891	CHEMBL4341351	Inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	156.0	CHEMBL2148	Homo sapiens	IC50	nM	156.0
	18991894	CHEMBL4341353	Potency index, ratio of tofacitinib IC50 to compound IC50 for inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)CC#N)C2		CHEMBL4590082	=	Ratio IC50		4.0	CHEMBL2148	Homo sapiens	Ratio IC50		4.0
	18991895	CHEMBL4341353	Potency index, ratio of tofacitinib IC50 to compound IC50 for inhibition of JAK3 in human HT-2 cells assessed as reduction in IL-2-induced cell proliferation	B	COc1cc(Nc2ncc(C)c(-c3cc4c(o3)CCN(C(=O)CC#N)C4)n2)cc(OC)c1OC		CHEMBL4440795	=	Ratio IC50		4.0	CHEMBL2148	Homo sapiens	Ratio IC50		4.0
	18992757	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	COc1ccc(F)c(Cl)c1C(C)Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N		CHEMBL4461078	=	IC50	nM	1759.0	CHEMBL2148	Homo sapiens	IC50	uM	1.759
	18992758	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL4541291	=	IC50	nM	513.0	CHEMBL2148	Homo sapiens	IC50	uM	0.513
	18992759	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	COc1ccc(F)cc1C(C)Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N		CHEMBL4465076	=	IC50	nM	1584.0	CHEMBL2148	Homo sapiens	IC50	uM	1.584
	18992760	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	CC(Oc1cc(-c2cn[nH]c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL4550335	=	IC50	nM	965.0	CHEMBL2148	Homo sapiens	IC50	uM	0.965
	18992761	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	CC(Oc1cc(-c2cccc(N3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL4452772	=	IC50	nM	2788.0	CHEMBL2148	Homo sapiens	IC50	uM	2.788
	18992762	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1360.0	CHEMBL2148	Homo sapiens	IC50	uM	1.36
	18992763	CHEMBL4341688	Inhibition of human recombinant C-terminal hexahistidine tagged JAK3 JH1 catalytic domain (811 to 1124 residues) expressed in baculovirus infected Sf9 cells using Tyr6 peptide as substrate incubated for 30 secs under shaking condition measured after 1 hr by Z'-LYTE assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	51.0	CHEMBL2148	Homo sapiens	IC50	uM	0.051
	18997605	CHEMBL4342906	Inhibition of JAK3 (unknown origin) assessed as dissociate constant	B	Cc1cc(Nc2nc([C@@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL3939800	=	Kd	nM	5.0	CHEMBL2148	Homo sapiens	Kd	nM	5.0
	18997610	CHEMBL4342911	Inhibition of JAK3 (unknown origin)	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1	Outside typical range	CHEMBL2110732	=	IC50	nM	3570000.0	CHEMBL2148	Homo sapiens	IC50	mM	3.57
	19018958	CHEMBL4347071	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD measured after 60 mins in the presence of ATP by LANCE method	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19018993	CHEMBL4347071	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD measured after 60 mins in the presence of ATP by LANCE method	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	19021243	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	O=C(CCCCCCn1cc(Nc2ncc(Cl)c(Nc3cccc(Cl)c3)n2)cn1)NO		CHEMBL4471710	=	IC50	nM	3.3	CHEMBL2148	Homo sapiens	IC50	uM	0.0033
	19021244	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	O=C(CCCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4575813	=	IC50	nM	7.6	CHEMBL2148	Homo sapiens	IC50	uM	0.0076
	19021245	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	O=C(CCCCCCn1cc(Nc2ncc(Cl)c(N3CCCCC3)n2)cn1)NO		CHEMBL4562491	=	IC50	nM	3.7	CHEMBL2148	Homo sapiens	IC50	uM	0.0037
	19021246	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	O=C(CCCCCCn1cc(Nc2ncc(Cl)c(NC3CC3)n2)cn1)NO		CHEMBL4466059	=	IC50	nM	2.0	CHEMBL2148	Homo sapiens	IC50	uM	0.002
	19021247	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	IC50	nM	7.4	CHEMBL2148	Homo sapiens	IC50	uM	0.0074
	19021248	CHEMBL4347602	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE assay	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	uM	0.0035
	19029981	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccncc4)c23)c1		CHEMBL4464404	=	IC50	nM	0.6	CHEMBL2148	Homo sapiens	IC50	nM	0.6
	19029982	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(Oc4ccccc4)c23)n1		CHEMBL4465231	=	IC50	nM	470.0	CHEMBL2148	Homo sapiens	IC50	nM	470.0
	19029983	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCCCC4)c23)n1		CHEMBL4520286	=	IC50	nM	104.0	CHEMBL2148	Homo sapiens	IC50	nM	104.0
	19029984	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCOCC4)c23)n1		CHEMBL4562744	=	IC50	nM	186.0	CHEMBL2148	Homo sapiens	IC50	nM	186.0
	19029985	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12		CHEMBL4543893	=	IC50	nM	3.7	CHEMBL2148	Homo sapiens	IC50	nM	3.7
	19029986	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12		CHEMBL4593230	=	IC50	nM	69.0	CHEMBL2148	Homo sapiens	IC50	nM	69.0
Not Determined	19029987	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@H](Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1		CHEMBL4563157		IC50			CHEMBL2148	Homo sapiens	IC50		
	19029988	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1		CHEMBL4469900	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	19029989	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(CC)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1		CHEMBL4457018	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	nM	1.2
	19029990	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1		CHEMBL4458344	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	nM	11.0
	19029991	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4463563	=	IC50	nM	51.0	CHEMBL2148	Homo sapiens	IC50	nM	51.0
	19029992	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)c4)c23)CC1		CHEMBL4440621	=	IC50	nM	84.0	CHEMBL2148	Homo sapiens	IC50	nM	84.0
	19029993	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cccc(NC)n4)c23)CC1		CHEMBL4574694	=	IC50	nM	1428.0	CHEMBL2148	Homo sapiens	IC50	nM	1428.0
	19029994	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccnc(NC)c4)c23)CC1		CHEMBL4549626	=	IC50	nM	4.2	CHEMBL2148	Homo sapiens	IC50	nM	4.2
	19029995	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C#CCCN1CCN(c2ccc(Nc3nc(OC4CCN(C(=O)C=C)CC4)c4c(-c5cncc(NC)n5)c[nH]c4n3)cc2)CC1		CHEMBL4562542	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	nM	61.0
	19030037	CHEMBL4349176	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	16.3	CHEMBL2148	Homo sapiens	Activity	%	16.3
	19030086	CHEMBL4349141	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells using STK as substrate by HTRF assay	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	IC50	nM	123.0	CHEMBL2148	Homo sapiens	IC50	nM	123.0
	19036719	CHEMBL4351043	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	487.0	CHEMBL2148	Homo sapiens	IC50	nM	487.0
	19036720	CHEMBL4351043	Inhibition of JAK3 (unknown origin)	B	c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1		CHEMBL3622376	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
Not Active	19039734	CHEMBL4351908	Inhibition of recombinant human JAK3 (781 to end residues) at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	19041151	CHEMBL4352412	Inhibition of human JAK3 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	19054049	CHEMBL4356087	Inhibition of JAK3 (unknown origin)	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	428.0	CHEMBL2148	Homo sapiens	IC50	uM	0.428
	19059637	CHEMBL4357938	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	88.0	CHEMBL2148	Homo sapiens	Activity	%	88.0
	19061222	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C		CHEMBL4483575	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	19061223	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	37.0	CHEMBL2148	Homo sapiens	Kd	nM	37.0
	19061224	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	19061225	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4071161	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	19061226	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833	>	Kd	nM	10000.0	CHEMBL2148	Homo sapiens	Kd	nM	10000.0
	19061227	CHEMBL4358521	Binding affinity to DNA-tagged recombinant JAK3 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	B	CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1		CHEMBL4297674	=	Kd	nM	1300.0	CHEMBL2148	Homo sapiens	Kd	nM	1300.0
	19090202	CHEMBL4365776	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	14.0	CHEMBL2148	Homo sapiens	Activity	%	14.0
	19091969	CHEMBL4366443	Inhibition of human JAK3 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-4.79	CHEMBL2148	Homo sapiens	INH	%	-4.79
Active	19114565	CHEMBL4371382	Inhibition of JAK3 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Active	19114566	CHEMBL4371381	Inhibition of JAK3 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	19118526	CHEMBL4372370	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using JAK3tide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	19140824	CHEMBL4376588	Inhibition of recombinant full length human GST-tagged JAK3 expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	19143991	CHEMBL4377457	Inhibition of JAK3 (unknown origin) in presence of Km ATP	A	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2		CHEMBL4238926	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	19143995	CHEMBL4377377	Inhibition of GST-fused recombinant human JAK3 catalytic domain (811-1103 residues) expressed in Sf9 cells in presence of 0.1 mM ATP	A	CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12		CHEMBL3622821	=	IC50	nM	2304.0	CHEMBL2148	Homo sapiens	IC50	nM	2304.0
	19143999	CHEMBL4377462	Inhibition of JAK3 (unknown origin)	A	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	19144003	CHEMBL4377466	Inhibition of recombinant human JAK3 kinase domain using FITC-KGGEEEEYFELVKK as substrate incubated for 75 mins by caliper method	A	Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1		CHEMBL4459585	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19144007	CHEMBL4377470	Inhibition of fluorescein labeled probe binding to human recombinant JAK3 JH1 domain incubated for 1 hr by HTRF assay	A	[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC		CHEMBL4435170	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19144029	CHEMBL4377470	Inhibition of fluorescein labeled probe binding to human recombinant JAK3 JH1 domain incubated for 1 hr by HTRF assay	A	[2H]C([2H])([2H])NC(=O)c1nnc(Nc2ccccn2)cc1Nc1ccccc1S(C)(=O)=O		CHEMBL4440718	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19144932	CHEMBL4377948	Inhibition of recombinant human JAK3 (781 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	83.0	CHEMBL2148	Homo sapiens	INH	%	83.0
	19146987	CHEMBL4378805	Inhibition of recombinant human JAK3 (781 to end residues) at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	5.0	CHEMBL2148	Homo sapiens	INH	%	5.0
	19147898	CHEMBL4379372	Inhibition of human recombinant JAK3 (781 to end residues) using GGEEEEYFELVKK as substrate after 40 mins by [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	19155125	CHEMBL4380951	Inhibition of wild type human partial length JAK3 (I781 to S1124 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC(C)Oc1cc(-c2cncc(-c3cnn(C4COC4)c3)c2)ccc1C(N)=O		CHEMBL4587832	>	Inhibition	%	90.0	CHEMBL2148	Homo sapiens	INH	%	90.0
	19159465	CHEMBL4382569	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	19168580	CHEMBL4384439	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control	B	CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CCl		CHEMBL4440618	=	Inhibition	%	32.0	CHEMBL2148	Homo sapiens	INH	%	32.0
	19168581	CHEMBL4384439	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control	B	C=CC(=O)Oc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC		CHEMBL4435699	=	Inhibition	%	92.0	CHEMBL2148	Homo sapiens	INH	%	92.0
	19168582	CHEMBL4384439	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control	B	CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1ncc[nH]1		CHEMBL4526992	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	19172315	CHEMBL4385139	Inhibition of JAK3 (unknown origin)	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	<	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	pIC50		5.0
	19181060	CHEMBL4387271	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	30.0	CHEMBL2148	Homo sapiens	INH	%	30.0
	19181286	CHEMBL4387271	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	61.5	CHEMBL2148	Homo sapiens	INH	%	61.5
	19191542	CHEMBL4389288	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.35	CHEMBL2148	Homo sapiens	INH	%	0.35
	19191951	CHEMBL4389765	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	4.3	CHEMBL2148	Homo sapiens	INH	%	4.3
	19200207	CHEMBL4391391	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	0.28	CHEMBL2148	Homo sapiens	Activity	%	0.28
	19225471	CHEMBL4395891	Inhibition of human recombinant JAK3 at 1 uM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	24.83	CHEMBL2148	Homo sapiens	INH	%	24.83
	19236746	CHEMBL4398819	Inhibition of JAK3 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL2148	Homo sapiens	INH	%	25.0
	19240673	CHEMBL4399590	Inhibition of JAK3 (unknown origin)	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ccc23)n1		CHEMBL4453941	=	Ki	nM	3.0	CHEMBL2148	Homo sapiens	Ki	nM	3.0
	19253584	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(Cn2nc(-c3cc(C)n(C)n3)c3c(N)ncnc32)CC1		CHEMBL4437684	=	IC50	nM	741.3	CHEMBL2148	Homo sapiens	IC50	nM	741.3
	19253585	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(n2nc(-c3cc(C)n(C)n3)c3c(N)ncnc32)CC1		CHEMBL4436334	=	IC50	nM	873.2	CHEMBL2148	Homo sapiens	IC50	nM	873.2
	19253586	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	Cc1cc(-c2nn(C3CCCN(C(=O)CN(C)C)C3)c3ncnc(N)c23)nn1C		CHEMBL4517545	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19253587	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(-c3cc(C)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4454783	=	IC50	nM	683.0	CHEMBL2148	Homo sapiens	IC50	nM	683.0
	19253588	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(n2nc(-c3cc(C)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4564903	=	IC50	nM	260.1	CHEMBL2148	Homo sapiens	IC50	nM	260.1
	19253589	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2nc(-c3cc(C)n(C)n3)c3c(N)ncnc32)c1		CHEMBL4440612	=	IC50	nM	932.9	CHEMBL2148	Homo sapiens	IC50	nM	932.9
	19253590	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(Cn2nc(-c3cc(C=O)n(C)n3)c3c(N)ncnc32)CC1		CHEMBL4526982	=	IC50	nM	837.0	CHEMBL2148	Homo sapiens	IC50	nM	837.0
	19253591	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(-c3cc(C=O)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4442778	=	IC50	nM	98.1	CHEMBL2148	Homo sapiens	IC50	nM	98.1
	19253592	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(n2nc(-c3cc(C=O)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4561431	=	IC50	nM	70.4	CHEMBL2148	Homo sapiens	IC50	nM	70.4
	19253593	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2nc(-c3cc(C=O)n(C)n3)c3c(N)ncnc32)c1		CHEMBL4465262	=	IC50	nM	481.7	CHEMBL2148	Homo sapiens	IC50	nM	481.7
	19253594	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(Cn2nc(-c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)CC1		CHEMBL4457338	=	IC50	nM	364.1	CHEMBL2148	Homo sapiens	IC50	nM	364.1
	19253595	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	Cn1nc(-c2nn(C3CCCN(C(=O)CC#N)C3)c3ncnc(N)c23)cc1C(C)(C)O		CHEMBL4590390	=	IC50	nM	319.3	CHEMBL2148	Homo sapiens	IC50	nM	319.3
	19253596	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(-c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4454392	=	IC50	nM	240.1	CHEMBL2148	Homo sapiens	IC50	nM	240.1
	19253597	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(n2nc(-c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4557416	=	IC50	nM	171.8	CHEMBL2148	Homo sapiens	IC50	nM	171.8
	19253598	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1ccc(Cn2nc(-c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)cc1		CHEMBL4590588	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19253599	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2nc(-c3cc(C(C)(C)O)n(C)n3)c3c(N)ncnc32)c1		CHEMBL4455024	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19253600	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(-c3cc(N4CCOCC4)n(C)n3)c3c(N)ncnc32)C1		CHEMBL4460560	=	IC50	nM	41.1	CHEMBL2148	Homo sapiens	IC50	nM	41.1
	19253601	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1ccc(Cn2nc(-c3cc(N4CCOCC4)n(C)n3)c3c(N)ncnc32)cc1		CHEMBL4452640	=	IC50	nM	783.9	CHEMBL2148	Homo sapiens	IC50	nM	783.9
	19253602	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2nc(-c3cc(N4CCOCC4)n(C)n3)c3c(N)ncnc32)c1		CHEMBL4576447	=	IC50	nM	397.0	CHEMBL2148	Homo sapiens	IC50	nM	397.0
	19253603	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	19253604	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	N#CCC(=O)N1CCC(Cn2nc(Br)c3c(N)ncnc32)CC1		CHEMBL4569850	=	IC50	nM	603.2	CHEMBL2148	Homo sapiens	IC50	nM	603.2
	19253605	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(Cn2nc(Br)c3c(N)ncnc32)CC1		CHEMBL4577281	=	IC50	nM	103.2	CHEMBL2148	Homo sapiens	IC50	nM	103.2
	19253606	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	N#CCC(=O)N1CCC(n2nc(Br)c3c(N)ncnc32)CC1		CHEMBL4437650	=	IC50	nM	109.4	CHEMBL2148	Homo sapiens	IC50	nM	109.4
	19253607	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCC(n2nc(Br)c3c(N)ncnc32)CC1		CHEMBL4584510	=	IC50	nM	80.5	CHEMBL2148	Homo sapiens	IC50	nM	80.5
	19253608	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	N#CCC(=O)N1CCCC(Cn2nc(Br)c3c(N)ncnc32)C1		CHEMBL4439150	=	IC50	nM	335.7	CHEMBL2148	Homo sapiens	IC50	nM	335.7
	19253609	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(Cn2nc(Br)c3c(N)ncnc32)C1		CHEMBL4517080	=	IC50	nM	20.7	CHEMBL2148	Homo sapiens	IC50	nM	20.7
	19253610	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	N#CCC(=O)N1CCCC(n2nc(Br)c3c(N)ncnc32)C1		CHEMBL4459635	=	IC50	nM	89.6	CHEMBL2148	Homo sapiens	IC50	nM	89.6
	19253611	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(Br)c3c(N)ncnc32)C1		CHEMBL4582632	=	IC50	nM	34.0	CHEMBL2148	Homo sapiens	IC50	nM	34.0
	19253612	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)N1CCCC(n2nc(I)c3c(N)ncnc32)C1		CHEMBL4554776	=	IC50	nM	21.8	CHEMBL2148	Homo sapiens	IC50	nM	21.8
	19253613	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2nc(Br)c3c(N)ncnc32)c1		CHEMBL4589134	=	IC50	nM	245.2	CHEMBL2148	Homo sapiens	IC50	nM	245.2
	19253614	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	Cn1cc(Nc2ncnc3c2cnn3Cc2cccc(NC#N)c2)cn1		CHEMBL4456730	=	IC50	nM	689.2	CHEMBL2148	Homo sapiens	IC50	nM	689.2
	19253615	CHEMBL4402149	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	A	C=CC(=O)Nc1cccc(Cn2ncc3c(Nc4cnn(C)c4)ncnc32)c1		CHEMBL4442811	=	IC50	nM	267.4	CHEMBL2148	Homo sapiens	IC50	nM	267.4
	19254774	CHEMBL4402477	Inhibition of JAK3 (unknown origin)	B	CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12		CHEMBL4532948	>	IC50	nM	2000.0	CHEMBL2148	Homo sapiens	IC50	uM	2.0
	19254777	CHEMBL4402480	Inhibition of JAK3 (unknown origin) by cell-based assay	B	CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12		CHEMBL4532948	>	IC50	nM	12500.0	CHEMBL2148	Homo sapiens	IC50	uM	12.5
	19264244	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CC(=O)NC34CCC(C(N)=O)(CC3)CC4)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4447497	=	IC50	nM	56.0	CHEMBL2148	Homo sapiens	IC50	nM	56.0
	19264245	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CC(=O)N[C@H]3CC[C@H](O)CC3)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4582390	=	IC50	nM	74.0	CHEMBL2148	Homo sapiens	IC50	nM	74.0
	19264246	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CC(=O)NCc3ccc(F)cc3)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4588333	=	IC50	nM	174.0	CHEMBL2148	Homo sapiens	IC50	nM	174.0
	19264247	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CNC(=O)CC3CC3)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4437638	=	IC50	nM	221.0	CHEMBL2148	Homo sapiens	IC50	nM	221.0
	19264248	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CC(=O)NCC(F)(F)F)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4439418	=	IC50	nM	69.0	CHEMBL2148	Homo sapiens	IC50	nM	69.0
	19264249	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	CC(C)(C#N)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1		CHEMBL4537718	=	IC50	nM	98.0	CHEMBL2148	Homo sapiens	IC50	nM	98.0
	19264250	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CC[C@H]1CC[C@H](n2c(CC(=O)N3CCC(N4CCOCC4)CC3)nc3cnc4[nH]ccc4c32)CC1		CHEMBL4456630	=	IC50	nM	106.0	CHEMBL2148	Homo sapiens	IC50	nM	106.0
	19264251	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	N#CCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1		CHEMBL4563534	=	IC50	nM	96.0	CHEMBL2148	Homo sapiens	IC50	nM	96.0
	19264252	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	CC(C)CN1CCC(NC(=O)Cc2nc3cnc4[nH]ccc4c3n2[C@H]2CC[C@H](CC#N)CC2)CC1		CHEMBL4514898	=	IC50	nM	31.0	CHEMBL2148	Homo sapiens	IC50	nM	31.0
	19264253	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	CC(C)(O)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1		CHEMBL4473572	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
	19264254	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1		CHEMBL4470339	=	IC50	nM	12.0	CHEMBL2148	Homo sapiens	IC50	nM	12.0
	19264255	CHEMBL4404826	Inhibition of JAK3-JH1/JH2 domain (512 to 1124 residues) (unknown origin) pre-incubated before NH2-KGGEEEEYFELVKK-CO2 substrate addition and measured after 45 mins by MS analysis	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	8.5	CHEMBL2148	Homo sapiens	IC50	nM	8.5
	19266466	CHEMBL4405416	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	19269111	CHEMBL4406250	Inhibition of JAK3 (unknown origin)	B	COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1		CHEMBL4577523	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	19292276	CHEMBL4411533	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)CC#N)n2)cc1		CHEMBL4519857	>	IC50	nM	4950.0	CHEMBL2148	Homo sapiens	IC50	nM	4950.0
	19292277	CHEMBL4411533	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@H]4C[C@@H]3CN4C(=O)CC#N)n2)cc1		CHEMBL4435302	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292278	CHEMBL4411533	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using ATP at its Km level by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3CCN(C(=O)CC#N)CC3)n2)cc1		CHEMBL4436287	=	IC50	nM	8737.0	CHEMBL2148	Homo sapiens	IC50	nM	8737.0
	19292303	CHEMBL4411554	Inhibition of N-terminal His tagged human JAK3 (795 to 1124 end residues) catalytic domain expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	92.0	CHEMBL2148	Homo sapiens	INH	%	92.0
	19292462	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)CC#N)n2)cc1		CHEMBL4519857	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292463	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H]3CN4C(=O)C3CC3)n2)cc1		CHEMBL4554881	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292464	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4CC[C@H]3CN4C(=O)C3CC3)n2)cc1		CHEMBL4460904	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292465	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@@H]4C[C@H](C3)N4C(=O)C3CC3)n2)cc1		CHEMBL4551587	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292466	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1		CHEMBL4587406	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292467	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1		CHEMBL4552370	=	IC50	nM	3078.0	CHEMBL2148	Homo sapiens	IC50	nM	3078.0
	19292468	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	O=C(C1CC1)N1[C@@H]2CC[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2		CHEMBL4535276	=	IC50	nM	2531.0	CHEMBL2148	Homo sapiens	IC50	nM	2531.0
	19292469	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cn1		CHEMBL4580985	=	IC50	nM	2878.0	CHEMBL2148	Homo sapiens	IC50	nM	2878.0
	19292470	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ncc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cc1C		CHEMBL4445892	=	IC50	nM	4962.0	CHEMBL2148	Homo sapiens	IC50	nM	4962.0
	19292471	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)c1ccc(Nc2ncc(F)c(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)nc1		CHEMBL4448796	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292472	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
	19292473	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)NCC#N)n2)cn1		CHEMBL4520790	=	IC50	nM	2477.0	CHEMBL2148	Homo sapiens	IC50	nM	2477.0
	19292474	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)NCC(F)(F)F)n2)cn1		CHEMBL4526032	=	IC50	nM	6872.0	CHEMBL2148	Homo sapiens	IC50	nM	6872.0
	19292475	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	CCNC(=O)N1[C@@H]2CC[C@@H]1CN(c1ccnc(Nc3cnn(C)c3)n1)C2		CHEMBL4517702	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292476	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	IC50	nM	6494.0	CHEMBL2148	Homo sapiens	IC50	nM	6494.0
	19292477	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)C3CC3)n2)cn1		CHEMBL4562564	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19292478	CHEMBL4411596	Inhibition of human JAK3 using fluorescence labeled peptide as substrate and using 1 mM ATP by microfluidic based mobility shift assay	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@H]3CC3(F)F)n2)cn1		CHEMBL4471304	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	19306056	CHEMBL4414891	Inhibition of JAK3 (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	580.0	CHEMBL2148	Homo sapiens	IC50	nM	580.0
	19306057	CHEMBL4414891	Inhibition of JAK3 (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
	19310337	CHEMBL4416120	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control	B	CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1		CHEMBL4521381	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	19312790	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#Cc1ccc2ncc(-c3ncc4[nH]c(=O)n(C5CCOCC5)c4n3)n2c1		CHEMBL4476445	=	IC50	nM	34.0	CHEMBL2148	Homo sapiens	IC50	nM	34.0
	19312791	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]c2cnc(-c3cnc4ccc(F)cn34)nc2n1C1CCOCC1		CHEMBL4463215	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	19312792	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	Cn1c(=O)n(C2CCOCC2)c2nc(-c3cnc4ccc(C#N)cn34)ncc21		CHEMBL4476802	=	IC50	nM	53.0	CHEMBL2148	Homo sapiens	IC50	nM	53.0
	19312793	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#Cc1ccc2ncc(-c3ncc4c(n3)n(C3CCOCC3)c(=O)n4CCO)n2c1		CHEMBL4467503	=	IC50	nM	59.0	CHEMBL2148	Homo sapiens	IC50	nM	59.0
	19312794	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1n(CCO)c2cnc(-c3cnc4ccc(F)cn34)nc2n1C1CCOCC1		CHEMBL4568482	=	IC50	nM	49.0	CHEMBL2148	Homo sapiens	IC50	nM	49.0
	19312795	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	COCCn1c(=O)n(C2CCOCC2)c2nc(-c3cnc4ccc(C#N)cn34)ncc21		CHEMBL4438810	=	IC50	nM	47.0	CHEMBL2148	Homo sapiens	IC50	nM	47.0
	19312796	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#Cc1ccc2ncc(-c3ncc4c(n3)n(C3CCOCC3)c(=O)n4C[C@@H](O)CO)n2c1		CHEMBL4446722	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
	19312797	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#Cc1ccc2ncc(-c3ncc4c(n3)n(C3CCOCC3)c(=O)n4C[C@H](O)CO)n2c1		CHEMBL4441275	=	IC50	nM	96.0	CHEMBL2148	Homo sapiens	IC50	nM	96.0
	19312798	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	CC(C)(O)Cn1c(=O)n(C2CCOCC2)c2nc(-c3cnc4ccc(C#N)cn34)ncc21		CHEMBL4536380	=	IC50	nM	80.0	CHEMBL2148	Homo sapiens	IC50	nM	80.0
	19312799	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	CN(C)CCn1c(=O)n(C2CCOCC2)c2nc(-c3cnc4ccc(C#N)cn34)ncc21		CHEMBL4441500	=	IC50	nM	490.0	CHEMBL2148	Homo sapiens	IC50	nM	490.0
	19312800	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#Cc1ccc2ncc(-c3ncc4c(n3)n(C3CCOCC3)c(=O)n4CCN3CCOCC3)n2c1		CHEMBL4440240	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	nM	260.0
	19312801	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	CC1(C)CC(n2c(=O)[nH]c3cnc(-c4cnc5ccc(F)cn45)nc32)CCO1		CHEMBL4574559	=	IC50	nM	4.9	CHEMBL2148	Homo sapiens	IC50	nM	4.9
	19312802	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]c2cnc(-c3cnc4ccc(F)cn34)nc2n1[C@H]1CC[C@H](O)CC1		CHEMBL4467200	=	IC50	nM	8.4	CHEMBL2148	Homo sapiens	IC50	nM	8.4
	19312803	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@]1(O)CC[C@H](n2c(=O)[nH]c3cnc(-c4cnc5ccc(F)cn45)nc32)CC1		CHEMBL4549136	=	IC50	nM	64.0	CHEMBL2148	Homo sapiens	IC50	nM	64.0
	19312804	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]c2cnc(-c3cnc4ccc(F)cn34)nc2n1[C@@H]1CC[C@@H](O)c2ccccc21		CHEMBL4471599	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	19312805	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@@H](c1ccccc1)n1c(=O)[nH]c2cnc(-c3cnc4ccc(F)cn34)nc21		CHEMBL4571980	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	nM	420.0
	19312806	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ccccc1)n1c(=O)[nH]c2cnc(-c3cnc4ccc(F)cn34)nc21		CHEMBL4450301	=	IC50	nM	2.7	CHEMBL2148	Homo sapiens	IC50	nM	2.7
	19312807	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ccc(F)cn1)n1c(=O)[nH]c2cnc(-c3cnc4ccc(F)cn34)nc21		CHEMBL4536396	=	IC50	nM	3.0	CHEMBL2148	Homo sapiens	IC50	nM	3.0
	19312808	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ncc(F)cn1)n1c(=O)[nH]c2cnc(-c3cnc4ccc(F)cn34)nc21		CHEMBL4469844	=	IC50	nM	3.9	CHEMBL2148	Homo sapiens	IC50	nM	3.9
	19312809	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]cccc1Nc1ncc2[nH]c(=O)n([C@@H]3CCOc4c(F)cccc43)c2n1		CHEMBL4558494	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	19312810	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]cc(F)cc1Nc1ncc2[nH]c(=O)n([C@@H]3CCOc4c(F)cccc43)c2n1		CHEMBL4526498	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	19312811	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]cc(Cl)cc1Nc1ncc2[nH]c(=O)n([C@@H]3CCOc4c(F)cccc43)c2n1		CHEMBL4482927	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	19312812	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	Cc1c[nH]c(=O)c(Nc2ncc3[nH]c(=O)n([C@@H]4CCOc5c(F)cccc54)c3n2)c1		CHEMBL4536419	=	IC50	nM	2.4	CHEMBL2148	Homo sapiens	IC50	nM	2.4
	19312813	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	COc1c[nH]c(=O)c(Nc2ncc3[nH]c(=O)n([C@@H]4CCOc5c(F)cccc54)c3n2)c1		CHEMBL4520559	=	IC50	nM	16.0	CHEMBL2148	Homo sapiens	IC50	nM	16.0
	19312814	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]cccc1Nc1ncc2[nH]c(=O)n([C@@H]3CC[C@@H](O)c4ccccc43)c2n1		CHEMBL4556988	=	IC50	nM	3.4	CHEMBL2148	Homo sapiens	IC50	nM	3.4
	19312815	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ccc(F)cn1)n1c(=O)[nH]c2cnc(Nc3ccc[nH]c3=O)nc21		CHEMBL4458055	=	IC50	nM	40.0	CHEMBL2148	Homo sapiens	IC50	nM	40.0
	19312816	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ccc(F)cn1)n1c(=O)[nH]c2cnc(Nc3cc(F)c[nH]c3=O)nc21		CHEMBL4517586	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	nM	6.0
	19312817	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	C[C@H](c1ccc(F)cn1)n1c(=O)[nH]c2cnc(Nc3cc(Cl)c[nH]c3=O)nc21		CHEMBL4460058	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
	19312818	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#CCC(=O)N1CCC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)C1		CHEMBL4550310	=	IC50	nM	3.6	CHEMBL2148	Homo sapiens	IC50	nM	3.6
	19312819	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#CCC(=O)N1CCC[C@H](n2c(=O)[nH]c3cnc(Nc4cc(Cl)c[nH]c4=O)nc32)C1		CHEMBL4443416	=	IC50	nM	1.4	CHEMBL2148	Homo sapiens	IC50	nM	1.4
	19312820	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#CCC(=O)N1CCC[C@@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)C1		CHEMBL4587709	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	19312821	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
	19312822	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4cc(Cl)c[nH]c4=O)nc32)CC1		CHEMBL4526485	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	19312958	CHEMBL4416513	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using JAK3tide as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	=	Inhibition	%	100.0	CHEMBL2148	Homo sapiens	INH	%	100.0
	19312989	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]c2cnc(-c3cnc4ccc(F)cn34)nc2n1[C@@H]1CCOc2c(F)cccc21		CHEMBL4448906	=	IC50	nM	2.6	CHEMBL2148	Homo sapiens	IC50	nM	2.6
	19312990	CHEMBL4416473	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in Sf1 cells using PolyGT-Biotin as substrate measured after 3 to 20 hrs by HTRF assay	B	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21		CHEMBL1079593	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	19319991	CHEMBL4417585	Inhibition of N-terminal GST tagged human JAK3 catalytic domain (795 to 1124 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	3.36	CHEMBL2148	Homo sapiens	INH	%	3.36
	19432834	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1		CHEMBL4463436	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	19432835	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1nccc(Nc2cc(N[C@@H]3CCN(c4ccc(C#N)cn4)C[C@@H]3F)c(C(N)=O)cn2)n1		CHEMBL4466236	=	IC50	nM	0.39	CHEMBL2148	Homo sapiens	IC50	nM	0.39
	19432836	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1nc2ccc(Nc3cc(NC4CCN(c5ccc(C#N)cn5)CC4)c(C(N)=O)cn3)cc2o1		CHEMBL4523034	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
	19432837	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1nc2cc(Nc3cc(NC4CCN(c5ccc(C#N)cn5)CC4)c(C(N)=O)cn3)ccc2o1		CHEMBL4476828	=	IC50	nM	22.0	CHEMBL2148	Homo sapiens	IC50	nM	22.0
	19432838	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)n1		CHEMBL4591633	=	IC50	nM	0.36	CHEMBL2148	Homo sapiens	IC50	nM	0.36
	19432839	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1cnc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)cn1		CHEMBL4471707	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	nM	1.1
	19432840	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	Cc1cncc(Nc2cc(NC3CCN(c4ccc(C#N)cn4)CC3)c(C(N)=O)cn2)n1		CHEMBL4470355	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	19432841	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CCC(Nc3cc(Nc4ccncn4)ncc3C(N)=O)CC2)nc1		CHEMBL4463043	=	IC50	nM	0.61	CHEMBL2148	Homo sapiens	IC50	nM	0.61
	19432842	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CCC(Nc3cc(Nc4cnccn4)ncc3C(N)=O)CC2)nc1		CHEMBL4454640	=	IC50	nM	0.72	CHEMBL2148	Homo sapiens	IC50	nM	0.72
	19432843	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CCC(Nc3cc(Nc4ccccn4)ncc3C(N)=O)CC2)nc1		CHEMBL4455068	=	IC50	nM	0.46	CHEMBL2148	Homo sapiens	IC50	nM	0.46
	19432844	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	NC(=O)c1cnc(N)cc1NCc1ccccc1		CHEMBL4583335	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19432845	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	CN(c1ccccc1)c1cc(NCc2ccccc2)c(C(N)=O)cn1		CHEMBL4579428	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	19432846	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1		CHEMBL4072239	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	nM	19.0
	19432847	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CCC(Nc3cc(Nc4ccccc4)ncc3C(N)=O)CC2)nc1		CHEMBL4474752	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	nM	18.0
	19432848	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	C[C@@H]1CCCC[C@@H]1Nc1cc(Nc2ccccc2)ncc1C(N)=O		CHEMBL4446468	=	IC50	nM	37.0	CHEMBL2148	Homo sapiens	IC50	nM	37.0
	19432849	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	19432850	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	N#Cc1ccc(N2CCC(Nc3c(C(N)=O)cnc4[nH]ccc34)CC2)nc1		CHEMBL3593771	=	IC50	nM	1.3	CHEMBL2148	Homo sapiens	IC50	nM	1.3
	19432851	CHEMBL4429526	Inhibition of human JAK3 assessed as reduction in phosphorylation of Biotin-Lyn-Substrate-2 after 1 hr in presence of ATP by ELISA	B	C[C@@H]1CCCC[C@@H]1Nc1c(C(N)=O)cnc2[nH]ccc12		CHEMBL3593761	=	IC50	nM	5.1	CHEMBL2148	Homo sapiens	IC50	nM	5.1
	19432890	CHEMBL4429532	Inhibition of human JAK3 assessed as phosphorylation of Biotin-Lyn-Substrate-2 at 1 uM after 1 hr in presence of ATP by ELISA	B	NC(=O)c1cnc(N)cc1NCc1ccccc1		CHEMBL4583335	=	Inhibition	%	41.0	CHEMBL2148	Homo sapiens	INH	%	41.0
	19432891	CHEMBL4429532	Inhibition of human JAK3 assessed as phosphorylation of Biotin-Lyn-Substrate-2 at 1 uM after 1 hr in presence of ATP by ELISA	B	CN(c1ccccc1)c1cc(NCc2ccccc2)c(C(N)=O)cn1		CHEMBL4579428	=	Inhibition	%	40.0	CHEMBL2148	Homo sapiens	INH	%	40.0
	19433335	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(C)nc1-c1ncnc2[nH]ccc12		CHEMBL4438079	=	Inhibition	%	1.6	CHEMBL2148	Homo sapiens	INH	%	1.6
	19433336	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1ccc(-c2nn(C)nc2-c2ncnc3[nH]ccc23)cc1		CHEMBL4450532	=	Inhibition	%	4.1	CHEMBL2148	Homo sapiens	INH	%	4.1
	19433337	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=Cn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4441918	=	Inhibition	%	-8.7	CHEMBL2148	Homo sapiens	INH	%	-8.7
	19433338	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=CCn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4447949	=	Inhibition	%	1.3	CHEMBL2148	Homo sapiens	INH	%	1.3
	19433339	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=C(C)Cn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4474787	=	Inhibition	%	15.6	CHEMBL2148	Homo sapiens	INH	%	15.6
	19433340	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	CC(C)=CCn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4467032	=	Inhibition	%	-4.3	CHEMBL2148	Homo sapiens	INH	%	-4.3
	19433341	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCN)nc1-c1ncnc2[nH]ccc12		CHEMBL4447208	=	Inhibition	%	4.8	CHEMBL2148	Homo sapiens	INH	%	4.8
	19433342	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCNC(=O)OC(C)(C)C)nc1-c1ncnc2[nH]ccc12		CHEMBL4583811	=	Inhibition	%	-3.7	CHEMBL2148	Homo sapiens	INH	%	-3.7
	19433343	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	COCCn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4459730	=	Inhibition	%	8.3	CHEMBL2148	Homo sapiens	INH	%	8.3
	19433344	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	COCCn1nc(-c2ccc(C)cc2)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4558149	=	Inhibition	%	7.1	CHEMBL2148	Homo sapiens	INH	%	7.1
	19433345	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCC(F)(F)F)nc1-c1ncnc2[nH]ccc12		CHEMBL4537821	=	Inhibition	%	10.8	CHEMBL2148	Homo sapiens	INH	%	10.8
	19433346	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCO)nc1-c1ncnc2[nH]ccc12		CHEMBL4473540	=	Inhibition	%	20.2	CHEMBL2148	Homo sapiens	INH	%	20.2
	19433347	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCCCO)nc1-c1ncnc2[nH]ccc12		CHEMBL4454716	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	19433348	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	CCOC(=O)CCCCn1nc(C)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4454734	=	Inhibition	%	-9.0	CHEMBL2148	Homo sapiens	INH	%	-9.0
	19433349	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCC#N)nc1-c1ncnc2[nH]ccc12		CHEMBL4445037	=	Inhibition	%	51.1	CHEMBL2148	Homo sapiens	INH	%	51.1
	19433369	CHEMBL4429699	Inhibition of JAK3 (unknown origin) measured after 1 hr in presence of ATP by TR-FRET assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	19433370	CHEMBL4429699	Inhibition of JAK3 (unknown origin) measured after 1 hr in presence of ATP by TR-FRET assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	IC50	nM	428.0	CHEMBL2148	Homo sapiens	IC50	nM	428.0
	19433375	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCCC#N)nc1-c1ncnc2[nH]ccc12		CHEMBL4475579	=	Inhibition	%	14.7	CHEMBL2148	Homo sapiens	INH	%	14.7
	19433376	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	N#CCCCCn1nc(-c2ccccc2)c(-c2ncnc3[nH]ccc23)n1		CHEMBL4472372	=	Inhibition	%	-1.1	CHEMBL2148	Homo sapiens	INH	%	-1.1
	19433377	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1ccc(-c2nn(CCCCC#N)nc2-c2ncnc3[nH]ccc23)cc1		CHEMBL4567693	=	Inhibition	%	1.2	CHEMBL2148	Homo sapiens	INH	%	1.2
	19433378	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCCCC#N)nc1-c1ncnc2[nH]ccc12		CHEMBL4458964	=	Inhibition	%	6.4	CHEMBL2148	Homo sapiens	INH	%	6.4
	19433379	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CC2CC2)nc1-c1ncnc2[nH]ccc12		CHEMBL4564551	=	Inhibition	%	21.6	CHEMBL2148	Homo sapiens	INH	%	21.6
	19433380	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CC2CCC2)nc1-c1ncnc2[nH]ccc12		CHEMBL4460736	=	Inhibition	%	22.5	CHEMBL2148	Homo sapiens	INH	%	22.5
	19433381	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CC2CCCC2)nc1-c1ncnc2[nH]ccc12		CHEMBL4518995	=	Inhibition	%	11.1	CHEMBL2148	Homo sapiens	INH	%	11.1
	19433382	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CC2CCCCC2)nc1-c1ncnc2[nH]ccc12		CHEMBL4472653	=	Inhibition	%	6.7	CHEMBL2148	Homo sapiens	INH	%	6.7
	19433401	CHEMBL4429699	Inhibition of JAK3 (unknown origin) measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CCCC#N)nc1-c1ncnc2[nH]ccc12		CHEMBL4445037	=	IC50	nM	1760.0	CHEMBL2148	Homo sapiens	IC50	nM	1760.0
	19433402	CHEMBL4429699	Inhibition of JAK3 (unknown origin) measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nn(CC2CC2)nc1-c1ncnc2[nH]ccc12		CHEMBL4564551	=	IC50	nM	2440.0	CHEMBL2148	Homo sapiens	IC50	nM	2440.0
	19433466	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1[nH]nnc1-c1ncnc2[nH]ccc12		CHEMBL4532636	=	Inhibition	%	2.2	CHEMBL2148	Homo sapiens	INH	%	2.2
	19433467	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1nnn(C)c1-c1ncnc2[nH]ccc12		CHEMBL4440844	=	Inhibition	%	-0.9	CHEMBL2148	Homo sapiens	INH	%	-0.9
	19433468	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1ccc(-c2nnn(C)c2-c2ncnc3[nH]ccc23)cc1		CHEMBL4469972	=	Inhibition	%	-4.4	CHEMBL2148	Homo sapiens	INH	%	-4.4
	19433469	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	COCCn1nnc(-c2ccc(C)cc2)c1-c1ncnc2[nH]ccc12		CHEMBL4530600	=	Inhibition	%	-3.8	CHEMBL2148	Homo sapiens	INH	%	-3.8
	19433470	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1C		CHEMBL4446204	=	Inhibition	%	6.1	CHEMBL2148	Homo sapiens	INH	%	6.1
	19433471	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1ccc(-c2c(-c3ncnc4[nH]ccc34)nnn2C)cc1		CHEMBL4445873	=	Inhibition	%	1.6	CHEMBL2148	Homo sapiens	INH	%	1.6
	19433472	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=Cn1nnc(-c2ncnc3[nH]ccc23)c1C	Outside typical range	CHEMBL4447425	=	Inhibition	%	-11.2	CHEMBL2148	Homo sapiens	INH	%	-11.2
	19433473	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=CCn1nnc(-c2ncnc3[nH]ccc23)c1C	Outside typical range	CHEMBL4573830	=	Inhibition	%	-11.6	CHEMBL2148	Homo sapiens	INH	%	-11.6
	19433474	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	C=C(C)Cn1nnc(-c2ncnc3[nH]ccc23)c1C		CHEMBL4547424	=	Inhibition	%	8.2	CHEMBL2148	Homo sapiens	INH	%	8.2
	19433475	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	CC(C)=CCn1nnc(-c2ncnc3[nH]ccc23)c1C		CHEMBL4445470	=	Inhibition	%	-6.9	CHEMBL2148	Homo sapiens	INH	%	-6.9
	19433476	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCN		CHEMBL4439087	=	Inhibition	%	13.0	CHEMBL2148	Homo sapiens	INH	%	13.0
	19433477	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	COCCn1nnc(-c2ncnc3[nH]ccc23)c1C		CHEMBL4573417	=	Inhibition	%	-7.6	CHEMBL2148	Homo sapiens	INH	%	-7.6
	19433478	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	COCCn1nnc(-c2ncnc3[nH]ccc23)c1-c1ccc(C)cc1		CHEMBL4566370	=	Inhibition	%	0.5	CHEMBL2148	Homo sapiens	INH	%	0.5
	19433479	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCC(F)(F)F		CHEMBL4436389	=	Inhibition	%	2.1	CHEMBL2148	Homo sapiens	INH	%	2.1
	19433480	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCO		CHEMBL4546704	=	Inhibition	%	-7.1	CHEMBL2148	Homo sapiens	INH	%	-7.1
	19433481	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCCCO		CHEMBL4453540	=	Inhibition	%	1.3	CHEMBL2148	Homo sapiens	INH	%	1.3
	19433482	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCC#N		CHEMBL4458883	=	Inhibition	%	-0.2	CHEMBL2148	Homo sapiens	INH	%	-0.2
	19433483	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCCC#N		CHEMBL4519083	=	Inhibition	%	-6.3	CHEMBL2148	Homo sapiens	INH	%	-6.3
	19433484	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	N#CCCCCn1nnc(-c2ncnc3[nH]ccc23)c1-c1ccccc1		CHEMBL4472309	=	Inhibition	%	-3.19	CHEMBL2148	Homo sapiens	INH	%	-3.19
	19433485	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1ccc(-c2c(-c3ncnc4[nH]ccc34)nnn2CCCCC#N)cc1		CHEMBL4575369	=	Inhibition	%	3.0	CHEMBL2148	Homo sapiens	INH	%	3.0
	19433486	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CCCCCC#N		CHEMBL4567271	=	Inhibition	%	-4.7	CHEMBL2148	Homo sapiens	INH	%	-4.7
	19433487	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CC1CC1		CHEMBL4466875	=	Inhibition	%	-2.6	CHEMBL2148	Homo sapiens	INH	%	-2.6
	19433488	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CC1CCC1		CHEMBL4576209	=	Inhibition	%	5.6	CHEMBL2148	Homo sapiens	INH	%	5.6
	19433489	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CC1CCCC1		CHEMBL4536384	=	Inhibition	%	3.4	CHEMBL2148	Homo sapiens	INH	%	3.4
	19433490	CHEMBL4429698	Inhibition of JAK3 (unknown origin) at 1 uM measured after 1 hr in presence of ATP by TR-FRET assay	B	Cc1c(-c2ncnc3[nH]ccc23)nnn1CC1CCCCC1		CHEMBL4536348	=	Inhibition	%	6.1	CHEMBL2148	Homo sapiens	INH	%	6.1
	19440081	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccccc1Nc1nc(Nc2cn[nH]c2)ncc1Cl		CHEMBL4459309	=	Inhibition	%	78.0	CHEMBL2148	Homo sapiens	INH	%	78.0
	19440082	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	COc1ccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)cc1		CHEMBL4476622	=	Inhibition	%	8.0	CHEMBL2148	Homo sapiens	INH	%	8.0
	19440083	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Fc1ccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)cc1		CHEMBL4439885	=	Inhibition	%	65.0	CHEMBL2148	Homo sapiens	INH	%	65.0
	19440084	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1cnc(Nc2cn[nH]c2)nc1Nc1ccccc1		CHEMBL4537769	=	Inhibition	%	44.0	CHEMBL2148	Homo sapiens	INH	%	44.0
	19440085	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)cc1		CHEMBL4474915	=	Inhibition	%	44.0	CHEMBL2148	Homo sapiens	INH	%	44.0
	19440086	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccccc1CNc1nc(Nc2cn[nH]c2)nc2[nH]ccc12		CHEMBL4483021	=	Inhibition	%	31.0	CHEMBL2148	Homo sapiens	INH	%	31.0
	19440087	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	COc1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4442977	=	Inhibition	%	39.0	CHEMBL2148	Homo sapiens	INH	%	39.0
	19440088	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	c1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4448847	=	Inhibition	%	48.0	CHEMBL2148	Homo sapiens	INH	%	48.0
	19440089	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4460646	=	Inhibition	%	19.0	CHEMBL2148	Homo sapiens	INH	%	19.0
	19440138	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	Inhibition	%	79.0	CHEMBL2148	Homo sapiens	INH	%	79.0
	19440139	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccc(Nc2ccnc(Nc3cn[nH]c3)n2)cc1	Outside typical range	CHEMBL4439293	=	Inhibition	%	-35.0	CHEMBL2148	Homo sapiens	INH	%	-35.0
	19440140	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccccc1Nc1ccnc(Nc2cn[nH]c2)n1		CHEMBL4591502	=	Inhibition	%	19.0	CHEMBL2148	Homo sapiens	INH	%	19.0
	19440141	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	N#Cc1ccccc1Nc1ccnc(Nc2cn[nH]c2)n1		CHEMBL4589723	=	Inhibition	%	20.0	CHEMBL2148	Homo sapiens	INH	%	20.0
	19440142	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	C#Cc1cccc(Nc2ccnc(Nc3cn[nH]c3)n2)c1		CHEMBL4550429	=	Inhibition	%	6.0	CHEMBL2148	Homo sapiens	INH	%	6.0
	19440143	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Fc1cnc(Nc2cn[nH]c2)nc1Nc1ccc(Cl)cc1		CHEMBL4555319	=	Inhibition	%	26.0	CHEMBL2148	Homo sapiens	INH	%	26.0
	19440144	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Fc1cnc(Nc2cn[nH]c2)nc1Nc1ccccc1		CHEMBL4546594	=	Inhibition	%	20.0	CHEMBL2148	Homo sapiens	INH	%	20.0
	19440145	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	COc1ccc(Nc2nc(Nc3cn[nH]c3)ncc2F)cc1	Outside typical range	CHEMBL4575013	=	Inhibition	%	-25.0	CHEMBL2148	Homo sapiens	INH	%	-25.0
	19440146	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccc(Nc2nc(Nc3cn[nH]c3)nc3ccccc23)cc1		CHEMBL4542644	=	Inhibition	%	2.0	CHEMBL2148	Homo sapiens	INH	%	2.0
	19440147	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	c1ccc(Nc2nc(Nc3cn[nH]c3)nc3ccccc23)cc1		CHEMBL4520551	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	19440148	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	COc1ccc(Nc2nc(Nc3cn[nH]c3)nc3ccccc23)cc1		CHEMBL4587058	=	Inhibition	%	-6.0	CHEMBL2148	Homo sapiens	INH	%	-6.0
	19440149	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)nc3ccccc23)c1	Outside typical range	CHEMBL4583672	=	Inhibition	%	-41.0	CHEMBL2148	Homo sapiens	INH	%	-41.0
	19440150	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	C#Cc1cccc(Nc2nc(Nc3cn[nH]c3)nc3ccccc23)c1	Outside typical range	CHEMBL4461225	=	Inhibition	%	-14.0	CHEMBL2148	Homo sapiens	INH	%	-14.0
	19440151	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	Clc1ccccc1CNc1nc(Nc2cn[nH]c2)nc2ccccc12		CHEMBL4453510	=	Inhibition	%	12.0	CHEMBL2148	Homo sapiens	INH	%	12.0
	19440152	CHEMBL4431264	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate at 20 nM by LANCE assay relative to control	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	19440157	CHEMBL4431267	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate by LANCE assay	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
	19440158	CHEMBL4431267	Inhibition of human recombinant JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate by LANCE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	19453555	CHEMBL4434408	Inhibition of human recombinant GST tagged JAK3 kinase domain (781 to 1124 amino acids) expressed in insect cells in presence of ATP	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	19472025	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NP(=O)(CC)CC)c2cn[nH]c2c1		CHEMBL4483484	=	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	pIC50		6.0
	19472026	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)N(C)C)c2cn[nH]c2c1		CHEMBL4534573	=	IC50	nM	3.162	CHEMBL2148	Homo sapiens	pIC50		8.5
	19472027	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2cccnc2)c2cn[nH]c2c1		CHEMBL4563039	=	IC50	nM	5.012	CHEMBL2148	Homo sapiens	pIC50		8.3
	19472028	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2ccccn2)c2cn[nH]c2c1		CHEMBL4528395	=	IC50	nM	1.995	CHEMBL2148	Homo sapiens	pIC50		8.7
	19472029	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2ccccc2Cl)c2cn[nH]c2c1		CHEMBL4560212	=	IC50	nM	3.162	CHEMBL2148	Homo sapiens	pIC50		8.5
	19472030	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCN2CCN(C)CC2)c2cn[nH]c2c1		CHEMBL4535413	=	IC50	nM	63.1	CHEMBL2148	Homo sapiens	pIC50		7.2
	19472031	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCN2CCCCC2)c2cn[nH]c2c1		CHEMBL4529314	=	IC50	nM	31.62	CHEMBL2148	Homo sapiens	pIC50		7.5
	19472032	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCC(=O)OC)c2cn[nH]c2c1		CHEMBL4483513	=	IC50	nM	3.162	CHEMBL2148	Homo sapiens	pIC50		8.5
	19472033	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCOC)c2cn[nH]c2c1		CHEMBL4569613	=	IC50	nM	3.981	CHEMBL2148	Homo sapiens	pIC50		8.4
	19472034	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CCO)c2cn[nH]c2c1		CHEMBL4543715	=	IC50	nM	6.31	CHEMBL2148	Homo sapiens	pIC50		8.2
	19472035	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C(F)(F)F)c2cn[nH]c2c1		CHEMBL4522317	=	IC50	nM	25.12	CHEMBL2148	Homo sapiens	pIC50		7.6
	19472036	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C2CCCC2)c2cn[nH]c2c1		CHEMBL4521312	=	IC50	nM	3.981	CHEMBL2148	Homo sapiens	pIC50		8.4
	19472037	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CC2CCC2)c2cn[nH]c2c1		CHEMBL4580425	=	IC50	nM	3.981	CHEMBL2148	Homo sapiens	pIC50		8.4
	19472038	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C2CC2)c2cn[nH]c2c1		CHEMBL4554460	=	IC50	nM	3.162	CHEMBL2148	Homo sapiens	pIC50		8.5
	19472039	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)C(C)C)c2cn[nH]c2c1		CHEMBL4517645	=	IC50	nM	2.512	CHEMBL2148	Homo sapiens	pIC50		8.6
	19472040	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(N(C)S(C)(=O)=O)c2cn[nH]c2c1		CHEMBL4544386	=	IC50	nM	31.62	CHEMBL2148	Homo sapiens	pIC50		7.5
	19472041	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)CC)c2cn[nH]c2c1		CHEMBL4483364	=	IC50	nM	2.512	CHEMBL2148	Homo sapiens	pIC50		8.6
	19472042	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)c(F)cc1-c1cc(NS(C)(=O)=O)c2cn[nH]c2c1		CHEMBL4539949	=	IC50	nM	2.512	CHEMBL2148	Homo sapiens	pIC50		8.6
	19472043	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2c(C)cc(O)cc2C)cc2[nH]ncc12		CHEMBL4577685	=	IC50	nM	2511.89	CHEMBL2148	Homo sapiens	pIC50		5.6
	19472044	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)c(OC)c2)cc2[nH]ncc12		CHEMBL4564318	=	IC50	nM	251.19	CHEMBL2148	Homo sapiens	pIC50		6.6
	19472045	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)c(F)c2)cc2[nH]ncc12		CHEMBL4516561	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	pIC50		8.0
	19472046	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)c(Cl)c2)cc2[nH]ncc12		CHEMBL4518744	=	IC50	nM	12.59	CHEMBL2148	Homo sapiens	pIC50		7.9
	19472047	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)c(C)c2)cc2[nH]ncc12		CHEMBL4551312	=	IC50	nM	63.1	CHEMBL2148	Homo sapiens	pIC50		7.2
	19472048	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2Cl)cc2[nH]ncc12		CHEMBL4589842	=	IC50	nM	15.85	CHEMBL2148	Homo sapiens	pIC50		7.8
	19472049	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCc1cc(O)ccc1-c1cc(NS(=O)(=O)CC)c2cn[nH]c2c1		CHEMBL4551061	=	IC50	nM	7.943	CHEMBL2148	Homo sapiens	pIC50		8.1
	19472050	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2C)cc2[nH]ncc12		CHEMBL4567992	=	IC50	nM	25.12	CHEMBL2148	Homo sapiens	pIC50		7.6
	19472051	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CCS(=O)(=O)Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12		CHEMBL4531121	=	IC50	nM	7.943	CHEMBL2148	Homo sapiens	pIC50		8.1
	19472052	CHEMBL4478763	Inhibition of human His-tagged JAK3 expressed in baculovirus using biotin-synthetic peptide as substrate after 20 mins by HTRF assay	B	CS(=O)(=O)Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12		CHEMBL4567359	=	IC50	nM	12.59	CHEMBL2148	Homo sapiens	pIC50		7.9
	19474682	CHEMBL4479371	Inhibition of JAK3 (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	pIC50		5.0
	19476588	CHEMBL4479736	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
	19476688	CHEMBL4479736	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	430.0	CHEMBL2148	Homo sapiens	IC50	nM	430.0
	19476788	CHEMBL4479736	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	19476888	CHEMBL4479736	Inhibition of recombinant human GST-tagged JAK3 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	1300.0	CHEMBL2148	Homo sapiens	IC50	nM	1300.0
	19485876	CHEMBL4481544	Inhibition of JAK3 (unknown origin) at 1 uM by proQinase-based assay relative to control	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(-c4ccc(C(C)=O)cc4)nn3)c3c(N)ncnc32)C1		CHEMBL4581088	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	19489424	CHEMBL4482005	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	33.1	CHEMBL2148	Homo sapiens	IC50	nM	33.1
	19489425	CHEMBL4482006	Inhibition of human GST-tagged JAK3 using FITC-KGGEEEEYFELVKK as substrate by fluorescence assay	B	CCC(=O)N1CCC(c2ccc(Nc3cc(NCc4cccc(-c5ccncc5)c4)c(C(N)=O)cn3)cc2)CC1		CHEMBL4584430	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	19489427	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncn2)c1		CHEMBL4587735	=	IC50	nM	730.0	CHEMBL2148	Homo sapiens	IC50	nM	730.0
	19489428	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(F)cc3)ncn2)c1		CHEMBL4556768	=	IC50	nM	589.0	CHEMBL2148	Homo sapiens	IC50	nM	589.0
	19489429	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(C)c3)ncn2)c1		CHEMBL4539137	=	IC50	nM	12.3	CHEMBL2148	Homo sapiens	IC50	nM	12.3
	19489430	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(C)c3)ncn2)cc1		CHEMBL4526018	=	IC50	nM	24.1	CHEMBL2148	Homo sapiens	IC50	nM	24.1
	19489431	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(CCO)c3)ncn2)c1		CHEMBL4572373	=	IC50	nM	7.2	CHEMBL2148	Homo sapiens	IC50	nM	7.2
	19489432	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(CCO)c3)ncn2)cc1		CHEMBL4541547	=	IC50	nM	9.4	CHEMBL2148	Homo sapiens	IC50	nM	9.4
	19489433	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3cnn(CCOC)c3)ncn2)c1		CHEMBL4574614	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	nM	7.0
	19489434	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1ccc(CNc2cc(Nc3cnn(CCOC)c3)ncn2)cc1		CHEMBL4593058	=	IC50	nM	9.3	CHEMBL2148	Homo sapiens	IC50	nM	9.3
	19489435	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4573218	=	IC50	nM	2.4	CHEMBL2148	Homo sapiens	IC50	nM	2.4
	19489436	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4566849	=	IC50	nM	8.4	CHEMBL2148	Homo sapiens	IC50	nM	8.4
	19489437	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL3601722	=	IC50	nM	2.1	CHEMBL2148	Homo sapiens	IC50	nM	2.1
	19489438	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C=CC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4577029	=	IC50	nM	7.9	CHEMBL2148	Homo sapiens	IC50	nM	7.9
	19489439	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.7	CHEMBL2148	Homo sapiens	IC50	nM	0.7
	19489440	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C/C=C/C(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL4566777	=	IC50	nM	89.0	CHEMBL2148	Homo sapiens	IC50	nM	89.0
	19489441	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CCC(=O)Nc1cccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL4537782	=	IC50	nM	212.0	CHEMBL2148	Homo sapiens	IC50	nM	212.0
	19489442	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CN1CCN(c2ccc(Nc3cc(NCc4cccc(NC(=O)CC#N)c4)ncn3)cc2)CC1		CHEMBL4546009	=	IC50	nM	3.5	CHEMBL2148	Homo sapiens	IC50	nM	3.5
	19489443	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CN1CCN(c2ccc(Nc3cc(NCc4cccc(NC#N)c4)ncn3)cc2)CC1		CHEMBL4581532	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489444	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4588496	=	IC50	nM	101.0	CHEMBL2148	Homo sapiens	IC50	nM	101.0
	19489445	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4521305	=	IC50	nM	290.0	CHEMBL2148	Homo sapiens	IC50	nM	290.0
	19489446	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CN1CCN(c2ccc(Nc3cc(NCc4ccc(NC(=O)CC#N)cc4)ncn3)cc2)CC1		CHEMBL4555932	=	IC50	nM	155.0	CHEMBL2148	Homo sapiens	IC50	nM	155.0
	19489447	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CN1CCN(c2ccc(Nc3cc(NCc4ccc(NC#N)cc4)ncn3)cc2)CC1		CHEMBL4524497	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489448	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4560222	=	IC50	nM	99.0	CHEMBL2148	Homo sapiens	IC50	nM	99.0
	19489449	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4528217	=	IC50	nM	278.0	CHEMBL2148	Homo sapiens	IC50	nM	278.0
	19489450	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	N#CCC(=O)Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4518786	=	IC50	nM	4.84	CHEMBL2148	Homo sapiens	IC50	nM	4.84
	19489451	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	N#CNc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4516549	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489452	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	O=C(Nc1cccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1)C(F)(F)F		CHEMBL4591192	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489453	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	O=C(Nc1ccc(CNc2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1)C(F)(F)F		CHEMBL4589415	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489454	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	COCCn1cc(Nc2cc(NCc3cccc(NC(=O)CC#N)c3)ncn2)cn1		CHEMBL4563864	=	IC50	nM	7.3	CHEMBL2148	Homo sapiens	IC50	nM	7.3
	19489455	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	COCCn1cc(Nc2cc(NCc3cccc(NC#N)c3)ncn2)cn1		CHEMBL4525246	>	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	nM	3000.0
	19489456	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C/C=C/C(=O)Nc1cccc(CNc2cc(Nc3cnn(C)c3)ncn2)c1		CHEMBL4552985	=	IC50	nM	342.0	CHEMBL2148	Homo sapiens	IC50	nM	342.0
	19489457	CHEMBL4482008	Inhibition of human JAK3 using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and further incubated for 30 mins and subsequently measured after 1 hr by HTRF assay	B	C/C=C/C(=O)Nc1ccc(CNc2cc(Nc3cnn(C)c3)ncn2)cc1		CHEMBL4571470	=	IC50	nM	389.0	CHEMBL2148	Homo sapiens	IC50	nM	389.0
	20599553	CHEMBL4603081	Inhibition of human JAK3 at 1 uM relative to control	B	Cn1nc2c3c(cc(-c4ccnc(N)n4)cc31)Oc1ccccc1N2		CHEMBL4638884	>	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	20600432	CHEMBL4603317	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	13660.0	CHEMBL2148	Homo sapiens	IC50	uM	13.66
	20601657	CHEMBL4603789	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using Tyr06 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	44.0	CHEMBL2148	Homo sapiens	INH	%	44.0
	20601683	CHEMBL4603815	Inhibition of JAK3 (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	IC50	nM	320.0	CHEMBL2148	Homo sapiens	IC50	nM	320.0
	20601684	CHEMBL4603815	Inhibition of JAK3 (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cc12		CHEMBL4639739	=	IC50	nM	447.0	CHEMBL2148	Homo sapiens	IC50	nM	447.0
	20631232	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc4c(c3)COB4O)ncc2OC)c1		CHEMBL4649397	=	IC50	nM	0.8	CHEMBL2148	Homo sapiens	IC50	nM	0.8
	20631237	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(B(O)O)cc3)ncc2C(F)(F)F)c1		CHEMBL4640647	=	IC50	nM	0.3	CHEMBL2148	Homo sapiens	IC50	nM	0.3
	20631243	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4(C)C)ncc2C(F)(F)F)c1		CHEMBL4645290	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	20631299	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	14.1	CHEMBL2148	Homo sapiens	IC50	nM	14.1
	20631300	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	8.5	CHEMBL2148	Homo sapiens	IC50	nM	8.5
	20631301	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	20.3	CHEMBL2148	Homo sapiens	IC50	nM	20.3
	20631302	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OCC4)ncc2C(F)(F)F)c1		CHEMBL4648104	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	nM	1.5
	20631303	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)COB4O)ncc2C(F)(F)F)c1		CHEMBL4642642	=	IC50	nM	0.4	CHEMBL2148	Homo sapiens	IC50	nM	0.4
	20631304	CHEMBL4610790	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system using Ulight-Poly GT as substrate incubated for 2 hrs by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)B(O)OC4)ncc2C(F)(F)F)c1		CHEMBL4648837	=	IC50	nM	0.5	CHEMBL2148	Homo sapiens	IC50	nM	0.5
	20638913	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc(-c3ccccc3)c12		CHEMBL4635464	=	IC50	nM	2600.0	CHEMBL2148	Homo sapiens	IC50	uM	2.6
	20638914	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc(C3CCCCC3)c12		CHEMBL4636371	=	IC50	nM	550.0	CHEMBL2148	Homo sapiens	IC50	uM	0.55
	20638915	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc(C3CCCC3)c12		CHEMBL4640335	=	IC50	nM	670.0	CHEMBL2148	Homo sapiens	IC50	uM	0.67
	20638916	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc(CC3CCC3)c12		CHEMBL4641076	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	uM	0.48
	20638917	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CCCC[C@H]3C)c12		CHEMBL4640521	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	uM	0.11
	20638918	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@H]4CC[C@@H]3C4)c12		CHEMBL4645613	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	uM	0.18
	20638919	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4CC[C@@H]3C4)c12		CHEMBL4636220	=	IC50	nM	240.0	CHEMBL2148	Homo sapiens	IC50	uM	0.24
	20638920	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc(C3CC4CCC3CC4)c12		CHEMBL4648612	=	IC50	nM	65.0	CHEMBL2148	Homo sapiens	IC50	uM	0.065
	20638921	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	O=c1cc(C2CCCCC2)c2c[nH]nc2[nH]1		CHEMBL4645113	=	IC50	nM	12000.0	CHEMBL2148	Homo sapiens	IC50	uM	12.0
	20638922	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	CCc1[nH]nc2[nH]c(=O)cc(C3CCCCC3)c12		CHEMBL4647966	=	IC50	nM	1600.0	CHEMBL2148	Homo sapiens	IC50	uM	1.6
	20638923	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	O=c1cc(C2CCCCC2)c2c(C3CC3)[nH]nc2[nH]1		CHEMBL4648246	=	IC50	nM	980.0	CHEMBL2148	Homo sapiens	IC50	uM	0.98
	20638924	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)c(CO)c(C3CCCCC3)c12		CHEMBL4638696	=	IC50	nM	1400.0	CHEMBL2148	Homo sapiens	IC50	uM	1.4
	20638925	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)c(CCO)c(C3CCCCC3)c12		CHEMBL4642546	=	IC50	nM	990.0	CHEMBL2148	Homo sapiens	IC50	uM	0.99
	20638926	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)c(C#N)c(C3CCCCC3)c12		CHEMBL4632980	=	IC50	nM	5400.0	CHEMBL2148	Homo sapiens	IC50	uM	5.4
	20638927	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.5	CHEMBL2148	Homo sapiens	IC50	uM	0.0015
	20638928	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC#N)CC3)c12		CHEMBL4645814	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	uM	0.27
	20638929	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CCC#N)CC3)c12		CHEMBL4640029	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	uM	0.28
	20638930	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](C#N)CC3)c12		CHEMBL4637596	=	IC50	nM	11000.0	CHEMBL2148	Homo sapiens	IC50	uM	11.0
	20638931	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)C4CC4)CC3)c12		CHEMBL4633028	=	IC50	nM	7000.0	CHEMBL2148	Homo sapiens	IC50	uM	7.0
	20638932	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](C(=O)NC4CC4)CC3)c12		CHEMBL4649054	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	uM	1.1
	20638933	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)C4CCCC4)CC3)c12		CHEMBL4632897	=	IC50	nM	4800.0	CHEMBL2148	Homo sapiens	IC50	uM	4.8
	20638934	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)[C@@H]4CC4(F)F)CC3)c12		CHEMBL4639973	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	uM	0.48
	20638935	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NC(=O)[C@H]4CC4(F)F)CC3)c12		CHEMBL4638953	=	IC50	nM	2700.0	CHEMBL2148	Homo sapiens	IC50	uM	2.7
	20638936	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](OC(=O)[C@@H]4CC4(F)F)CC3)c12		CHEMBL4632766	=	IC50	nM	91.0	CHEMBL2148	Homo sapiens	IC50	uM	0.091
	20638937	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NS(=O)(=O)C4CC4)CC3)c12		CHEMBL4638808	=	IC50	nM	6600.0	CHEMBL2148	Homo sapiens	IC50	uM	6.6
	20638938	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](NS(=O)(=O)CC4CCC4)CC3)c12		CHEMBL4639048	=	IC50	nM	1700.0	CHEMBL2148	Homo sapiens	IC50	uM	1.7
	20638939	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](N)CC3)c12		CHEMBL4636368	=	IC50	nM	11000.0	CHEMBL2148	Homo sapiens	IC50	uM	11.0
	20638940	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](O)CC3)c12		CHEMBL4647506	=	IC50	nM	1700.0	CHEMBL2148	Homo sapiens	IC50	uM	1.7
	20638941	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC(=O)N4CC(C#N)C4)CC3)c12		CHEMBL4647276	=	IC50	nM	97.0	CHEMBL2148	Homo sapiens	IC50	uM	0.097
	20638942	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC(=O)N4CCC(C#N)C4)CC3)c12		CHEMBL4638030	=	IC50	nM	150.0	CHEMBL2148	Homo sapiens	IC50	uM	0.15
	20638943	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC(=O)N4CC(Cc5ccccc5)C4)CC3)c12		CHEMBL4649484	=	IC50	nM	88.0	CHEMBL2148	Homo sapiens	IC50	uM	0.088
	20638944	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC(=O)N4CCC(c5ccccc5)C4)CC3)c12		CHEMBL4639606	=	IC50	nM	63.0	CHEMBL2148	Homo sapiens	IC50	uM	0.063
	20638945	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3CC[C@H](CC(=O)N4CCC(C)(C)CC4)CC3)c12		CHEMBL4636507	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	uM	0.057
	20638946	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@@H]4C[C@H]3C[C@H]4CC#N)c12		CHEMBL4647115	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	uM	0.42
	20638947	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4C[C@@H]3C[C@@H]4CC#N)c12		CHEMBL4643061	=	IC50	nM	88.0	CHEMBL2148	Homo sapiens	IC50	uM	0.088
	20638948	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@@H]3C[C@@H]4C[C@H]3C[C@@H]4CC#N)c12		CHEMBL4634289	=	IC50	nM	220.0	CHEMBL2148	Homo sapiens	IC50	uM	0.22
	20638949	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4C[C@@H]3C[C@H]4CC#N)c12		CHEMBL4648820	=	IC50	nM	970.0	CHEMBL2148	Homo sapiens	IC50	uM	0.97
	20638950	CHEMBL4612623	Inhibition of N-terminal His-tagged human JAK3 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	B	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1		CHEMBL3655081	=	IC50	nM	480.0	CHEMBL2148	Homo sapiens	IC50	uM	0.48
	20646794	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(SCCCN4CCOCC4)cc3)nc3ccsc23)c1		CHEMBL4645014	=	IC50	nM	46.0	CHEMBL2148	Homo sapiens	IC50	nM	46.0
	20646795	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OCCCN4CCOCC4)c(Cl)c3)nc3ccsc23)c1		CHEMBL4634992	=	IC50	nM	1.38	CHEMBL2148	Homo sapiens	IC50	nM	1.38
	20646796	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OCCCN4CCOCC4)cc3)nc3ccsc23)c1		CHEMBL4645703	=	IC50	nM	89.2	CHEMBL2148	Homo sapiens	IC50	nM	89.2
	20646797	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OCCN4CCOCC4)cc3)nc3ccsc23)c1		CHEMBL4649751	=	IC50	nM	90.8	CHEMBL2148	Homo sapiens	IC50	nM	90.8
	20646798	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(CN4CCOCC4)cc3)nc3ccsc23)c1		CHEMBL4637985	=	IC50	nM	85.3	CHEMBL2148	Homo sapiens	IC50	nM	85.3
	20646799	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCOCC4)cc3)nc3ccsc23)c1		CHEMBL4639986	=	IC50	nM	59.39	CHEMBL2148	Homo sapiens	IC50	nM	59.39
	20646803	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1		CHEMBL4163691	=	IC50	nM	14.6	CHEMBL2148	Homo sapiens	IC50	nM	14.6
	20646804	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	66.5	CHEMBL2148	Homo sapiens	IC50	nM	66.5
	20646805	CHEMBL4614396	Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	16.1	CHEMBL2148	Homo sapiens	IC50	nM	16.1
	20646837	CHEMBL4614413	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)CN4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4635399	<	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	nM	10.0
Not Active	20657777	CHEMBL4617592	Inhibition of human recombinant N-terminal His-tagged JAK3 (795 to 1124 residue) expressed in baculovirus infected Sf21 insect cells up to 100 uM using Srctide as substrate by mobility shift assay	B	C[C@H](O)c1cc2c(o1)C(=O)c1cccc(O)c1C2=O		CHEMBL392591		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	20657778	CHEMBL4617592	Inhibition of human recombinant N-terminal His-tagged JAK3 (795 to 1124 residue) expressed in baculovirus infected Sf21 insect cells up to 100 uM using Srctide as substrate by mobility shift assay	B	CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O		CHEMBL64130		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	20661621	CHEMBL4618353	Inhibition of human JAK3 using [GGEEEEYFELVKKKK] as substrate in presence of [gamma33P]ATP by hotspot assay	B	CC(O)(C#Cc1ccc(N2CCOCC2)c(Nc2ncnc3[nH]ccc23)c1)c1nccs1		CHEMBL4645565	=	IC50	nM	892.0	CHEMBL2148	Homo sapiens	IC50	nM	892.0
	20669594	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3CC4CCC(C3)N4C(=O)C3CC3)n2)cc1		CHEMBL4638206	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	20669595	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	O=C(C1CC1)N1C2CCC1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2		CHEMBL4640314	=	IC50	nM	2531.0	CHEMBL2148	Homo sapiens	IC50	nM	2531.0
	20669596	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	CCNC(=O)c1ccc(Nc2nccc(N3CC4CC(C3)N4C(=O)C3CC3)n2)cc1		CHEMBL4645039	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	20669597	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	O=C(N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2)C1CC1		CHEMBL4640981	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	20669598	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	O=C(N[C@]12C[C@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2)C1CC1		CHEMBL4635334	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	20669599	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)C1CC1		CHEMBL4647223	>	IC50	nM	8458.0	CHEMBL2148	Homo sapiens	IC50	nM	8458.0
	20669600	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	N#C[C@@H]1C[C@H]1C(=O)N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2		CHEMBL4644138	=	IC50	nM	949.0	CHEMBL2148	Homo sapiens	IC50	nM	949.0
	20669601	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	N#C[C@H]1C[C@@H]1C(=O)N[C@@]12C[C@@H]1CN(c1nc(Nc3cnn(CCO)c3)ncc1F)C2		CHEMBL4638906	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	20669602	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)[C@@H]1C[C@H]1C#N		CHEMBL4644578	=	IC50	nM	194.0	CHEMBL2148	Homo sapiens	IC50	nM	194.0
	20669603	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(CCO)c4)ncc3F)C[C@]12NC(=O)[C@H]1C[C@@H]1C#N		CHEMBL4637190	=	IC50	nM	2282.0	CHEMBL2148	Homo sapiens	IC50	nM	2282.0
	20669604	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1C[C@H]1C#N		CHEMBL4634433	=	IC50	nM	255.0	CHEMBL2148	Homo sapiens	IC50	nM	255.0
	20669605	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@H]1C[C@@H]1C#N		CHEMBL4648631	=	IC50	nM	3225.0	CHEMBL2148	Homo sapiens	IC50	nM	3225.0
	20669606	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F		CHEMBL4635625	=	IC50	nM	4267.0	CHEMBL2148	Homo sapiens	IC50	nM	4267.0
	20669607	CHEMBL4620432	Inhibition of human recombinant JAK3 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@H]1CC1(F)F		CHEMBL4635104	=	IC50	nM	4023.0	CHEMBL2148	Homo sapiens	IC50	nM	4023.0
	20669680	CHEMBL4620451	Inhibition of JAK3 (unknown origin) in presence of 1 mM ATP relative to control	B	C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F		CHEMBL4635625	=	Inhibition	%	16.0	CHEMBL2148	Homo sapiens	INH	%	16.0
	20687211	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	N#CCNC(=O)c1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL4642137	=	IC50	nM	1120.0	CHEMBL2148	Homo sapiens	IC50	nM	1120.0
	20687212	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(NCC(F)(F)F)c1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL4647737	=	IC50	nM	1015.0	CHEMBL2148	Homo sapiens	IC50	nM	1015.0
	20687213	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(-c3ccc(C(=O)N4CC(F)(F)C4)cc3)n2n1)C1CC1		CHEMBL4636613	=	IC50	nM	941.0	CHEMBL2148	Homo sapiens	IC50	nM	941.0
	20687214	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	N#CC1CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1		CHEMBL4641716	=	IC50	nM	659.0	CHEMBL2148	Homo sapiens	IC50	nM	659.0
	20687215	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(-c3ccc(C(=O)N4CCC(F)(F)CC4)cc3)n2n1)C1CC1		CHEMBL4636144	=	IC50	nM	923.0	CHEMBL2148	Homo sapiens	IC50	nM	923.0
	20687216	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	C=C(C#N)C(O)c1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL4644662	=	IC50	nM	285.0	CHEMBL2148	Homo sapiens	IC50	nM	285.0
	20687217	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	N#CCC(=O)N1CC=C(c2cccc3nc(NC(=O)C4CC4)nn23)CC1		CHEMBL4643764	=	IC50	nM	1640.0	CHEMBL2148	Homo sapiens	IC50	nM	1640.0
	20687218	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	N#CCNC(=O)N1CC=C(c2cccc3nc(NC(=O)C4CC4)nn23)CC1		CHEMBL4636957	=	IC50	nM	983.0	CHEMBL2148	Homo sapiens	IC50	nM	983.0
	20687219	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(C3=CCN(C(=O)NCC(F)(F)F)CC3)n2n1)C1CC1		CHEMBL4640289	=	IC50	nM	1740.0	CHEMBL2148	Homo sapiens	IC50	nM	1740.0
	20687220	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(C3=CCN(C(=O)C4CC4(F)F)CC3)n2n1)C1CC1		CHEMBL4641565	=	IC50	nM	2409.0	CHEMBL2148	Homo sapiens	IC50	nM	2409.0
	20687221	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	C=CC(=O)N1CC=C(c2cccc3nc(NC(=O)C4CC4)nn23)CC1		CHEMBL4636334	=	IC50	nM	2767.0	CHEMBL2148	Homo sapiens	IC50	nM	2767.0
	20687222	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	N#CC1(C(=O)N2CC=C(c3cccc4nc(NC(=O)C5CC5)nn34)CC2)CC1		CHEMBL4640450	=	IC50	nM	1547.0	CHEMBL2148	Homo sapiens	IC50	nM	1547.0
	20687223	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(C3=CCN(C(=O)C4(C(F)(F)F)CC4)CC3)n2n1)C1CC1		CHEMBL4633694	=	IC50	nM	5649.0	CHEMBL2148	Homo sapiens	IC50	nM	5649.0
	20687224	CHEMBL4624517	Inhibition of JAK3 (unknown origin) in presence of ATP at Km concentration by caliper assay	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	623.0	CHEMBL2148	Homo sapiens	IC50	nM	623.0
	20687233	CHEMBL4624522	Inhibition of JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as antiproliferative activity by cell-based assay	B	N#CC1CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1		CHEMBL4641716	>	IC50	nM	30000.0	CHEMBL2148	Homo sapiens	IC50	uM	30.0
	20687234	CHEMBL4624522	Inhibition of JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as antiproliferative activity by cell-based assay	B	C=C(C#N)C(O)c1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL4644662	=	IC50	nM	7050.0	CHEMBL2148	Homo sapiens	IC50	uM	7.05
	20687235	CHEMBL4624522	Inhibition of JAK3 (unknown origin) expressed in mouse BAF3 cells assessed as antiproliferative activity by cell-based assay	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	13260.0	CHEMBL2148	Homo sapiens	IC50	uM	13.26
	20702264	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCc1cccc(n1)Nc1cc2ccn1		CHEMBL4637587	=	IC50	nM	1900.0	CHEMBL2148	Homo sapiens	IC50	nM	1900.0
	20702265	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCc1cccc(n1)Nc1cc2ccn1		CHEMBL4645258	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	nM	130.0
	20702266	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCC(=O)NCCCc1cccc(n1)Nc1cc2ccn1		CHEMBL4641006	=	IC50	nM	43.0	CHEMBL2148	Homo sapiens	IC50	nM	43.0
	20702267	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C/COCc1cccc(n1)Nc1cc2ccn1		CHEMBL4645110	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	nM	180.0
	20702268	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COC/C=C\COCc1cccc(n1)Nc1cc2ccn1		CHEMBL4643899	=	IC50	nM	270.0	CHEMBL2148	Homo sapiens	IC50	nM	270.0
	20702269	CHEMBL4627622	Inhibition of JAK3 (unknown origin)	B	N#C[C@]1(C2CC2)C(=O)N2C[C@H]1COCCCCOCc1cccc(n1)Nc1cc2ccn1		CHEMBL4643392	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
	20702909	CHEMBL4627717	Inhibition of JAK3 (unknown origin)	B	OCCn1cc(Nc2ncc(Cl)c(NCc3cc(F)ccc3F)n2)cn1		CHEMBL4635876	=	IC50	nM	1.0	CHEMBL2148	Homo sapiens	pIC50		9.0
	20702910	CHEMBL4627717	Inhibition of JAK3 (unknown origin)	B	COc1cc(-c2cnc3cccc(-c4cc(F)c(CN5CCS(=O)(=O)CC5)c(F)c4)c3n2)ccc1OCCCN1CCOCC1		CHEMBL4634979	=	IC50	nM	7.943	CHEMBL2148	Homo sapiens	pIC50		8.1
	20707492	CHEMBL4628506	Inhibition of JAK3 (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL4634591	=	IC50	nM	228.0	CHEMBL2148	Homo sapiens	IC50	uM	0.228
	20707493	CHEMBL4628506	Inhibition of JAK3 (unknown origin)	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc([S+]([O-])NC(C)(C)C)c1		CHEMBL4637972	=	IC50	nM	263.0	CHEMBL2148	Homo sapiens	IC50	uM	0.263
	20714727	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	1.1	CHEMBL2148	Homo sapiens	IC50	uM	0.0011
	20714728	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ncnc2[nH]ccc12)C1CCCCC1		CHEMBL1630770	=	IC50	nM	79.0	CHEMBL2148	Homo sapiens	IC50	uM	0.079
	20714729	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ncnc2ccccc12)C1CCCCC1		CHEMBL4635905	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714730	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ccnc2ccccc12)C1CCCCC1.Cl		CHEMBL4632930	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714731	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1c(C(N)=O)cnc2[nH]ncc12)C1CCCCC1		CHEMBL4644838	=	IC50	nM	3000.0	CHEMBL2148	Homo sapiens	IC50	uM	3.0
	20714732	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC(=O)Nc1cc(N(C)C2CCCCC2)ncn1		CHEMBL4641433	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714733	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CNc1cc(N(C)C2CCCCC2)ncn1		CHEMBL4636726	=	IC50	nM	5000.0	CHEMBL2148	Homo sapiens	IC50	uM	5.0
	20714734	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1cc(NC2CC2)ncn1)C1CCCCC1		CHEMBL4632573	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714735	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1cc(Nc2ccccn2)ncn1)C1CCCCC1		CHEMBL4634530	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714736	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ccnc(Nc2ccccc2)n1)C1CCCCC1		CHEMBL4639875	=	IC50	nM	1800.0	CHEMBL2148	Homo sapiens	IC50	uM	1.8
	20714737	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C1CCCCC1)C1CCNC(=O)C1		CHEMBL4637223	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714738	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C1CCCCC1)C1CNC(=O)C1.Cl		CHEMBL4643597	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714739	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C1CCCCC1)C1CCOCC1		CHEMBL4646425	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	20714740	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ccnc(Nc2ccc(CO)cc2)n1)C1CCCCC1		CHEMBL4649366	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	uM	0.41
	20714741	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ccnc(Nc2ccc(C(=O)O)cc2)n1)C1CCCCC1		CHEMBL4644221	=	IC50	nM	73.0	CHEMBL2148	Homo sapiens	IC50	uM	0.073
	20714742	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1ccnc(Nc2ccc(C(N)=O)cc2)n1)C1CCCCC1		CHEMBL4639538	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	uM	0.11
	20714743	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C)C(=O)c1ccc(Nc2nccc(N(C)C3CCCCC3)n2)cc1		CHEMBL4636510	=	IC50	nM	210.0	CHEMBL2148	Homo sapiens	IC50	uM	0.21
	20714744	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	Cc1cnc(Nc2ccc(C(N)=O)cc2)nc1N(C)C1CCCCC1		CHEMBL4639774	=	IC50	nM	44.0	CHEMBL2148	Homo sapiens	IC50	uM	0.044
	20714745	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CCc1cnc(Nc2ccc(C(N)=O)cc2)nc1N(C)C1CCCCC1		CHEMBL4641927	=	IC50	nM	790.0	CHEMBL2148	Homo sapiens	IC50	uM	0.79
	20714746	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(c1nc(Nc2ccc(C(N)=O)cc2)ncc1C(F)(F)F)C1CCCCC1		CHEMBL4640920	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	uM	0.077
	20714747	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	NC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N3CCCC3)n2)cc1		CHEMBL4634866	=	IC50	nM	110.0	CHEMBL2148	Homo sapiens	IC50	uM	0.11
	20714748	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	NC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N3CCCCC3)n2)cc1		CHEMBL4637363	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	uM	0.12
	20714749	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCN(c2nc(Nc3ccc(C(N)=O)cc3)ncc2C(F)(F)F)C1		CHEMBL4639676	=	IC50	nM	61.0	CHEMBL2148	Homo sapiens	IC50	uM	0.061
	20714750	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	NC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N3CC[C@H](O)C3)n2)cc1		CHEMBL4635108	=	IC50	nM	53.0	CHEMBL2148	Homo sapiens	IC50	uM	0.053
	20714751	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCCN1c1nc(Nc2ccc(C(N)=O)cc2)ncc1C(F)(F)F		CHEMBL4646256	=	IC50	nM	18.0	CHEMBL2148	Homo sapiens	IC50	uM	0.018
	20714752	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	C=C(c1ncnc2[nH]ccc12)C1CCCCC1		CHEMBL4636397	=	IC50	nM	1100.0	CHEMBL2148	Homo sapiens	IC50	uM	1.1
	20714753	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC(c1ncnc2[nH]ccc12)C1CCCCC1.Cl		CHEMBL4639126	=	IC50	nM	3700.0	CHEMBL2148	Homo sapiens	IC50	uM	3.7
	20714754	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	O=C(c1ncnc2[nH]ccc12)C1CCCCC1		CHEMBL4648839	=	IC50	nM	2700.0	CHEMBL2148	Homo sapiens	IC50	uM	2.7
	20714755	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	Cl.c1nc(OC2CCCCC2)c2cc[nH]c2n1		CHEMBL4648694	=	IC50	nM	330.0	CHEMBL2148	Homo sapiens	IC50	uM	0.33
	20714756	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	c1nc(N2CCCC2)c2cc[nH]c2n1		CHEMBL4645765	=	IC50	nM	260.0	CHEMBL2148	Homo sapiens	IC50	uM	0.26
	20714757	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	c1nc(N2CCCCC2)c2cc[nH]c2n1		CHEMBL1630766	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	uM	0.16
	20714758	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	c1nc(N2CCOCC2)c2cc[nH]c2n1		CHEMBL4646093	=	IC50	nM	420.0	CHEMBL2148	Homo sapiens	IC50	uM	0.42
	20714759	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4637879	=	IC50	nM	94.0	CHEMBL2148	Homo sapiens	IC50	uM	0.094
	20714760	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCCN1c1ncnc2[nH]ccc12		CHEMBL4632611	=	IC50	nM	82.0	CHEMBL2148	Homo sapiens	IC50	uM	0.082
	20714761	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL4638326	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	uM	1.0
	20714762	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCCN(c2ncnc3[nH]ccc23)C1		CHEMBL4635687	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	uM	0.13
	20714763	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCCCN1c1ncnc2[nH]ccc12		CHEMBL4632796	=	IC50	nM	140.0	CHEMBL2148	Homo sapiens	IC50	uM	0.14
	20714764	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C(=O)CC#N)C1CCN(c2ncnc3[nH]ccc23)C1		CHEMBL4649779	=	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	uM	0.4
	20714765	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(C(=O)CC#N)C1CCCN(c2ncnc3[nH]ccc23)C1		CHEMBL3969009	=	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	uM	0.3
	20714766	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CN(CC1CCCN1c1ncnc2[nH]ccc12)C(=O)CC#N		CHEMBL4638316	=	IC50	nM	660.0	CHEMBL2148	Homo sapiens	IC50	uM	0.66
	20714767	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCC2CN(c3ncnc4[nH]ccc34)CC21		CHEMBL4642854	=	IC50	nM	1200.0	CHEMBL2148	Homo sapiens	IC50	uM	1.2
	20714768	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCC2CN(c3ncnc4[nH]ccc34)CC21		CHEMBL4643358	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	uM	0.2
	20714769	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CC2CCN(c3ncnc4[nH]ccc34)C2C1		CHEMBL4645444	=	IC50	nM	2700.0	CHEMBL2148	Homo sapiens	IC50	uM	2.7
	20714770	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693628	=	IC50	nM	88.0	CHEMBL2148	Homo sapiens	IC50	uM	0.088
	20714771	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCCC12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693620	=	IC50	nM	48.0	CHEMBL2148	Homo sapiens	IC50	uM	0.048
	20714772	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCC2(CCN(c3ncnc4[nH]ccc34)C2)C1		CHEMBL4639731	=	IC50	nM	640.0	CHEMBL2148	Homo sapiens	IC50	uM	0.64
	20714773	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689519	=	IC50	nM	36.0	CHEMBL2148	Homo sapiens	IC50	uM	0.036
	20714774	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693624	=	IC50	nM	41.0	CHEMBL2148	Homo sapiens	IC50	uM	0.041
	20714775	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693618	=	IC50	nM	180.0	CHEMBL2148	Homo sapiens	IC50	uM	0.18
	20714776	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693625	=	IC50	nM	250.0	CHEMBL2148	Homo sapiens	IC50	uM	0.25
	20714777	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	O=C(CO)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693592	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	uM	0.067
	20714778	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	COCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693596	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	uM	0.17
	20714779	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCNC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3693599	=	IC50	nM	10.0	CHEMBL2148	Homo sapiens	IC50	uM	0.01
	20714780	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689515	=	IC50	nM	38.0	CHEMBL2148	Homo sapiens	IC50	uM	0.038
	20714781	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CCC2(CCN2C(=O)CC#N)CN1c1ncnc2[nH]ccc12		CHEMBL3689524	=	IC50	nM	410.0	CHEMBL2148	Homo sapiens	IC50	uM	0.41
	20714782	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CN(c2ncnc3[nH]ccc23)CC2(CCN2C(=O)CC#N)C1		CHEMBL3689522	=	IC50	nM	58.0	CHEMBL2148	Homo sapiens	IC50	uM	0.058
	20714783	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	7.0	CHEMBL2148	Homo sapiens	IC50	uM	0.007
	20714784	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1(C)CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689526	=	IC50	nM	130.0	CHEMBL2148	Homo sapiens	IC50	uM	0.13
	20714785	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689517	=	IC50	nM	6.4	CHEMBL2148	Homo sapiens	IC50	uM	0.0064
	20714786	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CN(C(=O)CC#N)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689518	=	IC50	nM	21.0	CHEMBL2148	Homo sapiens	IC50	uM	0.021
	20714787	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CC(F)(F)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689516	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	uM	0.011
	20714788	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689519	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	uM	0.011
	20714789	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CCC12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689515	=	IC50	nM	19.0	CHEMBL2148	Homo sapiens	IC50	uM	0.019
	20714790	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	CC1CN(C(=O)CC#N)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689514	=	IC50	nM	4.0	CHEMBL2148	Homo sapiens	IC50	uM	0.004
	20714791	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CC(F)(F)C12CCCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689517	=	IC50	nM	6.0	CHEMBL2148	Homo sapiens	IC50	uM	0.006
	20714792	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL4297507	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	uM	0.013
	20714793	CHEMBL4630006	Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mins in presence of ATP by fluorescence method	B	N#CCC(=O)N1CC(F)(F)C12CCN(c1ncnc3[nH]ccc13)C2		CHEMBL3689516	=	IC50	nM	11.0	CHEMBL2148	Homo sapiens	IC50	uM	0.011
	22391611	CHEMBL4666943	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	95.0	CHEMBL2148	Homo sapiens	INH	%	95.0
	22391612	CHEMBL4666943	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	98.0	CHEMBL2148	Homo sapiens	INH	%	98.0
	22391613	CHEMBL4666943	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	94.0	CHEMBL2148	Homo sapiens	INH	%	94.0
	22392083	CHEMBL4667178	Inhibition of recombinant human GST-tagged JAK3 (781 to 1124 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.5	CHEMBL2148	Homo sapiens	INH	%	1.5
Not Active	22395656	CHEMBL4668247	Inhibition of JAK3 (unknown origin)	B	C=CC(=O)N(C)Cc1c[nH]c2ncnc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)c12		CHEMBL4762397		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	22395776	CHEMBL4668314	Inhibition of human JAK3 using FITC-KGGEEEEYFELVKK as substrate by caliper microfluidic mobility shift assay	B	C[C@@H]1CCN(C(=O)N2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL4068357	=	IC50	nM	2.8	CHEMBL2148	Homo sapiens	IC50	nM	2.8
	22421706	CHEMBL4673680	Inhibition of JAK3 (unknown origin)	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ncc12		CHEMBL4763913	=	IC50	nM	1.6	CHEMBL2148	Homo sapiens	IC50	nM	1.6
	22421710	CHEMBL4673684	Inhibition of human JAK3 expressed in baculovirus expression system using TK-substrate-biotin as substrate preincubated for 5 mins followed by ATP and substrate addition and measured after 60 mins by HTRF method	B	C=CC(=O)Nc1cccc(Cn2ncc3cnc(Nc4cnn(CCOC)c4)nc32)c1		CHEMBL4748313	=	IC50	nM	0.1	CHEMBL2148	Homo sapiens	IC50	nM	0.1
	22423533	CHEMBL4674342	Inhibition of human JAK3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	94.84	CHEMBL2148	Homo sapiens	Activity	%	94.84
	22423534	CHEMBL4674342	Inhibition of human JAK3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	17.82	CHEMBL2148	Homo sapiens	Activity	%	17.82
	22429185	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1ccc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)n1		CHEMBL4754005	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429186	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1ccc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](C#N)C4)c3)n2)n1		CHEMBL4777969	>	IC50	nM	9588.0	CHEMBL2148	Homo sapiens	IC50	nM	9588.0
	22429187	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	N#CC[C@]1(n2cc(-c3nc(-c4cc[nH]n4)cn4nccc34)cn2)C[C@H](C#N)C1		CHEMBL4750448	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429188	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	N#CC[C@]1(n2cc(-c3nc(-c4cc[nH]n4)cn4nccc34)cn2)C[C@@H](C#N)C1		CHEMBL4791733	=	IC50	nM	4448.0	CHEMBL2148	Homo sapiens	IC50	nM	4448.0
	22429189	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	N#CC[C@]1(n2cc(-c3nc(-c4cn[nH]c4)cn4nccc34)cn2)C[C@H](C#N)C1		CHEMBL4740831	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429190	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	N#CC[C@]1(n2cc(-c3nc(-c4cn[nH]c4)cn4nccc34)cn2)C[C@@H](C#N)C1		CHEMBL4781984	=	IC50	nM	2242.0	CHEMBL2148	Homo sapiens	IC50	nM	2242.0
	22429191	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1		CHEMBL4459585	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429192	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](C#N)C4)c3)n2)cn1		CHEMBL4740298	=	IC50	nM	1051.0	CHEMBL2148	Homo sapiens	IC50	nM	1051.0
	22429193	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](CC#N)C4)c3)n2)cn1		CHEMBL4781973	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429194	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@H](CC#N)C4)c3)n2)cn1		CHEMBL4780288	>	IC50	nM	6170.0	CHEMBL2148	Homo sapiens	IC50	nM	6170.0
	22429195	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	CO[C@H]1C[C@](CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1		CHEMBL4758753	>	IC50	nM	9121.0	CHEMBL2148	Homo sapiens	IC50	nM	9121.0
	22429196	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	CO[C@H]1C[C@@](CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1		CHEMBL4764176	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429197	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC#N)C4)c3)n2)cn1		CHEMBL4741903	=	IC50	nM	6682.0	CHEMBL2148	Homo sapiens	IC50	nM	6682.0
	22429198	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CCO)C4)c3)n2)cn1		CHEMBL4782355	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429199	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	CC(=O)N1CC(CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1		CHEMBL4761132	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429200	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC5CC5)C4)c3)n2)cn1		CHEMBL4761611	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429201	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	CCN1CC(CC#N)(n2cc(-c3nc(-c4cnn(C)c4)cn4nccc34)cn2)C1		CHEMBL4740088	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22429202	CHEMBL4675814	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using FITC-KGGEEEEYFELVKK as substrate in presence of ATP at Km by microfluidic assay	B	Cn1cc(-c2cn3nccc3c(-c3cnn(C4(CC#N)CN(CC(F)(F)F)C4)c3)n2)cn1		CHEMBL4778704	>	IC50	nM	9851.0	CHEMBL2148	Homo sapiens	IC50	nM	9851.0
	22432344	CHEMBL4676593	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system by Kinomescan method relative to control	B	CNC(=O)c1cn(C[C@H](F)CCc2ccc(NC(=O)Cc3cc(OC4CC(F)(F)C4)cc(C)n3)nn2)nn1		CHEMBL4741924	>	Kd	nM	30000.0	CHEMBL2148	Homo sapiens	Kd	nM	30000.0
	22471531	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(C)c3)ncn2)c1		CHEMBL4789894	=	IC50	nM	303.0	CHEMBL2148	Homo sapiens	IC50	nM	303.0
	22471532	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1		CHEMBL4793519	=	IC50	nM	101.0	CHEMBL2148	Homo sapiens	IC50	nM	101.0
	22471533	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4761545	=	IC50	nM	183.0	CHEMBL2148	Homo sapiens	IC50	nM	183.0
	22471534	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCN(C)C)c3)ncn2)c1		CHEMBL4750831	=	IC50	nM	309.0	CHEMBL2148	Homo sapiens	IC50	nM	309.0
	22471535	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CC(=O)NC)c3)ncn2)c1		CHEMBL4777645	=	IC50	nM	138.0	CHEMBL2148	Homo sapiens	IC50	nM	138.0
	22471536	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1		CHEMBL4778584	=	IC50	nM	599.0	CHEMBL2148	Homo sapiens	IC50	nM	599.0
	22471537	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)c1		CHEMBL4754557	=	IC50	nM	55.0	CHEMBL2148	Homo sapiens	IC50	nM	55.0
	22471538	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL4758891	=	IC50	nM	30.0	CHEMBL2148	Homo sapiens	IC50	nM	30.0
	22471539	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1ccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)cc1		CHEMBL4756089	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
	22471540	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4749364	=	IC50	nM	112.0	CHEMBL2148	Homo sapiens	IC50	nM	112.0
	22471541	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1ccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)cc1		CHEMBL4780984	=	IC50	nM	9.1	CHEMBL2148	Homo sapiens	IC50	nM	9.1
	22471542	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272	=	IC50	nM	1.7	CHEMBL2148	Homo sapiens	IC50	nM	1.7
	22471543	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.9	CHEMBL2148	Homo sapiens	IC50	nM	0.9
	22471544	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(C)c3)ncn2)c1		CHEMBL4740889	=	IC50	nM	567.0	CHEMBL2148	Homo sapiens	IC50	nM	567.0
	22471545	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	Cn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1		CHEMBL4753620	=	IC50	nM	145.0	CHEMBL2148	Homo sapiens	IC50	nM	145.0
	22471546	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1		CHEMBL4763424	=	IC50	nM	29.0	CHEMBL2148	Homo sapiens	IC50	nM	29.0
	22471547	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	COCCn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1		CHEMBL4741588	=	IC50	nM	65.0	CHEMBL2148	Homo sapiens	IC50	nM	65.0
	22471548	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4778980	=	IC50	nM	35.0	CHEMBL2148	Homo sapiens	IC50	nM	35.0
	22471549	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4778274	=	IC50	nM	170.0	CHEMBL2148	Homo sapiens	IC50	nM	170.0
	22471550	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCN(C)C)c3)ncn2)c1		CHEMBL4750671	=	IC50	nM	67.0	CHEMBL2148	Homo sapiens	IC50	nM	67.0
	22471551	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CC(=O)NC)c3)ncn2)c1		CHEMBL4754061	=	IC50	nM	92.0	CHEMBL2148	Homo sapiens	IC50	nM	92.0
	22471552	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1		CHEMBL4740191	=	IC50	nM	221.0	CHEMBL2148	Homo sapiens	IC50	nM	221.0
	22471553	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCO)c3)ncn2)c1		CHEMBL4739907	=	IC50	nM	243.0	CHEMBL2148	Homo sapiens	IC50	nM	243.0
	22471554	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)CC#N)c3)ncn2)cn1		CHEMBL4762354	=	IC50	nM	95.0	CHEMBL2148	Homo sapiens	IC50	nM	95.0
	22471555	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1		CHEMBL4756648	=	IC50	nM	66.0	CHEMBL2148	Homo sapiens	IC50	nM	66.0
	22471556	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)NCC(=O)Nc1cccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)c1		CHEMBL4758931	=	IC50	nM	108.0	CHEMBL2148	Homo sapiens	IC50	nM	108.0
	22471557	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C=CC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4796206	=	IC50	nM	103.0	CHEMBL2148	Homo sapiens	IC50	nM	103.0
	22471558	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4795109	=	IC50	nM	375.0	CHEMBL2148	Homo sapiens	IC50	nM	375.0
	22471559	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)NCC(=O)Nc1cccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)c1		CHEMBL4780644	=	IC50	nM	253.0	CHEMBL2148	Homo sapiens	IC50	nM	253.0
	22471560	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	CNC(=O)Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)CC#N)c3)ncn2)cn1		CHEMBL4746760	=	IC50	nM	127.0	CHEMBL2148	Homo sapiens	IC50	nM	127.0
	22471561	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL4743357	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	22471562	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)Nc1cccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1077575	=	IC50	nM	152.0	CHEMBL2148	Homo sapiens	IC50	nM	152.0
	22471563	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1ccc(-c2cc(Nc3cnn(CCOC)c3)ncn2)cc1		CHEMBL4777465	=	IC50	nM	76.0	CHEMBL2148	Homo sapiens	IC50	nM	76.0
	22471564	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	COCCn1cc(Nc2cc(-c3ccc(NC(=O)CC#N)cc3)ncn2)cn1		CHEMBL4755671	=	IC50	nM	86.0	CHEMBL2148	Homo sapiens	IC50	nM	86.0
	22471565	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4747498	=	IC50	nM	99.0	CHEMBL2148	Homo sapiens	IC50	nM	99.0
	22471566	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)Nc1ccc(-c2cc(Nc3ccc(N4CCOCC4)cc3)ncn2)cc1		CHEMBL4740169	=	IC50	nM	78.0	CHEMBL2148	Homo sapiens	IC50	nM	78.0
	22471567	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1ccc(-c2ccnc(Nc3cnn(CCOC)c3)n2)cc1		CHEMBL4782611	=	IC50	nM	14.0	CHEMBL2148	Homo sapiens	IC50	nM	14.0
	22471568	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	COCCn1cc(Nc2nccc(-c3ccc(NC(=O)CC#N)cc3)n2)cn1		CHEMBL4744519	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	nM	24.0
	22471569	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	C/C=C/C(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4750184	=	IC50	nM	6.1	CHEMBL2148	Homo sapiens	IC50	nM	6.1
	22471570	CHEMBL4685309	Inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin preincubated for 5 mins followed by substrate addition and measured after 30 mins by HTRF assay	B	N#CCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078166	=	IC50	nM	15.0	CHEMBL2148	Homo sapiens	IC50	nM	15.0
	22471783	CHEMBL4685323	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using Tyr06 peptide as substrate at 100 nM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272	=	Inhibition	%	100.0	CHEMBL2148	Homo sapiens	INH	%	100.0
Active	22471792	CHEMBL4685332	Time-dependent inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin by HTRF assay	B	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272		TDI			CHEMBL2148	Homo sapiens	TDI		
Not Active	22471793	CHEMBL4685332	Time-dependent inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system using TK-substrate-biotin by HTRF assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959		TDI			CHEMBL2148	Homo sapiens	TDI		
Active	22471794	CHEMBL4685333	Irreversible inhibition of recombinant human GST-tagged JAK3 cytoplasmic domain (781 to 1124 residues) expressed in baculovirus expression system at IC90 using TK-substrate-biotin preincubated for 30 mins followed by 1000 fold dilution and measured after 24 hrs by HTRF assay	B	C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL4746272		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	22471821	CHEMBL4685357	Inhibition of recombinant epitope tagged JAK3 (718 to 1124 residues) (unknown origin) using Chk2 as substrate by HTRF assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	IC50	nM	400.0	CHEMBL2148	Homo sapiens	IC50	nM	400.0
	22471826	CHEMBL4685362	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (811 to 1103 residues) expressed in Sf9 insect cells using Biotin-TYR2 (Biotin-(Ahx)-AEEEYFFLFA-amide) as substrate	B	CC[C@H]1CN(C(=O)NCC(F)(F)F)C[C@H]1C1C=NC2=CN=C3NC=CC3N21		CHEMBL4783966	=	IC50	nM	2304.0	CHEMBL2148	Homo sapiens	IC50	nM	2304.0
Not Determined	22803241	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccccc1		CHEMBL4778011		IC50			CHEMBL2148	Homo sapiens	IC50		
	22803242	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)cc1		CHEMBL4782433	=	IC50	nM	24.0	CHEMBL2148	Homo sapiens	IC50	uM	0.024
	22803243	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4744513	=	IC50	nM	569.0	CHEMBL2148	Homo sapiens	IC50	uM	0.569
	22803244	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4763483	=	IC50	nM	64.0	CHEMBL2148	Homo sapiens	IC50	uM	0.064
	22803245	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261	=	IC50	nM	57.0	CHEMBL2148	Homo sapiens	IC50	uM	0.057
Not Determined	22803246	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4761780		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	22803247	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCCCC4)cc3)c[nH]2)cc1		CHEMBL4750823		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	22803248	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4797744		IC50			CHEMBL2148	Homo sapiens	IC50		
	22803249	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4795804	=	IC50	nM	13.0	CHEMBL2148	Homo sapiens	IC50	uM	0.013000000000000001
	22803250	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	Cc1nc(Cl)cc(Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)n1		CHEMBL4794655	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	uM	0.023
	22803251	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.2	CHEMBL2148	Homo sapiens	IC50	uM	0.0012
Not Determined	22803252	CHEMBL4711871	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	CSc1nc(Cl)c(C)c(Nc2c[nH]nc2-c2ncc(-c3ccc(OCCCN4CCOCC4)cc3)[nH]2)n1		CHEMBL4789251		IC50			CHEMBL2148	Homo sapiens	IC50		
	22809436	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	NC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1		CHEMBL3593765	=	IC50	nM	23.0	CHEMBL2148	Homo sapiens	IC50	nM	23.0
	22809437	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1		CHEMBL4747270	=	IC50	nM	690.0	CHEMBL2148	Homo sapiens	IC50	nM	690.0
	22809438	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2OC)CC1		CHEMBL4756788	=	IC50	nM	305.0	CHEMBL2148	Homo sapiens	IC50	nM	305.0
	22809439	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(OC)c2)CC1		CHEMBL4763801	=	IC50	nM	862.0	CHEMBL2148	Homo sapiens	IC50	nM	862.0
	22809440	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(OC)cc2)CC1		CHEMBL4763821	=	IC50	nM	421.0	CHEMBL2148	Homo sapiens	IC50	nM	421.0
	22809441	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(OC)c(OC)c2)CC1		CHEMBL4787224	=	IC50	nM	2580.0	CHEMBL2148	Homo sapiens	IC50	nM	2580.0
	22809442	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(C#N)c2)CC1		CHEMBL4781679	=	IC50	nM	248.0	CHEMBL2148	Homo sapiens	IC50	nM	248.0
	22809443	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	O=C(NC1CC1)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1		CHEMBL4750665	=	IC50	nM	517.0	CHEMBL2148	Homo sapiens	IC50	nM	517.0
	22809444	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	COc1cccc(CN2CCC(Nc3c(C(=O)NC4CC4)cnc4[nH]ccc34)CC2)c1		CHEMBL4792719	=	IC50	nM	8490.0	CHEMBL2148	Homo sapiens	IC50	nM	8490.0
	22809445	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	COc1cccc(CN2CCC(Nc3c(C(=O)NC4CCCC4)cnc4[nH]ccc34)CC2)c1		CHEMBL4784576	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22809446	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NCC1CCN(Cc2ccc(Cl)cc2)CC1		CHEMBL4746952	=	IC50	nM	426.0	CHEMBL2148	Homo sapiens	IC50	nM	426.0
	22809447	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NCC1CCN(Cc2ccc(OC)cc2)CC1		CHEMBL4749677	=	IC50	nM	576.0	CHEMBL2148	Homo sapiens	IC50	nM	576.0
	22809448	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2cccc(Cl)c2)C1		CHEMBL4750605	=	IC50	nM	200.0	CHEMBL2148	Homo sapiens	IC50	nM	200.0
	22809449	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccc(Cl)cc2)C1		CHEMBL4742822	=	IC50	nM	375.6	CHEMBL2148	Homo sapiens	IC50	nM	375.6
	22809450	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1		CHEMBL4787974	=	IC50	nM	47.5	CHEMBL2148	Homo sapiens	IC50	nM	47.5
	22809451	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1cccc(OC)c1		CHEMBL4795901	=	IC50	nM	225.0	CHEMBL2148	Homo sapiens	IC50	nM	225.0
	22809452	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(OC)cc1		CHEMBL4786466	=	IC50	nM	391.0	CHEMBL2148	Homo sapiens	IC50	nM	391.0
	22809453	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(C#N)cc1		CHEMBL4785910	=	IC50	nM	78.3	CHEMBL2148	Homo sapiens	IC50	nM	78.3
	22809454	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccccc2)CC1		CHEMBL4761631	=	IC50	nM	341.0	CHEMBL2148	Homo sapiens	IC50	nM	341.0
	22809455	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(Cl)c2)CC1		CHEMBL4759666	=	IC50	nM	62.5	CHEMBL2148	Homo sapiens	IC50	nM	62.5
	22809456	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(Cl)cc2)CC1		CHEMBL4781706	=	IC50	nM	41.3	CHEMBL2148	Homo sapiens	IC50	nM	41.3
	22809457	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(OC)c2)CC1		CHEMBL4787133	=	IC50	nM	72.8	CHEMBL2148	Homo sapiens	IC50	nM	72.8
	22809458	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(OC)cc2)CC1		CHEMBL4741376	=	IC50	nM	283.0	CHEMBL2148	Homo sapiens	IC50	nM	283.0
	22809459	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2ccc(C#N)cc2)CC1		CHEMBL4747285	=	IC50	nM	343.0	CHEMBL2148	Homo sapiens	IC50	nM	343.0
	22809460	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccccc2)[C@@H](C)C1		CHEMBL4744048	=	IC50	nM	25.0	CHEMBL2148	Homo sapiens	IC50	nM	25.0
	22809461	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@@H](C)C1		CHEMBL4789693	=	IC50	nM	19.6	CHEMBL2148	Homo sapiens	IC50	nM	19.6
	22809462	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1		CHEMBL4777577	=	IC50	nM	24.5	CHEMBL2148	Homo sapiens	IC50	nM	24.5
	22809463	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)[C@@H](C)C1		CHEMBL4750779	=	IC50	nM	17.1	CHEMBL2148	Homo sapiens	IC50	nM	17.1
	22809464	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(OC)cc2)[C@@H](C)C1		CHEMBL4746186	=	IC50	nM	64.1	CHEMBL2148	Homo sapiens	IC50	nM	64.1
	22809465	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@H](C)C1		CHEMBL4779060	=	IC50	nM	36.2	CHEMBL2148	Homo sapiens	IC50	nM	36.2
	22809466	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	IC50	nM	3.36	CHEMBL2148	Homo sapiens	IC50	nM	3.36
	22809467	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)[C@H](C)C1		CHEMBL4755612	=	IC50	nM	27.6	CHEMBL2148	Homo sapiens	IC50	nM	27.6
	22809468	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(OC)cc2)[C@H](C)C1		CHEMBL4779340	=	IC50	nM	106.0	CHEMBL2148	Homo sapiens	IC50	nM	106.0
	22809469	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(C#N)cc2)[C@H](C)C1		CHEMBL4744772	=	IC50	nM	2.41	CHEMBL2148	Homo sapiens	IC50	nM	2.41
	22809470	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	C[C@@H]1C[C@H](Nc2c(C(N)=O)cnc3[nH]ccc23)CCN1Cc1cccc(Cl)c1		CHEMBL4785998	=	IC50	nM	9.94	CHEMBL2148	Homo sapiens	IC50	nM	9.94
	22809471	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	COc1cccc(CN2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)C[C@H]2C)c1		CHEMBL4787731	=	IC50	nM	8.84	CHEMBL2148	Homo sapiens	IC50	nM	8.84
	22809472	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)C[C@H]1F		CHEMBL4777200	=	IC50	nM	9.24	CHEMBL2148	Homo sapiens	IC50	nM	9.24
	22809473	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@H]1F		CHEMBL4742766	=	IC50	nM	314.0	CHEMBL2148	Homo sapiens	IC50	nM	314.0
	22809474	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@@H]1F		CHEMBL4747742	=	IC50	nM	88.7	CHEMBL2148	Homo sapiens	IC50	nM	88.7
	22809475	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	IC50	nM	0.98	CHEMBL2148	Homo sapiens	IC50	nM	0.98
	22809476	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	IC50	nM	932.0	CHEMBL2148	Homo sapiens	IC50	nM	932.0
	22809477	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1		CHEMBL4783938	=	IC50	nM	2.31	CHEMBL2148	Homo sapiens	IC50	nM	2.31
	22809478	CHEMBL4713241	Inhibition of recombinant JAK3 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	IC50	nM	809.0	CHEMBL2148	Homo sapiens	IC50	nM	809.0
	22809668	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CC2CCC(C1)N2Cc1ccc(Cl)cc1		CHEMBL4787974	=	GI50	nM	3895.0	CHEMBL2148	Homo sapiens	GI50	uM	3.895
	22809669	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1NC1CCCN(Cc2cccc(Cl)c2)CC1		CHEMBL4759666	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	22809670	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(Cl)c2)[C@@H](C)C1		CHEMBL4789693	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	22809671	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	GI50	nM	1357.0	CHEMBL2148	Homo sapiens	GI50	uM	1.357
	22809672	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2cccc(OC)c2)C[C@@H]1F		CHEMBL4747742	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	22809673	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	GI50	nM	503.0	CHEMBL2148	Homo sapiens	GI50	uM	0.503
	22809674	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	22809675	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@H]1CCN(Cc2ccc(Cl)cc2)[C@@H](C)C1		CHEMBL4783938	=	GI50	nM	1141.0	CHEMBL2148	Homo sapiens	GI50	uM	1.141
	22809676	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	>	GI50	nM	10000.0	CHEMBL2148	Homo sapiens	GI50	uM	10.0
	22809677	CHEMBL4713248	Inhibition of JAK3 (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay	B	CC(=O)Nc1cc(Oc2ccc3c(c2)CCN3C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)ncn1		CHEMBL4799398	=	GI50	nM	451.0	CHEMBL2148	Homo sapiens	GI50	uM	0.451
	22809747	CHEMBL4713282	Inhibition of recombinant human JAK3 (781 to end residues) assessed as residual activity at 1 uM using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	-1.0	CHEMBL2148	Homo sapiens	Activity	%	-1.0
	22813267	CHEMBL4714261	Inhibition of recombinant human JAK3 assessed as phosphorylation level in presence of 1 mM ATP	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22813268	CHEMBL4714261	Inhibition of recombinant human JAK3 assessed as phosphorylation level in presence of 1 mM ATP	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	33.0	CHEMBL2148	Homo sapiens	IC50	nM	33.0
	22813269	CHEMBL4714261	Inhibition of recombinant human JAK3 assessed as phosphorylation level in presence of 1 mM ATP	B	Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4747591	=	IC50	nM	6494.0	CHEMBL2148	Homo sapiens	IC50	nM	6494.0
	22813270	CHEMBL4714261	Inhibition of recombinant human JAK3 assessed as phosphorylation level in presence of 1 mM ATP	B	Cc1cc(Nc2cc3ncccc3c(N[C@H]3CC[C@@H]4C[C@H](C3)N4CCC#N)n2)n[nH]1		CHEMBL4782814	=	IC50	nM	992.0	CHEMBL2148	Homo sapiens	IC50	nM	992.0
	22813284	CHEMBL4714268	Inhibition of human JAK3 using Biotin-Lyn-Substrate-2 in presence of 1 mM ATP by phosphotyrosine-specific ELISA	B	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2		CHEMBL4238926	<	IC50	nM	1.0	CHEMBL2148	Homo sapiens	IC50	nM	1.0
	22820498	CHEMBL4716251	Inhibition of recombinant N-terminal His6-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	106.0	CHEMBL2148	Homo sapiens	Activity	%	106.0
	22820499	CHEMBL4716251	Inhibition of recombinant N-terminal His6-tagged human JAK3 (781 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	64.0	CHEMBL2148	Homo sapiens	Activity	%	64.0
	22822934	CHEMBL4716843	Inhibition of JAK3 (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	22843195	CHEMBL4720226	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate incubate for 60 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	nM	10000.0
	22843196	CHEMBL4720226	Inhibition of recombinant human JAK3 using Ulight-CAGAGAIETDKEYYTVKD as substrate incubate for 60 mins by LANCE assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	16.1	CHEMBL2148	Homo sapiens	IC50	nM	16.1
	22843705	CHEMBL4720691	Inhibition of human JAK3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.0913	CHEMBL2148	Homo sapiens	IC50	10^-11M	9.13
	22844056	CHEMBL4721042	Inhibition of human JAK3 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	105.12	CHEMBL2148	Homo sapiens	Activity	%	105.12
	22844746	CHEMBL4721421	Inhibition of wild type human partial length JAK3 (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	109.26	CHEMBL2148	Homo sapiens	Activity	%	109.26
	22851802	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1cnc(Nc2ccc3c(c2)CN(C(=O)/C=C/CN(C)C)CC3)nc1-c1cnn(C(C)C)c1		CHEMBL4756422	=	IC50	nM	147.0	CHEMBL2148	Homo sapiens	IC50	nM	147.0
	22851803	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1ccc(C(=O)/C=C/C(=O)N2CCc3ccc(Nc4ncc(C)c(-c5cnn(C(C)C)c5)n4)cc3C2)cc1		CHEMBL4789273	=	IC50	nM	28.0	CHEMBL2148	Homo sapiens	IC50	nM	28.0
	22851804	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1cnc(Nc2ccc3c(c2)CN(C(=O)/C=C/C(=O)c2ccccc2)CC3)nc1-c1cnn(C(C)C)c1		CHEMBL4741075	=	IC50	nM	89.0	CHEMBL2148	Homo sapiens	IC50	nM	89.0
	22851805	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1cnc(Nc2ccc3c(c2)CCN(C(=O)/C=C/CN(C)C)C3)nc1-c1cnn(C(C)C)c1		CHEMBL4753549	=	IC50	nM	94.0	CHEMBL2148	Homo sapiens	IC50	nM	94.0
	22851806	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1ccc(C(=O)/C=C/C(=O)N2CCc3cc(Nc4ncc(C)c(-c5cnn(C(C)C)c5)n4)ccc3C2)cc1		CHEMBL4759953	=	IC50	nM	50.0	CHEMBL2148	Homo sapiens	IC50	nM	50.0
	22851807	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1cnc(Nc2ccc3c(c2)CCN(C(=O)/C=C/C(=O)c2ccccc2)C3)nc1-c1cnn(C(C)C)c1		CHEMBL4748354	=	IC50	nM	120.0	CHEMBL2148	Homo sapiens	IC50	nM	120.0
	22851808	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	COC(=O)/C=C/CN1CCc2cc(Nc3ncc(C)c(-c4cnn(C(C)C)c4)n3)ccc2C1		CHEMBL4754856	=	IC50	nM	77.0	CHEMBL2148	Homo sapiens	IC50	nM	77.0
	22851809	CHEMBL4723821	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	Cc1cnc(Nc2ccc3c(c2)CCN(CC#N)C3)nc1-c1cnn(C(C)C)c1		CHEMBL4798378	=	IC50	nM	54.0	CHEMBL2148	Homo sapiens	IC50	nM	54.0
	22876502	CHEMBL4725962	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells at 1 uM relative to control	B	C=CC(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3901151	>	Inhibition	%	75.0	CHEMBL2148	Homo sapiens	INH	%	75.0
	22876503	CHEMBL4725962	Inhibition of recombinant human N-terminal His6-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf21 cells at 1 uM relative to control	B	C=CC(=O)Nc1cccc(-c2n[nH]c3cc(C)ccc23)c1		CHEMBL4749823	>	Inhibition	%	75.0	CHEMBL2148	Homo sapiens	INH	%	75.0
	22877452	CHEMBL4726199	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay	B	C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4cc(CC)ccn4)cc3)c2c1		CHEMBL4752700	=	IC50	nM	838.0	CHEMBL2148	Homo sapiens	IC50	nM	838.0
	22877453	CHEMBL4726199	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay	B	CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OCCN1CCOCC1		CHEMBL4782725	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	22877454	CHEMBL4726199	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay	B	COc1cc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2cc1NC(=O)C#CCCN1CCOCC1		CHEMBL4755977	=	IC50	nM	174.0	CHEMBL2148	Homo sapiens	IC50	nM	174.0
	22877455	CHEMBL4726199	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	32.0	CHEMBL2148	Homo sapiens	IC50	nM	32.0
	22877456	CHEMBL4726199	Inhibition of recombinant human GST-tagged JAK3 catalytic domain (781 to 1124 residues) expressed in baculovirus expression system using tyrosine-6 peptide as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay	B	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Not Active	22889519	CHEMBL4729038	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	22909922	CHEMBL4734068	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Tyr-06 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	22909923	CHEMBL4734068	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Tyr-06 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
Not Active	22909924	CHEMBL4734068	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system using Tyr-06 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL2148	Homo sapiens	INH		
	22952878	CHEMBL4766815	Inhibition of human JAK3 (781 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	106.0	CHEMBL2148	Homo sapiens	Activity	%	106.0
	22977633	CHEMBL4772144	Inhibition of recombinant human JAK3 C-terminal domain (781 to 1124 residues) expressed in baculovirus infected Sf9 insect cells using GGEEEEYFELVKKKK as substrate by ADP-glo assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	22977634	CHEMBL4772144	Inhibition of recombinant human JAK3 C-terminal domain (781 to 1124 residues) expressed in baculovirus infected Sf9 insect cells using GGEEEEYFELVKKKK as substrate by ADP-glo assay	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	>	IC50	nM	10000.0	CHEMBL2148	Homo sapiens	IC50	uM	10.0
	22979774	CHEMBL4772656	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	170.0	CHEMBL2148	Homo sapiens	Kd	nM	170.0
	22979808	CHEMBL4772690	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL2148	Homo sapiens	Activity	%	90.0
	23120497	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-12800.0	CHEMBL2148	Homo sapiens	IC50	uM	-12.8
	23120498	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	15200.0	CHEMBL2148	Homo sapiens	IC50	uM	15.2
	23120499	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	26800.0	CHEMBL2148	Homo sapiens	IC50	uM	26.8
	23120500	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	13400.0	CHEMBL2148	Homo sapiens	IC50	uM	13.4
	23120501	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	52100.0	CHEMBL2148	Homo sapiens	IC50	uM	52.1
	23120502	CHEMBL4804399	Inhibition of JAK3 domain 2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	2600.0	CHEMBL2148	Homo sapiens	IC50	uM	2.6
	23121536	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23121537	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23121538	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23121539	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23121540	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL2148	Homo sapiens	INH	%	50.0
	23121541	CHEMBL4804581	Inhibition of JAK3 domain 2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23122623	CHEMBL4804974	Inhibition of human JAK3 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	65.0	CHEMBL2148	Homo sapiens	Activity	%	65.0
	23123318	CHEMBL4805562	Inhibition of human JAK3 JH1 catalytic domain assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	70.0	CHEMBL2148	Homo sapiens	Activity	%	70.0
	23123580	CHEMBL4805824	Inhibition of DNA-tagged human JAK3 JH1 catalytic domain assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	74.0	CHEMBL2148	Homo sapiens	Activity	%	74.0
	23124726	CHEMBL4806579	Inhibition of human JAK3 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	83.0	CHEMBL2148	Homo sapiens	Activity	%	83.0
	23124727	CHEMBL4806579	Inhibition of human JAK3 JH1 catalytic domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL2148	Homo sapiens	Activity	%	80.0
	23128206	CHEMBL4807877	Inhibition of JAK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL2148	Homo sapiens	Activity	%	50.0
	23128207	CHEMBL4807877	Inhibition of JAK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2148	Homo sapiens	Activity	%	75.0
	23128208	CHEMBL4807877	Inhibition of JAK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2148	Homo sapiens	Activity	%	75.0
	23152089	CHEMBL4810651	Binding affinity to wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system measured after 1 hr by competitive binding assay	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Kd	nM	1800.0	CHEMBL2148	Homo sapiens	Kd	nM	1800.0
	23154601	CHEMBL4811103	Inhibition of human JAK3 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	CN1CCN(c2ccc(Nc3nccc(Nc4ccc5nc[nH]c5c4)n3)cc2)CC1		CHEMBL4858727	=	Inhibition	%	69.2	CHEMBL2148	Homo sapiens	INH	%	69.2
	23154602	CHEMBL4811103	Inhibition of human JAK3 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cc(Nc2nccc(Nc3ccc4nc[nH]c4c3)n2)ccc1N1CCN(C)CC1		CHEMBL4850121	=	Inhibition	%	57.8	CHEMBL2148	Homo sapiens	INH	%	57.8
	23154603	CHEMBL4811103	Inhibition of human JAK3 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cccc(Nc2ncc([N+](=O)[O-])c(Nc3ccc4nc[nH]c4c3)n2)c1		CHEMBL4855763	=	Inhibition	%	54.9	CHEMBL2148	Homo sapiens	INH	%	54.9
	23158833	CHEMBL4812085	Inhibition of N-terminal His-tagged JAK3 (795 to 1124 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	4.24	CHEMBL2148	Homo sapiens	INH	%	4.24
Not Determined	23160445	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-n3c(-c4ccc(CO)o4)cc4cnc5[nH]ccc5c43)cn2)C1		CHEMBL4870912		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23160446	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-n3c(-c4cccs4)cc4cnc5[nH]ccc5c43)cn2)C1		CHEMBL4869338		IC50			CHEMBL2148	Homo sapiens	IC50		
	23160447	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	N#CCCn1cc(-n2c(-c3cccs3)cc3cnc4[nH]ccc4c32)cn1		CHEMBL4867261	=	IC50	nM	160.0	CHEMBL2148	Homo sapiens	IC50	nM	160.0
	23160448	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	N#CCCCn1cc(-n2ccc3cnc4[nH]ccc4c32)cn1		CHEMBL4872996	>	IC50	nM	300.0	CHEMBL2148	Homo sapiens	IC50	nM	300.0
Not Determined	23160449	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	Cc1ccc(-c2cc3cnc4[nH]ccc4c3n2-c2cnn(CCCC#N)c2)o1		CHEMBL4853377		IC50			CHEMBL2148	Homo sapiens	IC50		
	23160450	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	Cc1ccc(-c2cc3cnc4[nH]ccc4c3n2-c2cnn(CCCC#N)c2)s1		CHEMBL4869982	=	IC50	nM	280.0	CHEMBL2148	Homo sapiens	IC50	nM	280.0
Not Determined	23160451	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	N#CCCCn1cc(-n2c(C3CCC3)cc3cnc4[nH]ccc4c32)cn1		CHEMBL4854943		IC50			CHEMBL2148	Homo sapiens	IC50		
	23160452	CHEMBL4812338	Inhibition of recombinant human N-terminal His-tagged JAK3 (795 to 1124 residues) expressed in baculovirus expression system	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	IC50	nM	787.0	CHEMBL2148	Homo sapiens	IC50	nM	787.0
	23180012	CHEMBL4816229	Inhibition of JAK3 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccccc4)sc3c2)c(OC)c1C		CHEMBL4864495	=	Inhibition	%	-4.7	CHEMBL2148	Homo sapiens	INH	%	-4.7
	23180013	CHEMBL4816229	Inhibition of JAK3 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccc(OC)cc4)sc3c2)c(OC)c1C		CHEMBL4846365	=	Inhibition	%	-6.8	CHEMBL2148	Homo sapiens	INH	%	-6.8
	23180014	CHEMBL4816229	Inhibition of JAK3 (unknown origin) at 1 uM by ELISA	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Inhibition	%	78.5	CHEMBL2148	Homo sapiens	INH	%	78.5
	23180262	CHEMBL4816265	Inhibition of human JAK3 at 0.1 uM using GGEEEEYFELVKKKK as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	B	Cc1ccc(NC(=O)c2ccc(C(F)(F)F)nc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL4846916	=	Inhibition	%	0.0	CHEMBL2148	Homo sapiens	INH	%	0.0
	23205684	CHEMBL4821571	Inhibition of JAK3 (unknown origin)	B	COc1cc(Nc2nc(NCc3cccc(NC(=O)CCl)c3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL4870513	=	IC50	nM	562.0	CHEMBL2148	Homo sapiens	IC50	nM	562.0
	23216102	CHEMBL4823617	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	23218830	CHEMBL4824348	Inhibition of JAK3 (unknown origin) measured after 40 mins by HTRF	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3ccccc3Cl)n2)cc1		CHEMBL4850588	=	IC50	nM	44.18	CHEMBL2148	Homo sapiens	IC50	nM	44.18
	23218831	CHEMBL4824348	Inhibition of JAK3 (unknown origin) measured after 40 mins by HTRF	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3OC)n2)cc1		CHEMBL4874046	=	IC50	nM	20.05	CHEMBL2148	Homo sapiens	IC50	nM	20.05
	23218832	CHEMBL4824348	Inhibition of JAK3 (unknown origin) measured after 40 mins by HTRF	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	IC50	nM	114.9	CHEMBL2148	Homo sapiens	IC50	nM	114.9
	23227132	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	IC50	nM	39.0	CHEMBL2148	Homo sapiens	IC50	nM	39.0
	23227133	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4862564	=	IC50	nM	688.0	CHEMBL2148	Homo sapiens	IC50	nM	688.0
	23227134	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C)c1		CHEMBL4851606	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Not Determined	23227135	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2C)cn1		CHEMBL4876711		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227136	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C2CC2)c1		CHEMBL4862667		IC50			CHEMBL2148	Homo sapiens	IC50		
	23227137	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C2CCC2)c1		CHEMBL4846148	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	23227138	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(CCC#N)c1		CHEMBL4873919	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	23227139	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CCOC(C)n1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2C)cn1		CHEMBL4872684	=	IC50	nM	510.0	CHEMBL2148	Homo sapiens	IC50	nM	510.0
Not Determined	23227140	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4)ncc2F)cn1		CHEMBL4851075		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227141	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CNC4=O)ncc2F)cn1		CHEMBL4871133		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227142	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CNC3=O)nc1-c1cnn(CCC#N)c1		CHEMBL4845662		IC50			CHEMBL2148	Homo sapiens	IC50		
	23227143	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)C(F)(F)F)ncc2F)cn1		CHEMBL4873109	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Not Determined	23227144	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4S(=O)(=O)c3ccc(C(F)(F)F)cc3)ncc2F)cn1		CHEMBL4853438		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227145	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)c3ccc(C(F)(F)F)cc3)ncc2F)cn1		CHEMBL4868858		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227146	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1ccc(C(=O)N2CCc3cc(Nc4ncc(F)c(-c5cnn(CCC#N)c5)n4)ccc32)cc1		CHEMBL4849617		IC50			CHEMBL2148	Homo sapiens	IC50		
	23227147	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)CN3CCS(=O)(=O)CC3)ncc2F)cn1		CHEMBL4865102	=	IC50	nM	244.0	CHEMBL2148	Homo sapiens	IC50	nM	244.0
	23227148	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(c3)CCN4C(=O)C3(C#N)CC3)ncc2F)cn1		CHEMBL4856634	=	IC50	nM	191.0	CHEMBL2148	Homo sapiens	IC50	nM	191.0
Not Determined	23227149	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cn1ccc2cc(Nc3ncc(F)c(-c4cnn(CCC#N)c4)n3)ccc21		CHEMBL4872338		IC50			CHEMBL2148	Homo sapiens	IC50		
	23227150	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)C(F)(F)F)c3)ncc2F)cn1		CHEMBL4864387	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Not Determined	23227151	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4S(=O)(=O)c4ccc(C(F)(F)F)cc4)c3)ncc2F)cn1		CHEMBL4871878		IC50			CHEMBL2148	Homo sapiens	IC50		
Not Determined	23227152	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	N#CCCn1cc(-c2nc(Nc3ccc4c(ccn4C(=O)C4CC4)c3)ncc2F)cn1		CHEMBL4872557		IC50			CHEMBL2148	Homo sapiens	IC50		
	23227153	CHEMBL4825787	Inhibition of recombinant human JAK3 (781 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc3c(c2)CCN3S(=O)(=O)c2ccc(C(F)(F)F)cc2)nc1-c1cnn(C(C)C)c1		CHEMBL4862231	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
	23233990	CHEMBL4827576	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	<	Activity	%	10.0	CHEMBL2148	Homo sapiens	Activity	%	10.0
	23233991	CHEMBL4827576	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	<	Activity	%	10.0	CHEMBL2148	Homo sapiens	Activity	%	10.0
	23233992	CHEMBL4827576	Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	<	Activity	%	10.0	CHEMBL2148	Homo sapiens	Activity	%	10.0
	23256924	CHEMBL4832288	Inhibition of JAK3 (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1		CHEMBL4860202	=	Inhibition	%	77.5	CHEMBL2148	Homo sapiens	INH	%	77.5
	23256931	CHEMBL4832292	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1		CHEMBL4860202	=	IC50	nM	8353.0	CHEMBL2148	Homo sapiens	IC50	nM	8353.0
	23256932	CHEMBL4832292	Inhibition of JAK3 (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.0	CHEMBL2148	Homo sapiens	IC50	nM	8.0
	23289187	CHEMBL4839025	Inhibition of JAK3 (unknown origin)	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	IC50	nM	3.2	CHEMBL2148	Homo sapiens	IC50	nM	3.2
	23289202	CHEMBL4839040	Inhibition of JAK3 (unknown origin) at 0.1 uM	B	CCN1CCN(c2ccc(Nc3ncc4scc(-c5cccc(NS(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL4846921	=	Inhibition	%	96.7	CHEMBL2148	Homo sapiens	INH	%	96.7
	23290878	CHEMBL4839434	Inhibition of wild type human partial length JAK3 (I781 to S1124 residues) expressed in mammalian expression system assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	23290879	CHEMBL4839434	Inhibition of wild type human partial length JAK3 (I781 to S1124 residues) expressed in mammalian expression system assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	Activity	%	0.0	CHEMBL2148	Homo sapiens	Activity	%	0.0
	23290900	CHEMBL4839445	Inhibition of NanoLuc-fused JAK3 (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	uM	50.0
	23290901	CHEMBL4839445	Inhibition of NanoLuc-fused JAK3 (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	>	IC50	nM	50000.0	CHEMBL2148	Homo sapiens	IC50	uM	50.0
	23299274	CHEMBL4841737	Inhibition of JAK3 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	1.0	CHEMBL2148	Homo sapiens	INH	%	1.0
	23299275	CHEMBL4841737	Inhibition of JAK3 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	54.0	CHEMBL2148	Homo sapiens	INH	%	54.0
	23310254	CHEMBL4843947	Inhibition of recombinant human GST-tagged JAK3 expressed in baculovirus expression system incubated for 1 hr by Z'lyte assay	B	C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3647964	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Not Active	23317458	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	80.0	CHEMBL2148	Homo sapiens	% Control	%	80.0
Not Active	23317926	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	94.0	CHEMBL2148	Homo sapiens	% Control	%	94.0
Not Active	23318593	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	72.0	CHEMBL2148	Homo sapiens	% Control	%	72.0
Not Active	23319076	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23319713	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	71.3	CHEMBL2148	Homo sapiens	% Control	%	71.3
Not Active	23320188	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	93.6	CHEMBL2148	Homo sapiens	% Control	%	93.6
Not Active	23320866	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23321334	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23321964	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL2148	Homo sapiens	% Control	%	84.0
Not Active	23322432	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	73.0	CHEMBL2148	Homo sapiens	% Control	%	73.0
Not Active	23323121	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL2148	Homo sapiens	% Control	%	88.0
Not Active	23323589	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23324039	CHEMBL4880658	JAK3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-7.0	CHEMBL2148	Homo sapiens	% inhibition	%	-7.0
Not Active	23324443	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23325078	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23325546	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	95.0	CHEMBL2148	Homo sapiens	% Control	%	95.0
Not Active	23326193	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	96.0	CHEMBL2148	Homo sapiens	% Control	%	96.0
Not Active	23326661	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	64.0	CHEMBL2148	Homo sapiens	% Control	%	64.0
Not Active	23327361	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	79.0	CHEMBL2148	Homo sapiens	% Control	%	79.0
Not Active	23327829	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	93.0	CHEMBL2148	Homo sapiens	% Control	%	93.0
Not Active	23328416	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	90.0	CHEMBL2148	Homo sapiens	% Control	%	90.0
Not Active	23328884	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23329387	CHEMBL4881094	JAK3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	118.0	CHEMBL2148	Homo sapiens	% residual kinase activity	%	118.0
Not Active	23329830	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23330298	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23331054	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23331522	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23332109	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.3	CHEMBL2148	Homo sapiens	% Control	%	95.3
Not Active	23332575	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	96.9	CHEMBL2148	Homo sapiens	% Control	%	96.9
Not Active	23333293	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	70.5	CHEMBL2148	Homo sapiens	% Control	%	70.5
Not Active	23333932	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	94.0	CHEMBL2148	Homo sapiens	% Control	%	94.0
Not Active	23334400	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL2148	Homo sapiens	% Control	%	99.0
Not Active	23335379	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	92.0	CHEMBL2148	Homo sapiens	% Control	%	92.0
Not Active	23335847	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	94.0	CHEMBL2148	Homo sapiens	% Control	%	94.0
Not Active	23336474	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	69.0	CHEMBL2148	Homo sapiens	% Control	%	69.0
Not Active	23336942	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	96.0	CHEMBL2148	Homo sapiens	% Control	%	96.0
Not Active	23337631	CHEMBL4882002	JAK3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.5	CHEMBL2148	Homo sapiens	% Ctrl	%	96.5
Not Active	23338023	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	95.0	CHEMBL2148	Homo sapiens	% Control	%	95.0
Not Active	23338491	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	80.0	CHEMBL2148	Homo sapiens	% Control	%	80.0
Not Active	23339103	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	72.0	CHEMBL2148	Homo sapiens	% Control	%	72.0
Not Active	23339571	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	76.0	CHEMBL2148	Homo sapiens	% Control	%	76.0
Not Active	23340208	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	75.0	CHEMBL2148	Homo sapiens	% Control	%	75.0
Not Active	23340676	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23341333	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23341801	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23342417	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23342885	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	98.0	CHEMBL2148	Homo sapiens	% Control	%	98.0
Slightly Active	23343260	CHEMBL4882445	JAK3 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	44.0	CHEMBL2148	Homo sapiens	% Ctrl	%	44.0
Not Active	23343515	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	82.0	CHEMBL2148	Homo sapiens	% Control	%	82.0
Not Active	23343983	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	65.0	CHEMBL2148	Homo sapiens	% Control	%	65.0
Not Active	23344621	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23345194	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	88.0	CHEMBL2148	Homo sapiens	% Control	%	88.0
Not Active	23345662	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23346239	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	60.9	CHEMBL2148	Homo sapiens	% Control	%	60.9
Slightly Active	23346708	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	42.0	CHEMBL2148	Homo sapiens	% Control	%	42.0
Not Active	23347310	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	64.5	CHEMBL2148	Homo sapiens	% Control	%	64.5
Not Active	23347799	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23348378	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23348846	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23349433	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23350051	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23350519	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	88.0	CHEMBL2148	Homo sapiens	% Control	%	88.0
Not Active	23351124	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL2148	Homo sapiens	% Control	%	98.0
Not Active	23351592	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23352081	CHEMBL4882772	JAK3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.054	CHEMBL2148	Homo sapiens	% Inhibition	%	7.054
Active	23352616	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	0.0	CHEMBL2148	Homo sapiens	% Control	%	0.0
Active	23353084	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	12.0	CHEMBL2148	Homo sapiens	% Control	%	12.0
Not Active	23353966	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23354434	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23355166	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	93.0	CHEMBL2148	Homo sapiens	% Control	%	93.0
Not Active	23355634	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	98.0	CHEMBL2148	Homo sapiens	% Control	%	98.0
Not Active	23356270	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23356738	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23357347	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23357994	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23358462	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23359048	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	78.4	CHEMBL2148	Homo sapiens	% Control	%	78.4
Not Active	23359646	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	94.0	CHEMBL2148	Homo sapiens	% Control	%	94.0
Not Active	23360114	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23360699	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	81.0	CHEMBL2148	Homo sapiens	% Control	%	81.0
Not Active	23361167	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23361740	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	77.0	CHEMBL2148	Homo sapiens	% Control	%	77.0
Not Active	23362276	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23362744	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23364386	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	84.0	CHEMBL2148	Homo sapiens	% Control	%	84.0
Not Active	23364854	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	85.0	CHEMBL2148	Homo sapiens	% Control	%	85.0
Not Active	23365593	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	58.0	CHEMBL2148	Homo sapiens	% Control	%	58.0
Not Active	23366136	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23366726	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23367194	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23367608	CHEMBL4883961	JAK3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	103.0	CHEMBL2148	Homo sapiens	% Residual activity with Skepinone-L	%	103.0
Not Active	23368072	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	91.0	CHEMBL2148	Homo sapiens	% Control	%	91.0
Not Active	23368540	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23369139	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	83.0	CHEMBL2148	Homo sapiens	% Control	%	83.0
Not Active	23369607	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	71.0	CHEMBL2148	Homo sapiens	% Control	%	71.0
Not Active	23370109	CHEMBL4884353	JAK3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	93.0	CHEMBL2148	Homo sapiens	% residual kinase activity	%	93.0
Not Active	23370575	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	79.0	CHEMBL2148	Homo sapiens	% Control	%	79.0
Not Active	23371043	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	83.0	CHEMBL2148	Homo sapiens	% Control	%	83.0
Not Active	23371852	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	69.0	CHEMBL2148	Homo sapiens	% Control	%	69.0
Not Active	23372320	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
	23372771	CHEMBL4884736	JAK3(JAK3LGRG) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2148	Homo sapiens	pIC50		6.0
	23373180	CHEMBL4885027	JAK3(JAK3LGRG) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2148	Homo sapiens	pIC50		6.0
	23373541	CHEMBL4885318	JAK3(JAK3LGRG) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2148	Homo sapiens	pIC50		6.0
Not Active	23375011	CHEMBL4886002	JAK3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	28.0	CHEMBL2148	Homo sapiens	% Inhibition	%	28.0
Not Active	23375280	CHEMBL4886262	Janus kinase 3 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-13.0	CHEMBL2148	Homo sapiens	% inhibition	%	-13.0
Not Active	23375747	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL2148	Homo sapiens	% Control	%	96.0
Not Active	23376215	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23376792	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23377260	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23378120	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	73.0	CHEMBL2148	Homo sapiens	% Control	%	73.0
Not Active	23378588	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	91.0	CHEMBL2148	Homo sapiens	% Control	%	91.0
Not Active	23379755	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL2148	Homo sapiens	% Control	%	95.0
Not Active	23380223	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23380917	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23381565	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23382033	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2148	Homo sapiens	% Control	%	100.0
Not Active	23382408	CHEMBL4887126	JAK3 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	94.0	CHEMBL2148	Homo sapiens	% inhibition	%	94.0
	23382409	CHEMBL4887126	JAK3 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	IC50	nM	1000.0	CHEMBL2148	Homo sapiens	IC50	nM	1000.0
Active	23382657	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	8.2	CHEMBL2148	Homo sapiens	% Control	%	8.2
Active	23383125	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	1.9	CHEMBL2148	Homo sapiens	% Control	%	1.9
Not Active	23383832	CHEMBL4887461	JAK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL2148	Homo sapiens	% Ctrl	%	92.0
Not Active	23383833	CHEMBL4887461	JAK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL2148	Homo sapiens	% Ctrl	%	95.0
Not Active	23384317	CHEMBL4887912	JAK3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-14.21	CHEMBL2148	Homo sapiens	% inhibition	%	-14.21
Not Active	23384663	CHEMBL4888189	JAK3 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1	Outside typical range	CHEMBL4795065		Inhibition	%	-11.0	CHEMBL2148	Homo sapiens	% Inhibition	%	-11.0
Not Active	23385040	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	99.0	CHEMBL2148	Homo sapiens	% Control	%	99.0
Not Active	23385507	CHEMBL4879764	KinomeScan assay: inhibition of JAK3(JH1domain-catalytic)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL2148	Homo sapiens	% Control	%	98.0
Not Active	23385889	CHEMBL4888362	JAK3 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	2.0	CHEMBL2148	Homo sapiens	% inhibition	%	2.0
